PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	SAMET, JM; UTELL, MJ				SAMET, JM; UTELL, MJ			THE ENVIRONMENT AND THE LUNG - CHANGING PERSPECTIVES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NITROGEN-DIOXIDE; PULMONARY-FUNCTION; PASSIVE SMOKING; AIR-POLLUTION; CANCER; EXPOSURE; HEALTH; RADON; RISK; ADMISSIONS	The focus Of public health concern and research in regard to environmental lung diseases has changed across the century. Illustrative agents include radon, indoor asbestos, environmental tobacco smoke, acidic aerosols, and oxidant gases. Tremendous progress has been made in understanding and preventing environmental lung diseases. However, we remain concerned about adverse consequences of breathing polluted outdoor and indoor air. In the persistent concerns about adverse effects of polluted air on the lung, a new emphasis is pervasive; the focus has shifted from avoiding clinical disease among highly exposed individuals to protecting the population from an unacceptable burden of risk. The technique of quantitative risk assessment has become increasingly important for characterizing the safety of environmental agents. The resulting emphasis on the final risk projection and attendant uncertainties may overly emphasize gaps in our knowledge.	UNIV NEW MEXICO, DEPT MED, DIV PULM & CRIT CARE, ALBUQUERQUE, NM 87131 USA; UNIV ROCHESTER, SCH MED, DEPT MED, ROCHESTER, NY 14627 USA; UNIV ROCHESTER, SCH MED, DEPT ENVIRONM HLTH SCI, ROCHESTER, NY 14627 USA; UNIV ROCHESTER, MED CTR, PULM & CRIT CARE UNIT, ROCHESTER, NY 14642 USA; UNIV ROCHESTER, MED CTR, OCCUPAT MED PROGRAM, ROCHESTER, NY 14642 USA	University of New Mexico; University of Rochester; University of Rochester; University of Rochester; University of Rochester	SAMET, JM (corresponding author), UNIV NEW MEXICO, MED CTR, CTR CANC, NEW MEXICO TUMOR REGISTRY, 900 CAMINO SALUD NE, ALBUQUERQUE, NM 87131 USA.				NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002679] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES02679] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABELSON PH, 1990, SCIENCE         1019, P250; AMES BN, 1987, SCIENCE, V236, P271, DOI 10.1126/science.3563506; [Anonymous], 1986, ENV TOBACCO SMOKE ME; BATES DV, 1987, ENVIRON RES, V43, P317, DOI 10.1016/S0013-9351(87)80032-4; BAUER MA, 1986, AM REV RESPIR DIS, V134, P1203; CAMERON P, 1969, J ALLERGY, V43, P336, DOI 10.1016/0021-8707(69)90078-1; CORN M, 1991, REGUL TOXICOL PHARM, V13, P99, DOI 10.1016/0273-2300(91)90044-V; FRAMPTON MW, 1989, ENVIRON RES, V48, P179, DOI 10.1016/S0013-9351(89)80033-7; GRAHAM JD, 1988, SEARCH SAFETY CHEM C; HARLAP S, 1974, LANCET, V1, P529; Harting F., 1879, VIERTELJ GERICHTL ME, V31, P102; Harting FH, 1879, VJSCHR GERICHTL MED, V31, P313; HIRAYAMA T, 1981, BRIT MED J, V282, P183, DOI 10.1136/bmj.282.6259.183; KOENIG JQ, 1989, ENVIRON HEALTH PERSP, V79, P173, DOI 10.2307/3430546; LAVE LB, 1985, RISK QUANTITATION RE, P3; LEE PN, 1988, MISCLASSIFICATION SM; LIPFERT FW, 1989, ENVIRON SCI TECHNOL, V23, P1316, DOI 10.1021/es00069a001; LIPPMANN M, 1989, JAPCA J AIR WASTE MA, V39, P672, DOI 10.1080/08940630.1989.10466554; LOGAN WPD, 1953, LANCET, V264, P336; Lowrance W., 1976, ACCEPTABLE RISK SCI; LUBIN JH, 1989, HEALTH PHYS, V57, P417, DOI 10.1097/00004032-198909000-00008; LUBIN JH, 1990, HEALTH PHYS, V59, P807, DOI 10.1097/00004032-199012000-00004; LUBIN JH, 1988, YALE J BIOL MED, V61, P195; MAZUMDAR S, 1982, ARCH ENVIRON HEALTH, V37, P213, DOI 10.1080/00039896.1982.10667567; MORGAN MV, 1986, HEALTH PHYS, V50, P656; MORROW PE, 1984, J TOXICOL ENV HEALTH, V13, P205, DOI 10.1080/15287398409530494; MOSSMAN BT, 1990, SCIENCE, V247, P294, DOI 10.1126/science.2153315; MURRAY R, 1990, BRIT J IND MED, V47, P361; NERO AV, 1988, RADON ITS DECAY PROD, P1; PUSKIN JS, 1989, JAPCA J AIR WASTE MA, V39, P915, DOI 10.1080/08940630.1989.10466577; REPACE JL, 1990, RISK ANAL, V10, P27, DOI 10.1111/j.1539-6924.1990.tb01017.x; RYLANDER R, 1990, NEW ENGL J MED, V323, P834; SAMET JM, 1989, J NATL CANCER I, V81, P745, DOI 10.1007/s00484-020-01860-w; SAMET JM, 1991, HEALTH PHYS, V60, P223, DOI 10.1097/00004032-199102000-00010; SAMET JM, 1990, TOXICOL IND HEALTH, V6, P247, DOI 10.1177/074823379000600204; SAMET JM, IN PRESS ARCH ENV HL; SELIKOFF IJ, 1991, JAMA-J AM MED ASSOC, V265, P898, DOI 10.1001/jama.265.7.898; SHEPPARD D, 1980, AM REV RESPIR DIS, V122, P873; SHRENK HH, 1909, PUBLIC HLTH B, V306; SPENGLER JD, 1990, ENVIRON SCI TECHNOL, V24, P946, DOI 10.1021/es00077a002; SPENGLER JD, 1983, ENVIRON SCI TECHNOL, V17, P164, DOI 10.1021/es00109a008; TAGER IB, 1979, AM J EPIDEMIOL, V110, P15, DOI 10.1093/oxfordjournals.aje.a112783; THURSTON GD, 1989, ENVIRON HEALTH PERSP, V79, P73, DOI 10.2307/3430532; TRICHOPOULOS D, 1981, INT J CANCER, V27, P1, DOI 10.1002/ijc.2910270102; UTELL MJ, 1990, MED CLIN N AM, V74, P291, DOI 10.1016/S0025-7125(16)30563-6; WARE JH, 1986, AM REV RESPIR DIS, V133, P834; WU AH, 1990, RISK ANAL, V10, P39; 1976, NITROGEN OXIDES; 1989, IMPROVING RISK COMMU; 1988, HLTH RISKS RADON OTH; 1983, REPORT CHRONIC HAZAR; 1991, COMP DOSIMETRY RADON; 1989, DHHS CDC898411 US DE; 1986, DHHS CDC878398 US DE; 1983, RISK ASSESSMENT FEDE; 1964, DHEW PHS1103 US DEP; 1984, ASBESTIFORM FIBERS N; 1986, IARC MONOGRAPHS EVAL, P38	58	26	26	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	1991	266	5					670	675		10.1001/jama.266.5.670	http://dx.doi.org/10.1001/jama.266.5.670			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ140	2072477				2022-12-28	WOS:A1991FZ14000025
J	ANNAS, GJ				ANNAS, GJ			RESTRICTING DOCTOR-PATIENT CONVERSATIONS IN FEDERALLY FUNDED CLINICS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		ANNAS GJ, 1990, JAMA-J AM MED ASSOC, V263, P858, DOI 10.1001/jama.263.6.858; BURTON T, 1991, WALL STREET J   0626, pB3; ENTRALGO PL, 1969, DOCTOR PATIENT, P30; 1988, FED REGISTER, V53, P2921	4	10	10	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 1	1991	325	5					362	364		10.1056/NEJM199108013250519	http://dx.doi.org/10.1056/NEJM199108013250519			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY715	2057044	Green Published			2022-12-28	WOS:A1991FY71500027
J	CRAGG, DR; FRIEDMAN, HZ; BONEMA, JD; JAIYESIMI, IA; RAMOS, RG; TIMMIS, GC; ONEILL, WW; SCHREIBER, TL				CRAGG, DR; FRIEDMAN, HZ; BONEMA, JD; JAIYESIMI, IA; RAMOS, RG; TIMMIS, GC; ONEILL, WW; SCHREIBER, TL			OUTCOME OF PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION WHO ARE INELIGIBLE FOR THROMBOLYTIC THERAPY	ANNALS OF INTERNAL MEDICINE			English	Article							TISSUE PLASMINOGEN-ACTIVATOR; INTRACORONARY STREPTOKINASE; TRIAL; ANGIOPLASTY; HEMORRHAGE	Objective: To determine what proportion of patients with acute myocardial infarction are not eligible for thrombolytic therapy and to assess their natural history. Design: Retrospective chart review. Setting: A large community-based hospital. Patients: All patients with acute myocardial infarction hospitalized during a 27-month period. Measurements: Of 1471 patients with acute myocardial infarction, 230 (16%) received thrombolytic therapy according to the protocol and an additional 97 (7%) received nonprotocol thrombolytic therapy, primary coronary balloon angioplasty, or both because of contraindications. The other 1144 patients (78%) did not receive reperfusion therapy. Main Results: The patients who did not receive thrombolytic therapy were older, more likely to be women, and more likely to have a history of hypertension, previous myocardial infarction, or chronic angina (all comparisons, P < 0.002). An average of 1.9 reasons for exclusion were identified per patient among the ineligible patients. Mortality was fivefold higher among ineligible patients (19%; Cl, 16% to 21%) than among protocol-treated patients (4%; Cl, 1 % to 6%) (P < 0.001). In-hospital mortality rates for excluded patients were 28% (Cl, 23% to 32%) in elderly patients (age, > 76 years; n = 396); 29% (Cl, 23% to 35%) in patients with stroke or bleeding risk (n = 209); 17% (Cl, 14% to 20%) in patients with delayed presentation (> 4 hours after the onset of chest pain; [n = 599]); 14% (Cl, 11% to 16%) in patients with an ineligible electrocardiogram (ECG) (n = 673); and 26% (Cl, 21 % to 32%) in patients with a miscellaneous reason for exclusion (n = 243). Independent predictors of increased mortality were: age greater than 76 years, stroke or other bleeding risk, ineligible ECG, or the presence of two or more exclusion criteria. Conclusions: Thrombolytic therapy is currently used in the United States for only a minority of patients with acute myocardial infarction: those who have low-risk prognostic characteristics.			CRAGG, DR (corresponding author), WILLIAM BEAUMONT HOSP, DIV CARDIOL, 3601 W 13 MILE RD, ROYAL OAK, MI 48073 USA.							[Anonymous], 1990, LANCET, V336, P65; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; [Anonymous], 1989, NEW ENGL J MED, V320, P618; CHAITMAN BR, 1989, J AM COLL CARDIOL, V14, P1159, DOI 10.1016/0735-1097(89)90410-5; CHAMBERLAIN DA, 1988, LANCET, V1, P545; DOOREY AJ, 1987, J AM COLL CARDIOL, V10, P1357, DOI 10.1016/S0735-1097(87)80141-9; GRINES CL, 1990, J AM COLL CARDIOL, V16, P223, DOI 10.1016/0735-1097(90)90482-5; GRINES CL, 1990, AM J CARDIOL, V65, P1292, DOI 10.1016/0002-9149(90)91315-W; HLATKY MA, 1988, AM J CARDIOL, V61, P510, DOI 10.1016/0002-9149(88)90755-2; JAGGER JD, 1987, LANCET, V1, P34; KENNEDY JW, 1985, AM J CARDIOL, V55, P871, DOI 10.1016/0002-9149(85)90709-X; LEE TH, 1989, ANN INTERN MED, V110, P957, DOI 10.7326/0003-4819-110-12-957; LEW AS, 1987, AM J CARDIOL, V59, P1, DOI 10.1016/S0002-9149(87)80059-0; MULLER DWM, 1990, ANN INTERN MED, V113, P949, DOI 10.7326/0003-4819-113-12-949; MURRAY N, 1987, BRIT HEART J, V57, P144; ONEILL W, 1986, NEW ENGL J MED, V314, P812, DOI 10.1056/NEJM198603273141303; ONEILL WW, 1988, PROG CARDIOVASC DIS, V30, P235, DOI 10.1016/0033-0620(88)90018-7; SCHRODER R, 1986, NEW ENGL J MED, V314, P1465; SIMOONS ML, 1988, LANCET, V1, P199; TIMMIS GC, 1984, CIRCULATION, V69, P1146, DOI 10.1161/01.CIR.69.6.1146; TIMMIS GC, 1985, ARCH INTERN MED, V145, P2188, DOI 10.1001/archinte.145.12.2188; TIMMIS GC, 1982, AM HEART J, V104, P925, DOI 10.1016/0002-8703(82)90266-6; TIMMIS GC, 1986, ARCH INTERN MED, V146, P667, DOI 10.1001/archinte.146.4.667; TOPOL EJ, 1987, NEW ENGL J MED, V317, P581, DOI 10.1056/NEJM198709033171001; WILCOX RG, 1988, LANCET, V2, P525	26	177	178	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	1991	115	3					173	177		10.7326/0003-4819-115-3-173	http://dx.doi.org/10.7326/0003-4819-115-3-173			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY152	2058871				2022-12-28	WOS:A1991FY15200002
J	STEINGART, RM; PACKER, M; HAMM, P; COGLIANESE, ME; GERSH, B; GELTMAN, EM; SOLLANO, J; KATZ, S; MOYE, L; BASTA, LL; LEWIS, SJ; GOTTLIEB, SS; BERNSTEIN, V; MCEWAN, P; JACOBSON, K; BROWN, EJ; KUKIN, ML; KANTROWITZ, NE; PFEFFER, MA				STEINGART, RM; PACKER, M; HAMM, P; COGLIANESE, ME; GERSH, B; GELTMAN, EM; SOLLANO, J; KATZ, S; MOYE, L; BASTA, LL; LEWIS, SJ; GOTTLIEB, SS; BERNSTEIN, V; MCEWAN, P; JACOBSON, K; BROWN, EJ; KUKIN, ML; KANTROWITZ, NE; PFEFFER, MA			SEX-DIFFERENCES IN THE MANAGEMENT OF CORONARY-ARTERY DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BYPASS-SURGERY; OPERATIVE MORTALITY; WOMEN; CASS; SURVIVAL; HISTORY; ANGINA; BIAS	Background. Despite the fact that coronary artery disease is the leading cause of death among women, previous studies have suggested that physicians are less likely to pursue an aggressive approach to coronary artery disease in women than in men. To define this issue further, we compared the care previously received by men and women who were enrolled in a large postinfarction intervention trial. Methods. We assessed the nature and severity of anginal symptoms and the use of antianginal and anti-ischemic interventions before enrollment in the 1842 men and 389 women with left ventricular ejection fractions less-than-or-equal-to 40 percent after an acute myocardial infarction who were randomized in the Survival and Ventricular Enlargement trial. Results. Before their index infarction, women were as likely as men to have had angina and to have been treated with antianginal drugs. However, despite reports by women of symptoms consistent with greater functional disability from angina, fewer women had undergone cardiac catheterization (15.4 percent of women vs. 27.3 percent of men, P < 0.001) or coronary bypass surgery (5.9 percent of women vs. 12.7 percent of men, P < 0.001). When these differences were adjusted for important covariates, men were still twice as likely to undergo an invasive cardiac procedure as women, but bypass surgery was performed with equal frequency among the men and women who did undergo cardiac catheterization. Conclusions. Physicians pursue a less aggressive management approach to coronary disease in women than in men, despite greater cardiac disability in women.	UNIV TEXAS, HLTH SCI CTR, HOUSTON, TX 77225 USA; CUNY MT SINAI SCH MED, NEW YORK, NY 10029 USA; MAYO CLIN & MAYO FDN, ROCHESTER, MN 55905 USA; WASHINGTON UNIV, SCH MED, ST LOUIS, MO 63110 USA; TULSA HEART CTR, TULSA, OK USA; UNIV MARYLAND, BALTIMORE, MD 21201 USA; UNIV BRITISH COLUMBIA, VANCOUVER V6T 1W5, BC, CANADA; WELLESLEY COLL HOSP, TORONTO M4Y 1J3, ONTARIO, CANADA; OREGON HEART INST, PORTLAND, OR USA; SACRED HEART HOSP, EUGENE, OR USA; SUNY STONY BROOK, STONY BROOK, NY 11794 USA; BRIGHAM & WOMENS HOSP, BOSTON, MA 02115 USA	University of Texas System; University of Texas Health Science Center Houston; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Mayo Clinic; Washington University (WUSTL); University System of Maryland; University of Maryland Baltimore; University of British Columbia; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Brigham & Women's Hospital	STEINGART, RM (corresponding author), WINTHROP UNIV HOSP, 259 1ST ST, MINEOLA, NY 11501 USA.		Arnold, Malcolm/G-2869-2011					Eaker E D, 1989, Cardiovasc Clin, V19, P129; FISHER LD, 1982, J THORAC CARDIOV SUR, V84, P334; GOLDMAN L, 1982, J CHRON DIS, V35, P763, DOI 10.1016/0021-9681(82)90087-X; GRIECO A, 1984, HEALTH PSYCHOL, V3, P129, DOI 10.1037/0278-6133.3.2.129; HILTS PJ, 1990, NY TIMES        0911, pC9; HUNG J, 1984, J AM COLL CARDIOL, V4, P8, DOI 10.1016/S0735-1097(84)80312-5; KANNEL WB, 1972, AM J CARDIOL, V29, P154, DOI 10.1016/0002-9149(72)90624-8; KANNEL WB, 1987, CORONARY HEART DISEA, P208; KENNEDY JW, 1981, CIRCULATION, V63, P793, DOI 10.1161/01.CIR.63.4.793; KHAN SS, 1990, ANN INTERN MED, V112, P561, DOI 10.7326/0003-4819-112-8-561; LOOP FD, 1983, J AM COLL CARDIOL, V1, P383, DOI 10.1016/S0735-1097(83)80064-3; MELLER J, 1979, AM J CARDIOL, V43, P717, DOI 10.1016/0002-9149(79)90069-9; Penckofer S M, 1990, Cardiovasc Nurs, V26, P13; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; SKETCH MH, 1975, AM J CARDIOL, V36, P169, DOI 10.1016/0002-9149(75)90521-4; STEINGART RM, 1990, HEART, P351; TOBIN JN, 1987, ANN INTERN MED, V107, P19, DOI 10.7326/0003-4819-107-1-19; WALKER SH, 1967, BIOMETRIKA, V54, P167, DOI 10.2307/2333860; WEINER DA, 1979, NEW ENGL J MED, V301, P230, DOI 10.1056/NEJM197908023010502; WEINER DA, 1986, J AM COLL CARDIOL, V8, P741, DOI 10.1016/S0735-1097(86)80412-0; WENGER NK, 1990, ANN INTERN MED, V112, P557, DOI 10.7326/0003-4819-112-8-557; 1964, NONMENCLATURE CRITER	22	751	758	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	1991	325	4					226	230		10.1056/NEJM199107253250402	http://dx.doi.org/10.1056/NEJM199107253250402			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX627	2057023				2022-12-28	WOS:A1991FX62700002
J	SHIMM, DS; SPECE, RG				SHIMM, DS; SPECE, RG			INDUSTRY REIMBURSEMENT FOR ENTERING PATIENTS INTO CLINICAL-TRIALS - LEGAL AND ETHICAL ISSUES	ANNALS OF INTERNAL MEDICINE			English	Article								Pharmaceutical manufacturers commonly contract with clinical investigators for pre-market testing of new products. The per-patient reimbursement offered to the investigator generally exceeds the per-patient costs incurred by the investigator. This excess represents a windfall that can be used to pay for travel, equipment, or supplies, or to fund research for which the investigator cannot obtain funding through peer-reviewed granting channels. This excess raises a potential conflict of interest, because it may lead the investigator to propose experimental treatment for a patient when the patient might be better served by conventional treatment or by no treatment at all. Not only does this situation pose a conflict of interest, it also is a conflict of which few patients are aware and fewer are informed. We propose that all experimental subjects be informed of the source, amount, and mechanism of funding for the experimental treatments they undergo. Further, we propose that payments from pharmaceutical manufacturers for pre-market testing of drugs go to the medical school dean rather than to the individual investigator. With this money, the dean can defray the direct as well as the indirect costs of the clinical study; the remainder, which would otherwise go directly to the investigator, should be placed in a funding pool for which the entire medical school could compete. This solution largely eliminates conflict of interest, addresses informed consent, and reasonably balances the interests of the experimental subject, the clinical investigator, the pharmaceutical manufacturer, and the academic institution.	UNIV ARIZONA, COLL LAW, TUCSON, AZ 85721 USA	University of Arizona	SHIMM, DS (corresponding author), UNIV ARIZONA, COLL MED, DEPT RADIAT ONCOL, 1501 N CAMPBELL AVE, TUCSON, AZ 85724 USA.				NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NCI NIH HHS [CA-23074] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; CARTER SK, 1977, CANCER-AM CANCER SOC, V40, P544, DOI 10.1002/1097-0142(197707)40:1+<544::AID-CNCR2820400721>3.0.CO;2-#; CONRADS B, 1990, DATAMATION, V36, P12; DAVIDSON RA, 1986, J GEN INTERN MED, V1, P155, DOI 10.1007/BF02602327; GREENBERG DS, 1990, LANCET, V336, P1568, DOI 10.1016/0140-6736(90)93329-N; HATHAWAY DR, 1988, CLIN RES, V36, P475; MARSHALL E, 1990, SCIENCE, V248, P152, DOI 10.1126/science.2326628; MARSHALL E, 1990, SCIENCE, V248, P154; MCKINNEY WP, 1990, JAMA-J AM MED ASSOC, V264, P1693, DOI 10.1001/jama.264.13.1693; MERVIS J, 1990, SCIENTIST, V4, P20; MERZ B, 1990, AM MED NEWS     0720, P3; MEYER H, 1990, AM MED NEWS     0112, P1; PALCA J, 1990, SCIENCE, V247, P154, DOI 10.1126/science.2294600; STOTO MA, 1988, REV INFECT DIS, V10, P406; WATSON JD, 1990, SCIENCE, V248, P44, DOI 10.1126/science.2181665; WHITE LJ, 1990, ANN INTERN MED, V112, P624, DOI 10.7326/0003-4819-112-8-624; 1990, CLIN RES, V38, P239; 1985, CANCER TREAT REP, V69, P1223	18	39	39	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	1991	115	2					148	151		10.7326/0003-4819-115-2-148	http://dx.doi.org/10.7326/0003-4819-115-2-148			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW091	2058862				2022-12-28	WOS:A1991FW09100011
J	DEANGELIS, GC; OHZAWA, I; FREEMAN, RD				DEANGELIS, GC; OHZAWA, I; FREEMAN, RD			DEPTH IS ENCODED IN THE VISUAL-CORTEX BY A SPECIALIZED RECEPTIVE-FIELD STRUCTURE	NATURE			English	Article							CAT STRIATE CORTEX; SPATIAL-FREQUENCY; LOCAL STEREOPSIS; BINOCULAR INTERACTION; SIMPLE CELLS; VISION; MODEL; DISCRIMINATION; ORGANIZATION; SELECTIVITY	BINOCULAR neurons in the visual cortex are thought to perform the first stage of processing for the fine stereoscopic depth discrimination exhibited by animals with frontally located eyes. Because lateral separation of the eyes gives a slightly different view to each eye, there are small variations in position (disparities), mainly along the horizontal dimension, between corresponding features in the two retinal images. The visual system uses these disparities to gauge depth. We studied neurons in the cat's visual cortex to determine whether the visual system uses the anisotropy in the range of horizontal and vertical disparities. We report here that there is a corresponding anisotropy in the cortical representation of binocular information: receptive-field profiles for left and right eyes are matched for cells that are tuned to horizontal orientations of image contours. For neurons tuned to vertical orientations, left and right receptive fields are predominantly dissimilar. Therefore, a major modification is required of the conventional notion of disparity processing. The modified scheme allows a unified encoding of monocular form and binocular disparity information.	UNIV CALIF BERKELEY,SCH OPT,BIOENGN GRP,BERKELEY,CA 94720; UNIV CALIF BERKELEY,SCH OPT,NEUROBIOL GRP,BERKELEY,CA 94720	University of California System; University of California Berkeley; University of California System; University of California Berkeley				Ohzawa, Izumi/0000-0002-7123-7318; DeAngelis, Gregory/0000-0002-1635-1273				BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; FERSTER D, 1981, J PHYSIOL-LONDON, V311, P623, DOI 10.1113/jphysiol.1981.sp013608; FREEMAN RD, 1990, VISION RES, V30, P1661, DOI 10.1016/0042-6989(90)90151-A; FREEMAN RD, 1982, EXP BRAIN RES, V48, P296; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1973, J PHYSL, V232, P29; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; JOSHUA DE, 1970, EXP BRAIN RES, V10, P389, DOI 10.1007/BF02324766; LEVAY S, 1988, VISUAL NEUROSCI, V1, P395, DOI 10.1017/S0952523800004168; MARCELJA S, 1980, J OPT SOC AM, V70, P1297, DOI 10.1364/JOSA.70.001297; MARR D, 1979, PROC R SOC SER B-BIO, V204, P301, DOI 10.1098/rspb.1979.0029; MASKE R, 1984, VISION RES, V24, P1921, DOI 10.1016/0042-6989(84)90026-9; NOMURA M, 1990, BIOL CYBERN, V63, P237, DOI 10.1007/BF00195863; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P221, DOI 10.1152/jn.1986.56.1.221; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; POGGIO GF, 1988, J NEUROSCI, V8, P4531; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; SAKITT B, 1982, BIOL CYBERN, V43, P97, DOI 10.1007/BF00336972; SCHOR CM, 1984, VISION RES, V24, P573, DOI 10.1016/0042-6989(84)90111-1; SCHOR CM, 1983, VISION RES, V23, P1649, DOI 10.1016/0042-6989(83)90179-7; von der Heydt R, 1978, Exp Brain Res, V31, P523	25	210	211	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 11	1991	352	6331					156	159		10.1038/352156a0	http://dx.doi.org/10.1038/352156a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW097	2067576				2022-12-28	WOS:A1991FW09700057
J	DENNY, FW				DENNY, FW			THE STREPTOCOCCUS SAGA CONTINUES	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RHEUMATIC-FEVER				DENNY, FW (corresponding author), UNIV N CAROLINA,CHAPEL HILL,NC 27599, USA.							GLEZEN WP, 1967, J AMER MED ASSOC, V202, P455, DOI 10.1001/jama.202.6.455; GORDIS L, 1973, NEW ENGL J MED, V289, P331, DOI 10.1056/NEJM197308162890701; GRAY GC, 1991, NEW ENGL J MED, V325, P92, DOI 10.1056/NEJM199107113250204; KAPLAN EL, 1989, J PEDIATR-US, V115, P146, DOI 10.1016/S0022-3476(89)80352-X; KAPLAN EL, 1989, J INFECT DIS, V159, P101, DOI 10.1093/infdis/159.1.101; Kaplan EL, 1984, MANAGEMENT PHARYNGIT, P92; KRAUSE RM, 1962, J CLIN INVEST, V41, P568, DOI 10.1172/JCI104510; Rammelkamp C.H., 1952, RHEUMATIC FEVER, P72; SHERWOOD RW, 1957, JAMA-J AM MED ASSOC, V165, P667, DOI 10.1001/jama.1957.02980240025007; Wannamaker L., 1954, STREPTOCOCCAL INFECT, P157	10	2	2	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	1991	325	2					127	128		10.1056/NEJM199107113250211	http://dx.doi.org/10.1056/NEJM199107113250211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV522	2052048				2022-12-28	WOS:A1991FV52200011
J	POLLER, L				POLLER, L			THE EFFECT OF LOW-DOSE WARFARIN ON THE RISK OF STROKE IN PATIENTS WITH NONRHEUMATIC ATRIAL-FIBRILLATION	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							DIFFERENT INTENSITIES; TRIAL				POLLER, L (corresponding author), WITHINGTON HOSP,MANCHESTER M20 8LR,LANCS,ENGLAND.							HIRSH J, 1989, CHEST, V95, pS5, DOI 10.1378/chest.95.2.5S; HULL R, 1982, NEW ENGL J MED, V307, P1676, DOI 10.1056/NEJM198212303072704; LOELIGER EA, 1985, THROMB HAEMOSTASIS, V54, P515; PETERSEN P, 1989, LANCET, V1, P175; POLLER L, 1982, BRIT J HAEMATOL, V51, P479, DOI 10.1111/j.1365-2141.1982.tb02805.x; SAOUR JN, 1990, NEW ENGL J MED, V322, P428, DOI 10.1056/NEJM199002153220703; 1990, J CLIN PATHOL, V43, P177; 1990, NEW ENGL J MED, V323, P1505	8	11	11	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	1991	325	2					129	130						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV522	2052049				2022-12-28	WOS:A1991FV52200012
J	WALDMANN, TA				WALDMANN, TA			MONOCLONAL-ANTIBODIES IN DIAGNOSIS AND THERAPY	SCIENCE			English	Article								Monoclonal antibodies have been applied clinically to the diagnosis and therapy of an array of human disorders, including cancer and infectious diseases, and have been used for the modulation of immune responses. Effective therapy using unmodified monoclonal antibodies has, however, been elusive. Recently, monoclonal antibody-mediated therapy has been revolutionized by advances such as the definition of cell-surface structures on abnormal cells as targets for effective monoclonal antibody action, genetic engineering to create less immunogenic and more effective monoclonal antibodies, and the arming of such antibodies with toxins or radionuclides to enhance their effector function.			WALDMANN, TA (corresponding author), NCI, METAB BRANCH, BETHESDA, MD 20892 USA.		Waldmann, Thomas/AAT-5972-2021	Waldmann, Thomas/0000-0003-4500-6660				ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; BAGSHAWE KD, 1989, BRIT J CANCER, V60, P275, DOI 10.1038/bjc.1989.270; BENJAMIN RJ, 1988, EUR J IMMUNOL, V18, P1079, DOI 10.1002/eji.1830180717; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; BLAKEY DC, 1988, PROG ALLERGY, V45, P50; BORREBAECK CAK, 1990, THERAPEUTIC MONOCLON, P1; BROWN PS, 1991, P NATL ACAD SCI USA, V88, P2663, DOI 10.1073/pnas.88.7.2663; BRUGGEMANN M, 1982, EMBO J, V1, P629, DOI 10.1002/j.1460-2075.1982.tb01219.x; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; BYERS VS, 1990, BLOOD, V75, P1426; CATANE R, 1988, J MED SCI, V24, P471; CHATENOUD L, 1989, CURR OPIN IMMUNOL, V2, P246, DOI 10.1016/0952-7915(89)90195-7; CHAUDHARY VK, 1989, NATURE, V339, P394, DOI 10.1038/339394a0; COOPER MM, 1990, TRANSPLANTATION, V50, P760, DOI 10.1097/00007890-199011000-00005; Croonian lecture, 1900, P R SOC LOND, V66, P424, DOI [DOI 10.1098/RSPL.1899.0121, 10.1098/rspl.1899.0121]; DILLMAN RO, 1989, ANN INTERN MED, V111, P592, DOI 10.7326/0003-4819-111-7-592; FISCHER A, 1986, LANCET, V2, P1058; FITZGERALD DJP, 1984, J CLIN INVEST, V74, P966, DOI 10.1172/JCI111516; GARRIDO MA, 1990, CANCER RES, V50, P4227; GILLILAND LK, 1988, P NATL ACAD SCI USA, V85, P7719, DOI 10.1073/pnas.85.20.7719; GOLDENBERG DM, 1989, SEMIN NUCL MED, V19, P332, DOI 10.1016/S0001-2998(89)80025-X; GOLDENBERG DM, 1991, J NATL CANCER I, V83, P78, DOI 10.1093/jnci/83.2.78; GOLDSTEIN G, 1985, NEW ENGL J MED, V313, P337; GOULD BJ, 1989, J NATL CANCER I, V81, P775, DOI 10.1093/jnci/81.10.775; HABER E, 1989, SCIENCE, V243, P51, DOI 10.1126/science.2492113; HALE G, 1988, LANCET, V2, P1394; HALL BM, 1989, AM J KIDNEY DIS, V14, P71; HERZOG C, 1987, LANCET, V2, P1461; HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; HWANG J, 1987, CELL, V48, P129, DOI 10.1016/0092-8674(87)90363-1; JANSON CH, 1989, CANCER IMMUNOL IMMUN, V28, P225; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; JUNGHANS RP, 1990, CANCER RES, V50, P1495; KAUFMAN DS, 1988, TRANSPLANTATION, V46, P210, DOI 10.1097/00007890-198808000-00005; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KOZAK R, 1986, P NATL ACAD SCI USA, V83, P182; KOZAK RW, 1986, TRENDS BIOTECHNOL, V4, P259, DOI 10.1016/0167-7799(86)90189-7; KOZAK RW, 1989, CANCER RES, V49, P2639; LOBUGLIO AF, 1989, P NATL ACAD SCI USA, V86, P4220, DOI 10.1073/pnas.86.11.4220; MAGE RG, 1988, NATURE, V333, P807, DOI 10.1038/333807c0; MAYFORTH RD, 1990, NEW ENGL J MED, V323, P173; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; MEEKER TC, 1985, BLOOD, V65, P1349, DOI 10.1182/blood.V65.6.1349.bloodjournal6561349; MILLER RA, 1982, NEW ENGL J MED, V306, P517, DOI 10.1056/NEJM198203043060906; MOOLTEN FL, 1970, SCIENCE, V169, P68, DOI 10.1126/science.169.3940.68; MORRISON SL, 1989, ADV IMMUNOL, V44, P65, DOI 10.1016/S0065-2776(08)60640-9; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; MUELLER BM, 1990, P NATL ACAD SCI USA, V87, P5702, DOI 10.1073/pnas.87.15.5702; MULLINAX RL, 1990, P NATL ACAD SCI USA, V87, P8095, DOI 10.1073/pnas.87.20.8095; NADLER L, 1990, 2ND P INT S IMM, P58; NEUBERGER MS, 1983, EMBO J, V2, P1373, DOI 10.1002/j.1460-2075.1983.tb01594.x; OI VT, 1983, P NATL ACAD SCI-BIOL, V80, P825, DOI 10.1073/pnas.80.3.825; ORDER SE, 1985, J CLIN ONCOL, V3, P1573, DOI 10.1200/JCO.1985.3.12.1573; ORDER SE, 1987, NATL CANCER I MONOGR, V3, P37; PASTAN I, 1986, CELL, V47, P641, DOI 10.1016/0092-8674(86)90506-4; PIROFSKI L, 1990, J CLIN IMMUNOL, V10, pS5, DOI 10.1007/BF00918686; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; RUDIKOFF S, 1982, P NATL ACAD SCI-BIOL, V79, P1979, DOI 10.1073/pnas.79.6.1979; SCHLITT HJ, 1988, TRANSPLANT P, V20, P103; SCHLOM J, IN PRESS MOL F ONCOL; SENTER PD, 1990, FASEB J, V4, P188, DOI 10.1096/fasebj.4.2.2404820; SIMPSON PJ, 1988, J CLIN INVEST, V81, P624, DOI 10.1172/JCI113364; SONGSIVILAI S, 1990, CLIN EXP IMMUNOL, V79, P315; STAERZ UD, 1985, NATURE, V314, P628, DOI 10.1038/314628a0; STEPLEWSKI Z, 1988, P NATL ACAD SCI USA, V85, P4852, DOI 10.1073/pnas.85.13.4852; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; VEDDER NB, 1988, J CLIN INVEST, V81, P939, DOI 10.1172/JCI113407; VITETTA ES, 1987, SCIENCE, V238, P1098, DOI 10.1126/science.3317828; VITETTA ES, BIOL THERAPY CANCER; WALDMANN H, 1989, ANNU REV IMMUNOL, V7, P407, DOI 10.1146/annurev.iy.07.040189.002203; WALDMANN H, 1988, MONOCLONAL ANTIBODY, P1; WALDMANN TA, 1986, SCIENCE, V232, P727, DOI 10.1126/science.3008337; WALDMANN TA, 1991, J BIOL CHEM, V266, P2681; WALDMANN TA, 1969, PROG ALLERGY, V13, P1, DOI 10.1159/000287491; WALDMANN TA, 1989, JNCI-J NATL CANCER I, V81, P914, DOI 10.1093/jnci/81.12.914; WALDMANN TA, 1988, BLOOD, V72, P1805; WAWRZYNCZAK EJ, 1990, CLIN EXP IMMUNOL, V82, P189; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; WOFSY D, 1988, PROG ALLERGY, V45, P106; YASMEEN D, 1976, J IMMUNOL, V116, P518; ZIEGLER EJ, 1991, NEW ENGL J MED, V324, P429, DOI 10.1056/NEJM199102143240701	83	312	727	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	1991	252	5013					1657	1662		10.1126/science.2047874	http://dx.doi.org/10.1126/science.2047874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT114	2047874				2022-12-28	WOS:A1991FT11400036
J	BELL, D; LAYTON, AJ; GABBAY, J				BELL, D; LAYTON, AJ; GABBAY, J			USE OF A GUIDELINE BASED QUESTIONNAIRE TO AUDIT HOSPITAL-CARE OF ACUTE ASTHMA	BRITISH MEDICAL JOURNAL			English	Article							MANAGEMENT	Objectives - To design an audit questionnaire and pilot its use by an audit assistant to monitor inpatient management of acute asthma and to compare the care given by chest physicians and general physicians. Design - Retrospective review by a chest physician and audit assistant of a random sample of 76 case records of patients by a criterion based questionnaire developed from hospital guidelines on management of acute asthma. Setting - One district general hospital. Patients - 76 adult patients with acute asthma: 38 admitted with a relevant primary diagnosis between April 1988 and March 1989 and a further 38 admitted through the accident and emergency department between April 1989 and March 1990. Main outcome measures - Conformity with recognised standards for assessment and management of acute asthma before and after the audit and by chest physicians and general physicians. Results - Age and sex did not differ significantly between the different groups of patients. Overall, deviations from the guidelines occurred in recording measures of severity of asthma, emergency treatment with beta-2 agonists (60/76, 79%) and steroids (43/76, 57%), and prescription of antibiotics in accordance with at least one criterion of the guidelines (29/45, 64%). Chest physicians were more rigorous than general physicians in recording severity measures, especially serum potassium concentration (chi-2 = 3.6, df = 1, p = 0.06), emergency steroid treatment within the correct period (chi-2 = 3.9, df = 1, p = 0.05), and referral for follow up at an outpatient chest clinic. Recording of arterial blood gas tensions improved significantly between the 1988-9 and 1989-90 samples (chi-2 = 7.0, df = 1, p = 0.08). Conclusions - The questionnaire proved easy to use for both doctor and audit assistant. The audit improved few standards of care and emphasises the need for further reinforcement and feedback.	CENT MIDDLESEX HOSP,ST MARYS HOSP,SCH MED,ACAD DEPT PUBL HLTH,HLTH CARE DEV UNIT,LONDON NW10 7NS,ENGLAND	Imperial College London				Bell, Derek/0000-0002-9944-1097				[Anonymous], 1990, BMJ, V301, P797; Averill B.A., 1980, CIENC BIOL COIMBRA, V5, P167; British Thoracic Association, 1982, BR MED J CLIN RES ED, V285, P1251; BUCKNALL CE, 1988, LANCET, V1, P748; GABBAY J, 1990, BRIT MED J, V301, P526, DOI 10.1136/bmj.301.6751.526; GRANT IWB, 1990, BRIT MED J, V301, P1045; HIGGINS RM, 1987, LANCET, V2, P863; Layton A, 1990, Health Serv J, V100, P1685; REBUCK AS, 1971, AM J MED, V51, P788, DOI 10.1016/0002-9343(71)90307-X; REED S, 1985, THORAX, V40, P897, DOI 10.1136/thx.40.12.897; 1989, STANDARD MORTALITY R	11	39	40	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1991	302	6790					1440	1443		10.1136/bmj.302.6790.1440	http://dx.doi.org/10.1136/bmj.302.6790.1440			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR403	2070112	Green Published, Bronze			2022-12-28	WOS:A1991FR40300024
J	ALDOVINI, A; YOUNG, RA				ALDOVINI, A; YOUNG, RA			HUMORAL AND CELL-MEDIATED IMMUNE-RESPONSES TO LIVE RECOMBINANT BCG-HIV VACCINES	NATURE			English	Article							HELPER T-CELLS; STRESS PROTEINS; FOREIGN DNA; HTLV-III; MYCOBACTERIA; VIRUS; EXPRESSION; PROTECTION; INFECTION	SEVERAL viral and bacterial live recombinant vaccine vehicles are being developed to produce a new generation of vaccines against a broad spectrum of infectious diseases 1. The human tuberculosis vaccine Mycobacterium bovis bacillus Calmette-Guerin (BCG) 2 has features that make it a particularly attractive live recombinant vaccine vehicle. BCG and other mycobacteria are highly effective adjuvants, and the immune response to mycobacteria has been studied extensively. With nearly two billion immunizations, BCG has a long record of safe use in man 3,4. It is one of the few vaccines that can be given at birth, it engenders long-lived immune responses with only a single dose, and there is a worldwide distribution network with experience in BCG vaccination. Recently developed molecular genetic tools and methods for mycobacteria have provided the means to introduce foreign genes into BCG 5-8. Here we report that a variety of human immunodeficiency virus type 1 polypeptides can be expressed in BCG recombinants under the control of the mycobacterial hsp70 promoter and that the foreign polypeptides produced in BCG can induce antibody and T-cell responses. These results demonstrate that BCG can be used as a live recombinant vaccine vehicle to induce immune responses to pathogen proteins produced by the bacillus.	MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA	Massachusetts Institute of Technology (MIT)	ALDOVINI, A (corresponding author), WHITEHEAD INST BIOMED RES, 9 CAMBRIDGE CTR, CAMBRIDGE, MA 02142 USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				ALDOVINI A, 1990, J VIROL, V64, P1920, DOI 10.1128/JVI.64.5.1920-1926.1990; BLOOM BR, 1986, J IMMUNOL, V137, pR1; BLOOM BR, 1989, NATURE, V342, P115, DOI 10.1038/342115a0; BUCHMEIER NA, 1990, SCIENCE, V248, P730, DOI 10.1126/science.1970672; Calmette A., 1924, B ACAD MED, V91, P787; DESROSIERS RC, 1989, P NATL ACAD SCI USA, V86, P6353, DOI 10.1073/pnas.86.16.6353; FISHER AG, 1985, NATURE, V316, P262, DOI 10.1038/316262a0; HUSSON RN, 1990, J BACTERIOL, V172, P519, DOI 10.1128/jb.172.2.519-524.1990; JACOBS WR, 1987, NATURE, V327, P532, DOI 10.1038/327532a0; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMB JR, 1990, MOL BIOL MED, V7, P311; Lotte A, 1984, Adv Tuberc Res, V21, P107; LUELMO F, 1982, AM REV RESPIR DIS, V125, P70; Maniatis T., 1982, MOL CLONING; MARTIN C, 1990, NATURE, V345, P739, DOI 10.1038/345739a0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MOSMANN TR, 1989, ADV IMMUNOL, V46, P111, DOI 10.1016/S0065-2776(08)60652-5; MURPHEYCORB M, 1989, SCIENCE, V246, P1293, DOI 10.1126/science.2555923; NAGLERANDERSON C, 1988, J IMMUNOL, V141, P3299; NEIDHARDT FC, 1987, CELLULAR MOL BIOL, P1654; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; SNAPPER SB, 1988, P NATL ACAD SCI USA, V85, P6987, DOI 10.1073/pnas.85.18.6987; SWAIN SL, 1988, J IMMUNOL, V141, P3445; WALKER BD, 1990, TECHNIQUES HIV RES, P201; WALL KA, 1988, P NATL ACAD SCI USA, V85, P5644, DOI 10.1073/pnas.85.15.5644; WYLER DJ, 1987, J IMMUNOL, V138, P1246; YOUNG RA, 1990, ANNU REV IMMUNOL, V8, P401, DOI 10.1146/annurev.immunol.8.1.401	28	283	325	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	1991	351	6326					479	482		10.1038/351479a0	http://dx.doi.org/10.1038/351479a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP758	2046750				2022-12-28	WOS:A1991FP75800055
J	BOICE, JD; MORIN, MM; GLASS, AG; FRIEDMAN, GD; STOVALL, M; HOOVER, RN; FRAUMENI, JF				BOICE, JD; MORIN, MM; GLASS, AG; FRIEDMAN, GD; STOVALL, M; HOOVER, RN; FRAUMENI, JF			DIAGNOSTIC-X-RAY PROCEDURES AND RISK OF LEUKEMIA, LYMPHOMA, AND MULTIPLE-MYELOMA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note							ACTIVE BONE-MARROW; CANCER MORTALITY; IONIZING-RADIATION; BREAST-CANCER; UNITED-STATES; RADIOGRAPHY; WORKERS; RADIOLOGISTS; CERVIX	Exposure to diagnostic x-rays and the risk of leukemia, non-Hodgkin's lymphoma (NHL), and multiple myeloma were studied within two prepaid health plans. Adult patients with leukemia (n = 565), NHL (n = 318), and multiple myeloma (n = 208) were matched to controls (n = 1390), and over 25 000 x-ray procedures were abstracted from medical records. Dose response was evaluated by assigning each x-ray procedure a score based on estimated bone marrow dose. X-ray exposure was not associated with chronic lymphocytic leukemia, one of the few malignant conditions never linked to radiation (relative risk [RR], 0.66). For all other forms of leukemia combined (n = 358), there was a slight elevation in risk (RR, 1.17) but no evidence of a dose-response relationship when x-ray procedures near the time of diagnosis were excluded. Similarly, patients with NHL were exposed to diagnostic x-ray procedures more often than controls (RR, 1.32), but the RR fell to 0.99 when the exposure to diagnostic x-ray procedures within 2 years of diagnosis was ignored. For multiple myeloma, overall risk was not significantly high (RR, 1.14), but there was consistent evidence of increasing risk with increasing numbers of diagnostic x-ray procedures. These data suggest that persons with leukemia and NHL undergo x-ray procedures frequently just prior to diagnosis for conditions related to the development or natural history of their disease. There was little evidence that diagnostic x-ray procedures were causally associated with leukemia or NHL. The risk for multiple myeloma, however, was increased among those patients who were frequently exposed to x-rays.	KAISER PERMANENTE MED CARE PROGRAM, PORTLAND, OR USA; KAISER PERMANENTE MED CARE PROGRAM, OAKLAND, CA USA; MD ANDERSON CANC CTR, HOUSTON, TX USA	Kaiser Permanente; Kaiser Permanente; University of Texas System; UTMD Anderson Cancer Center	BOICE, JD (corresponding author), NCI, DIV CANC ETIOL, RADIAT EPIDEMIOL BRANCH, EPIDEMIOL & BIOSTAT PROGRAM, 6130 EXECUT BLVD, BETHESDA, MD 20852 USA.				NCI NIH HHS [N01-CP0-1047, N01-CP1-1009, N01-CP0-1054] Funding Source: Medline; DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP001047] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics)		ABRAMS HL, 1979, NEW ENGL J MED, V300, P1213, DOI 10.1056/NEJM197905243002110; ANDERSON RE, 1964, ANN INTERN MED, V61, P853, DOI 10.7326/0003-4819-61-5-853; ANTOKU S, 1971, RADIOLOGY, V101, P669, DOI 10.1148/101.3.669; BERAL V, 1985, BRIT MED J, V291, P440, DOI 10.1136/bmj.291.6493.440; BOICE JD, 1988, RADIAT RES, V116, P3, DOI 10.2307/3577477; BOICE JD, 1987, J NATL CANCER I, V79, P1295; BOICE JD, 1986, NEW ENGL J MED, V315, P828, DOI 10.1056/NEJM198609253151310; BOICE JD, 1979, AM J PUBLIC HEALTH, V69, P137, DOI 10.2105/AJPH.69.2.137; CHECKOWAY H, 1985, BRIT J IND MED, V42, P525; COHEN M, 1985, CRITERIA METHODS Q S, V18, P134; CUZICK J, 1988, BRIT J CANCER, V57, P516, DOI 10.1038/bjc.1988.118; CUZICK J, 1981, NEW ENGL J MED, V304, P204, DOI 10.1056/NEJM198101223040404; DARBY SC, 1987, BRIT J CANCER, V55, P179, DOI 10.1038/bjc.1987.35; DAVIS FG, 1989, CANCER RES, V49, P6130; EVANS JS, 1986, NEW ENGL J MED, V315, P810, DOI 10.1056/NEJM198609253151306; FRIEDMAN GD, 1982, J CHRON DIS, V35, P233, DOI 10.1016/0021-9681(82)90079-0; FRIEDMAN GD, 1986, INT J EPIDEMIOL, V15, P424, DOI 10.1093/ije/15.3.424; GIBSON R, 1972, JNCI-J NATL CANCER I, V48, P301; GILBERT ES, 1989, HEALTH PHYS, V56, P11, DOI 10.1097/00004032-198901000-00001; GRAHAM S, 1963, ANN NY ACAD SCI, V107, P557, DOI 10.1111/j.1749-6632.1963.tb13300.x; GUNZ FW, 1964, BMJ-BRIT MED J, V1, P389, DOI 10.1136/bmj.1.5380.389; HOFFMAN DA, 1989, J NATL CANCER I, V81, P1307, DOI 10.1093/jnci/81.17.1307; JABLON S, 1980, PREV MED, V9, P219, DOI 10.1016/0091-7435(80)90079-1; JANKOWSKI J, 1984, HEALTH PHYS, V46, P229; JOHNSON DW, 1986, HEALTH PHYS, V50, P107, DOI 10.1097/00004032-198601000-00010; KEREIAKES JG, 1980, HDB RAD DOSES NUCLEA; KOHN HI, 1984, NEW ENGL J MED, V310, P504, DOI 10.1056/NEJM198402233100807; LAND CE, 1980, SCIENCE, V209, P1197, DOI 10.1126/science.7403879; LEWIS EB, 1963, SCIENCE, V142, P1492, DOI 10.1126/science.142.3598.1492; LINOS A, 1980, NEW ENGL J MED, V302, P1101, DOI 10.1056/NEJM198005153022001; LUBIN JH, 1981, COMPUT BIOMED RES, V14, P138, DOI 10.1016/0010-4809(81)90031-8; MATANOSKI GM, 1975, AM J EPIDEMIOL, V101, P199, DOI 10.1093/oxfordjournals.aje.a112087; MILLER RW, 1986, RAD CARCINOGENESIS, P245; PRESTONMARTIN S, 1989, BRIT J CANCER, V59, P639, DOI 10.1038/bjc.1989.130; RALL JE, 1985, NIH852748 US DEP HLT; SHIMIZU Y, 1990, RADIAT RES, V121, P120, DOI 10.2307/3577495; SHLEIEN B, 1978, HEALTH PHYS, V34, P587, DOI 10.1097/00004032-197806000-00007; SHRIMPTON PC, 1986, BRIT J RADIOL, V59, P749, DOI 10.1259/0007-1285-59-704-749; SMITH PG, 1981, BRIT J RADIOL, V54, P187, DOI 10.1259/0007-1285-54-639-187; SMITH PG, 1986, BRIT MED J, V293, P845, DOI 10.1136/bmj.293.6551.845; SPENGLER RF, 1983, PEDIATRICS, V71, P235; STEWART A, 1962, BMJ-BRIT MED J, P882, DOI 10.1136/bmj.2.5309.882; STEWART A, 1973, HEALTH PHYS, V24, P223, DOI 10.1097/00004032-197302000-00002; WANG JX, 1988, J NATL CANCER I, V80, P344, DOI 10.1093/jnci/80.5.344; WW. B. Exposure of the U. S, 1989, 100 NAT COUNC RAD PR; 1972, REPORT GENERAL ASS S, V25; 1970, INT COMM RAD PROTECT, V16; 1990, BEIR, V5; 1986, E86IX9 UN SCI COMM E; 1979, CALIFORNIA STANDARD; 1988, E88IX7 UN SCI COMM E; 1983, WHO TRS689 PUBL; 1977, REPORT GENERAL ASS S, V40; 1962, REPORT GENERAL ASS S, V16; 1990, LANCET, V336, P681	55	95	96	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	1991	265	10					1290	1294		10.1001/jama.265.10.1290	http://dx.doi.org/10.1001/jama.265.10.1290			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA511	2053936				2022-12-28	WOS:A1991FA51100025
J	KINNY, SJ; JONES, DHA				KINNY, SJ; JONES, DHA			TRAUMA SERVICES REQUIREMENTS IN A DISTRICT GENERAL-HOSPITAL SERVING A RURAL AREA	BRITISH MEDICAL JOURNAL			English	Article									GWYNEDD HOSP,ACCID UNIT,BANGOR LL57 2PW,GWYNEDD,WALES									BEVERLAND DE, 1983, INJURY, V15, P19, DOI 10.1016/0020-1383(83)90156-0; Buck N, 1987, REPORT CONFIDENTIAL; BULL JP, 1975, ACCIDENT ANAL PREV, V7, P249, DOI 10.1016/0001-4575(75)90026-3; CHRISTIAN MS, 1984, BRIT MED J, V289, P1525, DOI 10.1136/bmj.289.6457.1525; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; EASTMAN AB, 1986, J TRAUMA, V26, P812; MACKENZIE EJ, 1985, J TRAUMA, V25, P984, DOI 10.1097/00005373-198510000-00010; RAMSAY A, 1989, NSW DOCTOR J NEW MAR, P32; SEMMLOW JL, 1976, HEALTH SERV RES, V11, P45; WEST JG, 1983, ARCH SURG-CHICAGO, V118, P740; 1988, REPORT WORKING PARTY; 1987, HOSPITAL MED STAFFIN; 1989, MANAGEMENT TRAUMA GR	13	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	1990	300	6723					504	508		10.1136/bmj.300.6723.504	http://dx.doi.org/10.1136/bmj.300.6723.504			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107928	Bronze, Green Published			2022-12-28	WOS:A1990CQ87800019
J	PHILLIPSHOWARD, PA; RADALOWICZ, A; MITCHELL, J; BRADLEY, DJ				PHILLIPSHOWARD, PA; RADALOWICZ, A; MITCHELL, J; BRADLEY, DJ			RISK OF MALARIA IN BRITISH RESIDENTS RETURNING FROM MALARIOUS AREAS	BMJ-BRITISH MEDICAL JOURNAL			English	Article									UNIV LONDON LONDON SCH HYG & TROP MED, ROSS INST TROP HYG, DEPT EPIDEMIOL & POPULAT SCI, LONDON WC1E 7HT, ENGLAND; UNIV LONDON LONDON SCH HYG & TROP MED, MALARIA REFERENCE LAB, LONDON WC1E 7HT, ENGLAND	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine				Phillips-Howard, Penelope A/0000-0003-1018-116X				BRADLEY DJ, 1989, J ROY SOC MED, V82, P8; FOGH S, 1988, BMJ-BRIT MED J, V296, P820, DOI 10.1136/bmj.296.6625.820; HARRIES AD, 1988, T ROY SOC TROP MED H, V82, P690, DOI 10.1016/0035-9203(88)90200-3; KIRKWOOD B, 1988, ESSENTIALS MED STATI, P174; LOBEL HO, IN PRESS B WHO; MCLARTY DG, 1984, LANCET, V2, P656; PETO TEA, 1986, LANCET, V1, P1256; PHILLIPSHOWARD PA, 1988, BMJ-BRIT MED J, V296, P245, DOI 10.1136/bmj.296.6617.245; PHILLIPSHOWARD PA, 1989, J R SOC MED S17, V82, P18; PHILLIPSHOWARD PA, 1988, THESIS U LONDON LOND; PHILLIPSHOWARD PA, IN PRESS J EPIDEMIOL; PHILLIPSHOWARD PA, IN PRESS J R SOC MED; PHILLIPSHOWARD PA, 1988, TRAVEL MED INT, V6, P51; 1987, B WORLD HEALTH ORGAN, V65, P797; 1989, BRIT MED J, V299, P1087	15	112	112	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	1990	300	6723					499	503		10.1136/bmj.300.6723.499	http://dx.doi.org/10.1136/bmj.300.6723.499			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107927	Green Published, Bronze			2022-12-28	WOS:A1990CQ87800018
J	WINKLER, FK; DARCY, A; HUNZIKER, W				WINKLER, FK; DARCY, A; HUNZIKER, W			STRUCTURE OF HUMAN PANCREATIC LIPASE	NATURE			English	Article											WINKLER, FK (corresponding author), F HOFFMANN LA ROCHE & CO LTD, CENT RES UNIT, CH-4002 BASEL, SWITZERLAND.							BENGTSSON G, 1981, EUR J BIOCHEM, V113, P547, DOI 10.1111/j.1432-1033.1981.tb05097.x; BENGTSSONOLIVECRONA G, 1986, EUR J BIOCHEM, V161, P281, DOI 10.1111/j.1432-1033.1986.tb10444.x; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BODE W, 1975, J MOL BIOL, V98, P693, DOI 10.1016/S0022-2836(75)80005-2; BRICOGNE G, 1976, ACTA CRYSTALLOGR A, V32, P832, DOI 10.1107/S0567739476001691; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CHAPUS C, 1976, BIOCHEMISTRY-US, V15, P4980, DOI 10.1021/bi00668a006; CHAPUS C, 1976, BIOCHEMISTRY-US, V15, P4988, DOI 10.1021/bi00668a007; CHAPUS C, 1988, BIOCHIMIE, V70, P1223, DOI 10.1016/0300-9084(88)90188-5; DATTA S, 1988, J BIOL CHEM, V263, P1107; DECARO J, 1981, BIOCHIM BIOPHYS ACTA, V671, P129, DOI 10.1016/0005-2795(81)90126-4; DECARO JD, 1986, EUR J BIOCHEM, V158, P601; DICKERSO.RE, 1968, ACTA CRYSTALL B-STRU, VB 24, P997, DOI 10.1107/S0567740868003626; GARNER CW, 1980, J BIOL CHEM, V255, P5064; GUIDONI A, 1981, BIOCHIM BIOPHYS ACTA, V660, P148, DOI 10.1016/0005-2744(81)90120-0; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kerfelec B, 1986, Pancreas, V1, P430, DOI 10.1097/00006676-198609000-00007; MAYLIE MF, 1972, BIOCHIM BIOPHYS ACTA, V276, P162, DOI 10.1016/0005-2744(72)90017-4; PERSSON B, 1989, EUR J BIOCHEM, V179, P39, DOI 10.1111/j.1432-1033.1989.tb14518.x; RICHARDSON JS, 1985, METHOD ENZYMOL, V115, P341; RICHARDSON JS, 1976, P NATL ACAD SCI USA, V73, P2619, DOI 10.1073/pnas.73.8.2619; ROTANOVA TV, 1976, BIOORG KHIM+, V2, P837; STERNBERG MJE, 1977, J MOL BIOL, V110, P269, DOI 10.1016/S0022-2836(77)80072-7; STERNBY B, 1981, COMP BIOCHEM PHYS B, V68, P15, DOI 10.1016/0305-0491(81)90173-5	26	1088	1125	5	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	1990	343	6260					771	774		10.1038/343771a0	http://dx.doi.org/10.1038/343771a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP807	2106079				2022-12-28	WOS:A1990CP80700066
J	BARBARA, JAJ; CONTRERAS, M				BARBARA, JAJ; CONTRERAS, M			ABC OF TRANSFUSION - INFECTIOUS COMPLICATIONS OF BLOOD-TRANSFUSION - BACTERIA AND PARASITES	BRITISH MEDICAL JOURNAL			English	Article											BARBARA, JAJ (corresponding author), N LONDON BLOOD TRANSFUS CTR,MICROBIOL,LONDON,ENGLAND.								0	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					386	389		10.1136/bmj.300.6721.386	http://dx.doi.org/10.1136/bmj.300.6721.386			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106997	Green Published, Bronze			2022-12-28	WOS:A1990CN79900030
J	KERRIGAN, DD; BROWN, SR; HUTCHINSON, GH				KERRIGAN, DD; BROWN, SR; HUTCHINSON, GH			OPEN ACCESS GASTROSCOPY - TOO MUCH TO SWALLOW	BRITISH MEDICAL JOURNAL			English	Article									HALTON DIST GEN HOSP,RUNCORN WA7 3DA,CHESHIRE,ENGLAND		KERRIGAN, DD (corresponding author), UNIV SHEFFIELD,ROYAL HALLAMSHIRE HOSP,SURG UNIT,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND.		brown, steven/D-5833-2012; brown, steve/AAG-2066-2019	brown, steven/0000-0002-0980-2793; 				FISHER JA, 1977, BRIT MED J, V2, P1199, DOI 10.1136/bmj.2.6096.1199; GEAR MWL, 1989, BRIT J HOSP MED, V41, P438; HOLDSTOCK G, 1986, GASTROENTEROLOGY, V90, P1164, DOI 10.1016/0016-5085(86)90381-1; MANN J, 1983, BRIT MED J, V287, P937, DOI 10.1136/bmj.287.6397.937; MATHERS N, 1989, BRIT MED J, V298, P172, DOI 10.1136/bmj.298.6667.172; MEAD GM, 1977, BRIT MED J, V2, P1460	6	63	63	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					374	376		10.1136/bmj.300.6721.374	http://dx.doi.org/10.1136/bmj.300.6721.374			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106992	Green Published, Bronze			2022-12-28	WOS:A1990CN79900025
J	SOUMERAI, SB; AVORN, J				SOUMERAI, SB; AVORN, J			PRINCIPLES OF EDUCATIONAL OUTREACH (ACADEMIC DETAILING) TO IMPROVE CLINICAL DECISION-MAKING	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											SOUMERAI, SB (corresponding author), HARVARD UNIV,SCH MED,DEPT SOCIAL MED,PROGRAM ANAL CLIN STRATEGIES,643 HUNTINGTON AVE,BOSTON,MA 02115, USA.				AHRQ HHS [HS04933, HS 03880] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		AVORN J, 1988, ARCH INTERN MED, V148, P1720, DOI 10.1001/archinte.148.8.1720; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; AVORN J, 1988, CLIN RES, V36, pA331; BOWMAN MA, 1986, MOBIUS, V6, P66; BUCHWALD D, 1989, REV INFECT DIS, V11, P619; Coleman J. S., 1966, MED INNOVATION DIFFU; COOK T, 1968, J PERS SOC PSYCHOL, V9, P332; DAVRON MD, 1980, WEEKLY PHARM REP, V29, P4; EASTMAN M, 1978, AM PHARM, V18, P8, DOI 10.1016/S0160-3450(15)32362-X; EISENBERG JM, 1986, DOCTORS DECISIONS CO, P91; GORZALSKI EJ, 1986, MED MARKET MEDIA OCT, P187; HAYNES RB, 1984, JAMA-J AM MED ASSOC, V251, P61, DOI 10.1001/jama.251.1.61; HAYNES RB, 1987, PATIENT EDUC COUNS, V10, P155, DOI 10.1016/0738-3991(87)90095-4; HEMMINKI E, 1977, MED EDUC, V11, P210, DOI 10.1111/j.1365-2923.1977.tb00595.x; HEMMINKI E, 1977, SCAND J SOC MED, V5, P105, DOI 10.1177/140349487700500301; Hovland C.I., 1949, EXPT MASS COMMUNICAT; LABSON D, 1979, MED MARKET MEDIA FEB, P16; LONG HB, 1983, ADULT LEARNING RES P; LONG HB, 1983, ADULT LEARNING RES P, P244; LURIE N, 1984, NEW ENGL J MED, V311, P480, DOI 10.1056/NEJM198408163110735; RAGLAND B, 1985, PHARM REP, V15, P14; RAY WA, 1977, JAMA-J AM MED ASSOC, V237, P2069; ROSEMAN E, 1985, MED MARKET MEDIA SEP, P90; ROSEMAN E, 1985, MED MARKET MEDIA OCT, P40; ROSEMAN E, 1985, MED MARKET MEDIA OCT, P6; ROSEMAN E, 1985, MED MARKET MEDIA FEB, P24; RUCKER TD, 1976, MED CARE, V14, P156, DOI 10.1097/00005650-197602000-00005; SCHAFFNER W, 1983, JAMA-J AM MED ASSOC, V250, P1728, DOI 10.1001/jama.250.13.1728; SCHWARTZ RK, 1989, SOC SCI MED, V28, P577, DOI 10.1016/0277-9536(89)90252-9; Silverman Milton, 1974, PILLS PROFITS POLITI; SMITH MC, 1977, AM J PUBLIC HEALTH, V67, P171, DOI 10.2105/AJPH.67.2.171; SMITH MC, 1968, PRINCIPLES PHARM MAR, P299; SOUMERAI SB, 1984, MILBANK FUND Q, V62, P447, DOI 10.2307/3349860; SOUMERAI SB, 1986, MED CARE, V24, P313, DOI 10.1097/00005650-198604000-00003; SOUMERAI SB, 1987, NEW ENGL J MED, V317, P550, DOI 10.1056/NEJM198708273170906; SOUMERAI SB, 1988, MED J AUSTRALIA, V149, P574, DOI 10.5694/j.1326-5377.1988.tb120790.x; SOUMERAI SB, 1987, MED CARE, V25, P210, DOI 10.1097/00005650-198703000-00005; SOUMERAI SB, IN PRESS JAMA; SOUMERAI SB, IN PRESS MILBANK Q; STROSS JK, 1980, ARTHRITIS RHEUM, V23, P846, DOI 10.1002/art.1780230711; WATTS WA, 1967, J PERS SOC PSYCHOL, V5, P4, DOI 10.1037/h0021196; ZELNIO RB, 1985, MED MARKET MEDIA JAN, P51; 1983, LANCET, V1, P219; 1982, FDC REPORTS, V44, P3	45	795	798	0	40	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	1990	263	4					549	556		10.1001/jama.263.4.549	http://dx.doi.org/10.1001/jama.263.4.549			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ360	2104640	Green Submitted			2022-12-28	WOS:A1990CJ36000025
J	TYRRELL, DAJ; NICHOLSON, KG				TYRRELL, DAJ; NICHOLSON, KG			RABIES IN BRITAIN - BRITAIN REMAINS VIGILANT AND SAFE	BRITISH MEDICAL JOURNAL			English	Editorial Material									GROBY HOSP,LEICESTER LE3 9QE,ENGLAND		TYRRELL, DAJ (corresponding author), MRC,COMMON COLD UNIT,SALISBURY SP2 8BW,ENGLAND.							BROCHIER B, 1988, VET REC, V123, P618; BROCHIER BM, 1988, VET MICROBIOL, V18, P103, DOI 10.1016/0378-1135(88)90055-7; LLOYD HG, 1976, T ROY SOC TROP MED H, V70, P179, DOI 10.1016/0035-9203(76)90036-5; 1988, IMMUNIZATION INFECTI; 1984, MMWR, V33, P15; 1989, WEEKLY EPIDEMIOLOGIC, P112; 1989, WEEKLY EPIDEMIOLOGIC, P97; 1984, TECHNICAL REPORT SER, V709; 1989, WEEKLY EPIDEMIOLOGIC, P189	9	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					137	138		10.1136/bmj.300.6718.137	http://dx.doi.org/10.1136/bmj.300.6718.137			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105788	Green Published, Bronze			2022-12-28	WOS:A1990CK07700003
J	WRIGHT, JD; PEARL, L				WRIGHT, JD; PEARL, L			KNOWLEDGE AND EXPERIENCE OF YOUNG-PEOPLE REGARDING DRUG-ABUSE, 1969-89	BRITISH MEDICAL JOURNAL			English	Article									WOLVERHAMPTON POLYTECH,STAT,WOLVERHAMPTON,ENGLAND	University of Wolverhampton	WRIGHT, JD (corresponding author), COMMUNITY LONG STAY UNIT,WOLVERHAMPTON WV1 4TG,ENGLAND.							[Anonymous], 1988, AIDS DRUG MISUSE 1; BEAN PT, 1988, HLTH ED J, V47, P79; BROWN C, 1988, ILLICIT DRUG USE POR; COOKE BRB, 1988, COMMUNITY MED, V10, P8; Davies OL, 1978, DESIGN ANAL IND EXPT; DORN N, 1975, COMP 1973 1974 LEVEL; GRUBE JW, 1986, SMOKING DRINKING OTH; KANDEL DB, 1982, J AM ACAD CHILD PSY, V21, P328, DOI 10.1016/S0002-7138(09)60936-5; NEWCOMBE R, 1988, SURVEY DRUG USE YOUN; PLANT MA, 1984, BRIT J ADDICT, V79, P197; PLANT MA, 1985, ALCOHOL DRUGS SCH LE; SWADI H, 1988, BRIT J ADDICT, V83, P153; SWADI H, 1988, BRIT J ADDICT, V83, P935; SWADI H, 1987, BRIT J ADDICT, V82, P741; WRIGHT JD, 1976, MED SCI LAW, V16, P252, DOI 10.1177/002580247601600408; WRIGHT JD, 1981, BRIT MED J, V282, P793, DOI 10.1136/bmj.282.6266.793; WRIGHT JD, 1986, BRIT MED J, V292, P179, DOI 10.1136/bmj.292.6514.179; 1988, TACKLING DRUG MISUSE; 1984, PREVENTION REPORT AD; 1973, PUBLIC ATTITUDES DRU; 1987, SMOKING ED TEENAGERS; 1989, HLTH LIFE, V2; 1988, ANTI DRUGS AIDS CAMP; 1988, HEROIN MISUSE CAMPAI	24	21	21	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					99	103		10.1136/bmj.300.6717.99	http://dx.doi.org/10.1136/bmj.300.6717.99			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ080	2105785	Green Published, Bronze			2022-12-28	WOS:A1990CJ08000022
J	SMITH, OP; PRENTICE, HG; MADDEN, GM; NAZARETH, B				SMITH, OP; PRENTICE, HG; MADDEN, GM; NAZARETH, B			LINGUAL CELLULITIS CAUSING UPPER AIRWAYS OBSTRUCTION IN NEUTROPENIC PATIENTS	BRITISH MEDICAL JOURNAL			English	Article											SMITH, OP (corresponding author), ROYAL FREE HOSP,HAEMATOL,LONDON NW3 2QG,ENGLAND.		Smith, Owen/AAU-8929-2020					HALLOWAY Y, 1982, ANTIMICROB AGENTS CH, V22, P1073; HING NR, 1985, BRIT J ORAL MAX SURG, V23, P322, DOI 10.1016/0266-4356(85)90002-6; LEE M, 1980, CHEST, V77, P454, DOI 10.1378/chest.77.3.454; LEPARE NL, 1976, ARCH OTELARYNGOLOGY, V102, P505; ROBERTS RB, 1985, PRINCIPLES PRACTICE, P1162	5	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	1990	300	6716					24	24		10.1136/bmj.300.6716.24	http://dx.doi.org/10.1136/bmj.300.6716.24			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG773	2105119	Bronze, Green Accepted, Green Published			2022-12-28	WOS:A1990CG77300020
J	SANDLER, RH; EPSTEIN, PR; COOKDEEGAN, RM; SHUKRI, A				SANDLER, RH; EPSTEIN, PR; COOKDEEGAN, RM; SHUKRI, A			INITIAL MEDICAL ASSESSMENT OF KURDISH REFUGEES IN THE TURKEY-IRAQ BORDER REGION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							POPULATIONS; MORTALITY		RUSH PRESBYTERIAN ST LUKES MED CTR, CHICAGO, IL 60612 USA; HARVARD UNIV, CAMBRIDGE HOSP, SCH MED, BOSTON, MA 02115 USA; NATL ACAD SCI, INST MED, WASHINGTON, DC 20418 USA; NW MED CTR, DETROIT, MI USA	Rush University; Harvard University; Cambridge Health Alliance; Cambridge Hospital; Harvard Medical School; National Academies of Sciences, Engineering & Medicine				Cook-Deegan, Robert/0000-0002-8251-4237				AVERY ME, 1990, NEW ENGL J MED, V323, P891, DOI 10.1056/NEJM199009273231307; BROWN RE, 1987, MED CARE REFUGEES, P113; GLASS RI, 1980, LANCET, V1, P868; HIRSCHHORN N, 1991, SCI AM, V264, P50, DOI 10.1038/scientificamerican0591-50; Jelliffe D. B., 1978, HUMAN MILK MODERN WO; KINZER S, 1991, NY TIMES        0602, P1; LI TCM, 1987, MED CARE REFUGEES, P253; OLDFIELD EC, 1991, REV INFECT DIS, V13, pS199; SWENSON RH, 1987, MED CARE REFUGEES, P31; TOOLE MJ, 1988, B WORLD HEALTH ORGAN, V66, P237; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; 1991, 11 UN DIS REL ORG SI; 1991, MMWR, V40, P443	13	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	1991	266	5					638	640		10.1001/jama.266.5.638	http://dx.doi.org/10.1001/jama.266.5.638			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ140	2072471				2022-12-28	WOS:A1991FZ14000008
J	GETZ, MA; SUBRAMANIAN, R; LOGEMANN, T; BALLANTYNE, F				GETZ, MA; SUBRAMANIAN, R; LOGEMANN, T; BALLANTYNE, F			ACUTE NECROTIZING EOSINOPHILIC MYOCARDITIS AS A MANIFESTATION OF SEVERE HYPERSENSITIVITY MYOCARDITIS - ANTEMORTEM DIAGNOSIS AND SUCCESSFUL TREATMENT	ANNALS OF INTERNAL MEDICINE			English	Note									UNIV WISCONSIN, SCH MED, MADISON, WI 53706 USA; WILLIAM S MIDDLETON MEM VET AFFAIRS HOSP, MADISON, WI USA	University of Wisconsin System; University of Wisconsin Madison								Billingham M E, 1985, Heart Vessels Suppl, V1, P278; DEMELLO DE, 1990, NEW ENGL J MED, V323, P1542, DOI 10.1056/NEJM199011293232207; DOHERTY NE, 1985, AM HEART J, V110, P1257, DOI 10.1016/0002-8703(85)90023-7; FENOGLIO JJ, 1981, HUM PATHOL, V12, P900, DOI 10.1016/S0046-8177(81)80195-5; French AJ, 1942, AM J PATHOL, V18, P109; HERZOG CA, 1984, BRIT HEART J, V52, P343; MORROW PL, 1989, J FORENSIC SCI, V34, P1016; PARRILLO JE, 1990, NEW ENGL J MED, V323, P1560, DOI 10.1056/NEJM199011293232211; TALIERCIO CP, 1985, MAYO CLIN PROC, V60, P463, DOI 10.1016/S0025-6196(12)60870-2	9	42	44	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	1991	115	3					201	202		10.7326/0003-4819-115-3-201	http://dx.doi.org/10.7326/0003-4819-115-3-201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY152	2058874				2022-12-28	WOS:A1991FY15200007
J	MORROW, JF; BRAINE, HG; KICKLER, TS; NESS, PM; DICK, JD; FULLER, AK				MORROW, JF; BRAINE, HG; KICKLER, TS; NESS, PM; DICK, JD; FULLER, AK			SEPTIC REACTIONS TO PLATELET TRANSFUSIONS - A PERSISTENT PROBLEM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BACTERIAL PROLIFERATION; SALMONELLA SEPTICEMIA; ROOM-TEMPERATURE; STORAGE; SEPSIS; CONTAMINATION; FATALITIES; STERILITY	Objective.-To determine the medical and laboratory characteristics of bacteremia secondary to transfusion of microbiologically contaminated platelet concentrates. Design.-Febrile transfusion reactions were prospectively monitored over 42 months. Units involved in reactions were evaluated with Gram's stain and culture tests. Setting. -Comprehensive cancer center. Patients.- Patients receiving platelet transfusions for thrombocytopenia secondary to bone marrow failure. Result. - Seven cases of transfusion-associated sepsis were observed. Multidonor platelet products stored for 5 days resulted in an incidence of sepsis five times higher than those stored for 4 days or less (P < .01). Investigation indicates that contamination most likely occurred at the time of blood collection. Clinically, septic reactions were associated with greater temperature elevations (average increase, 2.0-degrees-C) than febrile reactions to sterile products. Conclusions.-Contamination of platelet concentrates remains a significant clinical problem. Septic episodes may be reduced by transfusion of platelets with shorter storage intervals.	JOHNS HOPKINS MED INST,DEPT PATHOL,BALTIMORE,MD 21205; JOHNS HOPKINS MED INST,DEPT ONCOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine								ANDERSON KC, 1986, AM J MED, V81, P405, DOI 10.1016/0002-9343(86)90290-1; ARNOW PM, 1986, ARCH INTERN MED, V146, P321, DOI 10.1001/archinte.146.2.321; BRAINE HG, 1986, TRANSFUSION, V26, P391, DOI 10.1046/j.1537-2995.1986.26486262752.x; BUCHHOLZ DH, 1971, NEW ENGL J MED, V285, P429, DOI 10.1056/NEJM197108192850803; BUCHHOLZ DH, 1973, TRANSFUSION, V13, P268, DOI 10.1111/j.1537-2995.1973.tb05488.x; CORDLE D, 1980, TRANSFUSION, V20, P105, DOI 10.1046/j.1537-2995.1980.20180125023.x; CUNNINGHAM M, 1973, J CLIN PATHOL, V26, P401, DOI 10.1136/jcp.26.6.401; DOUGLAS D, 1987, TRANSFUSION, V27, P512; GIBSON T, 1958, LANCET, V275, P983; HEAL JM, 1986, TRANSFUSION, V26, P388, DOI 10.1046/j.1537-2995.1986.26486262751.x; HEAL JM, 1987, TRANSFUSION, V27, P2, DOI 10.1046/j.1537-2995.1987.27187121466.x; HESS PM, 1980, TRANSFUSION, V20, P82; HONIG CL, 1980, TRANSFUSION, V20, P653, DOI 10.1046/j.1537-2995.1980.20681057154.x; INGELFINGER JA, 1987, BIOSTATISTICS CLIN M, V111, P123; Lennette E.H, 1985, MANUAL CLIN MICROBIO, V4th ed.; MURPHY S, 1969, NEW ENGL J MED, V280, P1094, DOI 10.1056/NEJM196905152802004; MYHRE BA, 1980, JAMA-J AM MED ASSOC, V244, P1333; MYHRE BA, 1974, TRANSFUSION, V14, P116, DOI 10.1111/j.1537-2995.1974.tb04502.x; PUNSALANG A, 1989, TRANSFUSION, V29, P596, DOI 10.1046/j.1537-2995.1989.29789369676.x; RHAME FS, 1973, ANN INTERN MED, V78, P633, DOI 10.7326/0003-4819-78-5-633; SAZAMA K, 1990, TRANSFUSION, V30, P583, DOI 10.1046/j.1537-2995.1990.30790385515.x; SIMON TL, 1983, TRANSFUSION, V23, P207, DOI 10.1046/j.1537-2995.1983.23383224896.x; SLICHTER SJ, 1976, BRIT J HAEMATOL, V34, P403, DOI 10.1111/j.1365-2141.1976.tb03587.x; SZYMANSKI IO, 1985, TRANSFUSION, V25, P290, DOI 10.1046/j.1537-2995.1985.25385219921.x; WALKER RH, 1990, TECHNICAL MANUAL	25	189	197	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1991	266	4					555	558						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX021	2061984				2022-12-28	WOS:A1991FX02100031
J	ZIMMERMAN, JL				ZIMMERMAN, JL			ORF	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		BLAKEMORE F, 1948, BRIT J DERMATOL SYPH, V60, P404, DOI 10.1111/j.1365-2133.1948.tb10972.x; FRASER CM, 1986, MERCK VET MANUAL, P757; FREEMAN G, 1984, AM J OPHTHALMOL, V97, P601, DOI 10.1016/0002-9394(84)90380-5; MENDEZ B, 1989, CUTIS, V44, P286; SANCHEZ RL, 1985, ARCH PATHOL LAB MED, V109, P166; SHELLEY WB, 1983, CUTIS, V31, P191	6	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1991	266	4					476	476		10.1001/jama.266.4.476	http://dx.doi.org/10.1001/jama.266.4.476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX021	2061969				2022-12-28	WOS:A1991FX02100008
J	HELMRICH, SP; RAGLAND, DR; LEUNG, RW; PAFFENBARGER, RS				HELMRICH, SP; RAGLAND, DR; LEUNG, RW; PAFFENBARGER, RS			PHYSICAL-ACTIVITY AND REDUCED OCCURRENCE OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLUCOSE-INTOLERANCE; RISK-FACTORS; EXERCISE; MEN; OBESITY; PREVALENCE; SENSITIVITY; MANAGEMENT; METABOLISM; MONOCYTES	Background. Physical activity is recommended by physicians to patients with non-insulin-dependent diabetes mellitus (NIDDM), because it increases sensitivity to insulin. Whether physical activity is effective in preventing this disease is not known. Methods. We used questionnaires to examine patterns of physical activity and other personal characteristics in relation to the subsequent development of NIDDM in 5990 male alumni of the University of Pennsylvania. The disease developed in a total of 202 men during 98,524 man-years of follow-up from 1962 to 1976. Results. Leisure-time physical activity, expressed in kilocalories expended per week in walking, stair climbing, and sports, was inversely related to the development of NIDDM. The incidence rates declined as energy expenditure increased from less than 500 kcal to 3500 kcal. For each 500-kcal increment in energy expenditure, the age-adjusted risk of NIDDM was reduced by 6 percent (relative risk, 0.94; 95 percent confidence interval, 0.90 to 0.98). This association remained the same when the data were adjusted for obesity, hypertension, and a parental history of diabetes. The association was weaker when we considered weight gain between the time of college attendance and 1962 (relative risk, 0.95; 95 percent confidence interval, 0.90 to 1.00). The protective effect of physical activity was strongest in persons at highest risk for NIDDM, defined as those with a high body-mass index, a history of hypertension, or a parental history of diabetes. These factors, in addition to weight gain since college, were also independent predictors of the disease. Conclusions. Increased physical activity is effective in preventing NIDDM, and the protective benefit is especially pronounced in persons at the highest risk for the disease.	STANFORD UNIV,MED CTR,SCH MED,DEPT HLTH RES & POLICY,STANFORD,CA 94305; UNIV CALIF BERKELEY,SCH PUBL HLTH,BERKELEY,CA 94720	Stanford University; University of California System; University of California Berkeley			Ragland, David R/G-6302-2017	Ragland, David R/0000-0002-8996-1320	NHLBI NIH HHS [R01 HL34174, T32 HL07365] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034174, T32HL007365] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AINSWORTH BE, IN PRESS MED SCI SPO; BARRETTCONNOR E, 1989, EPIDEMIOL REV, V11, P172, DOI 10.1093/oxfordjournals.epirev.a036035; BARRETTCONNOR E, 1981, AM J EPIDEMIOL, V113, P276, DOI 10.1093/oxfordjournals.aje.a113097; BEATY TH, 1982, AM J EPIDEMIOL, V115, P380, DOI 10.1093/oxfordjournals.aje.a113316; BJORNTORP P, 1970, METABOLIS, V19, P631, DOI 10.1016/0026-0495(70)90020-X; BLAIR SN, 1985, PUBLIC HEALTH REP, V100, P172; COX DR, 1972, J R STAT SOC B, V34, P187; DeFronzo R A, 1983, Am J Med, V74, P52, DOI 10.1016/0002-9343(83)90654-X; DEVLIN JT, 1985, DIABETES, V34, P973, DOI 10.2337/diabetes.34.10.973; DEVLIN JT, 1987, DIABETES, V36, P434, DOI 10.2337/diabetes.36.4.434; DONAHUE RP, 1990, AM J EPIDEMIOL, V132, P827, DOI 10.1093/oxfordjournals.aje.a115725; FRISCH RE, 1986, DIABETES, V35, P1101, DOI 10.2337/diabetes.35.10.1101; HORTON ES, 1988, DIABETES CARE, V11, P201, DOI 10.2337/diacare.11.2.201; JARRETT RJ, 1986, DIABETIC MED, V3, P549, DOI 10.1111/j.1464-5491.1986.tb00813.x; KAHN HA, 1971, J CHRON DIS, V23, P617, DOI 10.1016/0021-9681(71)90158-5; KANNEL WB, 1982, DIABETES MELLITUS OB, P734; KARAM JH, 1982, DIABETES MELLITUS OB, P294; KING H, 1984, AM J EPIDEMIOL, V119, P396, DOI 10.1093/oxfordjournals.aje.a113758; KOIVISTO VA, 1979, J CLIN INVEST, V64, P1011, DOI 10.1172/JCI109537; KOVAR MG, 1987, AM J PUBLIC HEALTH, V77, P1549, DOI 10.2105/AJPH.77.12.1549; KROTKIEWSKI M, 1983, SCAND J REHABIL ME S, V9, P55; LEON AS, 1979, AM J CLIN NUTR, V32, P1776, DOI 10.1093/ajcn/32.9.1776; LINGARDE F, 1981, DIABETOLOGIA, V20, P134; LOHMANN D, 1978, METABOLISM, V27, P521, DOI 10.1016/0026-0495(78)90017-3; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; MODAN M, 1986, DIABETOLOGIA, V29, P82, DOI 10.1007/BF00456115; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; PAFFENBARGER RS, 1973, AM J EPIDEMIOL, V97, P314, DOI 10.1093/oxfordjournals.aje.a121511; PASSMORE R, 1955, PHYSIOL REV, V35, P801, DOI 10.1152/physrev.1955.35.4.801; RAURAMAA R, 1984, PREV MED, V13, P37, DOI 10.1016/0091-7435(84)90039-2; REITMAN JS, 1984, DIABETES CARE, V7, P434, DOI 10.2337/diacare.7.5.434; SOMAN VR, 1979, NEW ENGL J MED, V301, P1200, DOI 10.1056/NEJM197911293012203; TAYLOR R, 1984, DIABETOLOGIA, V27, P578, DOI 10.1007/BF00276971; THORNE MC, 1968, AM J EPIDEMIOL, V87, P520, DOI 10.1093/oxfordjournals.aje.a120843; WEST KM, 1978, EPIDEMIOLOGY DIABETE; WILSON PW, 1981, AM J EPIDEMIOL, V114, P697, DOI 10.1093/oxfordjournals.aje.a113240; 1987, DIABETES CARE, V10, P639; 1985, NIH851468 DEP HLTH H; [No title captured]	39	1165	1196	2	123	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	1991	325	3					147	152		10.1056/NEJM199107183250302	http://dx.doi.org/10.1056/NEJM199107183250302			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW752	2052059				2022-12-28	WOS:A1991FW75200002
J	JAMES, TN; KAMB, ML; SANDBERG, GA; SILVER, RM; KILBOURNE, EM				JAMES, TN; KAMB, ML; SANDBERG, GA; SILVER, RM; KILBOURNE, EM			POSTMORTEM STUDIES OF THE HEART IN 3 FATAL CASES OF THE EOSINOPHILIA-MYALGIA-SYNDROME	ANNALS OF INTERNAL MEDICINE			English	Article							L-TRYPTOPHAN INGESTION; CARDIOGENIC HYPERTENSIVE CHEMOREFLEX; TOXIC-OIL SYNDROME; FUNCTIONAL-SIGNIFICANCE; SUBITANEIS-MORTIBUS; CORONARY-ARTERIES; SUDDEN-DEATH; FASCIITIS; SCLERODERMA; DISEASE	Objective: To examine the hearts of individuals who died from the eosinophilia-myalgia syndrome associated with ingestion Of L-tryptophan, with particular attention paid to the coronary arteries, the neural structures, and the conduction system of the heart because of reported terminal disturbances of cardiac rhythm and conduction. Study Material: Three hearts fixed in neutral formalin and well preserved with all the relevant areas of conduction system intact. Methods: Light microscopic examination of subserial sections of the sinus node, atrioventricular node and His bundle, coronary chemoreceptor and regional nerves, ganglia, and small coronary arteries. Routine stains used were Goldner trichrome and Verhoeff-van Gieson. Results: Arterial abnormalities were numerous and primarily of two types: focal fibromuscular dysplasia causing moderate to severe narrowing, as well as endarteritis and panarteritis. Extensive examples of neuritis and ganglionitis were present throughout the heart, including the conduction system, where arterial abnormalities were also abundant. In the coronary chemoreceptor there were both old and new lesions comprising focal inflammation with degeneration as well as older areas of fibrotic destruction. Within the sinus node, areas of dense fibrosis replaced all nodal tissue. These abnormalities were similar in nature and extent in all three hearts. Conclusions: The pathologic lesions present in the coronary arteries, neural structures, and conduction system of the heart in patients who died from the eosinophilia-myalgia syndrome provide a suitable anatomic substrate for substantial cardiac electrical instability, including the occurrence of sudden death. In cases of unexplained cardiac electrical instability or sudden unexpected death an inquiry should be made about previous use of L-tryptophan. In patients with the eosinophilia-myalgia syndrome, the possibility of cardiac electrical instability should be considered as part of long-range clinical management.	CTR DIS CONTROL, ATLANTA, GA 30333 USA; DEPT VET AFFAIRS MED CTR, WILMINGTON, DE USA; MED UNIV S CAROLINA, CHARLESTON, SC 29425 USA	Centers for Disease Control & Prevention - USA; Medical University of South Carolina	JAMES, TN (corresponding author), UNIV TEXAS, MED BRANCH, OFF PRESIDENT, GALVESTON, TX 77550 USA.							BELONGIA EA, 1990, NEW ENGL J MED, V323, P357, DOI 10.1056/NEJM199008093230601; CANOSO JJ, 1990, NEW ENGL J MED, V322, P252; CLAUW DJ, 1990, JAMA-J AM MED ASSOC, V263, P1502; CROFFORD LJ, 1990, J CLIN INVEST, V86, P1757, DOI 10.1172/JCI114902; DOUGLAS WW, 1985, GOODMAN GILMANS PHAR, P628; EIDSON M, 1990, LANCET, V335, P645, DOI 10.1016/0140-6736(90)90421-Z; FAUCI AS, 1982, ANN INTERN MED, V97, P78, DOI 10.7326/0003-4819-97-1-78; FREESE A, 1988, ANN INTERN MED, V108, P312, DOI 10.7326/0003-4819-108-2-312_2; FREUNDLICH B, 1990, ANN INTERN MED, V112, P758, DOI 10.7326/0003-4819-112-10-758; FRIES JF, 1973, ARCH INTERN MED, V131, P550, DOI 10.1001/archinte.1973.00320100078010; GORN A, 1990, NEW ENGL J MED, V322, P931; HERTZMAN PA, 1990, NEW ENGL J MED, V322, P869, DOI 10.1056/NEJM199003293221301; JAFFE I, 1990, AM J MED, V88, P542, DOI 10.1016/0002-9343(90)90439-K; JAMES TN, 1986, J AM COLL CARDIOL, V8, pA12, DOI 10.1016/S0735-1097(86)80024-9; JAMES TN, 1978, CIRCULATION, V57, P1221, DOI 10.1161/01.CIR.57.6.1221; JAMES TN, 1968, J PHARMACOL EXP THER, V163, P300; JAMES TN, 1979, ANN INTERN MED, V91, P727, DOI 10.7326/0003-4819-91-5-727; JAMES TN, 1964, J PHARMACOL EXP THER, V146, P209; JAMES TN, 1964, J PHARMACOL EXP THER, V144, P83; JAMES TN, 1977, AM J CARDIOL, V40, P965, DOI 10.1016/0002-9149(77)90048-0; JAMES TN, 1983, J AM COLL CARDIOL, V2, P983, DOI 10.1016/S0735-1097(83)80250-2; JAMES TN, 1974, CIRCULATION, V50, P844, DOI 10.1161/01.CIR.50.4.844; JAMES TN, 1989, ANESTH ANALG, V69, P633; JAMES TN, 1991, AM HEART J, V121, P803, DOI 10.1016/0002-8703(91)90192-K; JAMES TN, 1975, CIRCULATION, V52, P179, DOI 10.1161/01.CIR.52.2.179; JAMES TN, 1990, AM J CARDIOL, V65, pG12; JAMES TN, 1983, JPN CIRC J, V47, P1, DOI 10.1253/jcj.47.1; JAMES TN, 1980, CHEST, V78, P24, DOI 10.1378/chest.78.1.24; JAMES TN, 1984, NERVOUS CONTROL CARD, P435; KILBOURNE EM, 1983, NEW ENGL J MED, V309, P1408, DOI 10.1056/NEJM198312083092302; KILBOURNE EM, 1988, AM J EPIDEMIOL, V127, P1210, DOI 10.1093/oxfordjournals.aje.a114914; MARTIN RW, 1990, ANN INTERN MED, V113, P124, DOI 10.7326/0003-4819-113-2-124; MAYENO AN, 1990, SCIENCE, V250, P1707, DOI 10.1126/science.2270484; MEDSGER TA, 1990, NEW ENGL J MED, V322, P926, DOI 10.1056/NEJM199003293221309; PHILEN RM, 1991, ARCH INTERN MED, V151, P533, DOI 10.1001/archinte.151.3.533; SALE GE, 1990, LANCET, V335, P420; SHERF L, 1966, J PHARMACOL EXP THER, V153, P197; SILVER RM, 1990, NEW ENGL J MED, V322, P874, DOI 10.1056/NEJM199003293221302; SLUTSKER L, 1990, JAMA-J AM MED ASSOC, V264, P213, DOI 10.1001/jama.264.2.213; STACHOW A, 1977, BRIT J DERMATOL, V97, P147, DOI 10.1111/j.1365-2133.1977.tb15060.x; STERNBERG EM, 1980, NEW ENGL J MED, V303, P782, DOI 10.1056/NEJM198010023031403; STRONGWATER SL, 1990, ARCH INTERN MED, V150, P2178, DOI 10.1001/archinte.150.10.2178; SWYGERT LA, 1990, JAMA-J AM MED ASSOC, V264, P1698, DOI 10.1001/jama.264.13.1698; TAI PC, 1987, LANCET, V1, P643; TAZELAAR HD, 1990, CHEST, V97, P1032, DOI 10.1378/chest.97.5.1032; VARGA J, 1990, ANN INTERN MED, V112, P344, DOI 10.7326/0003-4819-112-5-344; WILLIAMS S, 1990, SCIENCE, V248, P958, DOI 10.1126/science.2343310; 1990, MMWR, V39, P789; 1990, FDA DRUG B       APR; 1990, MMWR, V39, P587	50	32	32	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	1991	115	2					102	110		10.7326/0003-4819-115-2-102	http://dx.doi.org/10.7326/0003-4819-115-2-102			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW091	2058857				2022-12-28	WOS:A1991FW09100005
J	HEIDRICH, FE; STERGACHIS, A; GROSS, KM				HEIDRICH, FE; STERGACHIS, A; GROSS, KM			DIURETIC DRUG-USE AND THE RISK FOR HIP FRACTURE	ANNALS OF INTERNAL MEDICINE			English	Article						DIURETICS, THIAZIDE; FUROSEMIDE; HIP FRACTURES; THIAZIDES; OSTEOPOROSIS	BONE-MINERAL CONTENT; THIAZIDE DIURETICS; ELDERLY WOMEN; FALLS; PREVENTION; ESTROGEN	Objective: To test the hypothesis that use of thiazide diuretics prevents hip fracture and to study the risk for hip fracture associated with furosemide use. Design: A case-control study. Setting: Hospitals owned by a health maintenance organization in Washington. Patients: Elderly patients (n = 462) hospitalized because of a hip fracture between 1977 and 1983 and an equal number of age- and sex-matched population-based control patients. Measurements: Use of thiazide diuretics and furosemide was ascertained from medical records and computerized pharmacy records. The relative risk for hip fracture associated with diuretic use was calculated and adjusted for the potentially confounding effects of nursing home residence; previous hospitalizations; a history of stroke, alcoholism, or the organic brain syndrome; body weight; leg paralysis; and use of phenobarbital, corticosteroids, or other diuretics. Current and former users of diuretics were analyzed separately. Main Results: The adjusted risk for hip fracture was 1.6 (95% Cl, 1.0 to 2.5) for current thiazide users. The adjusted risk for hip fracture for current furosemide use was 3.9 (Cl, 1.5 to 10.4). Conclusions: According to this study, use of thiazide diuretics did not protect against hip fracture and cannot be recommended for fracture prevention. Current furosemide use was also associated with hip fracture.	UNIV WASHINGTON, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	HEIDRICH, FE (corresponding author), GRP HLTH COOPERAT PUGET SOUND, 200 15TH AVE E, SEATTLE, WA 98112 USA.							ADLANDDAVENPORT P, 1985, AM J OBSTET GYNECOL, V152, P630, DOI 10.1016/S0002-9378(85)80035-1; CAMPBELL AJ, 1989, J GERONTOL, V44, pM112, DOI 10.1093/geronj/44.4.m112; HALE WE, 1984, J AM GERIATR SOC, V32, P5, DOI 10.1111/j.1532-5415.1984.tb05142.x; HUNT I, 1988, AM J EPIDEMIOL, V128, P903; JICK H, 1980, AM J EPIDEMIOL, V112, P577, DOI 10.1093/oxfordjournals.aje.a113030; JOHNSON RE, 1981, AM J PUBLIC HEALTH, V71, P138, DOI 10.2105/AJPH.71.2.138; LACROIX AZ, 1990, NEW ENGL J MED, V322, P286, DOI 10.1056/NEJM199002013220502; LINDSAY R, 1987, J BONE MINER RES  S1, V2, P529; MANNING WG, 1984, NEW ENGL J MED, V310, P1505, DOI 10.1056/NEJM198406073102305; MANTEL N, 1959, J NATL CANCER I, V22, P719; MELTON LJ, 1983, OSTEOPOROSIS SYNDROM; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; PEARSON DC, 1987, PREV MED, V16, P783, DOI 10.1016/0091-7435(87)90018-1; RASHIQ S, 1986, BRIT MED J, V292, P861, DOI 10.1136/bmj.292.6524.861; RAY WA, 1989, LANCET, V1, P687; RESNICK NM, 1989, JAMA-J AM MED ASSOC, V261, P1025, DOI 10.1001/jama.261.7.1025; ROSS RT, 1989, NEW ENGL J MED, V321, P1614; Sernbo I, 1987, Compr Gerontol A, V1, P93; SHELDON JH, 1960, BRIT MED J, V2, P1685, DOI 10.1136/bmj.2.5214.1685; SOWERS JR, 1989, J LAB CLIN MED, V114, P338; STERGACHIS A, 1989, PHARMACOEPIDEMIOLOGY; Stergachis AS, 1991, PHARMACOEPIDEMIOLOGY; SUKI WN, 1970, NEW ENGL J MED, V283, P836, DOI 10.1056/NEJM197010152831603; TAGGART HM, 1988, J AM GERIATR SOC, V36, P1006, DOI 10.1111/j.1532-5415.1988.tb04367.x; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TINETTI ME, 1989, NEW ENGL J MED, V320, P1055; TRANSBOL I, 1982, METABOLISM, V31, P383, DOI 10.1016/0026-0495(82)90115-9; WASNICH RD, 1986, OBSTET GYNECOL, V67, P457; WASNICH RD, 1983, NEW ENGL J MED, V309, P344, DOI 10.1056/NEJM198308113090605; WASNICH RD, 1987, OSTEOPOROSIS UPDATE; 1985, SAS RELEASE 5 18	32	110	111	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1991	115	1					1	6		10.7326/0003-4819-115-1-1	http://dx.doi.org/10.7326/0003-4819-115-1-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT937	2048857				2022-12-28	WOS:A1991FT93700001
J	AKIBA, T; YOSHIMURA, H; NAMBA, K				AKIBA, T; YOSHIMURA, H; NAMBA, K			MONOLAYER CRYSTALLIZATION OF FLAGELLAR L-P RINGS BY SEQUENTIAL ADDITION AND DEPLETION OF LIPID	SCIENCE			English	Article							BASAL-BODY COMPLEX; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; OUTER MEMBRANES; PROTEINS	The L-P ring complex is thought to be a molecular bushing that supports flagellar motor rotation at about 10,000 revolutions per minute with presumably very little friction. Structural studies of this complex have been limited because only very small amount of samples are available. Therefore devising an efficient method of crystallization was essential. The addition of a phospholipid and its subsequent slow depletion by phospholipase A2 have been used to successfully grow well-ordered monolayer crystals that extend up to about 10 micrometers. The interaction of the L-P ring complex with lipid membranes was also visualized during this process.	ERATO,MOLEC DYNAM ASSEMBLY PROJECT,5-9-5 TOKODAI,TSUKUBA 30026,JAPAN; JEOL LTD,BIOMETROL LAB,AKISHIMA 196,JAPAN	Jeol Ltd; JEOL Japan								AIZAWA S, 1985, J BACTERIOL, V161, P836, DOI 10.1128/JB.161.3.836-849.1985; DEPAMPHI.ML, 1971, J BACTERIOL, V105, P384, DOI 10.1128/JB.105.1.384-395.1971; JONES CJ, 1987, J BACTERIOL, V169, P1489, DOI 10.1128/jb.169.4.1489-1492.1987; JONES CJ, 1990, J MOL BIOL, V212, P377, DOI 10.1016/0022-2836(90)90132-6; JONES CJ, 1989, J BACTERIOL, V171, P3890, DOI 10.1128/jb.171.7.3890-3900.1989; KLEFFEL B, 1985, EMBO J, V4, P1589, DOI 10.1002/j.1460-2075.1985.tb03821.x; MANNELLA CA, 1984, SCIENCE, V224, P165, DOI 10.1126/science.6322311; NIKAIDO H, 1987, ESCHERICHIA COLI SAL, P7; PATTERSO.J, 1973, ARCH MIKROBIOL, V90, P107, DOI 10.1007/BF00414513; STALLMEYER MJB, 1989, J MOL BIOL, V205, P519, DOI 10.1016/0022-2836(89)90223-4; YOSHIMURA H, 1990, ULTRAMICROSCOPY, V32, P265, DOI 10.1016/0304-3991(90)90004-6	11	50	52	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1991	252	5012					1544	1546		10.1126/science.2047860	http://dx.doi.org/10.1126/science.2047860			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR040	2047860				2022-12-28	WOS:A1991FR04000045
J	MCCORMICK, PA; HUGHES, JE; BURROUGHS, AK; MCINTYRE, N				MCCORMICK, PA; HUGHES, JE; BURROUGHS, AK; MCINTYRE, N			LESSON OF THE WEEK - REFORMULATION OF INJECTABLE VITAMIN-A - POTENTIAL PROBLEMS	BRITISH MEDICAL JOURNAL			English	Article									ROYAL FREE HOSP,DEPT PHARM,LONDON NW3 2QG,ENGLAND	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	MCCORMICK, PA (corresponding author), ROYAL FREE HOSP,SCH MED,HEPATOBILIARY & LIVER TRANSPLANTAT UNIT,LONDON NW3 2QG,ENGLAND.		Burroughs, Andrew K/C-5645-2009	Burroughs, Andrew K/0000-0001-6527-457X					0	14	14	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 20	1990	301	6757					924	924		10.1136/bmj.301.6757.924	http://dx.doi.org/10.1136/bmj.301.6757.924			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED923	2091636	Green Published, Bronze			2022-12-28	WOS:A1990ED92300032
J	BUXBAUM, JN; CHUBA, JV; HELLMAN, GC; SOLOMON, A; GALLO, GR				BUXBAUM, JN; CHUBA, JV; HELLMAN, GC; SOLOMON, A; GALLO, GR			MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE - LIGHT CHAIN AND LIGHT AND HEAVY-CHAIN DEPOSITION DISEASES AND THEIR RELATION TO LIGHT CHAIN AMYLOIDOSIS - CLINICAL-FEATURES, IMMUNOPATHOLOGY, AND MOLECULAR ANALYSIS	ANNALS OF INTERNAL MEDICINE			English	Review									NYU, SCH MED, NEW YORK, NY 10003 USA; LENOX HILL HOSP, NEW YORK, NY 10021 USA; UNIV TENNESSEE, KNOXVILLE, TN 37996 USA	New York University; Northwell Health; University of Tennessee System; University of Tennessee Knoxville	BUXBAUM, JN (corresponding author), VET ADM MED CTR, RES SERV, 408 1ST AVE, NEW YORK, NY 10010 USA.				NCI NIH HHS [CA 10056] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA010056] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTONOVYCH T, 1973, LAB INVEST, V30, pA370; AURIOL M, 1985, Archives d'Anatomie et de Cytologie Pathologiques, V33, P209; BANGERTER AR, 1987, VIRCHOWS ARCH A, V410, P531; BEDOSSA P, 1988, HUM PATHOL, V19, P1008, DOI 10.1016/S0046-8177(88)80078-9; BENMAIZ H, 1984, 9TH P INT C NEPHR, pA107; BRADLEY JR, 1987, J CLIN PATHOL, V40, P53, DOI 10.1136/jcp.40.1.53; BRIEFEL GR, 1983, SURGERY, V93, P579; BRUNEVAL P, 1985, HUM PATHOL, V16, P477, DOI 10.1016/S0046-8177(85)80086-1; BUXBAUM J, 1986, J CLIN INVEST, V78, P798, DOI 10.1172/JCI112643; CARBONE PP, 1967, AM J MED, V42, P937, DOI 10.1016/0002-9343(67)90074-5; CHUBA JV, 1979, J APPL BIOCHEM, V1, P37; COHEN JJ, 1981, NEW ENGL J MED, V304, P33; DALAKAS MC, 1981, ANN NEUROL, V10, P45, DOI 10.1002/ana.410100109; ELFENBEIN IB, 1978, KIDNEY INT, V14, P710; FERNANDEZSOLA J, 1987, ACTA HAEMATOL-BASEL, V77, P231, DOI 10.1159/000206001; GALLO G, 1988, MODERN PATHOL, V1, P453; GALLO GR, 1980, AM J PATHOL, V99, P621; GANEVAL D, 1984, KIDNEY INT, V26, P1, DOI 10.1038/ki.1984.126; GANEVAL D, 1982, ADV NEPHROL, V11, P25; GAVAROTTI P, 1986, SCAND J HAEMATOL, V36, P115; GEPHARDT GN, 1983, CLEVELAND CLIN Q, V50, P243; GERLAG PGG, 1986, CLIN NEPHROL, V25, P101; GIPSTEIN RM, 1982, AM J NEPHROL, V2, P276, DOI 10.1159/000166661; GIRONE JF, 1986, 16TH P M NAT KIDN F; GRUSSENDORF M, 1984, DEUT MED WOCHENSCHR, V109, P1405, DOI 10.1055/s-2008-1069386; HEILMAN RL, 1989, KIDNEY INT, V35, P209; HERF S, 1979, AM J MED, V66, P1040, DOI 10.1016/0002-9343(79)90462-5; HILL GS, 1983, AM J KIDNEY DIS, V2, P423, DOI 10.1016/S0272-6386(83)80075-4; HOFFMANGUILAINE C, 1984, ANN PATHOL, V4, P105; HOFMANNGUILAINE C, 1985, PATHOL RES PRACT, V180, P214, DOI 10.1016/S0344-0338(85)80177-1; JACQUOT C, 1985, CLIN NEPHROL, V24, P93; KENNY JJ, 1957, ANN INTERN MED, V46, P1079, DOI 10.7326/0003-4819-46-6-1079; KIJNER CH, 1988, AM J SURG PATHOL, V12, P405, DOI 10.1097/00000478-198805000-00009; KING JT, 1978, LAB INVEST, V39, P591; KNOBLER H, 1983, NEPHRON, V34, P58, DOI 10.1159/000182980; KYLE RA, 1983, MAYO CLIN PROC, V58, P665; LAPENAS DJ, 1983, ARCH PATHOL LAB MED, V107, P319; LAURENT M, 1985, ARCH MAL COEUR VAISS, V78, P943; LINDER J, 1983, AM J SURG PATHOL, V7, P85, DOI 10.1097/00000478-198301000-00009; MALLICK NP, 1978, Q J MED, V47, P145; MCALLISTER HA, 1988, ARCH PATHOL LAB MED, V112, P1151; MORINAGA S, 1987, AM J SURG PATHOL, V11, P989, DOI 10.1097/00000478-198712000-00010; NAKAMOTO Y, 1985, AM J NEPHROL, V5, P53, DOI 10.1159/000166905; NOEL LH, 1984, CLIN NEPHROL, V21, P263; PALANT CE, 1986, AM J MED, V80, P98, DOI 10.1016/0002-9343(86)90055-0; PELLETIER G, 1988, POSTGRAD MED J, V64, P804, DOI 10.1136/pgmj.64.756.804; PENG SK, 1988, ARCH PATHOL LAB MED, V112, P844; PENNEC Y, 1983, SCAND J HAEMATOL, V30, P183; PICKEN MM, 1989, AM J PATHOL, V134, P749; PICKEN MM, 1986, AM J PATHOL, V124, P82; PREUDHOMME JL, 1980, AM J MED, V69, P703, DOI 10.1016/0002-9343(80)90421-0; PREUDHOMME JL, 1980, CLIN EXP IMMUNOL, V42, P545; PREUDHOMME JL, 1982, IMMUNOPATHOLOGY, P331; RANDALL RE, 1976, AM J MED, V60, P293, DOI 10.1016/0002-9343(76)90440-X; SCHUBERT GE, 1974, J CLIN PATHOL, V27, P800, DOI 10.1136/jcp.27.10.800; SEYMOUR AE, 1980, AM J PATHOL, V101, P557; SILVA F, 1980, LAB INVEST, V42, P151; SILVER MM, 1986, AM J PATHOL, V122, P17; SINNIAH R, 1985, AM J PATHOL, V118, P298; SMITH NM, 1986, HISTOPATHOLOGY, V10, P1057, DOI 10.1111/j.1365-2559.1986.tb02542.x; SOLLING K, 1973, ACTA MED SCAND, V194, P23; SOLLING K, 1980, ACTA MED SCAND, V207, P137; STAROS E, 1985, AM HEART J, V110, P1295, DOI 10.1016/0002-8703(85)90028-6; SWANTON RH, 1977, AM J CARDIOL, V39, P658, DOI 10.1016/S0002-9149(77)80125-2; TANGE T, 1978, ACTA PATHOL JAPON, V28, P325; TOYODA M, 1988, ACTA PATHOL JAPON, V38, P479; TUBBS RR, 1981, AM J MED, V71, P263, DOI 10.1016/0002-9343(81)90127-3; VENKATASESHAN VS, 1988, AM J NEPHROL, V8, P272, DOI 10.1159/000167600; VITAL C, 1985, NEUROLOGY, V35, P603, DOI 10.1212/WNL.35.4.603; VOINCHET O, 1988, GASTROENTEROLOGY, V95, P482, DOI 10.1016/0016-5085(88)90508-2; WARFEL KA, 1987, LAB INVEST, V56, pA84	71	221	229	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	1990	112	6					455	464		10.7326/0003-4819-76-3-112-6-455	http://dx.doi.org/10.7326/0003-4819-76-3-112-6-455			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT100	2106817				2022-12-28	WOS:A1990CT10000009
J	CAMERINI, D; SEED, B				CAMERINI, D; SEED, B			A CD4 DOMAIN IMPORTANT FOR HIV-MEDIATED SYNCYTIUM FORMATION LIES OUTSIDE THE VIRUS BINDING-SITE	CELL			English	Article									MASSACHUSETTS GEN HOSP,DEPT MOLEC BIOL,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital	CAMERINI, D (corresponding author), HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115, USA.							ARTHOS J, 1989, CELL, V57, P469, DOI 10.1016/0092-8674(89)90922-7; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; BIDDISON WE, 1982, J EXP MED, V156, P1065, DOI 10.1084/jem.156.4.1065; CHAO BH, 1989, J BIOL CHEM, V264, P5812; CHENGMAYER C, 1988, SCIENCE, V240, P80, DOI 10.1126/science.2832945; CLARK SJ, 1987, P NATL ACAD SCI USA, V84, P1649, DOI 10.1073/pnas.84.6.1649; CLAYTON LK, 1989, NATURE, V339, P548, DOI 10.1038/339548a0; CLAYTON LK, 1988, NATURE, V335, P363, DOI 10.1038/335363a0; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; ENGLEMAN EG, 1981, J IMMUNOL, V127, P2124; GAJDUSEK DC, 1985, LANCET, V1, P55; GARTNER S, 1986, JAMA-J AM MED ASSOC, V256, P2365, DOI 10.1001/jama.256.17.2365; JAMESON BA, 1988, SCIENCE, V240, P1335, DOI 10.1126/science.2453925; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; KOWALSKI M, 1987, SCIENCE, V237, P1351, DOI 10.1126/science.3629244; KRENSKY AM, 1982, P NATL ACAD SCI-BIOL, V79, P2365, DOI 10.1073/pnas.79.7.2365; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAMARRE D, 1989, SCIENCE, V245, P743, DOI 10.1126/science.2549633; LANDAU NR, 1988, NATURE, V334, P159, DOI 10.1038/334159a0; LASKY LA, 1987, CELL, V50, P975, DOI 10.1016/0092-8674(87)90524-1; LAZAROVITS AI, 1984, J IMMUNOL, V133, P1857; LEONARD R, 1988, P NATL ACAD SCI USA, V85, P3570, DOI 10.1073/pnas.85.10.3570; LIFSON JD, 1988, SCIENCE, V241, P712, DOI 10.1126/science.2969619; LIFSON JD, 1986, NATURE, V323, P725, DOI 10.1038/323725a0; LIFSON JD, 1986, SCIENCE, V232, P1123, DOI 10.1126/science.3010463; MADDON PJ, 1987, P NATL ACAD SCI USA, V84, P9155, DOI 10.1073/pnas.84.24.9155; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; MARSH M, 1984, BIOCHEM J, V218, P1; MCCLURE MO, 1988, EMBO J, V7, P513, DOI 10.1002/j.1460-2075.1988.tb02839.x; MCCLURE MO, 1987, NATURE, V330, P487, DOI 10.1038/330487a0; MCDOUGAL JS, 1986, J IMMUNOL, V137, P2937; MEUER SC, 1982, P NATL ACAD SCI-BIOL, V79, P4395, DOI 10.1073/pnas.79.14.4395; MIZUKAMI T, 1988, P NATL ACAD SCI USA, V85, P9273, DOI 10.1073/pnas.85.23.9273; NARA P, 1989, J MED PRIMATOL, V18, P343; NARA PL, 1989, P NATL ACAD SCI USA, V86, P7139, DOI 10.1073/pnas.86.18.7139; PETERSON A, 1988, CELL, V54, P65, DOI 10.1016/0092-8674(88)90180-8; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATTENTAU QJ, 1989, J EXP MED, V170, P1319, DOI 10.1084/jem.170.4.1319; SATTENTAU QJ, 1986, SCIENCE, V234, P1120, DOI 10.1126/science.2430333; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SODROSKI J, 1986, NATURE, V322, P470, DOI 10.1038/322470a0; SOMASUNDARAN M, 1987, J VIROL, V61, P3114, DOI 10.1128/JVI.61.10.3114-3119.1987; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; STOLER MH, 1986, JAMA-J AM MED ASSOC, V256, P2360, DOI 10.1001/jama.256.17.2360; TERSMETTE M, 1988, J VIROL, V62, P2026, DOI 10.1128/JVI.62.6.2026-2032.1988; TERSMETTE M, 1989, J VIROL, V63, P2118, DOI 10.1128/JVI.63.5.2118-2125.1989; VONBRIESEN H, 1987, J MED VIROL, V23, P51, DOI 10.1002/jmv.1890230107; WHITE J, 1983, Q REV BIOPHYS, V16, P151, DOI 10.1017/S0033583500005072; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	53	181	196	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAR 9	1990	60	5					747	754		10.1016/0092-8674(90)90089-W	http://dx.doi.org/10.1016/0092-8674(90)90089-W			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CV174	2107024				2022-12-28	WOS:A1990CV17400007
J	NAKAMURA, T; TAKIO, K; ETO, Y; SHIBAI, H; TITANI, K; SUGINO, H				NAKAMURA, T; TAKIO, K; ETO, Y; SHIBAI, H; TITANI, K; SUGINO, H			ACTIVIN-BINDING PROTEIN FROM RAT OVARY IS FOLLISTATIN	SCIENCE			English	Article									INST PHYS & CHEM RES,FRONTIER RES PROGRAM,WAKO,SAITAMA 35101,JAPAN; FUJITA GAKUEN HLTH UNIV,TOYOAKE,AICHI 47011,JAPAN; AJINOMOTO CO INC,CENT RES LABS,KAWASAKI KU,KAWASAKI,KANAGAWA 210,JAPAN	RIKEN; Fujita Health University; Ajinomoto Co Inc								CAMPEN CA, 1988, BIOCHEM BIOPH RES CO, V157, P844, DOI 10.1016/S0006-291X(88)80326-7; ESCH FS, 1987, MOL ENDOCRINOL, V1, P849, DOI 10.1210/mend-1-11-849; ESCH FS, 1987, MOL ENDOCRINOL, V1, P388, DOI 10.1210/mend-1-5-388; ETO Y, 1987, BIOCHEM BIOPH RES CO, V142, P1095, DOI 10.1016/0006-291X(87)91528-2; FORAGE RG, 1986, P NATL ACAD SCI USA, V83, P3091, DOI 10.1073/pnas.83.10.3091; FUKUDA M, 1986, MOL CELL ENDOCRINOL, V44, P55, DOI 10.1016/0303-7207(86)90105-X; HASEGAWA Y, 1988, BIOCHEM BIOPH RES CO, V156, P668, DOI 10.1016/S0006-291X(88)80894-5; HINO M, 1989, J BIOL CHEM, V264, P10309; HUTCHINSON LA, 1987, BIOCHEM BIOPH RES CO, V146, P1405, DOI 10.1016/0006-291X(87)90806-0; KITAOKA M, 1988, BIOCHEM BIOPH RES CO, V157, P48, DOI 10.1016/S0006-291X(88)80009-3; KONDO S, 1989, BIOCHEM BIOPH RES CO, V161, P1267, DOI 10.1016/0006-291X(89)91379-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVERSHA LJ, 1987, J ENDOCRINOL, V113, P213, DOI 10.1677/joe.0.1130213; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; LING N, 1985, P NATL ACAD SCI USA, V82, P7217, DOI 10.1073/pnas.82.21.7217; MASON AJ, 1985, NATURE, V318, P659, DOI 10.1038/318659a0; MASON AJ, 1986, BIOCHEM BIOPH RES CO, V135, P957, DOI 10.1016/0006-291X(86)91021-1; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MAYO KE, 1986, P NATL ACAD SCI USA, V83, P5849, DOI 10.1073/pnas.83.16.5849; MIYAMOTO K, 1985, BIOCHEM BIOPH RES CO, V129, P396, DOI 10.1016/0006-291X(85)90164-0; MURATA M, 1988, P NATL ACAD SCI USA, V85, P2434, DOI 10.1073/pnas.85.8.2434; MURATA M, 1988, BIOCHEM BIOPH RES CO, V151, P230, DOI 10.1016/0006-291X(88)90583-9; Nakamura T., UNPUB; RIVIER J, 1985, BIOCHEM BIOPH RES CO, V133, P120, DOI 10.1016/0006-291X(85)91849-2; ROBERTSON DM, 1986, MOL CELL ENDOCRINOL, V44, P271, DOI 10.1016/0303-7207(86)90133-4; ROBERTSON DM, 1987, BIOCHEM BIOPH RES CO, V149, P744, DOI 10.1016/0006-291X(87)90430-X; ROBERTSON DM, 1985, BIOCHEM BIOPH RES CO, V126, P220, DOI 10.1016/0006-291X(85)90594-7; SHIMASAKI S, 1989, MOL ENDOCRINOL, V3, P651, DOI 10.1210/mend-3-4-651; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; STEWART AG, 1986, FEBS LETT, V206, P329, DOI 10.1016/0014-5793(86)81006-7; SUGINO H, 1988, BIOCHEM BIOPH RES CO, V153, P281, DOI 10.1016/S0006-291X(88)81219-1; SUGINO H, 1988, J BIOL CHEM, V263, P15249; TOTSUKA Y, 1988, BIOCHEM BIOPH RES CO, V156, P335, DOI 10.1016/S0006-291X(88)80845-3; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; YING SY, 1987, BIOCHEM BIOPH RES CO, V149, P133, DOI 10.1016/0006-291X(87)91614-7; YU J, 1987, NATURE, V330, P765, DOI 10.1038/330765a0	37	826	857	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 16	1990	247	4944					836	838		10.1126/science.2106159	http://dx.doi.org/10.1126/science.2106159			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN990	2106159				2022-12-28	WOS:A1990CN99000030
J	MLODZIK, M; HIROMI, Y; WEBER, U; GOODMAN, CS; RUBIN, GM				MLODZIK, M; HIROMI, Y; WEBER, U; GOODMAN, CS; RUBIN, GM			THE DROSOPHILA 7-UP GENE, A MEMBER OF THE STEROID-RECEPTOR GENE SUPERFAMILY, CONTROLS PHOTORECEPTOR CELL FATES	CELL			English	Article									UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	MLODZIK, M (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,BERKELEY,CA 94720, USA.			Rubin, Gerald/0000-0001-8762-8703	NINDS NIH HHS [NS18366] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANERJEE U, 1987, CELL, V49, P281, DOI 10.1016/0092-8674(87)90569-1; BASLER K, 1988, CELL, V54, P299; BASLER K, 1989, SCIENCE, V243, P931, DOI 10.1126/science.2493159; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; BOWTELL DDL, 1989, CELL, V56, P931, DOI 10.1016/0092-8674(89)90626-0; BOWTELL DDL, 1988, GENE DEV, V2, P620, DOI 10.1101/gad.2.6.620; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; EVANS RM, 1989, NEURON, V2, P1105, DOI 10.1016/0896-6273(89)90177-3; FEIGL G, 1989, NUCLEIC ACIDS RES, V17, P7167, DOI 10.1093/nar/17.18.7167; GAUSZ J, 1981, GENETICS, V98, P775; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; HAFEN E, 1987, SCIENCE, V236, P55, DOI 10.1126/science.2882603; HANAHAN D, 1980, CELL, V21, P127, DOI 10.1016/0092-8674(80)90120-8; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HARDIE RC, 1986, TRENDS NEUROSCI, V9, P419, DOI 10.1016/0166-2236(86)90136-0; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; KOENIG RJ, 1989, NATURE, V337, P659, DOI 10.1038/337659a0; KORNBERG T, 1985, CELL, V40, P45, DOI 10.1016/0092-8674(85)90307-1; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LEVIS R, 1985, EMBO J, V4, P3489, DOI 10.1002/j.1460-2075.1985.tb04108.x; LIS JT, 1983, CELL, V35, P403, DOI 10.1016/0092-8674(83)90173-3; MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3; MISMER D, 1989, GENETICS, V121, P77; MITSUHASHI T, 1988, P NATL ACAD SCI USA, V85, P5804, DOI 10.1073/pnas.85.16.5804; MIYAJIMA N, 1988, NUCLEIC ACIDS RES, V16, P11057, DOI 10.1093/nar/16.23.11057; MONTELL C, 1987, J NEUROSCI, V7, P1558; NAUBER U, 1988, NATURE, V336, P489, DOI 10.1038/336489a0; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; ORO AE, 1988, NATURE, V336, P493, DOI 10.1038/336493a0; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; READY DF, 1989, TRENDS NEUROSCI, V12, P102, DOI 10.1016/0166-2236(89)90166-5; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; ROBERTSON HM, 1988, GENETICS, V118, P461; ROTHE M, 1989, EMBO J, V8, P3087, DOI 10.1002/j.1460-2075.1989.tb08460.x; RUBIN GM, 1989, CELL, V57, P519, DOI 10.1016/0092-8674(89)90120-7; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEGRAVES WA, 1988, THESIS STANFORD U ST; SIMON JA, 1985, CELL, V40, P805, DOI 10.1016/0092-8674(85)90340-X; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THALLER C, 1987, NATURE, V327, P625, DOI 10.1038/327625a0; TOMLINSON A, 1988, DEVELOPMENT, V104, P183; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; TOMLINSON A, 1986, SCIENCE, V231, P400, DOI 10.1126/science.231.4736.400; TSAI SY, 1987, CELL, V50, P701, DOI 10.1016/0092-8674(87)90328-X; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0; ZIPURSKY SL, 1989, TRENDS NEUROSCI, V12, P183, DOI 10.1016/0166-2236(89)90069-6; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	59	446	458	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 26	1990	60	2					211	224		10.1016/0092-8674(90)90737-Y	http://dx.doi.org/10.1016/0092-8674(90)90737-Y			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL816	2105166				2022-12-28	WOS:A1990CL81600006
J	WILLIAMS, EI; FITTON, F				WILLIAMS, EI; FITTON, F			GENERAL-PRACTITIONER RESPONSE TO ELDERLY PATIENTS DISCHARGED FROM HOSPITAL	BRITISH MEDICAL JOURNAL			English	Article											WILLIAMS, EI (corresponding author), UNIV NOTTINGHAM,QUEENS MED CTR,DEPT GEN PRACTICE,NOTTINGHAM NG7 2UH,ENGLAND.							Balint M., 1964, DOCTOR HIS PATIENT I; BROCKLEHURST JC, 1969, GERONTOL CLIN, V11, P115, DOI 10.1159/000245224; Dover S B, 1984, Health Trends, V16, P48; FITTON F, 1985, SOC SCI MED, V21, P1097, DOI 10.1016/0277-9536(85)90166-2; MAGEEAN RJ, 1986, BRIT MED J, V293, P1283, DOI 10.1136/bmj.293.6557.1283; SANDLER DA, 1987, BRIT MED J, V295, P1523, DOI 10.1136/bmj.295.6612.1523; WILLIAMS EI, 1988, BRIT MED J, V297, P784, DOI 10.1136/bmj.297.6651.784	7	39	39	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					159	161		10.1136/bmj.300.6718.159	http://dx.doi.org/10.1136/bmj.300.6718.159			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105794	Bronze, Green Published			2022-12-28	WOS:A1990CK07700021
J	LOCK, S				LOCK, S			MONITORING RESEARCH ETHICAL COMMITTEES	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Beecher H. K., 1959, EXPT MAN; Coney Sandra, 1989, Lancet, V2, P1445; DENHAM MJ, 1979, BRIT MED J, V2, P1042, DOI 10.1136/bmj.2.6197.1042; GILBERT C, 1989, BRIT MED J, V299, P1437, DOI 10.1136/bmj.299.6713.1437; GILDER S, 1964, BRIT MED J, V2, P299, DOI 10.1136/bmj.2.5404.299; LEVINE RJ, 1989, BMJ-BRIT MED J, V298, P1268, DOI 10.1136/bmj.298.6683.1268; LOWRY S, 1988, BRIT MED J, V297, P507; Pappworth M. H., 1967, HUMAN GUINEA PIGS EX; PAPPWORTH MH, 1967, BMJ-BRIT MED J, V2, P837, DOI 10.1136/bmj.2.5555.837-a; PAUL C, 1988, BMJ-BRIT MED J, V297, P533, DOI 10.1136/bmj.297.6647.533; RIIS P, 1988, IME B            JUN, P15; SMITH R, 1989, BRIT MED J, V298, P1125, DOI 10.1136/bmj.298.6681.1125; THOMPSON IE, 1981, BRIT MED J, V282, P718, DOI 10.1136/bmj.282.6265.718; WARNOCK M, 1988, BRIT MED J, V297, P1626, DOI 10.1136/bmj.297.6664.1626; WITTS LJ, 1967, BRIT MED J, V2, P689, DOI 10.1136/bmj.2.5553.689; WITTS LJ, 1973, BRIT MED J, V2, P220; 1968, SUPERVISION ETHICS C; 1989, ANN REPORT COUNCIL 1, P30; 1967, BRIT MED J, V4, P105; 1989, IME B            FEB, P6; 1990, GUIDELINES PRACTICE; 1989, DRAFT GUIDELINES LOC; 1967, BRIT MED J, V3, P429; 1964, BRIT MED J, V2, P178; 1986, RES ETHICS COMMITT S, V2; 1984, GUIDELINES PRACTICE	26	24	24	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					61	62		10.1136/bmj.300.6717.61	http://dx.doi.org/10.1136/bmj.300.6717.61			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CJ080	2105770	Bronze, Green Published			2022-12-28	WOS:A1990CJ08000001
J	BARRY, M				BARRY, M			IMPORTED DIPHTHERIA - ADVICE FOR TRAVELERS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											BARRY, M (corresponding author), YALE UNIV,SCH MED,INT TROP MED & TRAVELERS CLIN,NEW HAVEN,CT 06510, USA.							CHEN RT, 1985, AM J PUBLIC HEALTH, V75, P1393, DOI 10.2105/AJPH.75.12.1393; HARNISCH JP, 1989, ANN INTERN MED, V111, P71, DOI 10.7326/0003-4819-111-1-71; HOLMES RK, 1991, HARRISONS PRINCIPLES, P569; 1985, ANN INTERN MED, V103, P896	4	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1991	266	4					582	582						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FX021	2061989				2022-12-28	WOS:A1991FX02100037
J	POLITZER, RM; HARRIS, DL; GASTON, MH; MULLAN, F				POLITZER, RM; HARRIS, DL; GASTON, MH; MULLAN, F			PRIMARY CARE PHYSICIAN SUPPLY AND THE MEDICALLY UNDERSERVED - A STATUS-REPORT AND RECOMMENDATIONS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLICY				POLITZER, RM (corresponding author), US PHS,5600 FISHERS LN,ROOM 8-05,ROCKVILLE,MD 20857, USA.							BABITZ M, 1990, PROPOSED STRATEGIES; BARNETT PG, 1989, JAMA-J AM MED ASSOC, V262, P2864, DOI 10.1001/jama.262.20.2864; CHAPPEL J, 1990, FAM MED, V22, P226; COLWILL J, 1990, 2ND P HLTH RES SERV, P319; Colwill J M, 1988, Fam Med, V20, P250; EBELL MH, 1990, JAMA-J AM MED ASSOC, V262, P1630; GINSBURG PB, 1990, HEALTH AFFAIR, V9, P178, DOI 10.1377/hlthaff.9.1.178; HANFT R, 1990, SUPPORT GRADUATE MED; HARRIS DL, 1982, J MED EDUC, V57, P609; HEAD R, 1989, J FAM MED, V21, P187; HSAIO WC, 1988, JAMA-J AM MED ASSOC, V260, P2347; KLETKE PR, 1987, ANN INTERN MED, V107, P93, DOI 10.7326/0003-4819-107-1-93; MILLIS J, 1966, GRADUATE ED PHYSICIS; MULLAN F, 1988, PRIMARY CARE MED ED; MULLAN F, 1984, REFORMING MED LESSON; NOBLE J, 1987, HRP0907161 US DEP HL; POLITZER R, 1990, TRENDS PRIMARY CARE; Rabinowitz H K, 1988, Fam Med, V20, P118; RABINOWITZ HK, 1988, NEW ENGL J MED, V319, P480, DOI 10.1056/NEJM198808253190805; REINHARDT U, 1989, CLIN ED DOCTORS TOMO, P101; REISELBACH RE, 1986, NEW ENGL J MED, V314, P32; ROSENBLATT RA, 1991, WESTERN J MED, V154, P43; SARTELL A, 1988, US EXPT SOCIAL MED C; SHELOV SP, 1987, AM J DIS CHILD, V141, P65, DOI 10.1001/archpedi.1987.04460010065025; SHULKIN DJ, 1990, JAMA-J AM MED ASSOC, V262, P1630; TEICH JL, 1986, COTH SURVEY HOUSESTA; 1989, HEARINGS SUBCOMMITTE; 1978, MANPOWER POLICY PRIM; 1990, HLTH PEOPLE 2000 NAT; 1990, HRSPOD906 US DEPT HL; 1988, PHYSICIAN RECRUITMEN; 1990, PROPOSED STRATEGIES; 1991, AAMC DATA BOOK; 1986, IMPACT FEDERAL SUPPO; 1990, HRSAS LONG RANGE ACT; 1990, NRMP DATA; 1982, DHPA158212 PUBL; 1990, SUPPLYING PHYSICIANS; 1990, HRSPOD901 US DEPT HL; 1990, 1990 AAMC GRADUATION; 1988, PHYSICIAN CHARACTERI; 1988, HRSPOD881 PUBL; 1987, GPO0174719 US DEP HL; 1990, EVALUATION IMPACT NA; 1988, COUNCIL GRADUATE MED, P1	45	111	111	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	1991	266	1					104	109		10.1001/jama.266.1.104	http://dx.doi.org/10.1001/jama.266.1.104			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT934	2046118				2022-12-28	WOS:A1991FT93400036
J	WILLIAMS, GC; QUILL, TE; DECI, EL; RYAN, RM				WILLIAMS, GC; QUILL, TE; DECI, EL; RYAN, RM			THE FACTS CONCERNING THE RECENT CARNIVAL OF SMOKING IN CONNECTICUT AND ELSEWHERE	ANNALS OF INTERNAL MEDICINE			English	Article						SMOKING; SMOKING CESSATION; SELF-DETERMINATION THEORY; HUMAN MOTIVATION; TWAIN,MARK	RANDOMIZED TRIAL; QUIT-SMOKING; CESSATION; INTERVENTION; MOTIVATION; PROGRAM	The behavior of health care Practitioners toward their patients can greatly affect the patients' motivation for change. Mark Twain's story, "The Facts Concerning the Recent Carnival of Crime in Connecticut," is used to illustrate how traditional strategies for motivating patients to change can have the paradoxic effect of inhibiting change and growth. We use a theory of human motivation, referred to as self-determination theory, to explain this effect and suggest alternative strategies for facilitating patient motivation. Empirical tests of the theory have shown that people will accept more responsibility for behavior change when motivated internally rather than externally. In the doctor-patient relationship, this internal motivation for change can be facilitated when doctors allow choice, provide relevant information, and acknowledge the patient's perspective. We propose a simple, three-question model, consistent with self-determination theory, for physicians to use with patients who smoke and are not yet ready to try quitting.			WILLIAMS, GC (corresponding author), UNIV ROCHESTER, DEPT PSYCHOL, ROCHESTER, NY 14627 USA.		Ryan, Richard M./H-1459-2019; Deci, Edward L./Y-4790-2019; Deci, Edward L/T-7048-2017	Ryan, Richard M./0000-0002-2355-6154; Deci, Edward L./0000-0001-8246-8536; Deci, Edward L/0000-0001-8246-8536	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD019914] Funding Source: NIH RePORTER; NICHD NIH HHS [HD19914] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 1989, GUIDE CLIN PREVENTIV; BLONDAL T, 1989, ARCH INTERN MED, V149, P1818, DOI 10.1001/archinte.149.8.1818; CUMMINGS SR, 1989, ANN INTERN MED, V110, P640, DOI 10.7326/0003-4819-110-8-640; CURRY S, 1990, J CONSULT CLIN PSYCH, V58, P310, DOI 10.1037/0022-006X.58.3.310; Deci E. L., 1985, INTRINSIC MOTIVATION; DECI EL, 1989, J APPL PSYCHOL, V74, P580, DOI 10.1037/0021-9010.74.4.580; DECI EL, 1981, J PERS SOC PSYCHOL, V40, P1, DOI 10.1037/0022-3514.40.1.1; DECI EL, IN PRESS NEBRASKA S, V38; FIORE MC, 1990, JAMA-J AM MED ASSOC, V263, P2760, DOI 10.1001/jama.263.20.2760; GLYNN TJ, 1990, PROG CLIN BIOL RES, V339, P11; GLYNN TJ, 1988, ARCH INTERN MED, V148, P1013, DOI 10.1001/archinte.148.5.1013; GRITZ ER, 1988, CA-CANCER J CLIN, V38, P194, DOI 10.3322/canjclin.38.4.194; GROLNICK WS, 1989, J EDUC PSYCHOL, V81, P143, DOI 10.1037/0022-0663.81.2.143; JACKSON PH, 1986, PREV MED, V15, P244, DOI 10.1016/0091-7435(86)90044-7; Kaplain Justin, 1967, GREAT SHORT WORKS M; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; KOESTNER R, 1984, J PERS, V52, P233, DOI 10.1111/j.1467-6494.1984.tb00879.x; KOHUT H, 1971, ANALYSIS SELF; LANGER EJ, 1976, J PERS SOC PSYCHOL, V34, P191, DOI 10.1037/0022-3514.34.2.191; Maslow A.H., 1954, MOTIVATION PERSONALI; OCKENE JK, 1984, AM J PUBLIC HEALTH, V74, P1198, DOI 10.2105/AJPH.74.11.1198; OCKENE JK, 1988, ARCH INTERN MED, V148, P1039, DOI 10.1001/archinte.148.5.1039; OCKENE JK, 1991, J GEN INTERN MED, V6, P1, DOI 10.1007/BF02599381; ORLEANS CT, 1990, PREV MED, V19, P198, DOI 10.1016/0091-7435(90)90021-B; PEDERSON LL, 1984, SMOKING HLTH CHRONIC; PLANT RW, 1991, DISS ABSTR INT B, V1, P3579; PROCHASKA JO, 1988, J CONSULT CLIN PSYCH, V56, P520, DOI 10.1037/0022-006X.56.4.520; PROCHASKA JO, 1987, UNDERSTANDING YOURSE; Rogers C.A., 1961, BECOMING PERSON; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037/0022-3514.43.3.450; WALLSTON KA, 1978, HEALTH EDUC QUART, V6, P160, DOI 10.1177/109019817800600107; WHITE RW, 1963, PSYCHOL ISSUES SERIE, V11; WILLIAMS GC, 1991, IN PRESS CLIN RES; WILSON DM, 1988, JAMA-J AM MED ASSOC, V260, P1570, DOI 10.1001/jama.260.11.1570	35	21	21	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1991	115	1					59	63		10.7326/0003-4819-115-1-59	http://dx.doi.org/10.7326/0003-4819-115-1-59			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT937	2048862				2022-12-28	WOS:A1991FT93700011
J	CLORE, GM; GRONENBORN, AM				CLORE, GM; GRONENBORN, AM			STRUCTURES OF LARGER PROTEINS IN SOLUTION - 3-DIMENSIONAL AND 4-DIMENSIONAL HETERONUCLEAR NMR-SPECTROSCOPY	SCIENCE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; INTERPROTON DISTANCE RESTRAINTS; TWO-DIMENSIONAL NMR; MOLECULAR-DYNAMICS; STEREOSPECIFIC ASSIGNMENTS; SOLUTION CONFORMATION; COUPLING-CONSTANTS; AQUEOUS-SOLUTION; ANTENNAPEDIA HOMEODOMAIN; N-15-LABELED PROTEINS	Three- and four-dimensional heteronuclear nuclear magnetic resonance (NMR) spectroscopy offers dramatic improvements in spectral resolution by spreading through-bond and through-space correlations in three and four orthogonal frequency axes. Simultaneously, large heteronuclear couplings are exploited to circumvent problems due to the larger linewidths that are associated with increasing molecular weight. These novel experiments have been designed to extend the application of NMR as a method for determining three-dimensional structures of proteins in solution beyond the limits of conventional two-dimensional NMR (approximately 100 residues) to molecules in the 150- to 300-residue range. This potential has recently been confirmed with the determination of the high-resolution NMR structure of a protein greater than 150 residues, namely, interleukin-1-beta.			CLORE, GM (corresponding author), NIDDKD, CHEM PHYS LAB, BLDG 2, BETHESDA, MD 20892 USA.		Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027; Gronenborn, Angela M/0000-0001-9072-3525				ARSENIEV A, 1988, J MOL BIOL, V201, P637, DOI 10.1016/0022-2836(88)90644-4; AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; BALDWIN ET, 1991, P NATL ACAD SCI USA, V88, P502, DOI 10.1073/pnas.88.2.502; BAX A, 1988, J MAGN RESON, V79, P429, DOI 10.1016/0022-2364(88)90080-7; BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; BAX A, 1990, J MAGN RESON, V87, P620, DOI 10.1016/0022-2364(90)90320-9; BAX A, 1986, SCIENCE, V232, P960, DOI 10.1126/science.3518060; BAX A, 1989, ANNU REV BIOCHEM, V58, P223; BILLETER M, 1990, J MOL BIOL, V214, P183, DOI 10.1016/0022-2836(90)90155-F; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; BRAUN W, 1987, Q REV BIOPHYS, V19, P115, DOI 10.1017/S0033583500004108; BRAUN W, 1985, J MOL BIOL, V186, P611, DOI 10.1016/0022-2836(85)90134-2; BRUNGER AT, 1991, ANNU REV PHYS CHEM, V42, P197, DOI 10.1146/annurev.pc.42.100191.001213; BRUNGER AT, 1986, P NATL ACAD SCI USA, V83, P3801, DOI 10.1073/pnas.83.11.3801; BRUNGER AT, 1988, J MOL BIOL, V203, P803, DOI 10.1016/0022-2836(88)90211-2; BRUNGER AT, 1991, MOL DYNAMICS APPLICA, P137; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CLORE GM, 1990, J MOL BIOL, V214, P811, DOI 10.1016/0022-2836(90)90336-K; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P5671, DOI 10.1021/bi00476a004; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P12, DOI 10.1021/bi00215a002; CLORE GM, 1986, EMBO J, V5, P2729, DOI 10.1002/j.1460-2075.1986.tb04557.x; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P8172, DOI 10.1021/bi00487a027; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; CLORE GM, 1989, CRIT REV BIOCHEM MOL, V24, P479, DOI 10.3109/10409238909086962; CLORE GM, 1986, J MOL BIOL, V191, P523, DOI 10.1016/0022-2836(86)90146-4; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P2315, DOI 10.1021/bi00223a005; CLORE GM, 1987, PROTEIN ENG, V1, P275, DOI 10.1093/protein/1.4.275; CLORE GM, 1985, J MOL BIOL, V186, P435, DOI 10.1016/0022-2836(85)90116-0; CLORE GM, 1991, ANNU REV BIOPHYS BIO, V20, P29, DOI 10.1146/annurev.biophys.20.1.29; CLORE GM, 1991, THEOR BIOCH MOL BIOP, V2, P1; CLORE GM, IN PRESS J BIOMOL NM; CLORE GM, 1989, COMPUTER AIDED MOL D, P203; CLORE GM, IN PRESS J MOL BIOL; CRIPPEN GM, 1978, ACTA CRYSTALLOGR A, V34, P282, DOI 10.1107/S0567739478000522; CRIPPEN GM, 1988, DISTANCE GEOMETRY CO; DEMARCO A, 1978, BIOPOLYMERS, V17, P617, DOI 10.1002/bip.1978.360170307; DRISCOLL PC, 1990, BIOCHEMISTRY-US, V29, P4668, DOI 10.1021/bi00471a023; DRISCOLL PC, 1989, BIOCHEMISTRY-US, V28, P2188, DOI 10.1021/bi00431a033; DRISCOLL PC, 1989, FEBS LETT, V243, P223, DOI 10.1016/0014-5793(89)80134-6; DRISCOLL PC, 1990, BIOCHEMISTRY-US, V29, P3542, DOI 10.1021/bi00466a018; DYSON HJ, 1990, BIOCHEMISTRY-US, V29, P4129, DOI 10.1021/bi00469a016; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; FESIK SW, 1990, J AM CHEM SOC, V112, P886, DOI 10.1021/ja00158a069; FOLKERS PJM, 1989, BIOCHEMISTRY-US, V28, P2601, DOI 10.1021/bi00432a038; FORMANKAY JD, 1991, BIOCHEMISTRY-US, V30, P2685, DOI 10.1021/bi00224a017; FORMANKAY JD, 1990, BIOCHEMISTRY-US, V29, P1566, DOI 10.1021/bi00458a030; FRENKIEL T, 1990, J MAGN RESON, V90, P420, DOI 10.1016/0022-2364(90)90152-Y; GRIESINGER C, 1987, J MAGN RESON, V73, P574, DOI 10.1016/0022-2364(87)90027-8; GRONENBORN AM, 1989, FEBS LETT, V243, P93, DOI 10.1016/0014-5793(89)81224-4; GRONENBORN AM, 1989, BIOCHEMISTRY-US, V28, P5978, DOI 10.1021/bi00440a039; GRONENBORN AM, 1990, ANAL CHEM, V62, P2, DOI 10.1021/ac00200a003; GUNTERT P, 1989, J AM CHEM SOC, V111, P3997; HARUYAMA H, 1989, BIOCHEMISTRY-US, V28, P4301, DOI 10.1021/bi00436a027; HAVEL TF, 1985, J MOL BIOL, V182, P281, DOI 10.1016/0022-2836(85)90346-8; HAVEL TF, 1983, B MATH BIOL, V45, P665; HYBERTS SG, 1987, EUR J BIOCHEM, V164, P625, DOI 10.1111/j.1432-1033.1987.tb11173.x; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; IKURA M, 1990, J MAGN RESON, V86, P204, DOI 10.1016/0022-2364(90)90227-Z; IKURA M, 1990, J AM CHEM SOC, V112, P9020, DOI 10.1021/ja00180a080; IKURA M, IN PRESS J BIOMOL NM; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Jeener J., 1971, AMPERE INT SUMMER SC; KAPTEIN R, 1985, J MOL BIOL, V182, P179, DOI 10.1016/0022-2836(85)90036-1; KAPTEIN R, 1988, BIOCHEMISTRY-US, V27, P5389, DOI 10.1021/bi00415a001; KARPLUS M, 1963, J AM CHEM SOC, V85, P2870, DOI 10.1021/ja00901a059; KAY LE, 1991, J MAGN RESON, V91, P84, DOI 10.1016/0022-2364(91)90410-U; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1990, J AM CHEM SOC, V112, P888, DOI 10.1021/ja00158a070; KAY LE, 1989, J MAGN RESON, V84, P72, DOI 10.1016/0022-2364(89)90006-1; KAY LE, 1990, J MAGN RESON, V86, P110, DOI 10.1016/0022-2364(90)90215-U; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; KLINE AD, 1988, J MOL BIOL, V204, P675, DOI 10.1016/0022-2836(88)90364-6; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; KUNTZ ID, 1989, METHOD ENZYMOL, V177, P159; KURIYAN J, 1986, J MOL BIOL, V190, P227, DOI 10.1016/0022-2836(86)90295-0; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MARION D, 1988, J MAGN RESON, V80, P528, DOI 10.1016/0022-2364(88)90250-8; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; MARKLEY JL, 1989, METHOD ENZYMOL, V176, P12; MESSERLE BA, 1989, J MAGN RESON, V85, P608, DOI 10.1016/0022-2364(89)90252-7; MUELLER L, 1987, J MAGN RESON, V72, P191, DOI 10.1016/0022-2364(87)90188-0; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; NILGES M, 1990, BIOPOLYMERS, V29, P813, DOI 10.1002/bip.360290415; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; NILSSON L, 1986, J MOL BIOL, V188, P455, DOI 10.1016/0022-2836(86)90168-3; NOGGLE JH, 1971, NUCLEAR OVERHAUSER E; OMICHINSKI JG, 1990, BIOCHEMISTRY-US, V29, P9324, DOI 10.1021/bi00492a004; OSCHKINAT H, 1988, NATURE, V332, P374, DOI 10.1038/332374a0; OVERHAUSER AW, 1953, PHYS REV, V89, P689, DOI 10.1103/PhysRev.89.689; OVERHAUSER AW, 1953, PHYS REV, V92, P411, DOI 10.1103/PhysRev.92.411; PARDI A, 1984, J MOL BIOL, V180, P741, DOI 10.1016/0022-2836(84)90035-4; POWERS R, IN PRESS J MAGN RESO; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; SCHEEK RM, 1989, METHOD ENZYMOL, V177, P204; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; WAGNER G, 1987, J MOL BIOL, V196, P611, DOI 10.1016/0022-2836(87)90037-4; WILLIAMSON MP, 1985, J MOL BIOL, V182, P295, DOI 10.1016/0022-2836(85)90347-X; WUTHRICH K, 1989, SCIENCE, V243, P45, DOI 10.1126/science.2911719; WUTHRICH K, 1990, J BIOL CHEM, V265, P22059; WUTHRICH K, 1986, NMR PROTEINS; ZUIDERWEG ERP, 1991, J AM CHEM SOC, V113, P370, DOI 10.1021/ja00001a060; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P2387, DOI 10.1021/bi00432a008; ZUIDERWEG ERP, 1990, J MAGN RESON, V86, P210, DOI 10.1016/0022-2364(90)90228-2	106	407	414	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	1991	252	5011					1390	1399		10.1126/science.2047852	http://dx.doi.org/10.1126/science.2047852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP868	2047852	Green Submitted			2022-12-28	WOS:A1991FP86800025
J	GODWIN, JE; SAHN, SA				GODWIN, JE; SAHN, SA			THORACENTESIS - A SAFE PROCEDURE IN MECHANICALLY VENTILATED PATIENTS	ANNALS OF INTERNAL MEDICINE			English	Note									MED UNIV S CAROLINA, DIV PULM & CRIT CARE MED, 171 ASHLEY AVE, CHARLESTON, SC 29425 USA	Medical University of South Carolina								COLLINS TR, 1987, CHEST, V91, P817, DOI 10.1378/chest.91.6.817; GARRISON FH, 1929, INTRO HIST MED, P632; HALL WJ, 1985, ANN INTERN MED, V103, P799; JENKINS DW, 1983, SOUTHERN MED J, V76, P1383; KOHAN JM, 1986, AM REV RESPIR DIS, V133, P1124; SAHN SA, 1988, AM REV RESPIR DIS, V138, P184, DOI 10.1164/ajrccm/138.1.184; SENEFF MG, 1986, CHEST, V90, P97, DOI 10.1378/chest.90.1.97; SOKOLOWSKI JW, 1989, AM REV RESPIR DIS, V140, P257, DOI 10.1164/ajrccm/140.1.257	8	27	29	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1990	113	10					800	802		10.7326/0003-4819-113-10-800	http://dx.doi.org/10.7326/0003-4819-113-10-800			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH363	2091634				2022-12-28	WOS:A1990EH36300015
J	CLEVELAND, DW				CLEVELAND, DW			MICROTUBULE MAPPING	CELL			English	Review											CLEVELAND, DW (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205, USA.		Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682				AIZAWA H, 1989, J BIOL CHEM, V264, P5885; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; HIMMLER A, 1989, MOL CELL BIOL, V9, P1389, DOI 10.1128/MCB.9.4.1389; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; LEWIS SA, 1989, NATURE, V342, P498, DOI 10.1038/342498a0; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; OKABE S, 1989, P NATL ACAD SCI USA, V86, P4127, DOI 10.1073/pnas.86.11.4127; PAPANDRIKOPOULOU A, 1989, NATURE, V340, P650, DOI 10.1038/340650a0; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2	14	39	40	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAR 9	1990	60	5					701	702		10.1016/0092-8674(90)90083-Q	http://dx.doi.org/10.1016/0092-8674(90)90083-Q			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CV174	2107023	hybrid			2022-12-28	WOS:A1990CV17400003
J	GARDNER, MJ; SNEE, MP; HALL, AJ; POWELL, CA; DOWNES, S; TERRELL, JD				GARDNER, MJ; SNEE, MP; HALL, AJ; POWELL, CA; DOWNES, S; TERRELL, JD			RESULTS OF CASE-CONTROL STUDY OF LEUKEMIA AND LYMPHOMA AMONG YOUNG-PEOPLE NEAR SELLAFIELD NUCLEAR-PLANT IN WEST CUMBRIA	BRITISH MEDICAL JOURNAL			English	Article									W CUMBERLAND DIST GEN HOSP,W CUMBRIA HLTH AUTHOR,WHITEHAVEN CA28 8JG,CUMBRIA,ENGLAND		GARDNER, MJ (corresponding author), UNIV SOUTHAMPTON,SOUTHAMPTON GEN HOSP,MRC,ENVIRONM EPIDEMIOL UNIT,SOUTHAMPTON S09 4XY,ENGLAND.							BERAL V, 1985, BRIT MED J, V291, P440, DOI 10.1136/bmj.291.6493.440; BERAL V, 1988, BRIT MED J, V297, P757, DOI 10.1136/bmj.297.6651.757; BLACK D, 1984, INVESTIGATION POSSIB; BRESLOW NE, 1980, STATISTICAL METHODS, V1, pCH5; COOKMOZAFFARI P, 1989, LANCET, V2, P1145; DOLL R, 1989, J ROY STAT SOC A STA, V152, P341, DOI 10.2307/2983131; GARDNER MJ, 1989, J ROY STAT SOC A STA, V152, P307, DOI 10.2307/2983129; GARDNER MJ, 1987, BRIT MED J, V295, P819, DOI 10.1136/bmj.295.6602.819; GARDNER MJ, 1990, BRIT MED J, V300, P429, DOI 10.1136/bmj.300.6722.429; GARDNER MJ, 1987, BRIT MED J, V295, P822, DOI 10.1136/bmj.295.6602.822; HALL EJ, 1978, RADIOBIOLOGY RADIOLO, pCH19; ISHIMARU T, 1981, RERF1181 RAD EFF RES; KINLEN LJ, 1989, MED RESPONSE EFFECTS, P272; NOMURA T, 1982, NATURE, V296, P575, DOI 10.1038/296575a0; SMITH PG, 1986, BRIT MED J, V293, P845, DOI 10.1136/bmj.293.6551.845; 1988, INVESTIGATION POSSIB; 1987, NRPBG59 NAT RAD PROT, P4; 1989, EGRET; 1966, ICRP PUBLICATION, V9; 1989, REPORT INCIDENCE CHI; 1989, NRPBR227 NAT RAD PRO, P86	21	594	602	0	18	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 17	1990	300	6722					423	429		10.1136/bmj.300.6722.423	http://dx.doi.org/10.1136/bmj.300.6722.423			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP166	2107892	Green Published, Bronze			2022-12-28	WOS:A1990CP16600017
J	DAVIES, SC; BROZOVIC, M				DAVIES, SC; BROZOVIC, M			TRANSFUSION OF RED-CELLS	BRITISH MEDICAL JOURNAL			English	Article											DAVIES, SC (corresponding author), CENT MIDDLESEX HOSP,LONDON NW10 7NS,ENGLAND.								0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1990	300	6719					248	252		10.1136/bmj.300.6719.248	http://dx.doi.org/10.1136/bmj.300.6719.248			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL024	2106939	Bronze, Green Published			2022-12-28	WOS:A1990CL02400032
J	JAIN, D; LAHIRI, A; RAFTERY, EB				JAIN, D; LAHIRI, A; RAFTERY, EB			IMMUNOSCINTIGRAPHY FOR DETECTING ACUTE MYOCARDIAL-INFARCTION WITHOUT ELECTROCARDIOGRAPHIC CHANGES	BRITISH MEDICAL JOURNAL			English	Article									NORTHWICK PK HOSP & CLIN RES CTR,DEPT CARDIOL,HARROW HA1 3UJ,MIDDX,ENGLAND; NORTHWICK PK HOSP & CLIN RES CTR,DIV CLIN SCI,HARROW HA1 3UJ,MIDDX,ENGLAND; CLIN RES CTR,HARROW HA1 3UJ,MIDDX,ENGLAND	Imperial College London; Imperial College London								BERGER H, 1988, Journal of Nuclear Medicine, V29, P805; CARRIO I, 1988, J NUCL MED, V29, P1893; FISHER ML, 1985, AM HEART J, V110, P347, DOI 10.1016/0002-8703(85)90155-3; HAINS ADB, 1987, BRIT HEART J, V57, P242; HALL T S, 1986, Journal of Heart Transplantation, V5, P419; JAIN D, 1988, NUCL MED COMMUN, V9, P163; JAIN D, 1988, AM J CARDIAC IMAGING, V2, P158; KHAW BA, 1979, CIRCULATION, V60, P1527, DOI 10.1161/01.CIR.60.7.1527; KHAW BA, 1987, J NUCL MED, V28, P1671; KHAW BA, 1982, SCIENCE, V217, P1050, DOI 10.1126/science.7051286; MADSEN JK, 1982, ACTA MED SCAND, V211, P453; NAVIN TR, 1979, CURR PROB CARDIOLOGY, V3, P7; OHARA MJ, 1985, BRIT HEART J, V53, P616; RAUNIO H, 1979, AM HEART J, V98, P176, DOI 10.1016/0002-8703(79)90219-9; ROBERTS R, 1975, CIRCULATION, V52, P743, DOI 10.1161/01.CIR.52.5.743; SAVAGE RM, 1977, CIRCULATION, V55, P279, DOI 10.1161/01.CIR.55.2.279; SCHROEDER JS, 1980, NEW ENGL J MED, V303, P1, DOI 10.1056/NEJM198007033030101; TURI ZG, 1985, AM J CARDIOL, V55, P1467	18	26	26	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					151	153		10.1136/bmj.300.6718.151	http://dx.doi.org/10.1136/bmj.300.6718.151			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105792	Bronze, Green Published			2022-12-28	WOS:A1990CK07700018
J	STINCHCOMBE, SJ; MANHIRE, AR; BISHOP, MC; GREGSON, RHS				STINCHCOMBE, SJ; MANHIRE, AR; BISHOP, MC; GREGSON, RHS			FIBROMUSCULAR DYSPLASIA OF RENAL-ARTERIES - A NEGLECTED CAUSE OF ACUTE LOIN PAIN	BRITISH MEDICAL JOURNAL			English	Article									CITY HOSP,DEPT RADIOL,NOTTINGHAM NG5 1PB,ENGLAND; CITY HOSP,DEPT UROL,NOTTINGHAM NG5 1PB,ENGLAND	University of Nottingham; University of Nottingham	STINCHCOMBE, SJ (corresponding author), QUEENS MED CTR,DEPT RADIOL,NOTTINGHAM NG7 2UH,ENGLAND.							COBURN JW, 1988, DISEASES KIDNEY, P2361; GLAZER GM, 1983, AM J ROENTGENOL, V140, P721, DOI 10.2214/ajr.140.4.721; HILTON S, 1984, UROL RADIOL, V6, P158, DOI 10.1007/BF02923716; LESSMAN RK, 1978, ANN INTERN MED, V89, P477, DOI 10.7326/0003-4819-89-4-477; LISBONA R, 1981, Clinical Nuclear Medicine, V6, P253, DOI 10.1097/00003072-198106000-00005; Sherwood T, 1980, URORADIOLOGY	6	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					183	185		10.1136/bmj.300.6718.183	http://dx.doi.org/10.1136/bmj.300.6718.183			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105805	Bronze, Green Published			2022-12-28	WOS:A1990CK07700033
J	ALISON, LH; BULUGAHAPITIYA, D				ALISON, LH; BULUGAHAPITIYA, D			LAXATIVE INDUCED MAGNESIUM POISONING IN A 6-WEEK-OLD INFANT	BRITISH MEDICAL JOURNAL			English	Letter											ALISON, LH (corresponding author), ROTHERHAM DIST GEN HOSP,ROTHERHAM S60 2UD,ENGLAND.							BEHRMAN RE, 1977, NELSON TXB PAEDIATRI, P136; BRENTON DP, 1984, BR J HOSP MED, P60; HUMPHREY M, 1981, J PEDIATR-US, V98, P313, DOI 10.1016/S0022-3476(81)80669-5; LIPITZ PJ, 1971, PAEDIATRICS, V47, P501; Mordes J.P., 1978, PHARMACOL REV, V29, P273	5	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					125	125		10.1136/bmj.300.6717.125-a	http://dx.doi.org/10.1136/bmj.300.6717.125-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105768	Green Published, Bronze			2022-12-28	WOS:A1990CJ08000061
J	HOWIE, PW; FORSYTH, JS; OGSTON, SA; CLARK, A; FLOREY, CD				HOWIE, PW; FORSYTH, JS; OGSTON, SA; CLARK, A; FLOREY, CD			PROTECTIVE EFFECT OF BREAST-FEEDING AGAINST INFECTION	BRITISH MEDICAL JOURNAL			English	Article											HOWIE, PW (corresponding author), UNIV DUNDEE,NINEWELLS HOSP & MED SCH,OBSTET & GYNAECOL,DUNDEE DD1 9SY,SCOTLAND.							BAKER RJ, 1985, GLIM SYSTEM; BAUCHNER H, 1986, JAMA-J AM MED ASSOC, V256, P887, DOI 10.1001/jama.256.7.887; CHANDRA RK, 1979, ACTA PAEDIATR SCAND, V68, P691, DOI 10.1111/j.1651-2227.1979.tb18439.x; CUNNINGHAM AS, 1987, PEDIATRICS, V79, P1052; CUNNINGHAM AS, 1979, J PEDIATR-US, V95, P685, DOI 10.1016/S0022-3476(79)80711-8; CUNNINGHAM AS, 1987, J PEDIATR-US, V110, P658, DOI 10.1016/S0022-3476(87)80574-7; FERGUSSON DM, 1981, AUST PAEDIATR J, V17, P191; HABICHT JP, 1986, AM J EPIDEMIOL, V123, P279, DOI 10.1093/oxfordjournals.aje.a114236; KOVAR MG, 1984, PEDIATRICS, V74, P615; MARTIN J, 1988, INFANT FEEDING 1985; MATTA LJ, 1971, AM J CLIN NUTR, V24, P976; PLANK SJ, 1973, B WORLD HEALTH ORGAN, V48, P203; TAYLOR B, 1982, LANCET, V1, P1227; THEODORE CM, 1982, RECENT ADV MUCOSAL I, P393; WELSH JK, 1979, J PEDIATR-US, V94, P1, DOI 10.1016/S0022-3476(79)80340-6; 1988, 32 DEP HLTH SOC SEC	16	643	664	0	30	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	1990	300	6716					11	16		10.1136/bmj.300.6716.11	http://dx.doi.org/10.1136/bmj.300.6716.11			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG773	2105113	Bronze, Green Published			2022-12-28	WOS:A1990CG77300015
J	LAABAN, JP; WAKED, M; LAROMIGUIERE, M; VUONG, TK; ROCHEMAURE, J				LAABAN, JP; WAKED, M; LAROMIGUIERE, M; VUONG, TK; ROCHEMAURE, J			HYPOPHOSPHATEMIA COMPLICATING MANAGEMENT OF ACUTE SEVERE ASTHMA	ANNALS OF INTERNAL MEDICINE			English	Article											LAABAN, JP (corresponding author), HOP HOTEL DIEU, DEPT PNEUMOL & INTENS CARE, 1 PL PARVIS NOTRE DAME, F-75181 PARIS 04, FRANCE.							AUBIER M, 1985, NEW ENGL J MED, V313, P420, DOI 10.1056/NEJM198508153130705; BODY JJ, 1983, J CLIN INVEST, V71, P572, DOI 10.1172/JCI110802; COLIN AA, 1984, MINER ELECTROL METAB, V10, P359; GUNTUPALLI J, 1987, AM J PHYSIOL, V253, pF34, DOI 10.1152/ajprenal.1987.253.1.F34; KNOCHEL JP, 1985, KIDNEY PHYSL PATHOPH, P1397; LAABAN JP, 1989, IN PRESS CRIT CARE M; MONTANARI A, 1984, MINER ELECTROL METAB, V10, P52; MOSTELLAR ME, 1964, J CLIN INVEST, V43, P138, DOI 10.1172/JCI104888; SQUARA P, 1985, PRESSE MED, V14, P1225; STORM TL, 1984, BRIT MED J, V289, P456, DOI 10.1136/bmj.289.6443.456	10	10	11	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1990	112	1					68	69		10.7326/0003-4819-112-1-68	http://dx.doi.org/10.7326/0003-4819-112-1-68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG723	2104562				2022-12-28	WOS:A1990CG72300012
J	REED, CE				REED, CE			AEROSOL STEROIDS AS PRIMARY-TREATMENT OF MILD ASTHMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											REED, CE (corresponding author), MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905, USA.							[Anonymous], 1991, EXPERT PANEL REPORT; BEASLEY R, 1989, AM REV RESPIR DIS, V139, P806, DOI 10.1164/ajrccm/139.3.806; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; DUNNILL MS, 1960, J CLIN PATHOL, V13, P27, DOI 10.1136/jcp.13.1.27; FLOYER J, 1726, TREATISE ASTHMA; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; HARGREAVE FE, 1990, J ALLERGY CLIN IMMUN, V85, P1098, DOI 10.1016/0091-6749(90)90056-A; REED CE, 1986, J ALLERGY CLIN IMMUN, V77, P537, DOI 10.1016/0091-6749(86)90342-8; TOOGOOD J, 1980, J ALLERGY CLIN IMMUN, V65, P143; VEDAL S, 1988, AM REV RESPIR DIS, V137, P651, DOI 10.1164/ajrccm/137.3.651	10	55	57	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 8	1991	325	6					425	426		10.1056/NEJM199108083250610	http://dx.doi.org/10.1056/NEJM199108083250610			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ804	2062335				2022-12-28	WOS:A1991FZ80400010
J	CRAWSHAW, R				CRAWSHAW, R			THE QUALITY OF MERCY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		YOUNG S, 1990, NEW SCI         1222, P81	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	1991	266	5					614	615		10.1001/jama.266.5.614	http://dx.doi.org/10.1001/jama.266.5.614			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ140	2072465				2022-12-28	WOS:A1991FZ14000001
J	FOWLER, NO				FOWLER, NO			TUBERCULOUS PERICARDITIS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACQUIRED IMMUNODEFICIENCY SYNDROME; SHORT-COURSE CHEMOTHERAPY; EXTRAPULMONARY TUBERCULOSIS; MYCOBACTERIAL DISEASE; EXPERIENCE; DIAGNOSIS; TRANSKEI; THERAPY; VIRUS; LONG	Tuberculosis is responsible for approximately 4% of cases of acute pericarditis, 7% of cases of cardiac tamponade, and, in older studies, 6% of instances of constrictive pericarditis. However, in some nonindustrialized countries, tuberculosis is a leading cause of pericarditis. The diagnosis is based on demonstration of tubercle bacilli in pericardial fluid or on histologic section of the pericardium, or proof of tuberculosis elsewhere in a patient with otherwise unexplained pericarditis. Treatment consists of triple drug therapy for at least 9 months (isoniazid, rifampin, and streptomycin or ethambutol). Pyrazinamide can be used for the first 2 months, and the total therapeutic period can then be shortened to 6 months after culture conversion. Three months of corticosteroid therapy may be useful in patients in whom pericardial effusion persists or recurs despite the use of antituberculous drugs. Surgical resection of the pericardium is indicated for recurrent or life-threatening tamponade, or when there is persistent elevation of systemic venous pressure unrelieved by pericardiocentesis. As many as one third to one half of patients will eventually require pericardiectomy despite adequate drug therapy.			FOWLER, NO (corresponding author), UNIV CINCINNATI, COLL MED,DEPT INTERNAL MED,DIV CARDIOL, 231 BETHESDA AVE, ROOM 3354, CINCINNATI, OH 45267 USA.							ALVAREZ S, 1984, MEDICINE, V63, P25, DOI 10.1097/00005792-198401000-00003; ANDERSON DW, 1990, HUM PATHOL, V21, P253, DOI 10.1016/0046-8177(90)90224-S; BRISSONNOEL A, 1989, LANCET, V2, P1069; CARSON TJ, 1974, ANN THORAC SURG, V17, P163, DOI 10.1016/S0003-4975(10)65628-7; CHAISSON RE, 1987, AM REV RESPIR DIS, V136, P570, DOI 10.1164/ajrccm/136.3.570; COMBS DL, 1990, ANN INTERN MED, V112, P397, DOI 10.7326/0003-4819-76-3-112-6-397; DALLI E, 1987, AM HEART J, V114, P905, DOI 10.1016/0002-8703(87)90807-6; DAVIDSON PT, 1990, ANN INTERN MED, V112, P393, DOI 10.7326/0003-4819-76-3-112-6-393; DESAI HN, 1979, S AFR MED J, V55, P877; DUTT AK, 1986, ANN INTERN MED, V104, P7, DOI 10.7326/0003-4819-104-1-7; FENNELL WMP, 1982, S AFR MED J, V62, P353; FOWLER N O, 1973, Progress in Cardiovascular Diseases, V16, P323, DOI 10.1016/S0033-0620(73)80004-0; FOWLER NO, 1985, PERICARDIUM HLTH DIS; GIMLETTE TMD, 1959, BRIT HEART J, V21, P9; GOOI HC, 1978, THORAX, V33, P94, DOI 10.1136/thx.33.1.94; HAGEMAN JH, 1964, NEW ENGL J MED, V270, P327, DOI 10.1056/NEJM196402132700702; Harvey AM, 1937, MEDICINE, V16, P45, DOI 10.1097/00005792-193702000-00002; HOLMAN E, 1951, JAMA-J AM MED ASSOC, V146, P1; LARRIEU AJ, 1980, ANN THORAC SURG, V29, P464, DOI 10.1016/S0003-4975(10)61681-5; LONG R, 1989, AM HEART J, V117, P1133, DOI 10.1016/0002-8703(89)90873-9; MARGOLIS ML, 1985, BIOMED PHARMACOTHER, V39, P292; MCCAUGHAN BC, 1985, J THORAC CARDIOV SUR, V89, P340; ORTBALS DW, 1979, ARCH INTERN MED, V139, P231, DOI 10.1001/archinte.139.2.231; PERMANYERMIRALDA G, 1985, AM J CARDIOL, V56, P623, DOI 10.1016/0002-9149(85)91023-9; PITCHENIK AE, 1988, CLIN CHEST MED, V9, P425; PITCHENIK AE, 1985, AM REV RESPIR DIS, V131, P393; POHOST GM, 1991, PRINCIPLES PRACTICE; QUALE JM, 1987, ANN THORAC SURG, V43, P653, DOI 10.1016/S0003-4975(10)60243-3; RIEDER HL, 1989, ARCH INTERN MED, V149, P1268, DOI 10.1001/archinte.149.6.1268; ROBERTS GD, 1983, J CLIN MICROBIOL, V18, P689, DOI 10.1128/JCM.18.3.689-696.1983; ROONEY JJ, 1970, ANN INTERN MED, V72, P73, DOI 10.7326/0003-4819-72-1-73; SAGRISTASAULEDA J, 1988, J AM COLL CARDIOL, V11, P724, DOI 10.1016/0735-1097(88)90203-3; SATHE SS, 1989, CLIN CHEST MED, V10, P445; SCHEPERS GW, 1962, AM J CARDIOL, V9, P248, DOI 10.1016/0002-9149(62)90044-9; SILVER MD, 1983, CARDIOVASC PATHOL, P139; SNIDER DE, 1987, AM REV RESPIR DIS, V136, P492; SONNENBERG FA, 1986, MED DECIS MAKING, V6, P110, DOI 10.1177/0272989X8600600209; STRANG JIG, 1984, CLIN CARDIOL, V7, P667, DOI 10.1002/clc.4960071208; STRANG JIG, 1988, LANCET, V2, P759; WEIR MR, 1985, AM J MED, V79, P467, DOI 10.1016/0002-9343(85)90034-8; WOLINSKY E, 1988, CECILS TXB MED, P1682	41	150	158	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	1991	266	1					99	103		10.1001/jama.266.1.99	http://dx.doi.org/10.1001/jama.266.1.99			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT934	2046135				2022-12-28	WOS:A1991FT93400035
J	LIBRI, D; PISERI, A; FISZMAN, MY				LIBRI, D; PISERI, A; FISZMAN, MY			TISSUE-SPECIFIC SPLICING INVIVO OF THE BETA-TROPOMYOSIN GENE - DEPENDENCE ON AN RNA SECONDARY STRUCTURE	SCIENCE			English	Article								The beta-tropomyosin gene in chicken contains two mutually exclusive exons (exons 6A and 6B) which are used by the splicing apparatus in myogenic cells, respectively, before (myoblast stage) and after (myotube stage) differentiation. The myoblast splicing pattern is shown to depend on multiple sequence elements that are located in the upstream intron and in the exon 6B and that exert a negative control over exon 6B splicing. This regulation of splicing is due, at least in part, to a secondary structure of the primary transcript, which limits in vivo the accessibility of exon 6B in myoblasts.	DIPARTIMENTO GENET & BIOL MICROORGANISMI, I-20131 MILAN, ITALY		LIBRI, D (corresponding author), INST PASTEUR, 25 RUE DR ROUX, F-75724 PARIS 15, FRANCE.							CHEBLI K, 1989, MOL CELL BIOL, V9, P4852, DOI 10.1128/MCB.9.11.4852; DORVAL BC, 1991, SCIENCE, V252, P1823, DOI 10.1126/science.2063195; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; EPERON LP, 1986, NATURE, V324, P280, DOI 10.1038/324280a0; ERSTER SH, 1988, NUCLEIC ACIDS RES, V16, P5999, DOI 10.1093/nar/16.13.5999; FISZMAN MY, UNPUB; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; FU XY, 1987, MOL CELL BIOL, V7, P738, DOI 10.1128/MCB.7.2.738; GOUXPELLETAN M, 1990, EMBO J, V9, P241, DOI 10.1002/j.1460-2075.1990.tb08101.x; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HELFMAN DM, 1990, GENE DEV, V4, P98, DOI 10.1101/gad.4.1.98; HELFMAN DM, 1986, MOL CELL BIOL, V6, P3582, DOI 10.1128/MCB.6.11.3582; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEMONNIER M, 1989, NUCLEIC ACIDS RES, V17, P5400, DOI 10.1093/nar/17.13.5400; LIBRI D, 1989, J BIOL CHEM, V264, P2935; LIBRI D, 1990, MOL CELL BIOL, V10, P5036, DOI 10.1128/MCB.10.10.5036; LIBRI D, 1989, NUCLEIC ACIDS RES, V17, P6449; LIBRI D, UNPUB; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; SOLNICK D, 1987, MOL CELL BIOL, V7, P3194, DOI 10.1128/MCB.7.9.3194; WATAKABE A, 1989, NUCLEIC ACIDS RES, V17, P8159, DOI 10.1093/nar/17.20.8159; WILSON WD, 1988, NUCLEIC ACIDS RES, V16, P5137, DOI 10.1093/nar/16.11.5137; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	24	142	143	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	1991	252	5014					1842	1845		10.1126/science.2063196	http://dx.doi.org/10.1126/science.2063196			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU061	2063196				2022-12-28	WOS:A1991FU06100038
J	GEORGE, SL; SHANKS, NJ; WESTLAKE, L				GEORGE, SL; SHANKS, NJ; WESTLAKE, L			CENSUS OF SINGLE HOMELESS PEOPLE IN SHEFFIELD	BRITISH MEDICAL JOURNAL			English	Article							HEALTH-PROBLEMS; LONDON; MEN; WOMEN	Objective - To determine the number of single homeless people in Sheffield and to examine their demography and social and medical details. Design - Census carried out between 8 am and 8 pm on one day. Participants completed a questionnaire designed to provide data relating to employment history, contact with welfare and health services, social state, prison history, medical history, and health state. Setting - Sites in Sheffield identified by local workers as being places of residence of homeless people. Subjects - 340 single homeless people. Main outcome measures - Self reported history of alcohol or drug misuse, existence of a chronic medical condition, and use of general practitioner and hospital services. Results - The mean age of the population was 42.5 years and a quarter of the population were aged less than 30; there were 48 women. Significant differences were noted between men and women with respect to self reported psychiatric illness (77/266 men v 27/42 women), self reported alcoholism (83/273 v 4/44), prison history (152/255 v 8/41), and registration with a general practitioner (73/275 v 38/46). Various chronic medical conditions were reported, and the perceived health state of the population was low; 129 claimed to have been admitted to a psychiatric hospital. 220 people were registered with a general practitioner, and 179 claimed to see their doctor. Sixty five had attended or been admitted to a general hospital in the month preceding the study, 45 for accident and emergency services. Conclusions - The homeless in this population were younger than those found in previous studies. The prevalence of psychiatric illness was high in the population, and the overall health state was poor. Most subjects obtained health services from general practitioners.	UNIV SHEFFIELD,DEPT GEN PRACTICE,SHEFFIELD S10 2RX,S YORKSHIRE,ENGLAND; UNIV SHEFFIELD,DIV COMMUNITY MED,SHEFFIELD S10 2RX,S YORKSHIRE,ENGLAND	University of Sheffield; University of Sheffield	GEORGE, SL (corresponding author), UNIV SHEFFIELD,DEPT PUBL HLTH MED,SHEFFIELD S10 2RX,S YORKSHIRE,ENGLAND.							BREAKEY WR, 1989, JAMA-J AM MED ASSOC, V262, P1352, DOI 10.1001/jama.262.10.1352; CANTER D, 1989, FACES HOMELESSNESS L; CURTIS S, 1985, INTRAURBAN VARIATION, V1; HERZBERG JL, 1987, BRIT J PSYCHIAT, V150, P621, DOI 10.1192/bjp.150.5.621; HUNT SM, 1981, J EPIDEMIOL COMMUN H, V35, P297, DOI 10.1136/jech.35.4.297; Hunt SM, 1986, MEASURING HLTH STATU; LOWRY S, 1989, BRIT MED J, V298, P210; PATCH ICL, 1970, P ROY SOC MED, V63, P437, DOI 10.1177/003591577006300505; RAMSDEN SS, 1989, BRIT MED J, V298, P372, DOI 10.1136/bmj.298.6670.372; ROE M, 1988, HOUSE COMMONS OFFICI, V133; SHANDLER I, 1966, PHILADELPHIAS SKID R; SHANKS NJ, 1981, J EPIDEMIOL COMMUN H, V35, P133, DOI 10.1136/jech.35.2.133; SHANKS NJ, 1981, DEMOGRAPHIC FEATURES; VASSILAS C, 1990, HLTH TRENDS, V22, P89; WELLER MPI, 1986, PUBLIC HEALTH, V100, P76, DOI 10.1016/S0033-3506(86)80003-8; 1966, HOMELESS SINGLE PERS	16	31	33	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 8	1991	302	6789					1387	1389		10.1136/bmj.302.6789.1387	http://dx.doi.org/10.1136/bmj.302.6789.1387			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR057	2059721	Green Published, Bronze			2022-12-28	WOS:A1991FR05700028
J	FORMAN, D; NEWELL, DG; FULLERTON, F; YARNELL, JWG; STACEY, AR; WALD, N; SITAS, F				FORMAN, D; NEWELL, DG; FULLERTON, F; YARNELL, JWG; STACEY, AR; WALD, N; SITAS, F			ASSOCIATION BETWEEN INFECTION WITH HELICOBACTER-PYLORI AND RISK OF GASTRIC-CANCER - EVIDENCE FROM A PROSPECTIVE INVESTIGATION	BRITISH MEDICAL JOURNAL			English	Article							CAMPYLOBACTER-PYLORI; POPULATION; STOMACH; PREVALENCE; CARCINOMA; CHINA	Objective-To investigate the association between gastric cancer and prior infection with Helicobacter pylori. Design-Case-control comparison of prevalence of IgG antibodies to H pylori in blood samples collected prospectively, before diagnosis of gastric cancer in the cases. Presence of H pylori antibody (> 10-mu-gIgG/ml) determined by enzyme linked immunosorbent assay (ELISA). Subjects-29 men with a subsequent diagnosis of gastric cancer and 116 aged matched controls selected from over 22 000 middle aged men participating in two ongoing cohort studies (the British United Provident Association study and the Caerphilly collaborative heart disease study), who had provided blood samples during 1975-1982. Results-20 of the 29 cases (69%) and 54 of the 116 controls (47%) were positive for H pylori specific antibody. The median specific IgG concentration was significantly higher in the cases than controls (90-mu-g/ml v 3.6-mu-g/ml, p < 0.01). The estimated odds ratio for the risk of gastric cancer in those with a history of infection with H pylori was 2.77 (95% confidence interval 1.04 to 7.97, 2p = 0.039). Conclusions-H pylori infection may be an important cause of gastric cancer; between 35% and 55% of all cases may be associated with such an infection.	LLANDOUGH HOSP,MRC,EPIDEMIOL UNIT,PENARTH CF6 1XX,S GLAM,WALES; PUBL HLTH LAB SERV,CTR APPL MICROBIOL RES,DEPT PATHOL,SALISBURY SP4 0JG,WILTS,ENGLAND; ST BARTHOLOMEWS HOSP,COLL MED,DEPT ENVIRONM & PREVENT MED,BUPA EPIDEMIOL RES GRP,LONDON EC1 6BQ,ENGLAND	University of London; Queen Mary University London	FORMAN, D (corresponding author), RADCLIFFE INFIRM,IMPERIAL CANC RES FUND,CANC EPIDEMIOL UNIT,GIBSON BLDG,OXFORD OX2 6HE,ENGLAND.		Wald, Nicholas/AAY-2814-2021; Wald, Nicholas/AAY-8924-2021	Sitas, Freddy/0000-0001-9679-1481				BARKER DJP, 1990, BRIT J CANCER, V61, P575, DOI 10.1038/bjc.1990.129; Breslow N, 1980, STATISTICAL METHODS, V32; CORREA P, 1989, CAMPYLOBACTER PYLORI, P139; Dixon MF, 1989, CAMPYLOBACTER PYLORI, P106; FENG YY, 1988, LANCET, V1, P1055; FORMAN D, 1990, INT J CANCER, V46, P608, DOI 10.1002/ijc.2910460410; FOX JG, 1989, AM J GASTROENTEROL, V84, P775; HOWSON CP, 1986, EPIDEMIOL REV, V8, P1; JASKIEWICZ K, 1989, S AFR MED J, V75, P417; KWA G, 1981, BRIT J CANCER, V28, P673; Logan WPD, 1982, STUDIES MED POPULATI; MARSHALL BJ, 1990, REV INFECT DIS, V12, pS87; PAULL G, 1989, CAMPYLOBACTER PYLORI, P73; PEREZPEREZ GI, 1990, J INFECT DIS, V161, P1237, DOI 10.1093/infdis/161.6.1237; ROBEYCAFFERTY SS, 1989, MODERN PATHOL, V2, P473; SIPPONEN P, 1986, GASTRIC CARCINOMA, P152; SITAS F, 1991, GUT, V32, P25, DOI 10.1136/gut.32.1.25; SIURALA M, 1988, GUT, V29, P909, DOI 10.1136/gut.29.7.909; STEER HW, 1987, SERODIAGN IMMUNOTHER, V1, P253; TALLEY NJ, 1990, REV ESPANIOLA ENF S1, V78, P7; TALLEY NJ, IN PRESS J CLIN MICR; WALD N, 1980, LANCET, V2, P813; YANG PC, 1988, INT J EPIDEMIOL, V17, P293, DOI 10.1093/ije/17.2.293; 1990, AM J GASTROENTEROL, V85, P819; 1984, J EPIDEMIOL COMMUNIT, V38, P259	25	1185	1229	2	36	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1991	302	6788					1302	1305		10.1136/bmj.302.6788.1302	http://dx.doi.org/10.1136/bmj.302.6788.1302			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ444	2059685	Green Published, Bronze			2022-12-28	WOS:A1991FQ44400017
J	SARVER, N; CANTIN, EM; CHANG, PS; ZAIA, JA; LADNE, PA; STEPHENS, DA; ROSSI, JJ				SARVER, N; CANTIN, EM; CHANG, PS; ZAIA, JA; LADNE, PA; STEPHENS, DA; ROSSI, JJ			RIBOZYMES AS POTENTIAL ANTI-HIV-1 THERAPEUTIC AGENTS	SCIENCE			English	Article									NIAID,DIV AIDS,DEV PROGRAM,BETHESDA,MD 20892; CITY HOPE NATL MED CTR,DUARTE,CA 91010; CITY HOPE NATL MED CTR,BECKMAN RES INT,DEPT MOLEC GENET,DUARTE,CA 91010; LOMA LINDA UNIV,SCH MED,DEPT BIOCHEM,LOMA LINDA,CA 92350	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); City of Hope; City of Hope; Beckman Research Institute of City of Hope; Loma Linda University	SARVER, N (corresponding author), NIAID,DIV RES,DEV THERAPEUT BRANCH,BETHESDA,MD 20892, USA.				NATIONAL CANCER INSTITUTE [U01CA034991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI025959] Funding Source: NIH RePORTER; NCI NIH HHS [CA34991] Funding Source: Medline; NIAID NIH HHS [AI25959] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BUZAYAN JM, 1986, NATURE, V323, P349, DOI 10.1038/323349a0; CECH TR, 1986, ANNU REV BIOCHEM, V55, P599, DOI 10.1146/annurev.biochem.55.1.599; CHANG PS, 1990, CLIN BIOTECHNOL, V2, P1; EPSTEIN LM, 1987, CELL, V48, P535, DOI 10.1016/0092-8674(87)90204-2; FORSTER AC, 1987, CELL, V49, P211, DOI 10.1016/0092-8674(87)90562-9; GOODCHILD J, 1988, P NATL ACAD SCI USA, V85, P5507, DOI 10.1073/pnas.85.15.5507; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; HARLAND R, 1985, J CELL BIOL, V101, P109; HASELOFF J, 1988, NATURE, V334, P585, DOI 10.1038/334585a0; HUTCHINS CJ, 1986, NUCLEIC ACIDS RES, V14, P3627, DOI 10.1093/nar/14.9.3627; IZANT JG, 1984, CELL, V36, P1007, DOI 10.1016/0092-8674(84)90050-3; KEESE P, 1987, VIROIDS VIROID LIKE, P1; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MELTON DA, 1985, P NATL ACAD SCI USA, V82, P144, DOI 10.1073/pnas.82.1.144; MURAKAWA GJ, 1988, DNA-J MOLEC CELL BIO, V7, P287, DOI 10.1089/dna.1988.7.287; PRODY GA, 1986, SCIENCE, V231, P1577, DOI 10.1126/science.231.4745.1577; RATNER L, 1987, AIDS RES HUM RETROV, V3, P57, DOI 10.1089/aid.1987.3.57; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SARVER N, UNPUB; SHELDON CC, 1989, NUCLEIC ACIDS RES, V17, P5679, DOI 10.1093/nar/17.14.5679; SHELDON CC, 1989, NUCLEIC ACIDS RES, V17, P7059; SYMONS RH, 1989, TRENDS BIOCHEM SCI, V14, P445, DOI 10.1016/0968-0004(89)90103-5; TRITZ R, 1989, BIOCHEMISTRY-US, V28, P4929; UHLENBECK OC, 1987, NATURE, V328, P596, DOI 10.1038/328596a0; ZAIA JA, 1988, J VIROL, V62, P3914, DOI 10.1128/JVI.62.10.3914-3917.1988	25	599	838	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 9	1990	247	4947					1222	1225		10.1126/science.2107573	http://dx.doi.org/10.1126/science.2107573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT096	2107573				2022-12-28	WOS:A1990CT09600043
J	ASHTON, MR; SUTTON, D; NIELSEN, M				ASHTON, MR; SUTTON, D; NIELSEN, M			SEVERE MAGNESIUM TOXICITY AFTER MAGNESIUM-SULFATE ENEMA IN A CHRONICALLY CONSTIPATED CHILD	BMJ-BRITISH MEDICAL JOURNAL			English	Letter											ASHTON, MR (corresponding author), PRINCESS ANNE HOSP, SOUTHAMPTON SO9 4HA, ENGLAND.							BROWN AT, 1978, ARCH DIS CHILD, V53, P920, DOI 10.1136/adc.53.11.920-a; COLLINSON PO, 1986, BRIT MED J, V293, P1222; COLLINSON PO, 1986, BMJ-BRIT MED J, V293, P1013, DOI 10.1136/bmj.293.6553.1013; JONES J, 1986, ANN EMERG MED, V15, P1214, DOI 10.1016/S0196-0644(86)80870-8; MCCUBBIN JH, 1981, LANCET, V1, P1058; MORTON AR, 1985, BRIT MED J, V291, P516; OUTERBRIDGE EW, 1973, JAMA-J AM MED ASSOC, V224, P1392; RICHARDS A, 1985, S AFR MED J, V67, P145; STEVENS AR, 1950, ARCH NEURO PSYCHIATR, V63, P749, DOI 10.1001/archneurpsyc.1950.02310230071006	9	17	17	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	1990	300	6723					541	541		10.1136/bmj.300.6723.541-a	http://dx.doi.org/10.1136/bmj.300.6723.541-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107950	Green Published, Bronze			2022-12-28	WOS:A1990CQ87800061
J	HOWS, JM; BROZOVIC, B				HOWS, JM; BROZOVIC, B			ABC OF TRANSFUSION - PLATELET AND GRANULOCYTE TRANSFUSIONS	BRITISH MEDICAL JOURNAL			English	Article									N LONDON BLOOD TRANSFUS CTR,LONDON,ENGLAND		HOWS, JM (corresponding author), HAMMERSMITH HOSP,LONDON W12 0HS,ENGLAND.								0	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	1990	300	6723					520	523		10.1136/bmj.300.6723.520	http://dx.doi.org/10.1136/bmj.300.6723.520			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107934	Green Published, Bronze			2022-12-28	WOS:A1990CQ87800026
J	MATTHEWS, WB				MATTHEWS, WB			BOVINE SPONGIFORM ENCEPHALOPATHY	BRITISH MEDICAL JOURNAL			English	Editorial Material																		ALTER M, 1975, NEW ENGL J MED, V292, P927, DOI 10.1056/NEJM197504242921721; BARLOW RM, 1990, VET REC, V126, P111; BROWN P, 1987, NEUROLOGY, V37, P895, DOI 10.1212/WNL.37.6.895; BROWN P, 1988, PEDIATRICS, V81, P85; DAVANIPOUR Z, 1985, NEUROLOGY, V35, P1483, DOI 10.1212/WNL.35.10.1483; DAVANIPOUR Z, 1985, AM J EPIDEMIOL, V122, P443, DOI 10.1093/oxfordjournals.aje.a114125; FRASER H, 1988, VET REC, V123, P427; GALVEZ S, 1980, ARCH NEUROL-CHICAGO, V37, P11, DOI 10.1001/archneur.1980.00500500041004; GIBBS CJ, 1980, J INFECT DIS, V142, P205, DOI 10.1093/infdis/142.2.205; HARRIESJONES R, 1988, J NEUROL NEUROSUR PS, V51, P1113, DOI 10.1136/jnnp.51.9.1113; HARTSOUGH GR, 1965, J INFECT DIS, V115, P387, DOI 10.1093/infdis/115.4.387; KLITZMAN R L, 1984, Neuroepidemiology, V3, P3, DOI 10.1159/000110837; KONDO K, 1982, ANN NEUROL, V11, P377, DOI 10.1002/ana.410110410; LEIDERMAN DB, 1986, NEUROLOGY, V36, P835, DOI 10.1212/WNL.36.6.835; MATTHEWS WB, 1981, LANCET, V1, P937; MILLER DC, 1988, NEW ENGL J MED, V318, P853, DOI 10.1056/NEJM198803313181312; PRUSINER SB, 1987, NEW ENGL J MED, V317, P1571, DOI 10.1056/NEJM198712173172505; SITWELL L, 1988, NEW ENGL J MED, V318, P854; WELLS GAH, 1987, VET REC, V121, P134; WILL RG, 1982, J NEUROL NEUROSUR PS, V45, P235, DOI 10.1136/jnnp.45.3.235; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; WINTER MH, 1989, BRIT VET J, V145, P191, DOI 10.1016/0007-1935(89)90104-8; 1989, WORKING PARTY BOVINE	23	11	12	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 17	1990	300	6722					412	413		10.1136/bmj.300.6722.412	http://dx.doi.org/10.1136/bmj.300.6722.412			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP166	2107889	Green Published, Bronze			2022-12-28	WOS:A1990CP16600002
J	KYLE, V; HAZELMAN, BL				KYLE, V; HAZELMAN, BL			STOPPING STEROIDS IN POLYMYALGIA RHEUMATICA AND GIANT-CELL ARTERITIS	BRITISH MEDICAL JOURNAL			English	Editorial Material											KYLE, V (corresponding author), ADDENBROOKES HOSP,RHEUMATOL RES UNIT,CAMBRIDGE CB2 2QQ,ENGLAND.							AYOUB WT, 1985, AM J MED, V79, P309, DOI 10.1016/0002-9343(85)90309-2; BAGRATUNI L, 1963, Br Med J, V1, P513; BARBER HS, 1957, ANN RHEUM DIS, V16, P230, DOI 10.1136/ard.16.2.230; BEHN AR, 1983, ANN RHEUM DIS, V42, P374, DOI 10.1136/ard.42.4.374; BENGTSSON BA, 1981, ACTA MED SCAND, V209, P237; BENLAHRACHE C, 1983, ARTHRITIS RHEUM, V26, P1472, DOI 10.1002/art.1780261209; BIRKHEAD NC, 1957, JAMA-J AM MED ASSOC, V163, P821, DOI 10.1001/jama.1957.02970450023007; Bruce W, 1888, Br Med J, V2, P811; CHUANG TY, 1982, ANN INTERN MED, V97, P672, DOI 10.7326/0003-4819-97-5-672; Coomes E N, 1976, Rheumatol Rehabil, V15, P270, DOI 10.1093/rheumatology/15.4.270; DASGUPTA B, 1989, ANN RHEUM DIS, V48, P307, DOI 10.1136/ard.48.4.307; DELECOEUILLERIE G, 1988, ANN RHEUM DIS, V47, P733, DOI 10.1136/ard.47.9.733; DESILVA M, 1986, ANN RHEUM DIS, V45, P136, DOI 10.1136/ard.45.2.136; ELLING H, 1985, J RHEUMATOL, V12, P306; FAINARU M, 1979, J RHEUMATOL, V6, P330; FAUCHALD P, 1972, ANN INTERN MED, V77, P845, DOI 10.7326/0003-4819-77-6-845; GRAHAM E, 1981, BRIT MED J, V282, P269, DOI 10.1136/bmj.282.6260.269; HUSTON KA, 1980, AM HEART J, V100, P99, DOI 10.1016/0002-8703(80)90285-9; Hutchinson J., 1890, ARCH SURG-CHICAGO, V1, P323; JONES JG, 1981, ANN RHEUM DIS, V40, P1, DOI 10.1136/ard.40.1.1; KYLE V, 1989, ANN RHEUM DIS, V48, P662, DOI 10.1136/ard.48.8.662; Kyle V., 1988, BR J RHEUMATOL S1, V27, P7; Myles A B, 1975, Rheumatol Rehabil, V14, P231, DOI 10.1093/rheumatology/14.4.231; SPIERA H, 1982, ARTHRITIS RHEUM, V25, P120, DOI 10.1002/art.1780250124; VILASECA J, 1987, ANN RHEUM DIS, V46, P282, DOI 10.1136/ard.46.4.282; VONKNORRING J, 1979, ACTA MED SCAND, V205, P429	26	46	47	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					344	345		10.1136/bmj.300.6721.344	http://dx.doi.org/10.1136/bmj.300.6721.344			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106980	Green Published, Bronze			2022-12-28	WOS:A1990CN79900002
J	LOWRY, S				LOWRY, S			ACCIDENTS AT HOME	BRITISH MEDICAL JOURNAL			English	Article																		Chandler S.E., 1984, FIRE PREVENTION, V172, P15; COLVER AF, 1982, BRIT MED J, V285, P1177, DOI 10.1136/bmj.285.6349.1177; CONSTANTINIDES P, 1988, RADICAL COMMUNITY ME, P31; GLOAG D, 1987, C STRATEGIES ACCIDEN; JACKSON RH, 1981, BRIT MED J, V283, P1310, DOI 10.1136/bmj.283.6302.1310; PAGE M, 1986, CHILD SAFETY HOUSING; 1989, BASIC PRINCIPLES CHI; 1989, HOME LEISURE ACCIDEN; 1984, HOUSES MULTIPLE OCCU; 1989, FIRE STATISTICS UK 1	10	8	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					104	106		10.1136/bmj.300.6717.104	http://dx.doi.org/10.1136/bmj.300.6717.104			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105752	Bronze, Green Published			2022-12-28	WOS:A1990CJ08000023
J	SMITH, TDW; CLAYTON, D				SMITH, TDW; CLAYTON, D			INDIVIDUAL VARIATION BETWEEN GENERAL-PRACTITIONERS IN LABELING OF HYPERTENSION	BMJ-BRITISH MEDICAL JOURNAL			English	Article											SMITH, TDW (corresponding author), LEICESTER ROYAL INFIRM, DEPT COMMUNITY HLTH, LEICESTER LE2 7LX, ENGLAND.							[Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; [Anonymous], 1980, LANCET, V1, P1261; [Anonymous], 1970, JAMA, V213, P1143; PATTERSON HR, 1984, J ROY COLL GEN PRACT, V34, P97	4	15	15	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	1990	300	6717					74	75		10.1136/bmj.300.6717.74	http://dx.doi.org/10.1136/bmj.300.6717.74			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105776	Green Published, Bronze			2022-12-28	WOS:A1990CJ08000012
J	ROBBINS, J; MERINO, MJ; BOICE, JD; RON, E; AIN, KB; ALEXANDER, HR; NORTON, JA; REYNOLDS, J				ROBBINS, J; MERINO, MJ; BOICE, JD; RON, E; AIN, KB; ALEXANDER, HR; NORTON, JA; REYNOLDS, J			THYROID-CANCER - A LETHAL ENDOCRINE NEOPLASM	ANNALS OF INTERNAL MEDICINE			English	Discussion							FACTORS INFLUENCING PROGNOSIS; SERUM THYROGLOBULIN DETERMINATION; POORLY DIFFERENTIATED CARCINOMA; CARCINOEMBRYONIC ANTIGEN LEVELS; INAPPARENT MEDULLARY CARCINOMA; DOXORUBICIN PLUS CISPLATIN; COLUMNAR-CELL CARCINOMA; MB-1 ANTI-CD37 ANTIBODY; UNIVERSITY-OF-MICHIGAN; EARLY LIVER METASTASES	This conference focuses on the controversies about managing thyroid cancer, emphasizing the possibility that the treatment of patients with potentially fatal thyroid cancer may be improved. Although the mortality rate from thyroid cancer is low, it is the highest among cancers affecting the endocrine glands (excluding the ovary). Exposure to radiation during childhood in the 1930s and 1940s increased the incidence of but not the mortality from thyroid cancer, because these tumors are mainly papillary cancers developing in young adults. These rates may change as the exposed cohort ages. Risk factors that increase mortality include older patient age and the growth characteristics of the tumor at diagnosis, the presence of distant metastases, and cell type (for example, the tall-cell variants of papillary cancer, follicular cancer [to be distinguished from the more benign follicular variant of papillary cancer], medullary cancer, and anaplastic cancer). Local metastases in lymph nodes do not seem to increase the risk for death from papillary cancer, but they do increase the risk for death from follicular and medullary cancer. In the latter, mortality is decreased by the early detection and treatment of patients with the familial multiple endocrine neoplasia syndrome 2a. There are excellent tumor markers for differentiated cancer of the parafollicular and of the follicular cells (serum calcitonin and serum thyroglobulin levels, respectively). Measuring the calcitonin level allows early diagnosis of familial medullary cancer, whereas measuring the thyroglobulin level, although useful only after total thyroidectomy, allows early recognition of recurrence or metastases of papillary or follicular cancer. Initial surgery, protocols for follow-up, and the use of radioiodine for the ablation of any residual thyroid and the treatment of metastatic cancer are discussed. Because these tumors resist currently available chemotherapy regimens, possible ways to increase the effectiveness of radioiodine therapy are considered as are new approaches to treatment.	NCI, SURG BRANCH, SURG METAB SECT, BETHESDA, MD 20892 USA; NCI, PATHOL LAB, BETHESDA, MD 20892 USA; NCI, RADIAT EPIDEMIOL BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	ROBBINS, J (corresponding author), NIDDKD, CLIN ENDOCRINOL BRANCH, BLDG 10, ROOM 8N315, BETHESDA, MD 20892 USA.		Ain, Kenneth/A-5179-2012	Ain, Kenneth/0000-0002-2668-934X				ADELSTEIN SJ, 1987, NUCL MED BIOL, V14, P165; AHUJA S, 1987, J ENDOCRINOL INVEST, V10, P303, DOI 10.1007/BF03348135; ANSPAUGH LR, 1988, SCIENCE, V242, P1513, DOI 10.1126/science.3201240; ARNSTEIN NB, 1986, J NUCL MED, V27, P1764; ATKINS MB, 1988, NEW ENGL J MED, V318, P1557, DOI 10.1056/NEJM198806163182401; BEIERWALTES WH, 1984, J NUCL MED, V25, P1287; BENUA RS, 1962, AMER J ROENTGENOL RA, V87, P171; Benua RS, 1986, FRONTIERS THYROIDOLO, V2, P1317; BOICE JD, 1988, RADIAT RES, V116, P3, DOI 10.2307/3577477; Bronner MP, 1998, SURG PATHOL, V1, P137; BROWN I, 1986, APPL RADIAT ISOTOPES, V37, P789, DOI 10.1016/0883-2889(86)90273-X; BUSNARDO B, 1984, CANCER, V53, P278, DOI 10.1002/1097-0142(19840115)53:2<278::AID-CNCR2820530216>3.0.CO;2-Z; CADY B, 1985, SURGERY, V98, P1171; CANCE WG, 1985, CURR PROB SURG, V22, P1; Carcangiu M L, 1985, Pathol Annu, V20 Pt 1, P1; CHEN KTK, 1977, AM J SURG PATHOL, V1, P123, DOI 10.1097/00000478-197706000-00003; CLARK OH, 1988, EUR J CANCER CLIN ON, V24, P305, DOI 10.1016/0277-5379(88)90273-8; COBB LM, 1988, RADIOTHER ONCOL, V13, P203, DOI 10.1016/0167-8140(88)90057-6; COBB LM, 1988, HUM TOXICOL, V7, P529, DOI 10.1177/096032718800700602; CONARD RA, 1984, RAD CARCINOGENESIS E, P57; CRILE G, 1979, NEW ENGL J MED, V301, P997, DOI 10.1056/NEJM197911013011810; DEGROOT LJ, 1983, AM J MED, V74, P852, DOI 10.1016/0002-9343(83)91077-X; DEGROOT LJ, 1982, ANN INTERN MED, V96, P51, DOI 10.7326/0003-4819-96-1-51; DEVATHAIRE F, 1988, LANCET, V2, P455; DOBYNS BM, 1974, J CLIN ENDOCR METAB, V38, P976, DOI 10.1210/jcem-38-6-976; DUH QY, 1989, ARCH SURG-CHICAGO, V124, P1206; EDMONDS CJ, 1986, BRIT J RADIOL, V59, P45, DOI 10.1259/0007-1285-59-697-45; EDMONDS CJ, 1985, BRIT J CANCER, V52, P537, DOI 10.1038/bjc.1985.225; EVANS HL, 1986, AM J CLIN PATHOL, V85, P77, DOI 10.1093/ajcp/85.1.77; EZAKI H, 1986, GANN MONOGR CANCER R, V32, P129; FAIRWEATHER DS, 1983, CLIN ENDOCRINOL, V18, P563, DOI 10.1111/j.1365-2265.1983.tb00594.x; FITZGERALD PJ, 1950, CANCER, V3, P86, DOI 10.1002/1097-0142(1950)3:1<86::AID-CNCR2820030112>3.0.CO;2-Y; FRANSSILA KO, 1973, CANCER-AM CANCER SOC, V32, P853, DOI 10.1002/1097-0142(197310)32:4<853::AID-CNCR2820320417>3.0.CO;2-2; FRANSSILA KO, 1981, ACTA PATHOL MICRO S, V225, P5; FURST CJ, 1988, JNCI-J NATL CANCER I, V80, P1387, DOI 10.1093/jnci/80.17.1387; GAUTVIK KM, 1989, CANCER, V63, P175, DOI 10.1002/1097-0142(19890101)63:1<175::AID-CNCR2820630128>3.0.CO;2-9; GHARIB H, 1984, ANN INTERN MED, V101, P25, DOI 10.7326/0003-4819-101-1-25; GHARIB H, 1987, NEW ENGL J MED, V317, P70, DOI 10.1056/NEJM198707093170202; HAMBURGER JI, 1987, ARCH INTERN MED, V147, P97, DOI 10.1001/archinte.147.1.97; HAMILTON TE, 1987, JAMA-J AM MED ASSOC, V258, P629, DOI 10.1001/jama.258.5.629; HAPKE MR, 1979, AM J SURG PATHOL, V3, P31, DOI 10.1097/00000478-197902000-00004; HARACH HR, 1988, HISTOPATHOLOGY, V13, P43, DOI 10.1111/j.1365-2559.1988.tb02002.x; HAWK WA, 1976, CLEVELAND CLIN Q, V43, P207, DOI 10.3949/ccjm.43.4.207; HAZARD JB, 1959, J CLIN ENDOCR METAB, V19, P152, DOI 10.1210/jcem-19-1-152; HAZARD JB, 1968, THYROID NEOPLASIA, P2; HEDINGER C, 1989, CANCER-AM CANCER SOC, V63, P908, DOI 10.1002/1097-0142(19890301)63:5<908::AID-CNCR2820630520>3.0.CO;2-I; HEMPELMA.LH, 1968, SCIENCE, V160, P159, DOI 10.1126/science.160.3824.159; HOIE J, 1988, CANCER, V61, P1, DOI 10.1002/1097-0142(19880101)61:1<1::AID-CNCR2820610102>3.0.CO;2-R; HOLM LE, 1988, JNCI-J NATL CANCER I, V80, P1132, DOI 10.1093/jnci/80.14.1132; HOLM LE, 1991, IN PRESS CANCER RISK; HUMM JL, 1986, J NUCL MED, V27, P1490; JOHNSON TL, 1988, AM J SURG PATHOL, V12, P22, DOI 10.1097/00000478-198801000-00003; KAN NF, 1983, PATHOLOGY ANN MONO 1, V14, P221; KELLAND LR, 1988, RADIOTHER ONCOL, V13, P285, DOI 10.1016/0167-8140(88)90224-1; KIM JH, 1987, CANCER, V60, P2372, DOI 10.1002/1097-0142(19871115)60:10<2372::AID-CNCR2820601004>3.0.CO;2-1; KUSAKABE K, 1989, JPN J EXP MED, V59, P37; LANG W, 1986, AM J SURG PATHOL, V10, P246, DOI 10.1097/00000478-198604000-00003; LEGERFO P, 1983, SURGERY, V94, P959; LIAW KY, 1980, CANCER, V46, P285, DOI 10.1002/1097-0142(19800715)46:2<285::AID-CNCR2820460211>3.0.CO;2-3; LINDSAY S, 1960, CARCINOMA THYROID GL, P43; LIPPMAN SM, 1982, J CLIN ENDOCR METAB, V54, P233, DOI 10.1210/jcem-54-2-233; Livolsi V A, 1981, Pathol Annu, V16, P357; LIVOLSI VA, 1990, MAJOR PROBLEMS PATHO, P386; MAHESHWARI YK, 1981, CANCER-AM CANCER SOC, V47, P664, DOI 10.1002/1097-0142(19810215)47:4<664::AID-CNCR2820470408>3.0.CO;2-#; MATHEW CGP, 1987, NATURE, V328, P527, DOI 10.1038/328527a0; MAXON HR, 1983, NEW ENGL J MED, V309, P937, DOI 10.1056/NEJM198310203091601; MAZZAFERRI EL, 1987, SEMIN ONCOL, V14, P315; MCCONAHEY WM, 1986, MAYO CLIN PROC, V61, P978, DOI 10.1016/S0025-6196(12)62641-X; MERINO MJ, 1990, SURG PATHOL, V3, P59; MORTENSEN JD, 1954, SURG FORUM, V5, P659; MOVIUS EG, 1986, FRONTIERS THYROIDOLO, P1269; NEL CJC, 1985, MAYO CLIN PROC, V60, P51, DOI 10.1016/S0025-6196(12)65285-9; NELKIN BD, 1989, JAMA-J AM MED ASSOC, V261, P3130, DOI 10.1001/jama.261.21.3130; NIEDERLE B, 1986, SURGERY, V100, P1088; NORTON JA, 1979, SURG CLIN N AM, V59, P109; NORTON JA, 1980, SURGERY, V87, P616; PACINI F, 1988, INT CONGR SER, V796, P685; PACINI F, 1985, CLIN ENDOCRINOL, V23, P405, DOI 10.1111/j.1365-2265.1985.tb01098.x; PETURSSON SR, 1988, CANCER-AM CANCER SOC, V62, P1899, DOI 10.1002/1097-0142(19881101)62:9<1899::AID-CNCR2820620905>3.0.CO;2-C; PICKLE LW, 1987, DHHS NIH872900177 PU, P177; POCHIN E E, 1971, Seminars in Nuclear Medicine, V1, P503; PONS F, 1987, CLIN NUCL MED, V12, P644, DOI 10.1097/00003072-198708000-00014; POTTERN LM, 1990, J CLIN EPIDEMIOL, V43, P449, DOI 10.1016/0895-4356(90)90133-A; POTTERN LM, 1980, AM J EPIDEMIOL, V112, P764, DOI 10.1093/oxfordjournals.aje.a113049; Prentice R L, 1982, Natl Cancer Inst Monogr, V62, P207; PRESS OW, 1989, J CLIN ONCOL, V7, P1027, DOI 10.1200/JCO.1989.7.8.1027; RALLISON ML, 1975, JAMA-J AM MED ASSOC, V233, P1069, DOI 10.1001/jama.233.10.1069; RAMACCIOTTI C, 1982, J NUCL MED, V23, P483; ROBBINS J, 1981, ADV THYROID NEOPLASI, P233; RON E, 1989, RADIAT RES, V120, P516, DOI 10.2307/3577801; RON E, 1987, JNCI-J NATL CANCER I, V79, P1; ROSAI J, 1985, SEMIN DIAGN PATHOL, V2, P123; ROSAI J, 1983, AM J SURG PATHOL, V7, P809, DOI 10.1097/00000478-198307080-00010; ROSENBERG SA, 1989, CANCER PRINCIPLES PR, P301; ROSSI RL, 1980, AM J SURG, V139, P554, DOI 10.1016/0002-9610(80)90337-2; ROSSI RL, 1988, ARCH SURG-CHICAGO, V123, P569; SAMAAN NA, 1988, J CLIN ENDOCR METAB, V67, P801, DOI 10.1210/jcem-67-4-801; SCHELFHOUT LJDM, 1988, EUR J CANCER CLIN ON, V24, P331, DOI 10.1016/0277-5379(88)90276-3; SCHNEIDER AB, 1985, MEDICINE, V64, P1; SCHRODER S, 1986, VIRCHOWS ARCH A, V409, P555, DOI 10.1007/BF00713424; SCHRODER S, 1988, CANCER, V61, P806, DOI 10.1002/1097-0142(19880215)61:4<806::AID-CNCR2820610428>3.0.CO;2-G; SHEPHERD PS, 1985, EUR J NUCL MED, V10, P291; SHIMAOKA K, 1985, CANCER, V56, P2155, DOI 10.1002/1097-0142(19851101)56:9<2155::AID-CNCR2820560903>3.0.CO;2-E; SHORE RE, 1985, J NATL CANCER I, V74, P1177; SILVERBERG E, 1990, CA-CANCER J CLIN, V40, P9, DOI 10.3322/canjclin.40.1.9; SIMPSON NE, 1987, NATURE, V328, P528, DOI 10.1038/328528a0; SIMPSON WJ, 1987, AM J MED, V83, P479, DOI 10.1016/0002-9343(87)90758-3; SOBRINHOSIMOES M, 1988, AM J CLIN PATHOL, V89, P264, DOI 10.1093/ajcp/89.2.264; STANTA G, 1988, PATHOL ANNU, V23, P129; TELANDER RL, 1989, ARCH SURG-CHICAGO, V124, P841; THOMPSON NW, 1974, SURG GYNECOL OBSTET, V139, P555; TIPPINS JR, 1984, NEUROPEPTIDES, V4, P425, DOI 10.1016/0143-4179(84)90118-5; TISELL LE, 1986, SURGERY, V99, P60; TSCHOLLDUCOMMUN J, 1982, VIRCHOWS ARCH A, V396, P19, DOI 10.1007/BF00428498; TUBIANA M, 1985, CANCER-AM CANCER SOC, V55, P794, DOI 10.1002/1097-0142(19850215)55:4<794::AID-CNCR2820550418>3.0.CO;2-Z; TUCKER M A, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P211; VARMA VM, 1970, J AMER MED ASSOC, V214, P1437, DOI 10.1001/jama.214.8.1437; VICKERY AL, 1985, SEMIN DIAGN PATHOL, V2, P90; VICKERY AL, 1983, AM J SURG PATHOL, V7, P797, DOI 10.1097/00000478-198307080-00009; WANG ZY, 1990, JNCI-J NATL CANCER I, V82, P478, DOI 10.1093/jnci/82.6.478; WAXMAN A, 1981, J NUCL MED, V22, P861; WELLS SA, 1982, ANN SURG, V195, P595, DOI 10.1097/00000658-198205000-00008; WELLS SA, 1985, ARCH INTERN MED, V145, P1248, DOI 10.1001/archinte.145.7.1248; WILLIAMS ED, 1966, P ROY SOC MED, V59, P602, DOI 10.1177/003591576605900707; 1980, 64 NAT COUNC RAD PRO	125	176	180	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	1991	115	2					133	147		10.7326/0003-4819-115-2-133	http://dx.doi.org/10.7326/0003-4819-115-2-133			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW091	2058861				2022-12-28	WOS:A1991FW09100010
J	IUCHI, S; LIN, ECC				IUCHI, S; LIN, ECC			ADAPTATION OF ESCHERICHIA-COLI TO RESPIRATORY CONDITIONS - REGULATION OF GENE-EXPRESSION	CELL			English	Review							FUMARATE REDUCTASE; FNR; K-12; NARL; DEHYDROGENASE; REQUIREMENT; REPRESSION; RESPONSES; PATHWAYS; PROMOTER				IUCHI, S (corresponding author), HARVARD UNIV,SCH MED,DEPT MICROBIOL & MOLEC GENET,BOSTON,MA 02115, USA.							BHRIAIN NN, 1989, MOL MICROBIOL, V3, P933, DOI 10.1111/j.1365-2958.1989.tb00243.x; BIRKMANN A, 1989, MOL MICROBIOL, V3, P187, DOI 10.1111/j.1365-2958.1989.tb01807.x; COTTER PA, 1990, J BACTERIOL, V172, P6333, DOI 10.1128/jb.172.11.6333-6338.1990; EGAN SM, 1990, J BACTERIOL, V172, P5020, DOI 10.1128/jb.172.9.5020-5029.1990; FU HA, 1991, MOL GEN GENET, V226, P209, DOI 10.1007/BF00273605; IUCHI S, 1987, P NATL ACAD SCI USA, V84, P3901, DOI 10.1073/pnas.84.11.3901; IUCHI S, 1990, J BACTERIOL, V172, P6020, DOI 10.1128/jb.172.10.6020-6025.1990; IUCHI S, 1990, MOL MICROBIOL, V4, P715, DOI 10.1111/j.1365-2958.1990.tb00642.x; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; IUCHI S, 1990, J BACTERIOL, V172, P179, DOI 10.1128/JB.172.1.179-184.1990; KALMAN LV, 1990, J BACTERIOL, V172, P7049, DOI 10.1128/jb.172.12.7049-7056.1990; LI SF, 1988, J BIOL CHEM, V263, P13700; MINAGAWA J, 1990, J BIOL CHEM, V265, P11198; PAGE L, 1990, ARCH MICROBIOL, V154, P349, DOI 10.1007/BF00276530; RONSON CW, 1987, CELL, V49, P579, DOI 10.1016/0092-8674(87)90530-7; SILVERMAN P, 1986, BIOESSAYS, V2, P254; SPIRO S, 1990, FEMS MICROBIOL LETT, V75, P399, DOI 10.1016/0378-1097(90)90690-R; STEWART V, 1982, J BACTERIOL, V151, P1320, DOI 10.1128/JB.151.3.1320-1325.1982; STEWART V, 1988, J BACTERIOL, V170, P4437, DOI 10.1128/jb.170.10.4437-4444.1988; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; TARDAT B, 1991, MOL MICROBIOL, V5, P455, DOI 10.1111/j.1365-2958.1991.tb02129.x	21	101	103	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 12	1991	66	1					5	7		10.1016/0092-8674(91)90130-Q	http://dx.doi.org/10.1016/0092-8674(91)90130-Q			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FW913	2070418				2022-12-28	WOS:A1991FW91300002
J	TYBULEWICZ, VLJ; CRAWFORD, CE; JACKSON, PK; BRONSON, RT; MULLIGAN, RC				TYBULEWICZ, VLJ; CRAWFORD, CE; JACKSON, PK; BRONSON, RT; MULLIGAN, RC			NEONATAL LETHALITY AND LYMPHOPENIA IN MICE WITH A HOMOZYGOUS DISRUPTION OF THE C-ABL PROTOONCOGENE	CELL			English	Article							GERM-LINE TRANSMISSION; TYROSINE KINASE; STEM-CELLS; DIFFERENTIAL EXPRESSION; NUCLEOTIDE-SEQUENCE; CATALYTIC DOMAINS; PHOSPHOLIPASE-C; MESSENGER-RNAS; MOUSE; GENE	The c-abl proto-oncogene, which encodes a cytoplasmic protein-tyrosine kinase, is expressed throughout murine gestation and ubiquitously in adult mouse tissues. However, its levels are highest in thymus, spleen, and testes. To examine the in vivo role of c-abl, the gene was disrupted in embryonic stem cells, and the resulting genetically modified cells were used to establish a mouse strain carrying the mutation. Most mice homozygous for the c-abl mutation became runted and died 1 to 2 weeks after birth. In addition, many showed thymic and splenic atrophy and a T and B cell lymphopenia.	MIT,DEPT BIOL,CAMBRIDGE,MA 02139; TUFTS UNIV,SCH VET MED,BOSTON,MA 02111; TUFTS UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02111	Massachusetts Institute of Technology (MIT); Tufts University; Tufts University	TYBULEWICZ, VLJ (corresponding author), MIT,WHITEHEAD INST BIOMED RES,9 CAMBRIDGE CTR,CAMBRIDGE,MA 02139, USA.		Esguerra, Camila/D-7657-2014	Esguerra, Camila/0000-0001-7891-1427; Jackson, Peter/0000-0002-1742-2539	NHLBI NIH HHS [HL37569] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037569] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; ARRUSHDI A, 1988, ONCOGENE, V2, P353; BARTRAM CR, 1985, EMBO J, V4, P683, DOI 10.1002/j.1460-2075.1985.tb03683.x; BEN-NERIAH Y, 1986, CELL, V44, P577, DOI 10.1016/0092-8674(86)90267-9; BERNARDS A, 1988, ONCOGENE, V2, P297; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; CLARK SS, 1987, SCIENCE, V235, P85, DOI 10.1126/science.3541203; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GROSVELD G, 1986, MOL CELL BIOL, V6, P607, DOI 10.1128/MCB.6.2.607; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; HENKEMEYER M, 1990, CELL, V63, P949, DOI 10.1016/0092-8674(90)90498-4; HENKEMEYER MJ, 1987, CELL, V51, P821, DOI 10.1016/0092-8674(87)90105-X; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; KRUH GD, 1986, SCIENCE, V234, P1545, DOI 10.1126/science.3787260; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MULLER R, 1982, NATURE, V299, P640, DOI 10.1038/299640a0; OPPI C, 1987, P NATL ACAD SCI USA, V84, P8200, DOI 10.1073/pnas.84.23.8200; PAWSON T, 1988, ONCOGENE, V3, P491; PONZETTO C, 1985, MOL CELL BIOL, V5, P1791, DOI 10.1128/MCB.5.7.1791; RENSHAW MW, 1988, MOL CELL BIOL, V8, P4547, DOI 10.1128/MCB.8.10.4547; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; SCHIFFMAKER L, 1986, J VIROL, V57, P1182, DOI 10.1128/JVI.57.3.1182-1186.1986; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SHTIVELMAN E, 1986, CELL, V47, P227; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; WANG JYJ, 1983, MOL CELL BIOL, V3, P773, DOI 10.1128/MCB.3.5.773	39	1194	1248	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 28	1991	65	7					1153	1163		10.1016/0092-8674(91)90011-M	http://dx.doi.org/10.1016/0092-8674(91)90011-M			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FU899	2065352				2022-12-28	WOS:A1991FU89900008
J	MERCIER, N; VALLADAS, H; JORON, JL; REYSS, JL; LEVEQUE, F; VANDERMEERSCH, B				MERCIER, N; VALLADAS, H; JORON, JL; REYSS, JL; LEVEQUE, F; VANDERMEERSCH, B			THERMOLUMINESCENCE DATING OF THE LATE NEANDERTHAL REMAINS FROM SAINT-CESAIRE	NATURE			English	Article							SYSTEM; DATES	ANATOMICALLY modern humans have long been thought to have been responsible for the Aurignacian and Chatelperronian industries of the early Upper Palaeolithic of Western Europe, whereas the Middle Palaeolithic Mousterian industry has been attributed to Neanderthals. The presence of both Middle and Upper Palaeolithic strata at Saint-Cesaire in France offers an excellent opportunity for studying the cultural transition between the two. Saint-Cesaire is the only Chatelperronian site that has yielded really diagnostic hominid fossils, and the discovery there of Neanderthal remains 1 alongside Chatelperronian tools cast doubt on the exclusive association between industries and taxon. We report thermoluminescence dates for 20 burnt flints from the site. Those found near the Neanderthal remains were dated at 36,300 +/- 2,700 years BP (before present), making this specimen the youngest Neanderthal dated so far. This date places the stratum close in age to several French 2,3 but much younger than some Spanish 4,5 Aurignacian sites believed to have been occupied by modern humans. The possibility of contact between the West European Neanderthals and the intrusive modern humans who replaced them cannot therefore be excluded.	CENS,LAB PIERRE SUE,SCI TERRE GRP,F-91191 GIF SUR YVETTE,FRANCE; HOTEL ROCHEFORT,DIRECT ANTIQUITES REG POITOU CHARENTES,F-86020 POITIERS,FRANCE; UNIV BORDEAUX 1,ANTHROPOL LAB,CNRS,UA 376,F-33405 TALENCE,FRANCE	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	MERCIER, N (corresponding author), CEA,CNRS LAB,CTR FAIBLES RADIOACT,AVE TERRASSE,F-91198 GIF SUR YVETTE,FRANCE.		Klein, Richard G/B-5910-2009	Mercier, Norbert/0000-0002-6375-9108				AITKEN MJ, 1976, ARCHAEOMETRY, V18, P233, DOI 10.1111/j.1475-4754.1976.tb00168.x; Aitken MJ, 1985, THERMOLUMINESCENCE D; APSIMON AM, 1980, NATURE, V287, P272; BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0; BELL WT, 1979, ARCHAEOMETRY, V21, P243, DOI 10.1111/j.1475-4754.1979.tb00258.x; BELL WT, 1991, ARCHAEOMETRY, V33, P43, DOI 10.1111/j.1475-4754.1991.tb00684.x; BISCHOFF JL, 1989, J ARCHAEOL SCI, V16, P563, DOI 10.1016/0305-4403(89)90022-8; Bordes F., 1968, PALEOLITHIQUE MONDE; Cabrera-Valdes V., 1989, J ARCHAEOL SCI, V16, P577, DOI [10.1016/0305-4403(89)90023-X, DOI 10.1016/0305-4403(89)90023-X]; CHAYLA B, 1973, CR ACAD SCI D NAT, V277, P273; DEMARS PY, 1989, HOMME NEANDERTAL, V3, P23; GAMBIER D, 1989, HOMME NEANDERTAL, V3, P67; Girard M., 1990, MEM MUS PREHIST ILE, V3, P295; GOWLETT JAJ, 1986, ARCHAEOMETRY, V28, P206, DOI 10.1111/j.1475-4754.1986.tb00389.x; HUXTABLE J, 1982, ARCHAEOMETRY, V24, P164; Leroi-Gourhan A., 1965, PREHISTOIRE ART OCCI; Leroi-Gourhan A, 1984, B SOC PREHISTORIQUE, V81, P196; LEROIGOURHAN A, 1963, B SOC MERID SPELEO P, P6; LEVEQUE F, 1980, CR ACAD SCI D NAT, V291, P187; LEVEQUE F, 1983, ANTHROPOLOGIE, V87, P369; LEVEQUE F, 1989, HOMME NEANDERTAL, V3, P99; MELLARS P, 1989, CURR ANTHROPOL, V30, P349, DOI 10.1086/203755; Mellars P, 1989, HUMAN REVOLUTION; Prescott JR., 1982, LATITUDE, V6, P17; VALLADAS H, 1986, NATURE, V322, P452, DOI 10.1038/322452a0; VALLADAS H, 1987, ARCHAEOMETRY, V27, P214; Valladas H., 1982, PACT, V6, P171; VANDERMEERSCH B, 1984, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V1, P191, DOI 10.3406/bmsap.1984.3932; VANDERMEERSCH B, 1990, MEMOIRES MUSEE PREHI, V3, P25; VOGGEL JC, 1967, RADIOCARBON, V9, P107; WOLPOFF MH, 1981, NATURE, V289, P823, DOI 10.1038/289823a0	31	71	73	0	13	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 27	1991	351	6329					737	739		10.1038/351737a0	http://dx.doi.org/10.1038/351737a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FU201	2062366				2022-12-28	WOS:A1991FU20100061
J	GRAUR, D; HIDE, WA; LI, WH				GRAUR, D; HIDE, WA; LI, WH			IS THE GUINEA-PIG A RODENT	NATURE			English	Article							AMINO-ACID-SEQUENCES; MOLECULAR EVOLUTION; RIBONUCLEASE; PHYLOGENIES; NUCLEOTIDE; GENE	THE guinea-pig (Cavia porcellus), traditionally classified as a New World hystricomorph rodent, often shows anomalous morphological and molecular features in comparison with other eutherian mammals 1-14. For example, its insulin differs from that of other mammals in anabolic and growth-promoting activities and in its capability to form hexamers 5, 6. Indeed, the literature about the molecular evolution of guinea-pigs abounds in references to 'convergent evolution', 'extremely rapid rates of substitution', and 'unique evolutionary mechanisms'. These claims are based on the assumption that the guinea-pig is a rodent. Our phylogenetic analyses of amino-acid sequence data, however, imply that the guinea-pig diverged before the separation of the primates and the artiodactyls from the myomorph rodents (rats and mice). If true, then the myomorphs and the caviomorphs do not constitute a natural clade, and the Caviomorpha (or the Histricomorpha) should be elevated in taxonomical rank and regarded as a separate mammalian order distinct from the Rodentia. If, as suggested by recent data 15, 16, the myomorphs branched off before the divergence among the carnivores, lagomorphs, artiodactyls and primates, then the new order would represent an early divergence in eutherian radiation.	UNIV TEXAS, CTR DEMOG & POPULAT GENET, POB 20334, HOUSTON, TX 77225 USA; TEL AVIV UNIV, GEORGE S WISE FAC LIFE SCI, DEPT ZOOL, IL-69978 TEL AVIV, ISRAEL; BAYLOR UNIV, DEPT CELL BIOL, HOUSTON, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Tel Aviv University; Baylor University			Hide, Winston/R-3815-2019; Hide, Winston Hide/C-7217-2009; Hide, Winston A/V-2727-2017	Hide, Winston/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271; Li, Wen-Hsiung/0000-0003-1086-1456				BEINTEMA JJ, 1983, J MOL EVOL, V19, P145, DOI 10.1007/BF02300752; BEINTEMA JJ, 1987, MOL BIOL EVOL, V4, P10; EASTEAL S, 1990, GENETICS, V124, P165; ENG J, 1986, PEPTIDES, V7, P17, DOI 10.1016/0196-9781(86)90158-0; FAN ZW, 1988, PEPTIDES, V9, P429, DOI 10.1016/0196-9781(88)90280-X; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1985, SYST ZOOL, V34, P152, DOI 10.2307/2413323; FITCH WM, 1990, MOL BIOL EVOL, V7, P438; FITCH WM, 1980, AM NAT, V16, P111; LI WH, 1985, MOL BIOL EVOL, V2, P150; LI WH, 1990, P NATL ACAD SCI USA, V87, P603; LI WH, 1990, METHOD ENZYMOL, V183, P645; MANAO G, 1988, J PROTEIN CHEM, V7, P417, DOI 10.1007/BF01024889; Nowak RM, 1983, WALKERS MAMMALS WORL; ROMER A, 1968, NOTES COMMENTS VERTE; Sahni A, 1985, EVOLUTIONARY RELATIO, P133; SARICH VM, 1967, SCIENCE, V158, P1200, DOI 10.1126/science.158.3805.1200; SARKAR G, 1990, GENOMICS, V6, P133, DOI 10.1016/0888-7543(90)90458-7; SHINOMURA Y, 1990, COMP BIOCHEM PHYS B, V96, P239, DOI 10.1016/0305-0491(90)90369-5; SHOSHANI J, 1985, EVOLUTIONARY RELATIO, P191; SMITH AI, 1987, J ENDOCRINOL, V115, pR5, DOI 10.1677/joe.0.115R005; WAT VM, 1985, J BIOL CHEM, V260, P10926; WOLFE PB, 1980, MOL IMMUNOL, V17, P1493, DOI 10.1016/0161-5890(80)90175-3; Wood A.E., 1985, EVOLUTIONARY RELATIO, P475; YU JH, 1989, PEPTIDES, V10, P1195, DOI 10.1016/0196-9781(89)90012-0	25	274	278	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	1991	351	6328					649	652		10.1038/351649a0	http://dx.doi.org/10.1038/351649a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT112	2052090				2022-12-28	WOS:A1991FT11200065
J	SMITH, JR; KITCHEN, VS; MUNDAY, PE; PAINTIN, DB; FORSTER, GE; HOOI, YS; DOYLE, K; DELANY, L; SEEDHOUSE, D; MERCEY, D; BEWLEY, S				SMITH, JR; KITCHEN, VS; MUNDAY, PE; PAINTIN, DB; FORSTER, GE; HOOI, YS; DOYLE, K; DELANY, L; SEEDHOUSE, D; MERCEY, D; BEWLEY, S			INFERTILITY MANAGEMENT IN HIV POSITIVE COUPLES - A DILEMMA	BRITISH MEDICAL JOURNAL			English	Article							HUMAN IMMUNODEFICIENCY VIRUS		ROYAL LONDON HOSP,AMBROSE KING CTR,LONDON E1,ENGLAND; UNIV LIVERPOOL,STUDY HLTH CARE ETH UNIT,LIVERPOOL L69 3BX,ENGLAND; LONDON FERTIL CTR,LONDON W1N 1AF,ENGLAND; MIDDLESEX HOSP,DEPT GENITOURINARY MED,LONDON W1N 8AA,ENGLAND	Barts Health NHS Trust; Royal London Hospital; University of Liverpool; University of London; University College London	SMITH, JR (corresponding author), ST MARYS HOSP,GYNAECOL & GENITOURINARY MED,LONDON W2 1NY,ENGLAND.							ADLER MW, 1987, ABC AIDS, P13; BARBACCI M, 1991, LANCET, V337, P709, DOI 10.1016/0140-6736(91)90286-X; BIGGAR RJ, 1989, AM J OBSTET GYNECOL, V161, P1239, DOI 10.1016/0002-9378(89)90674-1; HESSOL NA, 1989, AM J EPIDEMIOL, V130, P1167, DOI 10.1093/oxfordjournals.aje.a115445; LETSKY E, 1980, CLIN PHYSL OBSTETRIC, P49; MOQ JQ, 1987, LANCET, V1, P1164; SMITH JR, 1990, LANCET, V335, P359, DOI 10.1016/0140-6736(90)90650-T; SMITH JR, 1991, BRIT J OBSTET GYNAEC, V98, P124, DOI 10.1111/j.1471-0528.1991.tb13356.x; 1988, LANCET, V2, P1039; 1991, LANCET, V337, P253	10	22	22	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1991	302	6790					1447	1450		10.1136/bmj.302.6790.1447	http://dx.doi.org/10.1136/bmj.302.6790.1447			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR403	2070114	Green Published, Bronze			2022-12-28	WOS:A1991FR40300026
J	BRZOZOWSKI, AM; DEREWENDA, U; DEREWENDA, ZS; DODSON, GG; LAWSON, DM; TURKENBURG, JP; BJORKLING, F; HUGEJENSEN, B; PATKAR, SA; THIM, L				BRZOZOWSKI, AM; DEREWENDA, U; DEREWENDA, ZS; DODSON, GG; LAWSON, DM; TURKENBURG, JP; BJORKLING, F; HUGEJENSEN, B; PATKAR, SA; THIM, L			A MODEL FOR INTERFACIAL ACTIVATION IN LIPASES FROM THE STRUCTURE OF A FUNGAL LIPASE-INHIBITOR COMPLEX	NATURE			English	Article							MIEHEI TRIGLYCERIDE LIPASE; TRANSITION-STATE ANALOG; MACROMOLECULAR STRUCTURES; VENOM PHOSPHOLIPASE-A2; PANCREATIC LIPASE; CRYSTAL-STRUCTURE; REFINEMENT; CRYSTALLOGRAPHY	LIPASES are hydrolytic enzymes which break down triacylglycerides into free fatty acids and glycerols. They have been classified as serine hydrolases owing to their inhibition by diethyl p-nitrophenyl phosphate 1. Lipase activity is greatly increased at the lipid-water interface 2,3, a phenomenon known as interfacial activation. X-ray analysis has revealed the atomic structures of two triacylglycerol lipases, unrelated in sequence: the human pancreatic lipase (hPL) 4, and an enzyme isolated from the fungus Rhizomucor (formerly Mucor) miehei 5 (RmL). In both enzymes the active centres contain structurally analogous Asp-His-Ser triads (characteristic of serine proteinases), which are buried completely beneath a short helical segment, or 'lid'. Here we present the crystal structure (at 3 angstrom resolution) of a complex of R. miehei lipase with n-hexylphosphonate ethyl ester in which the enzyme's active site is exposed by the movement of the helical lid. This movement also increases the nonpolarity of the surface surrounding the catalytic site. We propose that the structure of the enzyme in this complex is equivalent to the activated state generated by the oil-water interface.	UNIV ALBERTA,DEPT BIOCHEM,MRC,PROT STRUCT & FUNCT GRP,474 MED SCI BLDG,EDMONTON T6G 2H7,ALBERTA,CANADA; UNIV YORK,DEPT CHEM,YORK YO1 5DD,N YORKSHIRE,ENGLAND; UNIV LODZ,INST CHEM,DEPT CRYSTALLOG,PL-91416 LODZ,POLAND	University of Alberta; University of York - UK; University of Lodz			Lawson, David M/D-1810-2009	Turkenburg, Johan/0000-0001-6992-6838				BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BOEL E, 1988, LIPIDS, V23, P701, DOI 10.1007/BF02535672; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; BROCKERHOFF H, 1968, BIOCHIM BIOPHYS ACTA, V159, P296, DOI 10.1016/0005-2744(68)90078-8; BROCKMAN HL, 1973, J BIOL CHEM, V248, P965; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; CHAPUSAND C, 1976, BIOCHEMISTRY-US, V15, P4987; DEREWENDA Z, 1989, J APPL CRYSTALLOGR, V22, P123, DOI 10.1107/S0021889888012348; DEREWENDA ZS, 1989, ACTA CRYSTALLOGR A, V45, P227, DOI 10.1107/S0108767388010700; ENTRESSANGLES B, 1974, BIOCHIM BIOPHYS ACTA, V341, P437, DOI 10.1016/0005-2744(74)90236-8; FUKUTO TR, 1959, J AM CHEM SOC, V81, P372, DOI 10.1021/ja01511a025; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252; HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436; HUGEJENSEN B, 1987, LIPIDS, V22, P559, DOI 10.1007/BF02537281; HUGEJENSEN B, 1989, LIPIDS, V24, P781, DOI 10.1007/BF02544584; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; MARCH J, 1985, ADV ORG CHEM, P335; PEITERSON WA, 1974, BIOCHEMISTRY-US, V13, P1455; SARDA L, 1958, BIOCHIM BIOPHYS ACTA, V30, P513, DOI 10.1016/0006-3002(58)90097-0; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788; THUNNISSEN MMGM, 1990, NATURE, V347, P689, DOI 10.1038/347689a0; WELLS MA, 1974, BIOCHEMISTRY-US, V13, P2248, DOI 10.1021/bi00708a002; WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; 1986, CCP4 PROGRAM SUITE	26	1003	1035	2	188	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 6	1991	351	6326					491	494		10.1038/351491a0	http://dx.doi.org/10.1038/351491a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP758	2046751				2022-12-28	WOS:A1991FP75800059
J	HUGHES, DA; FUKUI, Y; YAMAMOTO, M				HUGHES, DA; FUKUI, Y; YAMAMOTO, M			HOMOLOGOUS ACTIVATORS OF RAS IN FISSION AND BUDDING YEAST	NATURE			English	Article									UNIV TOKYO,FAC SCI,DEPT BIOPHYS & BIOCHEM,TOKYO 113,JAPAN	University of Tokyo	HUGHES, DA (corresponding author), UNIV TOKYO,INST MED SCI,PO TAKANAWA,TOKYO 108,JAPAN.		Fukui, Yasuhisa/E-8806-2010					BACH ML, 1987, CURR GENET, V12, P527, DOI 10.1007/BF00419562; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BEACH D, 1982, MOL GEN GENET, V187, P326, DOI 10.1007/BF00331138; BOYMARCOTTE E, 1989, GENE, V77, P21, DOI 10.1016/0378-1119(89)90355-7; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; CAMONIS J, 1986, MOL CELL BIOL, V8, P2980; CAMONIS JH, 1986, EMBO J, V5, P375, DOI 10.1002/j.1460-2075.1986.tb04222.x; EGEL R, 1971, PLANTA, V98, P89, DOI 10.1007/BF00387025; FUKUI Y, 1988, MOL GEN GENET, V215, P26, DOI 10.1007/BF00331298; FUKUI Y, 1986, CELL, V44, P329, DOI 10.1016/0092-8674(86)90767-1; FUKUI Y, 1986, EMBO J, V5, P1991, DOI 10.1002/j.1460-2075.1986.tb04454.x; FUKUI Y, 1989, MOL CELL BIOL, V9, P5617, DOI 10.1128/MCB.9.12.5617; GIRGSDIES O, 1982, CURR GENET, V6, P223, DOI 10.1007/BF00390342; Gutz H., 1974, HDB GENETICS, V1, P395; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACQUET M, 1989, GUANINE NUCLEOTIDE B, P241; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; LUND PM, 1987, MOL GEN GENET, V209, P627, DOI 10.1007/BF00331175; MICHAEL H, 1987, YEAST, V3, P5, DOI 10.1002/yea.320030103; NADINDAVIS SA, 1986, EMBO J, V5, P2963, DOI 10.1002/j.1460-2075.1986.tb04593.x; POWERS S, 1989, MOL CELL BIOL, V9, P390, DOI 10.1128/MCB.9.2.390; ROBINSON LC, 1987, SCIENCE, V235, P1218, DOI 10.1126/science.3547648; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIPICZKI M, 1977, MOL GEN GENET, V151, P77, DOI 10.1007/BF00446915; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; THURIAUX P, 1980, J GEN MICROBIOL, V116, P525; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3	29	122	126	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 22	1990	344	6264					355	357		10.1038/344355a0	http://dx.doi.org/10.1038/344355a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV289	2107403				2022-12-28	WOS:A1990CV28900072
J	MAURICE, S; MEGRAUD, F; VIVARES, C; DABIS, F; TOULOUSE, C; TILLY, B; SALAMON, R				MAURICE, S; MEGRAUD, F; VIVARES, C; DABIS, F; TOULOUSE, C; TILLY, B; SALAMON, R			TELEMATICS - A NEW TOOL FOR EPIDEMIOLOGIC SURVEILLANCE OF DIARRHEAL DISEASES IN THE AQUITAINE SENTINEL NETWORK	BRITISH MEDICAL JOURNAL			English	Article											MAURICE, S (corresponding author), UNIV BORDEAUX 2,INSERM,U330,F-33076 BORDEAUX,FRANCE.		DABIS, FRANCOIS/S-9298-2019	DABIS, FRANCOIS/0000-0002-1614-8857				GARTHRIGHT WE, 1988, PUBLIC HEALTH REP, V103, P107; GRAITCER PL, 1986, AM J PUBLIC HEALTH, V76, P1285, DOI 10.2105/AJPH.76.11.1285; HANNOUN C, 1989, EUR J EPIDEMIOL, V5, P285, DOI 10.1007/BF00144828; KAPLAN JE, 1982, AM J PUBLIC HEALTH, V72, P1329, DOI 10.2105/AJPH.72.12.1329; MAURICE S, 1989, J EPIDEMIOL COMMUN H, V43, P290, DOI 10.1136/jech.43.3.290; MAURICE S, IN PRESS MED INF LON; MCCORMICK A, 1987, BRIT MED J, V294, P74, DOI 10.1136/bmj.294.6564.74-a; MEGRAUD F, 1987, B EPIDEMIOLOGIQUE HE, V77, P65; MOFFET HL, 1978, ANN INTERN MED, V89, P743, DOI 10.7326/0003-4819-89-5-743; PICCOLI S, 1981, MED MALADIES INFECT, V11, P125; QUENUM B, 1989, B EPIDEMIOLOGIQUE HE, V16, P61; THACKER SB, 1983, JAMA-J AM MED ASSOC, V249, P1181; VALLERON AJ, 1987, AM J PUBLIC HEALTH, V76, P1289; 1985, UNPUB TREATMENT PREV	14	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	1990	300	6723					514	516		10.1136/bmj.300.6723.514	http://dx.doi.org/10.1136/bmj.300.6723.514			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107932	Green Published, Bronze			2022-12-28	WOS:A1990CQ87800024
J	GRIFFIN, SM; CHUNG, SCS; LEUNG, JWC; LI, AKC				GRIFFIN, SM; CHUNG, SCS; LEUNG, JWC; LI, AKC			EFFECT OF INTRANASAL OXYGEN ON HYPOXIA AND TACHYCARDIA DURING ENDOSCOPIC CHOLANGIOPANCREATOGRAPHY	BRITISH MEDICAL JOURNAL			English	Article									CHINESE UNIV HONG KONG,PRINCE WALES HOSP,SHA TIN,HONG KONG	Chinese University of Hong Kong; Prince of Wales Hospital				Griffin, Selwyn Michael/0000-0003-1583-7009				HOFFMAN JIE, 1974, VASCULAR SURG, V8, P115; LIEBERMAN DA, 1985, GASTROENTEROLOGY, V88, P458; ROZEN P, 1979, SCAND J GASTROENTERO, V14, P577, DOI 10.3109/00365527909181392; SCHILLER KF, 1972, GUT, V13, P1027; WOODS SDS, IN PRESS GASTROINTES	5	60	60	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					83	84		10.1136/bmj.300.6717.83	http://dx.doi.org/10.1136/bmj.300.6717.83			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105779	Bronze, Green Published			2022-12-28	WOS:A1990CJ08000016
J	JOHNSTONE, FD; BRETTLE, RP; MACCALLUM, LR; MOK, J; PEUTHERER, JF; BURNS, S				JOHNSTONE, FD; BRETTLE, RP; MACCALLUM, LR; MOK, J; PEUTHERER, JF; BURNS, S			WOMENS KNOWLEDGE OF THEIR HIV ANTIBODY STATE - ITS EFFECT ON THEIR DECISION WHETHER TO CONTINUE THE PREGNANCY	BRITISH MEDICAL JOURNAL			English	Article									CITY HOSP EDINBURGH,SCREENING CLIN,EDINBURGH EH10 5SB,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,DEPT BACTERIOL,EDINBURGH EH8 9AG,MIDLOTHIAN,SCOTLAND; CITY HOSP EDINBURGH,REG VIRUS LAB,EDINBURGH EH10 5SB,MIDLOTHIAN,SCOTLAND	University of Edinburgh	JOHNSTONE, FD (corresponding author), DEPT OBSTET & GYNAECOL,SIMPSON MEM MATERN PAVIL,EDINBURGH EH3 9EF,SCOTLAND.							JOHNSTONE FD, 1988, BRIT MED J, V296, P467, DOI 10.1136/bmj.296.6620.467; JOHNSTONE FD, IN PRESS SCOTT MED J; SELWYN PA, 1989, JAMA-J AM MED ASSOC, V261, P3567, DOI 10.1001/jama.261.24.3567	3	57	57	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	1990	300	6716					23	24		10.1136/bmj.300.6716.23	http://dx.doi.org/10.1136/bmj.300.6716.23			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG773	2105118	Bronze, Green Published			2022-12-28	WOS:A1990CG77300019
J	SHINGLETON, BJ				SHINGLETON, BJ			CURRENT CONCEPTS - EYE INJURIES	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SYMPATHETIC OPHTHALMIA; TRAUMATIC HYPHEMA; AMINOCAPROIC ACID; CORTICOSTEROIDS; MANAGEMENT; DISEASE; SPORTS; MR		OPHTHALM CONSULTANTS BOSTON,BOSTON,MA 02114; MASSACHUSETTS EYE & EAR HOSP,BOSTON,MA 02114	Ophthalmic Consultants of Boston				Shingleton, Bradford/0000-0001-8134-8639				BELCHER CD, 1985, OPHTHALMIC SURG LAS, V16, P475; CHAN CC, 1986, OPHTHALMOLOGY, V93, P690; COLEMAN D J, 1977, P376; COLEMAN DJ, 1991, EYE TRAUMA, P25; COLLET BI, 1982, ANN OPHTHALMOL, V14, P52; DAVIS JK, 1988, INT OPHTHALMOL CLIN, V28, P215, DOI 10.1097/00004397-198802830-00008; DEUTSCH TA, 1984, ARCH OPHTHALMOL-CHIC, V102, P566; DONSHIK PC, 1978, ARCH OPHTHALMOL-CHIC, V96, P2117; EDWARDS WC, 1973, AM J OPHTHALMOL, V75, P110, DOI 10.1016/0002-9394(73)90659-4; FARBER MD, 1991, OPHTHALMOLOGY, V98, P279; FRIEDENWALD JS, 1946, ARCH OPHTHALMOL-CHIC, V35, P98; GLENN WV, 1975, INVEST RADIOL, V10, P403, DOI 10.1097/00004424-197509000-00002; HERSH PS, 1991, EYE TRAUMA, P143; HUGHES WF, 1946, ARCH OPHTHALMOL-CHIC, V36, P189, DOI 10.1001/archopht.1946.00890210194005; HUTTON WL, 1984, AM J OPHTHALMOL, V97, P715, DOI 10.1016/0002-9394(84)90503-8; KARLSON TA, 1986, ARCH OPHTHALMOL-CHIC, V104, P1473; KELLY WM, 1986, AM J NEURORADIOL, V7, P243; KUTNER B, 1987, ARCH OPHTHALMOL-CHIC, V105, P206; LUBIN JR, 1980, OPHTHALMOLOGY, V87, P109; MCCULLEY JP, 1980, INVEST OPHTHALMOL  S, V19, P228; McCulley JP, 1987, CORNEA SCI FDN CLIN, P527; NUSSENBLATT RB, 1983, AM J OPHTHALMOL, V96, P275, DOI 10.1016/S0002-9394(14)77814-6; PAHLITZSCH T, 1985, GRAEF ARCH CLIN EXP, V223, P278, DOI 10.1007/BF02153659; PALMER DJ, 1986, OPHTHALMOLOGY, V93, P102; Parver L M, 1986, Arch Ophthalmol, V104, P1452; PASHBY T, 1985, CAN J OPHTHALMOL, V20, P2; RAO VM, 1986, DIAGNOSTIC IMAGING O, P1; READ J, 1974, T AM ACAD OPHTHALMOL, V78, pOP799; REFOJO MF, 1968, ARCH OPHTHALMOL-CHIC, V80, P645; REYNARD M, 1983, AM J OPHTHALMOL, V96, P290, DOI 10.1016/S0002-9394(14)77816-X; ROWSEY JJ, 1984, OPHTHALMIC SURG LAS, V15, P569; SCHEIN OD, 1988, OPHTHALMOLOGY, V95, P300; SCHEIN OD, 1991, EYE TRAUMA, P395; SCHENCK JF, 1985, AM J ROENTGENOL, V144, P1033, DOI 10.2214/ajr.144.5.1033; STRAHLMAN E, 1988, INT OPHTHALMOL CLIN, V28, P199, DOI 10.1097/00004397-198802830-00003; THOFT RA, 1977, ARCH OPHTHALMOL-CHIC, V95, P1425; THOMPSON HS, 1981, SURV OPHTHALMOL, V26, P39, DOI 10.1016/0039-6257(81)90124-7; TIELSCH JM, 1989, ARCH OPHTHALMOL-CHIC, V107, P519, DOI 10.1001/archopht.1989.01070010533025; VINGER PF, 1978, JAMA-J AM MED ASSOC, V239, P2575, DOI 10.1001/jama.239.24.2575; VINGER PF, 1981, OPHTHALMOLOGY, V88, P108; VINGER PF, 1985, CLIN OPHTHALMOL, V5, P1; WAGONER MD, 1991, EYE TRAUMA, P79; 1988, PHYSICIAN SPORTS MED, V16, P49	43	14	15	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 8	1991	325	6					408	413						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ804	2062332				2022-12-28	WOS:A1991FZ80400007
J	SPRITZ, N				SPRITZ, N			OVERSIGHT OF PHYSICIANS CONDUCT BY STATE LICENSING AGENCIES - LESSONS FROM NEW-YORK ZION,LIBBY CASE	ANNALS OF INTERNAL MEDICINE			English	Article								The unexplained and highly publicized death of an 18-year-old woman in a New York Hospital in 1984 became the focus for debate throughout the country concerning working conditions and supervision of house officers. It also led to charges by the State of New York of gross negligence against her resident physicians. The residents were exonerated of all charges by a review panel with lay and physician representation after testimony of expert witnesses. Although the Commissioner of Health concurred with this verdict, residents were charged with gross negligence by the Board of Regents, a lay panel. Fundamental contrasts in the way the two panels made their judgments supports the importance of peer review in disciplining physicians in matters of medical judgment. Analysis of the actions by New York State against the residents also underscores the importance of other principles in the oversight of physician behavior that are applicable to all jurisdictions: resolution of charges without undo delay, an equitable and consistent standard for the administration of sanctions, and adherence to a clearly defined standard for the level of culpability required for disciplinary action. Both the structure of the review process and its application in this instance led to violations of each of these principles.	NYU, SCH MED, NEW YORK, NY 10003 USA	New York University	SPRITZ, N (corresponding author), VET AFFAIRS MED CTR, 423 E 23 ST, NEW YORK, NY 10010 USA.							ASCH DA, 1988, NEW ENGL J MED, V318, P771, DOI 10.1056/NEJM198803243181209	1	31	31	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	1991	115	3					219	222		10.7326/0003-4819-115-3-219	http://dx.doi.org/10.7326/0003-4819-115-3-219			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY152	2058876				2022-12-28	WOS:A1991FY15200010
J	HACK, M; BRESLAU, N; WEISSMAN, B; ARAM, D; KLEIN, N; BORAWSKI, E				HACK, M; BRESLAU, N; WEISSMAN, B; ARAM, D; KLEIN, N; BORAWSKI, E			EFFECT OF VERY-LOW-BIRTH-WEIGHT AND SUBNORMAL HEAD SIZE ON COGNITIVE-ABILITIES AT SCHOOL AGE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH ACHIEVEMENT; POSTNATAL-GROWTH; BRAIN GROWTH; INFANTS; CHILDREN; CIRCUMFERENCE; INTELLIGENCE; INTRAUTERINE; RETARDATION; FAILURE	Background. We tested the hypothesis that very-low-birth-weight (< 1.5 kg) infants with perinatal growth failure whose head size is not normal by eight months of age (corrected for prematurity) have significantly poorer growth and neurocognitive abilities at school age. than very-low-birth-weight children with a normal head size at eight months. We also hypothesized that these differences would persist even after control for major neurologic impairment and perinatal and sociodemographic risk factors. Methods. We have followed a cohort of very-low-birth-weight children since their birth during the period 1977 to 1979. At eight to nine years of age 249 children were evaluated with a neurologic examination and tests of intelligence; receptive and expressive language skills; speech, reading, mathematics, and spelling aptitude; visual and fine motor abilities; and behavior. Ages were corrected for premature birth. Results. Among these 249 very-low-birth-weight children, head size was subnormal (less than the mean -2 SD for age) at birth in 30 (12 percent), at term in 57 (23 percent), and at eight months in 33 (13 percent). As compared with the 216 children with normal head sizes, the 33 children with subnormal head sizes at the age of eight months had significantly lower mean birth weights (1.1 vs. 1.2 kg) and higher neonatal risk scores (71 vs. 53) and at the age of eight years had a higher incidence of neurologic impairment (21 percent vs. 8 percent) and lower IQ scores (mean verbal, 84 vs. 98). Even among the children without neurologic abnormalities, a subnormal head size at eight months of age was predictive of poorer verbal and performance IQ scores at eight years of age; lower scores for receptive language, speech, reading, mathematics, and spelling; and a higher incidence of hyperactivity. In multiple regression analyses to control for socioeconomic and neonatal risk factors, intrauterine growth failure, birth weight, and neurologic impairment, a subnormal head size at eight months of age had an independently adverse effect on IQ and on scores for receptive language, speech, reading, and spelling. Conclusions. In very-low-birth-weight infants, perinatal growth failure, as evidenced by a subnormal head circumference at eight months of age, is associated with poor cognitive function, academic achievement, and behavior at eight years of age.	CASE WESTERN RESERVE UNIV, SCH MED, DEPT PEDIAT, CLEVELAND, OH 44106 USA; HENRY FORD HOSP, DEPT PSYCHIAT, DETROIT, MI 48202 USA; HENRY FORD HOSP, DEPT BIOSTAT & RES EPIDEMIOL, DETROIT, MI 48202 USA; UNIV MICHIGAN, SCH MED, DEPT PSYCHIAT, ANN ARBOR, MI 48104 USA; EMORY UNIV, SCH MED, DEPT PEDIAT, ATLANTA, GA 30322 USA; CLEVELAND STATE UNIV, DEPT SPECIAL EDUC, CLEVELAND, OH 44115 USA	Case Western Reserve University; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University of Michigan System; University of Michigan; Emory University; University System of Ohio; Cleveland State University			Breslau, Naomi/I-3196-2012; Borawski, Elaine/R-9959-2019	Borawski, Elaine/0000-0001-7629-6889; Aram, Dorit/0000-0002-0984-7297	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020057] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD20057] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; ASTBURY J, 1986, DEV MED CHILD NEUROL, V28, P472; BABSON SG, 1969, AM J DIS CHILD, V117, P553, DOI 10.1001/archpedi.1969.02100030555009; BEARGIE RA, 1970, PEDIATR CLIN N AM, V17, P159; BERG AT, 1989, EARLY HUM DEV, V19, P271, DOI 10.1016/0378-3782(89)90062-5; BRANDT I, 1985, ACTA PAEDIATR SCAND, P38; BRAY PF, 1969, J PEDIATR, V75, P303, DOI 10.1016/S0022-3476(69)80404-X; Broman S. H., 1975, PRESCHOOL IQ PRENATA; Cravioto J., 1986, HUMAN GROWTH, V3, P501; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; DiSimoni F., 1978, TOKEN TEST CHILDREN; DOBBING J, 1987, EARLY NUTRITION LATE; ELSON KB, 1970, DEV MED CHILD NEUROL, V12, P487; FANCOURT R, 1976, BMJ-BRIT MED J, V1, P1435, DOI 10.1136/bmj.1.6023.1435; Fletcher S.G., 1978, FLETCHER TIME BY COU; GALLER JR, 1984, HUMAN NUTRITION COMP, V5, P63; GILLBERG C, 1982, DEV MED CHILD NEUROL, V24, P752; GROSS RT, 1990, JAMA-J AM MED ASSOC, V263, P3035; HACK M, 1986, PEDIATRICS, V77, P196; HACK M, 1984, AM J DIS CHILD, V138, P370, DOI 10.1001/archpedi.1984.02140420036013; HACK M, 1991, PEDIATRICS, V87, P587; HACK M, 1989, AM J DIS CHILD, V143, P63, DOI 10.1001/archpedi.1989.02150130073018; HACK M, 1982, AM J OBSTET GYNECOL, V143, P693, DOI 10.1016/0002-9378(82)90117-X; HOBEL CJ, 1973, AM J OBSTET GYNECOL, V117, P1; Jastak S., 1984, WIDE RANGE ACHIEVEME; KOPPITZ EM, 1975, BENDER GESTALT TEST, V2; LIPPER E, 1981, PEDIATRICS, V67, P502; MARTIN HP, 1970, AM J DIS CHILD, V119, P128, DOI 10.1001/archpedi.1970.02100050130007; OUNSTED MK, 1984, EARLY HUM DEV, V9, P323, DOI 10.1016/0378-3782(84)90077-X; Pendergast K, 1969, PHOTO ARTICULATION T; PRYOR HB, 1967, CLIN PEDIATR, V6, P501, DOI 10.1177/000992286700600819; ROCHE AF, 1987, PEDIATRICS, V79, P706; ROSS G, 1983, J PEDIATR-US, V103, P105, DOI 10.1016/S0022-3476(83)80791-4; ROSS G, 1990, J PEDIATR-US, V117, P307, DOI 10.1016/S0022-3476(05)80552-9; SELLS CJ, 1977, PEDIATRICS, V59, P262; SEMELMINTZ E, 1982, CIN EVALUATION LANGU; SMITH RD, 1981, DEV MED CHILD NEUROL, V23, P626; STOCH MB, 1982, DEV MED CHILD NEUROL, V24, P419; TUDEHOPE DI, 1983, AUST PAEDIATR J, V19, P3; USHER R, 1969, J PEDIATR-US, V74, P901, DOI 10.1016/S0022-3476(69)80224-6; Wechsler DW., 1999, INTELLIGENCE SCALE C; WEINBERG WA, 1974, J PEDIATR-US, V85, P482, DOI 10.1016/S0022-3476(74)80449-X; WILSON B C, 1982, Journal of Clinical Neuropsychology, V4, P19, DOI 10.1080/01688638208401113; WINGERD J, 1971, PEDIATRICS, V47, P818; WINICK M, 1969, J PEDIATR, V74, P667, DOI 10.1016/S0022-3476(69)80129-0; Woodcock R., 2011, WOODCOCK READING MAS, Vthird; Woodcock R.W., 1977, WOODCOCK JOHNSON PSY	47	386	394	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 25	1991	325	4					231	237		10.1056/NEJM199107253250403	http://dx.doi.org/10.1056/NEJM199107253250403			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX627	2057024				2022-12-28	WOS:A1991FX62700003
J	TIELSCH, JM; SOMMER, A; KATZ, J; ROYALL, RM; QUIGLEY, HA; JAVITT, J				TIELSCH, JM; SOMMER, A; KATZ, J; ROYALL, RM; QUIGLEY, HA; JAVITT, J			RACIAL VARIATIONS IN THE PREVALENCE OF PRIMARY OPEN-ANGLE GLAUCOMA - THE BALTIMORE EYE SURVEY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FRAMINGHAM EYE; RISK-FACTORS	Objective. - To compare the prevalence of primary open-angle glaucoma between black and white Americans. Design, Setting, and Participants. - The design was a population-based prevalence survey of a noninstitutionalized black and white population aged 40 years or older from the eastern and southeastern health districts of Baltimore, Md. A multistage random sampling strategy was used to identify 7104 eligible participants, of whom 5308 (2395 blacks, 2913 whites) received an ophthalmologic screening examination. Those with abnormalities were referred for definitive diagnostic evaluation. Main Outcome Measure. - Primary open-angle glaucoma was defined based on evidence of glaucomatous optic nerve damage, including abnormal visual fields and/or severe optic disc cupping, and was independent of intraocular pressure. Main Results. - Age-adjusted prevalence rates for primary open-angle glaucoma were four to five times higher in blacks as compared with whites. Rates among blacks ranged from 1.23% in those aged 40 through 49 years to 11.26% in those 80 years or older, whereas rates for whites ranged from 0.92% to 2.16%, respectively. There was no difference in rates of primary open-angle glaucoma between men and women for either blacks or whites in this population. Based on these data, an estimated 1.6 million persons aged 40 years or older in the United States have primary open-angle glaucoma. Conclusions. - Black Americans are at higher risk of primary open-angle glaucoma than their white neighbors. This may reflect an underlying genetic susceptibility to this disease and indicates that additional efforts are needed to identify and treat this sight-threatening disorder in high-risk communities.	JOHNS HOPKINS UNIV HOSP,WILMER OPHTHALMOL INST,DANA CTR PREVENT OPHTHALMOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT BIOSTAT,BALTIMORE,MD 21218	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University			Javitt, Jonathan/AAJ-5574-2021	Javitt, Jonathan/0000-0003-2371-1609; Katz, Joanne/0000-0002-5997-7823; Tielsch, James/0000-0002-1151-060X	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR004060] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY003605] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-04060] Funding Source: Medline; NEI NIH HHS [EY-05091, EY-03605] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BENGTSSON B, 1981, BRIT J OPHTHALMOL, V65, P46, DOI 10.1136/bjo.65.1.46; BENGTSSON B, 1989, BRIT J OPHTHALMOL, V73, P483, DOI 10.1136/bjo.73.7.483; COULEHAN JL, 1980, AM J EPIDEMIOL, V111, P759, DOI 10.1093/oxfordjournals.aje.a112954; FRYDMAN JE, 1966, J AMER MED ASSOC, V198, P1237, DOI 10.1001/jama.198.12.1237; HOLLOWS FC, 1966, BRIT J OPHTHALMOL, V50, P570, DOI 10.1136/bjo.50.10.570; KAHN HA, 1980, AM J EPIDEMIOL, V111, P769, DOI 10.1093/oxfordjournals.aje.a112955; KAHN HA, 1980, ARCH OPHTHALMOL-CHIC, V98, P2172, DOI 10.1001/archopht.1980.01020041024003; KAHN HA, 1973, DHEW NIH73427 NAT EY; KAHN HA, 1989, STATISTICAL METHODS; KOSOKO O, 1986, OPHTHALMOLOGY, V93, P882; Leibowitz H M, 1980, Surv Ophthalmol, V24, P335; MARTIN MJ, 1985, AM J OPHTHALMOL, V99, P383, DOI 10.1016/0002-9394(85)90001-7; MASON RP, 1989, OPHTHALMOLOGY, V96, P1363; SOMMER A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1766; TIELSCH JM, 1988, OPHTHALMOLOGY, V95, P350; TIELSCH JM, 1990, ARCH OPHTHALMOL-CHIC, V108, P286, DOI 10.1001/archopht.1990.01070040138048; VIGGOSSON G, 1986, ACTA OPHTHALMOL, V64, P138; WALLACE J, 1969, AM J OPHTHALMOL, V67, P93, DOI 10.1016/0002-9394(69)90013-0; WILENSKY JT, 1978, ANN OPHTHALMOL, V10, P1398; WILSON MR, 1987, ARCH OPHTHALMOL-CHIC, V105, P1066	20	998	1037	0	28	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	1991	266	3					369	374		10.1001/jama.266.3.369	http://dx.doi.org/10.1001/jama.266.3.369			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV960	2056646				2022-12-28	WOS:A1991FV96000026
J	VLEMINCKX, K; VAKAET, L; MAREEL, M; FIERS, W; VANROY, F				VLEMINCKX, K; VAKAET, L; MAREEL, M; FIERS, W; VANROY, F			GENETIC MANIPULATION OF E-CADHERIN EXPRESSION BY EPITHELIAL TUMOR-CELLS REVEALS AN INVASION SUPPRESSOR ROLE	CELL			English	Article							ADHESION MOLECULE UVOMORULIN; CYTOPLASMIC DOMAIN; CANCER METASTASIS; SORTING-OUT; TRANSFECTION; DIFFERENTIATION; INVITRO; IDENTIFICATION; CARCINOMAS; PHENOTYPES	A cDNA encoding the cell-cell adhesion molecule E-cadherin was transfected into highly invasive epithelial tumor cell lines of dog kidney or mouse mammary gland origin. Transfectants with a homogeneously high expression of E-cadherin showed a reproducible loss of activity in two types of in vitro invasion assays. invasiveness of these transfectants could be reinduced specifically by treatment with anti-E-cadherin antibodies. In vivo, they formed partly differentiated tumors, instead of fully undifferentiated tumors. Alternatively, a plasmid encoding E-cadherin-specific anti-sense RNA was introduced into noninvasive ras-transformed cells with high endogenous E-cadherin expression. The resulting down-regulation, albeit partial, rendered the cells invasive. These data provide direct evidence that E-cadherin acts as an invasion suppressor molecule.	STATE UNIV GHENT,EXPTL CANCEROL LAB,B-9000 GHENT,BELGIUM	Ghent University	VLEMINCKX, K (corresponding author), STATE UNIV GHENT,MOLEC BIOL LAB,B-9000 GHENT,BELGIUM.		van Roy, Frans M/C-6123-2009; Vakaet, Luc/A-6467-2010; Vleminckx, Kris/J-5699-2013	van Roy, Frans M/0000-0003-4358-1039; 				BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; BEHRENS J, 1985, J CELL BIOL, V101, P1307, DOI 10.1083/jcb.101.4.1307; EDELMAN GM, 1988, BIOCHEMISTRY-US, V27, P3533, DOI 10.1021/bi00410a001; EDELMAN GM, 1987, P NATL ACAD SCI USA, V84, P8502, DOI 10.1073/pnas.84.23.8502; EIDELMAN S, 1989, AM J PATHOL, V135, P101; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FIDLER IJ, 1987, CURR PROB SURG, V24, P137, DOI 10.1016/0011-3840(87)90002-5; FRIEDLANDER DR, 1989, P NATL ACAD SCI USA, V86, P7043, DOI 10.1073/pnas.86.18.7043; GARBISA S, 1987, CANCER RES, V47, P1523; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HASHIMOTO M, 1989, JPN J CANCER RES, V80, P459, DOI 10.1111/j.1349-7006.1989.tb02336.x; JAFFE SH, 1990, P NATL ACAD SCI USA, V87, P3589, DOI 10.1073/pnas.87.9.3589; LIOTTA LA, 1986, CANCER RES, V46, P1; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MAREEL M, 1979, VIRCHOWS ARCH B, V30, P95; MAREEL M, 1988, UCLA S MOL CELLULAR, V78, P179; MAREEL M M, 1981, Invasion and Metastasis, V1, P195; MAREEL MM, 1991, INT J CANCER, V47, P922, DOI 10.1002/ijc.2910470623; MAREEL MM, 1983, CANCER METAST REV, V2, P201, DOI 10.1007/BF00048970; MAREEL MM, 1990, CANCER METAST REV, V9, P45, DOI 10.1007/BF00047588; MAREEL MM, 1991, MECHANISMS INVASION; MAREEL MM, 1986, NEW FRONTIERS MAMMAR, P351; MCNEILL H, 1990, CELL, V62, P309, DOI 10.1016/0092-8674(90)90368-O; MEGE RM, 1988, P NATL ACAD SCI USA, V85, P7274, DOI 10.1073/pnas.85.19.7274; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; MUSCHEL RJ, 1985, AM J PATHOL, V121, P1; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NICOLSON GL, 1988, BIOCHIM BIOPHYS ACTA, V948, P175, DOI 10.1016/0304-419X(88)90010-8; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; OWENS RB, 1974, J NATL CANCER I, V53, P261, DOI 10.1093/jnci/53.1.261; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; PIERCE GB, 1988, CANCER RES, V48, P1996; SACHS L, 1987, CANCER RES, V47, P1981; Sambrook J, 1989, MOL CLONING LABORATO; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; SOBEL ME, 1990, JNCI-J NATL CANCER I, V82, P267, DOI 10.1093/jnci/82.4.267; SONNENBERG A, 1986, CANCER RES, V46, P5913; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STEEG PS, 1988, CANCER RES, V48, P6550; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; VANROY FM, 1989, ANTICANCER RES, V9, P1553; VANROY FM, 1986, CANCER RES, V46, P4787	46	1502	1555	1	42	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 12	1991	66	1					107	119		10.1016/0092-8674(91)90143-M	http://dx.doi.org/10.1016/0092-8674(91)90143-M			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FW913	2070412				2022-12-28	WOS:A1991FW91300013
J	CLEARY, PD; GREENFIELD, S; MULLEY, AG; PAUKER, SG; SCHROEDER, SA; WEXLER, L; MCNEIL, BJ				CLEARY, PD; GREENFIELD, S; MULLEY, AG; PAUKER, SG; SCHROEDER, SA; WEXLER, L; MCNEIL, BJ			VARIATIONS IN LENGTH OF STAY AND OUTCOMES FOR 6 MEDICAL AND SURGICAL CONDITIONS IN MASSACHUSETTS AND CALIFORNIA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE SERVICES; AREA VARIATIONS; MORTALITY; AGE	Objectives. - To determine the extent to which interinstitutional variations in length of stay are explained by differences in patient characteristics and to determine whether patients in hospitals with shorter lengths of stay had worse outcomes. Design. - We reviewed patients' medical records and surveyed patients between 3 and 12 months after hospital discharge using a questionnaire. Setting. - Six teaching hospitals in California and Massachusetts. Patients. - A cohort of 2484 selected patients who had been hospitalized for acute myocardial infarction or to rule out acute myocardial infarction, coronary artery bypass graft surgery, total hip replacement, cholecystectomy, or transurethral prostatectomy Between 73% and 84% of the patients with each condition completed a follow-up questionnaire. Outcome Measures. - In-hospital complications, deaths, length of stay, functional status after hospital discharge, readmission, and patient satisfaction with hospital care were analyzed. Results. - Significant interinstitutional differences in length of stay were noted for all conditions except rule-out acute myocardial infarction. Statistical adjustment for case-mix differences accounted for most of the interinstitutional differences in length of stay for total hip replacement but explained little of the differences in the other conditions. When we controlled statistically for other predictors, length of stay did not have a significant impact on deaths, functional status after hospital discharge, the probability of readmission, or patient satisfaction with hospital care. Conclusion. - More research is needed to determine the medical practices that are related to variations in lengths of stay. Routinely available outcome data may help preserve quality in the face of efforts to decrease costs by effecting more standardized practices of care.	HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; NEW ENGLAND MED CTR HOSP,DEPT MED,BOSTON,MA 02111; UNIV CALIF SAN FRANCISCO,SAN FRANCISCO,CA 94143; BRIGHAM & WOMENS HOSP,CTR COST EFFECT CARE,BOSTON,MA 02115; TUFTS UNIV,SCH MED,BOSTON,MA 02111; STANFORD UNIV,MED CTR,STANFORD,CA 94305; MASSACHUSETTS GEN HOSP,BOSTON,MA 02114	Harvard University; Harvard Medical School; Tufts Medical Center; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Tufts University; Stanford University; Harvard University; Massachusetts General Hospital	CLEARY, PD (corresponding author), HARVARD UNIV,SCH MED,DEPT HLTH CARE POLICY,PARCEL B,1ST FLOOR,25 SHATTUCK ST,BOSTON,MA 02115, USA.		Cleary, Paul/AAF-7048-2019	Greenfield, Sheldon/0000-0003-4628-1998	AHRQ HHS [HS06341] Funding Source: Medline; NIA NIH HHS [AG08331] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG008331] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAKWIN H, 1945, NEW ENGL J MED, V232, P691, DOI 10.1056/NEJM194506142322401; BARNES BA, 1985, JAMA-J AM MED ASSOC, V254, P371, DOI 10.1001/jama.254.3.371; BLUMBERG MS, 1987, MED CARE, V25, P340, DOI 10.1097/00005650-198704000-00007; BURNS LR, 1991, MED CARE, V29, P251, DOI 10.1097/00005650-199103000-00007; CHASSIN MP, 1983, HLTH TECHNOLOGY CASE, V24; CHASSIN MR, 1987, JAMA-J AM MED ASSOC, V258, P2533, DOI 10.1001/jama.258.18.2533; CLEARY PD, IN PRESS CONTROLLED; CRETIN S, 1986, ALTERNATIVE SYSTEMS; DALEY J, 1988, JAMA-J AM MED ASSOC, V260, P3617, DOI 10.1001/jama.260.24.3617; Glover J A, 1938, Proc R Soc Med, V31, P1219; GLOVER JA, 1949, MON B MINIST HLTH, V9, P63; GREENFIELD S, 1988, JAMA-J AM MED ASSOC, V260, P2253, DOI 10.1001/jama.260.15.2253; GREENFIELD S, 1987, JAMA-J AM MED ASSOC, V257, P2766, DOI 10.1001/jama.257.20.2766; Hornbrook M C, 1982, Med Care Rev, V39, P1, DOI 10.1177/107755878203900101; JENCKS SF, 1987, NEW ENGL J MED, V317, P679, DOI 10.1056/NEJM198709103171106; JETTE AM, 1987, PHYS THER, V67, P1854, DOI 10.1093/ptj/67.12.1854; JETTE AM, 1986, J GEN INTERN MED, V1, P143, DOI 10.1007/BF02602324; KERLINGER FN, 1973, MULTIPLE REGRESSION; LAGOE RJ, 1986, INQUIRY-J HEALTH CAR, V23, P183; LEAPE LL, 1990, JAMA-J AM MED ASSOC, V263, P669, DOI 10.1001/jama.263.5.669; LEE TH, 1988, J GEN INTERN MED, V3, P239, DOI 10.1007/BF02596338; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; PAULSHAHEEN P, 1987, J HEALTH POLIT POLIC, V12, P741, DOI 10.1215/03616878-12-4-741; PEARSON R J C, 1968, Lancet, P559; Roos N P, 1988, Health Care Financ Rev, V9, P53; ROOS NP, 1986, AM J PUBLIC HEALTH, V76, P45, DOI 10.2105/AJPH.76.1.45; ROTHBERG DL, 1980, HEALTH SERV RES, V15, P249; RUMMEL RJ, 1970, APPLIED FACTOR ANAL; WENNBERG J, 1982, SCI AM, V246, P120, DOI 10.1038/scientificamerican0482-120	29	194	197	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	1991	266	1					73	79		10.1001/jama.266.1.73	http://dx.doi.org/10.1001/jama.266.1.73			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT934	2046132				2022-12-28	WOS:A1991FT93400030
J	RATTO, GM; ROBINSON, DW; YAN, B; MCNAUGHTON, PA				RATTO, GM; ROBINSON, DW; YAN, B; MCNAUGHTON, PA			DEVELOPMENT OF THE LIGHT RESPONSE IN NEONATAL MAMMALIAN RODS	NATURE			English	Article							DEVELOPING RAT RETINA; OUTER SEGMENTS; SPECTRAL SENSITIVITY; POSTNATAL-DEVELOPMENT; HUMAN INFANTS; RHODOPSIN; DESENSITIZATION; MECHANISMS; ACTIVATION; VISION	THE sensitivity to light is low in many neonatal mammals when compared with that in the adult. In human infants at one month of age, for example, the dark-adapted sensitivity for detection of large stimuli is 50 times lower than in the adult 1-4, and in rats the overall sensitivity of the neonatal retina is also low compared with the adult 5, 6. This low sensitivity in the neonate has been attributed to a number of factors 5-11, but the possibility that the photoreceptors themselves might be an important limitation on the overall visual sensitivity has not so far been clearly established. Here we record the light response of single neonatal rat rods and find that the sensitivity is considerably lower than in the adult. The response to a single photoisomerization is normal in the neonate, and the sensitivity deficit can therefore be attributed to a low level of functional rhodopsin. Opsin, the protein component of rhodopsin, must be present in normal amounts, as the sensitivity can be restored to adult levels by treating the retina with 9-cis retinal, an active homologue of the native chromophore 11-cis retinal. The low sensitivity of photoreceptors in the neonate can therefore be attributed mainly to a low concentration of 11-cis retinal in the developing retina.			RATTO, GM (corresponding author), PHYSIOL LAB,DOWNING ST,CAMBRIDGE CB2 3EG,ENGLAND.		Ratto, Gian Michele/AAX-8514-2020; Yan, Bing/B-7903-2009; Ratto, Gian Michele/AAB-8719-2021	Yan, Bing/0000-0002-7970-6764; Ratto, Gian Michele/0000-0001-9632-7769; McNaughton, Peter/0000-0003-1946-9610				ALPERN M, 1987, VISION RES, V27, P1459, DOI 10.1016/0042-6989(87)90155-6; BANKS MS, 1988, J OPT SOC AM A, V5, P2059, DOI 10.1364/JOSAA.5.002059; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BROCKES JP, 1989, NEURON, V2, P1285, DOI 10.1016/0896-6273(89)90066-4; BROWN AM, 1986, VISION RES, V26, P707, DOI 10.1016/0042-6989(86)90084-2; CARTERDAWSON L, 1986, DEV BIOL, V116, P431, DOI 10.1016/0012-1606(86)90144-2; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; FULTON AB, 1980, VISION RES, V20, P819, DOI 10.1016/0042-6989(80)90062-0; FULTON AB, 1991, VISION RES, V31, P1259, DOI 10.1016/0042-6989(91)90050-F; FULTON AB, 1984, INVEST OPHTH VIS SCI, V25, P647; HAMER RD, 1984, VISION RES, V24, P77, DOI 10.1016/0042-6989(84)90146-9; HODGKIN AL, 1985, J PHYSIOL-LONDON, V358, P447, DOI 10.1113/jphysiol.1985.sp015561; JACOBS DS, 1988, VISION RES, V28, P947, DOI 10.1016/0042-6989(88)90104-6; LAMB TD, 1981, J PHYSIOL-LONDON, V319, P463, DOI 10.1113/jphysiol.1981.sp013921; Lewis JM, 1939, J PEDIATR-US, V15, P812, DOI 10.1016/S0022-3476(39)80081-6; MAKINO CL, 1990, J PHYSIOL-LONDON, V424, P545, DOI 10.1113/jphysiol.1990.sp018082; MCNAUGHTON PA, 1980, NATURE, V283, P85, DOI 10.1038/283085a0; NOELL WK, 1980, VISION RES, V20, P1163, DOI 10.1016/0042-6989(80)90055-3; POWERS MK, 1981, VISION RES, V21, P1005, DOI 10.1016/0042-6989(81)90004-3; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; WILSON HR, 1988, VISION RES, V28, P611; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700	24	61	66	1	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 20	1991	351	6328					654	657		10.1038/351654a0	http://dx.doi.org/10.1038/351654a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT112	2052091				2022-12-28	WOS:A1991FT11200067
J	WEBSTER, D				WEBSTER, D			PRODUCE A SERVICE SPECIFICATION	BRITISH MEDICAL JOURNAL			English	Article											WEBSTER, D (corresponding author), LEEDS DIST HLTH AUTHOR,ST MARYS HOUSE,LEEDS LS7 3JX,ENGLAND.							1990, CONTRACTS HLTH SERVI; 1990, EL90221 NHS MAN EX; 1990, EL90161 NHS MAN EX	3	3	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1991	302	6790					1450	1451		10.1136/bmj.302.6790.1450	http://dx.doi.org/10.1136/bmj.302.6790.1450			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR403	2070115	Green Published, Bronze			2022-12-28	WOS:A1991FR40300027
J	ORENTLICHER, D				ORENTLICHER, D			LEGAL INTERVENTIONS DURING PREGNANCY - COURT-ORDERED MEDICAL TREATMENTS AND LEGAL PENALTIES FOR POTENTIALLY HARMFUL BEHAVIOR BY PREGNANT-WOMEN	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											ORENTLICHER, D (corresponding author), AMER MED ASSOC, BOARD TRUSTEES, 515 N STATE ST, CHICAGO, IL 60610 USA.							ACKER D, 1983, AM J OBSTET GYNECOL, V146, P220, DOI 10.1016/0002-9378(83)91060-8; ANNAS GJ, 1987, AM J LAW MED, V13, P213; ANNAS GJ, 1982, HASTINGS CENT REP, V12, P16, DOI 10.2307/3561823; ANNAS GJ, 1987, NEW ENGL J MED, V316, P1213, DOI 10.1056/NEJM198705073161909; ANNAS GJ, 1982, HASTINGS CENT REP, V12, P45; Barry Ellen M., 1989, HARVARD WOMENS LAW J, P189; CHASNOFF IJ, 1989, ANN NY ACAD SCI, V562, P208, DOI 10.1111/j.1749-6632.1989.tb21019.x; CHASNOFF IJ, 1990, NEW ENGL J MED, V322, P1202, DOI 10.1056/NEJM199004263221706; CHASNOFF IJ, 1985, NEW ENGL J MED, V313, P666, DOI 10.1056/NEJM198509123131105; CHASNOFF IJ, 1989, JAMA-J AM MED ASSOC, V261, P1741, DOI 10.1001/jama.261.12.1741; CHASNOFF IJ, 1988, PEDIATR CLIN N AM, V82, P888; COLSHER PL, 1989, ANNU REV PUBL HEALTH, V10, P203, DOI 10.1146/annurev.pu.10.050189.001223; DIXON SD, 1989, WESTERN J MED, V150, P436; Field M A, 1989, Law Med Health Care, V17, P114; FREEMAN R, 1990, NEW ENGL J MED, V322, P624, DOI 10.1056/NEJM199003013220910; GOLD RB, 1985, FAM PLANN PERSPECT, V17, P103, DOI 10.2307/2135015; Hadi H A, 1987, Obstet Gynecol Surv, V42, P69; HUGHES D, 1986, CLEARINGHOUSE REV, V20, P472; JOHNSEN DE, 1986, YALE LAW J, V95, P599, DOI 10.2307/796491; KEETON W, 1984, PROSSER KEETON TORTS; KIRKWOOD K, 1990, NEW ENGL J MED, V322, P588; KOLDER VEB, 1987, NEW ENGL J MED, V316, P1192, DOI 10.1056/NEJM198705073161905; MOSS DC, 1988, ABA J, V74, P20; MURPHY JF, 1978, BMJ-BRIT MED J, V1, P1988; MURRAY TH, 1987, CLIN PERINATOL, V14, P329, DOI 10.1016/S0095-5108(18)30768-1; NELSON LJ, 1988, JAMA-J AM MED ASSOC, V259, P1060, DOI 10.1001/jama.259.7.1060; NURMI J, 1990, POTOMAC GAZETTE 0214; PRITCHARD JA, 1985, WILLIAMS OBSTETRICS; REGAN DO, 1987, NEUROTOXICOL TERATOL, V9, P315, DOI 10.1016/0892-0362(87)90022-5; REVKIN AC, 1989, DISCOVER, V10, P63; ROBERTSON JA, 1983, VA LAW REV, V69, P405, DOI 10.2307/1072766; SACHS BP, 1985, SMOKING REPRODUCTIVE, P144; SHAW MW, 1984, J LEGAL MED, V5, P63, DOI 10.1080/01947648409513403; SLOAN IJ, 1982, PROTECTION ABUSED VI, P19; STREISSGUTH AP, 1980, SCIENCE, V209, P353, DOI 10.1126/science.6992275; ZUCKERMAN B, 1989, NEW ENGL J MED, V320, P762, DOI 10.1056/NEJM198903233201203; 1987, PATIENT CHOICE MATER; 1989, FETAL EFFECTS MATERN; 1989, NY TIMES        0109, pA1; 1987, REV LAW SOC CHANGE, V16, P277; 1989, AM MED NEWS, V3, P41; 1988, 137TH P HOUS DEL ANN; 1988, HARVARD LAW REV, V101, P994; 1989, REPROD RIGHTS UPDATE, V1, P2; 1990, REPRODUCT RIGHT 0203, P2; 1989, CURRENT OPINIONS; 1989, WASH POST B     0703, P1; 1989, DRUG ABUSE US NEXT G; 1989, CHICAGO TRIBUNE 0510, P1	49	39	39	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	1990	264	20					2663	2670						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ584	2098015				2022-12-28	WOS:A1990EJ58400031
J	NEIL, HAW; MANT, D; JONES, L; MORGAN, B; MANN, JI				NEIL, HAW; MANT, D; JONES, L; MORGAN, B; MANN, JI			LIPID SCREENING - IS IT ENOUGH TO MEASURE TOTAL CHOLESTEROL CONCENTRATION	BMJ-BRITISH MEDICAL JOURNAL			English	Article									UNIV OTAGO, DEPT NUTR, DUNEDIN, NEW ZEALAND	University of Otago	NEIL, HAW (corresponding author), UNIV OXFORD, RADCLIFFE INFIRM, DEPT PUBL HLTH & PRIMARY CARE, OXFORD OX2 6HE, ENGLAND.		Mant, David CA/C-7763-2009					[Anonymous], 1989, LANCET, V1, P589; ASSMAN G, 1986, PROCAM TRIAL; AUSTIN MA, 1989, AM J EPIDEMIOL, V129, P249, DOI 10.1093/oxfordjournals.aje.a115130; BURSTEIN M, 1970, J LIPID RES, V11, P583; CASTELLI WP, 1986, AM HEART J, V112, P432, DOI 10.1016/0002-8703(86)90296-6; CASTELLI WP, 1908, REVERSING COURSE ATH; CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; FUH MMT, 1987, ARCH INTERN MED, V147, P1035, DOI 10.1001/archinte.147.6.1035; GORDON T, 1981, ARCH INTERN MED, V141, P1128, DOI 10.1001/archinte.141.9.1128; HJERMANN I, 1981, LANCET, V2, P1303; HULLEY SB, 1980, NEW ENGL J MED, V302, P1383, DOI 10.1056/NEJM198006193022503; JACOBS DR, 1990, AM J EPIDEMIOL, V131, P32, DOI 10.1093/oxfordjournals.aje.a115483; JACOBS DR, 1982, AM J EPIDEMIOL, V116, P878, DOI 10.1093/oxfordjournals.aje.a113490; LENTER C, 1982, GEIGY SCI TABLES, V2; LEWIS B, 1988, EUR HEART J, V9, P571; LEWIS B, 1989, HDB CORONARY HEART D; MANN JI, 1988, BRIT MED J, V296, P1702, DOI 10.1136/bmj.296.6638.1702; PETO R, 1985, CIRCULATION, V72, P451; POCOCK SJ, 1989, BMJ-BRIT MED J, V298, P998, DOI 10.1136/bmj.298.6679.998; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; SHEPHERD J, 1987, BRIT MED J, V295, P1245, DOI 10.1136/bmj.295.6608.1245; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; [No title captured]; 1988, SPSSX USERS GUIDE; 1984, JAMA-J AM MED ASSOC, V251, P1196; 1985, DIABETES MELLITUS	28	34	35	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	1990	301	6752					584	587		10.1136/bmj.301.6752.584	http://dx.doi.org/10.1136/bmj.301.6752.584			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ625	2082960	Green Published, Bronze			2022-12-28	WOS:A1990DZ62500020
J	VALORI, RM; COCKEL, R				VALORI, RM; COCKEL, R			OMEPRAZOLE FOR DUODENAL ULCERATION IN CROHNS-DISEASE	BRITISH MEDICAL JOURNAL			English	Article									SELLY OAK HOSP,DIV MED,BIRMINGHAM B29 6JD,ENGLAND									FIELDING JF, 1970, GUT, V11, P998, DOI 10.1136/gut.11.12.998; TYTGAT G N J, 1987, Alimentary Pharmacology and Therapeutics, V1, P31; WALT RP, 1983, BRIT MED J, V287, P12, DOI 10.1136/bmj.287.6384.12; WETERMAN IT, 1983, INFLAMM BOWEL DIS, P299; WOOLFSON K, 1989, Gastroenterology, V96, pA551	5	29	30	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 17	1990	300	6722					438	439		10.1136/bmj.300.6722.438	http://dx.doi.org/10.1136/bmj.300.6722.438			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP166	2107896	Bronze, Green Published			2022-12-28	WOS:A1990CP16600021
J	BURRELL, CJ; SKEHAN, JD; COWLEY, ML; BARRETT, CW; MILLS, PG				BURRELL, CJ; SKEHAN, JD; COWLEY, ML; BARRETT, CW; MILLS, PG			DISTRICTS USE OF THROMBOLYTIC AGENTS	BMJ-BRITISH MEDICAL JOURNAL			English	Article									LONDON HOSP, DEPT PHARM, LONDON E1 1BB, ENGLAND	University of London; Queen Mary University London	BURRELL, CJ (corresponding author), LONDON HOSP, DEPT CARDIAC, LONDON E1 1BB, ENGLAND.							[Anonymous], 1988, LANCET, V2, P349; BURRELL CJ, 1988, BRIT HEART J, V59, P607; DEBONO D, 1989, CARDIOLOGY PRACTICE, V7, P9; JAGGER JD, 1987, LANCET, V1, P34; 1989, DH2892 OFF POP CENS	5	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	1990	300	6719					237	238		10.1136/bmj.300.6719.237	http://dx.doi.org/10.1136/bmj.300.6719.237			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL024	2106934	Bronze, Green Published			2022-12-28	WOS:A1990CL02400026
J	MATTHEWS, JNS; ALTMAN, DG; CAMPBELL, MJ; ROYSTON, P				MATTHEWS, JNS; ALTMAN, DG; CAMPBELL, MJ; ROYSTON, P			ANALYSIS OF SERIAL MEASUREMENTS IN MEDICAL-RESEARCH	BRITISH MEDICAL JOURNAL			English	Article									UNIV SOUTHAMPTON,SOUTHAMPTON GEN HOSP,SOUTHAMPTON S09 4XY,ENGLAND; ROYAL POSTGRAD MED SCH,DEPT MED PHYS,LONDON W12 0NN,ENGLAND; IMPERIAL CANC RES FUND,MED STAT LAB,LONDON WC2A 3PX,ENGLAND	University of Southampton; Imperial College London; Cancer Research UK	MATTHEWS, JNS (corresponding author), UNIV NEWCASTLE UPON TYNE,SCH MED,DIV MED STAT,NEWCASTLE TYNE NE2 4HH,ENGLAND.		Matthews, John N S/H-7502-2013	Matthews, John N S/0000-0003-2559-037X				ARMITAGE P, 1987, STAT METHODS MED RES, P355; BRADLEY JR, 1988, BRIT MED J, V296, P1634, DOI 10.1136/bmj.296.6637.1634; DEKLERK NH, 1986, AUST NZ J MED, V16, P637; FIKRI MM, 1937, LANCET, V1, P800; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; GOLDSTEIN H, 1987, MULTILEVEL MODELS ED, P51; HEALY MJR, 1981, PERSPECTIVES MED STA, P155; ILLINGWORTH PJ, 1987, BRIT MED J, V294, P1573, DOI 10.1136/bmj.294.6587.1573; MORRISON DF, 1976, MULTIVARIATE STATIST; OLDHAM PD, 1962, J CHRON DIS, V15, P969, DOI 10.1016/0021-9681(62)90116-9; ROWELL JG, 1976, J AGR SCI, V87, P423, DOI 10.1017/S0021859600027763; TSAI KT, 1988, COMPUT METH PROG BIO, V27, P69, DOI 10.1016/0169-2607(88)90105-8; Wishart J, 1938, BIOMETRIKA, V30, P16, DOI 10.2307/2332221; YATES F, 1982, BIOMETRICS, V38, P850; [No title captured]	15	2680	2708	2	62	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1990	300	6719					230	235		10.1136/bmj.300.6719.230	http://dx.doi.org/10.1136/bmj.300.6719.230			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL024	2106931	Green Published, Bronze			2022-12-28	WOS:A1990CL02400023
J	ASHTON, CH				ASHTON, CH			SOLVENT ABUSE - LITTLE PROGRESS AFTER 20 YEARS	BRITISH MEDICAL JOURNAL			English	Editorial Material											ASHTON, CH (corresponding author), UNIV NEWCASTLE UPON TYNE,DEPT PHARMACOL SCI,CLIN PSYCHOPHARMACOL UNIT,NEWCASTLE TYNE NE2 4HH,ENGLAND.							BILLINGTON AC, 1989, HUM TOXICOL, V8, P323, DOI 10.1177/096032718900800412; BLACK D, 1982, HLTH TRENDS, V14, P27; CHADWICK O, 1989, BRIT MED J, V298, P1679, DOI 10.1136/bmj.298.6689.1679; DAVIES B, 1985, BRIT MED J, V290, P109, DOI 10.1136/bmj.290.6462.109; EDEH J, 1989, HUM TOXICOL, V8, P313, DOI 10.1177/096032718900800410; GLASER HH, 1962, JAMA-J AM MED ASSOC, V181, P300, DOI 10.1001/jama.1962.03050300020004; HOLMBERG PC, 1979, LANCET, V2, P177; KING MD, 1981, BRIT MED J, V283, P663, DOI 10.1136/bmj.283.6292.663; LEE JT, 1989, HUM TOXICOL, V8, P331, DOI 10.1177/096032718900800414; LISS BI, 1989, HUM TOXICOL, V8, P327, DOI 10.1177/096032718900800413; LOLIN Y, 1989, HUM TOXICOL, V8, P293, DOI 10.1177/096032718900800407; MARJOT R, 1989, HUM TOXICOL, V8, P301, DOI 10.1177/096032718900800408; MEREDITH TJ, 1989, HUM TOXICOL, V8, P227; OCONNOR D, 1982, HUM TOXICOL, V1, P313, DOI 10.1177/096032718200100315; RAMSEY J, 1989, HUM TOXICOL, V8, P261, DOI 10.1177/096032718900800403; RICHARDSON H, 1989, HUM TOXICOL, V8, P319, DOI 10.1177/096032718900800411; SHEPHERD RT, 1989, HUM TOXICOL, V8, P287, DOI 10.1177/096032718900800406; TOURANT C, 1979, LANCET, V1, P1356; Woods J. H., 1978, PSYCHOPHARMACOLOGY G, P595	19	22	22	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					135	136		10.1136/bmj.300.6718.135	http://dx.doi.org/10.1136/bmj.300.6718.135			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CK077	2105786	Green Published, Bronze			2022-12-28	WOS:A1990CK07700001
J	DAWSON, K; SINGER, P				DAWSON, K; SINGER, P			SHOULD FERTILE PEOPLE HAVE ACCESS TO INVITRO FERTILIZATION	BRITISH MEDICAL JOURNAL			English	Editorial Material											DAWSON, K (corresponding author), MONASH UNIV,CTR HUMAN BIOETH,CLAYTON,VIC 3168,AUSTRALIA.							[Anonymous], 1987, INSTRUCTION RESPECT; [Anonymous], 1987, HUMAN FERTILISATION; ARDITTI R, 1984, TEST TUBE WOMEN, P1; BRUMBY M, 1983, MED J AUSTRALIA, V2, P650, DOI 10.5694/j.1326-5377.1983.tb122733.x; CHEN C, 1986, LANCET, V1, P884, DOI 10.1016/S0140-6736(86)90989-X; FELDBERG D, 1989, FERTIL STERIL, V51, P42; HALLIDAY J, 1987, 1986 MURD I RES BIRT; HAMERTON JL, 1980, PRENATAL DIAGNOSIS, V1, P11; HANDYSIDE AH, 1989, LANCET, V1, P347; Kirkman Maggie, 1988, MY SISTERS CHILD; LESCHOT NJ, 1982, J PSYCHOSOMATIC OBST, V1, P47; LUTJEN PJ, 1983, NATURE, V307, P174; MONK M, 1988, BIOESSAYS, V8, P184, DOI 10.1002/bies.950080603; MONK M, 1987, LANCET, V2, P423; MORISON JE, 1963, FOETAL NEONATAL PATH, P159; NABER JM, 1987, PRENATAL DIAG, V7, P51, DOI 10.1002/pd.1970070109; OZAR DT, 1985, HASTINGS CENT REP, V15, P7, DOI 10.2307/3561377; Russell L B, 1985, Basic Life Sci, V36, P377; RUTHERFORD AJ, 1988, BRIT MED J, V296, P1765, DOI 10.1136/bmj.296.6639.1765; SATHANANTHAN AH, 1988, GAMETE RES, V21, P385, DOI 10.1002/mrd.1120210407; SMITZ J, 1988, Human Reproduction (Oxford), V3, P35; TROUNSON A, 1983, NATURE, V305, P707, DOI 10.1038/305707a0; WILTON LJ, 1989, BIOL REPROD, V40, P145, DOI 10.1095/biolreprod40.1.145; WOOD EC, 1988, MED J AUSTRALIA, V149, P426, DOI 10.5694/j.1326-5377.1988.tb120704.x; 1988, COMMONWEALTH PERSPEC; 1988, SURROGATE MOTHERHOOD, P18; 1988, MED J AUSTRALIA, V148, P429; 1988, INFERTILITY MED SOCI; 1988, IVF GIFT PREGNANCIES	29	10	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					167	170		10.1136/bmj.300.6718.167	http://dx.doi.org/10.1136/bmj.300.6718.167			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105800	Green Published, Bronze			2022-12-28	WOS:A1990CK07700027
J	PURDIE, JAM; RIDLEY, SA; WALLACE, PGM				PURDIE, JAM; RIDLEY, SA; WALLACE, PGM			EFFECTIVE USE OF REGIONAL INTENSIVE THERAPY UNITS	BRITISH MEDICAL JOURNAL			English	Article									WESTERN INFIRM & ASSOCIATED HOSP,DIV ANAESTHESIA,GLASGOW G11 6NT,SCOTLAND									Brunk HD., 1972, STAT-US; CHANG RWS, 1988, CRIT CARE MED, V16, P34, DOI 10.1097/00003246-198801000-00007; DIXON WJ, 1985, BMDP STATISTICAL SOF; KNAUS WA, 1986, ANN INTERN MED, V104, P410, DOI 10.7326/0003-4819-104-3-410; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEDINGHAM IM, 1988, LANCET, V1, P785; RIDLEY S, 1989, ANAESTHESIA, V44, P882; 1989, ANAESTHESIA, V44, P428; 1988, PROVISION INTENSIVE	9	16	16	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					79	81		10.1136/bmj.300.6717.79	http://dx.doi.org/10.1136/bmj.300.6717.79			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105778	Green Published, Bronze			2022-12-28	WOS:A1990CJ08000014
J	GREEN, DM; ZEVON, MA; LOWRIE, G; SEIGELSTEIN, N; HALL, B				GREEN, DM; ZEVON, MA; LOWRIE, G; SEIGELSTEIN, N; HALL, B			CONGENITAL-ANOMALIES IN CHILDREN OF PATIENTS WHO RECEIVED CHEMOTHERAPY FOR CANCER IN CHILDHOOD AND ADOLESCENCE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATOMIC-BOMB SURVIVORS; ANTI-NEOPLASTIC DRUGS; GLYCOPHORIN-A LOCUS; SALMONELLA-TYPHIMURIUM; WILMS TUMOR; MUTAGENIC ACTIVITY; MUTATIONS; AGENTS; PREGNANCY; MICROSOME	Background. Many patients who have been treated successfully for childhood cancer with regimens that contain one or more mutagenic chemotherapeutic agents are concerned that their own treatment during childhood or adolescence may adversely affect their children. Methods. To determine the effect of chemotherapy for cancer during childhood and adolescence on the outcome of subsequent pregnancies, we reviewed the records of 306 men and women who had been treated for pediatric cancer and who responded to our questionnaire. One hundred of the 306 patients reported 202 pregnancies. Among the patients who had received chemotherapy as part of their treatment for cancer, 60 patients or wives of patients had had one or more pregnancies of 20 or more weeks' gestation. The 60 former patients had a total of 100 live-born and 2 stillborn children. Results. The frequency of congenital anomalies was 8.1 percent (5 of 62) among the live-born children of the women and 7.9 percent (3 of 38) among the live-born children of the men. Structural congenital cardiac defects were identified in 10.0 percent (2 of 20) of the children of women who had been treated with dactinomycin, as compared with 0.6 percent (144 of 24,153) among the children in a multicenter survey of fetal anomalies (P = 0.0126). We found no relation between the number of mutagens received or the cumulative dose of any agent received and the frequency of congenital anomalies in the children. Conclusions. These data suggest that treatment of children and adolescents with mutagenic chemotherapeutic agents, in the dose ranges we examined, does not increase the frequency of congenital anomalies in the children subsequently born to the former patients. However, the possible adverse effect of dactinomycin on the children of such patients requires further study.	ROSWELL PK CANC INST, DEPT PSYCHOL, BUFFALO, NY 14263 USA; SUNY BUFFALO, SCH MED & BIOMED SCI, DEPT PEDIAT, BUFFALO, NY 14260 USA; NEW YORK STATE DEPT HLTH, ROSWELL PK MEM INST, ROSWELL PK GRAD DIV, DEPT NAT SCI, BUFFALO, NY 14263 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	GREEN, DM (corresponding author), ROSWELL PK CANC INST, DEPT PEDIAT, ELM & CARLTON ST, BUFFALO, NY 14263 USA.				NATIONAL CANCER INSTITUTE [R25CA018201] Funding Source: NIH RePORTER; NCI NIH HHS [CA-18201-15] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBERTINI RJ, 1985, MUTAT RES, V150, P411, DOI 10.1016/0027-5107(85)90138-1; ANDERSON D, 1978, BRIT J CANCER, V37, P924, DOI 10.1038/bjc.1978.134; AULETTA AE, 1978, J NATL CANCER I, V60, P1495, DOI 10.1093/jnci/60.6.1495; BENEDICT WF, 1977, CANCER RES, V37, P2209; BYRNE J, 1988, MED PEDIATR ONCOL, V16, P233, DOI 10.1002/mpo.2950160403; FRANZA BR, 1980, J NATL CANCER I, V65, P149; FREDERIC.PL, 1974, LANCET, V2, P707; GREEN DM, 1989, CANCER-AM CANCER SOC, V64, P2335, DOI 10.1002/1097-0142(19891201)64:11<2335::AID-CNCR2820641124>3.0.CO;2-7; GREEN DM, 1982, CANCER, V49, P2285, DOI 10.1002/1097-0142(19820601)49:11<2285::AID-CNCR2820491114>3.0.CO;2-N; GREEN DM, 1991, CANCER, V67, P206, DOI 10.1002/1097-0142(19910101)67:1<206::AID-CNCR2820670134>3.0.CO;2-2; HAKODA M, 1988, MUTAT RES, V201, P39, DOI 10.1016/0027-5107(88)90109-1; HAWKINS MM, 1988, J ROY COLL GEN PRACT, V38, P102; KYOIZUMI S, 1989, CANCER RES, V49, P581; LANGLOIS RG, 1987, SCIENCE, V236, P445, DOI 10.1126/science.3563520; LI FP, 1979, JNCI-J NATL CANCER I, V62, P1193; MATHESON D, 1978, DRUG CHEM TOXICOL, V1, P277, DOI 10.3109/01480547809105021; MATNEY TS, 1985, TERATOGEN CARCIN MUT, V5, P319, DOI 10.1002/tcm.1770050502; MULVIHILL JJ, 1983, MUTAT RES, V123, P345, DOI 10.1016/0165-1110(83)90028-3; MULVIHILL JJ, 1986, CLIN GENET, V39, P72; MYRIANTHOPOULOS NC, 1974, BIRTH DEFECTS ORI 11, V10; NEEL JV, 1988, AM J HUM GENET, V42, P663; NEEL JV, 1980, P NATL ACAD SCI-BIOL, V77, P4221, DOI 10.1073/pnas.77.7.4221; NGUYEN TV, 1982, CANCER RES, V42, P4792; PASTORFIDE GB, 1973, OBSTET GYNECOL, V42, P67; PREJEAN JD, 1984, DRUG METAB REV, V15, P619, DOI 10.3109/03602538409029975; PUEYO C, 1979, MUTAT RES, V67, P189, DOI 10.1016/0165-1218(79)90131-9; ROSS GT, 1976, CANCER, V37, P1043, DOI 10.1002/1097-0142(197602)37:2+<1043::AID-CNCR2820370809>3.0.CO;2-N; RUSTIN GJS, 1984, BRIT MED J, V288, P103, DOI 10.1136/bmj.288.6411.103; SEINO Y, 1978, CANCER RES, V38, P2148; STILLER CA, 1987, CARCINOGENESIS, V8, P129, DOI 10.1093/carcin/8.1.129; WILCOX AJ, 1984, AM J EPIDEMIOL, V120, P727, DOI 10.1093/oxfordjournals.aje.a113940; YAJIMA N, 1981, MUTAT RES, V88, P241, DOI 10.1016/0165-1218(81)90036-7; YOUNG J L JR, 1986, Cancer, V58, P598, DOI 10.1002/1097-0142(19860715)58:2+<598::AID-CNCR2820581332>3.0.CO;2-C	33	83	87	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 18	1991	325	3					141	146		10.1056/NEJM199107183250301	http://dx.doi.org/10.1056/NEJM199107183250301			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW752	2052058				2022-12-28	WOS:A1991FW75200001
J	EDDY, DM				EDDY, DM			WHATS GOING ON IN OREGON	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									DUKE UNIV,DURHAM,NC 27706	Duke University								DANIELS N, 1991, JAMA-J AM MED ASSOC, V265, P2232, DOI 10.1001/jama.265.17.2232; DIXON J, 1991, LANCET, V337, P891, DOI 10.1016/0140-6736(91)90213-9; EDDY DM, 1991, JAMA-J AM MED ASSOC, V265, P2399, DOI 10.1001/jama.265.18.2399; EDDY DM, 1990, JAMA-J AM MED ASSOC, V264, P1737, DOI 10.1001/jama.264.13.1737; EDDY DM, 1991, JAMA-J AM MED ASSOC, V265, P105, DOI 10.1001/jama.265.1.105; EDDY DM, 1991, JAMA-J AM MED ASSOC, V265, P1446, DOI 10.1001/jama.265.11.1446; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P1839, DOI 10.1001/jama.263.13.1839; EDDY DM, 1991, JAMA-J AM MED ASSOC, V265, P1449; Eddy DM, 1991, JAMA-J AM MED ASSOC, V265, P2405; HADORN DC, 1991, JAMA-J AM MED ASSOC, V265, P2218, DOI 10.1001/jama.265.17.2218; KITZHABER J, 1991, ISSUES SCI TECH, P7; MJOSBETH J, 1991, HLTH LEGISLATION REG, V17, P1	12	34	34	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	1991	266	3					417	420		10.1001/jama.266.3.417	http://dx.doi.org/10.1001/jama.266.3.417			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV960	2056654				2022-12-28	WOS:A1991FV96000036
J	VALERIANOMARCET, J; KERR, LD				VALERIANOMARCET, J; KERR, LD			MYONECROSIS AND MYOFIBROSIS AS COMPLICATIONS OF SICKLE-CELL-ANEMIA	ANNALS OF INTERNAL MEDICINE			English	Article								Painful crises in sickle cell anemia are associated with infarction and subsequent fibrosis of many different organs. Myonecrosis secondary to muscle infarction during a crisis and subsequent fibrosis are often not recognized as complications of sickle cell anemia. We describe four patients, all of whom had recurrent episodes of symmetric proximal muscle pain and swelling as prominent features of their crises. Muscle biopsies showed acute myonecrosis with a minimal inflammatory reaction as well as myofibrosis with abundant collagen deposition. Chronic sequelae consisted of muscle induration, atrophy, and contractures.	CUNY MT SINAI SCH MED,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai								DORWART BB, 1985, J RHEUMATOL, V12, P590; REYNOLDS MD, 1990, ARTHRITIS RHEUM, V33, P590; SERJEANT GR, 1985, SICKLE CELL DISEASE, P111; WILLIAMS JW, 1990, HEMATOLOGY, P614	4	24	24	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572	0003-4819			ANN INTERN MED	Ann. Intern. Med.	JUL 15	1991	115	2					99	101		10.7326/0003-4819-115-2-99	http://dx.doi.org/10.7326/0003-4819-115-2-99			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW091	2058869				2022-12-28	WOS:A1991FW09100004
J	MADDOX, J				MADDOX, J			THE CASE FOR THE HUMAN GENOME	NATURE			English	Editorial Material																		GILBERT W, 1991, NATURE, V349, P99, DOI 10.1038/349099a0; PHILIPSON L, 1991, NATURE, V351, P91, DOI 10.1038/351091a0	2	11	11	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1991	352	6330					11	14		10.1038/352011a0	http://dx.doi.org/10.1038/352011a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV178	2062370				2022-12-28	WOS:A1991FV17800033
J	VOSK, A				VOSK, A			NEW STRATAGEMS FOR DEALING WITH MEDICARES PROSPECTIVE PAYMENT SYSTEM AND OTHER COST-CONTAINMENT MEASURES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											VOSK, A (corresponding author), WILLIAMSPORT HOSP & MED CTR,DEPT EMERGENCY,777 RURAL AVE,WILLIAMSPORT,PA 17701, USA.							CORLEONE V, 1984, MANUAL MODERN HOSPIT, P105; FRANKENSTEIN DR, 1882, BALKAN J PATHOL, V40, P118; Gogol N. V., 1942, CHICHIKOVS JOURNEYS; Goldschmidt J., 1989, PRIMAL WHIMPER, P57; GONDORF H, 1988, MANUAL HOSPITAL STIN; GONIFF SA, 1990, ANN MED ASTROLOGY, V14, P80; HACKENBUSH HZ, 1979, RACING MED, V5, P116; Kubler-Ross E., 1969, DEATH DYING; MACHIAVELLI N, 1985, J CONT HOSP ADM, V22, P198; PERDU T, 1989, PRIMAL WHIMPER, P185; SCHMEER FA, 1977, J MANIPULATIVE PSYCH, V52, P385; SCHNORRER TB, 1987, FOLSOM PRISON J, V26, P492; TORQUEMADA T, 1981, HOSP TORTURE CHAMBER, V200, P9; YORICK P, 1979, BECOME RICH FAMOUS M, P218	14	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	1991	266	1					121	122						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT934	2046122				2022-12-28	WOS:A1991FT93400040
J	HILTON, E; SINGER, C; KOZARSKY, P; SMITH, MA; LARDIS, MP; BORENSTEIN, MT				HILTON, E; SINGER, C; KOZARSKY, P; SMITH, MA; LARDIS, MP; BORENSTEIN, MT			STATUS OF IMMUNITY TO TETANUS, MEASLES, MUMPS, RUBELLA, AND POLIO AMONG UNITED-STATES TRAVELERS	ANNALS OF INTERNAL MEDICINE			English	Note						RUBELLA; POLIOMYELITIS; MUMPS; MEASLES; TETANUS	DIPHTHERIA	Objective: To assess the susceptibility of travelers to vaccine-preventable diseases, including tetanus, polio, measles, mumps, and rubella. Design: Serologic testing in a cohort of persons before travel. Setting: Travel health centers at two university hospitals. Patients: Two hundred and thirty-three U.S. residents traveling to developing countries. Measurements: Tetanus titers were measured by passive hemagglutination; polio antibodies, by neutralization; and antibody levels to measles, mumps, and rubella, by indirect enzyme-linked immunosorbent assay. Main Results: Tetanus titers were negative in 22 travelers (9%), with the elderly and women more likely to be unprotected (P = 0.003). Twenty-eight travelers (twelve percent) were not protected against polio serotypes 1, 3, or both. Measles antibodies were absent in 4% of travelers, with men more likely than women to be seronegative (7% compared with 2%; P = 0.06). Those born after 1956 were more likely to be seronegative for measles (9% compared with 2%; P = 0.02). Mumps antibody titers were absent in 6% of travelers overall and in 20% of travelers in their twenties. Rubella titers were negative in 19 patients (8%), 5 of whom were women of child-bearing age. Conclusions: Many U.S. travelers are at risk for vaccine-preventable diseases.	EMORY UNIV, SCH MED, ATLANTA, GA 30322 USA	Emory University	HILTON, E (corresponding author), LONG ISL JEWISH MED CTR, LAKEVILLE RD, ROOM B-202, NEW HYDE PK, NY 11042 USA.							FEDSON DS, 1990, GUIDE ADULT IMMUNIZA, P51; GERSHON AA, 1979, DIAGNOSTIC PROCEDURE, P655; HARDEGREE M C, 1970, Bulletin of the World Health Organization, V43, P461; KLEIN EB, 1980, ARCH VIROL, V66, P321, DOI 10.1007/BF01320628; KOBLIN BA, 1989, AM J PUBLIC HEALTH, V79, P1297, DOI 10.2105/AJPH.79.9.1297; MARKOWITZ LE, 1988, INT J EPIDEMIOL, V17, P187, DOI 10.1093/ije/17.1.187; MELNICK JL, 1979, DIAGNOSTIC PROCEDURE, P65; PEEL MM, 1980, J BIOL STAND, V8, P177, DOI 10.1016/S0092-1157(80)80034-5; WEISS BP, 1983, AM J PUBLIC HEALTH, V73, P802, DOI 10.2105/AJPH.73.7.802	9	17	17	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1991	115	1					32	33		10.7326/0003-4819-115-1-32	http://dx.doi.org/10.7326/0003-4819-115-1-32			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT937	2048860				2022-12-28	WOS:A1991FT93700007
J	YAMADA, M; WASSERMAN, R; LANGE, B; REICHARD, BA; WOMER, RB; ROVERA, G				YAMADA, M; WASSERMAN, R; LANGE, B; REICHARD, BA; WOMER, RB; ROVERA, G			MINIMAL RESIDUAL DISEASE IN CHILDHOOD B-LINEAGE LYMPHOBLASTIC-LEUKEMIA - PERSISTENCE OF LEUKEMIC-CELLS DURING THE 1ST 18 MONTHS OF TREATMENT	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									WISTAR INST,36TH & SPRUCE ST,PHILADELPHIA,PA 19104; CHILDRENS HOSP PHILADELPHIA,DIV ONCOL,PHILADELPHIA,PA; UNIV PENN,SCH MED,PHILADELPHIA,PA 19104	The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania					NCI NIH HHS [CA 47983, CA 10819] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA047983] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BIRD J, 1988, J EXP MED, V168, P229, DOI 10.1084/jem.168.1.229; BLEYER WA, 1985, P AN M AM SOC CLIN, V4, P160; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BUCAN M, 1986, EMBO J, V5, P2899, DOI 10.1002/j.1460-2075.1986.tb04585.x; CLEARY ML, 1986, CELL, V44, P97, DOI 10.1016/0092-8674(86)90488-5; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; CRESCENZI M, 1988, P NATL ACAD SCI USA, V85, P4869, DOI 10.1073/pnas.85.13.4869; DAURIOL L, 1989, LEUKEMIA, V3, P155; ERIKSON J, 1982, P NATL ACAD SCI-BIOL, V79, P5611, DOI 10.1073/pnas.79.18.5611; ESTROV Z, 1986, NEW ENGL J MED, V315, P538, DOI 10.1056/NEJM198608283150902; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIALKOW PJ, 1987, NEW ENGL J MED, V317, P468, DOI 10.1056/NEJM198708203170802; GABERT J, 1989, LANCET, V2, P1125; GAYNON PS, 1988, LANCET, V2, P921; GREAVES MF, 1983, BLOOD, V61, P628; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; HAGENBEEK A, 1986, MINIMAL RESIDUAL DIS; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HANSENHAGGE TE, 1989, BLOOD, V74, P1762; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; IZAGUIRRE CA, 1981, BLOOD, V57, P823; KAWASAKI ES, 1988, P NATL ACAD SCI USA, V85, P5698, DOI 10.1073/pnas.85.15.5698; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; KOMP DM, 1983, J PEDIATR-US, V102, P395, DOI 10.1016/S0022-3476(83)80658-1; KWOK S, 1989, POLYM CHAIN REACTION, P151; LANGE B, IN PRESS HEMATOL ONC; LEE MS, 1988, BLOOD, V72, P893; LEE MS, 1987, SCIENCE, V237, P175, DOI 10.1126/science.3110950; MEADOWS AT, 1988, INT SOC PEDIATR ONCO, P8; MORGAN GJ, 1989, LANCET, V1, P928; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; RIEHM H, 1983, LEUKEMIA RES ADV CEL, P251; ROGERS PCJ, 1984, LANCET, V1, P1320; ROTH MS, 1989, BLOOD, V74, P882; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELIGER H, 1986, CHEM SCRIPTA, V26, P569; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; Suggs S. V., 1981, ICN UCLA S DEV BIOL, V23, P683; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; WALDMANN TA, 1987, ADV IMMUNOL, V40, P247, DOI 10.1016/S0065-2776(08)60241-2; WALDMANN TA, 1985, NEW ENGL J MED, V313, P776, DOI 10.1056/NEJM198509263131303; WATSON DK, 1981, ARCH DIS CHILD, V56, P392, DOI 10.1136/adc.56.5.392; WRIGHT JJ, 1987, J CLIN ONCOL, V5, P735, DOI 10.1200/JCO.1987.5.5.735; YAMADA M, 1989, P NATL ACAD SCI USA, V86, P5123, DOI 10.1073/pnas.86.13.5123; 1977, BMJ, V2, P495	51	220	221	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	1990	323	7					448	455		10.1056/NEJM199008163230705	http://dx.doi.org/10.1056/NEJM199008163230705			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU273	2095753	Bronze			2022-12-28	WOS:A1990DU27300005
J	DAVIES, KN				DAVIES, KN			EVERYDAY AIDS AND APPLIANCES - EMERGENCY ALARMS	BRITISH MEDICAL JOURNAL			English	Article											DAVIES, KN (corresponding author), ST JAMES UNIV HOSP,DEPT MED ELDERLY,LEEDS LS9 7TF,W YORKSHIRE,ENGLAND.							FEENEY R, 1981, ALARM SYSTEMS ELDERL; HUNT A, 1978, ELDERLY HOME; WILCOOCKS AJ, 1979, CARE HOUSING ELDERLY; 1986, DISPERSED ALARM SYST	4	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 30	1990	300	6741					1713	1715		10.1136/bmj.300.6741.1713	http://dx.doi.org/10.1136/bmj.300.6741.1713			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL816	2094239	Green Published, Bronze			2022-12-28	WOS:A1990DL81600032
J	EPSTEIN, AM; STERN, RS; WEISSMAN, JS				EPSTEIN, AM; STERN, RS; WEISSMAN, JS			DO THE POOR COST MORE - A MULTIHOSPITAL STUDY OF PATIENTS SOCIOECONOMIC-STATUS AND USE OF HOSPITAL RESOURCES	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									BRIGHAM & WOMENS HOSP,DEPT MED,DIV GEN MED,HLTH SERV & POLICY RES SECT,BOSTON,MA 02115; BETH ISRAEL HOSP,DEPT DERMATOL,BOSTON,MA 02215; HARVARD UNIV,SCH PUBL HLTH,DEPT HLTH POLICY & MANAGEMENT,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	EPSTEIN, AM (corresponding author), HARVARD UNIV,SCH MED,DEPT HLTH POLICY,PARCEL B,1ST FLOOR,25 SHATTUCK ST,BOSTON,MA 02115, USA.							Christoffersson J G, 1988, DRG Monit, V6, P1; CONKLIN JE, 1984, DRG REFINEMENT FEASI; CONKLIN JE, 1987, DRG REFINEMENT USING; DAVIS K, 1983, MILBANK FUND Q, V61, P149, DOI 10.2307/3349903; DAVIS K, 1975, J HUM RESOUR, V10, P361, DOI 10.2307/145196; EPSTEIN AM, 1985, AM J MED, V78, P101, DOI 10.1016/0002-9343(85)90469-3; EPSTEIN AM, 1988, NEW ENGL J MED, V318, P1579, DOI 10.1056/NEJM198806163182405; GONNELLA JS, 1975, MED CARE, V13, P467, DOI 10.1097/00005650-197506000-00003; HELLINGER FJ, 1985, INQUIRY-J HEALTH CAR, V22, P78; HORN SD, 1985, NEW ENGL J MED, V313, P20, DOI 10.1056/NEJM198507043130105; IEZONNI LI, 1989, PROVIDING QUALITY CA, P70; JENCKS SF, 1987, JAMA-J AM MED ASSOC, V257, P198, DOI 10.1001/jama.257.2.198; JENCKS SF, 1987, HCFA03254 DEP HLTH H, P15; KLEINBAUM DG, 1978, APPLIED REGRESSION A, P209; PEAR R, 1985, NY TIMES        0702, pA12; RUSHING WA, 1978, AM SOCIOL REV, V43, P521, DOI 10.2307/2094776; STERN RS, 1985, NEW ENGL J MED, V312, P621, DOI 10.1056/NEJM198503073121005; WEISSMAN J, 1989, JAMA-J AM MED ASSOC, V261, P3572, DOI 10.1001/jama.261.24.3572; WILENSKY GR, 1986, UNCOMPENSATED HOSP C, P148; 1984, FED REGISTER, V49, P276; 1986, FED REGISTER, V51, P31561; 1982, FED REGISTER, V47, P43285; 1985, PROSPECTIVE PAYMENT	23	184	184	0	5	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	1990	322	16					1122	1128		10.1056/NEJM199004193221606	http://dx.doi.org/10.1056/NEJM199004193221606			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ486	2108331	Bronze			2022-12-28	WOS:A1990CZ48600006
J	COLLEN, D				COLLEN, D			CORONARY THROMBOLYSIS - STREPTOKINASE OR RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR	ANNALS OF INTERNAL MEDICINE			English	Review									UNIV VERMONT, COLL MED, BURLINGTON, VT 05405 USA	University of Vermont	COLLEN, D (corresponding author), CATHOLIC UNIV LEUVEN, CTR THROMBOSIS & VASC RES, CAMPUS GASTHUISBERG, HERESTR 49, B-3000 LOUVAIN, BELGIUM.							ALDERMAN EL, 1984, AM J CARDIOL, V54, P14, DOI 10.1016/0002-9149(84)90297-2; ANDERSON JL, 1988, J AM COLL CARDIOL, V11, P1153, DOI 10.1016/0735-1097(88)90276-8; [Anonymous], 1988, LANCET, V2, P349; BLEICH SD, 1989, CIRCULATION S2, V80, P113; BRAUNWALD E, 1989, CIRCULATION, V79, P441, DOI 10.1161/01.CIR.79.2.441; BRAUNWALD E, 1987, J AM COLL CARDIOL, V10, P970, DOI 10.1016/S0735-1097(87)80296-6; BROCHIER ML, 1987, DRUGS, V33, P140, DOI 10.2165/00003495-198700333-00023; CHAMBERLAIN DA, 1988, LANCET, V1, P545; CHESEBRO JH, 1988, NEW ENGL J MED, V319, P1544; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; COLLEN D, 1984, CIRCULATION, V70, P1012, DOI 10.1161/01.CIR.70.6.1012; COLLEN D, 1988, ANNU REV MED, V39, P405, DOI 10.1146/annurev.me.39.020188.002201; CRIBIER A, 1986, HAEMOSTASIS, V16, P122; DEWOOD MA, 1980, NEW ENGL J MED, V303, P897, DOI 10.1056/NEJM198010163031601; GIMPLE LW, IN PRESS CIRCULATION; GOLD HK, 1986, CIRCULATION, V73, P347, DOI 10.1161/01.CIR.73.2.347; GUERCI AD, 1987, NEW ENGL J MED, V317, P1613, DOI 10.1056/NEJM198712243172601; HILLIS LD, 1985, J AM COLL CARDIOL, V6, P957, DOI 10.1016/S0735-1097(85)80294-1; JOHNS JA, 1988, CIRCULATION, V78, P546, DOI 10.1161/01.CIR.78.3.546; KENNEDY JW, 1985, NEW ENGL J MED, V312, P1073, DOI 10.1056/NEJM198504253121701; KENNEDY JW, 1988, CIRCULATION, V77, P345, DOI 10.1161/01.CIR.77.2.345; KENNEDY JW, 1983, NEW ENGL J MED, V309, P1477, DOI 10.1056/NEJM198312153092402; KENT RS, 1989, CONTROVERSIES CORONA, P3; KNATTERUD G, 1988, JAMA-J AM MED ASSOC, V260, P2849; LOPEZ-SENDON J, 1988, European Heart Journal, V9, P10; MAGNANI B, 1989, J AM COLL CARDIOL, V13, P19, DOI 10.1016/0735-1097(89)90543-3; MARDER VJ, 1988, NEW ENGL J MED, V318, P1585, DOI 10.1056/NEJM198806163182406; MARDER VJ, 1988, NEW ENGL J MED, V318, P1512, DOI 10.1056/NEJM198806093182306; MARDER VJ, 1984, AM J MED, V77, P921, DOI 10.1016/0002-9343(84)90543-6; MATHEY DG, 1985, AM J CARDIOL, V55, P878, DOI 10.1016/0002-9149(85)90710-6; MCNEILL AJ, 1988, BRIT MED J, V296, P1768, DOI 10.1136/bmj.296.6639.1768; MEYER J, 1989, LANCET, V1, P863; MONK JP, 1987, DRUGS, V34, P25, DOI 10.2165/00003495-198734010-00002; MONNIER P, 1987, DRUGS, V33, P175, DOI 10.2165/00003495-198700333-00029; MUELLER HS, 1987, J AM COLL CARDIOL, V10, P479, DOI 10.1016/S0735-1097(87)80188-2; NEUHAUS K L, 1988, European Heart Journal, V9, P9; NEUHAUS KL, 1988, J AM COLL CARDIOL, V12, P581, DOI 10.1016/S0735-1097(88)80040-8; NEUHAUS KL, 1983, FIBRINOLYTISCHE THER, P475; OROURKE M, 1988, CIRCULATION, V77, P1311, DOI 10.1161/01.CIR.77.6.1311; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; RAYNAUD P, 1988, ARCH MAL COEUR VAISS, V81, P25; RENTROP KP, 1984, NEW ENGL J MED, V311, P1457, DOI 10.1056/NEJM198412063112301; ROGERS WJ, 1983, CIRCULATION, V68, P1051, DOI 10.1161/01.CIR.68.5.1051; ROVELLI F, 1987, J AM COLL CARDIOL, V10, pB33, DOI 10.1016/S0735-1097(87)80426-6; SCHRODER R, 1986, NEW ENGL J MED, V314, P1465; SCHRODER R, 1983, CIRCULATION, V67, P536, DOI 10.1161/01.CIR.67.3.536; SCHULMAN S, 1984, THROMB HAEMOSTASIS, V51, P261; SCHWARZ F, 1984, AM J CARDIOL, V53, P1505, DOI 10.1016/0002-9149(84)90568-X; SHERRY S, 1987, AM J MED, V83, P31, DOI 10.1016/0002-9343(87)90885-0; SIMOONS ML, 1988, LANCET, V1, P199; SPANN JF, 1984, AM J CARDIOL, V53, P655; STACK RS, 1988, CIRCULATION, V77, P151, DOI 10.1161/01.CIR.77.1.151; TAYLOR GJ, 1984, AM J CARDIOL, V54, P256, DOI 10.1016/0002-9149(84)90177-2; THOMPSON PL, 1988, LANCET, V1, P203; TOPOL EJ, 1989, CIRCULATION, V79, P281, DOI 10.1161/01.CIR.79.2.281; TOPOL EJ, 1988, CIRCULATION, V77, P1100, DOI 10.1161/01.CIR.77.5.1100; TOPOL EJ, 1987, NEW ENGL J MED, V317, P581, DOI 10.1056/NEJM198709033171001; TOPOL EJ, 1987, J AM COLL CARDIOL, V9, P1205, DOI 10.1016/S0735-1097(87)80457-6; TOPOL EJ, 1987, J AM COLL CARDIOL, V10, P1173, DOI 10.1016/S0735-1097(87)80114-6; VANDEWERF F, 1989, LANCET, V1, P1367; VANDEWERF F, 1988, BMJ-BRIT MED J, V297, P1374, DOI 10.1136/bmj.297.6660.1374; VERSTRAETE M, 1987, AM J CARDIOL, V60, P231, DOI 10.1016/0002-9149(87)90219-0; VERSTRAETE M, 1985, LANCET, V1, P842, DOI 10.1016/S0140-6736(85)92208-1; VERSTRAETE M, 1985, LANCET, V2, P965; VOGT P, 1988, European Heart Journal, V9, P213; WHITE HD, 1987, NEW ENGL J MED, V317, P850, DOI 10.1056/NEJM198710013171402; WHITE HD, 1989, NEW ENGL J MED, V320, P817, DOI 10.1056/NEJM198903303201301; WILCOX RG, 1988, LANCET, V2, P525; WILLIAMS DO, 1986, CIRCULATION, V73, P338, DOI 10.1161/01.CIR.73.2.338; 1986, LANDET, V1, P397	70	121	125	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	1990	112	7					529	538		10.7326/0003-4819-112-7-529	http://dx.doi.org/10.7326/0003-4819-112-7-529			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW001	2107781				2022-12-28	WOS:A1990CW00100008
J	MILNE, RIG				MILNE, RIG			ASSESSMENT OF CARE OF CHILDREN WITH SICKLE-CELL DISEASE - IMPLICATIONS FOR NEONATAL SCREENING PROGRAMS	BRITISH MEDICAL JOURNAL			English	Article									UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,DEPT COMMUNITY MED,LONDON SE1 7EH,ENGLAND	University of London; King's College London				Milne, Ruairidh/0000-0002-5117-4380				Black Janet, 1986, LIVING SICKLE CELL D; BROZOVIC M, 1984, J CLIN PATHOL, V37, P1321, DOI 10.1136/jcp.37.12.1321; BUCHANAN GR, 1986, AM J DIS CHILD, V140, P428, DOI 10.1001/archpedi.1986.02140190038020; BUCHANAN GR, 1983, PEDIATRICS, V72, P93; BUCHANAN GR, 1982, PEDIATRICS, V20, P926; COCHRANE AL, 1971, BR MED B, V27, P1; FRANKLIN IM, 1988, BRIT MED J, V296, P592, DOI 10.1136/bmj.296.6622.592; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; GRIFFITHS PD, 1988, BRIT MED J, V296, P1583, DOI 10.1136/bmj.296.6636.1583; GROVER R, 1978, PEDIATRICS, V61, P740; HORN MEC, 1986, BRIT MED J, V292, P737, DOI 10.1136/bmj.292.6522.737; JOHN AB, 1984, BRIT MED J, V288, P1567, DOI 10.1136/bmj.288.6430.1567; OBRIEN RT, 1976, J PEDIATR-US, V89, P205, DOI 10.1016/S0022-3476(76)80449-0; POWARS D, 1987, AM J DIS CHILD, V141, P250, DOI 10.1001/archpedi.1987.04460030028017; ROWLEY PT, 1978, NEW YORK STATE J MED, V78, P42; ROWLEY PT, 1983, AM J DIS CHILD, V137, P341, DOI 10.1001/archpedi.1983.02140300023007; VICHINSKY E, 1988, PEDIATRICS, V81, P749; WARREN NS, 1982, J PEDIATR-US, V100, P373, DOI 10.1016/S0022-3476(82)80432-0; 1988, HAEMOGLOBINOPATHY CA, P11; 1986, LANCET, V2, P1432	20	11	12	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					371	374		10.1136/bmj.300.6721.371	http://dx.doi.org/10.1136/bmj.300.6721.371			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106991	Bronze, Green Published			2022-12-28	WOS:A1990CN79900024
J	RICHARDSON, SG; MORTON, P; MURTAGH, JG; OKEEFFE, DB; MURPHY, P; SCOTT, ME				RICHARDSON, SG; MORTON, P; MURTAGH, JG; OKEEFFE, DB; MURPHY, P; SCOTT, ME			MANAGEMENT OF ACUTE CORONARY-OCCLUSION DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - EXPERIENCE OF COMPLICATIONS IN A HOSPITAL WITHOUT ON SITE FACILITIES FOR CARDIAC-SURGERY	BRITISH MEDICAL JOURNAL			English	Article									BELFAST CITY HOSP,CARDIAC UNIT,BELFAST BT9 7AB,NORTH IRELAND	Belfast City Hospital								CALIFF RM, 1983, CIRCULATION, V67, P283, DOI 10.1161/01.CIR.67.2.283; DETRE K, 1988, NEW ENGL J MED, V318, P265, DOI 10.1056/NEJM198802043180501; MYERS WO, 1985, ANN THORAC SURG, V40, P245, DOI 10.1016/S0003-4975(10)60037-9; REEVES TJ, 1974, AM J CARDIOL, V33, P423, DOI 10.1016/0002-9149(74)90327-0; RYAN TJ, 1988, CIRCULATION, V78, P486, DOI 10.1161/01.CIR.78.2.486	5	45	45	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					355	358		10.1136/bmj.300.6721.355	http://dx.doi.org/10.1136/bmj.300.6721.355			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106983	Green Published, Bronze			2022-12-28	WOS:A1990CN79900016
J	LINDVALL, O; BRUNDIN, P; WIDNER, H; REHNCRONA, S; GUSTAVII, B; FRACKOWIAK, R; LEENDERS, KL; SAWLE, G; ROTHWELL, JC; MARSDEN, CD; BJORKLUND, A				LINDVALL, O; BRUNDIN, P; WIDNER, H; REHNCRONA, S; GUSTAVII, B; FRACKOWIAK, R; LEENDERS, KL; SAWLE, G; ROTHWELL, JC; MARSDEN, CD; BJORKLUND, A			GRAFTS OF FETAL DOPAMINE NEURONS SURVIVE AND IMPROVE MOTOR FUNCTION IN PARKINSONS-DISEASE	SCIENCE			English	Article									UNIV LONDON NATL HOSP, INST NEUROL, DEPT CLIN NEUROL, LONDON WC1N 3BG, ENGLAND; DEPT MED CELL RES, S-22362 LUND, SWEDEN; KAROLINSKA INST, HUDDINGE HOSP, DEPT CLIN IMMUNOL, S-14186 HUDDINGE, SWEDEN; UNIV LUND HOSP, DEPT GYNECOL, S-22185 LUND, SWEDEN; HAMMERSMITH HOSP, MRC, CYCLOTRON UNIT, LONDON W12 0HS, ENGLAND; PAUL SCHERRER INST, CH-5232 VILLIGEN, SWITZERLAND; NATL HOSP, MRC, HUMAN MOVEMENT & BALANCE UNIT, LONDON WC1N 3BG, ENGLAND; UNIV LUND HOSP, DEPT NEUROSURG, S-22185 LUND, SWEDEN	University of London; University College London; Karolinska Institutet; Lund University; Skane University Hospital; Imperial College London; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Lund University; Skane University Hospital	LINDVALL, O (corresponding author), UNIV LUND HOSP, DEPT NEUROL, S-22185 LUND, SWEDEN.		Frackowiak, Richard/H-4383-2011; Frackowiak, Richard S/I-1809-2013; Björklund, Anders/ABA-1326-2020	Frackowiak, Richard/0000-0002-3151-822X; Rothwell, John/0000-0003-1367-6467				BAKAY RAE, 1985, APPL NEUROPHYSIOL, V48, P358; BANKIEWICZ K S, 1988, Society for Neuroscience Abstracts, V14, P3; BENECKE R, 1986, BRAIN, V109, P739, DOI 10.1093/brain/109.4.739; BENECKE R, 1987, BRAIN, V110, P361, DOI 10.1093/brain/110.2.361; BJORKLUND A, 1980, BRAIN RES, V199, P307, DOI 10.1016/0006-8993(80)90692-7; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; BJORKLUND A, 1981, NATURE, V289, P497, DOI 10.1038/289497a0; BROADWELL RD, 1987, J COMP NEUROL, V260, P47, DOI 10.1002/cne.902600105; BROADWELL RD, 1989, EXP NEUROL, V105, P135, DOI 10.1016/0014-4886(89)90113-1; BRUNDIN P, 1986, EXP BRAIN RES, V65, P235; BRUNDIN P, 1988, EXP BRAIN RES, V70, P192; BRUNDIN P, 1985, BRAIN RES, V331, P251, DOI 10.1016/0006-8993(85)91550-1; BRUNDIN P, 1989, EXP BRAIN RES, V75, P195; BRUNDIN P, 1989, RSTOR NEUROL NEURO S, V1, P200; BRYNGER H, 1988, TRANSPLANT P, V20, P261; CLARKE DJ, 1988, EXP BRAIN RES, V73, P115, DOI 10.1007/BF00279666; DUNNETT SB, 1988, EXP BRAIN RES, V71, P411; DUSART I, 1989, DEV BRAIN RES, V48, P215, DOI 10.1016/0165-3806(89)90077-1; FINE A, 1988, PROG BRAIN RES, V78, P479; HITCHCOCK ER, 1988, LANCET, V1, P1274; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; LEENDERS KL, 1986, J NEUROL NEUROSUR PS, V49, P853, DOI 10.1136/jnnp.49.8.853; LEENDERS KL, 1989, J CEREB BLOOD FLOW M, V9, pS419; LINDVALL O, 1989, ARCH NEUROL-CHICAGO, V46, P615, DOI 10.1001/archneur.1989.00520420033021; LINDVALL O, 1987, ANN NEUROL, V22, P457, DOI 10.1002/ana.410220403; LINDVALL O, 1989, J NEUROL NEUROSUR PS, P39; LINDVALL O, 1988, LANCET, V2, P1483; MADRAZO I, 1988, NEW ENGL J MED, V318, P51; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; REDMOND DE, 1986, LANCET, V1, P1125; SLADEK JR, 1988, SCIENCE, V240, P1386, DOI 10.1126/science.3375820; SLADEK JR, 1986, BRAIN RES BULL, V17, P809, DOI 10.1016/0361-9230(86)90092-4; STROMBERG I, 1989, J NEUROSCI, V9, P614; STROMBERG I, 1988, P NATL ACAD SCI USA, V85, P8331, DOI 10.1073/pnas.85.21.8331	35	938	977	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	1990	247	4942					574	577		10.1126/science.2105529	http://dx.doi.org/10.1126/science.2105529			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM419	2105529				2022-12-28	WOS:A1990CM41900034
J	SIMPSON, IA; CAMM, AJ				SIMPSON, IA; CAMM, AJ			COLOR DOPPLER FLOW MAPPING	BRITISH MEDICAL JOURNAL			English	Editorial Material											SIMPSON, IA (corresponding author), ST GEORGE HOSP,SCH MED,DEPT CARDIOL SCI,LONDON SW17 0RE,ENGLAND.							CURRIE PJ, 1985, CIRCULATION, V71, P1162, DOI 10.1161/01.CIR.71.6.1162; DAVIDOFF R, 1987, J AM COLL CARDIOL, V9, pA110; HATLE L, 1978, BRIT HEART J, V40, P131; HATLE L, 1980, BRIT HEART J, V43, P284; HELMCKE F, 1987, CIRCULATION, V75, P175, DOI 10.1161/01.CIR.75.1.175; HORNBERGER LK, 1989, J AM COLL CARDIOL, V13, P1111, DOI 10.1016/0735-1097(89)90270-2; JONES M, 1989, J AM COLL CARDIOL, V13, P234, DOI 10.1016/0735-1097(89)90576-7; LIMA CO, 1983, CIRCULATION, V67, P866, DOI 10.1161/01.CIR.67.4.866; MIYATAKE K, 1986, J AM COLL CARDIOL, V7, P82, DOI 10.1016/S0735-1097(86)80263-7; MIYATAKE K, 1984, AM J CARDIOL, V54, P857, DOI 10.1016/S0002-9149(84)80222-2; OMOTO R, 1984, JPN HEART J, V25, P325; OTSUJI Y, 1987, AM HEART J, V114, P349, DOI 10.1016/0002-8703(87)90502-3; SAHN DJ, 1985, CIRCULATION, V71, P849, DOI 10.1161/01.CIR.71.5.849; SAHN DJ, 1988, CIRCULATION, V78, P1075, DOI 10.1161/01.CIR.78.4.1075; SIMPSON IA, 1985, BRIT HEART J, V53, P636; SIMPSON IA, 1989, J AM COLL CARDIOL, V13, P241, DOI 10.1016/0735-1097(89)90577-9; SIMPSON IA, 1989, J AM COLL CARDIOL, V13, P1195, DOI 10.1016/0735-1097(89)90284-2; SMITH MD, 1988, J AM COLL CARDIOL, V11, P579, DOI 10.1016/0735-1097(88)91534-3; SWITZER DF, 1987, CIRCULATION, V75, P837, DOI 10.1161/01.CIR.75.4.837	19	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	1990	300	6716					1	2		10.1136/bmj.300.6716.1	http://dx.doi.org/10.1136/bmj.300.6716.1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG773	2105112	Bronze, Green Published			2022-12-28	WOS:A1990CG77300001
J	DARST, SA; EDWARDS, AM; KUBALEK, EW; KORNBERG, RD				DARST, SA; EDWARDS, AM; KUBALEK, EW; KORNBERG, RD			3-DIMENSIONAL STRUCTURE OF YEAST RNA POLYMERASE-II AT 16-A RESOLUTION	CELL			English	Article							TWO-DIMENSIONAL CRYSTALS; ELECTRON-MICROSCOPY; LARGEST SUBUNIT; TRANSCRIPTION; DNA; HOLOENZYME; PROMOTER; INVITRO; VIEW; GENE	The structure of yeast RNA polymerase II has been determined by three-dimensional reconstruction from electron micrographs of two-dimensional crystals at approximately 16 angstrom resolution. The most prominent feature of the structure is an arm of protein density surrounding a channel about 25 angstrom in diameter, similar to that found previously for E. coli RNA polymerase. The 25 angstrom-diameter channel bifurcates on one face of the protein, connecting with a 25 angstrom-wide groove and with a channel about half as wide. The 25 angstrom channel and groove, and the narrow channel, may bind double- and single-stranded nucleic acids, respectively. A finger of protein density projecting from the molecule adjacent to the arm-like feature may represent the C-terminal domain of the largest subunit. These results provide a structural basis for analyses of the transcription process and its regulation.			DARST, SA (corresponding author), STANFORD UNIV,BECKMAN LABS STRUCT BIOL,DEPT CELL BIOL,STANFORD,CA 94305, USA.			Edwards, Aled/0000-0002-4782-6016	NIAID NIH HHS [AI21144] Funding Source: Medline; NIGMS NIH HHS [GM36659] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036659, R01GM036659] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGARD DA, 1983, J MOL BIOL, V167, P849, DOI 10.1016/S0022-2836(83)80114-4; AHEARN JM, 1987, J BIOL CHEM, V262, P10695; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; AMOS LA, 1983, PROG BIOPHYS MOL BIO, V39, P183, DOI 10.1016/0079-6107(83)90017-2; BERNHARD SL, 1986, BIOCHEMISTRY-US, V25, P6397, DOI 10.1021/bi00369a009; BIGGS J, 1985, CELL, V42, P611, DOI 10.1016/0092-8674(85)90118-7; CHUNG YJ, 1990, GENE REGULATION AIDS, P3; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; DARST SA, 1989, NATURE, V340, P730, DOI 10.1038/340730a0; DARST SA, 1988, J MOL BIOL, V203, P269, DOI 10.1016/0022-2836(88)90107-6; DARST SA, 1991, IN PRESS J MOL BIOL; DEZELEE S, 1976, EUR J BIOCHEM, V65, P543, DOI 10.1111/j.1432-1033.1976.tb10372.x; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; GOODSELL DS, 1989, J MOL GRAPHICS, V7, P41, DOI 10.1016/0263-7855(89)80055-4; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; HEUMANN H, 1988, EMBO J, V7, P4379, DOI 10.1002/j.1460-2075.1988.tb03336.x; KOLODZIEJ PA, 1990, MOL CELL BIOL, V10, P1915, DOI 10.1128/MCB.10.5.1915; KUHNKE G, 1987, EMBO J, V6, P507, DOI 10.1002/j.1460-2075.1987.tb04782.x; KUMAR S A, 1975, Journal of Biological Chemistry, V250, P2878; LAYBOURN PJ, 1990, J BIOL CHEM, V265, P13165; METZGER W, 1989, EMBO J, V8, P2745, DOI 10.1002/j.1460-2075.1989.tb08416.x; MONFORTE JA, 1990, BIOCHEMISTRY-US, V29, P7882, DOI 10.1021/bi00486a015; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; RUET A, 1980, J BIOL CHEM, V255, P6450; SCHULTZ P, 1990, J MOL BIOL, V216, P353, DOI 10.1016/S0022-2836(05)80326-2; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; TRAVERS AA, 1990, CELL, V60, P177, DOI 10.1016/0092-8674(90)90729-X; WOYCHIK NA, 1990, TRENDS BIOCHEM SCI, V15, P347, DOI 10.1016/0968-0004(90)90074-L; WOYCHIK NA, 1990, GENE DEV, V4, P313, DOI 10.1101/gad.4.3.313	30	144	144	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 12	1991	66	1					121	128		10.1016/0092-8674(91)90144-N	http://dx.doi.org/10.1016/0092-8674(91)90144-N			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FW913	2070414				2022-12-28	WOS:A1991FW91300014
J	ISSARTEL, JP; KORONAKIS, V; HUGHES, C				ISSARTEL, JP; KORONAKIS, V; HUGHES, C			ACTIVATION OF ESCHERICHIA-COLI PROHAEMOLYSIN TO THE MATURE TOXIN BY ACYL CARRIER PROTEIN-DEPENDENT FATTY ACYLATION	NATURE			English	Article							MULTIDRUG RESISTANCE; BACTERIAL TRANSPORT; HEMOLYSIN HLYA; GENE; SECRETION; BINDING; RECEPTOR	HAEMOLYSIN secreted by pathogenic Escherichia coli binds to mammalian cell membranes, disrupting cellular activities and lysing cells by pore-formation. It is synthesized as nontoxic prohaemolysin (proHlyA), which is activated intracellularly by a mechanism dependent on the cosynthesized HlyC. Haemolysin is one of a family of membrane-targeted toxins, including the leukotoxins of Pasteurella and Actinobacillus and the bifunctional adenylate cyclase haemolysin of Bordetella pertussis, which require this protoxin activation 1-5. HlyC alone cannot activate proHlyA, but requires a cytosolic activating factor 6. Here we report the cytosolic activating factor is identical to the acyl carrier protein and that activation to mature toxin is achieved by the transfer of a fatty acyl group from acyl carrier protein to proHlyA. Only acyl carrier protein, not acyl-CoA, can promote HlyC-directed proHlyA acylation, but a range of acyl groups are effective.			ISSARTEL, JP (corresponding author), UNIV CAMBRIDGE,DEPT PATHOL,TENNIS COURT RD,CAMBRIDGE CB2 1QP,ENGLAND.		ISSARTEL, Jean-Paul/B-8727-2014	Koronakis, Vassilis/0000-0002-1353-1092	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARRY EM, 1991, J BACTERIOL, V173, P720, DOI 10.1128/jb.173.2.720-726.1991; BOEHM DF, 1990, INFECT IMMUN, V58, P1959, DOI 10.1128/IAI.58.6.1959-1964.1990; CROSS GAM, 1987, CELL, V48, P179, DOI 10.1016/0092-8674(87)90419-3; DURONIO RJ, 1989, SCIENCE, V243, P796, DOI 10.1126/science.2644694; FORESTIER C, 1990, INFECT IMMUN, V58, P828, DOI 10.1128/IAI.58.3.828-832.1990; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; GYGI D, 1990, MOL MICROBIOL, V4, P123, DOI 10.1111/j.1365-2958.1990.tb02021.x; HARDIE KR, IN PRESS MOL MICROBI, V5; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; HEDO JA, 1987, J BIOL CHEM, V262, P954; HIGGINS C, 1989, NATURE, V340, P342, DOI 10.1038/340342a0; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; JACKOWSKI S, 1987, J BACTERIOL, V169, P1469, DOI 10.1128/jb.169.4.1469-1473.1987; KORONAKIS V, 1987, J BACTERIOL, V169, P1509, DOI 10.1128/jb.169.4.1509-1515.1987; LUDWIG A, 1988, MOL GEN GENET, V214, P553, DOI 10.1007/BF00330494; MAGEE AI, 1985, EMBO J, V4, P1137, DOI 10.1002/j.1460-2075.1985.tb03751.x; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; NICAUD JM, 1985, FEBS LETT, V187, P339, DOI 10.1016/0014-5793(85)81272-2; OLSON EN, 1984, J BIOL CHEM, V259, P5364; PELLETT S, 1990, INFECT IMMUN, V58, P822, DOI 10.1128/IAI.58.3.822-827.1990; PILLAI S, 1987, P NATL ACAD SCI USA, V84, P7654, DOI 10.1073/pnas.84.21.7654; ROCK CO, 1979, J BIOL CHEM, V254, P7123; SCHMIDT MFG, 1989, BIOCHIM BIOPHYS ACTA, V988, P411, DOI 10.1016/0304-4157(89)90013-0; THERISOD H, 1987, P NATL ACAD SCI USA, V84, P8235, DOI 10.1073/pnas.84.23.8235; VANAMAN TC, 1968, J BIOL CHEM, V243, P6420; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x	27	268	276	1	10	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 27	1991	351	6329					759	761		10.1038/351759a0	http://dx.doi.org/10.1038/351759a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU201	2062368				2022-12-28	WOS:A1991FU20100069
J	ZHONG, Y; WU, CF				ZHONG, Y; WU, CF			ALTERATION OF 4 IDENTIFIED K+ CURRENTS IN DROSOPHILA MUSCLE BY MUTATIONS IN EAG	SCIENCE			English	Article							POTASSIUM-CHANNEL PROTEINS; VOLTAGE-CLAMP ANALYSIS; SHAKER LOCUS; XENOPUS-OOCYTES; COMPONENTS; DIVERSITY; MUTANTS; CALCIUM; MELANOGASTER; FIBERS	Voltage-clamp analysis of Drosophila larval muscle revealed that ether a go-go (eag) mutations affected all identified potassium currents, including those specifically eliminated by mutations in the Shaker or slowpoke gene. Together with DNA sequence analysis, the results suggest that the eag locus encodes a subunit common to different potassium channels. Thus, combinatorial assembly of polypeptides from different genes may contribute to potassium channel diversity.	UNIV IOWA, DEPT BIOL, IOWA CITY, IA 52242 USA	University of Iowa				Zhong, Yi/0000-0002-7927-5976; Zhong, Yi/0000-0001-7810-9899; Wu, Chun-Fang/0000-0002-4973-2021				AIDLEY DJ, 1989, PHYSL EXCITABLE CELL, P289; COVARRUBIAS AM, 1990, SOC NEUR ABSTR, V16, P3; DRYSDALE R, 1991, GENETICS, V127, P497; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; GANETZKY B, 1986, ANNU REV GENET, V20, P13; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; GHO M, 1986, PFLUG ARCH EUR J PHY, V407, P526, DOI 10.1007/BF00657511; GORCZYCA MG, 1991, J MEMBRANE BIOL, V121, P237, DOI 10.1007/BF01951557; HAGIWARA S, 1981, ANNU REV NEUROSCI, V4, P69, DOI 10.1146/annurev.ne.04.030181.000441; HAUGLAND FN, 1990, J NEUROSCI, V10, P1357; HAUGLAND FN, 1987, SOC NEUR ABSTR, V13, P150; Hille B, 1984, IONIC CHANNELS EXCIT; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HUFFAKER TC, 1987, ANNU REV GENET, V21, P259; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; JAN LY, 1990, TRENDS NEUROSCI, V13, P415, DOI 10.1016/0166-2236(90)90123-R; JOHN AK, 1990, CELL, V62, P165; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KAPLAN WD, 1969, GENETICS, V61, P399; MCCORMACK K, 1990, BIOPHYS J, V57, pA209; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; SALKOFF L, 1981, NATURE, V293, P228, DOI 10.1038/293228a0; SALKOFF L, 1983, NATURE, V302, P249, DOI 10.1038/302249a0; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SINGH S, 1989, NEURON, V2, P1325, DOI 10.1016/0896-6273(89)90070-6; SOLC CK, 1987, SCIENCE, V236, P1094, DOI 10.1126/science.2437657; TANOUYE MA, 1986, ANNU REV NEUROSCI, V9, P255, DOI 10.1146/annurev.ne.09.030186.001351; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; WEI A, 1986, SCIENCE, V233, P780, DOI 10.1126/science.2426780; WU CF, 1985, J NEUROSCI, V5, P2626; WU CF, 1983, SCIENCE, V220, P1076, DOI 10.1126/science.6302847; WU CF, 1989, J EXP BIOL, V147, P21; WU CF, 1986, ION CHANNELS NEURAL, P407; ZHONG Y, UNPUB	38	116	118	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	1991	252	5012					1562	1564		10.1126/science.2047864	http://dx.doi.org/10.1126/science.2047864			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR040	2047864				2022-12-28	WOS:A1991FR04000052
J	HICKMAN, M; ALDOUS, J; PORTER, J; DURMAN, L				HICKMAN, M; ALDOUS, J; PORTER, J; DURMAN, L			HIV SURVEILLANCE - THE VALUE OF AUDIT	BRITISH MEDICAL JOURNAL			English	Article									PUBL HLTH LAB SERV,COMMUNICABLE DIS SURVEILLANCE CTR,LONDON NW9 5EQ,ENGLAND	Public Health England	HICKMAN, M (corresponding author), RIVERSIDE HLTH AUTHOR,DEPT PUBL HLTH,LONDON SW6 4UL,ENGLAND.		Hickman, Matthew/Y-2400-2019	Hickman, Matthew/0000-0001-9864-459X				BOBBY JJ, 1988, PUBLIC HEALTH, V102, P519, DOI 10.1016/S0033-3506(88)80020-9; DUFF C, 1988, BRIT MED J, V297, P965, DOI 10.1136/bmj.297.6654.965; GILL ON, 1989, BRIT MED J, V299, P1295, DOI 10.1136/bmj.299.6711.1295; MCCORMICK A, 1989, PHILOS T ROY SOC B, V325, P163, DOI 10.1098/rstb.1989.0081	4	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 8	1991	302	6789					1376	1377		10.1136/bmj.302.6789.1376	http://dx.doi.org/10.1136/bmj.302.6789.1376			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR057	2059717	Green Published, Bronze			2022-12-28	WOS:A1991FR05700021
J	PALCA, J				PALCA, J			TRIALS AND TRIBULATIONS OF AIDS DRUG-TESTING	SCIENCE			English	Editorial Material																		1989, SCIENCE, V245, P353; 1989, APR P NAT AC SCI, P2844; 1989, SCIENCE, V245, P412	3	8	10	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 23	1990	247	4949					1406	1406		10.1126/science.2108496	http://dx.doi.org/10.1126/science.2108496			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV282	2108496				2022-12-28	WOS:A1990CV28200014
J	CARNE, CA; DOCKERTY, G				CARNE, CA; DOCKERTY, G			LESSON OF THE WEEK - GENITAL WARTS - NEED TO SCREEN FOR COINFECTION	BRITISH MEDICAL JOURNAL			English	Editorial Material											CARNE, CA (corresponding author), ADDENBROOKES HOSP,DEPT GENITOURINARY MED,CAMBRIDGE CB2 2QQ,ENGLAND.							GRUBB GS, 1986, INT J EPIDEMIOL, V15, P1, DOI 10.1093/ije/15.1.1; KINGHORN GR, 1978, BRIT J DERMATOL, V99, P405, DOI 10.1111/j.1365-2133.1978.tb06178.x; MOORE DE, 1982, LANCET, V2, P574; ORIEL JD, 1971, BRIT J VENER DIS, V47, P1; 1989, NEW CASES GENITOURIN	5	16	17	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 17	1990	300	6722					459	459		10.1136/bmj.300.6722.459	http://dx.doi.org/10.1136/bmj.300.6722.459			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP166	2107904	Green Published, Bronze			2022-12-28	WOS:A1990CP16600032
J	FENTON, AC; FIELD, DJ; MASON, E; CLARKE, M				FENTON, AC; FIELD, DJ; MASON, E; CLARKE, M			ATTITUDES TO VIABILITY OF PRETERM INFANTS AND THEIR EFFECT ON FIGURES FOR PERINATAL-MORTALITY	BRITISH MEDICAL JOURNAL			English	Article									LEICESTER ROYAL INFIRM,DEPT CHILD HLTH,POB 65,LEICESTER LE2 7LX,ENGLAND; LEICESTER ROYAL INFIRM,DEPT COMMUNITY HLTH,LEICESTER LE2 7LX,ENGLAND	University of Leicester; University of Leicester								BRINDLE D, 1988, GUARDIAN        0714, P2; Field D J, 1988, Paediatr Perinat Epidemiol, V2, P213, DOI 10.1111/j.1365-3016.1988.tb00209.x; KEIRSE MJNC, 1984, LANCET, V1, P1166; 1977, INT CLASSIFICATION D, P765	4	60	61	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 17	1990	300	6722					434	436		10.1136/bmj.300.6722.434	http://dx.doi.org/10.1136/bmj.300.6722.434			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP166	2107894	Green Published, Bronze			2022-12-28	WOS:A1990CP16600019
J	GARDNER, MJ; HALL, AJ; SNEE, MP; DOWNES, S; POWELL, CA; TERRELL, JD				GARDNER, MJ; HALL, AJ; SNEE, MP; DOWNES, S; POWELL, CA; TERRELL, JD			METHODS AND BASIC DATA OF CASE-CONTROL STUDY OF LEUKEMIA AND LYMPHOMA AMONG YOUNG-PEOPLE NEAR SELLAFIELD NUCLEAR-PLANT IN WEST CUMBRIA	BRITISH MEDICAL JOURNAL			English	Article									W CUMBERLAND DIST GEN HOSP,W CUMBRIA HLTH AUTHOR,WHITEHAVEN CA28 8JG,CUMBRIA,ENGLAND		GARDNER, MJ (corresponding author), UNIV SOUTHAMPTON,SOUTHAMPTON GEN HOSP,MRC,ENVIRONM EPIDEMIOL UNIT,SOUTHAMPTON S09 4XY,ENGLAND.		Rohlf, F J/A-8710-2008					ADELSTEIN AM, 1972, BMJ-BRIT MED J, V4, P629, DOI 10.1136/bmj.4.5841.629; BLACK D, 1984, INVESTIGATION POSSIB; CRAFT AW, 1984, LANCET, V2, P96; DOLL R, 1989, J ROY STAT SOC A STA, V152, P341, DOI 10.2307/2983131; FEDRICK J, 1972, BRIT MED J, V2, P485, DOI 10.1136/bmj.2.5812.485; GARDNER MJ, 1984, LANCET, V1, P216; GARDNER MJ, 1987, BRIT MED J, V295, P819, DOI 10.1136/bmj.295.6602.819; GARDNER MJ, 1990, BRIT MED J, V300, P423, DOI 10.1136/bmj.300.6722.423; GARDNER MJ, 1987, BRIT MED J, V295, P822, DOI 10.1136/bmj.295.6602.822; HOPTON PA, 1985, LANCET, V2, P773; Knox E. G., 1987, J SOC RADIOL PROT, V7, P3; Monson R.R., 1984, RAD CARCINOGENESIS E, P97; OPENSHAW S, 1988, LANCET, V1, P272; SMITH PG, 1986, BRIT MED J, V293, P845, DOI 10.1136/bmj.293.6551.845; STEWART A, 1958, BRIT MED J, V1, P1495, DOI 10.1136/bmj.1.5086.1495; Swindell R., 1982, STUDIES MED POPULATI, V37; URQUHART J, 1984, LANCET, V1, P217; 1986, NRPBM136 NAT RAD PRO; 1966, CLASSIFICATION OCCUP; 1968, STANDARD IND CLASSIF	20	82	82	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 17	1990	300	6722					429	434		10.1136/bmj.300.6722.429	http://dx.doi.org/10.1136/bmj.300.6722.429			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP166	2107893	Bronze, Green Published			2022-12-28	WOS:A1990CP16600018
J	DIXON, B				DIXON, B			UNIFYING BIOLOGY	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1990	300	6719					253	253		10.1136/bmj.300.6719.253	http://dx.doi.org/10.1136/bmj.300.6719.253			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL024	2106940	Green Published, Bronze			2022-12-28	WOS:A1990CL02400033
J	FEELY, J; CHAN, R; COCOMAN, L; MULPETER, K; OCONNOR, P				FEELY, J; CHAN, R; COCOMAN, L; MULPETER, K; OCONNOR, P			HOSPITAL FORMULARIES - NEED FOR CONTINUOUS INTERVENTION	BRITISH MEDICAL JOURNAL			English	Article											FEELY, J (corresponding author), ST JAMES HOSP,TRINITY COLL,SCH MED,DEPT PHARMACOL & THERAPEUT,DUBLIN 8,IRELAND.							BAKER JA, 1988, BRIT MED J, V297, P465, DOI 10.1136/bmj.297.6646.465; COLLIER J, 1985, LANCET, V1, P331; CROOKS J, 1983, BRIT J CLIN PHARMACO, V16, P351, DOI 10.1111/j.1365-2125.1983.tb02177.x; FEELY J, 1987, IRISH MED J, V80, P286; FERRANO MC, 1986, J CLIN HOSPITAL PHAR, V2, P131; GEORGE CF, 1983, WORLD DEV, V2, P229; GREEN JA, 1986, AM J HOSP PHARM, V43, P2830, DOI 10.1093/ajhp/43.11.2830; PETRIE JC, 1987, BRIT MED J, V294, P919, DOI 10.1136/bmj.294.6577.919; PLUMRIDGE RJ, 1984, DRUG INTEL CLIN PHAR, V18, P652, DOI 10.1177/106002808401800732; SWALLOW RD, 1985, PHARM J, V235, P722; TURNER P, 1984, BRIT MED J, V288, P348, DOI 10.1136/bmj.288.6414.348; 1989, DRUG THER B, V27, P13; 1986, LANCET, V2, P1078; 1985, AM J HOSP PHARM, V42, P375	14	41	41	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	1990	300	6716					28	30		10.1136/bmj.300.6716.28	http://dx.doi.org/10.1136/bmj.300.6716.28			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG773	2105122	Green Published, Bronze			2022-12-28	WOS:A1990CG77300024
J	BELL, WR; BRAINE, HG; NESS, PM; KICKLER, TS				BELL, WR; BRAINE, HG; NESS, PM; KICKLER, TS			IMPROVED SURVIVAL IN THROMBOTIC THROMBOCYTOPENIC PURPURA HEMOLYTIC UREMIC SYNDROME - CLINICAL-EXPERIENCE IN 108 PATIENTS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAVENOUS GAMMA-GLOBULIN; VONWILLEBRAND-FACTOR MULTIMERS; IMMUNODEFICIENCY SYNDROME AIDS; ANTI-PLATELET AGENTS; PLASMA; AGGREGATION; THERAPY; PLASMAPHERESIS; PATHOGENESIS; TRANSFUSIONS	Background and Methods. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) is characterized by microangiopathic hemolytic anemia, thrombocytopenia, fever, central nervous system abnormalities, and renal dysfunction. In early reports the mortality approached 100 percent. A treatment protocol was introduced in 1979 for patients admitted to Johns Hopkins Hospital with the diagnosis of TTP-HUS. Treatment regimens included 200 mg of prednisone a day, for patients with minimal symptoms and no central nervous system symptoms, and prednisone plus plasma exchange, for patients with rapid clinical deterioration who did not improve after 48 hours of prednisone alone and for patients presenting with central nervous system symptoms and rapidly declining hematocrit values and platelet counts. Results. A total of 108 patients were treated, and 91 percent survived. Prednisone alone was judged to be effective in 30 patients with mild TTP-HUS (2 relapses and 2 deaths). Plasma exchange plus prednisone was given to 78 patients with complicated TTP-HUS, resulting in 67 relapses and 8 deaths. Relapses occurred in 22 of 36 patients given maintenance plasma infusions. Neither splenectomy nor treatment with aspirin and dipyridamole was effective in those with a poor response to plasma exchange. None of the 71 patients tested had positive cultures for O157:H7 Escherichia coli. Nine percent of the patients were pregnant, and none gave birth to infants with TTP-HUS. Conclusions. Effective treatment with 91 percent survival is available for patients with TTP-HUS.	JOHNS HOPKINS UNIV,SCH MED,CTR HEMAPHERESIS TREATMENT,DEPT ONCOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV HOSP,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	BELL, WR (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DIV HEMATOL,600 N WOLFE ST,BLALOCK 1036,BALTIMORE,MD 21205, USA.				NHLBI NIH HHS [HL 07525, HL 36260, HL 24898] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024898, T32HL007525, R01HL036260] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMOROSI EL, 1966, MEDICINE, V45, P139, DOI 10.1097/00005792-196603000-00003; ANSELL J, 1978, ANN INTERN MED, V89, P647, DOI 10.7326/0003-4819-89-5-647; ARMITAGE P, 1983, STATISTICAL METHODS, P99; ASTER RH, 1985, NEW ENGL J MED, V312, P985, DOI 10.1056/NEJM198504113121510; BOTTI AC, 1988, ANN INTERN MED, V109, P242, DOI 10.7326/0003-4819-109-3-242; Breckenridge R L Jr, 1982, J Clin Apher, V1, P6, DOI 10.1002/jca.2920010104; BUKOWSKI RM, 1981, SEMIN THROMB HEMOST, V7, P1, DOI 10.1055/s-2007-1005062; BUKOWSKI RM, 1976, SEMIN HEMATOL, V13, P219; BYRNES JJ, 1977, NEW ENGL J MED, V297, P1386, DOI 10.1056/NEJM197712222972507; BYRNES JJ, 1986, CLIN HAEMATOL, V15, P413; Caggiano V, 1983, J Clin Apher, V1, P71, DOI 10.1002/jca.2920010204; CHIN D, 1987, TRANSFUSION, V27, P115, DOI 10.1046/j.1537-2995.1987.27187121458.x; CUTTNER J, 1980, BLOOD, V56, P302; FELDMAN JD, 1966, LAB INVEST, V15, P927; FINN NG, 1987, ARCH INTERN MED, V147, P2165, DOI 10.1001/archinte.147.12.2165; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; GILCHER RO, 1984, BLOOD S, V64, pA237; GORDON LI, 1987, SEMIN HEMATOL, V24, P194; GUTTERMAN LA, 1990, BLOOD S1, V76, pA509; HARKNESS DR, 1981, JAMA-J AM MED ASSOC, V246, P1931, DOI 10.1001/jama.246.17.1931; HARRINGTON WJ, 1990, BLOOD S1, V76, pA487; HEYMAN MR, 1990, SOUTHERN MED J, V83, P1471, DOI 10.1097/00007611-199012000-00025; JOKELA J, 1987, AM J HEMATOL, V25, P341, DOI 10.1002/ajh.2830250315; JONEAU M, 1985, SCAND J HAEMATOL, V34, P157; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KATZ JA, 1989, BLOOD, V73, P1851; KELTON JG, 1987, BLOOD, V69, P924; Krishnamurthy M, 1985, BLOOD S, V66, p291a; LAMBERT SR, 1985, ARCH OPHTHALMOL-CHIC, V103, P1172; LEAF AN, 1988, ANN INTERN MED, V109, P194, DOI 10.7326/0003-4819-109-3-194; LIAN ECY, 1981, BLOOD, V58, P354; LIAN ECY, 1987, SEMIN HEMATOL, V24, P82; MEISENBERG BR, 1988, AM J HEMATOL, V27, P212, DOI 10.1002/ajh.2830270312; MESSMORE HL, 1985, THROMB HAEMOSTASIS, V54, P127; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; MOORE JC, 1990, BRIT J HAEMATOL, V74, P457, DOI 10.1111/j.1365-2141.1990.tb06335.x; Moschcowitz E., 1924, P NY PATHOL SOC, V24, P21; MURPHY EA, 1982, BIOSTATISTICS MED; MYERS TJ, 1981, SEMIN THROMB HEMOST, V7, P37, DOI 10.1055/s-2007-1005068; NAIR JMG, 1988, ANN INTERN MED, V109, P209, DOI 10.7326/0003-4819-109-3-209; RANIELE DP, 1990, INT SOC BLOOD TRANSF, V1, P90; REMUZZI G, 1987, KIDNEY INT, V32, P292, DOI 10.1038/ki.1987.206; REYNOLDS PM, 1976, AM J MED, V61, P439, DOI 10.1016/0002-9343(76)90385-5; RIDOLFI RL, 1981, MEDICINE, V60, P413, DOI 10.1097/00005792-198111000-00003; ROSE M, 1987, AM J MED, V83, P437, DOI 10.1016/0002-9343(87)90753-4; ROSOVE MH, 1982, ANN INTERN MED, V96, P27, DOI 10.7326/0003-4819-96-1-27; ROTHBERG H, 1982, AM J HEMATOL, V12, P281, DOI 10.1002/ajh.2830120311; RUBENSTEIN MICHAEL A., 1959, ANN INTERNAL MED, V51, P1409; SCHMIDT JL, 1989, MAYO CLIN PROC, V64, P956, DOI 10.1016/S0025-6196(12)61223-3; SEGAL GH, 1990, CLEV CLIN J MED, V57, P360, DOI 10.3949/ccjm.57.4.360; SIDDIQUI FA, 1988, BLOOD, V71, P299; SINGER K, 1954, ADV INTERNAL MED, V6, P195; VIERO P, 1986, ANN INTERN MED, V104, P282, DOI 10.7326/0003-4819-104-2-282_1; WONG P, 1986, NEW ENGL J MED, V314, P385	54	650	675	0	16	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 8	1991	325	6					398	403		10.1056/NEJM199108083250605	http://dx.doi.org/10.1056/NEJM199108083250605			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ804	2062331				2022-12-28	WOS:A1991FZ80400005
J	AYANIAN, JZ; EPSTEIN, AM				AYANIAN, JZ; EPSTEIN, AM			DIFFERENCES IN THE USE OF PROCEDURES BETWEEN WOMEN AND MEN HOSPITALIZED FOR CORONARY HEART-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ARTERY BYPASS-SURGERY; LONG-TERM; SEX-DIFFERENCES; UNITED-STATES; MORTALITY; SURVIVAL; GENDER; CASS; TRANSPLANTATION	Background and Methods. Previous studies at individual hospitals have reported differences in the use of major diagnostic and therapeutic procedures for women and men with coronary heart disease. To assess whether these differences can be generalized, we performed retrospective analyses of coronary angiography and revascularization (coronary-artery bypass surgery or percutaneous transluminal coronary angioplasty) in women and men hospitalized for coronary heart disease in 1987, using abstract data on 49,623 discharges in Massachusetts and 33,159 discharges in Maryland. We used multiple logistic regression to estimate the adjusted odds of the use of a procedure, controlling for principal diagnosis, age, secondary diagnosis of congestive heart failure or diabetes mellitus, race, and insurance status. Results. The adjusted odds of undergoing angiography were 28 percent and 15 percent higher for men than for women in Massachusetts and Maryland, respectively (95 percent confidence intervals for the odds ratios, 1.22 to 1.35 and 1.08 to 1.22). The respective adjusted odds of undergoing revascularization were 45 percent and 27 percent higher for men than for women (95 percent confidence intervals, 1.35 to 1.55 and 1.16 to 1.40). Because these differences could be related to differing thresholds for hospital admission, we performed a second analysis limited to patients with diagnosed acute myocardial infarction (11,865 discharges in Massachusetts and 6894 discharges in Maryland), a group in which all patients would be expected to receive hospital care. The male-to-female odds ratios in both states remained similar in magnitude and were statistically significant for angiography and revascularization. Conclusions. These findings demonstrate that women who are hospitalized for coronary heart disease undergo fewer major diagnostic and therapeutic procedures than men. These differences may represent appropriate levels of care for men and women, but it is also possible that they reflect underuse in women or overuse in men. Further study should assess the cause of these differences and their effect on patients' outcomes.	HARVARD UNIV,SCH MED,DEPT HLTH CARE POLICY,25 SHATTUCK ST,PARCEL B,1ST FLOOR,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,DIV GEN MED,HLTH SERV & POLICY RES SECT,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT HLTH POLICY & MANAGEMENT,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health					AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P01HS006341] Funding Source: NIH RePORTER; AHRQ HHS [1 PO1 HS 06341] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ADLER DS, 1986, AM J CARDIOL, V58, P195, DOI 10.1016/0002-9149(86)90046-9; BROGAN D, 1988, NEW ENGL J MED, V319, P55; BROOK RH, 1990, NEW ENGL J MED, V323, P1173, DOI 10.1056/NEJM199010253231705; CHAITMAN BR, 1981, CIRCULATION, V64, P360, DOI 10.1161/01.CIR.64.2.360; CHIRIKOS TN, 1984, WOMEN HEALTH, V9, P55, DOI 10.1300/J013v09n01_05; CHRISTAKIS GT, 1989, CIRCULATION, V80, P151; COWLEY MJ, 1985, CIRCULATION, V71, P90, DOI 10.1161/01.CIR.71.1.90; DITTRICH H, 1988, AM J CARDIOL, V62, P1, DOI 10.1016/0002-9149(88)91356-2; DOUGLAS JS, 1981, CIRCULATION, V64, P11; EAKER ED, 1989, AM HEART J, V117, P71, DOI 10.1016/0002-8703(89)90658-3; ELVEBACK LR, 1986, MAYO CLIN PROC, V61, P896, DOI 10.1016/S0025-6196(12)62612-3; FIEBACH NH, 1990, JAMA-J AM MED ASSOC, V263, P1092, DOI 10.1001/jama.263.8.1092; FISHER LD, 1982, J THORAC CARDIOV SUR, V84, P334; GARDNER TJ, 1985, ANN SURG, V201, P780, DOI 10.1097/00000658-198506000-00016; GILLUM RF, 1987, AM HEART J, V113, P1255, DOI 10.1016/0002-8703(87)90952-5; GREENLAND P, 1991, CIRCULATION, V83, P484, DOI 10.1161/01.CIR.83.2.484; HELD PJ, 1988, ARCH INTERN MED, V148, P2594, DOI 10.1001/archinte.148.12.2594; HLATKY MA, 1988, AM J CARDIOL, V61, P515, DOI 10.1016/0002-9149(88)90756-4; IEZZONI LI, 1988, ANN INTERN MED, V109, P745, DOI 10.7326/0003-4819-109-9-745; JOHANSSON S, 1984, EUR HEART J, V5, P374, DOI 10.1093/oxfordjournals.eurheartj.a061671; KANNEL WB, 1990, HEART ARTERIES VEINS, P627; KENNEDY RH, 1982, NEW ENGL J MED, V307, P986, DOI 10.1056/NEJM198210143071605; KHAN SS, 1990, ANN INTERN MED, V112, P561, DOI 10.7326/0003-4819-112-8-561; KJELLSTRAND CM, 1987, NEPHRON, V45, P257, DOI 10.1159/000184160; KJELLSTRAND CM, 1988, ARCH INTERN MED, V148, P1305; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; LOOP FD, 1983, J AM COLL CARDIOL, V1, P383, DOI 10.1016/S0735-1097(83)80064-3; PRYOR DB, 1983, ANN INTERN MED, V99, P528, DOI 10.7326/0003-4819-99-4-528; TOBIN JN, 1987, ANN INTERN MED, V107, P19, DOI 10.7326/0003-4819-107-1-19; TOFLER GH, 1987, J AM COLL CARDIOL, V9, P473, DOI 10.1016/S0735-1097(87)80038-4; WENGER NK, 1990, ANN INTERN MED, V112, P557, DOI 10.7326/0003-4819-112-8-557	31	942	952	0	18	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	1991	325	4					221	225		10.1056/NEJM199107253250401	http://dx.doi.org/10.1056/NEJM199107253250401			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX627	2057022				2022-12-28	WOS:A1991FX62700001
J	BLUMENTHAL, D				BLUMENTHAL, D			THE TIMING AND COURSE OF HEALTH-CARE REFORM	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INSURANCE				BLUMENTHAL, D (corresponding author), BRIGHAM & WOMENS HOSP,BOSTON,MA 02115, USA.							BLENDON RJ, 1990, NEW ENGL J MED, V323, P208, DOI 10.1056/NEJM199007193230329; BLUMENTHAL D, 1989, NEW ENGL J MED, V321, P908, DOI 10.1056/NEJM198909283211324; BLUMENTHAL D, 1988, RENEWING PROMISE MED, P3; BRANDON RM, 1990, PREMIUMS BENEFITS WA; FREUDENHEIM M, 1991, NW TIMES, pD1; FUCHS VR, 1990, SCIENCE, V247, P534, DOI 10.1126/science.2300814; GABEL J, 1990, HEALTH AFFAIR, V9, P161, DOI 10.1377/hlthaff.9.3.161; GINZBERG E, 1990, NEW ENGL J MED, V322, P1464, DOI 10.1056/NEJM199005173222012; HADLEY J, 1991, JAMA-J AM MED ASSOC, V265, P374, DOI 10.1001/jama.265.3.374; LEVIT KR, 1990, HEALTH AFFAIR, V9, P171, DOI 10.1377/hlthaff.9.2.171; LUNDBERG GD, 1991, JAMA-J AM MED ASSOC, V265, P2566; MOYER ME, 1989, HEALTH AFFAIR, V8, P102, DOI 10.1377/hlthaff.8.2.102; PEAR R, 1991, NY TIMES        0113, P19; ROCKEFELLER JD, 1990, NEW ENGL J MED, V323, P1005, DOI 10.1056/NEJM199010043231429; WEISSMAN J, 1989, JAMA-J AM MED ASSOC, V261, P3572, DOI 10.1001/jama.261.24.3572; WOOLHANDLER S, 1991, NEW ENGL J MED, V324, P1253, DOI 10.1056/NEJM199105023241805; 1991, NY TIMES        0526; 1991, NY TIMES        0131, pA22; 1990, HLTH CARE FINANAC RE, V1, P1; 1991, HLTH POLICY WEEK, P3; 1990, SOURCE BOOK HLTH INS; 1991, NY TIMES A      0527, P18	22	6	6	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	1991	325	3					198	200		10.1056/NEJM199107183250309	http://dx.doi.org/10.1056/NEJM199107183250309			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW752	2052063				2022-12-28	WOS:A1991FW75200009
J	SECKLER, AB; MEIER, DE; MULVIHILL, M; PARIS, BEC				SECKLER, AB; MEIER, DE; MULVIHILL, M; PARIS, BEC			SUBSTITUTED JUDGMENT - HOW ACCURATE ARE PROXY PREDICTIONS	ANNALS OF INTERNAL MEDICINE			English	Article							ELDERLY OUTPATIENTS; CARDIOPULMONARY RESUSCITATION; ALZHEIMERS-DISEASE; CARE; PREFERENCES; PHYSICIANS; OLDER; POPULATION; DECISIONS; RESIDENTS	Substituted judgment has been proposed as a method of promoting the autonomy of the mentally incapacitated patient, but little is known about the accuracy of surrogate decision makers in reflecting the true wishes of patients. In this study, surrogate decision makers' views (those of primary care providers and close family members) were compared with the decisions of currently competent chronically ill elderly patients, using a hypothetic cardiopulmonary resuscitation scenario under circumstances of current health and progressive dementia. Concordance between patients and their surrogates was evaluated by assessing percent agreement, kappa coefficient (for concordance beyond chance), and directionality of discrepant responses. Most patient respondents chose to be resuscitated in both scenarios. Although patients predicted that both their physicians (90%) and family members (87%) would accurately represent their wishes, neither family members nor physicians, in fact, were able to adequately predict patients' wishes in both scenarios (kappa less-than-or-equal-to 0.3 in all scenarios; percent agreement range, 59% to 88%). Few patients had ever discussed their resuscitation preferences with either their family member (16%) or their physician (7%). These results cast doubt on the usefulness of a strict substituted judgment standard as an approach to medical decision making for patients with diminished mental capacity.	CUNY MT SINAI SCH MED, NEW YORK, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK007420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG000358] Funding Source: NIH RePORTER; NIA NIH HHS [K08AG00358] Funding Source: Medline; NIDDK NIH HHS [T35 DK07420-10] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANNAS GJ, 1990, NEW ENGL J MED, V323, P670, DOI 10.1056/NEJM199009063231010; BEDELL SE, 1984, NEW ENGL J MED, V310, P1089, DOI 10.1056/NEJM198404263101706; CASSEL CK, 1990, GERIATRIC MED, P16; DANIS M, 1988, JAMA-J AM MED ASSOC, V260, P797, DOI 10.1001/jama.260.6.797; DIAMOND EL, 1989, GERONTOLOGIST, V29, P622, DOI 10.1093/geront/29.5.622; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; FINUCANE TE, 1988, J GEN INTERN MED, V3, P322, DOI 10.1007/BF02595788; FITTEN LJ, 1990, J AM GERIATR SOC, V38, P1097, DOI 10.1111/j.1532-5415.1990.tb01372.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GREENE MG, 1989, GERONTOLOGIST, V29, P808, DOI 10.1093/geront/29.6.808; HENDERSON M, 1990, GERONTOLOGIST, V30, P480, DOI 10.1093/geront/30.4.480; HIGH DM, 1988, GERONTOLOGIST, V28, P46, DOI 10.1093/geront/28.Suppl.46; KOHN M, 1988, J AM GERIATR SOC, V36, P840, DOI 10.1111/j.1532-5415.1988.tb04270.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lewin Tamar, 1990, N Y Times Web, pA15; OUSLANDER JG, 1989, ARCH INTERN MED, V149, P1367, DOI 10.1001/archinte.149.6.1367; SCHOENBERG BS, 1987, ANN NEUROL, V22, P724, DOI 10.1002/ana.410220608; SHMERLING RH, 1988, J GEN INTERN MED, V3, P317, DOI 10.1007/BF02595786; STOLMAN CJ, 1990, ARCH INTERN MED, V150, P653, DOI 10.1001/archinte.150.3.653; TOMLINSON T, 1990, GERONTOLOGIST, V30, P54, DOI 10.1093/geront/30.1.54; UHLMANN RF, 1991, ARCH INTERN MED, V151, P495, DOI 10.1001/archinte.151.3.495; UHLMANN RF, 1988, J GERONTOL, V43, pM115, DOI 10.1093/geronj/43.5.M115; UHLMANN RF, 1989, WESTERN J MED, V150, P705; WIKLER D, 1988, J AM GERIATR SOC, V36, P951, DOI 10.1111/j.1532-5415.1988.tb05790.x; ZWEIBEL NR, 1989, GERONTOLOGIST, V29, P615, DOI 10.1093/geront/29.5.615; 1982, MAKING HLTH CRE DECI, V1; 1983, DECIDING FOREGO LIFE, P132	27	426	426	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	1991	115	2					92	98		10.7326/0003-4819-115-2-92	http://dx.doi.org/10.7326/0003-4819-115-2-92			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW091	2058868				2022-12-28	WOS:A1991FW09100003
J	CHOSSON, P; LANAU, C; CONNAN, J; DESSORT, D				CHOSSON, P; LANAU, C; CONNAN, J; DESSORT, D			BIODEGRADATION OF REFRACTORY HYDROCARBON BIOMARKERS FROM PETROLEUM UNDER LABORATORY CONDITIONS	NATURE			English	Article							CRUDE OILS; STERANES; SEDIMENTS; TERPANES	BIOMARKERS are of great value in petroleum exploration because they provide essential information about the geological history of oils and source rocks. Steranes 1 are of particular importance as they can be related to naturally occurring precursors 2, 3. These compounds generally experience intense biodegradation, however, which alters their original distribution 4-6 and obscures the information that they carry regarding oil maturity and source material. In an attempt to identify the microorganisms responsible for this degradation, we have investigated the capacity of 73 aerobic bacteria to degrade steranes present in Rozel Point (Utah) oil 7. Seven Gram-positive strains, belonging to a limited number of genera, were found to be active. Using Nocardia sp. SEBR 16, which caused the most extensive alteration, we have determined biodegradation rates for several isomers of steranes and methylsteranes. The preference for alteration of different isomers reflects that observed in natural environments, suggesting that the degradation intermediates could be used as indicators of the extent of the biodegradation in an oil. In addition, the microorganisms used here might be effective in biodegrading oil spills.	ELF AQUITAINE,CSTJF,F-64018 PAU,FRANCE	Total SA; Centre Scientifique et Technique Jean Feger (CSTJF)	CHOSSON, P (corresponding author), SANOFI ELF BIORECH,BP 137,F-31328 LABEGE,FRANCE.							BORTZ LC, 1987, AAPG STUDIES GEOLOGY, P555; DASTILLUNG M, 1977, NATURE, V269, P678, DOI 10.1038/269678b0; ENSMINGER A, 1978, TETRAHEDRON LETT, P1575; GOODWIN NS, 1988, ORG GEOCHEM, V12, P495, DOI 10.1016/0146-6380(88)90159-3; Goodwin NS, 1983, ADV ORG GEOCHEM, P650; Landais P., 1986, SCI GEOL B, V39, P293; Mackenzie AS, 1984, ADV PETROLEUM GEOCHE, P115, DOI DOI 10.1016/B978-0-12-032001-1.50008-0; McKirdy D.M., 1983, ADV ORG GEOCHEM, P99; OCONNOR JG, 1962, ANAL CHEM, V34, P82, DOI 10.1021/ac60181a022; RULKOTER J, 1982, GOECHIM COSMOCHIM AC, V46, P1545; SEIFERT WK, 1979, GEOCHIM COSMOCHIM AC, V43, P111, DOI 10.1016/0016-7037(79)90051-6; SEIFERT WK, 1978, GEOCHIM COSMOCHIM AC, V42, P77, DOI 10.1016/0016-7037(78)90219-3; SUMMONS RE, 1987, GEOCHIM COSMOCHIM AC, V51, P3075, DOI 10.1016/0016-7037(87)90381-4; VOLKMAN JK, 1983, GEOCHIM COSMOCHIM AC, V47, P785, DOI 10.1016/0016-7037(83)90112-6; [No title captured]	15	58	62	0	16	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 20	1991	351	6328					640	642		10.1038/351640a0	http://dx.doi.org/10.1038/351640a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT112	2052089				2022-12-28	WOS:A1991FT11200061
J	SCHLAGGAR, BL; OLEARY, DDM				SCHLAGGAR, BL; OLEARY, DDM			POTENTIAL OF VISUAL-CORTEX TO DEVELOP AN ARRAY OF FUNCTIONAL UNITS UNIQUE TO SOMATOSENSORY CORTEX	SCIENCE			English	Article							EARLY POSTNATAL MOUSE; FETAL CORTICAL TRANSPLANTS; CEREBRAL-CORTEX; BARREL-FIELD; NEONATAL RAT; NEWBORN RATS; NEURONS; CONNECTIONS; PROJECTIONS; AXONS	The identification of specialized areas in the mammalian neocortex, such as the primary visual or somatosensory cortex, is based on distinctions in architectural and functional features. The extent to which certain features that distinguish neocortical areas in rats are prespecified or emerge as a result of epigenetic interactions was investigated. Late embryonic visual cortex transplanted to neonatal somatosensory cortex was later assayed for "barrels," anatomically identified functional units unique to somatosensory cortex, and for boundaries of glycoconjugated molecules associated with barrels. Barrels and boundaries form in transplanted visual cortex and are organized in an array that resembles the pattern in the normal barrelfield. These findings show that different regions of the developing neocortex have similar potentials to differentiate features that distinguish neocortical areas and contribute to their unique functional organizations.	SALK INST BIOL STUDIES,MOLEC NEUROBIOL LAB,LA JOLLA,CA 92037	Salk Institute			Schlaggar, Bradley/AAZ-4153-2020		NEI NIH HHS [R01 EY07025] Funding Source: Medline; NINDS NIH HHS [P01 NS17763] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS017763] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRES FL, 1985, DEV BRAIN RES, V20, P115, DOI 10.1016/0165-3806(85)90093-8; BRODMANN K, 1909, LOKCALISATIONSLEHRE; CASTRO AJ, 1987, EXP BRAIN RES, V66, P533, DOI 10.1007/BF00270686; CHANG FLF, 1984, DEV BRAIN RES, V13, P164, DOI 10.1016/0165-3806(84)90088-9; CHANG FLF, 1986, J COMP NEUROL, V244, P401, DOI 10.1002/cne.902440311; COOPER NGF, 1989, BRAIN RES, V489, P167, DOI 10.1016/0006-8993(89)90020-6; COOPER NGF, 1986, J COMP NEUROL, V249, P157, DOI 10.1002/cne.902490204; COOPER NGF, 1986, BRAIN RES, V380, P341, DOI 10.1016/0006-8993(86)90232-5; COWAN WM, 1972, BRAIN RES, V37, P21, DOI 10.1016/0006-8993(72)90344-7; CROSSIN KL, 1989, DEV BIOL, V136, P381, DOI 10.1016/0012-1606(89)90264-9; DAWSON DR, 1987, J COMP NEUROL, V256, P246, DOI 10.1002/cne.902560205; ERZURUMLU RS, 1990, DEV BRAIN RES, V56, P229; FLOETER MK, 1985, DEV BRAIN RES, V22, P19, DOI 10.1016/0165-3806(85)90065-3; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; HARRIS RM, 1981, J COMP NEUROL, V196, P357, DOI 10.1002/cne.901960302; HUTCHINS JB, 1990, J COMP NEUROL, V298, P113, DOI 10.1002/cne.902980109; HUTTON JC, 1984, PHILOS T R SOC LONDO, V304, P255; INNOCENTI GM, 1981, SCIENCE, V212, P824, DOI 10.1126/science.7221566; IVY GO, 1982, J NEUROSCI, V2, P735; JAEGER CB, 1981, EXP BRAIN RES, V40, P265; JEANMONOD D, 1981, NEUROSCIENCE, V6, P1503, DOI 10.1016/0306-4522(81)90222-0; Kaas J. H., 1986, HIGHER BRAIN FUNCTIO, P347; Killackey H P, 1990, J Cogn Neurosci, V2, P1, DOI 10.1162/jocn.1990.2.1.1; KILLACKEY HP, 1979, J COMP NEUROL, V183, P285, DOI 10.1002/cne.901830206; KOSTOVIC I, 1984, J NEUROSCI, V4, P25; KRIEG WJS, 1946, J COMP NEUROL, V84, P221, DOI 10.1002/cne.900840205; KRISTT DA, 1979, J COMP NEUROL, V186, P1, DOI 10.1002/cne.901860102; KRISTT DA, 1989, NEUROSCIENCE, V29, P27, DOI 10.1016/0306-4522(89)90330-8; KULJIS RO, 1990, P NATL ACAD SCI USA, V87, P5503; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; LUND RD, 1977, J COMP NEUROL, V173, P289, DOI 10.1002/cne.901730206; MCCANDLISH C, 1989, EXP BRAIN RES, V77, P425, DOI 10.1007/BF00275001; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MCCONNELL SK, 1989, TRENDS NEUROSCI, V12, P342, DOI 10.1016/0166-2236(89)90041-6; METIN C, 1989, P NATL ACAD SCI USA, V86, P357, DOI 10.1073/pnas.86.1.357; O'LEARY D D M, 1988, Society for Neuroscience Abstracts, V14, P1113; OLAND LA, 1990, J NEUROSCI, V10, P2096; OLEARY DDM, 1989, J NEUROSCI, V9, P2230; OLEARY DDM, 1981, DEV BRAIN RES, V1, P607, DOI 10.1016/0165-3806(81)90012-2; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; PEINADO A, 1990, Society for Neuroscience Abstracts, V16, P1127; PEINADO A, 1989, Society for Neuroscience Abstracts, V15, P960; PURVES D, 1990, P NATL ACAD SCI USA, V87, P5764, DOI 10.1073/pnas.87.15.5764; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; REINOSO B S, 1990, Society for Neuroscience Abstracts, V16, P493; REINOSO B S, 1988, Society for Neuroscience Abstracts, V14, P1113; ROBERTSON RT, 1987, NEUROSCI LETT, V75, P259, DOI 10.1016/0304-3940(87)90531-3; ROBERTSON RT, 1991, DEV BRAIN RES, V58, P81, DOI 10.1016/0165-3806(91)90240-J; ROBERTSON RT, 1988, DEV BRAIN RES, V41, P1, DOI 10.1016/0165-3806(88)90165-4; SCHLAGGAR B L, 1988, Society for Neuroscience Abstracts, V14, P475; SCHLAGGAR B L, 1989, Society for Neuroscience Abstracts, V15, P1050; SCHLAGGAR BL, UNPUC; STANFIELD BB, 1985, NATURE, V313, P135, DOI 10.1038/313135a0; STANFIELD BB, 1982, NATURE, V298, P371, DOI 10.1038/298371a0; STEINDLER DA, 1989, DEV BIOL, V131, P243, DOI 10.1016/S0012-1606(89)80056-9; STEINDLER DA, 1990, EXP NEUROL, V109, P35, DOI 10.1016/S0014-4886(05)80007-X; STEINDLER DA, 1989, COMMENTS DEV NEUROBI, V1, P29; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; THONG IG, 1986, DEV BRAIN RES, V25, P227, DOI 10.1016/0165-3806(86)90212-9; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; VANESSEN DC, 1985, CEREBRAL CORTEX, V3, P289; WELKER E, 1986, J NEUROSCI, V6, P3355; WISE SP, 1978, J COMP NEUROL, V178, P187, DOI 10.1002/cne.901780202; Woolsey T.A., 1990, P461; WOOLSEY TA, 1976, J COMP NEUROL, V170, P53, DOI 10.1002/cne.901700105; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; ZHOU HF, 1990, J COMP NEUROL, V292, P320, DOI 10.1002/cne.902920213	67	240	245	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1991	252	5012					1556	1560		10.1126/science.2047863	http://dx.doi.org/10.1126/science.2047863			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR040	2047863				2022-12-28	WOS:A1991FR04000050
J	CHAMBERLAIN, G				CHAMBERLAIN, G			ABC OF ANTENATAL CARE - ABDOMINAL-PAIN IN PREGNANCY	BRITISH MEDICAL JOURNAL			English	Article											CHAMBERLAIN, G (corresponding author), ST GEORGE HOSP,SCH MED,DEPT OBSTET & GYNECOL,LONDON,ENGLAND.								0	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 8	1991	302	6789					1390	1394		10.1136/bmj.302.6789.1390	http://dx.doi.org/10.1136/bmj.302.6789.1390			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR057	2059722	Bronze, Green Published			2022-12-28	WOS:A1991FR05700029
J	VANNOORDZAADSTRA, BM; LOOMAN, CWN; ALSBACH, H; HABBEMA, JDF; VELDE, ERT; KARBAAT, J				VANNOORDZAADSTRA, BM; LOOMAN, CWN; ALSBACH, H; HABBEMA, JDF; VELDE, ERT; KARBAAT, J			DELAYING CHILDBEARING - EFFECT OF AGE ON FECUNDITY AND OUTCOME OF PREGNANCY	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FERTILITY; INSEMINATION	Objectives - To study the age of the start of the fall (critical age) in fecundity; the probability of a pregnancy leading to a healthy baby taking into account the age of the woman; and, combining these results, to determine the age dependent probability of getting a healthy baby. Design - Cohort study of all women who had entered a donor insemination programme. Setting - Two fertility clinics serving a large part of The Netherlands. Subjects - Of 1637 women attending for artificial insemination 751 fulfilled the selection criteria, being married to an azoospermic husband and nulliparous and never having received donor insemination before. Main outcome measures - The number of cycles before pregnancy (a positive pregnancy test result) or stopping treatment; and result of the pregnancy (successful outcome). Results - Of the 751 women, 555 became pregnant and 461 had healthy babies. The fall in fecundity was estimated to start at around 31 years (critical age); after 12 cycles the probability of pregnancy in a woman aged > 31 was 0.54 compared with 0.74 in a woman aged 20-31. After 24 cycles this difference had decreased (probability of conception 0.75 in women > 31 and 0.85 in women 20-31). The probability of having a healthy baby also decreased-by 3.5% a year after the age of 30. Combining both these age effects, the chance of a woman aged 35 having a healthy baby was about half that of a woman aged 25. Conclusion - After the age of 31 the probability of conception fall rapidly, but this can be partly compensated for by continuing insemination for more cycles. In addition, the probability of an adverse pregnancy outcome starts to increase at about the same age.	ERASMUS UNIV, SCH MED, DEPT PUBL HLTH & SOCIAL MED, 3000 DR ROTTERDAM, NETHERLANDS; STATE UNIV UTRECHT HOSP, DEPT OBSTET & GYNAECOL, 3511 GV UTRECHT, NETHERLANDS; CRYO BIOL LABS, BARENDRECHT, NETHERLANDS	Erasmus University Rotterdam; Utrecht University; Utrecht University Medical Center	VANNOORDZAADSTRA, BM (corresponding author), DIV CHILD HLTH, POB 124, 2300 AC LEIDEN, NETHERLANDS.							AITKIN M, 1989, STATISTICAL MODELLIN; BERKOWITZ GS, 1990, NEW ENGL J MED, V322, P659, DOI 10.1056/NEJM199003083221004; BONGAARTS J, 1982, FAM PLANN PERSPECT, V14, P75, DOI 10.2307/2134817; COX DR, 1972, J R STAT SOC B, V34, P187; EMPERAIRE JC, 1982, FERTIL STERIL, V37, P90; HARRISON KL, 1989, AUST NZ J OBSTET GYN, V29, P326, DOI 10.1111/j.1479-828X.1989.tb01755.x; HARTZ SC, 1991, FERTIL STERIL, V55, P14; HOWE G, 1985, BRIT MED J, V290, P1697, DOI 10.1136/bmj.290.6483.1697; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LAMB EJ, 1989, AM J OBSTET GYNECOL, V160, P1470, DOI 10.1016/0002-9378(89)90872-7; MENKEN J, 1986, SCIENCE, V233, P1389, DOI 10.1126/science.3755843; SAUER MV, 1990, NEW ENGL J MED, V323, P1157, DOI 10.1056/NEJM199010253231702; SCHWARTZ D, 1982, NEW ENGL J MED, V306, P404, DOI 10.1056/NEJM198202183060706; SPIRA A, 1988, MATURITAS, P15; STEIN ZA, 1985, AM J EPIDEMIOL, V121, P327, DOI 10.1093/oxfordjournals.aje.a114004; van Noord-Zaadstra B M, 1989, Paediatr Perinat Epidemiol, V3, P11; YOSHIMURA Y, 1986, FERTIL STERIL, V45, P800	17	285	290	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	1991	302	6789					1361	1365		10.1136/bmj.302.6789.1361	http://dx.doi.org/10.1136/bmj.302.6789.1361			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR057	2059713	Green Published, Bronze			2022-12-28	WOS:A1991FR05700016
J	LEDERLE, FA				LEDERLE, FA			ORAL COBALAMIN FOR PERNICIOUS-ANEMIA - MEDICINES BEST KEPT SECRET	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VITAMIN-B12 INJECTIONS				LEDERLE, FA (corresponding author), VET AFFAIRS MED CTR, DEPT MED, DIV GEN INTERNAL MED 1110, 1 VET DR, MINNEAPOLIS, MN 55417 USA.							BABIOR BM, 1983, HARRISONS PRINCIPLES, P1859; BECK WS, 1988, CECIL TXB MED, P905; BERLIN H, 1968, ACTA MED SCAND, V184, P247; BERLIN R, 1978, ACTA MED SCAND, V204, P81; BERLIN R, 1985, BRIT MED J, V291, P56, DOI 10.1136/bmj.291.6487.56-a; BETHELL FH, 1959, JAMA-J AM MED ASSOC, V171, P2092, DOI 10.1001/jama.1959.73010330006014; CROSBY WH, 1986, ARCH INTERN MED, V146, P779, DOI 10.1001/archinte.146.4.779; CROSBY WH, 1980, ARCH INTERN MED, V140, P1582, DOI 10.1001/archinte.140.12.1582; DOSCHERHOLMEN A, 1957, J CLIN INVEST, V36, P1551, DOI 10.1172/JCI103552; LOWENSTEIN L, 1961, J CLIN INVEST, V40, P1656, DOI 10.1172/JCI104388; MCINTYRE PA, 1960, ARCH INTERN MED, V106, P280, DOI 10.1001/archinte.1960.03820020120018; MIDDLETON J, 1985, BRIT MED J, V290, P1254, DOI 10.1136/bmj.290.6477.1254; REISNER EH, 1955, NEW ENGL J MED, V253, P502, DOI 10.1056/NEJM195509222531204; WAIFE SO, 1963, ANN INTERN MED, V58, P810, DOI 10.7326/0003-4819-58-5-810; WINTROBE MN, 1981, CLIN HEMATOLOGY, P592	15	83	84	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					94	95		10.1001/jama.265.1.94	http://dx.doi.org/10.1001/jama.265.1.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	2064638				2022-12-28	WOS:A1991EP55500036
J	GOTO, Y; NONAKA, I; HORAI, S				GOTO, Y; NONAKA, I; HORAI, S			A MUTATION IN THE TRANSFER RNALEU(UUR) GENE ASSOCIATED WITH THE MELAS SUBGROUP OF MITOCHONDRIAL ENCEPHALOMYOPATHIES	NATURE			English	Article									NATL INST GENET,DEPT HUMAN GENET,MISHIMA,SHIZUOKA 411,JAPAN; NATL CTR NEUROL & PSYCHIAT,NATL INST NEUROSCI,DIV ULTRASTRUCT RES,KODAIRA,TOKYO 187,JAPAN; HOKKAIDO UNIV,SCH MED,DEPT PEDIAT,SAPPORO,HOKKAIDO 060,JAPAN	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; National Center for Neurology & Psychiatry - Japan; Hokkaido University								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; CANTATORE P, 1989, J BIOL CHEM, V264, P10965; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602; FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; GARESSE R, 1988, GENETICS, V118, P649; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; JACOBS HT, 1988, J MOL BIOL, V202, P185, DOI 10.1016/0022-2836(88)90452-4; KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; NAKASE H, 1990, AM J HUM GENET, V46, P418; NISHIO T, 1988, CLIN NEUROL, V28, P1266; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; RICH A, 1976, ANNU REV BIOCHEM, V45, P805, DOI 10.1146/annurev.bi.45.070176.004105; ROE BA, 1985, J BIOL CHEM, V260, P9757; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; SHY GM, 1967, AM J MED, V42, P163, DOI 10.1016/0002-9343(67)90015-0; YONEDA M, 1990, BIOCHEM INT, V21, P789; ZEVIANI M, 1988, NEUROLOGY, V38, P1339	28	1681	1729	3	58	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 13	1990	348	6302					651	653		10.1038/348651a0	http://dx.doi.org/10.1038/348651a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM760	2102678				2022-12-28	WOS:A1990EM76000067
J	VALENTINE, MD; SCHUBERTH, KC; KAGEYSOBOTKA, A; GRAFT, DF; KWITEROVICH, KA; SZKLO, M; LICHTENSTEIN, LM				VALENTINE, MD; SCHUBERTH, KC; KAGEYSOBOTKA, A; GRAFT, DF; KWITEROVICH, KA; SZKLO, M; LICHTENSTEIN, LM			THE VALUE OF IMMUNOTHERAPY WITH VENOM IN CHILDREN WITH ALLERGY TO INSECT STINGS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									JOHNS HOPKINS UNIV, SCH MED, JOHNS HOPKINS ASTHMA & ALLERGY CTR, DIV ALLERGY & CLIN IMMUNOL, BALTIMORE, MD 21224 USA; JOHNS HOPKINS UNIV, SCH MED, JOHNS HOPKINS ASTHMA & ALLERGY CTR, DEPT EPIDEMIOL, BALTIMORE, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine				Szklo, Moyses/0000-0001-9433-6266	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI008270, R01AI008270] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 08270] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHIPPS BE, 1980, J PEDIATR-US, V97, P177, DOI 10.1016/S0022-3476(80)80470-7; GOLDEN DBK, 1980, ANN INTERN MED, V92, P620, DOI 10.7326/0003-4819-92-5-620; GOLDEN DBK, 1989, JAMA-J AM MED ASSOC, V262, P240, DOI 10.1001/jama.262.2.240; GRAFT DF, 1987, J ALLERGY CLIN IMMUN, V80, P162, DOI 10.1016/0091-6749(87)90125-4; HUNT KJ, 1976, ANN INTERN MED, V85, P56, DOI 10.7326/0003-4819-85-1-56; HUNT KJ, 1978, NEW ENGL J MED, V299, P157, DOI 10.1056/NEJM197807272990401; LICHTENSTEIN LM, 1974, NEW ENGL J MED, V290, P1223, DOI 10.1056/NEJM197405302902204; PARKER JL, 1982, J ALLERGY CLIN IMMUN, V69, P200, DOI 10.1016/0091-6749(82)90100-2; PARRISH HM, 1963, AM J MED SCI, V245, P129; SCHUBERTH KC, 1983, J PEDIATR-US, V102, P361, DOI 10.1016/S0022-3476(83)80649-0; SETTIPANE GA, 1979, CLIN ALLERGY, V9, P385, DOI 10.1111/j.1365-2222.1979.tb02497.x; SETTIPANE GA, 1972, J ALLERGY CLIN IMMUN, V50, P146, DOI 10.1016/0091-6749(72)90045-0; SMITH PL, 1980, J CLIN INVEST, V66, P1072, DOI 10.1172/JCI109936	13	175	177	0	4	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 6	1990	323	23					1601	1603		10.1056/NEJM199012063232305	http://dx.doi.org/10.1056/NEJM199012063232305			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EK696	2098016	Bronze			2022-12-28	WOS:A1990EK69600005
J	RUMI, MG; COLOMBO, M; GRINGERI, A; MANNUCCI, PM				RUMI, MG; COLOMBO, M; GRINGERI, A; MANNUCCI, PM			HIGH PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS IN MULTITRANSFUSED HEMOPHILIACS WITH NORMAL TRANSAMINASE LEVELS	ANNALS OF INTERNAL MEDICINE			English	Note									A BIANCHI BONOMI HEMOPHILIA & THROMBOSIS CTR, VIA PACE 9, I-20122 MILAN, ITALY; UNIV MILAN, I-20122 MILAN, ITALY	University of Milan				RUMI, MARIAGRAZIA/0000-0002-5876-8528				CEDERBAUM AI, 1982, ARCH INTERN MED, V142, P481, DOI 10.1001/archinte.142.3.481; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; COLOMBO M, 1985, LANCET, V2, P1; DIENSTAG JL, 1986, SEMIN LIVER DIS, V6, P67, DOI 10.1055/s-2008-1040795; FLETCHER ML, 1983, BRIT MED J, V287, P1754, DOI 10.1136/bmj.287.6407.1754; KUHNL P, 1989, LANCET, V2, P324; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; RESNICK RH, 1983, DIGEST DIS SCI, V28, P908, DOI 10.1007/BF01317042; WEINER AJ, 1990, LANCET, V335, P1, DOI 10.1016/0140-6736(90)90134-Q; WHITE GC, 1982, BLOOD, V60, P1259	10	139	141	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	1990	112	5					379	380		10.7326/0003-4819-112-5-379	http://dx.doi.org/10.7326/0003-4819-112-5-379			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ139	2106281				2022-12-28	WOS:A1990CQ13900011
J	HASLE, H				HASLE, H			ASSOCIATION BETWEEN LIVING-CONDITIONS IN CHILDHOOD AND MYOCARDIAL-INFARCTION	BRITISH MEDICAL JOURNAL			English	Article											HASLE, H (corresponding author), UNIV ODENSE,INST COMMUNITY HLTH,DEPT SOCIAL MED,DK-5000 ODENSE C,DENMARK.			Hasle, Henrik/0000-0003-3976-9231				BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; BARKER DJP, 1986, LANCET, V1, P1077; HASLE H, 1989, Ugeskrift for Laeger, V151, P1926; POCOCK SJ, 1987, LANCET, V2, P197; WILLIAMS DRR, 1979, J EPIDEMIOL COMMUN H, V33, P199, DOI 10.1136/jech.33.3.199	5	10	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	1990	300	6723					512	513		10.1136/bmj.300.6723.512	http://dx.doi.org/10.1136/bmj.300.6723.512			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107930	Bronze, Green Published			2022-12-28	WOS:A1990CQ87800022
J	MANN, RS; HOGNESS, DS				MANN, RS; HOGNESS, DS			FUNCTIONAL DISSECTION OF ULTRABITHORAX PROTEINS IN DROSOPHILA-MELANOGASTER	CELL			English	Article											MANN, RS (corresponding author), STANFORD UNIV, BECKMAN CTR, SCH MED, DEPT BIOCHEM, STANFORD, CA 94305 USA.							AKAM ME, 1983, EMBO J, V2, P2075, DOI 10.1002/j.1460-2075.1983.tb01703.x; BEACHY PA, 1985, NATURE, V313, P545, DOI 10.1038/313545a0; BEACHY PA, 1988, CELL, V55, P1069, DOI 10.1016/0092-8674(88)90251-6; BEACHY PA, 1986, THESIS STANFORD U ST; BIENZ M, 1988, NATURE, V333, P576, DOI 10.1038/333576a0; BIENZ M, 1988, CELL, V53, P567, DOI 10.1016/0092-8674(88)90573-9; BOTAS J, 1988, ROUX ARCH DEV BIOL, V197, P424, DOI 10.1007/BF00398994; CARROLL SB, 1988, GENE DEV, V2, P350, DOI 10.1101/gad.2.3.350; CASANOVA J, 1988, EMBO J, V7, P1097, DOI 10.1002/j.1460-2075.1988.tb02918.x; CASANOVA J, 1985, J EMBRYOL EXP MORPH, V90, P179; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; DESPLAN C, 1985, NATURE, V318, P630, DOI 10.1038/318630a0; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.ge.21.120187.001441; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Garcia-Bellido A, 1975, Ciba Found Symp, V0, P161; GARCIABELLIDO A, 1977, AM ZOOL, V17, P613; GIBSON G, 1988, DEVELOPMENT, V102, P657; HAFEN E, 1984, NATURE, V307, P287, DOI 10.1038/307287a0; HALL MN, 1987, SCIENCE, V237, P1007, DOI 10.1126/science.2887035; HAN KH, 1989, CELL, V56, P573, DOI 10.1016/0092-8674(89)90580-1; HARTENSTEIN V, 1987, ROUX ARCH DEV BIOL, V196, P101, DOI 10.1007/BF00402031; HAYES PH, 1984, P NATL ACAD SCI-BIOL, V81, P545, DOI 10.1073/pnas.81.2.545; HOEY T, 1988, NATURE, V332, P858, DOI 10.1038/332858a0; JAYNES JB, 1988, NATURE, V336, P744, DOI 10.1038/336744a0; KAUFMAN T, 1990, IN PRESS ADV GENETIC; KAUFMAN TC, 1984, MOL ASPECTS EARLY DE, P189; KO HS, 1988, CELL, V55, P135, DOI 10.1016/0092-8674(88)90016-5; KORNBERG MC, 1989, CELL, V58, P955; KORNBERG T, 1985, CELL, V40, P45, DOI 10.1016/0092-8674(85)90307-1; KORNFELD K, 1989, GENE DEV, V3, P243, DOI 10.1101/gad.3.2.243; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; KUZIORA MA, 1988, CELL, V55, P477, DOI 10.1016/0092-8674(88)90034-7; KUZIORA MA, 1989, CELL, V59, P563, DOI 10.1016/0092-8674(89)90039-1; LAWRENCE PA, 1987, NATURE, V328, P440, DOI 10.1038/328440a0; LEVINE M, 1983, EMBO J, V2, P2037, DOI 10.1002/j.1460-2075.1983.tb01697.x; Lewis E B, 1982, Prog Clin Biol Res, V85 Pt A, P269; Lewis E. B., 1981, ICN UCLA S MOL CELLU, V23, P189; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LEWIS EB, 1963, AM ZOOL, V3, P33; LEWIS EB, 1964, ROLE CHROMOSOMES DEV, P231; LOHSSCHARDIN M, 1979, DEV BIOL, V73, P239, DOI 10.1016/0012-1606(79)90065-4; MARTINEZARIAS A, 1986, EMBO J, V5, P135, DOI 10.1002/j.1460-2075.1986.tb04187.x; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; MORATA G, 1981, NATURE, V290, P778, DOI 10.1038/290778a0; MULLER M, 1988, EMBO J, V7, P4299, DOI 10.1002/j.1460-2075.1988.tb03328.x; OCONNOR MB, 1988, EMBO J, V7, P435, DOI 10.1002/j.1460-2075.1988.tb02831.x; OTTING G, 1988, EMBO J, V7, P4305, DOI 10.1002/j.1460-2075.1988.tb03329.x; Pirrotta V, 1988, VECTORS SURVEY MOL C, P437; RILEY PD, 1987, GENE DEV, V1, P716, DOI 10.1101/gad.1.7.716; ROWE A, 1988, EMBO J, V7, P1107, DOI 10.1002/j.1460-2075.1988.tb02919.x; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; SATO T, 1985, DEV BIOL, V111, P171, DOI 10.1016/0012-1606(85)90444-0; SCHNEUWLY S, 1987, EMBO J, V6, P201, DOI 10.1002/j.1460-2075.1987.tb04739.x; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STRUHL G, 1981, NATURE, V292, P635, DOI 10.1038/292635a0; STRUHL G, 1984, NATURE, V308, P454, DOI 10.1038/308454a0; STRUHL G, 1983, J EMBRYOL EXP MORPH, V76, P297; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; STRUHL G, 1985, CELL, V43, P507, DOI 10.1016/0092-8674(85)90180-1; THALI M, 1988, NATURE, V336, P598, DOI 10.1038/336598a0; THUMMEL CS, 1988, GENE, V74, P445, DOI 10.1016/0378-1119(88)90177-1; TURNER FR, 1979, DEV BIOL, V68, P96, DOI 10.1016/0012-1606(79)90246-X; WAKIMOTO BT, 1984, DEV BIOL, V102, P147, DOI 10.1016/0012-1606(84)90182-9; WAKIMOTO BT, 1981, DEV BIOL, V81, P51, DOI 10.1016/0012-1606(81)90347-X; WEIR MP, 1988, GENE DEV, V2, P1194, DOI 10.1101/gad.2.9.1194; WHITE RAH, 1986, CELL, V47, P311, DOI 10.1016/0092-8674(86)90453-8; WHITE RAH, 1985, NATURE, V318, P567, DOI 10.1038/318567a0; WHITE RAH, 1985, EMBO J, V4, P2035, DOI 10.1002/j.1460-2075.1985.tb03889.x; Wieschaus E., 1986, P199; WINSLOW GM, 1989, CELL, V57, P1017, DOI 10.1016/0092-8674(89)90340-1	73	255	257	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	1990	60	4					597	610		10.1016/0092-8674(90)90663-Y	http://dx.doi.org/10.1016/0092-8674(90)90663-Y			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ723	2105847				2022-12-28	WOS:A1990CQ72300010
J	MEGEE, PC; MORGAN, BA; MITTMAN, BA; SMITH, MM				MEGEE, PC; MORGAN, BA; MITTMAN, BA; SMITH, MM			GENETIC-ANALYSIS OF HISTONE-H4 - ESSENTIAL ROLE OF LYSINES SUBJECT TO REVERSIBLE ACETYLATION	SCIENCE			English	Article									UNIV VIRGINIA,SCH MED,DEPT MICROBIOL,CHARLOTTESVILLE,VA 22908	University of Virginia				Megee, Paul/0000-0002-9397-2161	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028920] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28920] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEGRA P, 1987, J MOL BIOL, V196, P379, DOI 10.1016/0022-2836(87)90698-X; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; ALLFREY VG, 1980, CELL BIOL, V3, P347; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BOUTON AH, 1986, MOL CELL BIOL, V6, P2354, DOI 10.1128/MCB.6.7.2354; CHICOINE LG, 1986, J BIOL CHEM, V261, P1071; CORLISS DA, 1981, J HISTOCHEM CYTOCHEM, V29, P45, DOI 10.1177/29.1.6162881; COUPPEZ M, 1987, J BIOL CHEM, V262, P2854; DANNA JA, 1980, BIOCHEMISTRY-US, V19, P2656, DOI 10.1021/bi00553a019; DAVIE JR, 1981, NUCLEIC ACIDS RES, V9, P3205, DOI 10.1093/nar/9.13.3205; FALLON RJ, 1979, J CELL PHYSIOL, V100, P251, DOI 10.1002/jcp.1041000206; FUJITAKI JM, 1981, BIOCHEMISTRY-US, V20, P3658, DOI 10.1021/bi00515a055; GATEWOOD JM, 1988, SCIENCE, V236, P962; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; HERSKOWITZ I, 1988, MICROBIOL REV, V52, P536, DOI 10.1128/MMBR.52.4.536-553.1988; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; KIM UJ, 1988, EMBO J, V7, P2211, DOI 10.1002/j.1460-2075.1988.tb03060.x; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LOIDL P, 1987, NUCLEIC ACIDS RES, V15, P8351, DOI 10.1093/nar/15.20.8351; LOIDL P, 1988, FEBS LETT, V227, P91, DOI 10.1016/0014-5793(88)80874-3; MATHEWS HR, 1984, MOL CELL BIOCHEM, V59, P81; Matthews HR, 1985, ENZYMOLOGY POSTTRANS, V2, P125; MORGAN BA, 1987, YEAST CELL BIOL, P25; NASMYTH KA, 1982, ANNU REV GENET, V16, P439, DOI 10.1146/annurev.ge.16.120182.002255; NASMYTH KA, 1982, CELL, V30, P567, DOI 10.1016/0092-8674(82)90253-7; NELSON DA, 1982, J BIOL CHEM, V257, P1565; PESIS KH, 1986, ARCH BIOCHEM BIOPHYS, V251, P665, DOI 10.1016/0003-9861(86)90376-0; Sherman F., 1986, METHODS YEAST GENETI; SLATER ML, 1977, P NATL ACAD SCI USA, V74, P3850, DOI 10.1073/pnas.74.9.3850; SMITH MM, 1983, J MOL BIOL, V169, P663, DOI 10.1016/S0022-2836(83)80164-8; SMITH MM, 1983, J MOL BIOL, V169, P641, DOI 10.1016/S0022-2836(83)80163-6; SMITH MM, 1988, J CELL BIOL, V106, P557, DOI 10.1083/jcb.106.3.557; SMITH MM, 1984, HISTONE GENES STRUCT, P3; TURNER BM, 1989, EUR J BIOCHEM, V179, P131, DOI 10.1111/j.1432-1033.1989.tb14530.x; TURNER BM, 1989, EXP CELL RES, V182, P206, DOI 10.1016/0014-4827(89)90292-9; WATERBORG JH, 1984, EUR J BIOCHEM, V142, P329, DOI 10.1111/j.1432-1033.1984.tb08290.x; Williamson D H, 1975, Methods Cell Biol, V12, P335; WU RS, 1986, CRIT REV BIOCHEM MOL, V20, P201, DOI 10.3109/10409238609083735; ZHANG DE, 1988, BIOCHEM J, V250, P233, DOI 10.1042/bj2500233	41	296	309	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 16	1990	247	4944					841	845		10.1126/science.2106160	http://dx.doi.org/10.1126/science.2106160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN990	2106160				2022-12-28	WOS:A1990CN99000032
J	SHALLCROSS, TM; HEATLEY, RV				SHALLCROSS, TM; HEATLEY, RV			EFFECT OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS ON DYSPEPTIC SYMPTOMS	BRITISH MEDICAL JOURNAL			English	Article											SHALLCROSS, TM (corresponding author), ST JAMES UNIV HOSP,DEPT MED,LEEDS LS9 7TF,W YORKSHIRE,ENGLAND.							HORROCKS JC, 1978, GUT, V19, P19, DOI 10.1136/gut.19.1.19; MANN J, 1983, BRIT MED J, V287, P937, DOI 10.1136/bmj.287.6397.937; SKANDER MP, 1988, BRIT MED J, V297, P833, DOI 10.1136/bmj.297.6652.833; SOMMERVILLE K, 1986, LANCET, V1, P462	4	28	28	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					368	369		10.1136/bmj.300.6721.368	http://dx.doi.org/10.1136/bmj.300.6721.368			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106988	Green Published, Bronze			2022-12-28	WOS:A1990CN79900021
J	HARDIN, PE; HALL, JC; ROSBASH, M				HARDIN, PE; HALL, JC; ROSBASH, M			FEEDBACK OF THE DROSOPHILA PERIOD GENE-PRODUCT ON CIRCADIAN CYCLING OF ITS MESSENGER-RNA LEVELS	NATURE			English	Article									BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254	Brandeis University	HARDIN, PE (corresponding author), BRANDEIS UNIV,HOWARD HUGHES MED INST,WALTHAM,MA 02254, USA.			Hardin, Paul/0000-0002-3370-9011				BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; Dowse H.B., 1987, Journal of Biological Rhythms, V2, P65, DOI 10.1177/074873048700200106; DUSHAY MS, 1989, J BIOL RHYTHM, V4, P1, DOI 10.1177/074873048900400101; GUILANO G, 1988, EMBO J, V7, P3635; HALL JC, 1987, BIOESSAYS, V7, P108, DOI 10.1002/bies.950070304; HALL JC, 1988, ANNU REV NEUROSCI, V11, P373, DOI 10.1146/annurev.ne.11.030188.002105; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; HAMBLENCOYLE M, 1989, J NEUROGENET, V5, P229, DOI 10.3109/01677068909066210; KLOPPSTECH K, 1985, PLANTA, V165, P502, DOI 10.1007/BF00398095; KONOPKA R, 1983, MOL GEN GENET, V190, P284, DOI 10.1007/BF00330652; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; LIU X, 1988, GENE DEV, V2, P228, DOI 10.1101/gad.2.2.228; LORENZ LJ, 1989, DEVELOPMENT, V107, P869; LOROS JJ, 1989, SCIENCE, V243, P385, DOI 10.1126/science.2563175; NAGY F, 1988, GENE DEV, V2, P376, DOI 10.1101/gad.2.4.376; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; Oliver D., 1970, DROS INFORM SERV, V45, P58; PETERSEN G, 1988, EMBO J, V7, P3939, DOI 10.1002/j.1460-2075.1988.tb03280.x; PIECHULLA B, 1987, EMBO J, V6, P3593, DOI 10.1002/j.1460-2075.1987.tb02690.x; REDDY P, 1984, CELL, V38, P701, DOI 10.1016/0092-8674(84)90265-4; SAEZ L, 1988, MOL CELL BIOL, V8, P5378, DOI 10.1128/MCB.8.12.5378; SIWICKI KK, 1988, NEURON, V1, P141, DOI 10.1016/0896-6273(88)90198-5; SMITH RF, 1982, MOL GEN GENET, V185, P30, DOI 10.1007/BF00333786; SMITH RF, 1981, MOL GEN GENET, V183, P243, DOI 10.1007/BF00270625; SPILLER SC, 1987, PLANT PHYSIOL, V84, P409, DOI 10.1104/pp.84.2.409; TAYLOR WC, 1989, PLANT CELL, V1, P259, DOI 10.1105/tpc.1.2.259; UHL GR, 1986, SCIENCE, V232, P390, DOI 10.1126/science.3961487; YOUNG MW, 1985, COLD SPRING HARB SYM, V50, P865, DOI 10.1101/SQB.1985.050.01.104; YU Q, 1987, P NATL ACAD SCI USA, V84, P784, DOI 10.1073/pnas.84.3.784; ZEHRING WA, 1984, CELL, V39, P369, DOI 10.1016/0092-8674(84)90015-1; ZERR DM, UNPUB	34	820	848	3	185	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 8	1990	343	6258					536	540		10.1038/343536a0	http://dx.doi.org/10.1038/343536a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM830	2105471				2022-12-28	WOS:A1990CM83000056
J	JADAYEL, D; FAIN, P; UPADHYAYA, M; PONDER, MA; HUSON, SM; CAREY, J; FRYER, A; MATHEW, CGP; BARKER, DF; PONDER, BAJ				JADAYEL, D; FAIN, P; UPADHYAYA, M; PONDER, MA; HUSON, SM; CAREY, J; FRYER, A; MATHEW, CGP; BARKER, DF; PONDER, BAJ			PATERNAL ORIGIN OF NEW MUTATIONS IN VONRECKLINGHAUSEN NEUROFIBROMATOSIS	NATURE			English	Article									UNIV UTAH,DEPT MED INFORMAT,SALT LAKE CITY,UT 84108; INST CANC RES,HUMAN CANC GENET SECT,SUTTON SM2 5NG,SURREY,ENGLAND; UNIV COLL CARDIFF,INST MED GENET,CARDIFF CF4 4XN,S GLAM,WALES	Utah System of Higher Education; University of Utah; University of London; Institute of Cancer Research - UK; Cardiff University			Mathew, Christopher G/G-3434-2015; Barker, David/HHZ-0471-2022	Mathew, Christopher G/0000-0003-4178-1838; Barker, David/0000-0002-1438-4100				COLLINS FS, 1989, TRENDS GENET, V5, P217, DOI 10.1016/0168-9525(89)90085-1; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; FAIN PR, 1989, AM J HUM GENET, V45, P721; FRASER NJ, 1987, NUCLEIC ACIDS RES, V15, P9616, DOI 10.1093/nar/15.22.9616; HUSON SM, 1989, J MED GENET, V26, P704, DOI 10.1136/jmg.26.11.704; HUSON SM, 1988, BRAIN, V111, P1355, DOI 10.1093/brain/111.6.1355; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; OCONNELL P, 1989, AM J HUM GENET, V44, P51; REIK W, 1989, NATURE, V338, P112, DOI 10.1038/338112a0; RICCARDI VM, 1984, AM J MED GENET, V18, P169, DOI 10.1002/ajmg.1320180121; RICCARDI VM, 1986, NEUROFIBROMATOSIS; STUMPF DA, 1987, NEUROFIBROMATOSIS, V6; VOGEL F, 1986, HUMAN GENETICS; WINTER RM, 1982, AM J MED GENET, V12, P437, DOI 10.1002/ajmg.1320120407; WOLFF RK, 1989, GENOMICS, V5, P382, DOI 10.1016/0888-7543(89)90076-1; WONG Z, 1986, NUCLEIC ACIDS RES, V14, P4605, DOI 10.1093/nar/14.11.4605; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x; ZHU XP, 1989, NATURE, V340, P312, DOI 10.1038/340312a0	18	156	160	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 8	1990	343	6258					558	559		10.1038/343558a0	http://dx.doi.org/10.1038/343558a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM830	2105472				2022-12-28	WOS:A1990CM83000065
J	BAUMANN, R; MAGOS, AL; KAY, JDS; TURNBULL, AC				BAUMANN, R; MAGOS, AL; KAY, JDS; TURNBULL, AC			ABSORPTION OF GLYCINE IRRIGATING SOLUTION DURING TRANSCERVICAL RESECTION OF ENDOMETRIUM	BRITISH MEDICAL JOURNAL			English	Article									UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT OBSTET & GYNAECOL,OXFORD OX3 9DU,ENGLAND; UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT CLIN BIOCHEM,OXFORD OX3 9DU,ENGLAND	University of Oxford; University of Oxford								IGLESIAS JJ, 1975, J UROLOGY, V114, P929, DOI 10.1016/S0022-5347(17)67177-5; MAGOS AL, 1989, LANCET, V2, P925; MAGOS AL, 1989, BRIT MED J, V298, P1209, DOI 10.1136/bmj.298.6682.1209; MORRISON LMM, 1989, BRIT J OBSTET GYNAEC, V96, P346, DOI 10.1111/j.1471-0528.1989.tb02396.x; RAO PN, 1987, BRIT J UROL, V60, P93, DOI 10.1111/j.1464-410X.1987.tb04940.x	5	60	60	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 3	1990	300	6720					304	305		10.1136/bmj.300.6720.304	http://dx.doi.org/10.1136/bmj.300.6720.304			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM195	2106961	Bronze, Green Published			2022-12-28	WOS:A1990CM19500020
J	WATSON, ML; MACNICOL, AM; WRIGHT, AF				WATSON, ML; MACNICOL, AM; WRIGHT, AF			ADULT POLYCYSTIC KIDNEY-DISEASE	BRITISH MEDICAL JOURNAL			English	Editorial Material									WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	University of Edinburgh	WATSON, ML (corresponding author), ROYAL INFIRM,DEPT MED,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND.							BEAR JC, 1984, AM J MED GENET, V18, P45, DOI 10.1002/ajmg.1320180108; DALGAARD OZ, 1957, ACTA MED SCAND S328, V158, P98; KIMBERLING WJ, 1988, NEW ENGL J MED, V319, P913, DOI 10.1056/NEJM198810063191405; MACNICOL AM, 1986, ASPECTS RENAL CARE, V1, P219; REEDERS ST, 1987, HUM GENET, V76, P348, DOI 10.1007/BF00272443; REEDERS ST, 1986, BRIT MED J, V292, P851, DOI 10.1136/bmj.292.6524.851; Wilkie P, 1985, Health Bull (Edinb), V43, P76	7	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					62	63		10.1136/bmj.300.6717.62	http://dx.doi.org/10.1136/bmj.300.6717.62			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105771	Bronze, Green Published			2022-12-28	WOS:A1990CJ08000002
J	SHULKIN, DJ				SHULKIN, DJ			COST-EFFECTIVENESS AND THE FUTURE OF MEDICINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	1990	263	1					40	40		10.1001/jama.263.1.40	http://dx.doi.org/10.1001/jama.263.1.40			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF777	2104547				2022-12-28	WOS:A1990CF77700019
J	MCPHEE, SJ; BIRD, JA; FORDHAM, D; RODNICK, JE; OSBORN, EH				MCPHEE, SJ; BIRD, JA; FORDHAM, D; RODNICK, JE; OSBORN, EH			PROMOTING CANCER PREVENTION ACTIVITIES BY PRIMARY CARE PHYSICIANS - RESULTS OF A RANDOMIZED, CONTROLLED TRIAL	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERIODIC HEALTH EXAMINATION; FAMILY PHYSICIANS; SMOKING CESSATION; TRAINING PHYSICIANS; REMINDER SYSTEM; UNITED-STATES; IMPLEMENTATION; GUIDELINES; RECOMMENDATIONS; PERFORMANCE	Background.-Previous interventions to promote performance of cancer prevention activities have largely targeted physicians in university-based practices. Methods.-We randomly assigned 40 primary care physicians in community based practices to either (1) Cancer Prevention Reminders, computer-generated lists of overdue screening tests, and smoking and dietary assessment and counseling, supplemented by cancer education materials; or (2) controls. For each physician, we reviewed a random sample of 60 medical records for data about screening test, assessment, and counseling performance during 12-month preintervention and intervention periods. We calculated performance scores as percentage compliance with American Cancer Society and/or National Cancer institute recommendations. Multiple regression analyses provided estimates of incremental differences in performance scores between intervention and control groups. Results.-Controlling for preintervention performance levels, significant incremental differences in performance scores between intervention and control groups (P < .05) were achieved for nine maneuvers: stool occult-blood test, +14.5; rectal examination, +10.5; pelvic examination, +11.8; Papanicolaou's smear, +30.7; breast examination, +8.7; smoking assessment, +10.2; smoking counseling, +17.3; dietary assessment, +12.3; and dietary counseling, +13.9. Increments for sigmoidoscopy and mammography were not significant. Conclusion.-Computerized reminders can significantly increase physicians' performance of cancer prevention activities in community-based practices.	UNIV CALIF SAN FRANCISCO,DEPT FAMILY & COMMUNITY MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,INST HLTH POLICY STUDIES,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	MCPHEE, SJ (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT MED,DIV GEN INTERNAL MED,400 PARNASSUS AVE,A-405,SAN FRANCISCO,CA 94143, USA.				NATIONAL CANCER INSTITUTE [R01CA046020] Funding Source: NIH RePORTER; NCI NIH HHS [5 R01 CA46020-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1989, GUIDE CLIN PREVENTIV; BATTISTA RN, 1983, AM J PUBLIC HEALTH, V73, P1040, DOI 10.2105/AJPH.73.9.1040; BECKER DM, 1989, AM J PREV MED, V5, P353, DOI 10.1016/S0749-3797(18)31056-0; BIRD JA, 1990, MED CARE, V28, P1005, DOI 10.1097/00005650-199011000-00003; CHAMBERS CV, 1989, J FAM PRACTICE, V29, P273; CHENEY C, 1987, AM J MED, V83, P129, DOI 10.1016/0002-9343(87)90507-9; COHEN DI, 1982, MED CARE, V20, P1040, DOI 10.1097/00005650-198210000-00006; COHEN SJ, 1987, AM J PUBLIC HEALTH, V77, P313, DOI 10.2105/AJPH.77.3.313; COHEN SJ, 1989, ANN INTERN MED, V110, P648, DOI 10.7326/0003-4819-110-8-648; CUMMINGS KM, 1983, J FAM PRACTICE, V17, P1029; CUMMINGS KM, 1984, PUBLIC HEALTH REP, V99, P307; CUMMINGS SR, 1989, ANN INTERN MED, V110, P640, DOI 10.7326/0003-4819-110-8-640; CUMMINGS SR, 1989, J GEN INTERN MED, V4, P482, DOI 10.1007/BF02599545; DAVIDSON RA, 1984, ARCH INTERN MED, V144, P2167, DOI 10.1001/archinte.144.11.2167; DIETRICH AJ, 1984, AM J PUBLIC HEALTH, V74, P223, DOI 10.2105/AJPH.74.3.223; FORDHAM D, 1990, M D COMPUT, V7, P289; FRAME P S, 1990, Journal of General Internal Medicine, V5, pS112, DOI 10.1007/BF02600855; Green L. W., 1988, AM J PREV MED, V4, pS101; GREEN LW, 1986, PREV MED, V15, P508, DOI 10.1016/0091-7435(86)90027-7; GREENWALD P, 1986, NIH862820 US DEP HLT; HAHN DL, 1990, J FAM PRACTICE, V31, P492; HATWICK MA, 1982, 6TH P ANN S COMP APP, P72; KNIGHT BP, 1987, AM J PREV MED, V3, P19; MARTIN AR, 1987, WESTERN J MED, V146, P751; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; MCDONALD CJ, 1984, ANN INTERN MED, V100, P130, DOI 10.7326/0003-4819-100-1-130; MCDOWELL I, 1989, J FAM PRACTICE, V28, P420; MCPHEE S J, 1990, Journal of General Internal Medicine, V5, pS116, DOI 10.1007/BF02600856; MCPHEE SJ, 1989, ARCH INTERN MED, V149, P1866, DOI 10.1001/archinte.149.8.1866; MCPHEE SJ, 1987, AM J PUBLIC HEALTH, V77, P780, DOI 10.2105/AJPH.77.7.780; MCPHEE SJ, 1986, J GEN INTERN MED, V1, P275, DOI 10.1007/BF02596202; NATTINGER AB, 1989, ARCH INTERN MED, V149, P2087, DOI 10.1001/archinte.149.9.2087; ORLANDI MA, 1987, PREV MED, V16, P119, DOI 10.1016/0091-7435(87)90011-9; ORLEANS CT, 1985, PREV MED, V14, P636, DOI 10.1016/0091-7435(85)90083-0; ORNSTEIN SM, 1989, J FAM PRACTICE, V29, P163; Osborn E H, 1988, J Am Board Fam Pract, V1, P29; OSBORN EH, 1991, J FAM PRACTICE, V32, P465; PATRAVAGE J, 1988, J FAM PRACTICE, V27, P387; PIERCE M, 1989, BMJ-BRIT MED J, V299, P160, DOI 10.1136/bmj.299.6692.160; Prislin M D, 1986, Fam Med, V18, P290; ROBIE PW, 1988, SOUTHERN MED J, V81, P902, DOI 10.1097/00007611-198807000-00022; ROMM FJ, 1981, SOUTHERN MED J, V74, P265, DOI 10.1097/00007611-198103000-00004; SCHMITTLING GT, 1989, J FAM PRACTICE, V29, P198; SCHREINER DT, 1988, SOUTHERN MED J, V81, P1553, DOI 10.1097/00007611-198812000-00021; SOLBERG LI, 1990, J FAM PRACTICE, V30, P6647; TIERNEY WM, 1986, MED CARE, V24, P659, DOI 10.1097/00005650-198608000-00001; TURNER BJ, 1989, J GEN INTERN MED, V4, P403, DOI 10.1007/BF02599691; VALENTE C M, 1986, American Journal of Preventive Medicine, V2, P82; WECHSLER H, 1983, NEW ENGL J MED, V308, P97, DOI 10.1056/NEJM198301133080211; WELLS KB, 1984, JAMA-J AM MED ASSOC, V252, P2846, DOI 10.1001/jama.252.20.2846; WILSON DM, 1988, JAMA-J AM MED ASSOC, V260, P1570, DOI 10.1001/jama.260.11.1570; WOO B, 1985, JAMA-J AM MED ASSOC, V254, P1480, DOI 10.1001/jama.254.11.1480; 1991, CA, V41, P28; 1982, CA, V32, P226; 1990, NIH903107 US DEP HLT; 1987, WORKING GUIDELINES E; 1985, CA, V35, P197; 1980, CA, V30, P194	58	235	235	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1991	266	4					538	544		10.1001/jama.266.4.538	http://dx.doi.org/10.1001/jama.266.4.538			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FX021	2061981				2022-12-28	WOS:A1991FX02100028
J	PFEFFER, MA; MOYE, LA; BRAUNWALD, E; BASTA, L; BROWN, EJ; CUDDY, TE; DAGENAIS, GR; FLAKER, GC; GELTMAN, EM; GERSH, BJ; GOLDMAN, S; LAMAS, GA; PACKER, M; ROULEAU, JL; RUTHERFORD, JD; STEINGART, RM; WERTHEIMER, JH				PFEFFER, MA; MOYE, LA; BRAUNWALD, E; BASTA, L; BROWN, EJ; CUDDY, TE; DAGENAIS, GR; FLAKER, GC; GELTMAN, EM; GERSH, BJ; GOLDMAN, S; LAMAS, GA; PACKER, M; ROULEAU, JL; RUTHERFORD, JD; STEINGART, RM; WERTHEIMER, JH			SELECTION BIAS IN THE USE OF THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TISSUE PLASMINOGEN-ACTIVATOR; INTRAVENOUS THROMBOLYSIS; TRIAL; REPERFUSION; REDUCTION; SURVIVAL; RATES	Objective.-To determine whether clinical selection for thrombolytic therapy for acute myocardial infarction results in a skewed population for subsequent adverse cardiovascular events. Design.-A comparison of the clinical, features of the patients in the Survival and Ventricular Enlargement Study who either had or had not received thrombolytic therapy was conducted in both univariate and multiple logistic regression analyses. Setting.-Hospitalized patients experiencing acute myocardial infarction from 112 broadly representative, private, academic, and government hospitals in the United States and Canada. Patients. - All patients in the Survival and Ventricular Enlargement Study had had a recent myocardial infarction (< l6 days) and had a left ventricular ejection fraction of 40% or less. Intervention.-Thrombolytic therapy was administered to 733 patients and was not given to 1498. Main Outcome Measures.-The comparisons with respect to use of thrombolytic therapy were formulated after the completion of enrollment and indicated that the majority of patients did not receive thrombolytic therapy. Results. -The 1498 (67.1 %) patients who did not receive thrombolytic therapy were at higher risk (older age, lower functional capacity, greater likelihood of a history of prior myocardial infarction, angina, diabetes, and hypertension) for subsequent cardiovascular events and, as anticipated, were more likely to have concomitant gastrointestinal and neurological diseases. A multiple logistic regression analysis indicated that older age, prior myocardial infarction, impaired functional status, employment status, diabetes, and neurological diseases were predictors of use of thrombolytic therapy. Conclusion.-Although the Survival and Ventricular Enlargement Study population was selected for left ventricular dysfunction, the majority of patients who currently are judged clinically as unsuitable for thrombolytic therapy have a higher risk for adverse cardiovascular events.	UNIV TEXAS, HLTH SCI CTR, HOUSTON, TX 77225 USA; TULSA HEART CTR, TULSA, OK USA; SUNY STONY BROOK, STONY BROOK, NY 11794 USA; UNIV MANITOBA, WINNIPEG R3T 2N2, MANITOBA, CANADA; INST CARDIOL QUEBEC, QUEBEC CITY G1V 4G5, QUEBEC, CANADA; UNIV MISSOURI, COLUMBIA, MO 65201 USA; WASHINGTON UNIV, SCH MED, ST LOUIS, MO 63110 USA; MAYO CLIN & MAYO FDN, ROCHESTER, MN 55905 USA; VET ADM MED CTR, TUCSON, AZ 85723 USA; MT SINAI MED CTR, NEW YORK, NY 10029 USA; HOP SACRE COEUR, MONTREAL H4J 1C5, QUEBEC, CANADA; WINTHROP UNIV HOSP, MINEOLA, NY USA; ALBERT EINSTEIN MED CTR, NO DIV, PHILADELPHIA, PA 19141 USA	University of Texas System; University of Texas Health Science Center Houston; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Manitoba; Laval University; University of Missouri System; University of Missouri Columbia; Washington University (WUSTL); Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); Southern Arizona Veterans Affairs Health Care System; Icahn School of Medicine at Mount Sinai; Universite de Montreal; Winthrop University Hospital; Yeshiva University	PFEFFER, MA (corresponding author), HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, DIV CARDIOVASC, 75 FRANCIS ST, BOSTON, MA 02115 USA.							[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; ANTMAN EM, 1989, INT J CARDIOL, V23, P185, DOI 10.1016/0167-5273(89)90247-7; BRAUNWALD E, 1989, J AM COLL CARDIOL, V14, P1570, DOI 10.1016/0735-1097(89)90400-2; BRAUNWALD E, 1989, CIRCULATION, V79, P441, DOI 10.1161/01.CIR.79.2.441; BREZINSKI D, 1991, AM HEART J, V121, P1374, DOI 10.1016/0002-8703(91)90141-4; CALIFF RM, 1989, J AM COLL CARDIOL, V14, P1382, DOI 10.1016/0735-1097(89)90445-2; CHAMBERLAIN DA, 1988, LANCET, V1, P545; CRAGG DR, 1989, CIRCULATION S2, V80, P1; DOOREY AJ, 1987, J AM COLL CARDIOL, V10, P1357, DOI 10.1016/S0735-1097(87)80141-9; EISENBERG MS, 1989, ANN EMERG MED, V18, P838, DOI 10.1016/S0196-0644(89)80207-0; GERSH BJ, 1990, CIRCULATION S3, V82, P1; GOLD HK, 1990, NEW ENGL J MED, V323, P1483, DOI 10.1056/NEJM199011223232110; GRINES CL, 1990, J AM COLL CARDIOL, V16, P223, DOI 10.1016/0735-1097(90)90482-5; HSIA J, 1990, NEW ENGL J MED, V323, P1433, DOI 10.1056/NEJM199011223232101; KARLSON BW, 1990, CIRCULATION, V82, P1140, DOI 10.1161/01.CIR.82.4.1140; KENNEDY JW, 1990, ANN INTERN MED, V113, P907, DOI 10.7326/0003-4819-113-12-907; LEE TH, 1989, ANN INTERN MED, V110, P957, DOI 10.7326/0003-4819-110-12-957; MOSS AJ, 1990, NEW ENGL J MED, V322, P743, DOI 10.1056/NEJM199003153221107; MULLER DWM, 1990, ANN INTERN MED, V113, P949, DOI 10.7326/0003-4819-113-12-949; MURRAY N, 1987, BRIT HEART J, V57, P144; NAYLOR CD, 1990, JAMA-J AM MED ASSOC, V264, P697, DOI 10.1001/jama.264.6.697; SCHULMAN SP, 1988, J AM COLL CARDIOL, V11, P1164, DOI 10.1016/0735-1097(88)90277-X; TOPOL EJ, 1987, NEW ENGL J MED, V317, P581, DOI 10.1056/NEJM198709033171001; TURI ZG, 1986, AM J CARDIOL, V58, P203, DOI 10.1016/0002-9149(86)90047-0; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; WILCOX RG, 1988, LANCET, V2, P525	27	124	127	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1991	266	4					528	532		10.1001/jama.266.4.528	http://dx.doi.org/10.1001/jama.266.4.528			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX021	2061979				2022-12-28	WOS:A1991FX02100026
J	SALEM, M; CHERNOW, B; BURKE, R; STACEY, J; SLOGOFF, M; SOOD, S				SALEM, M; CHERNOW, B; BURKE, R; STACEY, J; SLOGOFF, M; SOOD, S			BEDSIDE DIAGNOSTIC BLOOD TESTING - ITS ACCURACY, RAPIDITY, AND UTILITY IN BLOOD CONSERVATION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY ILL PATIENTS; CARE UNIT; GAS ANALYSIS; WHOLE-BLOOD; POTASSIUM; SODIUM; STAT; ELECTRODES; ANALYZERS; QUALITY	Objective. - Bedside diagnostic testing utilizing microchemistry instruments potentially offers physicians the opportunity to evaluate urgent blood test results rapidly and reliably using only drops (250-mu-L) of whole blood. The use of microchemistry technology may also represent an essential component of a blood conservation program in acutely ill patients. We tested the hypothesis that a microchemistry instrument would have important advantages in the intensive care unit, including rapid turnaround time, decreased iatrogenic blood loss, and the provision of accurate analyte results. Design. - One-year prospective, random-sample comparative study. Setting. - A tertiary, acute care, 1000-bed university teaching hospital and a 450-bed university-affiliated community hospital. Patients. - Blood samples from 850 patients were analyzed. Results. - There were strong correlations (for pH, R2 = .97; PCO2, R2 = .97; PO2,R2 =.99; sodium, R2 =.83; potassium, R2 =.94; chloride, R2 =.90; glucose, R2 =.98; and hematocrit, R2 =.92) when paired samples were analyzed simultaneously in the laboratory comparing the microchemistry instrument and currently accepted clinical laboratory instruments. There were significant correlations (for pH, R2 = .91; PCO2, R2 = .94; Po2, R2 = .97; sodium, R2 = .91; potassium, R2 = .86; chloride, R2 = .91; ionized calcium, R2 = .82; glucose, R2 = .96; and hematocrit, R2 = .75) but increased variability occurred in some analyte results when samples were first analyzed in the intensive care unit (using the microchemistry instrument) and then transported to the laboratory in the routine fashion for "stat" determinations. Conclusions. - The multichannel microchemistry instrument provided accurate analyte determinations when compared with accepted clinical laboratory instruments. Significant savings of time and blood were also realized by the use of a microchemistry instrument in the intensive care unit. Bedside microchemistry may provide clinically important advantages in emergency departments, operating rooms, and neonatal, pediatric, coronary, adult medical and surgical, trauma, and burn intensive care units.	SINAI HOSP,DEPT MED,BELVEDERE AVE & GREENSPRING,BALTIMORE,MD 21215; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT ANESTHESIOL CRIT CARE,BOSTON,MA 02114; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT ANESTHESIOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT CRIT CARE MED,BALTIMORE,MD 21205	Sinai Hospital of Baltimore; Harvard University; Harvard Medical School; Massachusetts General Hospital; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University								BASHEIN G, 1989, ANESTHESIOLOGY, V70, P123, DOI 10.1097/00000542-198901000-00023; BAUER DM, 1990, CHEST, V97, pS191; BELSEY R, 1987, JAMA-J AM MED ASSOC, V258, P1634, DOI 10.1001/jama.258.12.1634; BELSEY R, 1986, JAMA-J AM MED ASSOC, V255, P775, DOI 10.1001/jama.255.6.775; BELSEY R, 1987, JAMA-J AM MED ASSOC, V258, P357, DOI 10.1001/jama.258.3.357; BHASKARAN NC, 1988, ANAESTHESIA, V43, P811, DOI 10.1111/j.1365-2044.1988.tb05793.x; BISWAS CK, 1982, BRIT MED J, V284, P923, DOI 10.1136/bmj.284.6320.923; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BONE RC, 1988, CHEST, V93, P390, DOI 10.1378/chest.93.2.390; BRONSON WR, 1966, NEW ENGL J MED, V274, P369, DOI 10.1056/NEJM196602172740702; BURRITT MF, 1990, CLIN CHEM, V36, P1562; CEMBROWSKI GS, 1991, EMERGENCY DEP TURNAR, V90, pA13; CHERNOW B, 1990, CHEST, V97, pS183, DOI 10.1378/chest.97.5_Supplement.183S; CONRAD PD, 1989, J PEDIATR-US, V114, P281, DOI 10.1016/S0022-3476(89)80798-X; DENNIS RC, 1985, CRIT CARE MED, V13, P1067, DOI 10.1097/00003246-198512000-00018; EICHHORN J, 1989, C27T NAT COMM CLIN L; EYSTER E, 1973, JAMA-J AM MED ASSOC, V223, P73, DOI 10.1001/jama.223.1.73; FAYE S, 1988, LANCET, V2, P59; FLEISHER M, 1990, CLIN CHEM, V36, P1557; FLEISHER M, 1989, CLIN CHEM, V35, P1532; FOGHANDERSEN N, 1984, CLIN CHEM, V30, P433; HALL JR, 1984, CRIT CARE MED, V12, P530, DOI 10.1097/00003246-198406000-00014; HASHIMOTO F, 1982, JAMA-J AM MED ASSOC, V248, P171, DOI 10.1001/jama.1982.03330020017013; HILBORNE LH, 1989, AM J CLIN PATHOL, V91, P331, DOI 10.1093/ajcp/91.3.331; HUTCHISON AS, 1983, BRIT MED J, V287, P1131, DOI 10.1136/bmj.287.6399.1131; INGRAM RH, 1962, NEW ENGL J MED, V267, P894; LADENSON JH, 1977, CLIN CHEM, V23, P1912; MADIEDO G, 1980, J CLIN PATHOL, V33, P864, DOI 10.1136/jcp.33.9.864; MIKKELSEN DJ, 1987, NEW ZEAL MED J, V100, P686; MILLER ES, 1975, NEW ENGL J MED, V292, P319; MISIANO DR, 1990, CHEST, V97, pS204, DOI 10.1378/chest.97.5.204S; MORAN RF, 1990, METHODOLOGY CLIN APP, V11, P191; MORAN RF, 1990, METHODOLOGY CLIN APP, V11, P231; MYERHOFF ME, 1990, CLIN CHEM B, V36, P1567; NANJI AA, 1988, CAN MED ASSOC J, V138, P517; OESCH U, 1986, CLIN CHEM, V32, P1448; RILEY JB, 1987, J EXTRA-CORP TECHNOL, V19, P322; SCHWARTZ MKI, 1976, ADV CLIN CHEM, V16, P1; SCRIBNER BH, 1954, JAMA-J AM MED ASSOC, V155, P644, DOI 10.1001/jama.1954.03690250024008; SCRIBNER BH, 1950, MAYO CLIN P, V9, P209; SEVERINGHAUS JW, 1969, ANN NY ACAD SCI, V148, P115; SHEK CC, 1985, INTENS CARE MED, V11, P309, DOI 10.1007/BF00273542; SMOLLER BR, 1989, NEW ENGL J MED, V314, P281; STATLAND BE, 1990, CHEST, V97, pS198, DOI 10.1378/chest.97.5.198S; STRICKLAND RA, 1988, ANESTHESIOLOGY, V69, pA255; THORSON SH, 1988, CRIT CARE MED, V15, P14; WEIL MH, 1981, AM J CLIN PATHOL, V76, P34; ZALOGA GP, 1989, CRIT CARE MED, V17, P920, DOI 10.1097/00003246-198909000-00017; ZALOGA GP, 1990, CHEST, V97, pS185	49	59	61	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	1991	266	3					382	389						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV960	2056648				2022-12-28	WOS:A1991FV96000028
J	HOWARD, JB; MCKINNON, JT; MAKAROVSKY, Y; LAFLEUR, AL; JOHNSON, ME				HOWARD, JB; MCKINNON, JT; MAKAROVSKY, Y; LAFLEUR, AL; JOHNSON, ME			FULLERENES C60 AND C70 IN FLAMES	NATURE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PERFORMANCE LIQUID-CHROMATOGRAPHY; CARBON; C-60; SOOT; BUCKMINSTERFULLERENE; FORM	THE fullerenes C60 and C70 were first identified 1 in carbon vapour produced by laser irradiation of graphite, and have recently been produced in macroscopic quantities 2-5 by vaporization of graphite with resistive heating. It has also been suggested 6-9 that fullerenes might be formed in sooting flames, and indeed all-carbon ions with mass/charge ratios suggestive of fullerenes have been detected in flames 10-12. These species were assumed to have the cage structures of fullerenes, but the mass spectroscopic evidence could not establish this conclusively. We have now collected samples of condensible compounds and soot from hydrocarbon combustion under a range of conditions, and analysed these using conventional techniques in an effort to detect fullerenes. Spectroscopic studies reveal the presence of C60 and C70 in yields and ratios that depend on temperature, pressure, carbon/oxygen ratio and residence time in the flame. Control of these conditions allows optimal yields of 3 g of fullerenes per kilogram of fuel carbon burned, and variation of the C70/C60 ratio over the range 0.26-5.7.	MIT,CTR ENVIRONM HLTH SCI,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)	HOWARD, JB (corresponding author), MIT,DEPT CHEM ENGN,CAMBRIDGE,MA 02139, USA.							AJIE H, 1990, J PHYS CHEM-US, V94, P8630, DOI 10.1021/j100387a004; Bittner J.D., 1983, SOOT COMBUSTION SYST, P57, DOI 10.1007/978-1-4684- 4463-6_5; Bittner J.D., 1981, S INT COMBUST, V18, P1105; BOCKHORN H, 1983, BER BUNSEN PHYS CHEM, V87, P1067, DOI 10.1002/bbpc.19830871121; CURL RF, 1988, SCIENCE, V242, P1017, DOI 10.1126/science.242.4881.1017; FETZER JC, 1985, J CHROMATOGR, V346, P81, DOI 10.1016/S0021-9673(00)90496-5; FETZER JC, 1985, J CHROMATOGR, V322, P275, DOI 10.1016/S0021-9673(01)97687-3; FETZER JC, 1984, J CHROMATOGR, V295, P161, DOI 10.1016/S0021-9673(01)87607-X; GERHARDT P, 1987, CHEM PHYS LETT, V137, P306, DOI 10.1016/0009-2614(87)80889-8; GERHARDT P, 1989, 22ND S INT COMB PITT, P395; HAUFLER RE, 1990, J PHYS CHEM-US, V94, P8634, DOI 10.1021/j100387a005; Homann K -H, 1963, Z PHYS CHEM NF, V37, P299; HOMANN KH, 1973, P COMBUSTION I EUROP, P394; HOWARD JB, IN PRESS 23RD INT S; Kraschmer W., 1990, CHEM PHYS LETT, V170, P167; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; KROTO H, 1988, SCIENCE, V242, P1139, DOI 10.1126/science.242.4882.1139; KROTO HW, 1988, NATURE, V331, P328, DOI 10.1038/331328a0; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; LAFLEUR AL, 1987, ANAL LETT, V20, P1171; LOFFLER S, 1990, 23 S INT COMB COMB I, P355; LUFFER DR, 1990, RAPID COMMUN MASS SP, V4, P552, DOI 10.1002/rcm.1290041218; McKinnon J.T, 1989, THESIS MIT; MCKINNON JT, 1990, COMBUST SCI TECHNOL, V74, P175, DOI 10.1080/00102209008951687; OLSON DB, 1981, 18TH S INT COMB PITT, P453; TAYLOR R, 1990, J CHEM SOC CHEM COMM, P1423, DOI 10.1039/c39900001423; ZHANG QL, 1986, J PHYS CHEM-US, V90, P525, DOI 10.1021/j100276a001	27	466	493	2	124	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 11	1991	352	6331					139	141		10.1038/352139a0	http://dx.doi.org/10.1038/352139a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW097	2067575				2022-12-28	WOS:A1991FW09700049
J	KURIYAN, J; KRISHNA, TSR; WONG, L; GUENTHER, B; PAHLER, A; WILLIAMS, CH; MODEL, P				KURIYAN, J; KRISHNA, TSR; WONG, L; GUENTHER, B; PAHLER, A; WILLIAMS, CH; MODEL, P			CONVERGENT EVOLUTION OF SIMILAR FUNCTION IN 2 STRUCTURALLY DIVERGENT ENZYMES	NATURE			English	Article							GLUTATHIONE-REDUCTASE; THIOREDOXIN REDUCTASE; ESCHERICHIA-COLI; ACTIVE-SITE; RESOLUTION; PROTEIN; BINDING; CRYSTALLOGRAPHY; REFINEMENT; DISULFIDE	AN example of two related enzymes that catalyse similar reactions but possess different active sites is provided by comparing the structure of Escherichia coli thioredoxin reductase with glutathione reductase 1. Both are dimeric enzymes that catalyse the reduction of disulphides by pyridine nucleotides through an enzyme disulphide and a flavin 2. Human glutathione reductase contains four structural domains within each molecule: the flavin-adenine dinucleotide (FAD)- and nicotinamide-adenine dinucleotide phosphate (NADPH)-binding domains, the 'central' domain and the C-terminal domain that provides the dimer interface and part of the active site 3,4. Although both enzymes share the same catalytic mechanism and similar tertiary structures, their active sites do not resemble each other 5,6. We have determined the crystal structure of E. coli thioredoxin reductase at 2 angstrom resolution, and show that thioredoxin reductase lacks the domain that provides the dimer interface in glutathione reductase, and forms a completely different dimeric structure. The catalytically active disulphides are located in different domains on opposite sides of the flavin ring system. This suggests that these enzymes diverged from an ancestral nucleotide-binding protein and acquired their disulphide reductase activities independently.	ROCKEFELLER UNIV,HOWARD HUGHES MED INST,NEW YORK,NY 10021; COLUMBIA UNIV,DEPT MOLEC BIOPHYS & BIOCHEM,NEW YORK,NY 10032; DEPT VET AFFAIRS MED CTR,ANN ARBOR,MI 48105; UNIV MICHIGAN,DEPT BIOL CHEM,ANN ARBOR,MI 48109	Howard Hughes Medical Institute; Rockefeller University; Columbia University; University of Michigan System; University of Michigan	KURIYAN, J (corresponding author), ROCKEFELLER UNIV,1230 YORK AVE,NEW YORK,NY 10021, USA.							BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNGER AT, 1988, XPLOR VERSION 15 MAN; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARPLUS PA, 1987, J MOL BIOL, V195, P701, DOI 10.1016/0022-2836(87)90191-4; KARPLUS PA, 1989, J MOL BIOL, V210, P163, DOI 10.1016/0022-2836(89)90298-2; KURIYAN J, 1989, J BIOL CHEM, V264, P12752; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; ODONNELL ME, 1983, J BIOL CHEM, V258, P3795; ODONNELL ME, 1985, BIOCHEMISTRY-US, V24, P7617, DOI 10.1021/bi00347a018; PRIESTLE JP, 1988, J APPL CRYSTALLOGR, V21, P572, DOI 10.1107/S0021889888005746; PRONGAY AJ, 1989, J BIOL CHEM, V264, P265; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; ROYER WE, 1990, SCIENCE, V249, P518, DOI 10.1126/science.2382132; RUSSEL M, 1988, J BIOL CHEM, V263, P9015; SCHIRMER RH, 1987, PYRIDINE NUCLEOTID B, V2, P333; SCHULZ GE, 1980, J MOL BIOL, V138, P335, DOI 10.1016/0022-2836(80)90290-9; TERWILLIGER TC, 1983, ACTA CRYSTALLOGR A, V39, P813, DOI 10.1107/S0108767383001592; THIEME R, 1981, J MOL BIOL, V152, P763, DOI 10.1016/0022-2836(81)90126-1; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WIERENGA RK, 1983, J MOL BIOL, V167, P725, DOI 10.1016/S0022-2836(83)80106-5; WILLIAMS CH, IN PRESS FLAVINS FLA; Williams CH., 1976, ENZYMES, P89	26	169	171	0	10	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 11	1991	352	6331					172	174		10.1038/352172a0	http://dx.doi.org/10.1038/352172a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW097	2067578	Green Submitted			2022-12-28	WOS:A1991FW09700062
J	SCHWARTZBERG, PL; STALL, AM; HARDIN, JD; BOWDISH, KS; HUMARAN, T; BOAST, S; HARBISON, ML; ROBERTSON, EJ; GOFF, SP				SCHWARTZBERG, PL; STALL, AM; HARDIN, JD; BOWDISH, KS; HUMARAN, T; BOAST, S; HARBISON, ML; ROBERTSON, EJ; GOFF, SP			MICE HOMOZYGOUS FOR THE ABLM1 MUTATION SHOW POOR VIABILITY AND DEPLETION OF SELECTED B-CELL AND T-CELL POPULATIONS	CELL			English	Article							MURINE LEUKEMIA-VIRUS; ACUTE LYMPHOBLASTIC-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; HEMATOPOIETIC STEM-CELLS; TARGETED GENE DISRUPTION; C-ABL; HOMOLOGOUS RECOMBINATION; PHILADELPHIA-CHROMOSOME; DIFFERENTIAL EXPRESSION; KINASE-ACTIVITY	The c-abl gene, originally identified as the cellular homolog of the transforming gene of the Abelson murine leukemia virus, encodes a protein-tyrosine kinase of unknown function that is expressed in all mammalian tissues. We have previously described the introduction of a mutation in the c-abl gene into the mouse germline via targeted gene disruption of embryonic stem cells. We now show that mice homozygous for this mutation are severely affected, displaying increased perinatal mortality, runtedness, and abnormal spleen, head, and eye development. We have examined components of the immune system and have found major reductions in B cell progenitors in the adult bone marrow, with less dramatic reductions in developing T cell compartments.	COLUMBIA UNIV COLL PHYS & SURG, DEPT MICROBIOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT GENET & DEV, NEW YORK, NY 10032 USA; HOFFMANN LA ROCHE INC, DEPT TOXICOL & PATHOL, NUTLEY, NJ 07110 USA	Columbia University; Columbia University; Roche Holding	SCHWARTZBERG, PL (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT BIOCHEM & MOLEC BIOPHYS, NEW YORK, NY 10032 USA.				NCI NIH HHS [P01 CA23767] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABELSON HT, 1970, CANCER RES, V30, P2213; BEN-NERIAH Y, 1986, CELL, V44, P577, DOI 10.1016/0092-8674(86)90267-9; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BOULTER CA, 1988, EXP CELL RES, V179, P214, DOI 10.1016/0014-4827(88)90360-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHAN LC, 1987, NATURE, V325, P635, DOI 10.1038/325635a0; CLARK SS, 1987, SCIENCE, V235, P85, DOI 10.1126/science.3541203; COFFMAN RL, 1981, NATURE, V289, P681, DOI 10.1038/289681a0; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207, DOI 10.1016/S0065-2776(08)60643-4; GERSHWIN ME, 1975, CLIN IMMUNOL IMMUNOP, V4, P324, DOI 10.1016/0090-1229(75)90002-1; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; HARDY RR, 1984, J EXP MED, V159, P1169, DOI 10.1084/jem.159.4.1169; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; HENKEMEYER M, 1990, CELL, V63, P949, DOI 10.1016/0092-8674(90)90498-4; HENKEMEYER MJ, 1987, CELL, V51, P821, DOI 10.1016/0092-8674(87)90105-X; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; HOGAN B, 1986, MANIPULATING MOUSE E; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471; KELLIHER MA, 1990, P NATL ACAD SCI USA, V87, P6649, DOI 10.1073/pnas.87.17.6649; KINCADE PW, 1989, ANNU REV IMMUNOL, V7, P111, DOI 10.1146/annurev.iy.07.040189.000551; KINCADE PW, 1981, J IMMUNOL METHODS, V13, P215; KONOPKA JB, 1984, J VIROL, V51, P223, DOI 10.1128/JVI.51.1.223-232.1984; KONOPKA JB, 1985, MOL CELL BIOL, V5, P3116, DOI 10.1128/MCB.5.11.3116; KRUH GD, 1990, P NATL ACAD SCI USA, V87, P5802, DOI 10.1073/pnas.87.15.5802; KURZROCK R, 1987, NATURE, V325, P631, DOI 10.1038/325631a0; LANE PW, 1968, J HERED, V59, P300, DOI 10.1093/oxfordjournals.jhered.a107725; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; MACKENSEN JUDITH A., 1960, JOUR HEREDITY, V51, P188; Maniatis T., 1982, MOL CLONING; MAYER BJ, 1991, P NATL ACAD SCI USA, V88, P627, DOI 10.1073/pnas.88.2.627; MELCHERS F, 1975, TRANSPLANT REV, V25, P26; MULLER R, 1982, NATURE, V299, P640, DOI 10.1038/299640a0; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NISHIKAWA SI, 1988, EUR J IMMUNOL, V18, P1767, DOI 10.1002/eji.1830181117; PARKS DR, 1986, HDB EXPT IMMUNOLOGY; PEI YF, 1970, ANAT REC, V168, P105, DOI 10.1002/ar.1091680109; PONZETTO C, 1989, ONCOGENE, V4, P685; PREMKUMAR E, 1975, CELL, V6, P149, DOI 10.1016/0092-8674(75)90005-7; RENSHAW MW, 1988, MOL CELL BIOL, V8, P4547, DOI 10.1128/MCB.8.10.4547; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; ROSENBERG N, 1988, ADV VIRUS RES, V35, P39; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHWARTZBERG PL, 1990, P NATL ACAD SCI USA, V87, P3210, DOI 10.1073/pnas.87.8.3210; SCHWARTZBERG PL, 1989, SCIENCE, V246, P799, DOI 10.1126/science.2554496; SEFTON BM, 1981, P NATL ACAD SCI-BIOL, V78, P1552, DOI 10.1073/pnas.78.3.1552; SIDEN EJ, 1979, CELL, V16, P389, DOI 10.1016/0092-8674(79)90014-X; SIRACUSA LD, 1990, GENOMICS, V6, P491, DOI 10.1016/0888-7543(90)90479-E; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; STEIN KF, 1967, DEV BIOL, V16, P315, DOI 10.1016/0012-1606(67)90045-0; Strickberger MW., 1976, GENETICS; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WILDE DB, 1983, J IMMUNOL, V131, P2178; WITTE ON, 1980, NATURE, V283, P826, DOI 10.1038/283826a0	61	313	322	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 28	1991	65	7					1165	1175		10.1016/0092-8674(91)90012-N	http://dx.doi.org/10.1016/0092-8674(91)90012-N			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FU899	2065353				2022-12-28	WOS:A1991FU89900009
J	SCHUCHAT, A; BROOME, CV; HIGHTOWER, A; COSTA, SJ; PARKIN, W				SCHUCHAT, A; BROOME, CV; HIGHTOWER, A; COSTA, SJ; PARKIN, W			USE OF SURVEILLANCE FOR INVASIVE PNEUMOCOCCAL DISEASE TO ESTIMATE THE SIZE OF THE IMMUNOSUPPRESSED HIV-INFECTED POPULATION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE-DEFICIENCY SYNDROME; PERSISTENT GENERALIZED LYMPHADENOPATHY; INTRAVENOUS DRUG-USERS; AIDS-RELATED COMPLEX; BACTERIAL PNEUMONIA; ANTIBODY-RESPONSES; BACTEREMIA; VACCINE	We used population-based surveillance in New Jersey in 1986 to quantify the risk of invasive pneumococcal disease in persons with the acquired immunodeficiency syndrome (AIDS) and in those who went on to develop AIDS. Using pneumococcal surveillance, we also devised a method to estimate the size of the immunosuppressed population infected with the human immunodeficiency virus (HIV), the so-called pre-AIDS population. From rates of pneumococcal disease that occurred in areas with a low incidence of AIDS, we calculated the number of patients expected to contract pneumococcal disease in areas with a high incidence of AIDS. There were 59 more cases of pneumococcal disease observed than expected; 14 of these patients had AIDS by the time of pneumococcal infection. We attributed the remaining 45 cases to the increased risk of pneumococcal infection in pre-AIDS. The pre-AIDS pneumococcal cases and the attack rate of pneumococcal disease in pre-AIDS were used to estimate the size of the 1986 pre-AIDS New Jersey population as 8823 pre-AIDS cases (95% confidence interval, 7377 to 10 714) or 0.37% of the adult New Jersey population. Surveillance for marker diseases may provide a simple, independent method of estimating the pre-AIDS population.	CTR DIS CONTROL,DIV BACTERIAL & MYCOT DIS,STAT SERV,ATLANTA,GA 30333; NEW JERSEY STATE DEPT HLTH,DIV AIDS PREVENT & CONTROL,DATA ANAL UNIT,TRENTON,NJ; NEW JERSEY STATE DEPT HLTH,DIV EPIDEMIOL & DIS CONTROL,TRENTON,NJ	Centers for Disease Control & Prevention - USA; New Jersey Department of Health & Senior Services; New Jersey Department of Health & Senior Services	SCHUCHAT, A (corresponding author), CTR DIS CONTROL,MENINGITIS & SPECIAL PATHOGENS BRANCH,BLDG 1,ROOM 4415,ATLANTA,GA 30333, USA.							AMMANN AJ, 1984, JAMA-J AM MED ASSOC, V251, P1447, DOI 10.1001/jama.251.11.1447; [Anonymous], MMWR MORB MORTAL WKL; [Anonymous], MMWR MORB MORTAL WKL; ARMITAGE P, 1987, STATISTICAL METHODS, P118; BALLET JJ, 1987, CLIN EXP IMMUNOL, V68, P479; BURKE DS, 1987, NEW ENGL J MED, V317, P131, DOI 10.1056/NEJM198707163170302; JANOFF EN, 1988, J INFECT DIS, V158, P983, DOI 10.1093/infdis/158.5.983; KLEIN RS, 1989, J INFECT DIS, V160, P826, DOI 10.1093/infdis/160.5.826; OCHS HD, 1988, J CLIN IMMUNOL, V8, P57, DOI 10.1007/BF00915157; PARKIN JM, 1989, AIDS, V3, P37, DOI 10.1097/00002030-198903010-00008; POLSKY B, 1986, ANN INTERN MED, V104, P38, DOI 10.7326/0003-4819-104-1-38; RAGNI MV, 1987, J LAB CLIN MED, V109, P545; REDD SC, 1990, J INFECT DIS, V162, P1012, DOI 10.1093/infdis/162.5.1012; SELWYN PA, 1988, AIDS, V2, P267, DOI 10.1097/00002030-198808000-00005; SIMBERKOFF MS, 1984, AM REV RESPIR DIS, V130, P1174; STONEBURNER R, 1988, 4 INT C AIDS STODKH; WHIMBEY E, 1986, ANN INTERN MED, V104, P511, DOI 10.7326/0003-4819-104-4-511; WITT DJ, 1987, AM J MED, V82, P900, DOI 10.1016/0002-9343(87)90150-1; 1988, SAS STAT USERS GUIDE, P690; 1988, MMWR, V37, P593	20	69	69	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1991	265	24					3275	3279		10.1001/jama.265.24.3275	http://dx.doi.org/10.1001/jama.265.24.3275			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR835	2046109				2022-12-28	WOS:A1991FR83500034
J	MAGGIONI, A; FRANZOSI, MG; FARINA, ML; SANTORO, E; CELANI, MG; RICCI, S; TOGNONI, G				MAGGIONI, A; FRANZOSI, MG; FARINA, ML; SANTORO, E; CELANI, MG; RICCI, S; TOGNONI, G			CEREBROVASCULAR EVENTS AFTER MYOCARDIAL-INFARCTION - ANALYSIS OF THE GISSI TRIAL	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives - To describe the epidemiology of cerebrovascular events in patients given or not given fibrinolytic treatment and to assess the prognostic implications and risk factors. Design - Case series derived from the GISSI randomised trial. Setting - 176 coronary care units in Italy giving various levels of care. Patients - 5860 patients with acute myocardial infarction treated with 1.5 million units of intravenous streptokinase and 5852 patients not given fibrinolytic treatment. Main outcome measures - Cerebrovascular event, sex, age, blood pressure, history of previous infarct, site of infarction, and Killip class. Results - 99 of 11712 patients (0.84%) had a cerebrovascular event. Older age, worse Killip class, and anterior location of infarction seemed to be risk factors for cerebrovascular events (40/3201 aged 65-75 v 42/7295 aged < 65, odds ratio 2.18; 9/437 class 3 v 55/8277 class 1, 1.81; and 57/4878 anterior v 24/4013 posterior, 1.96). No significant difference was found in the rate of cerebrovascular events between patients treated with streptokinase and controls (45/5852 (0.92%) streptokinase v 54/5860 (0.77) control). More patients in the streptokinase group than in the control group had cerebrovascular events (especially haemorrhagic strokes) on day 0-1 after randomisation (27 streptokinase v 7, control), although this was balanced by late events in control patients (54 streptokinase v 45 control at one year). The mortality of patients who had a cerebrovascular event was higher than that of those who did not (47% (47/99) v 11.6% (1350/11 613)). Conclusions - Although the incidence of cerebrovascular events complicating myocardial infarction was low, they increased morbidity and mortality. Treatment with streptokinase did not significantly alter the incidence, but age and poor haemodynamic state were associated with an increased risk.	UNIV PERUGIA, NEUROL CLIN, I-06100 PERUGIA, ITALY	University of Perugia	MAGGIONI, A (corresponding author), MARIO NEGRI INST PHARMACOL RES, VIA ERITREA 62, I-20157 MILAN, ITALY.		Maggioni, Aldo Pietro/AAL-5334-2020; celani, maria grazia/AAF-4143-2020; santoro, eugenio/ABG-7901-2020	Maggioni, Aldo Pietro/0000-0003-2764-6779; santoro, eugenio/0000-0002-5719-9896; celani, maria grazia/0000-0002-0739-4140				[Anonymous], 1990, LANCET, V336, P65; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1989, NEW ENGL J MED, V320, P618; [Anonymous], 1969, Br Med J, V1, P335; ASINGER RW, 1981, NEW ENGL J MED, V305, P297, DOI 10.1056/NEJM198108063050601; CALIFF RM, 1988, ACUTE CORONARY CARE, P539; CHAMBERLAIN DA, 1990, LANCET, V335, P427; CHIN P L, 1977, Age and Ageing, V6, P29, DOI 10.1093/ageing/6.1.29; DIMANT J, 1977, STROKE, V8, P449, DOI 10.1161/01.STR.8.4.448; FULTON RM, 1976, LANCET, V2, P1161; GRINES CL, 1990, J AM COLL CARDIOL, V16, P223, DOI 10.1016/0735-1097(90)90482-5; JOHANNESSEN KA, 1988, BRIT HEART J, V60, P104; KOMRAD MS, 1984, NEUROLOGY, V34, P1403, DOI 10.1212/WNL.34.11.1403; MCALLEN PM, 1977, J NEUROL NEUROSUR PS, V40, P951, DOI 10.1136/jnnp.40.10.951; OCONNOR CM, 1990, J AM COLL CARDIOL, V16, P533, DOI 10.1016/0735-1097(90)90338-P; PULETTI M, 1987, ITAL J NEUROL SCI, V8, P245, DOI 10.1007/BF02337481; SCHRODER R, 1986, NEW ENGL J MED, V314, P1465; THOMPSON PL, 1978, BRIT MED J, V2, P457, DOI 10.1136/bmj.2.6135.457; TURPIE AGG, 1989, NEW ENGL J MED, V320, P352, DOI 10.1056/NEJM198902093200604; WEINREICH DJ, 1984, ANN INTERN MED, V100, P789, DOI 10.7326/0003-4819-100-6-789; WILCOX RG, 1988, LANCET, V2, P525; YUSUF S, 1985, EUR HEART J, V6, P556, DOI 10.1093/oxfordjournals.eurheartj.a061905; 1973, JAMA-J AM MED ASSOC, V225, P724; 1986, LANCET, V1, P297	24	72	73	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	1991	302	6790					1428	1431		10.1136/bmj.302.6790.1428	http://dx.doi.org/10.1136/bmj.302.6790.1428			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR403	2070108	Green Published, Bronze			2022-12-28	WOS:A1991FR40300020
J	CURFMAN, GD				CURFMAN, GD			STEIN-BOCKENHEIM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 7	1990	264	17					2283	2283						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF488	2094241				2022-12-28	WOS:A1990EF48800035
J	BEAUCHAMP, DE; ROUSE, RL				BEAUCHAMP, DE; ROUSE, RL			UNIVERSAL NEW-YORK HEALTH-CARE - A SINGLE-PAYER STRATEGY LINKING COST CONTROL AND UNIVERSAL ACCESS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									SUNY ALBANY,SCH PUBL HLTH,ALBANY,NY 12222	State University of New York (SUNY) System; State University of New York (SUNY) Albany	BEAUCHAMP, DE (corresponding author), NEW YORK STATE DEPT HLTH,DIV PLANNING POLICY & RESOURCE DEV,EMPIRE STATE PLAZA,ALBANY,NY 12237, USA.							Bodenheimer T S, 1989, Med Care Rev, V46, P3, DOI 10.1177/107755878904600102; ENTHOVEN A, 1989, NEW ENGL J MED, V320, P94, DOI 10.1056/NEJM198901123200205; ENTHOVEN A, 1989, NEW ENGL J MED, V320, P29, DOI 10.1056/NEJM198901053200106; ENTHOVEN AC, 1988, HEALTH AFFAIR, V7, P25, DOI 10.1377/hlthaff.7.3.25; EVANS RG, 1989, NEW ENGL J MED, V320, P571, DOI 10.1056/NEJM198903023200906; EVANS RG, 1986, J HEALTH POLIT POLIC, V11, P585, DOI 10.1215/03616878-11-4-585; HIMMELSTEIN DU, 1986, NEW ENGL J MED, V314, P441, DOI 10.1056/NEJM198602133140710; HIMMELSTEIN DU, 1989, NEW ENGL J MED, V320, P102, DOI 10.1056/NEJM198901123200206; VLADECK BC, TREATING SYMPTOMS; 1989, POLICY RESOURCE DEV; 1987, ANN REPORT SMALL BUS	11	19	20	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	1990	323	10					640	644		10.1056/NEJM199009063231005	http://dx.doi.org/10.1056/NEJM199009063231005			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DW787	2100984				2022-12-28	WOS:A1990DW78700005
J	SZILAGYI, PG; ROGHMANN, KJ; FOYE, HR; PARKS, C; MACWHINNEY, J; MILLER, R; NAZARIAN, L; MCINERNY, T; KLEIN, S				SZILAGYI, PG; ROGHMANN, KJ; FOYE, HR; PARKS, C; MACWHINNEY, J; MILLER, R; NAZARIAN, L; MCINERNY, T; KLEIN, S			THE EFFECT OF INDEPENDENT PRACTICE ASSOCIATION PLANS ON USE OF PEDIATRIC AMBULATORY MEDICAL-CARE IN ONE GROUP-PRACTICE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											SZILAGYI, PG (corresponding author), UNIV ROCHESTER,STRONG MEM HOSP,DEPT PEDIAT,DIV GEN PEDIAT & ADOLESCENT MED,601 ELMWOOD AVE,ROCHESTER,NY 14642, USA.				AHRQ HHS [I F32 HS0001801] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ASHCRAFT M, 1978, MED CARE, V16, P14, DOI 10.1097/00005650-197801000-00002; BICE TW, 1975, MED CARE, V13, P698, DOI 10.1097/00005650-197508000-00011; Brown Lawrence D., 1983, POLITICS HLTH CARE O; BUCHANAN JL, 1986, MED CARE, V24, P39, DOI 10.1097/00005650-198601000-00005; Cochran W.G, 1957, STAT METHODS, V6th ed; Duan N., 1983, J BUS STAT, V1, P115, DOI DOI 10.2307/1391852; GAUS CR, 1976, SOC SECUR BULL, V39, P3; Haggerty RJ, 1975, CHILD HLTH COMMUNITY; Hellinger F J, 1987, Health Care Financ Rev, V9, P55; HERSHEY JC, 1984, INQUIRY-J HEALTH CAR, V21, P349; HILLMAN AL, 1987, NEW ENGL J MED, V317, P1743, DOI 10.1056/NEJM198712313172725; Hollingshead AA., 1957, 2 FACTOR INDEX SOCIA; HORNBROOK MC, 1985, MED CARE, V23, P484, DOI 10.1097/00005650-198505000-00011; IGLEHART JK, 1984, NEW ENGL J MED, V310, P1203, DOI 10.1056/NEJM198405033101837; JACKSONBEECK M, 1983, JAMA-J AM MED ASSOC, V250, P2826, DOI 10.1001/jama.250.20.2826; LEIBOWITZ A, 1985, PEDIATRICS, V75, P942; LONG T, 1975, PEDIATRICS, V6, P295; LUFT HS, 1981, HLTH MAINTENANCE ORG; MANNING WG, 1984, NEW ENGL J MED, V310, P1505, DOI 10.1056/NEJM198406073102305; MCINERNY TK, 1978, PEDIATRICS, V61, P389, DOI 10.1542/peds.61.3.389; PERKOFF GT, 1976, MED CARE, V14, P432, DOI 10.1097/00005650-197605000-00005; PERRIN JM, 1984, PEDIATR CLIN N AM, V31, P235; ROGHMANN K, 1975, PUBLIC HEALTH REP, V90, P516; ROGHMANN KJ, 1984, PEDIATRICS, V73, P363; ROGHMANN KJ, 1977, COHORT ANAL IMPACT 3; SCITOVSKY AA, 1981, SOC SCI MED-MED ECON, V15, P107, DOI 10.1016/0160-7995(81)90024-1; STARFIELD B, 1985, PEDIATRICS, V76, P14; VALDEZ RB, 1989, PEDIATRICS, V83, P168; VALDEZ RB, 1986, R3270HHS RAND CORP P; WARE JE, 1986, LANCET, V1, P1017; Wilensky G R, 1986, Health Aff (Millwood), V5, P66, DOI 10.1377/hlthaff.5.1.66; ZUCKERMAN AE, 1975, PEDIATRICS, V56, P407; 1980, HLTH MAINTENANCE ORG; 1981, PHS841736 US DEP 13	34	16	16	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	1990	263	16					2198	2203		10.1001/jama.263.16.2198	http://dx.doi.org/10.1001/jama.263.16.2198			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ676	2108261				2022-12-28	WOS:A1990CZ67600034
J	HOLAHAN, J; DOR, A; ZUCKERMAN, S				HOLAHAN, J; DOR, A; ZUCKERMAN, S			UNDERSTANDING THE RECENT GROWTH IN MEDICARE PHYSICIAN EXPENDITURES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											HOLAHAN, J (corresponding author), URAL FERROUS MET RES INST,2100 M ST NW,SVERDLOVSK,USSR.							FEDER J, 1987, NEW ENGL J MED, V317, P867, DOI 10.1056/NEJM198710013171405; HOLAHAN J, 1989, 365006 URB I WORK PA; RUSSELL LB, 1989, NEW ENGL J MED, V320, P439, DOI 10.1056/NEJM198902163200706; 1988, ANN REPORT C	4	36	36	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	1990	263	12					1658	1661		10.1001/jama.263.12.1658	http://dx.doi.org/10.1001/jama.263.12.1658			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT964	2106592				2022-12-28	WOS:A1990CT96400030
J	WYATT, TD; PASSMORE, CM; MORROW, NC; REILLY, PM				WYATT, TD; PASSMORE, CM; MORROW, NC; REILLY, PM			ANTIBIOTIC PRESCRIBING - THE NEED FOR A POLICY IN GENERAL-PRACTICE	BRITISH MEDICAL JOURNAL			English	Article									QUEENS UNIV BELFAST,DUNLUCE HLTH CTR,DEPT GEN PRACTICE,BELFAST BT7 1NN,ANTRIM,NORTH IRELAND	Queens University Belfast	WYATT, TD (corresponding author), MATER HOSP,BELFAST BT14 6AB,NORTH IRELAND.							AMYES S, 1989, MIMS            0201, P33; ESSEX B, 1989, BRIT MED J, V298, P1052, DOI 10.1136/bmj.298.6680.1052; FOX JS, 1988, INT PHARM J, V2, P7; FRAZER A, 1987, AUST FAM PHYSICIAN, V16, P1264; GOULD IM, 1988, J ANTIMICROB CHEMOTH, V22, P395, DOI 10.1093/jac/22.4.395; GRANT GB, 1985, LANCET, V1, P1030; HAMILTONMILLER JMT, 1984, BRIT J CLIN PHARMACO, V18, P469, DOI 10.1111/j.1365-2125.1984.tb02493.x; Howie J G, 1972, J R Coll Gen Pract, V22, P310; HOWIE JGR, 1989, BMJ-BRIT MED J, V298, P1008, DOI 10.1136/bmj.298.6679.1008; HOWIE JGR, 1980, BRIT MED J, V280, P836, DOI 10.1136/bmj.280.6217.836; HOWIE JRG, 1975, BRIT MED J, V2, P1061; LISS RH, 1987, REV INFECT DIS, V9, pS297; MAKI DG, 1978, AM J MED SCI, V275, P271, DOI 10.1097/00000441-197805000-00005; MORROW NC, 1986, AM J HOSP PHARM, V43, P360, DOI 10.1093/ajhp/43.2.360; NEEDHAM A, 1988, J ROY COLL GEN PRACT, V38, P166; PEDLER S, 1988, MIMS            0501, P25; Sutherland R, 1972, Br Med J, V3, P13; WILLIAMS JD, 1986, SCAND J INFECT DIS S, V49, P175; WYATT TD, 1976, BRIT MED J, V2, P1503, DOI 10.1136/bmj.2.6050.1503-a; WYATT TD, 1977, J ANTIMICROB CHEMOTH, V3, P213, DOI 10.1093/jac/3.3.213; 1987, BRIT NATIONAL FORMUL, P186; 1980, DRUG THER B, V18, P65; 1988, WHICH            NOV, P510; 1986, DRUG THER B, V24, P17; 1984, BRIT MED J, V289, P1397	25	23	23	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 17	1990	300	6722					441	444		10.1136/bmj.300.6722.441	http://dx.doi.org/10.1136/bmj.300.6722.441			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP166	2107899	Green Published, Bronze			2022-12-28	WOS:A1990CP16600024
J	PELL, ACH; FRIER, BM				PELL, ACH; FRIER, BM			RESTORATION OF PERCEPTION OF HYPOGLYCEMIA AFTER HEMIPARESIS IN AN INSULIN-DEPENDENT DIABETIC PATIENT	BRITISH MEDICAL JOURNAL			English	Article									ROYAL INFIRM,DEPT DIABET,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND	Royal Infirmary of Edinburgh			Frier, Brian/ABC-6941-2020					FRIER BM, 1986, DIABETIC MED, V3, P513, DOI 10.1111/j.1464-5491.1986.tb00807.x; LAWRENCE RD, 1967, LANCET, V1, P1321; MONTGOMERY BM, 1964, ARCH INTERN MED, V114, P680, DOI 10.1001/archinte.1964.03860110150017; NEIL HAW, 1987, DIABETOLOGIA, V30, P305, DOI 10.1007/BF00299022; SILAS JH, 1981, BRIT MED J, V282, P132, DOI 10.1136/bmj.282.6258.132	5	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					369	370		10.1136/bmj.300.6721.369	http://dx.doi.org/10.1136/bmj.300.6721.369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106989	Green Published, Bronze			2022-12-28	WOS:A1990CN79900022
J	TEASDALE, GM; MURRAY, G; ANDERSON, E; MENDELOW, AD; MACMILLAN, R; JENNETT, B; BROOKES, M				TEASDALE, GM; MURRAY, G; ANDERSON, E; MENDELOW, AD; MACMILLAN, R; JENNETT, B; BROOKES, M			RISKS OF ACUTE TRAUMATIC INTRACRANIAL HEMATOMA IN CHILDREN AND ADULTS - IMPLICATIONS FOR MANAGING HEAD-INJURIES	BRITISH MEDICAL JOURNAL			English	Article									UNIV GLASGOW,DEPT SURG,GLASGOW G12 8QQ,SCOTLAND; MONKLANDS DIST GEN HOSP,DEPT ACCID & EMERGENCY MED,AIRDRIE,LANARK,SCOTLAND	University of Glasgow	TEASDALE, GM (corresponding author), UNIV GLASGOW,SO GEN HOSP,INST NEUROL SCI,DEPT NEUROSURG,GLASGOW G51 4TF,SCOTLAND.		Mendelow, Alexander/AAW-2878-2021	Murray, Gordon/0000-0001-9866-4734				Bishop YM., 2007, DISCRETE MULTIVARIAT; BOWERS SA, 1980, NEUROSURGERY, V6, P237; BRICOLO AP, 1974, NEUROSURGERY, V14, P8; BRIGGS M, 1984, BRIT MED J, V288, P983; BROOKES M, IN PRESS J EPIDEMIOL; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; DERSHEWITZ RA, 1983, PEDIATRICS, V72, P602; DHELLEMMES P, 1985, J NEUROSURG, V62, P861, DOI 10.3171/jns.1985.62.6.0861; FOWKES FGR, 1984, LANCET, V2, P795; GALBRAITH S, 1973, LANCET, V2, P1217; GENTLEMAN D, 1981, LANCET, V2, P853; HEWER RL, 1989, BRIT MED J, V298, P1219, DOI 10.1136/bmj.298.6682.1219; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; Leggate JRS, 1989, BRIT J NEUROSURG, V3, P533, DOI 10.3109/02688698909002844; LEONIDAS JC, 1982, PEDIATRICS, V69, P139; MAZZA C, 1982, ACTA NEUROCHIR, V65, P67, DOI 10.1007/BF01405443; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; Miller J D, 1988, Brain Inj, V2, P83, DOI 10.3109/02699058809150934; MORRIS JA, 1988, BRIT MED J, V296, P1313, DOI 10.1136/bmj.296.6632.1313; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; ROSENTHAL BW, 1989, J PEDIATR-US, V115, P346, DOI 10.1016/S0022-3476(89)80830-3; SAINSBURY CPQ, 1984, ARCH DIS CHILD, V59, P856, DOI 10.1136/adc.59.9.856; SERVADEI F, 1988, SURG NEUROL, V30, P364, DOI 10.1016/0090-3019(88)90199-1; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; STRANG I, 1978, INJURY, V10, P154; SWANN I, 1982, INJURY, V12, P274; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; THILLAINAYAGAM K, 1987, INJURY, V18, P319, DOI 10.1016/0020-1383(87)90051-9; THORNBURY JR, 1987, AM J ROENTGENOL, V149, P781; 1983, LANCET, V1, P115	33	167	169	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					363	367		10.1136/bmj.300.6721.363	http://dx.doi.org/10.1136/bmj.300.6721.363			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106986	Green Published, Bronze			2022-12-28	WOS:A1990CN79900019
J	BLANC, PD; GALBO, M; HIATT, P; OLSON, KR				BLANC, PD; GALBO, M; HIATT, P; OLSON, KR			MORBIDITY FOLLOWING ACUTE IRRITANT INHALATION IN A POPULATION-BASED STUDY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OCCUPATIONAL EXPOSURES; DYSFUNCTION SYNDROME; CHLORINE GAS; ASTHMA; BRONCHIECTASIS; ILLNESS; DIOXIDE	Study Objective.-To estimate the incidence of and risk factors for morbidity due to inhalation of respiratory irritants. Design.-Six-month case series of inhalational exposures reported to a poison control center with follow-up, structured interviews of subjects. Setting.-A regional poison control center providing 24-hour telephone consultation to health professionals and the public. Patients.-Consecutive sample of 683 inhalation cases, with interviews of 323 subjects. Measurements and Main Results.-Moderate to severe irritants accounted for 160 (50%) of the inhalational exposures in interviewed subjects. Persistent symptoms lasting 14 days or longer were reported by only 20 (6%) of the subjects. Irritant exposure was a statistically significant risk factor for acute respiratory symptoms (relative risk [RR] = 1.7; 95% confidence interval [Cl], 1.4 to 2.1) but was unrelated to persistent symptoms. Preexisting lung conditions RR = 2.4; 95% Cl, 1.4 to 4.2) and cigarette smoking (RR = 1.7; 95% Cl, 1.3 to 2.2) were both statistically significant risk factors for persistent symptoms. Conclusions.-Symptomatic inhalational exposures due to irritants are frequent in reports from poison control centers. Residual morbidity was uncommon and did not appear to be statistically related to the degree of irritant exposure. Host-related factors may be better predictors of ongoing morbidity after inhalational exposure.	UNIV CALIF SAN FRANCISCO,SCH PHARM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,SCH MED,SAN FRANCISCO,CA 94143; SAN FRANCISCO BAY AREA REG POISON CONTROL CTR,SAN FRANCISCO,CA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	BLANC, PD (corresponding author), UNIV CALIF SAN FRANCISCO,DIV OCCUPAT & ENVIRONM MED,BOX 0924,SAN FRANCISCO,CA 94143, USA.				PHS HHS [R49CCR903697-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALFORD P T, 1988, Chest, V94, p87S; BECKLAKE MR, 1989, AM REV RESPIR DIS, V140, pS85, DOI 10.1164/ajrccm/140.3_Pt_2.S85; BLANC PD, 1989, ANN INTERN MED, V111, P238, DOI 10.7326/0003-4819-111-3-238; BOULET LP, 1988, CHEST, V94, P476, DOI 10.1378/chest.94.3.476; BROOKS SM, 1987, AM REV RESPIR DIS, V135, P268; BROOKS SM, 1985, CHEST, V88, P376, DOI 10.1378/chest.88.3.376; DEVINENI R, 1989, CHEST, V96, pS169; DOUGLAS WW, 1989, MAYO CLIN PROC, V64, P291, DOI 10.1016/S0025-6196(12)65249-5; FLETA J, 1986, HUM TOXICOL, V5, P99, DOI 10.1177/096032718600500205; HARKONEN H, 1983, AM REV RESPIR DIS, V128, P890; HEDBERG K, 1989, JAMA-J AM MED ASSOC, V262, P3014; KASS I, 1972, CHEST, V62, P282, DOI 10.1378/chest.62.3.282; KORN RJ, 1987, AM REV RESPIR DIS, V136, P298, DOI 10.1164/ajrccm/136.2.298; KRAUT A, 1988, CHEST, V94, P208, DOI 10.1378/chest.94.1.208; LERMAN S, 1988, AM FAM PHYSICIAN, V38, P135; LITOVITZ TL, 1990, AM J EMERG MED, V8, P394, DOI 10.1016/0735-6757(90)90234-Q; MITCHELL JT, 1989, CHEST, V96, pS169; MORABIA A, 1988, INT J EPIDEMIOL, V17, P148, DOI 10.1093/ije/17.1.148; RABONOWITZ S, 1989, AM REV RESPIR DIS, V139, P556; SCHWARTZ DA, 1987, OCCUP MED, V2, P297; SCHWARTZ DA, 1990, CHEST, V97, P820, DOI 10.1378/chest.97.4.820; SEGEV JS, 1983, CHEST, V83, P169; SLUTZKER AD, 1989, CHEST, V95, P1349, DOI 10.1378/chest.95.6.1349; SUMMER W, 1981, CLIN CHEST MED, V2, P273; TARLO SM, 1989, CHEST, V96, P297, DOI 10.1378/chest.96.2.297; WALD PH, 1987, INTENS CARE MED, V2, P260; 1983, MMWR, V32, P541	27	29	29	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	1991	266	5					664	669		10.1001/jama.266.5.664	http://dx.doi.org/10.1001/jama.266.5.664			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ140	2072476				2022-12-28	WOS:A1991FZ14000024
J	SCHIERING, N; KABSCH, W; MOORE, MJ; DISTEFANO, MD; WALSH, CT; PAI, EF				SCHIERING, N; KABSCH, W; MOORE, MJ; DISTEFANO, MD; WALSH, CT; PAI, EF			STRUCTURE OF THE DETOXIFICATION CATALYST MERCURIC ION REDUCTASE FROM BACILLUS SP STRAIN-RC607	NATURE			English	Article							X-RAY-DIFFRACTION; GLUTATHIONE-REDUCTASE; ACTIVE-SITE; ORGANOMERCURIAL LYASE; NUCLEOTIDE-SEQUENCE; BINDING; ENZYME; MUTANT; NADPH; PURIFICATION	SEVERAL hundred million tons of toxic mercurials are dispersed in the biosphere 1. Microbes can detoxify organo-mercurials and mercury salts through sequential action of two enzymes, organomercury lyase 2 and mercuric ion reductase (MerA) 3-5. The latter, a homodimer with homology to the FAD-dependent disulphide oxidoreductases 6, catalyses the reaction NADPH + Hg(II) --> NADP+ + H+ + Hg(0), one of the very rare enzymic reactions with metal substrates. Human glutathione reductase 7,8 serves as a reference molecule for FAD-dependent disulphide reductases and between its primary structure 9 and that of MerA from Tn501 (Pseudomonas), Tn21 (Shigella), pI258 (Staphylococcus) and Bacillus, 25-30% of the residues have been conserved 10,11. All MerAs have a C-terminal extension about 15 residues long but have very varied N termini. Although the enzyme from Streptomyces lividans has no addition, from Pseudomonas aeruginosa Tn501 and Bacillus sp. strain RC607 it has one and two copies respectively of a domain of 80-85 residues, highly homologous to MerP, the periplasmic component of proteins encoded by the mer operon 11. These domains can be proteolytically cleaved off without changing the catalytic efficiency 3. We report here the crystal structure of MerA from the Gram-positive bacterium Bacillus sp. strain RC607. Analysis of its complexes with nicotinamide dinucleotide substrates and the inhibitor Cd(II) reveals how limited structural changes enable an enzyme to accept as substrate what used to be a dangerous inhibitor. Knowledge of the mode of mercury ligation is a prerequisite for understanding this unique detoxification mechanism.	HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,240 LONGWOOD AVE,BOSTON,MA 02115; MAX PLANCK INST MED RES,BIOPHYS ABT,W-6900 HEIDELBERG 1,GERMANY	Harvard University; Harvard Medical School; Max Planck Society			Pai, Emil F/D-2526-2013; Pai, Emil/R-8908-2019	Pai, Emil/0000-0002-1162-7242				BEGLEY TP, 1986, BIOCHEMISTRY-US, V25, P7186, DOI 10.1021/bi00370a063; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; DICKERSO.RE, 1968, ACTA CRYSTALL B-STRU, VB 24, P997, DOI 10.1107/S0567740868003626; DISTEFANO MD, 1989, BIOCHEMISTRY-US, V28, P1168, DOI 10.1021/bi00429a035; DISTEFANO MD, 1990, BIOCHEMISTRY-US, V29, P2703, DOI 10.1021/bi00463a013; DISTEFANO MD, 1989, THESIS MIT; FOX B, 1982, J BIOL CHEM, V257, P2498; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARPLUS PA, 1987, J MOL BIOL, V195, P701, DOI 10.1016/0022-2836(87)90191-4; KARPLUS PA, 1989, J MOL BIOL, V210, P163, DOI 10.1016/0022-2836(89)90298-2; KRAUTHSIEGEL RL, 1982, EUR J BIOCHEM, V121, P259, DOI 10.1111/j.1432-1033.1982.tb05780.x; KURIYAN J, 1991, NATURE, V352, P172, DOI 10.1038/352172a0; LADDAGA RA, 1987, P NATL ACAD SCI USA, V84, P5106, DOI 10.1073/pnas.84.15.5106; MATTEVI A, IN PRESS J MOL BIOL; MILLER SM, 1991, BIOCHEMISTRY-US, V30, P2600, DOI 10.1021/bi00224a006; MILLER SM, 1990, BIOCHEMISTRY-US, V29, P2831, DOI 10.1021/bi00463a028; MILLER SM, 1989, BIOCHEMISTRY-US, V28, P1194, DOI 10.1021/bi00429a037; MILLER SM, 1986, J BIOL CHEM, V261, P8081; MISRA TK, 1985, GENE, V34, P253, DOI 10.1016/0378-1119(85)90134-9; MOORE MJ, 1989, J BIOL CHEM, V264, P14386; MOORE MJ, 1990, ACCOUNTS CHEM RES, V23, P301, DOI 10.1021/ar00177a006; PAI EF, 1983, J BIOL CHEM, V258, P1752; PAI EF, 1988, BIOCHEMISTRY-US, V27, P4465, DOI 10.1021/bi00412a038; PRIESTLE JP, 1988, J APPL CRYSTALLOGR, V21, P572, DOI 10.1107/S0021889888005746; RAYBUCK SA, 1990, J AM CHEM SOC, V112, P1983, DOI 10.1021/ja00161a051; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; RINDERLE SJ, 1983, BIOCHEMISTRY-US, V22, P869, DOI 10.1021/bi00273a025; SAHLMAN L, 1986, EUR J BIOCHEM, V156, P479, DOI 10.1111/j.1432-1033.1986.tb09606.x; SUMMERS AO, 1978, ANNU REV MICROBIOL, V32, P637, DOI 10.1146/annurev.mi.32.100178.003225; WANG Y, 1989, J BACTERIOL, V171, P83, DOI 10.1128/jb.171.1.83-92.1989; WILLIAMS CH, 1976, ENZYMES            C, V13, P90	35	175	180	2	34	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 11	1991	352	6331					168	172		10.1038/352168a0	http://dx.doi.org/10.1038/352168a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW097	2067577				2022-12-28	WOS:A1991FW09700061
J	WERY, JP; SCHEVITZ, RW; CLAWSON, DK; BOBBITT, JL; DOW, ER; GAMBOA, G; GOODSON, T; HERMANN, RB; KRAMER, RM; MCCLURE, DB; MIHELICH, ED; PUTNAM, JE; SHARP, JD; STARK, DH; TEATER, C; WARRICK, MW; JONES, ND				WERY, JP; SCHEVITZ, RW; CLAWSON, DK; BOBBITT, JL; DOW, ER; GAMBOA, G; GOODSON, T; HERMANN, RB; KRAMER, RM; MCCLURE, DB; MIHELICH, ED; PUTNAM, JE; SHARP, JD; STARK, DH; TEATER, C; WARRICK, MW; JONES, ND			STRUCTURE OF RECOMBINANT HUMAN RHEUMATOID ARTHRITIC SYNOVIAL-FLUID PHOSPHOLIPASE-A2 AT 2.2 A RESOLUTION	NATURE			English	Article							BOVINE PANCREATIC PHOSPHOLIPASE-A2; TRANSITION-STATE ANALOG; CRYSTAL-STRUCTURE; EXTRACELLULAR PHOSPHOLIPASE-A2; VENOM PHOSPHOLIPASE-A2; NUCLEIC-ACIDS; FORCE-FIELD; PURIFICATION; EXPRESSION; REFINEMENT	PHOSPHOLIPASES A2 (PLA2s) may be grouped into distinct families of proteins that catalyse the hydrolysis of the 2-acyl bond of phospholipids and perform a variety of biological functions. The best characterized are the small (relative molecular mass approximately 14,000) calcium-dependent, secretory enzymes of diverse origin, such as pancreatic and venom PLA2s 1. The structures and functions of several PLA2s are known 2. Recently, high-resolution crystal structures of complexes of secretory PLA2s with phosphonate phospholipid analogues have provided information about the detailed stereochemistry of transition-state binding 3, confirming the proposed catalytic mechanism of esterolysis 4. By contrast, studies on mammalian nonpancreatic secretory PLA2S (s-PLA2S) have only recently begun; s-PLA2S are scarce in normal cells and tissues but large amounts are found in association with local and systemic inflammatory processes and tissue injury in animals and man 5-7. Such s-PLAs have been purified from rabbit and rat inflammatory exudate 8,9, from synovial fluid from patients with rheumatoid arthritis 10,11 and from human platelets 11. Cloning and sequencing shows that the primary structure of the human s-PLA2 11,12 has about 37% homology with that of bovine pancreatic PLA2 13 and 44% homology with that of Crotalus atrox PLA2 14. The human s-PLA2 is an unusually basic protein, yet contains most of the highly conserved amino-acid residues and sequences characteristic of the PLA2S sequenced so far 1,15. Here we report the refined, three-dimensional crystal structure at 2.2 angstrom resolution of recombinant human rheumatoid arthritic synovial fluid PLA2. This may aid the development of potent and specific inhibitors of this enzyme using structure-based design.			WERY, JP (corresponding author), ELI LILLY & CO,LILLY RES LAB,LILLY CORP CTR,INDIANAPOLIS,IN 46285, USA.							BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNIE S, 1985, J BIOL CHEM, V260, P9742; CHANG HW, 1987, J BIOCHEM, V102, P147, DOI 10.1093/oxfordjournals.jbchem.a122026; CHANG J, 1987, BIOCHEM PHARMACOL, V36, P2429, DOI 10.1016/0006-2952(87)90512-0; DAVIDSON FF, 1990, J MOL EVOL, V31, P228, DOI 10.1007/BF02109500; DIJKSTRA BW, 1981, J MOL BIOL, V147, P97, DOI 10.1016/0022-2836(81)90081-4; FLEER EAM, 1978, EUR J BIOCHEM, V82, P261, DOI 10.1111/j.1432-1033.1978.tb12019.x; FORST S, 1986, BIOCHEMISTRY-US, V25, P8381, DOI 10.1021/bi00374a008; GRINNELL BW, 1987, BIO-TECHNOL, V5, P1189, DOI 10.1038/nbt1187-1189; HEINRIKSON RL, 1991, METHOD ENZYMOL, V197, P210; Hendrickson W. A., 1981, BIOMOLECULAR STRUCTU, V1, P43; HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Kramer R M, 1990, Adv Exp Med Biol, V275, P35; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; RANDOLPH A, 1982, J BIOL CHEM, V257, P2155; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788; SEILHAMER JJ, 1989, J BIOL CHEM, V264, P5335; STEFANSKI E, 1986, J BIOCHEM-TOKYO, V100, P1297, DOI 10.1093/oxfordjournals.jbchem.a121836; THUNNISSEN MMGM, 1990, NATURE, V347, P689, DOI 10.1038/347689a0; VADAS P, 1986, LAB INVEST, V55, P391; VADAS P, 1988, AGENTS ACTIONS, V24, P320, DOI 10.1007/BF02028289; VERHEIJ HM, 1980, BIOCHEMISTRY-US, V19, P743, DOI 10.1021/bi00545a021; WAITE M, 1987, PHOSPHOLIPASES, P155; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WHITE SP, 1990, SCIENCE, V250, P1560, DOI 10.1126/science.2274787	29	229	243	0	7	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1991	352	6330					79	82		10.1038/352079a0	http://dx.doi.org/10.1038/352079a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV178	2062381				2022-12-28	WOS:A1991FV17800076
J	HEALY, B				HEALY, B			GENETIC-MARKER FOR LONG QT SYNDROME IDENTIFIED	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											HEALY, B (corresponding author), NIH,BETHESDA,MD 20892, USA.							1991, SCIENCE, V252, P704	1	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	1991	266	1					19	19						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT934	2046123				2022-12-28	WOS:A1991FT93400005
J	HOROWITZ, MM; MESSERER, D; HOELZER, D; GALE, RP; NEISS, A; ATKINSON, K; BARRETT, AJ; BUCHNER, T; FREUND, M; HEIL, G; HIDDEMANN, W; KOLB, HJ; LOFFLER, H; MARMONT, AM; MASCHMEYER, G; RIMM, AA; ROZMAN, C; SOBOCINSKI, KA; SPECK, B; THIEL, E; WEISDORF, DJ; ZWAAN, FE; BORTIN, MM				HOROWITZ, MM; MESSERER, D; HOELZER, D; GALE, RP; NEISS, A; ATKINSON, K; BARRETT, AJ; BUCHNER, T; FREUND, M; HEIL, G; HIDDEMANN, W; KOLB, HJ; LOFFLER, H; MARMONT, AM; MASCHMEYER, G; RIMM, AA; ROZMAN, C; SOBOCINSKI, KA; SPECK, B; THIEL, E; WEISDORF, DJ; ZWAAN, FE; BORTIN, MM			CHEMOTHERAPY COMPARED WITH BONE-MARROW TRANSPLANTATION FOR ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN 1ST REMISSION	ANNALS OF INTERNAL MEDICINE			English	Article						BONE MARROW TRANSPLANTATION; LEUKEMIA, LYMPHOCYTIC, ACUTE; ANTINEOPLASTIC AGENTS, COMBINED; CHEMOTHERAPY; LEUKEMIA, REMISSION	SURVIVAL; THERAPY	Objective: To compare efficacy of intensive postremission chemotherapy with allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia (ALL) in first remission. Design: Retrospective comparison of two cohorts of patients. Setting: Chemotherapy recipients were treated in 44 hospitals in West Germany in two cooperative group trials; transplants were done in 98 hospitals worldwide. Patients: Patients (484) receiving intensive postremission chemotherapy and 251 recipients of HLA-identical sibling bone marrow transplants for ALL in first remission. Patients ranged from 15 to 45 years of age and were treated between 1980 and 1987. Main Results: Similar prognostic factors predicted treatment failure (non-T-cell phenotype, high leukocyte count at diagnosis, and 8 or more weeks to achieve first remission) of both therapies. After statistical adjustments were made for differences in disease characteristics and time-to-treatment, survival was similar in the chemotherapy and transplant cohorts: Five-year leukemia-free survival probability was 38% (95% Cl, 33% to 43%) with chemotherapy and 44% (Cl, 37% to 52%) with transplant. No specific prognostic group had a significantly better outcome with one treatment compared with the other (6% for the difference; Cl, - 3% to 15%). Causes of treatment failure differed: With chemotherapy, 268 (96%) failures were from relapse and 11 (4%) were treatment-related; with transplants, 43 (32%) failures were from relapse and 92 (68%) were treatment-related. Conclusions: These results suggest that bone marrow transplants currently offer no special advantage over chemotherapy for adults with acute lymphoblastic leukemia in first remission.	UNIV FRANKFURT, W-6000 FRANKFURT 1, GERMANY; UNIV CALIF LOS ANGELES, LOS ANGELES, CA 90024 USA; UNIV INNSBRUCK, A-6020 INNSBRUCK, AUSTRIA; ST VINCENTS HOSP, DARLINGHURST, NSW 2010, AUSTRALIA; ROYAL POSTGRAD MED SCH, LONDON W12 0HS, ENGLAND; UNIV MUNSTER, W-4400 MUNSTER, GERMANY; UNIV HANOVER, W-3000 HANNOVER, GERMANY; UNIV ULM, W-7900 ULM, GERMANY; UNIV MUNICH, W-8000 MUNICH 2, GERMANY; UNIV KIEL, W-2300 KIEL 1, GERMANY; EV KRANKENHAUS ESSEN WERDEN, ESSEN, GERMANY; UNIV BARCELONA, BARCELONA 7, SPAIN; UNIV BASEL, MED KLIN, CH-4051 BASEL, SWITZERLAND; FREE UNIV BERLIN, W-1000 BERLIN 33, GERMANY; UNIV MINNESOTA, MINNEAPOLIS, MN 55455 USA; RIYADH ARMED FORCES HOSP, RIYADH, SAUDI ARABIA; BIOMETR CTR THERAPEUT STUDIES, MUNICH, GERMANY; OSPED SAN MARTINO GENOVA, GENOA, ITALY	Goethe University Frankfurt; University of California System; University of California Los Angeles; University of Innsbruck; St Vincents Hospital Sydney; Imperial College London; University of Munster; Leibniz University Hannover; Ulm University; University of Munich; University of Kiel; University of Barcelona; University of Basel; Free University of Berlin; University of Minnesota System; University of Minnesota Twin Cities; Prince Sultan Military Medical City; University of Genoa; IRCCS AOU San Martino IST	HOROWITZ, MM (corresponding author), MED COLL WISCONSIN, INT BONE MARROW TRANSPLANT REGISTRY, POB 26509, MILWAUKEE, WI 53226 USA.		horowitz, Mary/ABH-2173-2021		NCI NIH HHS [CA 40053] Funding Source: Medline; PHS HHS [N01-A1-62530] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA040053] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARRETT AJ, 1989, BLOOD, V74, P862; BARRETT AJ, 1982, BRIT J HAEMATOL, V52, P181, DOI 10.1111/j.1365-2141.1982.tb03879.x; BEGG CB, 1984, J CLIN ONCOL, V2, P369, DOI 10.1200/JCO.1984.2.5.369; BERKSON J, 1950, P STAFF M MAYO CLIN, V25, P270; BLACKLOCK HA, 1981, CANCER, V48, P1931, DOI 10.1002/1097-0142(19811101)48:9<1931::AID-CNCR2820480903>3.0.CO;2-D; BLUME KG, 1987, TRANSPLANTATION, V43, P389, DOI 10.1097/00007890-198703000-00014; CHAO NJ, 1990, ANN INTERN MED, V113, P340, DOI 10.7326/0003-4819-113-5-340; CLIFT R, 1989, BONE MARROW TRANSPL, V4, P445; COX DR, 1972, J R STAT SOC B, V34, P187; DONEY K, 1987, BONE MARROW TRANSPL, V2, P355; FORMAN SJ, 1987, BLOOD, V70, P587; GALE RP, 1989, LANCET, V1, P1119; GALE RP, 1987, BRIT J HAEMATOL, V65, P261, DOI 10.1111/j.1365-2141.1987.tb06851.x; HERMANS J, 1989, EUR J CANCER CLIN ON, V25, P545, DOI 10.1016/0277-5379(89)90268-X; HERZIG RH, 1987, LANCET, V1, P786; HOELZER D, 1984, BLOOD, V64, P38; HOELZER D, 1988, BLOOD, V71, P123, DOI 10.1182/blood.V71.1.123.123; KERSEY JH, 1987, NEW ENGL J MED, V317, P461, DOI 10.1056/NEJM198708203170801; MARCUS RE, 1986, BRIT J CANCER, V53, P175, DOI 10.1038/bjc.1986.32; MCCARTHY DM, 1988, BONE MARROW TRANSPL, V3, P315; MOON TE, 1984, STAT MED, V3, P333, DOI 10.1002/sim.4780030408; PROCTOR S J, 1987, Bone Marrow Transplantation, V2, P21; RAMSAY NKC, 1990, BLOOD, V75, P815; SANCHEZFAYOS J, 1985, BRIT J HAEMATOL, V59, P689, DOI 10.1111/j.1365-2141.1985.tb07364.x; SCHAUER P, 1983, J CLIN ONCOL, V1, P462, DOI 10.1200/JCO.1983.1.8.462; VERNANT JP, 1988, J CLIN ONCOL, V6, P227, DOI 10.1200/JCO.1988.6.2.227; WEISDORF DJ, 1987, J CLIN ONCOL, V5, P1348, DOI 10.1200/JCO.1987.5.9.1348; ZANDER AR, 1988, J CLIN ONCOL, V6, P1548, DOI 10.1200/JCO.1988.6.10.1548; ZWAAN FE, 1984, BRIT J HAEMATOL, V58, P33, DOI 10.1111/j.1365-2141.1984.tb06056.x; 1986, LANCET, V1, P952	30	162	164	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1991	115	1					13	18		10.7326/0003-4819-115-1-13	http://dx.doi.org/10.7326/0003-4819-115-1-13			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT937	2048858				2022-12-28	WOS:A1991FT93700003
J	OBRIEN, RJ				OBRIEN, RJ			HEPATOXIC REACTION TO ANTITUBERCULOUS DRUGS - ADJUSTMENTS TO THERAPEUTIC REGIMEN	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											OBRIEN, RJ (corresponding author), CTR DIS CONTROL,ATLANTA,GA 30333, USA.								0	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1991	265	24					3323	3323		10.1001/jama.265.24.3323	http://dx.doi.org/10.1001/jama.265.24.3323			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR835	2046117				2022-12-28	WOS:A1991FR83500045
J	POWER, RF; LYDON, JP; CONNEELY, OM; OMALLEY, BW				POWER, RF; LYDON, JP; CONNEELY, OM; OMALLEY, BW			DOPAMINE ACTIVATION OF AN ORPHAN OF THE STEROID-RECEPTOR SUPERFAMILY	SCIENCE			English	Article							COUP TRANSCRIPTION FACTOR; PROGESTERONE-RECEPTOR; MOLECULAR-CLONING; GENE; UPSTREAM; PHOSPHORYLATION; PURIFICATION; MEMBER; CELLS; DNA	The chicken ovalbumin upstream promoter transcription factor (COUP-TF) is a member of the steroid receptor superfamily and participates in the regulation of several genes. While a number of functions have been ascribed to COUP-TF, no ligand or activator molecule has been identified, and thus it is classified as one of a group of orphan receptors. Activation of COUP-TF by physiological concentrations of the neurotransmitter dopamine was observed in transient transfection assays. Treatment of transfected cells with the dopamine receptor agonist alpha-ergocryptine also activated COUP-dependent expression of a reporter gene. COUP-TF that contained a deletion in the COOH-terminal domain was not activated by these compounds. These observations suggest that dopamine may be a physiological activator of COUP-TF.	BAYLOR UNIV,DEPT CELL BIOL,HOUSTON,TX 77030	Baylor University								CONNEELY OM, 1989, J BIOL CHEM, V264, P14062; DEARRY A, 1990, NATURE, V347, P72, DOI 10.1038/347072a0; DENNER LA, 1989, ENDOCRINOLOGY, V125, P3051, DOI 10.1210/endo-125-6-3051; DENNER LA, 1990, SCIENCE, V250, P1740, DOI 10.1126/science.2176746; DROUIN J, 1989, GENOME, V31, P510, DOI 10.1139/g89-099; EHINGER B, 1983, PROGR RETINAL RES, V2, P213, DOI DOI 10.1016/0278-4327(83)90009-3; FELDER CC, 1989, J BIOL CHEM, V264, P8739; FELDER RA, 1984, AM J PHYSIOL, V247, pF499, DOI 10.1152/ajprenal.1984.247.3.F499; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; HWUNG YP, 1988, MOL CELL BIOL, V8, P2070, DOI 10.1128/MCB.8.5.2070; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; Makman M H, 1975, Adv Cyclic Nucleotide Res, V5, P661; MLODZIK M, 1990, CELL, V60, P211, DOI 10.1016/0092-8674(90)90737-Y; POWER R, UNPUB; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SULLIVAN WP, 1986, ENDOCRINOLOGY, V119, P1549, DOI 10.1210/endo-119-4-1549; WANG LH, 1987, J BIOL CHEM, V262, P16080; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; WATLING KJ, 1981, J NEUROCHEM, V36, P559, DOI 10.1111/j.1471-4159.1981.tb01628.x; WIJNHOLDS J, 1988, EMBO J, V7, P2757, DOI 10.1002/j.1460-2075.1988.tb03130.x; WONG GG, 1985, SCIENCE, V228, P810, DOI 10.1126/science.3923623	23	208	210	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1991	252	5012					1546	1548		10.1126/science.2047861	http://dx.doi.org/10.1126/science.2047861			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR040	2047861				2022-12-28	WOS:A1991FR04000046
J	MCCORMICK, A				MCCORMICK, A			EXCESS MORTALITY ASSOCIATED WITH THE HIV EPIDEMIC IN ENGLAND AND WALES	BRITISH MEDICAL JOURNAL			English	Article							TRENDS; AIDS				MCCORMICK, A (corresponding author), OFF POPULAT CENSUSES & SURVEYS,LONDON WC2B 6JP,ENGLAND.							BUEHLER JW, 1990, AM J PUBLIC HEALTH, V80, P1080, DOI 10.2105/AJPH.80.9.1080; DARBY SC, 1989, BMJ, V298, P1046; MARZUK PM, 1988, JAMA-J AM MED ASSOC, V259, P1333, DOI 10.1001/jama.259.9.1333; MCCORMICK A, 1988, BRIT MED J, V296, P1289, DOI 10.1136/bmj.296.6632.1289; 1988, MMWR, V37, P593	5	14	14	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 8	1991	302	6789					1375	1376		10.1136/bmj.302.6789.1375	http://dx.doi.org/10.1136/bmj.302.6789.1375			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR057	2059716	Bronze, Green Published			2022-12-28	WOS:A1991FR05700020
J	STEPHENS, SDG; CALLAGHAN, DE; HOGAN, S; MEREDITH, R; RAYMENT, A; DAVIS, AC				STEPHENS, SDG; CALLAGHAN, DE; HOGAN, S; MEREDITH, R; RAYMENT, A; DAVIS, AC			HEARING DISABILITY IN PEOPLE AGED 50-65 - EFFECTIVENESS AND ACCEPTABILITY OF REHABILITATIVE INTERVENTION	BRITISH MEDICAL JOURNAL			English	Article									UNIV NOTTINGHAM,INST HEARING RES,MRC,NOTTINGHAM NG7 2RD,ENGLAND	University of Nottingham	STEPHENS, SDG (corresponding author), UNIV HOSP WALES,WELSH HEARING INST,CARDIFF CF4 4XW,S GLAM,WALES.		Davis, Adrian C/E-6022-2015	Davis, Adrian C/0000-0001-7134-7528				BROOKS DN, 1976, DISORDERS AUDITORY F, V2, P255; DAVIES JE, IN PRESS CLIN OTOLAR; DAVIS A, 1983, HEARING BALANCE ELDE, P1; DAVIS AC, 1987, SCOTTBROWNS OTOLARYN, V2, P90; STEPHENS SDG, 1976, DISORDERS AUDITORY F, V3, P265; STEPHENS SDG, IN PRESS AUDIOLOGY; STEPHENS SDG, IN PRESS ACTA OTOLAR	7	42	43	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	1990	300	6723					508	511		10.1136/bmj.300.6723.508	http://dx.doi.org/10.1136/bmj.300.6723.508			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107929	Bronze, Green Published			2022-12-28	WOS:A1990CQ87800020
J	ELLIOTT, MW; STEVEN, MH; PHILLIPS, GD; BRANTHWAITE, MA				ELLIOTT, MW; STEVEN, MH; PHILLIPS, GD; BRANTHWAITE, MA			NONINVASIVE MECHANICAL VENTILATION FOR ACUTE RESPIRATORY-FAILURE	BRITISH MEDICAL JOURNAL			English	Article									BROMPTON HOSP,DEPT THORAC MED,LONDON SW3 6HP,ENGLAND	Royal Brompton Hospital								CARROLL N, 1988, THORAX, V43, P349, DOI 10.1136/thx.43.5.349; ELLIS ER, 1987, AM REV RESPIR DIS, V135, P148; KESTEN S, 1988, LANCET, V2, P1414; SEARLE JF, 1985, ANN ROY COLL SURG, V67, P187; SIMONDS AK, 1986, THORAX, V41, P586, DOI 10.1136/thx.41.8.586; SULLIVAN CE, 1981, LANCET, V1, P862	6	84	85	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					358	360		10.1136/bmj.300.6721.358	http://dx.doi.org/10.1136/bmj.300.6721.358			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106984	Bronze, Green Published			2022-12-28	WOS:A1990CN79900017
J	GALIANO, S; GAETANI, GF; BARABINO, A; COTTAFAVA, F; ZEITLIN, H; TOWN, M; LUZZATTO, L				GALIANO, S; GAETANI, GF; BARABINO, A; COTTAFAVA, F; ZEITLIN, H; TOWN, M; LUZZATTO, L			FAVISM IN THE AFRICAN TYPE OF GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY (A-)	BRITISH MEDICAL JOURNAL			English	Article									HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HAEMATOL,LONDON W12 0NN,ENGLAND; UNIV GENOA,DIV HAEMATOL,I-16126 GENOA,ITALY; IST GIANNINA GASLINI,DEPT PAEDIAT,I-16148 GENOA,ITALY; ALEXANDRA HOSP,REDDITCH B98 7UB,ENGLAND	Imperial College London; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini								BEUTLER E, IN PRESS RED CELL ME; CALABRO V, 1989, HAEMATOLOGICA, V74, P71; HOLT JM, 1965, ARCH DIS CHILD, V40, P271, DOI 10.1136/adc.40.211.271; LUZZATTO L, 1989, METABOLIC BASIS INHE, V2, P2237; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171	5	27	27	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1990	300	6719					236	236		10.1136/bmj.300.6719.236	http://dx.doi.org/10.1136/bmj.300.6719.236			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL024	2106932	Green Published, Bronze			2022-12-28	WOS:A1990CL02400024
J	LOWRY, S				LOWRY, S			HOUSING AND HEALTH - SANITATION	BRITISH MEDICAL JOURNAL			English	Article																		ALVAREZ ML, 1987, CAN J PUBLIC HLTH, V70, P43; CONWAY J, 1988, PRESCRIPTION POOR HL; Goldberg A., 1974, Environmental Health Perspectives, P103; MCCARTHY M, 1989, TIMES           0419; 1989, WATER SUPPLY WATER Q; 1988, DAILY HAZARD, V19, P1; 1988, GUIDELINES HLTH HOUS; 1988, ENGLISH HOUSE CONDIT	8	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					177	179		10.1136/bmj.300.6718.177	http://dx.doi.org/10.1136/bmj.300.6718.177			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105803	Green Published, Bronze			2022-12-28	WOS:A1990CK07700030
J	WARLOW, C				WARLOW, C			HOW TO DO IT - ORGANIZE A MULTICENTER TRIAL	BRITISH MEDICAL JOURNAL			English	Article											WARLOW, C (corresponding author), WESTERN GEN HOSP,DEPT CLIN NEUROSCI,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.								0	26	27	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					180	183		10.1136/bmj.300.6718.180	http://dx.doi.org/10.1136/bmj.300.6718.180			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105804	Bronze, Green Published			2022-12-28	WOS:A1990CK07700032
J	DICKENS, CM; HESELTINE, D; WALTON, S; BENNETT, JR				DICKENS, CM; HESELTINE, D; WALTON, S; BENNETT, JR			THE ESOPHAGUS IN LICHEN-PLANUS - AN ENDOSCOPIC STUDY	BRITISH MEDICAL JOURNAL			English	Article									HULL ROYAL INFIRM,DEPT MED,HULL HU3 2JZ,N HUMBERSIDE,ENGLAND; HULL ROYAL INFIRM,DEPT MED & GASTROENTEROL,HULL HU3 2JZ,N HUMBERSIDE,ENGLAND; HULL ROYAL INFIRM,DEPT DERMATOL,HULL HU3 2JZ,N HUMBERSIDE,ENGLAND									ALSHIHABI BMS, 1982, J LARYNGOL OTOL, V96, P567, DOI 10.1017/S0022215100092835; ALTMAN J, 1961, ARCH DERMATOL, V84, P47; JOBARDDROBACHEFF C, 1988, CLIN EXP DERMATOL, V13, P38, DOI 10.1111/j.1365-2230.1988.tb00648.x; LEFER LG, 1982, AM J DERMATOPATH, V4, P267, DOI 10.1097/00000372-198206000-00017; SHEEHANDARE RA, 1986, BRIT J DERMATOL, V115, P729, DOI 10.1111/j.1365-2133.1986.tb06655.x	5	55	55	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					84	84		10.1136/bmj.300.6717.84	http://dx.doi.org/10.1136/bmj.300.6717.84			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105780	Bronze, Green Published			2022-12-28	WOS:A1990CJ08000017
J	FEELY, J; MORIARTY, S; OCONNOR, P				FEELY, J; MORIARTY, S; OCONNOR, P			STIMULATING REPORTING OF ADVERSE DRUG-REACTIONS BY USING A FEE	BRITISH MEDICAL JOURNAL			English	Article											FEELY, J (corresponding author), ST JAMES HOSP,TRINITY COLL,SCH MED,DEPT PHARMACOL & THERAPEUT,DUBLIN 8,IRELAND.							BEM JL, 1988, BRIT MED J, V296, P1319, DOI 10.1136/bmj.296.6632.1319; FAICH GA, 1986, NEW ENGL J MED, V314, P1589, DOI 10.1056/NEJM198606123142427; IRVIN LE, 1987, BRIT J PHARM PRACTIC, V9, P316; RAWLINS MD, 1988, BRIT J CLIN PHARMACO, V26, P1	4	42	44	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	1990	300	6716					22	23		10.1136/bmj.300.6716.22	http://dx.doi.org/10.1136/bmj.300.6716.22			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG773	2105117	Green Published, Bronze			2022-12-28	WOS:A1990CG77300018
J	STAMPFER, MJ; SACKS, FM; SALVINI, S; WILLETT, WC; HENNEKENS, CH				STAMPFER, MJ; SACKS, FM; SALVINI, S; WILLETT, WC; HENNEKENS, CH			A PROSPECTIVE-STUDY OF CHOLESTEROL, APOLIPOPROTEINS, AND THE RISK OF MYOCARDIAL-INFARCTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY DISEASE; HIGH-DENSITY LIPOPROTEIN; ISCHEMIC HEART-DISEASE; A-I; CARDIOVASCULAR-DISEASE; DISCRIMINATIVE VALUES; MALE SURVIVORS; TROMSO HEART; SERUM-LIPIDS; SUBFRACTIONS	Background. The independent contributions of subfractions of high-density lipoprotein (HDL) cholesterol (HDL2 and HDL3) and apolipoproteins in predicting the risk of myocardial infarction are unclear. Prospective data are sparse, but HDL2 is widely believed to be a more important predictor than HDL3. Methods. Blood samples were collected at base line from 14,916 men (ages, 40 to 84 years) who were participants in the Physicians' Health Study. After five years of follow-up, plasma samples from 246 men with new myocardial infarction (case subjects) were analyzed together with specimens from 246 men matched to them for age and smoking status who had not had a myocardial infarction. Results. The levels of total cholesterol and apolipoprotein B-100 were significantly associated with an increased risk of myocardial infarction (data on levels of low-density lipoprotein cholesterol were unavailable). Both HDL cholesterol and HDL2 levels were associated with a substantially decreased risk of myocardial infarction, but the HDL3 level was the strongest predictor; the relative risk was 0.3 (95 percent confidence interval, 0.2 to 0.6) for those in the fifth of the group with the highest HDL3 levels, as compared with the fifth with the lowest levels. The benefit of a higher HDL cholesterol level was most pronounced among those with lower total cholesterol levels. Levels of apolipoprotein A-I and apolipoprotein A-II were also associated with decreased risk. However, the levels of HDL subfractions and apolipoproteins did not add significantly to the value of a multivariate model that included the ratio of total to HDL cholesterol in predicting myocardial infarction, whereas that ratio remained a significant independent predictor of risk. After adjustment for other risk factors, a change of one unit in the ratio of total to HDL cholesterol was associated with a 53 percent change in risk (95 percent confidence interval, 26 percent to 85 percent). Conclusions. This study underscores the importance of HDL cholesterol in predicting the risk of myocardial infarction and demonstrates protective effects of both the HDL3 and HDL2 subfractions of HDL cholesterol. We found little or no predictive value for the levels of apolipoproteins A-1, A-11, and B or HDL subfractions after conventional risk factors and the ratio of total to HDL cholesterol were considered.	BRIGHAM & WOMENS HOSP,DEPT PREVENT MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT NUTR,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	STAMPFER, MJ (corresponding author), BRIGHAM & WOMENS HOSP,DEPT MED,CHANNING LAB,180 LONGWOOD AVE,BOSTON,MA 02115, USA.				NCI NIH HHS [CA 42182] Funding Source: Medline; NHLBI NIH HHS [HL 26490, HL 34595] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042182] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERS JJ, 1978, METABOLISM, V27, P479, DOI 10.1016/0026-0495(78)90102-6; ALBERS JJ, 1976, METABOLISM, V25, P633, DOI 10.1016/0026-0495(76)90060-3; [Anonymous], 1989, NEW ENGL J MED, V321, P129; AVOGARO P, 1979, LANCET, V1, P901; AVOGARO P, 1980, ATHEROSCLEROSIS, V37, P69, DOI 10.1016/0021-9150(80)90094-5; AVOGARO P, 1982, LIPOPROTEINS CORONAR, P123; Bachorik P S, 1986, Methods Enzymol, V129, P78; BALLANTYNE FC, 1982, METABOLISM, V31, P433, DOI 10.1016/0026-0495(82)90230-X; BENNETT WI, 1988, NY TIMES MAGAZI 0110, P55; BERG K, 1976, LANCET, V1, P499; BERG K, 1976, LANCET, V2, P40; BITTOLO BG, 1984, ATHEROSCLEROSIS, V53, P69; BROOK JG, 1982, CIRCULATION, V66, P923, DOI 10.1161/01.CIR.66.5.923; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; CREMER P, 1988, KLIN WOCHENSCHR, V66, P42; DEBACKER G, 1982, ATHEROSCLEROSIS, V42, P197, DOI 10.1016/0021-9150(82)90150-2; DESAGER JP, 1984, LATENT DYSLIPOPROTEI, P165; ENGER SC, 1979, ARTERY, V5, P170; FAGER G, 1981, ARTERIOSCLEROSIS, V1, P273, DOI 10.1161/01.ATV.1.4.273; FAGER G, 1980, ATHEROSCLEROSIS, V36, P67, DOI 10.1016/0021-9150(80)90199-9; FRANZEN J, 1986, ATHEROSCLEROSIS, V59, P37, DOI 10.1016/0021-9150(86)90030-4; GIDEZ LI, 1982, J LIPID RES, V23, P1206; GOFMAN JW, 1966, CIRCULATION, V34, P679, DOI 10.1161/01.CIR.34.4.679; GOLDBOURT U, 1979, AM J EPIDEMIOL, V109, P296, DOI 10.1093/oxfordjournals.aje.a112683; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1981, ARCH INTERN MED, V141, P1128, DOI 10.1001/archinte.141.9.1128; GRUNDY SM, 1987, INTERNAL MED, P2035; HAMSTEN A, 1986, ATHEROSCLEROSIS, V59, P223, DOI 10.1016/0021-9150(86)90051-1; HENNEKENS CH, 1987, CIRCULATION, V76, P501; ISHIKAWA T, 1978, EUR J CLIN INVEST, V8, P179, DOI 10.1111/j.1365-2362.1978.tb00832.x; JAMES RW, 1986, ATHEROSCLEROSIS, V60, P49, DOI 10.1016/0021-9150(86)90086-9; JOHANSSON S, 1988, ARTERIOSCLEROSIS, V8, P742, DOI 10.1161/01.ATV.8.6.742; JONES PH, 1990, HEART ARTERIES VEINS, P378; KAUPPINENMAKELIN R, 1988, ATHEROSCLEROSIS, V74, P65, DOI 10.1016/0021-9150(88)90192-X; KEMPEN HJ, 1987, J LAB CLIN MED, V109, P19; KLADETZKY RG, 1980, ARTERY, V7, P191; KUKITA H, 1984, ATHEROSCLEROSIS, V51, P261, DOI 10.1016/0021-9150(84)90173-4; LAAKSO M, 1985, ARTERIOSCLEROSIS, V5, P653, DOI 10.1161/01.ATV.5.6.653; LEHTONEN A, 1986, ATHEROSCLEROSIS, V59, P215, DOI 10.1016/0021-9150(86)90050-X; LEITERSDORF E, 1986, ATHEROSCLEROSIS, V59, P75, DOI 10.1016/0021-9150(86)90035-3; LEVY RI, 1984, CIRCULATION, V69, P325, DOI 10.1161/01.CIR.69.2.325; MACIEJKO JJ, 1983, NEW ENGL J MED, V309, P385, DOI 10.1056/NEJM198308183090701; MILLER NE, 1981, BRIT MED J, V282, P1741, DOI 10.1136/bmj.282.6278.1741; MILLER NE, 1987, AM HEART J, V113, P589, DOI 10.1016/0002-8703(87)90638-7; MILLER NE, 1977, LANCET, V1, P965, DOI 10.1016/S0140-6736(77)92274-7; MOGADAM M, 1990, ARCH INTERN MED, V150, P1645, DOI 10.1001/archinte.150.8.1645; MUSLINER TA, 1988, CLIN CHEM, V34, pB78; NOMA A, 1983, ATHEROSCLEROSIS, V49, P1, DOI 10.1016/0021-9150(83)90002-3; OHTA T, 1989, ARTERIOSCLEROSIS, V9, P90, DOI 10.1161/01.ATV.9.1.90; PARRA H, 1984, LATENT DYSLIPOPROTEI, P187; REARDON MF, 1985, CIRCULATION, V71, P881, DOI 10.1161/01.CIR.71.5.881; REINHART RA, 1990, ARCH INTERN MED, V150, P1629, DOI 10.1001/archinte.150.8.1629; RIESEN WF, 1980, ATHEROSCLEROSIS, V37, P157, DOI 10.1016/0021-9150(80)90104-5; SALONEN JT, 1985, AM J CARDIOL, V56, P226, DOI 10.1016/0002-9149(85)90839-2; SATTERFIELD S, 1990, AM J PREV MED, V6, P290, DOI 10.1016/S0749-3797(18)30997-8; SCHMIDT SB, 1985, AM J CARDIOL, V55, P1459, DOI 10.1016/0002-9149(85)90953-1; STAMPFER MJ, 1985, STAT MED, V4, P111, DOI 10.1002/sim.4780040202; STORER BE, 1983, APPL STAT-J ROY ST C, V32, P172; THOMAS DJB, 1987, BRIT J CLIN PRACT, V41, P741; WALLENTIN L, 1986, ATHEROSCLEROSIS, V59, P131, DOI 10.1016/0021-9150(86)90041-9; WIKLUND O, 1980, ATHEROSCLEROSIS, V37, P631, DOI 10.1016/0021-9150(80)90070-2; 1985, SAS USERS GUIDE STAT; 1988, ARCH INTERN MED, V148, P36; 1982, SAS USERS GUIDE BASI; [No title captured]	65	972	1011	0	16	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 8	1991	325	6					373	381		10.1056/NEJM199108083250601	http://dx.doi.org/10.1056/NEJM199108083250601			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ804	2062328				2022-12-28	WOS:A1991FZ80400001
J	YUSUF, S				YUSUF, S			EFFECT OF ENALAPRIL ON SURVIVAL IN PATIENTS WITH REDUCED LEFT-VENTRICULAR EJECTION FRACTIONS AND CONGESTIVE-HEART-FAILURE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; THERAPY	Background. Patients with congestive heart failure have a high mortality rate and are also hospitalized frequently. We studied the effect of an angiotensin-converting-enzyme inhibitor, enalapril, on mortality and hospitalization in patients with chronic heart failure and ejection fractions less-than-or-equal-to 0.35. Methods. Patients receiving conventional treatment for heart failure were randomly assigned to receive either placebo (n = 1284) or enalapril (n = 1285) at doses of 2.5 to 20 mg per day in a double-blind trial. Approximately 90 percent of the patients were in New York Heart Association functional classes II and III. The follow-up averaged 41.4 months. Results. There were 510 deaths in the placebo group (39.7 percent), as compared with 452 in the enalapril group (35.2 percent) (reduction in risk, 16 percent; 95 percent confidence interval, 5 to 26 percent; P = 0.0036). Although reductions in mortality were observed in several categories of cardiac deaths, the largest reduction occurred among the deaths attributed to progressive heart failure (251 in the placebo group vs. 209 in the enalapril group; reduction in risk, 22 percent; 95 percent confidence interval, 6 to 35 percent). There was little apparent effect of treatment on deaths classified as due to arrhythmia without pump failure. Fewer patients died or were hospitalized for worsening heart failure (736 in the placebo group and 613 in the enalapril group; risk reduction, 26 percent; 95 percent confidence interval, 18 to 34 percent; P < 0.0001). Conclusions. The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and low ejection fractions.			YUSUF, S (corresponding author), NHLBI, DIV EPIDEMIOL & CLIN APPLICAT, CLIN TRIALS BRANCH, FED BLDG, RM 5C08, BETHESDA, MD 20892 USA.			Yusuf, Salim/0000-0003-4776-5601				ADER R, 1980, CIRCULATION, V61, P931, DOI 10.1161/01.CIR.61.5.931; [Anonymous], 1990, Am J Cardiol, V66, P315; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; COHN JN, 1983, J AM COLL CARDIOL, V2, P755; COX DR, 1972, J R STAT SOC B, V34, P187; FRANCIS GS, 1990, CIRCULATION, V82, P1724, DOI 10.1161/01.CIR.82.5.1724; FURBERG CD, 1988, AM J CARDIOL, V62, pA41, DOI 10.1016/S0002-9149(88)80084-5; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; YUSUF S, 1989, HYPERTENSION S5, V13, P174	15	5525	5667	6	106	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	1991	325	5					293	302		10.1056/NEJM199108013250501	http://dx.doi.org/10.1056/NEJM199108013250501			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY715	2057034	Bronze			2022-12-28	WOS:A1991FY71500001
J	THERIOT, JA; MITCHISON, TJ				THERIOT, JA; MITCHISON, TJ			ACTIN MICROFILAMENT DYNAMICS IN LOCOMOTING CELLS	NATURE			English	Article							HEAVY-CHAIN GENE; ELECTRIC-FIELDS; MICROTUBULES; FLUORESCENCE; FIBROBLASTS; MOTILITY; MYOSIN; ORGANIZATION; LAMELLIPODIA; CYTOSKELETON	The dynamic behaviour of actin filaments has been directly observed in living, motile cells using fluorescence photoactivation. In goldfish epithelial keratocytes, the actin microfilaments in the lamellipodium remain approximately fixed relative to the substrate as the cell moves over them, regardless of cell speed. The rate of turnover of actin subunits in the lamellipodium is remarkably rapid. Cell movement is directly and tightly coupled to the formation of new actin filaments at the leading edge.	UNIV CALIF SAN FRANCISCO, DEPT PHARMACOL, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco	THERIOT, JA (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL & BIOPHYS, SAN FRANCISCO, CA 94143 USA.		Theriot, Julie/HHN-2034-2022	Theriot, Julie/0000-0002-2334-2535				AMATO PA, 1986, J CELL BIOL, V102, P1074, DOI 10.1083/jcb.102.3.1074; BEREITERHAHN J, 1988, CELL MOTIL CYTOSKEL, V10, P528, DOI 10.1002/cm.970100409; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; COOPER MS, 1985, J NEUROSCI RES, V13, P223, DOI 10.1002/jnr.490130116; COOPER MS, 1986, J CELL BIOL, V102, P1384, DOI 10.1083/jcb.102.4.1384; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; DOSREMEDIOS CG, 1987, J MUSCLE RES CELL M, V8, P97, DOI 10.1007/BF01753986; EGELHOFF TT, 1991, TRENDS GENET, V7, P161, DOI 10.1016/0168-9525(91)90380-9; EUTENEUER U, 1984, NATURE, V310, P58, DOI 10.1038/310058a0; FISHER GW, 1988, CELL MOTIL CYTOSKEL, V11, P235, DOI 10.1002/cm.970110403; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; HAUGLAND RP, 1989, MIL PROBES HDB FLUOR; HEGYI G, 1974, EUR J BIOCHEM, V44, P7, DOI 10.1111/j.1432-1033.1974.tb03452.x; HILL TL, 1982, P NATL ACAD SCI-BIOL, V79, P490, DOI 10.1073/pnas.79.2.490; HUXLEY HE, 1973, NATURE, V244, P445, DOI 10.1038/243445a0; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; KOLEGA J, 1986, J CELL BIOL, V102, P1400, DOI 10.1083/jcb.102.4.1400; Korn ED, 1990, CURR OPIN CELL BIOL, V2, P57, DOI 10.1016/S0955-0674(05)80031-6; KREIS TE, 1982, CELL, V29, P835, DOI 10.1016/0092-8674(82)90445-7; KUCIK DF, 1989, NATURE, V340, P315, DOI 10.1038/340315a0; KUCIK DF, 1990, J CELL BIOL, V111, P1617, DOI 10.1083/jcb.111.4.1617; LEE J, 1990, SCIENCE, V247, P1229, DOI 10.1126/science.2315695; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; OSTER GF, 1987, J CELL SCI, P35; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pollard TD, 1990, CURR OPIN CELL BIOL, V2, P33, DOI 10.1016/S0955-0674(05)80028-6; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; RINNERTHALER G, 1988, J CELL BIOL, V106, P747, DOI 10.1083/jcb.106.3.747; RINNERTHALER G, 1991, J STRUCT BIOL, V106, P1, DOI 10.1016/1047-8477(91)90058-5; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; Small J V, 1988, Electron Microsc Rev, V1, P155; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; SVITKINA TM, 1986, J CELL SCI, V82, P235; SYMONS M, IN PRESS J CELL BIOL; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Taylor D L, 1979, Int Rev Cytol, V56, P57, DOI 10.1016/S0074-7696(08)61821-5; TRINKAUS JP, 1984, CELLS ORGANS FORCES, P202; WALKER JW, 1989, METHOD ENZYMOL, V172, P288; WANG YL, 1980, J HISTOCHEM CYTOCHEM, V28, P1198, DOI 10.1177/28.11.6107318; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; YIN HL, 1988, J CELL SCI, P169	41	673	682	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 11	1991	352	6331					126	131		10.1038/352126a0	http://dx.doi.org/10.1038/352126a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW097	2067574				2022-12-28	WOS:A1991FW09700045
J	BROOKMEYER, R				BROOKMEYER, R			RECONSTRUCTION AND FUTURE-TRENDS OF THE AIDS EPIDEMIC IN THE UNITED-STATES	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; SHORT-TERM PROJECTIONS; LYMPHOCYTE-T COUNTS; HIV-INFECTION; SAN-FRANCISCO; YOUNG-ADULTS; ZIDOVUDINE; MODELS; PROGRESSION; PREVALENCE	There has been considerable uncertainty in estimates of past and current human immunodeficiency virus (HIV) infection rates in the United States. Statistical estimates of historical infection rates can be obtained from acquired immunodeficiency syndrome (AIDS) incidence data and the incubation period. However, this approach is subject to a number of sources of uncertainty and two other approaches, epidemic models of HIV transmission and surveys of HIV prevalence, are used to corroborate and refine the statistical estimates. Analyses suggest the HIV infection rate in the United States grew rapidly in the early 1980s, peaked in the mid-1980s, and subsequently declined markedly. Due both to the decline in the underlying infection rate and to the development of effective therapies that may delay AIDS diagnosis, overall AIDS incidence may plateau during the next 5 years. However, the number of individuals with advanced HIV disease without a diagnosis of AIDS who could potentially benefit from therapy is expected to increase 40% by 1995 as infected individuals progress to more advanced stages of HIV disease. Thus, although the overall HIV infection rate has declined, the demands on the U.S. health care system for treatment and care of HIV-infected individuals remain enormous.			BROOKMEYER, R (corresponding author), JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT BIOSTAT, BALTIMORE, MD 21205 USA.				NATIONAL CANCER INSTITUTE [R01CA048723] Funding Source: NIH RePORTER; NCI NIH HHS [CA-48723] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREWS EB, 1990, J ACQ IMMUN DEF SYND, V3, P460; BACCHETTI P, 1989, NATURE, V338, P251, DOI 10.1038/338251a0; BACCHETTI P, 1990, J AM STAT ASSOC, V85, P1001; BROOKMEYER R, 1990, BIOMETRICS, V46, P1151, DOI 10.2307/2532455; BROOKMEYER R, 1989, BIOMETRICS, V45, P325, DOI 10.2307/2532057; BROOKMEYER R, 1989, STAT MED, V8, P23, DOI 10.1002/sim.4780080105; BROOKMEYER R, 1988, J AM STAT ASSOC, V83, P301, DOI 10.2307/2288844; BRUNDAGE JF, 1990, J ACQ IMMUN DEF SYND, V3, P1168; BRUNDAGE JF, 1990, J ACQ IMMUN DEF SYND, V3, P92; CURRAN JW, 1985, SCIENCE, V229, P1352, DOI 10.1126/science.2994217; DAY NE, 1989, PHILOS T ROY SOC B, V325, P123, DOI 10.1098/rstb.1989.0077; DEGRUTTOLA V, 1989, STAT MED, V8, P35, DOI 10.1002/sim.4780080106; DONDERO TJ, 1989, 5TH INT C AIDS MONTR; FOX RJ, UNPUB; GAIL MH, 1988, J NATL CANCER I, V80, P900, DOI 10.1093/jnci/80.12.900; GAIL MH, 1989, STAT MED, V8, P59, DOI 10.1002/sim.4780080108; GAIL MH, 1990, J ACQ IMMUN DEF SYND, V3, P296; GAIL MH, 1990, JAMA-J AM MED ASSOC, V263, P1538; GRAHAM NMH, 1991, J ACQ IMMUN DEF SYND, V4, P267; HARDY AM, 1987, PUBLIC HEALTH REP, V102, P386; HESSOL NA, 1989, AM J EPIDEMIOL, V130, P1167, DOI 10.1093/oxfordjournals.aje.a115445; Hethcote H., 1984, LECT NOTES BIOMATHEM; HYMAN JM, 1988, MATH BIOSCI, V90, P415, DOI 10.1016/0025-5564(88)90078-8; KARON JM, 1988, J ACQ IMMUN DEF SYND, V1, P542; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; LONGINI IM, 1990, J ACQ IMMUN DEF SYND, V3, P930; LONGINI IM, 1989, STAT MED, V8, P831, DOI 10.1002/sim.4780080708; MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0; MCKUSICK L, 1985, AM J PUBLIC HEALTH, V75, P493, DOI 10.2105/AJPH.75.5.493; MCNEIL JG, 1989, NEW ENGL J MED, V320, P1581, DOI 10.1056/NEJM198906153202403; MOORE RD, 1991, NEW ENGL J MED, V324, P1412, DOI 10.1056/NEJM199105163242006; O'Sullivan F., 1986, STAT SCI, V1, P502, DOI DOI 10.1214/ss/1177013525; OSULLIVAN F, 1986, J AM STAT ASSOC, V81, P96, DOI 10.2307/2287973; PHILLIPS DL, 1962, J ACM, V9, P84, DOI 10.1145/321105.321114; PICKERING J, 1986, MATH MODELLING, V7, P661, DOI 10.1016/0270-0255(86)90127-2; Rosenberg Philip S., 1990, Annals of Epidemiology, V1, P105; ROSENBERG PS, 1991, J ACQ IMMUN DEF SYND, V4, P392; ROSENBERG PS, 1991, AM J EPIDEMIOL, V133, P276, DOI 10.1093/oxfordjournals.aje.a115872; ROSENBERG PS, 1991, APPL STAT-J ROY ST C, V40, P269; ROSENBERG PS, IN PRESS STAT MED; SCHECHTER MT, 1989, LANCET, V1, P1026; Segal M, 1990, J Acquir Immune Defic Syndr (1988), V3, P832; TAYLOR JMG, 1989, STAT MED, V8, P45, DOI 10.1002/sim.4780080107; TAYLOR JMG, 1991, J ACQ IMMUN DEF SYND, V4, P69; Tikhonov A., 1963, SOV MATH DOKL, V4, P1035; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; 1988, MORB MORTAL WKLY REP, V37, P294; 1990, MORB MORTAL WKLY REP, V39, P112; 1991, MORB MORTAL WKLY S6, V40, P1; 1987, MORB MORTAL WKLY S6, V36	50	227	233	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	1991	253	5015					37	42		10.1126/science.2063206	http://dx.doi.org/10.1126/science.2063206			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV177	2063206				2022-12-28	WOS:A1991FV17700028
J	KNUDSEN, EI; BRAINARD, MS				KNUDSEN, EI; BRAINARD, MS			VISUAL INSTRUCTION OF THE NEURAL MAP OF AUDITORY SPACE IN THE DEVELOPING OPTIC TECTUM	SCIENCE			English	Article							PRIMATE SUPERIOR COLLICULUS; BARN OWL; GUINEA-PIG; SENSORIMOTOR INTEGRATION; RESPONSE PROPERTIES; SOUND LOCALIZATION; EYE-MOVEMENTS; SENSITIVITY; DEPRIVATION; MATURATION	Neural maps of visual and auditory space are aligned in the adult optic tectum. In barn owls, this alignment of sensory maps was found to be controlled during ontogeny by visual instruction of the auditory spatial tuning of neurons. Large adaptive changes in auditory spatial tuning were induced by raising owls with displacing prisms mounted in spectacle frames in front of the eyes; neurons became tuned to sound source locations corresponding to their optically displaced, rather than their normal, visual receptive field locations. The results demonstrate that visual experience during development calibrates the tectal auditory space map in a site-specific manner, dictating its topography and alignment with the visual space map.			KNUDSEN, EI (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROBIOL,SHERMAN FAIRCHILD SCI BLDG,STANFORD,CA 94305, USA.			Brainard, Michael/0000-0002-9425-9907	NIDCD NIH HHS [R01 DC00155-12] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000155] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		DULAC S, 1990, J NEUROPHYSIOL, V63, P131, DOI 10.1152/jn.1990.63.1.131; JAY MF, 1987, J NEUROPHYSIOL, V57, P35, DOI 10.1152/jn.1987.57.1.35; JAY MF, 1987, J NEUROPHYSIOL, V57, P22, DOI 10.1152/jn.1987.57.1.22; KALIL R, 1967, PERCEPT MOTOR SKILL, V24, P475, DOI 10.2466/pms.1967.24.2.475; KING AJ, 1983, J PHYSIOL-LONDON, V342, P361, DOI 10.1113/jphysiol.1983.sp014856; KING AJ, 1988, NATURE, V332, P73, DOI 10.1038/332073a0; KING AJ, 1987, J NEUROPHYSIOL, V57, P596, DOI 10.1152/jn.1987.57.2.596; KNUDSEN EI, 1983, SCIENCE, V222, P939, DOI 10.1126/science.6635667; KNUDSEN EI, 1985, J NEUROSCI, V5, P3094; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KNUDSEN EI, 1991, J NEUROSCI, V11, P1727; KNUDSEN EI, 1989, J NEUROSCI, V9, P3306; KNUDSEN EI, 1990, J NEUROSCI, V10, P222; KNUDSEN EI, 1988, P NATL ACAD SCI USA, V85, P6211, DOI 10.1073/pnas.85.16.6211; KNUDSEN EI, 1989, VISUAL NEUROSCI, V2, P35, DOI 10.1017/S0952523800004302; MIDDLEBROOKS JC, 1984, J NEUROSCI, V4, P2621; MOISEFF A, 1981, J NEUROSCI, V1, P40, DOI 10.1523/JNEUROSCI.01-01-00040.1981; OLSEN JF, 1989, J NEUROSCI, V9, P2591; SPARKS DL, 1986, PHYSIOL REV, V66, P118, DOI 10.1152/physrev.1986.66.1.118; STEINBACH MJ, 1973, VISION RES, V13, P889, DOI 10.1016/0042-6989(73)90055-2; WISE LZ, 1985, J NEUROPHYSIOL, V54, P185, DOI 10.1152/jn.1985.54.2.185; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P682, DOI 10.1111/j.1460-9568.1990.tb00458.x; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P693, DOI 10.1111/j.1460-9568.1990.tb00459.x	23	162	162	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 5	1991	253	5015					85	87		10.1126/science.2063209	http://dx.doi.org/10.1126/science.2063209			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV177	2063209				2022-12-28	WOS:A1991FV17700041
J	BUSCH, MP; EBLE, BE; KHAYAMBASHI, H; HEILBRON, D; MURPHY, EL; KWOK, S; SNINSKY, J; PERKINS, HA; VYAS, GN				BUSCH, MP; EBLE, BE; KHAYAMBASHI, H; HEILBRON, D; MURPHY, EL; KWOK, S; SNINSKY, J; PERKINS, HA; VYAS, GN			EVALUATION OF SCREENED BLOOD DONATIONS FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION BY CULTURE AND DNA AMPLIFICATION OF POOLED CELLS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYMERASE CHAIN-REACTION; LOW COPY NUMBERS; MONONUCLEAR-CELLS; HOMOSEXUAL MEN; WESTERN BLOT; HIV; TRANSFUSION; TRANSMISSION; ANTIBODY; INDIVIDUALS	Background. Reports of transmission of the human immunodeficiency virus type 1 (HIV-1) from transfusions of screened blood and reports of silent, antibody-negative HIV-1 infections in persons at high risk continue to foster concern about the safety of the blood supply. Previous estimates of the risk of HIV-1 range from 1 in 38,000 to 1 in 300,000 per unit of blood but are based on either epidemiologic models or the demonstration of seroconversion in recipients. Methods. We isolated peripheral-blood mononuclear cells from blood that was fully screened and found to be seronegative, combined them into pools of cells from 50 donors, and tested them for HIV-1 by viral culture and the polymerase chain reaction, using protocols specifically adapted for this analysis. Results. The 1530 pools of mononuclear cells were prepared from 76,500 blood donations made in San Francisco between November 1987 and December 1989. Of these pools, 1436 (representing 71,800 donations) were cultured successfully; 873 (43,650 donations) were evaluated by the polymerase chain reaction. Only one pool was confirmed as HIV-1-infected by both methods. After adjustment for sample-based estimates of the sensitivity of the detection systems using culture and the polymerase chain reaction, the probability that a screened donor will be positive for HIV-1 was estimated as 1 in 61,171 (95 percent upper confidence bound, 1 in 10,695). Conclusions. Silent HIV-1 infections are exceedingly rare among screened blood donors, so the current risk of HIV-1 transmission from blood transfusions, even in high-prevalence metropolitan areas, is extremely low.	UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT EPIDEMIOL & BIOSTAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; IRWIN MEM BLOOD CTR,SAN FRANCISCO,CA; CETUS CORP,EMERYVILLE,CA 94608	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco				Vyas, Girish/0000-0003-1090-4911	NHLBI NIH HHS [N01-HB-86-7024] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BUGAWAN TL, 1988, BIO-TECHNOL, V6, P943, DOI 10.1038/nbt0888-943; BUSCH MP, 1987, AM J CLIN PATHOL, V88, P673, DOI 10.1093/ajcp/88.6.673; BUSCH MP, 1991, TRANSFUSION, V31, P4, DOI 10.1046/j.1537-2995.1991.31191096183.x; CLARK SJ, 1991, NEW ENGL J MED, V324, P954, DOI 10.1056/NEJM199104043241404; COHEN ND, 1989, NEW ENGL J MED, V320, P1172, DOI 10.1056/NEJM198905043201803; Cox DR., 1970, ANAL BINARY DATA; CUMMING PD, 1989, NEW ENGL J MED, V321, P941, DOI 10.1056/NEJM198910053211405; DAAR ES, 1991, NEW ENGL J MED, V324, P961, DOI 10.1056/NEJM199104043241405; DONAHUE JG, 1990, NEW ENGL J MED, V323, P1709; EBLE BE, 1990, 14TH INT C CLIN CHEM; EISENSTEIN BI, 1990, NEW ENGL J MED, V322, P178; GALLO D, 1987, J CLIN MICROBIOL, V25, P1291, DOI 10.1128/JCM.25.7.1291-1294.1987; GUATELLI JC, 1989, CLIN MICROBIOL REV, V2, P217, DOI 10.1128/CMR.2.2.217-226.1989; HWANG LY, 1989, TRANSFUSION, V29, P113, DOI 10.1046/j.1537-2995.1989.29289146827.x; IMAGAWA DT, 1989, NEW ENGL J MED, V320, P1458, DOI 10.1056/NEJM198906013202205; JACKSON JB, 1990, J CLIN MICROBIOL, V28, P16, DOI 10.1128/JCM.28.1.16-19.1990; JACKSON JB, 1990, NEW ENGL J MED, V322, P217, DOI 10.1056/NEJM199001253220402; JACKSON JB, 1988, J CLIN MICROBIOL, V26, P1416, DOI 10.1128/JCM.26.7.1416-1418.1988; JULIEN AM, 1988, LANCET, V2, P1248; KELLOGG DE, 1990, ANAL BIOCHEM, V189, P202, DOI 10.1016/0003-2697(90)90108-L; KELLOGG DE, 1990, PCR PROTOCOLS GUIDE, P337; KLEINMAN S, 1988, TRANSFUSION, V28, P499, DOI 10.1046/j.1537-2995.1988.28588337347.x; KLEINMAN SH, 1989, TRANSFUSION, V29, P572, DOI 10.1046/j.1537-2995.1989.29789369672.x; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; LEE TH, IN PRESS AIDS; LIFSON AR, 1990, J INFECT DIS, V161, P436, DOI 10.1093/infdis/161.3.436; LOCHE M, 1988, LANCET, V2, P418; NETER J, 1974, APPLIED LINEAR STATI; PERKINS HA, 1987, TRANSFUSION, V27, P502, DOI 10.1046/j.1537-2995.1987.27688071706.x; PERKINS HA, 1989, NEW ENGL J MED, V320, P463; SHEPPARD HW, 1991, J ACQ IMMUN DEF SYND, V4, P277; SIMMONDS P, 1990, J VIROL, V64, P864, DOI 10.1128/JVI.64.2.864-872.1990; SOBEL M, 1975, BIOMETRIKA, V62, P181, DOI 10.1093/biomet/62.1.181; ULRICH PP, 1988, J MED VIROL, V25, P1, DOI 10.1002/jmv.1890250102; WARD JW, 1988, NEW ENGL J MED, V318, P473, DOI 10.1056/NEJM198802253180803; WOLINSKY SM, 1989, ANN INTERN MED, V111, P961, DOI 10.7326/0003-4819-111-12-961	36	129	130	0	6	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	1991	325	1					1	5		10.1056/NEJM199107043250101	http://dx.doi.org/10.1056/NEJM199107043250101			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU342	2046708				2022-12-28	WOS:A1991FU34200001
J	RUDOLPH, AS; RATNA, BR; KAHN, B				RUDOLPH, AS; RATNA, BR; KAHN, B			SELF-ASSEMBLING PHOSPHOLIPID FILAMENTS	NATURE			English	Article							MEMBRANES; FLUCTUATIONS; SHAPES	AQUEOUS dispersions of double-chain phospholipids spontaneously assemble into closed bilayers called vesicles (or liposomes). Although the vesicles are in general topologically spherical, cylindrical 1 and helical 2 liposomes have sometimes been observed. We present here video-enhanced microscopic studies of a diacetylenic phospholipid dispersed in ethanol/water, which reveal the existence of unusual bilayer morphologies. On cooling the dispersion from the isotropic phase, we have observed the formation of long (of the order of hundreds of micrometres), thin (0.2-2-mu-m) filaments, which fluctuate strongly. When the temperature is decreased further, the filaments rapidly retract into a mass of lipid. At constant temperature, on the other hand, the filaments transform into torus or ring-like vesicles. Such nonspherical structures have been predicted theoretically 3,4 but not previously observed experimentally.	GEORGETOWN UNIV,MED CTR,DEPT BIOCHEM,WASHINGTON,DC 20007; GEOCENTERS INC,FT WASHINGTON,MD 20744	Georgetown University	RUDOLPH, AS (corresponding author), USN,RES LAB,CTR BIOMOLEC SCI & ENGN,CODE 6090,WASHINGTON,DC 20375, USA.							BESSIS M, 1973, LIVING BLOOD CELLS T, P61; Cevc G., 1987, PHOSPHOLIPID BILAYER; CHAPMAN D, 1982, Patent No. 4348329; CULLIS PR, 1986, CHEM PHYS LIPIDS, V40, P127, DOI 10.1016/0009-3084(86)90067-8; CULLIS PR, 1985, PHOSPHOLIPIDS CELLUL, V1; DEKRUIJFF B, 1987, NATURE, V329, P587, DOI 10.1038/329587a0; DEULING HJ, 1976, J PHYS-PARIS, V37, P1335, DOI 10.1051/jphys:0197600370110133500; DEULING HJ, 1977, BLOOD CELLS, V3, P713; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P7132, DOI 10.1073/pnas.83.19.7132; HUB HH, 1980, ANGEW CHEM INT EDIT, V19, P938, DOI 10.1002/anie.198009381; Israelachvili JN, 1985, INTERMOLECULAR SURFA; LIN KC, 1982, NATURE, V296, P164, DOI 10.1038/296164a0; OUYANG ZC, 1990, PHYS REV A, V41, P4517, DOI 10.1103/PhysRevA.41.4517; SCHNEIDER MB, 1984, BIOPHYS J, V45, P891, DOI 10.1016/S0006-3495(84)84235-6; SINGH A, 1986, SYNTHETIC COMMUN, V16, P847, DOI 10.1080/00397918608059667; Zhong-can, 1989, Phys Rev A Gen Phys, V39, P5280, DOI 10.1103/PhysRevA.39.5280	16	42	43	2	16	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1991	352	6330					52	55		10.1038/352052a0	http://dx.doi.org/10.1038/352052a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV178	2062377				2022-12-28	WOS:A1991FV17800066
J	BAILEY, JE				BAILEY, JE			TOWARD A SCIENCE OF METABOLIC ENGINEERING	SCIENCE			English	Article							RECOMBINANT ESCHERICHIA-COLI; VITREOSCILLA HEMOGLOBIN GENE; HOST-PLASMID INTERACTIONS; HAMSTER OVARY CELLS; BREVIBACTERIUM-LACTOFERMENTUM; SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; HOMOSERINE DEHYDROGENASE; STREPTOMYCES-LIVIDANS; THREONINE PRODUCTION	Application of recombinant DNA methods to restructure metabolic networks can improve production of metabolite and protein products by altering pathway distributions and rates. Recruitment of heterologous proteins enables extension of existing pathways to obtain new chemical products, alter posttranslational protein processing, and degrade recalcitrant wastes. Although some of the experimental and mathematical tools required for rational metabolic engineering are available, complex cellular responses to genetic perturbations can complicate predictive design.			BAILEY, JE (corresponding author), CALTECH,CHEM ENGN,PASADENA,CA 91125, USA.		Zhang, Shuyun/F-8177-2011					AIBA S, 1980, BIOTECHNOL LETT, V2, P525, DOI 10.1007/BF00134901; ALTERTHUM F, 1989, APPL ENVIRON MICROB, V55, P1943, DOI 10.1128/AEM.55.8.1943-1948.1989; ANDERSON S, 1985, SCIENCE, V230, P144, DOI 10.1126/science.230.4722.144; BACKMAN K, 1990, ANN NY ACAD SCI, V589, P16, DOI 10.1111/j.1749-6632.1990.tb24231.x; BAILEY JE, 1986, ANN NY ACAD SCI, V469, P194, DOI 10.1111/j.1749-6632.1986.tb26498.x; BENBASSAT A, 1987, J BACTERIOL, V169, P751, DOI 10.1128/jb.169.2.751-757.1987; BIRNBAUM S, 1991, BIOTECHNOL BIOENG, V37, P736, DOI 10.1002/bit.260370808; BOERMAN SJ, 1982, J GEN APPL MICROBIOL, V28, P35, DOI 10.2323/jgam.28.35; BRAU B, 1986, ARCH MICROBIOL, V144, P296, DOI 10.1007/BF00410966; CARY JW, 1990, ANN NY ACAD SCI, V589, P67, DOI 10.1111/j.1749-6632.1990.tb24235.x; DANHASH N, 1991, BIO-TECHNOL, V9, P179, DOI 10.1038/nbt0291-179; DELGADO JP, 1991, BIOTECHNOL PROGR, V7, P15, DOI 10.1021/bp00007a003; DELLACIOPPA G, 1990, BIO-TECHNOL, V8, P634, DOI 10.1038/nbt0790-634; DOMACH MM, 1984, BIOTECHNOL BIOENG, V26, P203, DOI 10.1002/bit.260260303; DORNER AJ, 1988, MOL CELL BIOL, V8, P4063, DOI 10.1128/MCB.8.10.4063; DRATHS KM, 1990, J AM CHEM SOC, V112, P1657, DOI 10.1021/ja00160a071; ENSLEY BD, 1983, SCIENCE, V222, P167, DOI 10.1126/science.6353574; EPP JK, 1989, GENE, V85, P293, DOI 10.1016/0378-1119(89)90421-6; ERNST LK, 1989, J BIOL CHEM, V264, P3436; FERNANDEZ EJ, 1987, ENZYME MICROB TECH, V9, P259, DOI 10.1016/0141-0229(87)90001-9; GADIAN DG, 1982, NUCLEAR MAGNETIC RES; GALAZZO J, 1991, ENZYME MICROB TECH, V13, P363; GALAZZO JL, 1990, ENZYME MICROB TECH, V12, P162, DOI 10.1016/0141-0229(90)90033-M; GATENBY AA, 1990, TRENDS BIOTECHNOL, V8, P354, DOI 10.1016/0167-7799(90)90224-L; HAMILL JD, 1990, PLANT MOL BIOL, V15, P27, DOI 10.1007/BF00017721; HASHIMOTO T, COMMUNICATION; HEINRICH R, 1977, PROG BIOPHYS MOL BIO, V32, P1; HODGSON J, 1990, BIO-TECHNOL, V8, P281, DOI 10.1038/nbt0490-281; HOPWOOD DA, 1985, NATURE, V314, P642, DOI 10.1038/314642a0; HUI A, 1987, P NATL ACAD SCI USA, V84, P4762, DOI 10.1073/pnas.84.14.4762; INGRAM LO, 1988, APPL ENVIRON MICROB, V54, P397, DOI 10.1128/AEM.54.2.397-404.1988; ISOGAI T, 1991, BIO-TECHNOL, V9, P188, DOI 10.1038/nbt0291-188; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KHOSLA C, 1989, J BACTERIOL, V171, P5995, DOI 10.1128/jb.171.11.5995-6004.1989; KHOSLA C, 1990, BIO-TECHNOL, V8, P849, DOI 10.1038/nbt0990-849; KHOSLA C, 1988, MOL GEN GENET, V214, P158, DOI 10.1007/BF00340195; KHOSLA C, 1988, NATURE, V331, P633, DOI 10.1038/331633a0; KHOSRAVI M, 1990, PLASMID, V24, P190, DOI 10.1016/0147-619X(90)90002-T; KIINO DR, 1990, J BACTERIOL, V172, P185, DOI 10.1128/JB.172.1.185-192.1990; KOCH AK, 1988, BIO-TECHNOL, V6, P1335, DOI 10.1038/nbt1188-1335; LEE EU, 1989, J BIOL CHEM, V264, P13848; LEE SB, 1984, BIOTECHNOL BIOENG, V26, P1372, DOI 10.1002/bit.260261115; LEE SB, 1984, BIOTECHNOL BIOENG, V26, P1383, DOI 10.1002/bit.260261116; LEE SB, 1984, BIOTECHNOL BIOENG, V26, P66, DOI 10.1002/bit.260260113; LEE SB, 1984, PLASMID, V11, P166, DOI 10.1016/0147-619X(84)90021-0; LEE SB, 1984, PLASMID, V11, P151, DOI 10.1016/0147-619X(84)90020-9; MAGNOLO SK, 1991, BIO-TECHNOL, V9, P473, DOI 10.1038/nbt0591-473; MALPARTIDA F, 1990, GENE, V93, P91, DOI 10.1016/0378-1119(90)90141-D; MALPARTIDA F, 1984, NATURE, V309, P462, DOI 10.1038/309462a0; MCALPINE JB, 1987, J ANTIBIOT, V40, P1115, DOI 10.7164/antibiotics.40.1115; MIWA K, 1983, AGR BIOL CHEM TOKYO, V47, P2329, DOI 10.1080/00021369.1983.10865958; MORINAGA Y, 1987, AGR BIOL CHEM TOKYO, V51, P93, DOI 10.1080/00021369.1987.10868000; NAKAMORI S, 1987, AGR BIOL CHEM TOKYO, V51, P87, DOI 10.1080/00021369.1987.10867999; PEOPLES OP, 1989, J BIOL CHEM, V264, P15298; PEOPLES OP, 1990, NATO ADV SCI I E-APP, V186, P191; PERETTI SW, 1987, BIOTECHNOL BIOENG, V29, P316, DOI 10.1002/bit.260290305; PHILLIPS GJ, 1990, NATURE, V344, P882, DOI 10.1038/344882a0; RAMOS JL, 1986, P NATL ACAD SCI USA, V83, P8467, DOI 10.1073/pnas.83.22.8467; REDER C, 1988, J THEOR BIOL, V135, P175, DOI 10.1016/S0022-5193(88)80073-0; ROJO F, 1987, SCIENCE, V238, P1395, DOI 10.1126/science.3479842; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; SANO K, 1987, AGR BIOL CHEM TOKYO, V51, P597, DOI 10.1080/00021369.1987.10868075; SCHEIN CH, 1989, BIO-TECHNOL, V7, P1141; SCHLOSSER PM, 1990, MATH BIOSCI, V100, P87, DOI 10.1016/0025-5564(90)90049-5; SHANKS JV, 1988, BIOTECHNOL BIOENG, V32, P1138, DOI 10.1002/bit.260320907; SKATRUD PL, 1989, BIO-TECHNOL, V7, P477, DOI 10.1038/nbt0589-477; SMITH DJ, 1990, BIO-TECHNOL, V8, P39, DOI 10.1038/nbt0190-39; STANZAK R, 1986, BIO-TECHNOL, V4, P229, DOI 10.1038/nbt0386-229; STEPHANOPOULOS G, 1991, SCIENCE, V252, P1675, DOI 10.1126/science.1904627; SUIHKO ML, 1990, J BIOTECHNOL, V14, P285, DOI 10.1016/0168-1656(90)90113-P; TAKEUCHI M, 1988, J BIOL CHEM, V263, P3657; TIMMIS KN, 1990, ADV AP BIOT, V4, P61; TOLAN JS, 1987, APPL ENVIRON MICROB, V53, P2039, DOI 10.1128/AEM.53.9.2039-2044.1987; ULMER KM, 1983, SCIENCE, V219, P666, DOI 10.1126/science.6572017; VANDERAAR PC, 1990, APPL MICROBIOL BIOT, V32, P577, DOI 10.1007/BF00173731; WALSH K, 1984, J BIOL CHEM, V259, P9646; Walsh K, 1987, Biochem Soc Symp, V54, P183; WEBER JM, 1991, SCIENCE, V252, P114, DOI 10.1126/science.2011746; WINDASS JD, 1980, NATURE, V287, P396, DOI 10.1038/287396a0; WINTER RB, 1989, BIO-TECHNOL, V7, P282, DOI 10.1038/nbt0389-282; WISE RJ, 1990, P NATL ACAD SCI USA, V87, P9378, DOI 10.1073/pnas.87.23.9378; WOOD TK, 1990, BIOTECHNOL BIOENG, V36, P865, DOI 10.1002/bit.260360902; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	96	810	955	6	237	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1991	252	5013					1668	1675		10.1126/science.2047876	http://dx.doi.org/10.1126/science.2047876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT114	2047876				2022-12-28	WOS:A1991FT11400038
J	ERLICH, HA; GELFAND, D; SNINSKY, JJ				ERLICH, HA; GELFAND, D; SNINSKY, JJ			RECENT ADVANCES IN THE POLYMERASE CHAIN-REACTION	SCIENCE			English	Review							SICKLE-CELL ANEMIA; SINGLE-STRANDED-DNA; ENZYMATICALLY AMPLIFIED DNA; OLIGONUCLEOTIDE PROBES; MESSENGER-RNA; BETA-GLOBIN; GENOMIC SEQUENCES; MITOCHONDRIAL-DNA; GENETIC-ANALYSIS; DIRECT CLONING	The polymerase chain reaction (PCR) has dramatically altered how molecular studies are conducted as well as what questions can be asked. In addition to simplifying molecular tasks typically carried out with the use of recombinant DNA technology, PCR has allowed a spectrum of advances ranging from the identification of novel genes and pathogens to the quantitation of characterized nucleotide sequences. PCR can provide insights into the intricacies of single cells as well as the evolution of species. Some recent developments in instrumentation, methodology, and applications of the PCR are presented in this review.	CETUS CORP,DEPT INFECT DIS,EMERYVILLE,CA 94608		ERLICH, HA (corresponding author), CETUS CORP,DEPT HUMAN GENET,EMERYVILLE,CA 94608, USA.							ABRAMSON RK, UNPUB; ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; ALLEN RC, 1989, BIOTECHNIQUES, V7, P736; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; BECKERANDRE M, 1989, NUCLEIC ACIDS RES, V17, P9347; BILL J, 1989, J EXP MED, V169, P115, DOI 10.1084/jem.169.1.115; BLAKE E, UNPUB; BOS JL, 1989, CANCER RES, V49, P4682; BROCK TD, 1969, J BACTERIOL, V98, P289, DOI 10.1128/JB.98.1.289-297.1969; BROW MAD, 1990, PCR PROTOCOLS GUIDE, P189; BRUNS TD, IN PRESS ANN REV ECO; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; CHEHAB FF, 1989, P NATL ACAD SCI USA, V86, P9178, DOI 10.1073/pnas.86.23.9178; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; ECKERT KA, 1990, NUCLEIC ACIDS RES, V18, P3739, DOI 10.1093/nar/18.13.3739; EMBURY SH, 1987, NEW ENGL J MED, V316, P656, DOI 10.1056/NEJM198703123161103; ERLICH H, 1991, EUR J IMMUNOGENET, V18, P33, DOI 10.1111/j.1744-313X.1991.tb00005.x; ERLICH HA, 1989, PCR TECHNOLOGY PRINC, P193; FALOONA F, 1990, 6TH INT C AIDS SAN F; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gelfand D.H., 1990, PC PRO, P129; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; GIRGIS SI, 1988, NUCLEIC ACIDS RES, V16, P10371, DOI 10.1093/nar/16.21.10371; GYLLENSTEN UB, 1989, P NATL ACAD SCI USA, V86, P9986, DOI 10.1073/pnas.86.24.9986; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HAFF L, 1991, BIOTECHNIQUES, V10, P102; HANDYSIDE AH, 1989, LANCET, V1, P347; HELMUTH R, 1990, AM J HUM GENET, V47, P515; Higuchi R., 1989, PCR TECHNOLOGY, P61; HIGUCHI R, UNPUB; HIGUCHI R, 1989, NATURE, V339, P237; HIGUCHI RG, 1989, NUCLEIC ACIDS RES, V17, P5865, DOI 10.1093/nar/17.14.5865; HOLLAND PM, IN PRESS P NATL ACAD; HOLM T, UNPUB; HORNES E, 1990, BIOTECHNIQUES, V9, P730; HUBER HE, 1987, J BIOL CHEM, V262, P16224; ISAACS ST, 1991, NUCLEIC ACIDS RES, V19, P109, DOI 10.1093/nar/19.1.109; KASAI K, 1990, J FORENSIC SCI, V35, P1196; KAWASAKI ES, 1988, P NATL ACAD SCI USA, V85, P5698, DOI 10.1073/pnas.85.15.5698; KELLOGG DE, 1990, ANAL BIOCHEM, V189, P202, DOI 10.1016/0003-2697(90)90108-L; KEOHAVONG P, 1989, P NATL ACAD SCI USA, V86, P9253, DOI 10.1073/pnas.86.23.9253; KINZLER KW, 1989, NUCLEIC ACIDS RES, V17, P3645, DOI 10.1093/nar/17.10.3645; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; KWOK S, 1989, PCR TECHNOLOGY PRINC, P235; LAWLOR DA, 1991, NATURE, V349, P785, DOI 10.1038/349785a0; LEDBETTER SA, 1990, GENOMICS, V6, P475, DOI 10.1016/0888-7543(90)90477-C; LEE CC, 1988, SCIENCE, V239, P1288, DOI 10.1126/science.3344434; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; LICHTER P, 1990, P NATL ACAD SCI USA, V87, P6634, DOI 10.1073/pnas.87.17.6634; LOH EY, 1989, SCIENCE, V243, P217, DOI 10.1126/science.2463672; LONGO MC, 1990, GENE, V93, P125, DOI 10.1016/0378-1119(90)90145-H; MACK DH, 1988, P NATL ACAD SCI USA, V85, P6977, DOI 10.1073/pnas.85.18.6977; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; MONK M, 1990, LANCET, V335, P985, DOI 10.1016/0140-6736(90)91060-N; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; MYERS TW, IN PRESS BIOCHEMISTR; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; NICKERSON DA, 1990, P NATL ACAD SCI USA, V87, P8923, DOI 10.1073/pnas.87.22.8923; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; OCHMAN H, 1988, GENETICS, V120, P621; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PAABO S, 1989, J BIOL CHEM, V264, P9709; PAABO S, 1990, J BIOL CHEM, V265, P4718; PARKER D, IN PRESS NUCLEIC ACI; PERSING DH, 1990, SCIENCE, V249, P1420, DOI 10.1126/science.2402635; PHADNIS SH, 1989, P NATL ACAD SCI USA, V86, P5908, DOI 10.1073/pnas.86.15.5908; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSE EA, 1991, FASEB J, V5, P46, DOI 10.1096/fasebj.5.1.1991584; RUANO G, 1991, P NATL ACAD SCI USA, V88, P2815, DOI 10.1073/pnas.88.7.2815; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAIKI RK, 1988, NEW ENGL J MED, V319, P537, DOI 10.1056/NEJM198809013190903; SARKAR G, 1990, NATURE, V343, P27, DOI 10.1038/343027a0; SARKAR G, 1989, SCIENCE, V244, P331, DOI 10.1126/science.2565599; SCHARF S, UNPUB; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; SILVER J, 1989, J VIROL, V63, P1924, DOI 10.1128/JVI.63.5.1924-1928.1989; SNINSKY JJ, UNPUB; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; STONEKING M, 1991, AM J HUM GENET, V48, P370; STRAUSBAUGH LD, IN PRESS P NATL ACAD; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P81; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WEBER JL, 1989, AM J HUM GENET, V44, P388; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; WHITE TJ, 1991, LABORATORY DIAGNOSIS, P147; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; WITTWER CT, 1990, ANAL BIOCHEM, V186, P328, DOI 10.1016/0003-2697(90)90090-V; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757	102	816	941	5	218	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1991	252	5013					1643	1651		10.1126/science.2047872	http://dx.doi.org/10.1126/science.2047872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT114	2047872				2022-12-28	WOS:A1991FT11400034
J	GILBERT, GL; MACINNES, SJ; GUISE, IA				GILBERT, GL; MACINNES, SJ; GUISE, IA			RIFAMPICIN PROPHYLAXIS FOR THROAT CARRIAGE OF HAEMOPHILUS-INFLUENZAE TYPE-B IN PATIENTS WITH INVASIVE DISEASE AND THEIR CONTACTS	BRITISH MEDICAL JOURNAL			English	Article							HEMOPHILUS-INFLUENZAE; COLONIZATION; PREVENTION; INFECTIONS; SPREAD	Objective - To determine rates of colonisation with Haemophilus influenzae type b among household contacts of children with invasive H influenzae type b disease; compliance among medical staff with recommendations for use of rifampicin prophylaxis; and effects of rifampicin treatment in H influenzae type b colonisation of patients and contacts. Design - Prospective study of patients and their household contacts. Setting - Royal Children's Hospital (the major paediatric hospital) in Victoria, Australia, with catchment population of 4.2 million, including 300 000 children aged under 5 years. Subjects - 234 patients (age range 6 weeks to 8 years) with 235 episodes of all types of invasive H influenzae type b disease admitted during 1988-9 and their contacts. Main outcome measures - Positive cultures of H influenzae type b from throat swabs taken at admission and six weeks subsequently; recording of rifampicin prophylaxis. Results - The percentage of patients with positive throat cultures fell from 69% (33/48) on day 1 of admission to 9% (4/47) after three days' treatment; at six weeks' follow up 32% (32/99) of patients who had not received rifampicin and 8% (5/61) who had, had positive throat cultures. Among household contacts, 33% (62/190) of children and 7% (25/359) of adults were colonised, and the colonisation rates were similar in contacts of patients with all types of H influenzae type b disease. Rifampicin prophylaxis was indicated in 85 families; in 34% it was not prescribed at all for contacts and in 41% not as recommended. The colonisation rates at follow up were significantly less in siblings given rifampicin (12%, 9/78), particularly in families in which all members were treated (3%), than in those in which they were not (36%) (odds ratio 21.5; 95% confidence interval 3.0 to 103.4). Conclusions - The rate of throat colonisation with H influenzae type b was similar among siblings of children with all types of invasive H influenzae type b disease. Colonisation in contacts can be reduced by rifampicin prophylaxis, but some contacts remained colonised or were recolonised by the time of follow up. Medical staff complied poorly with current recommendations for rifampicin prophylaxis, which reduces its intrinsically limited value in preventing H influenzae type b disease.	ROYAL CHILDRENS HOSP,DEPT MICROBIOL & INFECT DIS,PARKVILLE,VIC 3052,AUSTRALIA	Royal Children's Hospital Melbourne			Gilbert, Gwendolyn/B-7733-2013	Gilbert, Gwendolyn/0000-0001-7490-6727				APERT GA, 1985, J PEDIATR, V107, P555; BAND JD, 1984, JAMA-J AM MED ASSOC, V251, P2381, DOI 10.1001/jama.251.18.2381; BODIES EG, 1982, PEDIATRICS, V70, P141; CAMPBELL LR, 1980, PEDIATRICS, V66, P115; CLEMENTS DA, 1990, AUST NZ J MED, V20, P828, DOI 10.1111/j.1445-5994.1990.tb00435.x; FILICE GA, 1978, AM J DIS CHILD, V132, P578; GAUM RS, 1981, J PEDIATR, V98, P485; GILBERT GL, 1987, AUST PAEDIATR J, V23, P323; GILBERT GL, 1990, PEDIATR INFECT DIS J, V9, P252, DOI 10.1097/00006454-199004000-00006; GILBERT GL, 1987, ANTIOBIOTIC PROPHYLA; GILSDORF JR, 1986, PEDIATRICS, V77, P242; GLODE MP, 1985, PEDIATRICS, V76, P537; GLODE MP, 1990, BRIT MED J, V28, P899; LI KI, 1986, AM J DIS CHILD, V140, P381, DOI 10.1001/archpedi.1986.02140180115040; MICHAELS RH, 1976, J CLIN MICROBIOL, V4, P413; MICHAELS RH, 1975, PEDIATR RES, V9, P513, DOI 10.1203/00006450-197505000-00010; MICHAELS RH, 1977, J INFECT DIS, V136, P2228; MURPHY TV, 1981, J PEDIATR-US, V99, P406, DOI 10.1016/S0022-3476(81)80328-9; SCHWARTZ B, 1988, LANCET, V1, P1239; SHAPIRO ED, 1980, PEDIATRICS, V66, P5; WARD JI, 1979, NEW ENGL J MED, V301, P122, DOI 10.1056/NEJM197907193010302; 1982, MMWR-MORBID MORTAL W, V31, P679; 1982, MMWR-MORBID MORTAL W, V31, P672; 1984, PEDIATRICS, V74, P301	24	12	12	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1991	302	6790					1432	1435		10.1136/bmj.302.6790.1432	http://dx.doi.org/10.1136/bmj.302.6790.1432			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR403	2070109	Green Published, Bronze			2022-12-28	WOS:A1991FR40300021
J	KINGDOM, JCP; KELLY, T; MACLEAN, AB; MCALLISTER, EJ				KINGDOM, JCP; KELLY, T; MACLEAN, AB; MCALLISTER, EJ			RAPID ONE-STEP URINE TEST FOR HUMAN CHORIONIC-GONADOTROPIN IN EVALUATING SUSPECTED COMPLICATIONS OF EARLY-PREGNANCY	BRITISH MEDICAL JOURNAL			English	Article							ECTOPIC PREGNANCY	Objective - To determine the ability of a sensitive one step urine test to detect human chorionic gonadotrophin in women with suspected complications of early pregnancy. Design - Test on women presenting to accident and emergency department with gynaecological problems over six months. Results were validated using a quantitative assay for human chorionic gonadotrophin in serum and urine. Setting - Accident and emergency department and gynaecology wards of a university teaching hospital. Subjects - 130 unselected women. Main outcome measures-Detection of human chorionic gonadotrophin by one step test, presence of ectopic pregnancy, and results of quantitative analysis of chorionic gonadotrophin in serum and urine. Results - 79 women had a positive urine test-result and 51 a negative result. All 12 women with ectopic pregnancy had a positive test result, although urinary concentration varied from 191 IU/1 to 47 800 IU/1. Only one woman, who had a faintly positive result, was found not to be pregnant on subsequent examination. The sensitivity and negative predictive values of the urine test were 100% respectively. 33 women were sent home from the accident and emergency department with normal clinical findings after a negative urine test result. All these women had undetectable concentrations of chorionic gonadotrophin in matched samples of urine and serum. Conclusions - A simple, rapid one step test for chorionic gonadotrophin should be available for the initial evaluation of emergency gynaecological problems. The additional cost of the test is offset by not admitting those patients whose clinical findings are normal and who have a negative urine test result and by reducing the number of women requiring quantitative assays of chorionic gonadotrophin.	WESTERN INFIRM & ASSOCIATED HOSP,DEPT GYNAECOL,GLASGOW G11 6NT,SCOTLAND; WESTERN INFIRM & ASSOCIATED HOSP,DEPT BIOCHEM,GLASGOW G11 6NT,SCOTLAND				Kingdom, John/AAF-2145-2020; Kingdom, John/A-3247-2013					BATEMAN BG, 1990, OBSTET GYNECOL, V75, P421; DIMARCHI JM, 1989, OBSTET GYNECOL, V74, P851; NORMAN RJ, 1988, OBSTET GYNECOL, V71, P315; SHEPHERD RW, 1990, OBSTET GYNECOL, V75, P417; TINDALL VR, 1987, JEFFEOATES PRINCIPLE, P212; TURNER MJ, 1991, BRIT J OBSTET GYNAEC, V98, P306, DOI 10.1111/j.1471-0528.1991.tb13398.x; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401	7	15	15	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1991	302	6788					1308	1311		10.1136/bmj.302.6788.1308	http://dx.doi.org/10.1136/bmj.302.6788.1308			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ444	2059687	Green Published, Bronze			2022-12-28	WOS:A1991FQ44400019
J	SMITH, R				SMITH, R			MEDICAL-RESEARCH IN AUSTRALIA - TOP OF THE PILE - THE INSTITUTES	BRITISH MEDICAL JOURNAL			English	Article																			0	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	APR 27	1991	302	6783					1006	1010		10.1136/bmj.302.6783.1006	http://dx.doi.org/10.1136/bmj.302.6783.1006			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FJ508	2059247	Bronze, Green Published			2022-12-28	WOS:A1991FJ50800023
J	COHN, DL; CATLIN, BJ; PETERSON, KL; JUDSON, FN; SBARBARO, JA				COHN, DL; CATLIN, BJ; PETERSON, KL; JUDSON, FN; SBARBARO, JA			A 62-DOSE, 6-MONTH THERAPY FOR PULMONARY AND EXTRAPULMONARY TUBERCULOSIS - A TWICE-WEEKLY, DIRECTLY OBSERVED, AND COST-EFFECTIVE REGIMEN	ANNALS OF INTERNAL MEDICINE			English	Article									DENVER DEPT HLTH & HOSP, DENVER, CO USA; UNIV COLORADO, HLTH SCI CTR, DENVER, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver								ADDINGTON WW, 1979, CHEST, V76, P741, DOI 10.1378/chest.76.6_Supplement.741; ADDINGTON WW, 1985, CHEST, V87, pS125; ALLAN WGL, 1982, TUBERCLE, V63, P89; [Anonymous], 1984, Br J Dis Chest, V78, P330; BARNES PF, 1987, AM REV RESPIR DIS, V136, P325, DOI 10.1164/ajrccm/136.2.325; BASS JB, 1986, AM REV RESPIR DIS, V134, P431; Centers for Disease Control and Prevention, 1989, MMWR-MORBID M      S, V38, P1; COMBS DL, 1990, ANN INTERN MED, V112, P397, DOI 10.7326/0003-4819-76-3-112-6-397; DESOPO ND, 1982, AM REV RESPIR DIS, V125, P85; DUTT AK, 1982, J INFECT DIS, V146, P698, DOI 10.1093/infdis/146.5.698; DUTT AK, 1986, ANN INTERN MED, V104, P7, DOI 10.7326/0003-4819-104-1-7; DUTT AK, 1981, CHEST, V80, P724, DOI 10.1378/chest.80.6.724; EDSALL JR, 1977, AM REV RESPIR DIS, V116, P559, DOI 10.1164/arrd.1977.116.3.559; FOX W, 1986, AM REV RESPIR DIS, V133, P779; FOX W, 1981, BRIT J DIS CHEST, V75, P331, DOI 10.1016/0007-0971(81)90022-X; GIRLING DJ, 1978, TUBERCLE, V59, P13; GIRLING DJ, 1988, AM REV RESPIR DIS, V137, P1147; GOW JG, 1979, BRIT J UROL, V51, P239, DOI 10.1111/j.1464-410X.1979.tb04700.x; HOPEWELL PC, 1985, AM REV RESPIR DIS, V132, P737; ISEMAN M D, 1980, American Review of Respiratory Disease, V121, P611; KENDIG EL, 1958, NEW ENGL J MED, V258, P928, DOI 10.1056/NEJM195805082581902; Kent P. T., 1985, PUBLIC HLTH MYCOBACT, P31; KENT P W, 1970, Tubercle, V51, P24, DOI 10.1016/0041-3879(70)90125-X; KLEEBERG HH, 1984, WORLD ATLAS INITIAL; LEFF AR, 1981, AM REV RESPIR DIS, V123, P176; MANDELL GL, 1980, GOODMAN GILMANS PHAR, P1200; MILES SH, 1984, AM REV RESPIR DIS, V130, P827; MITCHISON DA, 1980, TUBERCLE, V61, P135, DOI 10.1016/0041-3879(80)90002-1; MONIE RDH, 1982, BRIT MED J, V285, P415, DOI 10.1136/bmj.285.6339.415; PRABHAKAR R, 1986, AM REV RESPIR DIS, V134, P27; SBARBARO JA, 1980, AM REV RESPIR DIS, V121, P172; SBARBARO JA, 1979, CHEST, V76, P750, DOI 10.1378/chest.76.6.750; SBARBARO JA, 1980, CLIN CHEST MED, V1, P253; SNIDER DE, 1985, CHEST, V87, pS117, DOI 10.1378/chest.87.2.117S; SNIDER DE, 1984, AM REV RESPIR DIS, V130, P1091; SNIDER DE, 1982, AM REV RESPIR DIS, V125, P265; SNIDER DE, 1985, IMPROVING PATIENT CO, P1; SUMMERS GD, 1980, BRIT J DIS CHEST, V74, P369, DOI 10.1016/0007-0971(80)90071-6; 1981, AM REV RESPIR DIS, V123, P165; 1982, AM REV RESPIR DIS, V126, P460; 1981, TUBERCLE, V62, P95	41	201	204	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	1990	112	6					407	415		10.7326/0003-4819-76-3-112-6-407	http://dx.doi.org/10.7326/0003-4819-76-3-112-6-407			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT100	2106816				2022-12-28	WOS:A1990CT10000003
J	REUTER, G; GIARRE, M; FARAH, J; GAUSZ, J; SPIERER, A; SPIERER, P				REUTER, G; GIARRE, M; FARAH, J; GAUSZ, J; SPIERER, A; SPIERER, P			DEPENDENCE OF POSITION-EFFECT VARIEGATION IN DROSOPHILA ON DOSE OF A GENE ENCODING AN UNUSUAL ZINC-FINGER PROTEIN	NATURE			English	Article									UNIV GENEVA,DEPT MOLEC BIOL,CH-1211 GENEVA 4,SWITZERLAND; BIOL RES CTR,INST GENET,H-6701 SZEGED,HUNGARY	University of Geneva; Hungarian Academy of Sciences; Hungarian Biological Research Center	REUTER, G (corresponding author), MARTIN LUTHER UNIV,DEPT GENET,O-4020 HALLE,GERMANY.							BAIROCH A, 1989, PC GENE SOFTWARE; BAKER WK, 1968, ADV GENET, V14, P133, DOI 10.1016/S0065-2660(08)60426-5; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; BOURBON HM, 1988, J MOL BIOL, V200, P627, DOI 10.1016/0022-2836(88)90476-7; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; DINGWALL C, 1987, EMBO J, V6, P69, DOI 10.1002/j.1460-2075.1987.tb04720.x; DORN R, 1986, CHROMOSOMA, V93, P398, DOI 10.1007/BF00285820; Duncan I., 1982, DEV ORDER ITS ORIGIN, P533; EISSENBERG JC, 1989, BIOESSAYS, V11, P14, DOI 10.1002/bies.950110105; FOURNIER D, 1989, J MOL BIOL, V210, P15, DOI 10.1016/0022-2836(89)90287-8; GASSER SM, 1987, TRENDS GENET, V3, P16, DOI 10.1016/0168-9525(87)90156-9; GAUSZ J, 1986, GENETICS, V112, P65; HALL LMC, 1983, J MOL BIOL, V169, P83, DOI 10.1016/S0022-2836(83)80176-4; HENIKOFF S, 1979, GENETICS, V93, P105; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; LEWIS J, 1989, NATURE, V341, P382, DOI 10.1038/341382a0; LOCKE J, 1988, GENETICS, V120, P181; NAGOSHI RN, 1987, GENETICS, V117, P487; PEIFER M, 1987, GENE DEV, V1, P891, DOI 10.1101/gad.1.9.891; REUTER G, 1981, MOL GEN GENET, V182, P516, DOI 10.1007/BF00293947; REUTER G, 1987, MOL GEN GENET, V210, P429, DOI 10.1007/BF00327193; REUTER G, 1986, MOL GEN GENET, V202, P481, DOI 10.1007/BF00333281; REUTER G, 1982, MOL GEN GENET, V148, P480; ROBERTSON HM, 1988, GENETICS, V118, P461; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; RUSSELL LB, 1963, SCIENCE, V140, P976, DOI 10.1126/science.140.3570.976; SEALY L, 1978, CELL, V14, P115, DOI 10.1016/0092-8674(78)90306-9; SINCLAIR DAR, 1981, MOL GEN GENET, V182, P516; SPOFFORD JB, 1967, GENETICS, V57, P751; SPOFFORD JB, 1976, GENETICS BIOL DROS C, V1, P955; STRUHL G, 1984, NATURE, V308, P454, DOI 10.1038/308454a0; STRUHL K, 1989, TRENDS BIOCHEM SCI, V14, P137, DOI 10.1016/0968-0004(89)90145-X; WUSTMANN G, 1989, MOL GEN GENET, V217, P520, DOI 10.1007/BF02464926; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; ZINK B, 1989, NATURE, V337, P468, DOI 10.1038/337468a0	35	228	230	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 15	1990	344	6263					219	223		10.1038/344219a0	http://dx.doi.org/10.1038/344219a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU138	2107402				2022-12-28	WOS:A1990CU13800049
J	BUTLER, J; DAVIES, AH; WESTABY, S				BUTLER, J; DAVIES, AH; WESTABY, S			STREPTOKINASE IN ACUTE AORTIC DISSECTION	BMJ-BRITISH MEDICAL JOURNAL			English	Article											BUTLER, J (corresponding author), JOHN RADCLIFFE HOSP, OXFORD HEART CTR, DEPT CARDIAC SURG, OXFORD OX3 9DU, ENGLAND.							[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; BIDSTRUP BP, 1989, J THORAC CARDIOV SUR, V97, P364; CALIFF RM, 1988, J AM COLL CARDIOL, V11, P20, DOI 10.1016/0735-1097(88)90160-X; CASTAIGNE AD, 1989, AM J CARDIOL, V64, pA30, DOI 10.1016/0002-9149(89)90927-2; CHAMBERLAIN DA, 1988, LANCET, V1, P545; DALTON H, 1989, J ROY SOC MED, V82, P394, DOI 10.1177/014107688908200708; HILLIS S, 1989, MIMS MONTHLY IND JUN, P23; KENNEDY JW, 1989, AM J CARDIOL, V64, pA8, DOI 10.1016/0002-9149(89)90922-3; LEE KF, 1988, J THORAC CARDIOV SUR, V95, P216; MAGNANI B, 1989, J AM COLL CARDIOL, V13, P19, DOI 10.1016/0735-1097(89)90543-3; MEYER J, 1989, LANCET, V1, P863; ONEILL WW, 1988, PROG CARDIOVASC DIS, V30, P235, DOI 10.1016/0033-0620(88)90018-7; RENTROP KP, 1985, CIRCULATION, V71, P627, DOI 10.1161/01.CIR.71.4.627; SCHRODER R, 1986, NEW ENGL J MED, V314, P1465; SOBEL BE, 1984, CIRCULATION, V70, P160, DOI 10.1161/01.CIR.70.2.160; VANOEVEREN W, 1987, ANN THORAC SURG, V44, P640, DOI 10.1016/S0003-4975(10)62153-4; VERSTRAETE M, 1985, DRUGS, V29, P236, DOI 10.2165/00003495-198529030-00003; WHEAT MW, 1982, CARDIAC SURGERY, P177; WILCOX R, 1989, TOPICS CIRCULATION, V3, P4; 1987, LANCET, V1, P502	21	40	41	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	1990	300	6723					517	519		10.1136/bmj.300.6723.517	http://dx.doi.org/10.1136/bmj.300.6723.517			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107933	Green Published, Bronze			2022-12-28	WOS:A1990CQ87800025
J	CURZEN, NP; CLARKE, B; GRAY, HH				CURZEN, NP; CLARKE, B; GRAY, HH			INTRAVENOUS THROMBOLYSIS FOR SUSPECTED MYOCARDIAL-INFARCTION - A CAUTIONARY NOTE	BMJ-BRITISH MEDICAL JOURNAL			English	Article									SOUTHAMPTON GEN HOSP, WESSEX REG CARDIOTHOR UNIT, SOUTHAMPTON SO9 4XY, HANTS, ENGLAND	University of Southampton			curzen, nick/AAD-8161-2020					[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; DAVIES A, 1989, BMJ-BRIT MED J, V299, P408, DOI 10.1136/bmj.299.6696.408; SCHRODER R, 1986, NEW ENGL J MED, V314, P1465; WILCOX RG, 1988, LANCET, V2, P525	5	12	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	1990	300	6723					513	513		10.1136/bmj.300.6723.513	http://dx.doi.org/10.1136/bmj.300.6723.513			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107931	Bronze, Green Published			2022-12-28	WOS:A1990CQ87800023
J	CAINELLI, T				CAINELLI, T			LICHEN-PLANUS AND LIVER-DISEASES - A MULTICENTER CASE-CONTROL STUDY	BRITISH MEDICAL JOURNAL			English	Article													Naldi, Luigi/K-6343-2016	Naldi, Luigi/0000-0002-3160-2835				ANONIDE A, 1989, INT J DERMATOL, V28, P524, DOI 10.1111/j.1365-4362.1989.tb04605.x; ARONSON IK, 1978, ARCH DERMATOL, V114, P255, DOI 10.1001/archderm.114.2.255; AYALA F, 1981, Annali Italiani di Dermatologia Clinica e Sperimentale, V35, P79; BAKER RJ, 1978, GLIM SYSTEM; CALANDRA P, 1972, G MINERVA DERMATOL, V47, P436; CHAPUT JC, 1985, BRIT MED J, V291, P25, DOI 10.1136/bmj.291.6487.25; CUSANO F, 1984, ARCH DERMATOL, V120, P994, DOI 10.1001/archderm.1984.01650440024011; EPSTEIN O, 1984, BRIT J DERMATOL, V111, P473, DOI 10.1111/j.1365-2133.1984.tb06612.x; GRAHAMBROWN RAC, 1982, BRIT J DERMATOL, V106, P699, DOI 10.1111/j.1365-2133.1982.tb14708.x; GRAZE PR, 1979, AM J MED, V66, P611, DOI 10.1016/0002-9343(79)91171-9; KATZ M, 1985, J AM ACAD DERMATOL, V12, P719, DOI 10.1016/S0190-9622(85)80160-2; KORKIJ W, 1984, J AM ACAD DERMATOL, V11, P609, DOI 10.1016/S0190-9622(84)70215-5; MANN RJ, 1982, BRIT J DERMATOL, V106, P357, DOI 10.1111/j.1365-2133.1982.tb01736.x; MANTEL N, 1959, J NATL CANCER I, V22, P719; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; MOBACKEN H, 1984, ACTA DERM-VENEREOL, V64, P70; MONK B, 1985, J AM ACAD DERMATOL, V12, P122, DOI 10.1016/S0190-9622(85)80251-6; MONK BE, 1986, DERMATOLOGICA, V173, P57, DOI 10.1159/000249219; POWELL FC, 1985, J AM ACAD DERMATOL, V12, P123, DOI 10.1016/S0190-9622(85)80252-8; POWELL FC, 1984, J AM ACAD DERMATOL, V11, P142, DOI 10.1016/S0190-9622(84)80172-3; POWELL FC, 1982, BRIT J DERMATOL, V107, P616, DOI 10.1111/j.1365-2133.1982.tb00416.x; REBORA A, 1984, ACTA DERM-VENEREOL, V64, P52; REBORA A, 1985, J AM ACAD DERMATOL, V12, P123, DOI 10.1016/S0190-9622(85)80253-X; REBORA A, 1985, ANN DERMATOL VENER, V112, P27; REBORA A, 1981, LANCET, V2, P805; REBORA A, 1978, ITALIAN GENERAL REV, V18, P1232; SAURAT JH, 1977, CLIN EXP DERMATOL, V2, P335; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; TAN RSH, 1974, P ROY SOC MED, V67, P196, DOI 10.1177/003591577406700309; TAN RSH, 1974, P ROY SOC MED, V67, P195, DOI 10.1177/003591577406700308; VALSECCHI R, 1988, ACTA DERM-VENEREOL, V68, P77; WALKER DM, 1976, BRIT J DERMATOL, V94, P529, DOI 10.1111/j.1365-2133.1976.tb05141.x; WILES JC, 1984, J AM ACAD DERMATOL, V10, P671, DOI 10.1016/S0190-9622(84)80279-0	33	87	87	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1990	300	6719					227	230						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL024	2106930				2022-12-28	WOS:A1990CL02400022
J	THOMAS, S; ODOHERTY, M; BATEMAN, N				THOMAS, S; ODOHERTY, M; BATEMAN, N			PNEUMOCYSTIS-CARINII PNEUMONIA	BRITISH MEDICAL JOURNAL			English	Editorial Material											THOMAS, S (corresponding author), ST THOMAS HOSP,LONDON SE1 7EH,ENGLAND.							ABD AG, 1988, CHEST, V94, P329, DOI 10.1378/chest.94.2.329; BERNARD EM, 1987, CLIN RES, V35, pA468; CONTE JE, 1987, ANN INTERN MED, V107, P495, DOI 10.7326/0003-4819-107-4-495; FALLAT R J, 1988, American Review of Respiratory Disease, V137, P120; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; GIRARD PM, 1988, LANCET, V1, P1165; GIRARD PM, 1987, ANTIMICROB AGENTS CH, V31, P978, DOI 10.1128/AAC.31.7.978; GIRARD PM, 1989, LANCET, V1, P1348; GOLDEN JA, 1989, LANCET, V1, P654; GORDIN FM, 1984, ANN INTERN MED, V100, P495, DOI 10.7326/0003-4819-100-4-495; HARDY WD, 1989, AM J MED, V87, P329, DOI 10.1016/S0002-9343(89)80159-7; HAVERKOS HW, 1984, AM J MED, V76, P501, DOI 10.1016/0002-9343(84)90670-3; HERER B, 1989, BRIT MED J, V298, P605, DOI 10.1136/bmj.298.6673.605-a; KARBOSKI JA, 1988, ANN INTERN MED, V108, P490, DOI 10.7326/0003-4819-108-3-490_1; KOVACS JA, 1988, J INFECT DIS, V158, P254, DOI 10.1093/infdis/158.1.254; MARTINEZ CM, 1988, CHEST, V94, P1317, DOI 10.1378/chest.94.6.1317b; MILLER RF, 1989, THORAX, V44, P565, DOI 10.1136/thx.44.7.565; MONTGOMERY AB, 1987, LANCET, V2, P480; MURRAY JF, 1984, NEW ENGL J MED, V310, P1682, DOI 10.1056/NEJM198406213102529; MURRAY JF, 1987, AM REV RESPIR DIS, V135, P504; ODOHERTY M, 1989, EUROPEAN RESPIRAT S8, V2, P657; ODOHERTY MJ, 1988, LANCET, V2, P1283; ODOHERTY MJ, IN PRESS JAMA; SIMMONDS AK, 1989, LANCET, V2, P953; SIMONDS AK, 1989, LANCET, V1, P221; SMITH DE, 1988, LANCET, V2, P905; THOMAS S, 1989, EUROPEAN RESPIRAT S8, V2, P657	27	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1990	300	6719					211	212		10.1136/bmj.300.6719.211	http://dx.doi.org/10.1136/bmj.300.6719.211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL024	2106927	Bronze, Green Published			2022-12-28	WOS:A1990CL02400005
J	FARRELL, PJS; GLANVILL, P				FARRELL, PJS; GLANVILL, P			DIVING PRACTICES OF SCUBA-DIVERS WITH ASTHMA	BRITISH MEDICAL JOURNAL			English	Article																			0	35	35	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					166	166		10.1136/bmj.300.6718.166	http://dx.doi.org/10.1136/bmj.300.6718.166			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105799	Green Published, Bronze			2022-12-28	WOS:A1990CK07700026
J	SYKES, D; DEWAR, R; MOHANARUBAN, K; DONOVAN, K; NICKLASON, F; THOMAS, DM; FISHER, D				SYKES, D; DEWAR, R; MOHANARUBAN, K; DONOVAN, K; NICKLASON, F; THOMAS, DM; FISHER, D			MEASURING BLOOD-PRESSURE IN THE ELDERLY - DOES ATRIAL-FIBRILLATION INCREASE OBSERVER VARIABILITY	BMJ-BRITISH MEDICAL JOURNAL			English	Article									UNIV COLL CARDIFF, CARDIFF ROYAL INFIRM, DEPT MED, CARDIFF CF2 1SZ, WALES	Cardiff Royal Infirmary; Cardiff University	SYKES, D (corresponding author), UNIV COLL CARDIFF, CARDIFF ROYAL INFIRM, DEPT GERIATR MED, CARDIFF CF2 1SZ, WALES.							AMERY A, 1985, LANCET, V1, P1349; [Anonymous], 1970, JAMA, V213, P1143; BRUCE NG, 1988, J HYPERTENS, V6, P375; CAMPBELL MJ, 1989, CONFIDENCE INTERVALS, P74; HLA KM, 1986, ARCH INTERN MED, V146, P2373, DOI 10.1001/archinte.146.12.2373; JACKSON G, 1976, LANCET, V2, P1317; NIELSEN PE, 1975, ACTA MED SCAND, V198, P35; OBRIEN E, 1985, BRIT MED J, V290, P729, DOI 10.1136/bmj.290.6470.729; PATTERSON HR, 1984, BRIT MED J, V289, P1661, DOI 10.1136/bmj.289.6459.1661; PETRIE JC, 1986, BRIT MED J, V293, P611, DOI 10.1136/bmj.293.6547.611; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973	11	32	32	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	1990	300	6718					162	163		10.1136/bmj.300.6718.162	http://dx.doi.org/10.1136/bmj.300.6718.162			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105795	Bronze, Green Published			2022-12-28	WOS:A1990CK07700022
J	DAVID, A				DAVID, A			HOW TO DO IT - WRITE A CLASSIC PAPER	BRITISH MEDICAL JOURNAL			English	Article											DAVID, A (corresponding author), INST PSYCHIAT,LONDON SE5 8AF,ENGLAND.		David, Anthony/O-1750-2019; David, Anthony S/C-1315-2011	David, Anthony/0000-0003-0967-774X; David, Anthony S/0000-0003-0967-774X					0	5	5	1	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	1990	300	6716					30	31		10.1136/bmj.300.6716.30	http://dx.doi.org/10.1136/bmj.300.6716.30			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG773	2105123	Green Published, Bronze			2022-12-28	WOS:A1990CG77300025
J	MORIARTY, TM; PADRELL, E; CARTY, DJ; OMRI, G; LANDAU, EM; IYENGAR, R				MORIARTY, TM; PADRELL, E; CARTY, DJ; OMRI, G; LANDAU, EM; IYENGAR, R			GO-PROTEIN AS SIGNAL TRANSDUCER IN THE PERTUSSIS TOXIN-SENSITIVE PHOSPHATIDYLINOSITOL PATHWAY	NATURE			English	Article									CUNY MT SINAI SCH MED,DEPT PSYCHIAT,1 GUSTAVE L LEVY PL,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT PHARMACOL,NEW YORK,NY 10029; VET ADM MED CTR,DEPT PSYCHIAT,BRONX,NY 10468	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA)								ASHKENAZI A, 1989, CELL, V56, P487, DOI 10.1016/0092-8674(89)90251-1; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; CODINA J, 1987, SCIENCE, V236, P442, DOI 10.1126/science.2436299; CODINA J, 1984, J BIOL CHEM, V259, P5874; DASCAL N, 1984, J PHYSIOL-LONDON, V352, P551, DOI 10.1113/jphysiol.1984.sp015310; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; GILLMAN AG, 1987, ANNU REV BIOCHEM, V56, P615; GILLO B, 1987, J PHYSIOL-LONDON, V392, P349, DOI 10.1113/jphysiol.1987.sp016784; KUSANO K, 1982, J PHYSIOL-LONDON, V328, P143, DOI 10.1113/jphysiol.1982.sp014257; MASTERS SB, 1988, SCIENCE, V241, P448, DOI 10.1126/science.2899356; MORIARTY TM, 1988, P NATL ACAD SCI USA, V85, P8865, DOI 10.1073/pnas.85.23.8865; MORIARTY TM, 1989, J BIOL CHEM, V264, P13524; MUMBY S, 1988, J BIOL CHEM, V263, P2020; OLATE J, 1989, FEBS LETT, V244, P188, DOI 10.1016/0014-5793(89)81190-1; ORON Y, 1985, NATURE, V313, P141, DOI 10.1038/313141a0; PREMONT RT, 1989, J BIOL CHEM, V264, P14960; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; ROUOT B, 1989, BIOCHEM J, V260, P307, DOI 10.1042/bj2600307; STERNWEIS PC, 1979, J BIOL CHEM, V254, P3333; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; TERASHIMA T, 1987, BRAIN RES, V417, P190, DOI 10.1016/0006-8993(87)90199-5; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0	24	189	189	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 4	1990	343	6253					79	82		10.1038/343079a0	http://dx.doi.org/10.1038/343079a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG614	2104959				2022-12-28	WOS:A1990CG61400060
J	HAVAS, S; KOUMJIAN, L; REISMAN, J; HSU, L; WOZENSKI, S				HAVAS, S; KOUMJIAN, L; REISMAN, J; HSU, L; WOZENSKI, S			RESULTS OF THE MASSACHUSETTS MODEL SYSTEMS FOR BLOOD CHOLESTEROL SCREENING PROJECT	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROGRAM; HYPERTENSION; COMMUNITY; MORTALITY; IMPACT	Objective. - To evaluate the effectiveness of a model blood cholesterol screening program. Design. - Principal components included physician education, community-based screenings, and follow-up. A lay or professional educator provided counseling and referral advice. Half of the subjects with high blood cholesterol levels received a reminder to see their physician. Setting. - 135 sites in four Massachusetts communities. Participants. - 10 428 adults. Males, the young, the poor, the less educated, and minorities were underrepresented. Main Outcome Measures.-Referral completion rates, blood cholesterol changes. Results. - 51.5% of those referred had visited their physicians within 2 to 4 months, increasing to 65.6% within 6 to 12 months. Older age (odds ratio [OR], 1.17 per additional decade), more education (OR, 1.17 per additional level), higher blood cholesterol levels (OR, 1.19 per additional 0.51 mmol/L), previous knowledge of level (OR, 1.34), and receiving a reminder (OR, 1.24) were significantly associated with greater likelihood of referral completion, whereas the type of educator providing counseling was not. Physicians had remeasured the blood cholesterol level of 76% of those seen, given dietary counseling to 70%, and prescribed medication to 15%. Significant changes in dietary fat were reported by both compliers and noncompliers with advice to follow up with their physicians. Six months after screening, blood cholesterol levels were 3.6% lower in noncompliers, 4.4% lower in compliers not taking cholesterol-lowering medications, and 8.8% in compliers taking such medications. Conclusions. - An effective, community-based blood cholesterol screening program can attract diverse populations and can result in most participants with high levels following up with their physicians, making dietary changes, and lowering their cholesterol levels. Additional strategies may be needed to attract underrepresented groups and to reduce the apparent overuse of cholesterol-lowering medications.	MASSACHUSETTS DEPT PUBL HLTH,BOSTON,MA 02130; UNIV LOWELL,COLL HLTH PROFESS,LOWELL,MA 01854	Massachusetts Department of Public Health; University of Massachusetts System; University of Massachusetts Lowell	HAVAS, S (corresponding author), UNIV MARYLAND,SCH MED,DEPT EPIDEMIOL & PREVENT MED,655 W BALTIMORE ST,BALTIMORE,MD 21201, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037832] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL37832] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLOCK G, 1985, AM J EPIDEMIOL, V122, P27, DOI 10.1093/oxfordjournals.aje.a114084; DAVIS CE, 1976, AM J EPIDEMIOL, V104, P493, DOI 10.1093/oxfordjournals.aje.a112321; FISCHER PM, 1990, ARCH INTERN MED, V150, P2567, DOI 10.1001/archinte.150.12.2567; GARRAWAY WM, 1987, JAMA-J AM MED ASSOC, V258, P214, DOI 10.1001/jama.258.2.214; GREENLAND P, 1987, AM J PUBLIC HEALTH, V77, P73, DOI 10.2105/AJPH.77.1.73; HAVAS S, 1989, AM J PREV MED, V5, P337, DOI 10.1016/S0749-3797(18)31054-7; KOTCHEN JM, 1986, JAMA-J AM MED ASSOC, V255, P2177, DOI 10.1001/jama.255.16.2177; LEFEBVRE RC, 1987, PREV MED, V16, P80, DOI 10.1016/0091-7435(87)90008-9; LEVY RI, 1984, AM J CARDIOL, V54, pC7, DOI 10.1016/0002-9149(84)90850-6; NAUGHTON MJ, 1990, JAMA-J AM MED ASSOC, V263, P1213, DOI 10.1001/jama.263.9.1213; RASTAM L, 1988, AM J PREV MED, V4, P244, DOI 10.1016/S0749-3797(18)31156-5; ROCHELLA E, 1984, HLTH ED Q, V11, P225; WYNDER EL, 1989, AM HEART J, V117, P649, DOI 10.1016/0002-8703(89)90741-2; WYNDER EL, 1986, JAMA-J AM MED ASSOC, V256, P2839, DOI 10.1001/jama.256.20.2839; 1968, NATIONAL DIET HEART, V18; 1985, JAMA-J AM MED ASSOC, V253, P2080; 1988, ARCH INTERN MED, V148, P36; 1990, MMWR, V39, P633; 1990, PREVENTION 89 90 FED, P34; 1986, HOME GARDEN B    APR, V232, P1; 1990, US PHS NIH902964 PUB	21	16	16	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	1991	266	3					375	381		10.1001/jama.266.3.375	http://dx.doi.org/10.1001/jama.266.3.375			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV960	2056647				2022-12-28	WOS:A1991FV96000027
J	CLEVENGER, CV; ALTMANN, SW; PRYSTOWSKY, MB				CLEVENGER, CV; ALTMANN, SW; PRYSTOWSKY, MB			REQUIREMENT OF NUCLEAR PROLACTIN FOR INTERLEUKIN-2 - STIMULATED PROLIFERATION OF LYMPHOCYTES-T	SCIENCE			English	Article							NB2 LYMPHOMA-CELLS; DNA-TRANSFECTION; TREATED-CELLS; C-MYC; GROWTH; EXPRESSION; PROTEIN; GENE; RECEPTOR; LOCATION	Prolactin (PRL) is necessary for the proliferation of cloned T lymphocytes in response to interleukin-2 (IL-2). Translocation of PRL into the nucleus occurs during IL-2-stimulated mitogenesis. Therefore, the function of intranuclear PRL in T cell proliferation was tested. Eukaryotic expression vectors were prepared to express wild-type PRL [PRL(WT)], PRL that lacks the signal sequence for translocation into the endoplasmic reticulum [PRL(ER-)], and chimeric PRL in which the signal peptide was replaced with the sequence that directs the nuclear translocation of the SV40 large T antigen [PRL(NT+)]. Expression of these constructs in a T cell line (Nb2) responsive to PRL and IL-2 resulted in localization of PRL in the extracellular milieu, cytoplasm, or nucleus, respectively. Stimulation with IL-2 alone resulted in a five- to tenfold increase in the incorporation of [H-3]thymidine by cells expressing PRL(NT+) or PRL(WT) as compared to PRL(ER-) or the parental Nb2 cells. Only the PRL(NT+) clone proliferated continuously with IL-2 stimulation in the presence of antiserum to PRL. These results demonstrate that nuclear PRL is necessary for IL-2-stimulated proliferation and suggest that a peptide hormone can function in the nucleus without binding to its cell surface receptor.			CLEVENGER, CV (corresponding author), UNIV PENN,DEPT PATHOL & LAB MED,545 CLIN RES BLDG,422 CURIE BLVD,PHILADELPHIA,PA 19104, USA.				NIGMS NIH HHS [GM-36962, GM-13901] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036962] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREWS GK, 1987, BIOCHIM BIOPHYS ACTA, V909, P231, DOI 10.1016/0167-4781(87)90082-0; BERCZI I, 1981, ACTA ENDOCRINOL-COP, V98, P506, DOI 10.1530/acta.0.0980506; BERNTON EW, 1988, SCIENCE, V239, P401, DOI 10.1126/science.3122324; BOUTIN JM, 1988, CELL, V53, P69, DOI 10.1016/0092-8674(88)90488-6; BOUTIN JM, 1989, MOL ENDOCRINOL, V3, P1455, DOI 10.1210/mend-3-9-1455; BUCKLEY AR, 1988, P NATL ACAD SCI USA, V85, P8649, DOI 10.1073/pnas.85.22.8649; CLEVENGER CV, 1990, ENDOCRINOLOGY, V127, P3151, DOI 10.1210/endo-127-6-3151; CLEVENGER CV, 1990, P NATL ACAD SCI USA, V87, P6460, DOI 10.1073/pnas.87.16.6460; CONNORS RW, 1988, DNA-J MOLEC CELL BIO, V7, P651, DOI 10.1089/dna.1988.7.651; CROZE F, 1988, MOL CELL ENDOCRINOL, V55, P253, DOI 10.1016/0303-7207(88)90140-2; DAVIS JA, 1988, MOL ENDOCRINOL, V2, P740, DOI 10.1210/mend-2-8-740; EMR SD, 1980, NATURE, V285, P82, DOI 10.1038/285082a0; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; GOUT PW, 1980, CANCER RES, V40, P2433; GRENFELL S, 1989, BIOCHEM J, V264, P813, DOI 10.1042/bj2640813; GUBBINS EJ, 1980, J BIOL CHEM, V255, P8655; HARTMANN DP, 1989, FASEB J, V3, P2194, DOI 10.1096/fasebj.3.10.2787766; HIGUCHI R, 1990, PCR PROTOCOLS, pCH22; IMMAMURA T, 1990, SCIENCE, V249, P1567; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; LANFORD RE, 1990, EXP CELL RES, V186, P32, DOI 10.1016/0014-4827(90)90206-P; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MAHER DW, 1989, MOL CELL BIOL, V9, P2251, DOI 10.1128/MCB.9.5.2251; MCCUTCHAN JH, 1968, JNCI-J NATL CANCER I, V41, P351; MURPHY PR, 1988, ENDOCRINOLOGY, V122, P2476, DOI 10.1210/endo-122-6-2476; NAGY E, 1978, ACTA ENDOCRINOL-COP, V89, P530; NAGY E, 1983, IMMUNOPHARMACOLOGY, V6, P231, DOI 10.1016/0162-3109(83)90023-1; NICOLL CS, 1974, HDB PHYSL 2, V4, pCH32; NOBLE RL, 1980, CANCER RES, V40, P2437; RILLEMA JA, 1989, BIOCHIM BIOPHYS ACTA, V1014, P78, DOI 10.1016/0167-4889(89)90243-7; ROBERTS BL, 1987, CELL, V50, P465, DOI 10.1016/0092-8674(87)90500-9; SMITH RM, 1988, J HISTOCHEM CYTOCHEM, V36, P359, DOI 10.1177/36.4.3279110; SOLER AP, 1989, P NATL ACAD SCI USA, V86, P6640, DOI 10.1073/pnas.86.17.6640; SUSSMAN DJ, 1984, MOL CELL BIOL, V4, P1641, DOI 10.1128/MCB.4.8.1641; VERNER K, 1988, SCIENCE, V241, P1307, DOI 10.1126/science.2842866; YULEE LY, 1990, MOL CELL ENDOCRINOL, V68, P21; YULEE LY, 1990, MOL CELL BIOL, V10, P3087, DOI 10.1128/MCB.10.6.3087	39	160	165	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 5	1991	253	5015					77	79		10.1126/science.2063207	http://dx.doi.org/10.1126/science.2063207			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV177	2063207				2022-12-28	WOS:A1991FV17700038
J	ENDO, I; SOEDA, E; MURAKAMI, Y; NISHI, K				ENDO, I; SOEDA, E; MURAKAMI, Y; NISHI, K			HUMAN GENOME ANALYSIS SYSTEM	NATURE			English	Article											ENDO, I (corresponding author), INST PHYS & CHEM RES,DIV GENOME RES,TSUKUBAO,IBARAKI 305,JAPAN.							DEININGER PL, 1983, ANAL BIOCHEM, V129, P216, DOI 10.1016/0003-2697(83)90072-6; SAKABE M, 1990, REV SCI INSTRUM, V61, P1966; WADA A, 1984, NATURE, V305, P193	3	7	8	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1991	352	6330					89	90		10.1038/352089a0	http://dx.doi.org/10.1038/352089a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV178	2062384				2022-12-28	WOS:A1991FV17800080
J	RUFF, M; KRISHNASWAMY, S; BOEGLIN, M; POTERSZMAN, A; MITSCHLER, A; PODJARNY, A; REES, B; THIERRY, JC; MORAS, D				RUFF, M; KRISHNASWAMY, S; BOEGLIN, M; POTERSZMAN, A; MITSCHLER, A; PODJARNY, A; REES, B; THIERRY, JC; MORAS, D			CLASS-II AMINOACYL TRANSFER-RNA SYNTHETASES - CRYSTAL-STRUCTURE OF YEAST ASPARTYL-TRANSFER RNA-SYNTHETASE COMPLEXED WITH TRANSFER RNAASP	SCIENCE			English	Article								The crystal structure of the binary complex tRNA(Asp)-aspartyl tRNA synthetase from yeast was solved with the use of multiple isomorphous replacement to 3 angstrom resolution. The dimeric synthetase, a member of class II aminoacyl tRNA synthetases (aaRS's) exhibits the characteristic signature motifs conserved in eight aaRS's. These three sequence motifs are contained in the catalytic site domain, built around an antiparallel beta-sheet, and flanked by three alpha-helices that form the pocket in which adenosine triphosphate (ATP) and the CCA end of tRNA bind. The tRNA(Asp) molecule approaches the synthetase from the variable loop side. The two major contact areas are with the acceptor end and the anticodon stem and loop. In both sites the protein interacts with the tRNA from the major groove side. The correlation between aaRS class II and the initial site of aminoacylation at 3'-OH can be explained by the structure. The molecular association leads to the following features: (i) the backbone of the GCCA single-stranded portion of the acceptor end exhibits a regular helical conformation; (ii) the loop between residues 320 and 342 in motif 2 interacts with the acceptor stem in the major groove and is in contact with the discriminator base G and the first base pair UA; and (iii) the anticodon loop undergoes a large conformational change in order to bind the protein. The conformation of the tRNA molecule in the complex is dictated more by the interaction with the protein than by its own sequence.	UNIV STRASBOURG 1, CNRS,INST BIOL MOLEC & CELLULAIRE, CRISTALLOG BIOL LAB,15 RUE RENE DESCARTES, F-67084 STRASBOURG, FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg			ruff, marc/J-3011-2013	ruff, marc/0000-0001-5451-6377; POTERSZMAN, Arnaud/0000-0002-6702-5777; Podjarny, Alberto/0000-0002-7685-1077; Krishnaswamy, Sankaran/0000-0002-6797-4614				AMIRI I, 1985, BIOCHIMIE, V67, P607, DOI 10.1016/S0300-9084(85)80200-5; ANSELME J, 1989, GENE, V84, P481, DOI 10.1016/0378-1119(89)90524-6; BRICK P, 1989, J MOL BIOL, V208, P83, DOI 10.1016/0022-2836(89)90090-9; BRICOGNE G, 1976, ACTA CRYSTALLOGR A, V32, P832, DOI 10.1107/S0567739476001691; BRUNIE S, 1990, J MOL BIOL, V216, P411, DOI 10.1016/S0022-2836(05)80331-6; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; DIETRICH A, 1980, J MOL BIOL, V138, P129, DOI 10.1016/S0022-2836(80)80008-8; DOCK AC, 1984, BIOCHIMIE, V66, P179, DOI 10.1016/0300-9084(84)90063-4; DOCKBREGEON AC, 1990, EUR J BIOCHEM, V188, P283, DOI 10.1111/j.1432-1033.1990.tb15401.x; ERIANI G, 1990, NUCLEIC ACIDS RES, V18, P7109, DOI 10.1093/nar/18.23.7109; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; ERIANI G, IN PRESS NUCLEIC ACI; FRASER TH, 1975, P NATL ACAD SCI USA, V72, P3044, DOI 10.1073/pnas.72.8.3044; FREIST W, 1981, H-S Z PHYSIOL CHEM, V362, P1247, DOI 10.1515/bchm2.1981.362.2.1247; FREIST W, 1988, ANGEW CHEM INT EDIT, V27, P773, DOI 10.1002/anie.198807731; GANGLOFF J, 1971, NATURE, V230, P726; GIEGE R, 1980, CR ACAD SCI D NAT, V291, P393; HECK JD, 1988, J BIOL CHEM, V263, P868; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; HOUNTONDJI C, 1985, BIOCHEMISTRY-US, V24, P1175, DOI 10.1021/bi00326a018; HOUNTONDJI C, 1986, BIOCHIMIE, V68, P1071, DOI 10.1016/S0300-9084(86)80181-X; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KERN D, 1990, EUR J BIOCHEM, V193, P97, DOI 10.1111/j.1432-1033.1990.tb19309.x; KERN D, 1981, BIOCHIM BIOPHYS ACTA, V653, P83, DOI 10.1016/0005-2787(81)90106-4; KIM SH, 1974, SCIENCE, V185, P435, DOI 10.1126/science.185.4149.435; LEVEQUE F, 1990, NUCLEIC ACIDS RES, V18, P305, DOI 10.1093/nar/18.2.305; MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483; MORAS D, 1986, P NATL ACAD SCI USA, V83, P932, DOI 10.1073/pnas.83.4.932; MORAS D, 1980, NATURE, V288, P669, DOI 10.1038/288669a0; NICHOLAS HB, 1987, COMPUT APPL BIOSCI, V3, P53; NORMANLY J, 1989, ANNU REV BIOCHEM, V58, P1029, DOI 10.1146/annurev.bi.58.070189.005121; PERRET V, 1990, NATURE, V344, P787, DOI 10.1038/344787a0; PODJARNY A, 1987, J BIOMOL STRUCT DYN, V5, P187, DOI 10.1080/07391102.1987.10506389; PRIESTLE JP, 1988, J APPL CRYSTALLOGR, V21, P572, DOI 10.1107/S0021889888005746; RICH A, 1977, NUCLEIC ACIDS RES, V4, P1649, DOI 10.1093/nar/4.5.1649; Rich A., 1962, HORIZONS BIOCH, P103; RISLER JL, 1981, NATURE, V292, P384, DOI 10.1038/292384a0; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; RUFF M, 1988, J MOL BIOL, V201, P235, DOI 10.1016/0022-2836(88)90450-0; RUFF M, UNPUB; SELLAMI M, 1986, NUCLEIC ACIDS RES, V14, P1657, DOI 10.1093/nar/14.4.1657; SHARP KA, 1990, BIOCHEMISTRY-US, V29, P340, DOI 10.1021/bi00454a006; VONDERHAAR F, 1975, BIOCHEMISTRY-US, V15, P4131; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WEBSTER T, 1984, SCIENCE, V226, P1315, DOI 10.1126/science.6390679; WESTHOF E, 1985, J MOL BIOL, V184, P119, DOI 10.1016/0022-2836(85)90048-8	48	657	667	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	1991	252	5013					1682	1689		10.1126/science.2047877	http://dx.doi.org/10.1126/science.2047877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT114	2047877				2022-12-28	WOS:A1991FT11400040
J	CHAMBERLAIN, G				CHAMBERLAIN, G			RAISED BLOOD-PRESSURE IN PREGNANCY	BRITISH MEDICAL JOURNAL			English	Article											CHAMBERLAIN, G (corresponding author), ST GEORGE HOSP,SCH MED,DEPT OBSTET & GYNAECOL,LONDON,ENGLAND.								0	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1991	302	6790					1454	1458		10.1136/bmj.302.6790.1454	http://dx.doi.org/10.1136/bmj.302.6790.1454			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR403	2070116	Green Published, Bronze			2022-12-28	WOS:A1991FR40300029
J	MURRAY, TS; DYKER, GS; CAMPBELL, LM				MURRAY, TS; DYKER, GS; CAMPBELL, LM			CHARACTERISTICS OF GENERAL-PRACTITIONERS WHO DID NOT CLAIM THE 1ST POSTGRADUATE EDUCATION ALLOWANCE	BRITISH MEDICAL JOURNAL			English	Article											MURRAY, TS (corresponding author), UNIV GLASGOW,W SCOTLAND COMM POSTGRAD MED EDUC,GLASGOW G12 8QQ,SCOTLAND.							Branthwaite A, 1988, 38 ROYAL COLL GEN PR; REEDY BLE, 1979, 9 ROYAL COLL GEN PRA; WOOD J, 1980, 11 ROYAL COLL GEN PR; 1989, GENERAL PRACTICE NAT	4	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 8	1991	302	6789					1377	1377		10.1136/bmj.302.6789.1377	http://dx.doi.org/10.1136/bmj.302.6789.1377			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR057	2059718	Bronze, Green Published			2022-12-28	WOS:A1991FR05700022
J	ECKMAN, MH; BESHANSKY, JR; DURANDZALESKI, I; LEVINE, HJ; PAUKER, SG				ECKMAN, MH; BESHANSKY, JR; DURANDZALESKI, I; LEVINE, HJ; PAUKER, SG			ANTICOAGULATION FOR NONCARDIAC PROCEDURES IN PATIENTS WITH PROSTHETIC HEART-VALVES - DOES LOW-RISK MEAN HIGH COST	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									NEW ENGLAND MED CTR,DEPT MED,DIV CARDIOL,BOSTON,MA 02111; TUFTS UNIV,SCH MED,BOSTON,MA 02111	Tufts Medical Center; Tufts University	ECKMAN, MH (corresponding author), NEW ENGLAND MED CTR,DIV CLIN DECIS MAKING,BOX 302,750 WASHINGTON AVE,BOSTON,MA 02111, USA.			Eckman, Mark/0000-0001-8253-269X	NLM NIH HHS [5T15 LM07044] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [T15LM007044] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		AARON HJ, 1984, PAINFUL PRESCRIPTION; AKBARIAN M, 1968, CIRCULATION, V37, P826, DOI 10.1161/01.CIR.37.5.826; ALTMAN R, 1976, J THORAC CARDIOV SUR, V72, P127; AYUSO LA, 1982, J THORAC CARDIOV SUR, V84, P906; BARNHORST DA, 1975, AM J CARDIOL, V35, P228, DOI 10.1016/0002-9149(75)90006-5; BARNHORST DA, 1976, J THORAC CARDIOV SUR, V71, P230; BECK JR, 1982, AM J MED, V73, P883, DOI 10.1016/0002-9343(82)90786-0; BECK JR, 1982, AM J MED, V73, P889, DOI 10.1016/0002-9343(82)90787-2; BJERKELUND CJ, 1963, AM J CARDIOL, V1, P158; BJORK VO, 1979, J THORAC CARDIOV SUR, V78, P331; BJORK VO, 1975, SCAND J THORAC CARD, V9, P183, DOI 10.3109/14017437509138637; BLOODWELL RD, 1979, J THORAC CARDIOVASC, V58, P457; Bodnar A G, 1984, Cardiovasc Clin, V14, P247; CAPLAN LR, 1983, STROKE, V14, P530, DOI 10.1161/01.STR.14.4.530; CHESBRO JH, 1988, J AM COLL CARDIOL S, V8, pB41; CHESEBRO JH, 1983, AM J CARDIOL, V51, P1537, DOI 10.1016/0002-9149(83)90673-2; CHEUNG D, 1981, ANN THORAC SURG, V32, P138, DOI 10.1016/S0003-4975(10)61020-X; CHRISTO MC, 1980, ARTIF ORGANS, V4, P199, DOI 10.1111/j.1525-1594.1980.tb03934.x; COPANS H, 1980, CIRCULATION, V61, P169, DOI 10.1161/01.CIR.61.1.169; COPELAND JG, 1977, J THORAC CARDIOV SUR, V74, P875; DALE J, 1977, AM HEART J, V93, P715, DOI 10.1016/S0002-8703(77)80066-5; DALE J, 1977, AM HEART J, V94, P101, DOI 10.1016/S0002-8703(77)80351-7; DALE J, 1976, AM HEART J, V91, P653, DOI 10.1016/S0002-8703(76)80152-4; Doubilet P, 1985, Med Decis Making, V5, P293, DOI 10.1177/0272989X8500500305; DUVOISIN GE, 1967, CIRCULATION       S1, V35, P70; EDMUNDS LH, 1982, ANN THORAC SURG, V34, P96, DOI 10.1016/S0003-4975(10)60862-4; EFFLER D B, 1965, Ann Thorac Surg, V1, P4; EISENBERG J, 1986, DOCTORS DECISIONS CO; EVANS RW, 1968, CIRCUULATION S6, V37, P74; FERNANDEZ J, 1976, CHEST, V70, P12, DOI 10.1378/chest.70.1.12; FISCHER HW, 1988, JAMA-J AM MED ASSOC, V260, P1614; FISHMAN NH, 1971, J THORAC CARDIOV SUR, V62, P345, DOI 10.1016/S0022-5223(19)42044-8; Frankl W S, 1986, Cardiovasc Clin, V16, P415; FRIEDLI B, 1971, AM HEART J, V81, P702, DOI 10.1016/0002-8703(71)90015-9; GADBOYS HL, 1967, J AMER MED ASSOC, V202, P282, DOI 10.1001/jama.202.4.282; GLOCK Y, 1984, J CARDIOVASC SURG, V25, P205; GRADY RF, 1985, MT SINAI J MED, V52, P634; GRAY LA, 1976, J THORAC CARDIOV SUR, V71, P429; HARVALD B, 1962, LANCET, V2, P626; HIATT HH, 1975, NEW ENGL J MED, V293, P235, DOI 10.1056/NEJM197507312930506; HYLEN JC, 1972, AM J CARDIOL, V30, P396, DOI 10.1016/0002-9149(72)90571-1; JACOBSON PD, 1988, JAMA-J AM MED ASSOC, V260, P1586, DOI 10.1001/jama.260.11.1586; KANNEL WB, 1984, NEW ENGL J MED, V311, P1144, DOI 10.1056/NEJM198411013111802; KATHOLI RE, 1976, AM HEART J, V92, P162, DOI 10.1016/S0002-8703(76)80251-7; KONTOS GJ, 1985, MAYO CLIN PROC, V60, P118, DOI 10.1016/S0025-6196(12)60297-3; LARSEN GL, 1977, ANN THORAC SURG, V23, P323, DOI 10.1016/S0003-4975(10)64133-1; LEE SJK, 1975, CIRCULATION, V52, P1132, DOI 10.1161/01.CIR.52.6.1132; LEPLEY D, 1980, ANN THORAC SURG, V30, P164, DOI 10.1016/S0003-4975(10)61235-0; LIMET R, 1977, ANN THORAC SURG, V23, P529, DOI 10.1016/S0003-4975(10)63696-X; LOELIGER EA, 1967, ACTA MED SCAND, V182, P549; LYTLE BW, 1986, ANN THORAC SURG, V42, P632, DOI 10.1016/S0003-4975(10)64597-3; MARSHALL WG, 1984, ANN THORAC SURG, V37, P398, DOI 10.1016/S0003-4975(10)60764-3; MCGOON MD, 1984, J AM COLL CARDIOL, V3, P930, DOI 10.1016/S0735-1097(84)80351-4; MCHENRY MM, 1978, J THORAC CARDIOV SUR, V75, P709; MCMANUS Q, 1980, J THORAC CARDIOVASC, V80, P834; MCMANUS Q, 1977, CIRCULATION, V56, P623; MESSMER BJ, 1971, J THORAC CARDIOV SUR, V62, P938, DOI 10.1016/S0022-5223(19)41986-7; MEUWISSE.OJ, 1969, ACTA MED SCAND, V186, P361; MICHAELS L, 1971, J AMER MED ASSOC, V215, P595, DOI 10.1001/jama.215.4.595; MITHA AS, 1976, J THORAC CARDIOV SUR, V72, P401; MOGGIO RA, 1978, J THORAC CARDIOV SUR, V75, P296; MORENOCABRAL RJ, 1978, J THORAC CARDIOV SUR, V75, P321; NICOLOFF DM, 1981, J THORAC CARDIOV SUR, V82, P674; OXMAN HA, 1975, J THORAC CARDIOV SUR, V69, P247; PLANTE DA, 1983, SEMIN ULTRASOUND CT, V4, P308; RACKLEY CE, 1985, HEART, P754; SADE RM, 1988, J THORAC CARDIOV SUR, V95, P553; SILVER MD, 1986, CARDIOVASC CLIN, V16, P273; SINGER RA, 1976, MECHANISMS BACTERIAL, P2; STANFORD W, 1972, J THORAC CARDIOV SUR, V63, P648, DOI 10.1016/S0022-5223(19)41883-7; STAREK PJK, 1976, ANN THORAC SURG, V22, P362, DOI 10.1016/S0003-4975(10)64968-5; STARR A, 1976, CIRCULATION, V54, P47; STARR A, 1975, ANN THORAC SURG, V19, P289, DOI 10.1016/S0003-4975(10)64019-2; STARR A, 1977, CIRCULATION, V56, P133; STEIN DW, 1976, J THORAC CARDIOV SUR, V71, P680; STEIN PD, 1986, CHEST, V89, pS46, DOI 10.1378/chest.89.2_Supplement.46S; STRANGE PV, 1978, NEW ENGL J MED, V298, P372; SULLIVAN JM, 1971, NEW ENGL J MED, V284, P1391, DOI 10.1056/NEJM197106242842501; SUTTON MGSJ, 1978, BRIT HEART J, V40, P558; THEVENET A, 1980, J CARDIOVASC SURG, V21, P669; TINKER JH, 1978, JAMA-J AM MED ASSOC, V239, P738, DOI 10.1001/jama.239.8.738; VIDNE B, 1974, ISRAEL J MED SCI, V10, P586; WEINSTEIN MC, 1976, HYPERTENSION POLICY; Winters W L Jr, 1986, Cardiovasc Clin, V16, P437; WRIGHT JO, 1982, J THORAC CARDIOV SUR, V84, P138; YEH TJ, 1967, CIRCULATION       S1, V35, P77; ZWART HHJ, 1979, ANN THORAC SURG, V28, P158, DOI 10.1016/S0003-4975(10)63774-5; 1986, MORTALITY A, V2; 1982, LANCET, V1, P64	89	66	71	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	1990	263	11					1513	1521		10.1001/jama.263.11.1513	http://dx.doi.org/10.1001/jama.263.11.1513			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT013	2106590				2022-12-28	WOS:A1990CT01300026
J	MATAYOSHI, ED; WANG, GT; KRAFFT, GA; ERICKSON, J				MATAYOSHI, ED; WANG, GT; KRAFFT, GA; ERICKSON, J			NOVEL FLUOROGENIC SUBSTRATES FOR ASSAYING RETROVIRAL PROTEASES BY RESONANCE ENERGY-TRANSFER	SCIENCE			English	Article									ABBOTT LABS,ABBOTT DIAGNOST DIV,N CHICAGO,IL 60064	Abbott Laboratories	MATAYOSHI, ED (corresponding author), ABBOTT LABS,DIV PHARMACEUT DISCOVERY,N CHICAGO,IL 60064, USA.				NIAID NIH HHS [AI27720] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BILLICH S, 1988, J BIOL CHEM, V263, P17905; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARMEL A, 1973, FEBS LETT, V30, P11, DOI 10.1016/0014-5793(73)80607-6; COPELAND TD, 1982, PEPTIDES SYNTHESIS S, P497; CORNISHB.A, 1974, BIOCHEM J, V137, P143, DOI 10.1042/bj1370143; CRAWFORD S, 1985, J VIROL, V53, P899, DOI 10.1128/JVI.53.3.899-907.1985; DARKE PL, 1989, J BIOL CHEM, V264, P2307; DARKE PL, 1988, BIOCHEM BIOPH RES CO, V156, P297, DOI 10.1016/S0006-291X(88)80839-8; DEYRUP C, 1983, ANAL BIOCHEM, V129, P502, DOI 10.1016/0003-2697(83)90584-5; Fairclough R H, 1978, Methods Enzymol, V48, P347; GIAM CZ, 1988, J BIOL CHEM, V263, P14617; HAAS E, 1978, BIOPOLYMERS, V17, P11, DOI 10.1002/bip.1978.360170103; KATOH I, 1987, NATURE, V329, P654, DOI 10.1038/329654a0; KATOH I, 1985, VIROLOGY, V145, P284; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4684; KOTLER M, 1988, P NATL ACAD SCI USA, V85, P4185, DOI 10.1073/pnas.85.12.4185; KRAUSSLICH HG, 1989, P NATL ACAD SCI USA, V86, P807, DOI 10.1073/pnas.86.3.807; LATT SA, 1972, ANAL BIOCHEM, V50, P56, DOI 10.1016/0003-2697(72)90485-X; Lloyd J.B.F., 1981, STANDARDS FLUORESCEN, P27; MATAYOSHI ED, UNPUB; MILLER M, 1989, NATURE, V337, P576, DOI 10.1038/337576a0; MOORE ML, 1989, BIOCHEM BIOPH RES CO, V159, P420, DOI 10.1016/0006-291X(89)90008-9; NASHED NT, 1989, BIOCHEM BIOPH RES CO, V163, P1079, DOI 10.1016/0006-291X(89)92331-0; NAVIA MA, 1989, NATURE, V337, P615, DOI 10.1038/337615a0; NAVIA MA, 1989, SCIENCE, V245, P616; NISHINO N, 1980, J BIOL CHEM, V255, P3482; OROSZLAN S, 1985, CURR TOP MICROBIOL, V115, P221; PEARL LH, 1987, NATURE, V329, P351, DOI 10.1038/329351a0; POHL J, 1987, ANAL BIOCHEM, V165, P96, DOI 10.1016/0003-2697(87)90205-3; RICHARDS AD, 1989, FEBS LETT, V247, P113, DOI 10.1016/0014-5793(89)81251-7; RITTENHOUSE J, UNPUB; SEELMEIER S, 1988, P NATL ACAD SCI USA, V85, P6612, DOI 10.1073/pnas.85.18.6612; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; WANG GC, UNPUB; Weiss R, 1985, RNA TUMOR VIRUSES; YARON A, 1979, ANAL BIOCHEM, V95, P228, DOI 10.1016/0003-2697(79)90210-0	36	538	669	0	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 23	1990	247	4945					954	958		10.1126/science.2106161	http://dx.doi.org/10.1126/science.2106161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP906	2106161				2022-12-28	WOS:A1990CP90600037
J	CALE, ARJ; FAROUK, M; PRESCOTT, RJ; WALLACE, IWJ				CALE, ARJ; FAROUK, M; PRESCOTT, RJ; WALLACE, IWJ			DOES VASECTOMY ACCELERATE TESTICULAR-TUMOR - IMPORTANCE OF TESTICULAR EXAMINATIONS BEFORE AND AFTER VASECTOMY	BRITISH MEDICAL JOURNAL			English	Article									UNIV EDINBURGH,MED STAT UNIT,EDINBURGH EH8 9AG,MIDLOTHIAN,SCOTLAND; BANGOUR GEN HOSP,W LOTHIAN EH25 6LR,SCOTLAND	University of Edinburgh								MOSS AR, 1986, AM J EPIDEMIOL, V124, P39, DOI 10.1093/oxfordjournals.aje.a114369; RUMKE PH, 1979, VASECTOMY IMMUNOLOGI; STRADER CH, 1988, AM J EPIDEMIOL, V128, P56, DOI 10.1093/oxfordjournals.aje.a114958; THORNHILL JA, 1987, BRIT J UROL, V59, P367, DOI 10.1111/j.1464-410X.1987.tb04660.x; 1978, ANN REPORT REGISTRAR	5	36	36	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					370	370		10.1136/bmj.300.6721.370	http://dx.doi.org/10.1136/bmj.300.6721.370			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106990	Green Published, Bronze			2022-12-28	WOS:A1990CN79900023
J	CRUICKSHANK, JK; RICHARDSON, JH; MORGAN, OSC; PORTER, J; KLENERMAN, P; KNIGHT, J; NEWELL, AL; RUDGE, P; DALGLEISH, AG				CRUICKSHANK, JK; RICHARDSON, JH; MORGAN, OSC; PORTER, J; KLENERMAN, P; KNIGHT, J; NEWELL, AL; RUDGE, P; DALGLEISH, AG			SCREENING FOR PROLONGED INCUBATION OF HTLV-I INFECTION IN BRITISH AND JAMAICAN RELATIVES OF BRITISH PATIENTS WITH TROPICAL SPASTIC PARAPARESIS	BRITISH MEDICAL JOURNAL			English	Article									NORTHWICK PK HOSP & CLIN RES CTR,RETROVIRUS RES GRP,HARROW HA1 3UJ,ENGLAND; UNIV W INDIES,FAC MED,KINGSTON 7,JAMAICA; UNIV OXFORD,SCH MED,OXFORD,ENGLAND	Imperial College London; University West Indies Mona Jamaica; University of Oxford	CRUICKSHANK, JK (corresponding author), NORTHWICK PK HOSP & CLIN RES CTR,DEPT MED,HARROW HA1 3UJ,ENGLAND.		Dalgleish, Angus/AAZ-4450-2020; Porter, Joanna/C-7162-2009	Dalgleish, Angus/0000-0003-3511-3059; Porter, Joanna/0000-0002-7307-169X; klenerman, paul/0000-0003-4307-9161	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BLATTNER WA, 1986, P NATL ACAD SCI USA, V83, P4895, DOI 10.1073/pnas.83.13.4895; CATOVSKY D, 1982, LANCET, V1, P639; CLAPHAM P, 1983, SCIENCE, V222, P1125, DOI 10.1126/science.6316502; CRUICKSHANK E K, 1956, West Indian Med J, V5, P147; CRUICKSHANK JK, 1989, BRAIN, V112, P1057, DOI 10.1093/brain/112.4.1057; DALGLEISH A, 1988, AIDS RES HUM RETROV, V4, P475, DOI 10.1089/aid.1988.4.475; HINO S, 1985, JPN J CANCER RES, V76, P474; HIROSE S, 1988, VIROLOGY, V162, P487, DOI 10.1016/0042-6822(88)90492-8; HO DD, 1984, P NATL ACAD SCI-BIOL, V81, P7588, DOI 10.1073/pnas.81.23.7588; HOXIE JA, 1984, P NATL ACAD SCI-BIOL, V81, P7591, DOI 10.1073/pnas.81.23.7591; INABA S, 1989, TRANSFUSION, V7, P1; KAJIYAMA W, 1986, J INFECT DIS, V154, P851, DOI 10.1093/infdis/154.5.851; KINOSHITA K, 1984, JPN J CANCER RES, V75, P103; KONDO T, 1989, INT J CANCER, V43, P1061, DOI 10.1002/ijc.2910430618; KUSUHARA K, 1987, INT J CANCER, V40, P755, DOI 10.1002/ijc.2910400607; MADISEN L, 1987, AM J MED GENET, V27, P379, DOI 10.1002/ajmg.1320270216; MARMOT MG, 1989, ETHNIC FACTORS HLTH; MILLER GJ, 1986, INT J CANCER, V38, P801, DOI 10.1002/ijc.2910380604; MONTGOMERY RD, 1964, BRAIN, V87, P425, DOI 10.1093/brain/87.3.425; MORGAN OS, 1988, Q J MED, V67, P273; MURPHY EL, 1989, INT J CANCER, V43, P250, DOI 10.1002/ijc.2910430214; MURPHY EL, 1989, ANN INTERN MED, V111, P555, DOI 10.7326/0003-4819-111-7-555; NEWTON M, 1987, LANCET, V1, P415; PATE E, 1989, W INDIAN MED J S, V38, P34; RICHARDSON JH, 1989, SCIENCE, V246, P821, DOI 10.1126/science.246.4931.821-a; RODGERSJOHNSON P, 1988, ANN NEUROL S, V23, P121; SINCLAIR AL, 1988, AIDS, V2, P465, DOI 10.1097/00002030-198812000-00009; Strachan H., 1897, PRACTITIONER, V59, P477; TAJIMA K, 1987, INT J CANCER, V40, P741, DOI 10.1002/ijc.2910400605; TEDDER RS, 1984, LANCET, V2, P125; TOKUDOME S, 1989, CANCER RES, V49, P226; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; 1988, LANCET, V1, P217	33	21	21	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 3	1990	300	6720					300	304		10.1136/bmj.300.6720.300	http://dx.doi.org/10.1136/bmj.300.6720.300			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM195	2106960	Bronze, Green Published			2022-12-28	WOS:A1990CM19500019
J	DAMSGAARD, EM; FROLAND, A; JORGENSEN, OD; MOGENSEN, CE				DAMSGAARD, EM; FROLAND, A; JORGENSEN, OD; MOGENSEN, CE			MICROALBUMINURIA AS PREDICTOR OF INCREASED MORTALITY IN ELDERLY PEOPLE	BRITISH MEDICAL JOURNAL			English	Article									FREDERICIA CTY HOSP,DEPT MED,FREDERICIA,DENMARK; ODENSE UNIV,DEPT CLIN PHYSIOL,DK-5230 ODENSE M,DENMARK; AARHUS UNIV,AARHUS KOMMUNE HOSP,DEPT MED,DK-8000 AARHUS C,DENMARK	University of Southern Denmark; Aarhus University			Jørgensen, Ole/F-6986-2016	Jørgensen, Ole/0000-0003-0092-0846; Damsgaard, Else Marie Skjode/0000-0001-5499-4731				CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; COX DR, 1972, J R STAT SOC B, V34, P187; DAMSGAARD EM, 1986, DIABETIC MED, V3, P430, DOI 10.1111/j.1464-5491.1986.tb00785.x; DAMSGAARD EM, 1984, SCAND J SOC MED, V12, P115, DOI 10.1177/140349488401200304; Dyerberg J., 1978, Protides of the biological fluids, P419; ELLESTAD MH, 1975, STRESS TESTING PRINC, P15; ESCHWEGE E, 1985, HORM METAB RES, V15, P41; FABER OK, 1984, ACTA ENDOCR-COP    S, V106, P2; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; HEDING LG, 1975, DIABETOLOGIA, V11, P541, DOI 10.1007/BF01222104; Jarrett R J, 1984, Diabet Med, V1, P17; KANNEL WB, 1984, AM HEART J, V108, P1347, DOI 10.1016/0002-8703(84)90763-4; KUSUMI RK, 1981, JAMA-J AM MED ASSOC, V245, P1653, DOI 10.1001/jama.245.16.1653; MATTOCK MB, 1988, DIABETOLOGIA, V31, P82, DOI 10.1007/BF00395552; MILES DW, 1970, SCAND J CLIN LAB INV, V26, P5, DOI 10.3109/00365517009049206; MOGENSEN CE, 1985, UREMIA INVEST, V9, P85, DOI 10.3109/08860228509088195; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; MOGENSEN CE, 1988, DIABETES METAB REV, V4, P453, DOI 10.1002/dmr.5610040504; PYORALA K, 1985, ACTA MED SCAND S, V701, P38; PYORALA K, 1987, DIABETES METABOL REV, V3, P436; Rose GA, 1968, CARDIOVASCULAR SURVE, P137; SCHMIDT FH, 1973, INT DONAU S DIABETES, V3, P567; SCHMITZ A, 1988, DIABETIC MED, V5, P126, DOI 10.1111/j.1464-5491.1988.tb00958.x; SHEARMAN CP, 1988, LANCET, V2, P906; VIBERTI G, 1988, DIABETES CARE, V11, P840, DOI 10.2337/diacare.11.10.840; Welborn T A, 1979, Diabetes Care, V2, P154, DOI 10.2337/diacare.2.2.154; YUDKIN JS, 1988, LANCET, V2, P530	28	539	556	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 3	1990	300	6720					297	300		10.1136/bmj.300.6720.297	http://dx.doi.org/10.1136/bmj.300.6720.297			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM195	2106959	Green Published, Bronze			2022-12-28	WOS:A1990CM19500018
J	CONTRERAS, M; MOLLISON, PL				CONTRERAS, M; MOLLISON, PL			ABC OF TRANSFUSION - IMMUNOLOGICAL COMPLICATIONS OF TRANSFUSION	BRITISH MEDICAL JOURNAL			English	Article									UNIV LONDON,HAEMATOL,LONDON,ENGLAND	University of London	CONTRERAS, M (corresponding author), N LONDON BLOOD TRANSFUS CTR,LONDON,ENGLAND.								0	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					173	176		10.1136/bmj.300.6718.173	http://dx.doi.org/10.1136/bmj.300.6718.173			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105802	Bronze, Green Published			2022-12-28	WOS:A1990CK07700029
J	LOKE, RHT; MURRAYLYON, IM; CARTER, GD				LOKE, RHT; MURRAYLYON, IM; CARTER, GD			POSTURAL HYPOTENSION RELATED TO ZIDOVUDINE IN A PATIENT INFECTED WITH HIV	BRITISH MEDICAL JOURNAL			English	Article									CHARING CROSS HOSP,DEPT GASTROENTEROL,LONDON W6 8RF,ENGLAND; CHARING CROSS HOSP,DEPT CHEM PATHOL,LONDON W6 8RF,ENGLAND	Imperial College London; Imperial College London								ARON DC, 1989, ARCH INTERN MED, V149, P330, DOI 10.1001/archinte.149.2.330; BLUM MR, 1988, AM J MED, V85, P189; GLASGOW BJ, 1985, AM J CLIN PATHOL, V84, P94; GUY RJC, 1989, BRIT MED J, V298, P498; RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402	5	4	5	1	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					163	164		10.1136/bmj.300.6718.163	http://dx.doi.org/10.1136/bmj.300.6718.163			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105796	Bronze, Green Published			2022-12-28	WOS:A1990CK07700023
J	REEVE, WG; RUNCIE, CJ; REIDY, J; WALLACE, PGM				REEVE, WG; RUNCIE, CJ; REIDY, J; WALLACE, PGM			CURRENT PRACTICE IN TRANSFERRING CRITICALLY ILL PATIENTS AMONG HOSPITALS IN THE WEST OF SCOTLAND	BRITISH MEDICAL JOURNAL			English	Article											REEVE, WG (corresponding author), WESTERN INFIRM & ASSOCIATED HOSP,CLIN SHOCK STUDY GRP,GLASGOW G11 6NT,SCOTLAND.							BION JF, 1985, BRIT MED J, V291, P432, DOI 10.1136/bmj.291.6493.432; BION JF, 1988, BRIT MED J, V296, P170, DOI 10.1136/bmj.296.6616.170; LEDINGHAM IM, 1980, HOSPITAL UPDATE  JAN, V6, P43; OLSON CM, 1987, AM J EMERG MED, V5, P33, DOI 10.1016/0735-6757(87)90285-3; RIDLEY S, 1989, ANAESTHESIA, V44, P822, DOI 10.1111/j.1365-2044.1989.tb09099.x; WADDELL G, 1975, BRIT MED J, V1, P386, DOI 10.1136/bmj.1.5954.386; WRIGHT IH, 1988, BRIT MED J, V296, P543, DOI 10.1136/bmj.296.6621.543; 1989, ANAESTHESIA, V44, P428; 1988, REPORT WORKING PARTY; 1988, INTENSIVE CARE SERVI	10	30	30	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					85	87		10.1136/bmj.300.6717.85	http://dx.doi.org/10.1136/bmj.300.6717.85			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105781	Green Published, Bronze			2022-12-28	WOS:A1990CJ08000018
J	HENKIN, RI				HENKIN, RI			HYPOSMIA IN WOMAN WITH ASTHMA AND ALLERGIC RHINITIS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter																		BOOT TF, 1990, NEW ENGL J MED, V323, P1700; HENKIN RI, 1984, BIOL TRACE ELEM RES, V6, P263, DOI 10.1007/BF02917511; HENKIN RI, 1981, PERCEPTION BEHAV CHE, P227; Henkin RI, 1982, LOOSELEAF SERIES OTO, P1; Henkin RJ, 1976, SCI F OTOLARYNGOLOGY, P468; HOYE RC, 1970, AM J SURG, V120, P485, DOI 10.1016/S0002-9610(70)80012-5	6	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1991	266	4					583	583						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX021	2061990				2022-12-28	WOS:A1991FX02100038
J	RACKOW, EC; ASTIZ, ME				RACKOW, EC; ASTIZ, ME			PATHOPHYSIOLOGY AND TREATMENT OF SEPTIC SHOCK	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							GRAM-NEGATIVE BACTEREMIA; TUMOR-NECROSIS-FACTOR; CRITICALLY ILL PATIENTS; ACUTE-RENAL-FAILURE; MYOCARDIAL DEPRESSANT SUBSTANCE; RESPIRATORY-DISTRESS SYNDROME; HIGH-DOSE METHYLPREDNISOLONE; LEFT-VENTRICULAR PERFORMANCE; CANINE ENDOTOXIN-SHOCK; SYSTEM ORGAN FAILURE	The mortality from septic shock continues to range between 40% to 60% despite advances in cardiovascular support and antibiotic therapy impairment of host defenses predisposes to the development of both severe infection and septic shock. The activation of a myriad of cellular and plasma mediators by microbial toxins produces the systemic and metabolic manifestations of sepsis. The clinical presentation includes characteristic clinical, hemodynamic, and laboratory abnormalities. Multiple organ systems are involved during septic shock, with outcome dependent on the circulatory response and the development of sequential organ failures. Initial resuscitation is directed at restoring tissue perfusion with fluids and vasoactive drugs, guided by assessment of the patient's hemodynamic status. Identification of the site of infection and choice of appropriate antibiotics are critical to the success of therapy Newer therapeutic modalities include immunologic interventions that attenuate mediator activity and modulate the immune response. Pharmacologic therapies are also being developed that are aimed at blocking the actions of specific mediators.			RACKOW, EC (corresponding author), ST VINCENTS HOSP & MED CTR, DEPT MED, CRIT CARE MED SECT, 153 W 11TH ST, NEW YORK, NY 10011 USA.							ARCHER LT, 1975, BRIT J PHARMACOL, V54, P145, DOI 10.1111/j.1476-5381.1975.tb06923.x; ARCHIE JP, 1977, ANN SURG, V186, P171, DOI 10.1097/00000658-197708000-00008; ASTIZ ME, 1989, CHEST, V96, P363, DOI 10.1378/chest.96.2.363; ASTIZ ME, 1991, CIRC SHOCK, V33, P92; ASTIZ ME, 1987, CRIT CARE MED, V15, P26, DOI 10.1097/00003246-198701000-00005; ASTIZ ME, 1991, CHEST, V99, P1072, DOI 10.1378/chest.99.5.1072; BANKS JG, 1982, J CLIN PATHOL, V35, P1249, DOI 10.1136/jcp.35.11.1249; BAUMGARTNER JD, 1985, LANCET, V2, P59; BEAUFILS M, 1976, NEW ENGL J MED, V295, P185, DOI 10.1056/NEJM197607222950402; BENASSAYAG C, 1984, EUR J CLIN INVEST, V14, P288, DOI 10.1111/j.1365-2362.1984.tb01183.x; BERRY LJ, 1977, CRC CR REV TOXICOL, V5, P239, DOI 10.3109/10408447709082601; BESSEY PQ, 1984, ANN SURG, V200, P264, DOI 10.1097/00000658-198409000-00004; Bessey PQ, 1988, TRAUMA SEPSIS SHOCK, P245; BEULTER B, 1987, NEW ENGL J MED, V316, P379; BEULTER B, 1985, SCIENCE, V229, P869; BIHARI D, 1987, NEW ENGL J MED, V317, P397, DOI 10.1056/NEJM198708133170701; BLACK PR, 1982, ANN SURG, V196, P420, DOI 10.1097/00000658-198210000-00005; BLAIN CM, 1970, ARCH INTERN MED, V126, P260, DOI 10.1001/archinte.126.2.260; BLAIR E, 1970, AM J SURG, V119, P433, DOI 10.1016/0002-9610(70)90146-7; BOCZKOWSKI J, 1988, AM REV RESPIR DIS, V138, P260, DOI 10.1164/ajrccm/138.2.260; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; BONE RC, 1987, CHEST, V92, P1032, DOI 10.1378/chest.92.6.1032; BONE RC, 1989, CRIT CARE MED, V17, P389, DOI 10.1097/00003246-198905000-00002; BONE RC, 1991, ANN INTERN MED, V114, P332, DOI 10.7326/0003-4819-114-4-332; BONNET F, 1985, CRIT CARE MED, V13, P972, DOI 10.1097/00003246-198511000-00039; BORZOTTA AP, 1983, SURG CLIN N AM, V63, P315; BRYAN CS, 1983, REV INFECT DIS, V5, P629; BURSZTEIN S, 1978, CRIT CARE MED, V6, P162, DOI 10.1097/00003246-197805000-00008; CANNON JG, 1990, J INFECT DIS, V161, P79, DOI 10.1093/infdis/161.1.79; CERRA FB, 1987, SURGERY, V101, P1; CERRA FB, 1978, J SURG RES, V25, P180, DOI 10.1016/0022-4804(78)90074-4; CHASE JJ, 1986, INFECT IMMUN, V53, P711, DOI 10.1128/IAI.53.3.711-712.1986; CHELLURI L, 1989, CHEST, V95, P1295, DOI 10.1378/chest.95.6.1295; CHERNOW B, 1986, CIRC SHOCK, V18, P141; CLOWES GHA, 1985, ANN SURG, V202, P446, DOI 10.1097/00000658-198510000-00006; CLOWES GHA, 1983, NEW ENGL J MED, V308, P545, DOI 10.1056/NEJM198303103081001; COOK JA, 1980, J CLIN INVEST, V65, P227, DOI 10.1172/JCI109655; CRUM C, 1985, CHEST, V88, P763; CUNNION RE, 1986, CIRCULATION, V73, P637, DOI 10.1161/01.CIR.73.4.637; CZER LSC, 1978, SURG GYNECOL OBSTET, V147, P363; DAHN MS, 1987, SURGERY, V101, P69; DAMAS P, 1989, CRIT CARE MED, V17, P975, DOI 10.1097/00003246-198910000-00001; DANIEL AM, 1978, SURGERY, V84, P588; DEMARIA A, 1985, LANCET, V1, P1363; DESJARS P, 1987, CRIT CARE MED, V15, P134, DOI 10.1097/00003246-198702000-00011; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; ELIN RJ, 1975, NEW ENGL J MED, V293, P521, DOI 10.1056/NEJM197509112931102; ELLMAN H, 1984, CRIT CARE MED, V12, P629, DOI 10.1097/00003246-198408000-00004; ELLRODT AG, 1985, AM HEART J, V110, P402, DOI 10.1016/0002-8703(85)90163-2; FADEN AI, 1984, JAMA-J AM MED ASSOC, V252, P1177, DOI 10.1001/jama.252.9.1177; FEIN AM, 1983, CHEST, V83, P40, DOI 10.1378/chest.83.1.40; FIELD B, 1984, J CRIT CARE, V4, P9; FIELD S, 1982, AM REV RESPIR DIS, V126, P9; FILKINS JP, 1985, FED PROC, V44, P300; FLECK A, 1985, LANCET, V1, P781; FRANSON TR, 1985, REV INFECT DIS, V7, P1; FREUND H, 1979, ANN SURG, V190, P571, DOI 10.1097/00000658-197911000-00003; Fry D E, 1981, Adv Shock Res, V6, P45; FRY DE, 1980, ARCH SURG-CHICAGO, V115, P136; FRY DE, 1979, SURGERY, V85, P652; GILBERT EM, 1986, AM REV RESPIR DIS, V134, P873, DOI 10.1164/arrd.1986.134.5.873; GOLENBOCK DT, 1988, INFECT IMMUN, V56, P779, DOI 10.1128/IAI.56.4.779-784.1988; GRELICK K, 1990, THERAPEUTIC MONOCLON, P253; GROEGER JS, 1983, CRIT CARE MED, V11, P650, DOI 10.1097/00003246-198308000-00013; GROENEVELD ABJ, 1986, SURGERY, V99, P140; GUMP FE, 1970, ANN SURG, V171, P321, DOI 10.1097/00000658-197003000-00001; GUMP FE, 1974, J TRAUMA, V14, P378, DOI 10.1097/00005373-197405000-00004; GURLL NJ, 1988, CRIT CARE MED, V16, P521, DOI 10.1097/00003246-198805000-00011; HACK CE, 1989, BLOOD, V74, P1704; HALUSHKA PV, 1985, CRIT CARE MED, V13, P451, DOI 10.1097/00003246-198506000-00001; HARLAN J, 1985, SEPTIC SHOCK, P85; HAUPT M, 1989, CHEST, V96, pS291; HAUPT MT, 1985, AM REV RESPIR DIS, V131, P912; HAUPT MT, 1987, CRIT CARE MED, V15, P442, DOI 10.1097/00003246-198704000-00205; HINSHAW LB, 1970, ARCH SURG-CHICAGO, V100, P600; HOLADAY JW, 1978, NATURE, V275, P450, DOI 10.1038/275450a0; HUSSAIN SNA, 1986, J APPL PHYSIOL, V60, P486, DOI 10.1152/jappl.1986.60.2.486; HUSSAIN SNA, 1985, J APPL PHYSIOL, V58, P2033, DOI 10.1152/jappl.1985.58.6.2033; HUSSAIN SNA, 1985, J APPL PHYSIOL, V59, P1802, DOI 10.1152/jappl.1985.59.6.1802; JACOBS ER, 1982, J CLIN INVEST, V70, P536, DOI 10.1172/JCI110645; JACOBS RF, 1989, CRIT CARE CLIN, V5, P9; KALTER ES, 1982, CRIT CARE MED, V10, P662, DOI 10.1097/00003246-198210000-00009; KAPLAN RL, 1979, ARCH INTERN MED, V139, P867, DOI 10.1001/archinte.139.8.867; KAUFMAN BS, 1984, CHEST, V85, P336, DOI 10.1378/chest.85.3.336; KELTON JG, 1979, NEW ENGL J MED, V300, P760, DOI 10.1056/NEJM197904053001404; KIKERI D, 1986, AM J PHYSIOL, V250, P1098, DOI 10.1152/ajprenal.1986.250.6.F1098; KILBOURN RG, 1990, J NATL CANCER I, V82, P772, DOI 10.1093/jnci/82.9.772; KNAUS WA, 1985, ANN SURG, V202, P685, DOI 10.1097/00000658-198512000-00004; KREGER BE, 1980, AM J MED, V68, P332, DOI 10.1016/0002-9343(80)90101-1; KREGER BE, 1980, AM J MED, V68, P344, DOI 10.1016/0002-9343(80)90102-3; KWAAN HM, 1969, SURG GYNECOL OBSTETR, V128, P37; LEDINGHAM IM, 1978, LANCET, V1, P1194; LEFER AM, 1989, CIRC SHOCK, V27, P3; LONG CL, 1976, METABOLISM, V25, P193, DOI 10.1016/0026-0495(76)90049-4; LUCAS CE, 1973, ARCH SURG-CHICAGO, V106, P444; LUCE JM, 1988, AM REV RESPIR DIS, V138, P62, DOI 10.1164/ajrccm/138.1.62; MACLEAN LD, 1967, ANN SURG, V166, P543, DOI 10.1097/00000658-196710000-00004; MCCABE WR, 1972, J IMMUNOL, V108, P601; MCCABE WR, 1983, AM J MED, V75, P7, DOI 10.1016/0002-9343(83)90067-0; MCCABE WR, 1972, NEW ENGL J MED, V287, P261, DOI 10.1056/NEJM197208102870601; MECHER C, 1991, CRIT CARE MED, V19, P705, DOI 10.1097/00003246-199105000-00018; MENASHE PI, 1988, CRIT CARE MED, V16, P1106, DOI 10.1097/00003246-198811000-00005; MICHIE HR, 1988, SURGERY, V104, P280; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; MIERJEDREZJOWIC.A, 1986, AM REV RESPIR DIS, V138, P5; MORRISON DC, 1978, AM J PATHOL, V93, P526; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; NANNI G, 1984, J TRAUMA, V24, P14, DOI 10.1097/00005373-198401000-00003; NASRAWAY SA, 1989, CHEST, V95, P612, DOI 10.1378/chest.95.3.612; NEELY WA, 1971, ANN SURG, V173, P657, DOI 10.1097/00000658-197105000-00005; NISHIJIMA H, 1973, MEDICINE, V52, P287, DOI 10.1097/00005792-197307000-00007; OGNIBENE FP, 1988, CHEST, V93, P903, DOI 10.1378/chest.93.5.903; OKRENT DG, 1987, AM J MED, V83, P681, DOI 10.1016/0002-9343(87)90898-9; OKUSAWA S, 1988, J CLIN INVEST, V81, P1162, DOI 10.1172/JCI113431; OPPENHEIMER L, 1976, J SURG RES, V20, P211, DOI 10.1016/0022-4804(76)90141-4; PACKMAN MI, 1983, CRIT CARE MED, V11, P165, DOI 10.1097/00003246-198303000-00003; PARKER MM, 1984, ANN INTERN MED, V100, P483, DOI 10.7326/0003-4819-100-4-483; PARKER MM, 1987, CRIT CARE MED, V15, P923, DOI 10.1097/00003246-198710000-00006; PARKER MM, 1983, JAMA-J AM MED ASSOC, V250, P3324, DOI 10.1001/jama.250.24.3324; PARRILLO JE, 1985, J CLIN INVEST, V76, P1539, DOI 10.1172/JCI112135; PEDUZZI P, 1987, NEW ENGL J MED, V317, P659; POLLACK M, 1983, J CLIN INVEST, V72, P1874, DOI 10.1172/JCI111150; POLLACK M, 1983, REV INFECT DIS, V5, pS979; RACKOW EC, 1988, JAMA-J AM MED ASSOC, V259, P1989, DOI 10.1001/jama.259.13.1989; RACKOW EC, 1983, CRIT CARE MED, V11, P839, DOI 10.1097/00003246-198311000-00001; RACKOW EC, 1987, CIRC SHOCK, V22, P11; RASMUSSEN HH, 1982, AM J MED, V73, P211, DOI 10.1016/0002-9343(82)90181-4; RAWSON JS, 1985, SOUTHERN MED J, V78, P1421, DOI 10.1097/00007611-198512000-00006; RECTOR F, 1973, ANN SURG, V178, P222, DOI 10.1097/00000658-197308000-00021; REILLY JM, 1989, CHEST, V95, P1072, DOI 10.1378/chest.95.5.1072; REINES HD, 1982, LANCET, V2, P174; REUHAUG A, 1988, ARCH SURG-CHICAGO, V123, P162; RICHMOND JM, 1982, NEPHRON, V31, P219, DOI 10.1159/000182650; ROBERTS DE, 1988, LANCET, V2, P699; ROCK P, 1985, CRIT CARE MED, V13, P28, DOI 10.1097/00003246-198501000-00008; ROMANO FD, 1986, AM J PHYSIOL, V251, pR359, DOI 10.1152/ajpregu.1986.251.2.R359; ROSBERG B, 1981, ACTA ANAESTH SCAND, V25, P402, DOI 10.1111/j.1399-6576.1981.tb01674.x; RUIZ CE, 1979, JAMA-J AM MED ASSOC, V242, P165, DOI 10.1001/jama.242.2.165; SCHAER GL, 1985, CRIT CARE MED, V13, P492, DOI 10.1097/00003246-198506000-00011; SCHUMER W, 1976, ANN SURG, V184, P333, DOI 10.1097/00000658-197609000-00011; SHAW JHF, 1987, ANN SURG, V205, P288, DOI 10.1097/00000658-198703000-00012; SHEAGREN JN, 1984, NEW ENGL J MED, V310, P1368, DOI 10.1056/NEJM198405243102107; SHELL K, 1978, INFECT IMMUNOL, V19, P839; SHEPPARD BC, 1989, SURGERY, V106, P156; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; SIBBALD WJ, 1978, CHEST, V73, P583, DOI 10.1378/chest.73.5.583; SIEGEL JH, 1979, SURGERY, V86, P163; SLOTMAN GJ, 1986, SURGERY, V99, P744; SMITH EF, 1988, CIRC SHOCK, V25, P21; SPANGA G, 1985, ARCH SURG-CHICAGO, V120, P187; SPRUNG CL, 1984, NEW ENGL J MED, V311, P1137, DOI 10.1056/NEJM198411013111801; STUMACHER RJ, 1973, NEW ENGL J MED, V288, P1261, DOI 10.1056/NEJM197306142882402; STYRT B, 1989, NEW ENGL J MED, V321, P240, DOI 10.1056/NEJM198907273210407; SUFFREDINI AF, 1989, NEW ENGL J MED, V321, P280, DOI 10.1056/NEJM198908033210503; TAKAYAMA K, 1984, REV INFECT DIS, V6, P439; TALZAK E, 1985, SEPTIC SHOCK, P275; TENG NNH, 1985, P NATL ACAD SCI USA, V82, P1790, DOI 10.1073/pnas.82.6.1790; THIJS LG, 1983, CIRC SHOCK, V10, P147; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; TUCHSCHMIDT J, 1989, CRIT CARE MED, V17, P719, DOI 10.1097/00003246-198908000-00001; URBASCHEK R, 1987, REV INFECT DIS, V9, pS607; VITEK V, 1971, ANN SURG, V173, P308, DOI 10.1097/00000658-197102000-00021; WATTERS JM, 1986, ARCH SURG-CHICAGO, V121, P179; WEIL MH, 1970, CIRCULATION, V41, P989, DOI 10.1161/01.CIR.41.6.989; WEIL MH, 1978, AM J MED, V64, P920, DOI 10.1016/0002-9343(78)90444-8; WEIL MH, 1964, ANN INTERN MED, V60, P384, DOI 10.7326/0003-4819-60-3-384; WEIL MH, 1956, J CLIN INVEST, V35, P1191, DOI 10.1172/JCI103373; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P54; WIENER M, 1987, CRIT CARE CLIN, V3, P25, DOI 10.1016/S0749-0704(18)30560-8; WILES JB, 1980, CRIT CARE MED, V8, P55, DOI 10.1097/00003246-198002000-00001; WILMORE DW, 1980, ANN SURG, V192, P491, DOI 10.1097/00000658-198010000-00008; WILMORE DW, 1988, SURGERY, V104, P917; WOLFF SM, 1973, J INFECT DIS, V128, pS259, DOI 10.1093/infdis/128.Supplement_1.S259; WOOLLISCROFT JO, 1982, AM J MED, V72, P58, DOI 10.1016/0002-9343(82)90578-2; YOUNG LS, 1977, ANN INTERN MED, V86, P456, DOI 10.7326/0003-4819-86-4-456; ZAGER RA, 1986, J CLIN INVEST, V78, P196, DOI 10.1172/JCI112552; ZIEGLER EJ, 1982, NEW ENGL J MED, V307, P1225, DOI 10.1056/NEJM198211113072001; ZIEGLER EJ, 1991, NEW ENGL J MED, V324, P429, DOI 10.1056/NEJM199102143240701; ZIEGLER EJ, 1973, J IMMUNOL, V111, P433; ZIMMERMAN HJ, 1979, GASTROENTEROLOGY, V77, P362	181	109	110	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1991	266	4					548	554						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX021	2061983				2022-12-28	WOS:A1991FX02100030
J	BIALEK, W; RIEKE, F; VANSTEVENINCK, RRD; WARLAND, D				BIALEK, W; RIEKE, F; VANSTEVENINCK, RRD; WARLAND, D			READING A NEURAL CODE	SCIENCE			English	Article								Traditional approaches to neural coding characterize the encoding of known stimuli in average neural responses. Organisms face nearly the opposite task - extracting information about an unknown time-dependent stimulus from short segments of a spike train. Here the neural code was characterized from the point of view of the organism, culminating in algorithms for real-time stimulus estimation based on a single example of the spike train. These methods were applied to an identified movement-sensitive neuron in the fly visual system. Such decoding experiments determined the effective noise level and fault tolerance of neural computation, and the structure of the decoding algorithms suggested a simple model for real-time analog signal processing with spiking neurons.	UNIV CALIF BERKELEY, DEPT PHYS, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA; STATE UNIV GRONINGEN, DEPT BIOPHYS, 9700 AB GRONINGEN, NETHERLANDS	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Groningen								Adrian ED, 1926, J PHYSIOL-LONDON, V61, P49, DOI 10.1113/jphysiol.1926.sp002273; BIALEK W, 1990, J STAT PHYS, V59, P103, DOI 10.1007/BF01015565; BIALEK W, 1990, 1989 LECT COMPL SYST, V2, P513; FITZHUGH R, 1958, J GEN PHYSIOL, V41, P675, DOI 10.1085/jgp.41.4.675; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Hausen K., 1984, PHOTORECEPTION VISIO; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; Marmarelis P.Z., 1978, ANAL PHYSL SYSTEMS; MILLER MI, 1987, J ACOUST SOC AM, V81, P665, DOI 10.1121/1.394835; Perkel D.H., 1968, NEUROSCI RES PROGRAM, V6, P221; Reichardt W., 1961, PRINCIPLES SENSORY C; RICHMOND BJ, 1990, J NEUROPHYSIOL, V64, P351, DOI 10.1152/jn.1990.64.2.351; RIEKE F, IN PRESS 1991 P EUR; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SZEKELY G, 1981, ADV PHYSL SCI, V30, P103; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; VANSTEVENINCK RRD, 1986, REAL TIME PERFORMANC; WARLAND D, IN PRESS ANAL MODELI; WESTHEIMER G, 1975, INVEST OPHTH VISUAL, V14, P570	20	695	722	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	1991	252	5014					1854	1857		10.1126/science.2063199	http://dx.doi.org/10.1126/science.2063199			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU061	2063199				2022-12-28	WOS:A1991FU06100042
J	FRIEDELL, GH				FRIEDELL, GH			THE SQUEAKY WHEEL AND HEALTH-CARE POLICY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											FRIEDELL, GH (corresponding author), LUCILLE P MARKEY CANC CTR,CANC CONTROL PROGRAM,800 ROSE ST,LEXINGTON,KY 40536, USA.							MOSKOWITZ M, 1988, AM J ROENTGENOL, V151, P659, DOI 10.2214/ajr.151.4.659	1	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1991	265	24					3300	3300		10.1001/jama.265.24.3300	http://dx.doi.org/10.1001/jama.265.24.3300			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR835	2046113				2022-12-28	WOS:A1991FR83500039
J	PUTZ, J; PUGLISI, JD; FLORENTZ, C; GIEGE, R				PUTZ, J; PUGLISI, JD; FLORENTZ, C; GIEGE, R			IDENTITY ELEMENTS FOR SPECIFIC AMINOACYLATION OF YEAST TRANSFER RNAASP BY COGNATE ASPARTYL-TRANSFER RNA-SYNTHETASE	SCIENCE			English	Article								The nucleotides crucial for the specific aminoacylation of yeast tRNA(Asp) by its cognate synthetase have been identified. Steady-state aminoacylation kinetics of unmodified tRNA transcripts indicate that G34, U35, C36, and G73 are important determinants of tRNA(Asp) identity. Mutations at these positions result in a large decrease (19- to 530-fold) of the kinetic specificity constant (ratio of the catalytic rate constant k(cat) and the Michaelis constant K(m)) for aspartylation relative to wild-type tRNA(Asp). Mutation to G10-C25 within the D-stem reduced k(cat)/K(m) eightfold. This fifth mutation probably indirectly affects the presentation of the highly conserved G10 nucleotide to the synthetase. A yeast tRNA(Phe) was converted into an efficient substrate for aspartyl-tRNA synthetase through introduction of the five identity elements. The identity nucleotides are located in regions of tight interaction between tRNA and synthetase as shown in the crystal structure of the complex and suggest sites of base-specific contacts.	CNRS, INST BIOL MOLEC & CELLULAIRE, BIOCHIM LAB, 15 RUE RENE DESCARTES, F-67084 STRASBOURG, FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg								BRUCE AG, 1982, BIOCHEMISTRY-US, V21, P3921, DOI 10.1021/bi00260a003; CROTHERS DM, 1972, P NATL ACAD SCI USA, V69, P3063, DOI 10.1073/pnas.69.10.3063; EBEL JP, 1973, BIOCHIMIE, V55, P547, DOI 10.1016/S0300-9084(73)80415-8; FLORENTZ C, 1991, EUR J BIOCHEM, V195, P229, DOI 10.1111/j.1432-1033.1991.tb15698.x; FREIST W, 1989, BIOCHEMISTRY-US, V28, P6787, DOI 10.1021/bi00443a001; GANGLOFF J, 1971, NATURE, V230, P726; GARCIA A, 1990, NUCLEIC ACIDS RES, V18, P89, DOI 10.1093/nar/18.1.89; GARCIA A, UNPUB; HASEGAWA T, 1989, BIOCHEM BIOPH RES CO, V163, P1534, DOI 10.1016/0006-291X(89)91154-6; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; LORBER B, 1983, BIOCHEM BIOPH RES CO, V117, P259, DOI 10.1016/0006-291X(83)91569-3; MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483; NICHOLAS HB, 1987, COMPUT APPL BIOSCI, V3, P177; NORMANLY J, 1989, ANNU REV BIOCHEM, V58, P1029, DOI 10.1146/annurev.bi.58.070189.005121; PERRET V, 1990, NATURE, V344, P787, DOI 10.1038/344787a0; PERRET V, 1990, BIOCHIMIE, V72, P735, DOI 10.1016/0300-9084(90)90158-D; PUGLISI J, UNPUB; RAJBHANDARY UL, 1968, J BIOL CHEM, V243, P598; ROGERS MJ, 1988, P NATL ACAD SCI USA, V85, P6627, DOI 10.1073/pnas.85.18.6627; ROMBY P, 1985, J MOL BIOL, V184, P455, DOI 10.1016/0022-2836(85)90294-3; ROMBY P, 1986, THESIS U L PASTEUR S; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; SAMPSON JR, 1989, SCIENCE, V243, P1363; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; SAYERS JR, 1989, PROTEIN FUNCTION PRA, P279; SCHIMMEL P, 1989, BIOCHEMISTRY-US, V28, P2747, DOI 10.1021/bi00433a001; SCHULMAN LH, 1989, SCIENCE, V246, P1595, DOI 10.1126/science.2688091; SCHULMAN LH, 1988, SCIENCE, V242, P765, DOI 10.1126/science.3055296; SCHULMAN LH, 1990, NUCLEIC ACIDS RES, V18, P285, DOI 10.1093/nar/18.2.285; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; SEKIYA T, 1980, NUCLEIC ACIDS RES, V8, P3809, DOI 10.1093/nar/8.17.3809; SHI JP, 1990, BIOCHEMISTRY-US, V29, P3621, DOI 10.1021/bi00467a005; SPRINZL M, 1989, NUCLEIC ACIDS RES, V17, pR1, DOI 10.1093/nar/17.1.1; WESTHOF E, 1985, J MOL BIOL, V184, P119, DOI 10.1016/0022-2836(85)90048-8; YARUS M, 1988, CELL, V55, P739, DOI 10.1016/0092-8674(88)90127-4	36	166	168	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	1991	252	5013					1696	1699		10.1126/science.2047878	http://dx.doi.org/10.1126/science.2047878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT114	2047878				2022-12-28	WOS:A1991FT11400043
J	SEDGWICK, DM; AKOH, JA; MACINTYRE, IMC				SEDGWICK, DM; AKOH, JA; MACINTYRE, IMC			GASTRIC-CANCER IN SCOTLAND - CHANGING EPIDEMIOLOGY, UNCHANGING WORKLOAD	BRITISH MEDICAL JOURNAL			English	Article								Objective-To determine the changes in incidence of and mortality from gastric cancer in Scotland between 1978 and 1987 and in the operative workload in Lothian between 1979 and 1988. Design-Analysis of national incidence statistics for gastric cancer derived from the Scottish national cancer registry, deaths from gastric cancer recorded by the registrar general for Scotland, and Lothian surgical audit data. Setting-Scotland and Lothian Health Board area. Patients-Patients in Scotland with gastric cancer during 1978 to 1987 inclusive; patients in Scotland with gastric cancer recorded on their death certificate as cause of death during 1978 to 1987; patients who had an operation in Lothian for gastric cancer during 1979 to 1988. Main outcome measures-Changes in incidence of and mortality from gastric cancer in Scotland from 1978 to 1987 and in the number of operations performed for gastric cancer in Lothian from 1979 to 1988. Results-Mortality from gastric cancer in Scotland fell by about 25% over the 10 years. The incidence and standardised incidence of gastric cancer showed a marginal decline of about 9%. The differences in trends between incidence and mortality were significant (p < 0.05). Conclusions-This study shows that the surgical workload associated with gastric cancer is not declining. This is because the incidence has remained almost static, which may be due to the relative increase in the numbers of older people in the population, who are at greater risk of developing gastric cancer. Gastric cancer should not be regarded as a disease in decline. Incidence and workload should determine resources allocated to this disease rather than mortality statistics.	WESTERN GEN HOSP,GASTROINTESTINAL UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; WESTERN GEN HOSP,SURG REVIEW OFF,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	University of Edinburgh; University of Edinburgh				Macintyre, Iain/0000-0003-2716-8500				AKOH JA, 1991, BRIT J SURG, V78, P349, DOI 10.1002/bjs.1800780325; ALLUM WH, 1989, BRIT J SURG, V76, P535, DOI 10.1002/bjs.1800760604; ARMITAGE P, 1987, STATISTICAL METHODS; BOYLE P, 1989, RECENT RESULTS CANC, P41; COGGON D, 1984, BRIT MED BULL, V40, P335, DOI 10.1093/oxfordjournals.bmb.a072000; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; GRUER R, 1986, LANCET, V1, P23; HISAMICHI S, 1989, WORLD J SURG, V13, P31, DOI 10.1007/BF01671151; HOWSON CP, 1986, EPIDEMIOL REV, V8, P1; MACINTYRE IMC, 1970, IN PRESS BR J SURG; WATERHOUSE J, 1982, CANCER INCIDENCE 5 C, V4; WATERHOUSE JAH, 1986, CANCER STOMACH, P1; 1990, 1989 ANN REP 1	13	16	16	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1991	302	6788					1305	1307		10.1136/bmj.302.6788.1305	http://dx.doi.org/10.1136/bmj.302.6788.1305			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ444	2059686	Bronze, Green Published			2022-12-28	WOS:A1991FQ44400018
J	THOMPSON, TL; FILLEY, CM; MITCHELL, WD; CULIG, KM; LOVERDE, M; BYYNY, RL				THOMPSON, TL; FILLEY, CM; MITCHELL, WD; CULIG, KM; LOVERDE, M; BYYNY, RL			LACK OF EFFICACY OF HYDERGINE IN PATIENTS WITH ALZHEIMERS-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV COLORADO, SCH MED, DEPT PSYCHIAT, DENVER, CO 80202 USA; UNIV COLORADO, SCH MED, DEPT MED, DENVER, CO 80202 USA; UNIV COLORADO, SCH MED, DEPT NEUROL, DENVER, CO 80202 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver								CROSS PS, 1986, EPIDEMIOLOGY DEMENTI; FINE T, 1988, AM J PSYCHIAT, V145, P1550; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; HOLLISTER LE, 1984, ANN INTERN MED, V100, P894, DOI 10.7326/0003-4819-100-6-894; HUGHES JR, 1976, J AM GERIATR SOC, V24, P490, DOI 10.1111/j.1532-5415.1976.tb03271.x; KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506; KRASSNER M B, 1984, Advances in Therapy, V1, P172; MARTIN RL, 1989, HOSP COMMUNITY PSYCH, V40, P593; MCDONALD RS, 1986, HDB CLIN MEMORY ASSE; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; REISBERG B, 1981, AM J PSYCHIAT, V138, P593; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; RUSSELL EW, 1975, J CONSULT CLIN PSYCH, V43, P800, DOI 10.1037/0022-006X.43.6.800; SCHRAN HF, 1985, CLIN THER, V8, P71; SCHWARTZ GE, 1983, PSYCHOL REP, V53, P479, DOI 10.2466/pr0.1983.53.2.479; SHADER RI, 1974, J AM GERIATR SOC, V22, P107, DOI 10.1111/j.1532-5415.1974.tb01521.x; Wechsler D., 2008, WAIS 4 WECHSLER ADUL; 1980, DIAGNOSTIC STATISTIC, P126; 1987, OTA BA323 OFF TECHN	20	58	58	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	1990	323	7					445	448		10.1056/NEJM199008163230704	http://dx.doi.org/10.1056/NEJM199008163230704			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU273	2082953				2022-12-28	WOS:A1990DU27300004
J	ARENBERG, IK; COUNTRYMAN, LF; BERNSTEIN, LH; SHAMBAUGH, GE				ARENBERG, IK; COUNTRYMAN, LF; BERNSTEIN, LH; SHAMBAUGH, GE			VANGOGH HAD MENIERES-DISEASE AND NOT EPILEPSY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									COLORADO NEUROL INST & SWEDISH MED CTR,INT MENIERES DIS RES INST,ENGLEWOOD,CO; SHAMBAUGH HEARING & ALLERGY PC,HINSDALE,IL									ALFORD B R, 1972, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V76, P1462; ARENBERG IK, 1989, AM J OTOL, V10, P314; CHARCOT JM, 1962, NEW YORK ACADEMY MED; MENIERE P, 1961, ACTA OTOLARYNGOL S, V162; Rewald John, 1956, POST IMPRESSIONISM V; RUNYAN WM, 1981, J PERS SOC PSYCHOL, V40, P1070, DOI 10.1037/0022-3514.40.6.1070; SHAMBAUGH GE, 1967, SURGERY EAR; Spratling W., 1904, EPILEPSY ITS TREATME; TROUSSEAU A, 1861, GAZETTE MED PARIS, V16, P51; YASUDA K, 1979, OTOLOGIA, V25, P1427; 1958, COMPLETE LETT V VANG, P3	11	37	38	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	1990	264	4					491	493		10.1001/jama.264.4.491	http://dx.doi.org/10.1001/jama.264.4.491			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	DP335	2094236				2022-12-28	WOS:A1990DP33500028
J	CONNOR, CD; SHULKIN, DJ				CONNOR, CD; SHULKIN, DJ			MEASLES - AN INCREASING OCCUPATIONAL RISK FOR PHYSICIANS-IN-TRAINING	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											CONNOR, CD (corresponding author), UNIV PENN,SCH MED,PHILADELPHIA,PA 19104, USA.							POLAND GA, 1990, ANN INTERN MED, V113, P628, DOI 10.7326/0003-4819-113-8-628; 1990, HOSPITAL IMMUNIZATIO, P1; 1990, MMWR, V39, P430; 1989, MMWR, V38, P5	4	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1991	266	2					220	220						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU896	2056623				2022-12-28	WOS:A1991FU89600029
J	SISK, JE; GIANFRANCESCO, FD; COSTER, JM				SISK, JE; GIANFRANCESCO, FD; COSTER, JM			RECOMBINANT ERYTHROPOIETIN AND MEDICARE PAYMENT	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANEMIA	The biologic recombinant human erythropoietin provides a recent case study of the great influence federal policies, especially Medicare payment, exert over the use and cost of medical technologies. By covering most dialysis patients, Medicare has been the predominant payer for recombinant erythropoietin, which corrects anemia associated with chronic renal disease. Medicare's leverage seems to have produced a low US price for the product. Paying a fixed rate per treatment with the biologic agent gave dialysis facilities a financial incentive to use low doses, but Medicare did not routinely monitor patients' responses. By August 1990, average and modal doses were low, and fewer than 45% of patients who had been treated for 6 months or more had ever attained the target hematocrit. Medicare should recognize the financial incentives of its payment policies and routinely evaluate the quality of care for beneficiaries.	US CONGRESS,OFF TECHNOL ASSESSMENT,WASHINGTON,DC									BERKOW R, 1987, MERCK MANUAL, P1096; ESCHBACH J, 1990, CURRENT NEPHROLOGY, P14; ESCHBACH J, IN PRESS AM J KIDNEY; ESCHBACH JW, 1989, NEW ENGL J MED, V321, P158, DOI 10.1056/NEJM198907203210305; GIBBONS A, 1990, SCIENCE, V250, P905, DOI 10.1126/science.2237437; KLEINMAN K, 1988, AM SOC NEPHR ABSTR; LIM VS, 1989, ANN INTERN MED, V110, P108, DOI 10.7326/0003-4819-110-2-108; RAINE AEG, IN PRESS AM J KIDNEY; SINAITRIEMAN L, 1989, J PEDIATR, V114, P530; SOBOTA J, 1990, ERYTHROPOIETIN CLIN; SOBOTA JT, 1989, CONTRIB NEPHROL, V76, P166; STEVEN JM, 1988, DIALYSIS TRANSPLANT, V3, P33; TEEHAN BP, 1989, TRANSPL P, V21, P63; 1991, HHS NEWS        0102; 1989, MEDICARE PROVIDER 1, pCH27; 1990, RECOMBINANT ERYTHROP; 1989, KIDN INT ABSTR, V35, P195; 1990, EFFECT INTERIM PAYME; 1986, LISTING PROVIDERS FU; 1989, MEDICARE CARRIERS MA; 1989, SUMMARY BASIS APPROV	21	25	25	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1991	266	2					247	252		10.1001/jama.266.2.247	http://dx.doi.org/10.1001/jama.266.2.247			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU896	2056627				2022-12-28	WOS:A1991FU89600034
J	LASPADA, AR; WILSON, EM; LUBAHN, DB; HARDING, AE; FISCHBECK, KH				LASPADA, AR; WILSON, EM; LUBAHN, DB; HARDING, AE; FISCHBECK, KH			ANDROGEN RECEPTOR GENE-MUTATIONS IN X-LINKED SPINAL AND BULBAR MUSCULAR-ATROPHY	NATURE			English	Article							LOCALIZATION; EXPRESSION; CLONING; FAMILY; LOCUS; ACID; OPA	X-LINKED spinal and bulbar muscular atrophy (Kennedy's disease) is an adult-onset form of motorneuron disease which may be associated with signs of androgen insensitivity. We have now investigated whether the androgen receptor gene on the proximal long arm of the X chromosome is a candidate gene for this disease. In patient samples we found androgen receptor gene mutations with increased size of a polymorphic tandem CAG repeat in the coding region. These amplified repeats were absolutely associated with the disease, being present in 35 unrelated patients and none of 75 controls. They segregated with the disease in 15 families, with no recombination in 61 meioses (the maximum log likelihood ratio (lod score) is 13.2 at a recombination rate of 0). The association is unlikely to be due to linkage disequilibrium, because 11 different disease alleles were observed. We conclude that enlargement of the CAG repeat in the androgen receptor gene is probably the cause of this disorder.	UNIV N CAROLINA,REPROD BIOL LABS,CHAPEL HILL,NC 27599; NATL HOSP,INST NEUROL,LONDON WC1N 3BG,ENGLAND	University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	LASPADA, AR (corresponding author), UNIV PENN,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19104, USA.		La Spada, Albert/AAG-8809-2020					ARBIZU T, 1983, J NEUROL SCI, V59, P371, DOI 10.1016/0022-510X(83)90022-9; BROWN CJ, 1989, AM J HUM GENET, V44, P264; DUBOULE D, 1987, MOL CELL BIOL, V7, P2003, DOI 10.1128/MCB.7.5.2003; EDWARDS A, UNPUB GENOMICS; FISCHBECK KH, 1991, ADV NEUROL, V56, P209; FISCHBECK KH, 1986, NEUROLOGY, V36, P1595, DOI 10.1212/WNL.36.12.1595; HARDING AE, 1982, J NEUROL NEUROSUR PS, V45, P1012, DOI 10.1136/jnnp.45.11.1012; KAO CC, 1990, SCIENCE, V248, P1646, DOI 10.1126/science.2194289; KURZ EM, 1986, SCIENCE, V232, P395, DOI 10.1126/science.3961488; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; OTT J, 1974, AM J HUM GENET, V26, P588; SAR M, 1977, SCIENCE, V197, P77, DOI 10.1126/science.867053; TAN JA, 1988, MOL ENDOCRINOL, V2, P1276, DOI 10.1210/mend-2-12-1276; TILLEY WD, 1989, P NATL ACAD SCI USA, V86, P327, DOI 10.1073/pnas.86.1.327; WARNER C L, 1991, Neurology, V41, P313; WHARTON KA, 1985, CELL, V40, P55, DOI 10.1016/0092-8674(85)90308-3; YANDELL DW, 1989, AM J HUM GENET, V45, P547; YU WHA, 1989, J NEUROSCI, V9, P3908	19	2014	2074	3	68	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1991	352	6330					77	79		10.1038/352077a0	http://dx.doi.org/10.1038/352077a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV178	2062380				2022-12-28	WOS:A1991FV17800075
J	DORVAL, BC; CARAFA, YD; SIRANDPUGNET, P; GALLEGO, M; BRODY, E; MARIE, J				DORVAL, BC; CARAFA, YD; SIRANDPUGNET, P; GALLEGO, M; BRODY, E; MARIE, J			RNA SECONDARY STRUCTURE REPRESSION OF A MUSCLE-SPECIFIC EXON IN HELA-CELL NUCLEAR EXTRACTS	SCIENCE			English	Article								The chicken beta-tropomyosin pre-messenger RNA (pre-mRNA) is spliced in a tissue-specific manner to yield messenger RNA's (mRNA's) coding for different isoforms of this protein. Exons 6A and 6B are spliced in a mutually exclusive manner; exon 6B was included in skeletal muscle, whereas exon 6A was preferred in all other tissues. The distal portion of the intron upstream of exon 6B was shown to form stable double-stranded regions with part of the intron downstream of exon 6B and with sequences in exon 6B. This structure repressed splicing of exon 6B to exon 7 in a HeLa cell extract. Derepression of splicing occurred on disruption of this structure and repression followed when the structure was re-formed, even if the structure was formed between two different RNA molecules. Repression leads to inhibition of formation of spliceosomes. Disrupting either of the two double-stranded regions could lead to derepression, whereas re-forming the helices by suppressor mutations reestablished repression. These results support a simple model of tissue-specific splicing in this region of the pre-mRNA.			DORVAL, BC (corresponding author), UNIV PARIS 06, CNRS, CTR GENET MOLEC, F-91198 GIF SUR YVETTE, FRANCE.		Gallego, Maria E/F-1044-2011	Gallego, Maria E/0000-0001-5588-9116; SIRAND-PUGNET, Pascal/0000-0003-2613-0762; Clouet-d'Orval, Beatrice/0000-0002-3591-8538				BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; BRODY E, 1985, SCIENCE, V228, P963, DOI 10.1126/science.3890181; BRODY E, 1989, EVOLUTIONARY TINKERI, P203; CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440; DALBADIEMCFARLAND G, 1990, P NATL ACAD SCI USA, V87, P4236, DOI 10.1073/pnas.87.11.4236; DORVAL BC, IN PRESS J MOL BIOL; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; FRENDEWEY D, 1985, CELL, V42, P355, DOI 10.1016/S0092-8674(85)80131-8; FU XY, 1988, EMBO J, V7, P809, DOI 10.1002/j.1460-2075.1988.tb02879.x; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; GOUXPELLETAN M, 1990, EMBO J, V9, P241, DOI 10.1002/j.1460-2075.1990.tb08101.x; GRABOWSKI PJ, 1985, CELL, V42, P345, DOI 10.1016/S0092-8674(85)80130-6; HALL KB, 1988, P NATL ACAD SCI USA, V85, P704, DOI 10.1073/pnas.85.3.704; HELFMAN DM, 1990, GENE DEV, V4, P98, DOI 10.1101/gad.4.1.98; HELFMAN DM, 1988, GENE DEV, V2, P1627, DOI 10.1101/gad.2.12a.1627; HODGKIN J, 1989, CELL, V56, P905, DOI 10.1016/0092-8674(89)90619-3; KAKIZUKA A, 1990, J BIOL CHEM, V265, P10102; KONARSKA MM, 1989, METHOD ENZYMOL, V180, P442; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; LEAR AL, 1990, J MOL BIOL, V211, P103, DOI 10.1016/0022-2836(90)90014-D; LIBRI D, 1989, J BIOL CHEM, V264, P2935; LIBRI D, 1990, MOL CELL BIOL, V10, P5036, DOI 10.1128/MCB.10.10.5036; LIBRI D, 1991, SCIENCE, V252, P1842, DOI 10.1126/science.2063196; LIBRI D, 1989, NUCLEIC ACIDS RES, V17, P6449; MUNROE SH, 1988, EMBO J, V7, P2523, DOI 10.1002/j.1460-2075.1988.tb03100.x; NASIM FH, 1990, GENE DEV, V4, P1172, DOI 10.1101/gad.4.7.1172; NELSON KK, 1988, GENE DEV, V2, P319, DOI 10.1101/gad.2.3.319; NOBLE JCS, 1988, GENE DEV, V2, P1460, DOI 10.1101/gad.2.11.1460; PACE NR, 1989, GENE, V82, P65, DOI 10.1016/0378-1119(89)90031-0; PIKIELNY CW, 1986, NATURE, V324, P341, DOI 10.1038/324341a0; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; SAMBOOK J, 1989, MOL CLONING LABORATO; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; SIEBEL CW, 1990, SCIENCE, V248, P1200, DOI 10.1126/science.2161558; SKINNER MA, 1989, J MOL BIOL, V207, P379, DOI 10.1016/0022-2836(89)90261-1; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; SOLNICK D, 1987, MOL CELL BIOL, V7, P3194, DOI 10.1128/MCB.7.9.3194; WAGNER RW, 1988, MOL CELL BIOL, V8, P770, DOI 10.1128/MCB.8.2.770; ZILLMANN M, 1988, MOL CELL BIOL, V8, P814, DOI 10.1128/MCB.8.2.814; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	46	132	132	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	1991	252	5014					1823	1828		10.1126/science.2063195	http://dx.doi.org/10.1126/science.2063195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU061	2063195				2022-12-28	WOS:A1991FU06100032
J	ROGERS, DJ; RANDOLPH, SE				ROGERS, DJ; RANDOLPH, SE			MORTALITY-RATES AND POPULATION-DENSITY OF TSETSE-FLIES CORRELATED WITH SATELLITE IMAGERY	NATURE			English	Article							AFRICA; GLOSSINA; KENYA	TSETSE flies are a major constraint on animal production in about 10 million km 2 of Africa through their transmission of animal trypanosomiasis 1. Up to 25 million people are at risk from human trypanosomiasis, or sleeping sickness 2. Tsetse research has been concentrated on the factors that control the distribution and abundance of these vectors and the means by which their numbers can be reduced 3. Eradication successes in some countries are insignificant compared with the continental scale of the problem and the long-term reduction in the area infested by tsetse has been negligible 4. We report here that the mortality rates of tsetse from sites in both West and East Africa, the size of male and female tsetse (related to the mortality rate of the parental female population) along a north-south transect in West Africa, and the abundance of two species of tsetse over the northern half of Cote d'lvoire, are significantly correlated with data from meteorological satellites. This information could be used to predict both the mortality rate and the abundance (key determinants of disease transmission potential) of tsetse over very large areas of the continent and to produce maps of high risk areas of disease transmission for the African trypanosomiases and, by implication, for many other vector-borne diseases.			ROGERS, DJ (corresponding author), DEPT ZOOL,S PARKS RD,OXFORD OX1 3PS,ENGLAND.		Randolph, Sarah/AAR-9346-2021					[Anonymous], 2005, AFRICA BUSINESS APR; AVERY MI, 1990, NATURE, V344, P860, DOI 10.1038/344860a0; BARRETT EC, 1986, 20TH P INT S REM SEN, V3, P955; BARTHOLOME E, 1988, INT J REMOTE SENS, V9, P1539, DOI 10.1080/01431168808954959; Bourn D., 1983, THESIS OXFORD U; BUXTON PA, 1955, LONDON SCH HYGIENE T, V10; CHALLIER A, 1973, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V11, P251; CROSS ER, 1984, MIL MED, V149, P28; DEMUYNCK A, 1989, ANN SOC BELGE MED TR, V69; DRANSFIELD RD, 1989, MED VET ENTOMOL, V3, P83, DOI 10.1111/j.1365-2915.1989.tb00478.x; HIELKEMA JU, 1986, INT J REMOTE SENS, V7, P1609, DOI 10.1080/01431168608948956; HUETE AR, 1987, REMOTE SENS ENVIRON, V23, P213, DOI 10.1016/0034-4257(87)90038-1; HUGHJONES ME, 1988, ACTA VET SCAND, V84, P256; HUTCHINSON CF, IN PRESS INT J REM S; LINTHICUM KJ, 1987, SCIENCE, V235, P1656, DOI 10.1126/science.3823909; MILFORD JR, 1986, RAINFALL MAPPING W A; MORAN PAP, 1950, BIOMETRICS, V6, P250, DOI 10.2307/3001822; MULLIGAN HW, 1970, AFRICAN TRYPANOSOMIA; MURRAY M, 1984, PREV VET MED, V2, P23, DOI 10.1016/0167-5877(84)90045-X; NICHOLSON SE, 1990, CLIMATIC CHANGE, V17, P209, DOI 10.1007/BF00138369; RANDOLPH SE, 1978, B ENTOMOL RES, V68, P655, DOI 10.1017/S0007485300009627; ROGERS D, 1979, J ANIM ECOL, V48, P825, DOI 10.2307/4197; ROGERS DJ, 1988, PARASITOLOGY, V97, P193, DOI 10.1017/S0031182000066853; ROGERS DJ, 1986, J ANIM ECOL, V55, P1007, DOI 10.2307/4430; ROGERS DJ, 1984, INSECT SCI APPL, V5, P397, DOI 10.1017/S1742758400008729; TUCKER CJ, 1986, INT J REMOTE SENS, V7, P1395, DOI 10.1080/01431168608948944; TUCKER CJ, 1985, SCIENCE, V227, P369, DOI 10.1126/science.227.4685.369; Varley G.C., 1973, INSECT POPULATION EC; WASHINO RK, 1987, 1987 U CAL DIV AGR N; 1983, HMSO TABLES TEMPER 4; 1982, CARTOGRAPHIE REPARTI	31	138	141	1	18	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 27	1991	351	6329					739	741		10.1038/351739a0	http://dx.doi.org/10.1038/351739a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU201	2062367				2022-12-28	WOS:A1991FU20100062
J	CROMBIE, IK; DAVIES, HTO				CROMBIE, IK; DAVIES, HTO			AUDIT OF OUTPATIENTS - ENTERING THE LOOP	BRITISH MEDICAL JOURNAL			English	Article							SURGICAL AUDIT	Objective - To develop and test a method for routine data collection to observe current practice in outpatient pain clinics. Design - Prospective questionnaire survey completed by consultants on each patient seen during October 1989 to May 1990. Setting - Outpatient pain clinics of five teaching and five district general hospitals in Scotland and northern England. Main outcome measures - Number of new referrals and their source, and characteristics of pain at presentation. Results - 4354 forms were completed by 21 consultants over 29 weeks, corresponding to 2241 patients, of whom 981 were new referrals. The proportion of consultations at which new referrals were seen varied among the 10 clinics from 15% to 34%. The difference could not be accounted for by type of hospital. Sources of new referrals varied widely between the clinics (for example, range 22% to 78% for general practitioner referrals), as did new referrals by the type of pain (range 10.8% to 55.2% for low back pain, 10.5% to 32.5% for pain associated with surgery). However, these differences in types of patients seen could not be accounted for by variations in referral patterns among clinics. Problems identified in performing an audit of outpatients included the difficulty of obtaining firm diagnoses, the need for a method to link successive patient contacts, and the complexity of the presenting problem in many patients. Conclusions - It is possible to collect data for audit routinely in outpatient clinics. Observation of current practice in the clinics suggested possible unmet need or inappropriate management, which may require changes in practice.			CROMBIE, IK (corresponding author), UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT EPIDEMIOL & PUBL HLTH,DUNDEE DD1 9SY,SCOTLAND.			Davies, Huw/0000-0002-2653-3695				BOND MR, 1984, PAIN ITS NATURE ANAL, P203; Bonica JJ, 1990, MANAGEMENT PAIN, V1, P180; ELLIS BW, 1989, BRIT MED J, V298, P1635, DOI 10.1136/bmj.298.6688.1635; ELLIS BW, 1987, J ROY SOC MED, V80, P157, DOI 10.1177/014107688708000311; FOWKES FGR, 1982, MED EDUC, V16, P228; FOWKES FGR, 1986, COMMUNITY MED, V8, P286; GRUER R, 1986, LANCET, V1, P23; JONES RG, 1990, BRIT MED J, V300, P1467, DOI 10.1136/bmj.300.6737.1467-a; SCOTT DL, 1990, ANN RHEUM DIS, V49, P3, DOI 10.1136/ard.49.1.3; Shaw C D, 1981, Health Trends, V13, P107; SWERDLOW M, 1987, CHRONIC NONCANCER PA, P189; TYNDAL R, 1990, COMPUTERS MED AUDIT; 1989, MED AUDIT 1ST REPORT; 1989, HLTH PERSONAL SOCIAL	14	14	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1991	302	6790					1437	1439		10.1136/bmj.302.6790.1437	http://dx.doi.org/10.1136/bmj.302.6790.1437			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR403	2070111	Green Published, Bronze			2022-12-28	WOS:A1991FR40300023
J	MCCLUNG, JA; KAMER, RS				MCCLUNG, JA; KAMER, RS			LEGISLATING ETHICS - IMPLICATIONS OF NEW-YORK DO-NOT-RESUSCITATE LAW	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											MCCLUNG, JA (corresponding author), NEW YORK MED COLL,VALHALLA,NY 10595, USA.							BLACKHALL LJ, 1987, NEW ENGL J MED, V317, P1281, DOI 10.1056/NEJM198711123172009; FADER AM, 1989, J AM GERIATR SOC, V37, P544, DOI 10.1111/j.1532-5415.1989.tb05687.x; FRIED C, 1976, NEW ENGL J MED, V295, P390, DOI 10.1056/NEJM197608122950711; Jude J. R., 1965, FUNDAMENTALS CARDIOP; KAMER RS, 1990, AM J MED, V88, P108, DOI 10.1016/0002-9343(90)90457-O; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; MILES SH, 1982, ANN INTERN MED, V96, P660, DOI 10.7326/0003-4819-96-5-660; PRAGER KM, 1989, WALL STREET J   0309, P16; QUILL TE, 1986, NEW YORK STATE J MED, V86, P622; RABKIN MT, 1976, NEW ENGL J MED, V295, P364, DOI 10.1056/NEJM197608122950705; ROSNER F, 1988, JAMA-J AM MED ASSOC, V260, P3129, DOI 10.1001/jama.1988.03410210039021; SULLIVAN R, 1984, NY TIMES        0321, pB1; Sullivan Ronald, 1982, NY TIMES; SWIDLER RN, 1989, NEW YORK STATE J MED, V89, P69; 1978, RE DINNERSTEIN, P134; 1988, STATE NEW YORK PUBLI; 1974, JAMA-J AM MED ASSOC, V227, P833; 1976, NEW ENGL J MED, V295, P362; 1966, JAMA-J AM MED ASSOC, V193, P372	19	25	25	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 26	1990	323	4					270	272		10.1056/NEJM199007263230411	http://dx.doi.org/10.1056/NEJM199007263230411			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DP597	2078209				2022-12-28	WOS:A1990DP59700011
J	ENEVOLDSON, TP; WILES, CM; SAWLE, GV				ENEVOLDSON, TP; WILES, CM; SAWLE, GV			ACUTE PARKINSONISM ASSOCIATED WITH FLURBIBROFEN	BRITISH MEDICAL JOURNAL			English	Letter									HAMMERSMITH HOSP,MRC,CYCLOTRON UNIT,PET SECT,LONDON W12 0HS,ENGLAND	Imperial College London	ENEVOLDSON, TP (corresponding author), ST THOMAS HOSP,DEPT NEUROL,LONDON SE1 7EH,ENGLAND.							ANDERSON CB, 1984, NEUROLOGY, V34, P400, DOI 10.1212/WNL.34.3.400; CREMONDBARBARO A, 1983, J ROY SOC MED, V76, P435, DOI 10.1177/014107688307600533; LEENDERS KL, 1986, J NEUROL NEUROSUR PS, V49, P853, DOI 10.1136/jnnp.49.8.853; REDMOND AD, 1981, J ROY SOC MED, V74, P558, DOI 10.1177/014107688107400733; SANDYK R, 1985, ANN NEUROL, V17, P104, DOI 10.1002/ana.410170124; WOOD N, 1988, J NEUROL NEUROSUR PS, V51, P731, DOI 10.1136/jnnp.51.5.731	6	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	1990	300	6723					540	541		10.1136/bmj.300.6723.540-c	http://dx.doi.org/10.1136/bmj.300.6723.540-c			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107948	Green Published, Bronze			2022-12-28	WOS:A1990CQ87800059
J	GREAVES, MW				GREAVES, MW			THE NEW DERMATOLOGY	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											GREAVES, MW (corresponding author), ST JOHNS HOSP DIS SKIN, DERMATOL, LONDON WC2H 7BJ, ENGLAND.							BARKER BS, 1984, BRIT J DERMATOL, V110, P555; BERNSTEIN JJ, 1989, AM ACAD DERMATOL, V5, P277; CAMP RDR, 1986, J IMMUNOL, V137, P3469; CARPENTER SE, 1981, BRIT J PHARMACOL, V73, P755, DOI 10.1111/j.1476-5381.1981.tb16812.x; CECCOLI J, 1989, J INVEST DERMATOL, V93, P190, DOI 10.1111/1523-1747.ep12277569; EADY RAJ, 1988, 17TH P WORLD C DERM, P127; ELLIS CN, 1986, JAMA-J AM MED ASSOC, V256, P3110, DOI 10.1001/jama.256.22.3110; FISHER MS, 1989, J INVEST DERMATOL, V92, P337, DOI 10.1111/1523-1747.ep12277156; GREAVES MW, 1988, BRIT J DERMATOL, V119, P419, DOI 10.1111/j.1365-2133.1988.tb03245.x; HERSHFIELD MS, 1987, NEW ENGL J MED, V316, P589, DOI 10.1056/NEJM198703053161005; KISHIMOTO TK, 1989, ADV IMMUNOL, V46, P149, DOI 10.1016/S0065-2776(08)60653-7; KRAUSE L, 1983, BRIT MED J, V287, P1199, DOI 10.1136/bmj.287.6400.1199; MALLET AI, 1983, BIOMED MASS SPECTROM, V10, P120, DOI 10.1002/bms.1200100304; MANZARI V, 1987, SCIENCE, V238, P1581, DOI 10.1126/science.2825353; NICKOLOFF BJ, 1988, ARCH DERMATOL, V124, P1835, DOI 10.1001/archderm.124.12.1835; SUMMERFIELD JA, 1980, BRIT J CLIN PHARMACO, V10, P180, DOI 10.1111/j.1365-2125.1980.tb01742.x; TIDY JA, 1989, LANCET, V1, P434; YOUNG LS, 1989, BRIT MED J, V298, P14, DOI 10.1136/bmj.298.6665.14	18	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	1990	300	6722					413	414		10.1136/bmj.300.6722.413	http://dx.doi.org/10.1136/bmj.300.6722.413			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP166	2107890	Bronze, Green Published			2022-12-28	WOS:A1990CP16600003
J	STEVENS, A; LITTLE, J; KERR, S; KILBANE, P; DOHERTY, C				STEVENS, A; LITTLE, J; KERR, S; KILBANE, P; DOHERTY, C			HIV TESTING IN PATIENTS WITH END STAGE RENAL-DISEASE	BRITISH MEDICAL JOURNAL			English	Article									E HLTH & SOCIAL SERV BOARD,BELFAST,NORTH IRELAND; BELFAST CITY HOSP,REG DEPT NEPHROL,BELFAST BT9 7AB,NORTH IRELAND	Belfast City Hospital	STEVENS, A (corresponding author), PARKSIDE HLTH AUTHOR,DEPT PUBL HLTH,MINT WING CTR BLDG,LONDON W2 1NY,ENGLAND.							ANDERSON KC, 1986, ANN INTERN MED, V105, P519, DOI 10.7326/0003-4819-105-4-519; ASSOGBA U, 1988, CLIN NEPHROL, V29, P312; Baillod R A, 1986, Br Med J (Clin Res Ed), V293, P819; BOURGOIGNIE JJ, 1988, SEMINARS DIALYSIS, V1, P187; BRUNNER FP, 1987, COMBINED REPORT RENA, V18; CHALLAH S, 1984, BRIT MED J, V288, P1119, DOI 10.1136/bmj.288.6424.1119; CHATTERJEE SN, 1988, DIALYSIS TRANSPLANT, V17, P285; Chirgwin K, 1988, ASAIO Trans, V34, P194; DUMMER JS, 1989, TRANSPLANTATION, V47, P134, DOI 10.1097/00007890-198901000-00030; KEIDAN AJ, 1988, BRIT MED J, V296, P288, DOI 10.1136/bmj.296.6617.288; ORTIZ C, 1988, KIDNEY INT, V34, P248, DOI 10.1038/ki.1988.172; PEREZ GO, 1988, AM J NEPHROL, V8, P123, DOI 10.1159/000167570; RAO KV, 1988, DIALYSIS TRANSPLANT, V17, P285; RAO TKS, 1988, SEMIN DIALYSIS, V1, P203; RODGER RSC, 1986, BRIT MED J, V293, P565, DOI 10.1136/bmj.293.6546.565; SHERER R, 1988, JAMA-J AM MED ASSOC, V259, P264, DOI 10.1001/jama.259.2.264; SHERRARD M, 1987, BRIT MED J, V295, P911, DOI 10.1136/bmj.295.6603.911; WEISS R, 1988, NEW ENGL J MED, V319, P1010, DOI 10.1056/NEJM198810133191509; WILLIAMS PF, 1986, BRIT MED J, V293, P885, DOI 10.1136/bmj.293.6551.885; 1988, F AIDS HIV INFECTION; 1987, BRIT MED J, V295, P940; 1986, 17 EUR DIAL TRANSPL; 1985, 16 EUR DIAL TRANSPL; 1988, BRIT MED J, V296, P1613; 1988, DIALYSIS TRANSPLANT, V17, P286; 1987, BRIT MED J, V295, P1292	26	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 17	1990	300	6722					447	449		10.1136/bmj.300.6722.447	http://dx.doi.org/10.1136/bmj.300.6722.447			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP166	2107901	Green Published, Bronze			2022-12-28	WOS:A1990CP16600026
J	DUANE, PD; SHALLCROSS, TM; HEATLEY, RV				DUANE, PD; SHALLCROSS, TM; HEATLEY, RV			DUODENAL CARCINOID-TUMOR IN A PATIENT WITH RHEUMATOID-ARTHRITIS RECEIVING LONG-TERM RANITIDINE TREATMENT	BRITISH MEDICAL JOURNAL			English	Letter											DUANE, PD (corresponding author), ST JAMES UNIV HOSP,DEPT MED,LEEDS LS9 7TF,W YORKSHIRE,ENGLAND.							BARCLAY THC, 1983, CANCER, V51, P878, DOI 10.1002/1097-0142(19830301)51:5<878::AID-CNCR2820510521>3.0.CO;2-V; BORCH K, 1986, DIGESTION, V35, P106, DOI 10.1159/000199386; HAKANSON R, 1986, SCAND J GASTROENTERO, V21, P18, DOI 10.3109/00365528609090883; PENSTON J, 1987, GUT, V28, P488, DOI 10.1136/gut.28.4.488; SUNDLER F, 1986, SCAND J GASTROENTERO, V21, P39, DOI 10.3109/00365528609090885	5	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					124	125		10.1136/bmj.300.6717.124-d	http://dx.doi.org/10.1136/bmj.300.6717.124-d			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105767	Green Published			2022-12-28	WOS:A1990CJ08000059
J	BADARO, R; FALCOFF, E; BADARO, FS; CARVALHO, EM; PEDRALSAMPAIO, D; BARRAL, A; CARVALHO, JS; BARRALNETTO, M; BRANDELY, M; SILVA, L; BINA, JC; TEIXEIRA, R; FALCOFF, R; ROCHA, H; HO, JL; JOHNSON, WD				BADARO, R; FALCOFF, E; BADARO, FS; CARVALHO, EM; PEDRALSAMPAIO, D; BARRAL, A; CARVALHO, JS; BARRALNETTO, M; BRANDELY, M; SILVA, L; BINA, JC; TEIXEIRA, R; FALCOFF, R; ROCHA, H; HO, JL; JOHNSON, WD			TREATMENT OF VISCERAL LEISHMANIASIS WITH PENTAVALENT ANTIMONY AND INTERFERON-GAMMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV FED BAHIA,SALVADOR,BA,BRAZIL; INST CURIE,F-75231 PARIS 05,FRANCE; ROUSSEL UCLAF,ROMAINVILLE,FRANCE	Universidade Federal da Bahia; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	BADARO, R (corresponding author), CORNELL UNIV,MED CTR,COLL MED,DIV INT MED,1300 YORK AVE,NEW YORK,NY 10021, USA.		Barral-Netto, Manoel/B-3904-2009; Barral, Aldina/B-4191-2009	Barral-Netto, Manoel/0000-0002-5823-7903; Barral, Aldina/0000-0002-7177-464X; Brasil Pedral Sampaio, Diana/0000-0002-2446-5828	NIAID NIH HHS [AI-16282] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI016282] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003; BRYCESON ADM, 1985, T ROY SOC TROP MED H, V79, P705, DOI 10.1016/0035-9203(85)90199-3; CARVALHO EM, 1981, INFECT IMMUN, V33, P498, DOI 10.1128/IAI.33.2.498-500.1981; CARVALHO EM, 1989, J CLIN INVEST, V83, P860, DOI 10.1172/JCI113969; CARVALHO EM, 1985, J CLIN INVEST, V76, P2066, DOI 10.1172/JCI112209; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; CRAWFORD GD, 1985, J INFECT DIS, V152, P315, DOI 10.1093/infdis/152.2.315; DURUM SK, 1985, ANNU REV IMMUNOL, V3, P263; EICKHOFF TC, 1982, J INFECT DIS, V145, P407, DOI 10.1093/infdis/145.3.407; EZEKOWITZ RAB, 1988, NEW ENGL J MED, V319, P146, DOI 10.1056/NEJM198807213190305; GERRARD TL, 1988, J IMMUNOL, V140, P3450; HO M, 1983, CLIN EXP IMMUNOL, V51, P207; HOOVER DL, 1985, CELL IMMUNOL, V94, P500, DOI 10.1016/0008-8749(85)90274-6; KAPLAN EH, 1988, P AN M AM SOC CLIN, V7, P226; LEE SH, 1984, J IMMUNOL, V133, P1083; Marsden P.D., 1985, HUMAN PARASITIC DISE, V1, P183; MARSDEN PD, 1984, REV INFECT DIS, V6, P736; MIZEL SB, 1982, IMMUNOL REV, V63, P51, DOI 10.1111/j.1600-065X.1982.tb00411.x; MURPHY PM, 1988, ANN INTERN MED, V108, P36, DOI 10.7326/0003-4819-108-1-36; MURRAY HW, 1985, J IMMUNOL, V134, P1619; MURRAY HW, 1983, J CLIN INVEST, V72, P1506, DOI 10.1172/JCI111107; MURRAY HW, 1988, J INFECT DIS, V157, P973, DOI 10.1093/infdis/157.5.973; NATHAN C, 1988, INFLAMMATION BASIC P, P229; NATHAN CF, 1986, NEW ENGL J MED, V315, P6, DOI 10.1056/NEJM198607033150102; NATHAN CF, 1985, P NATL ACAD SCI USA, V82, P8686, DOI 10.1073/pnas.82.24.8686; REINER NE, 1988, P NATL ACAD SCI USA, V85, P4330, DOI 10.1073/pnas.85.12.4330; REINER NE, 1985, J IMMUNOL, V134, P556; REINER NE, 1987, J IMMUNOL, V138, P1926; REINER NE, 1987, J IMMUNOL, V138, P1919; SPITALNY GL, 1984, J EXP MED, V159, P1560, DOI 10.1084/jem.159.5.1560; STEEG PS, 1982, J EXP MED, V156, P1780, DOI 10.1084/jem.156.6.1780; TALPAZ M, 1988, SEMIN HEMATOL, V25, P62; TRINCHIERI G, 1984, J EXP MED, V160, P1147, DOI 10.1084/jem.160.4.1147	33	276	281	0	7	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 4	1990	322	1					16	21		10.1056/NEJM199001043220104	http://dx.doi.org/10.1056/NEJM199001043220104			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG234	2104665	Green Published			2022-12-28	WOS:A1990CG23400004
J	KASE, CS; ONEAL, AM; FISHER, M; GIRGIS, GN; ORDIA, JI				KASE, CS; ONEAL, AM; FISHER, M; GIRGIS, GN; ORDIA, JI			INTRACRANIAL HEMORRHAGE AFTER USE OF TISSUE PLASMINOGEN-ACTIVATOR FOR CORONARY THROMBOLYSIS	ANNALS OF INTERNAL MEDICINE			English	Article									WALTHAM WESTON HOSP, WALTHAM, MA USA; WORCESTER MEM HOSP, WORCESTER, MA USA; UNIV MASSACHUSETTS, SCH MED, WORCESTER, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	KASE, CS (corresponding author), BOSTON UNIV, SCH MED, DEPT NEUROL, 720 HARRISON AVE, SUITE 600, BOSTON, MA 02118 USA.			Kase, Carlos/0000-0002-3047-5010				CARLSON SE, 1988, ARCH NEUROL-CHICAGO, V45, P1070, DOI 10.1001/archneur.1988.00520340024005; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; GIMPLE L W, 1988, Journal of the American College of Cardiology, V11, p231A; GUERCI AD, 1987, NEW ENGL J MED, V317, P1613, DOI 10.1056/NEJM198712243172601; KASE CS, 1985, NEUROLOGY, V35, P943, DOI 10.1212/WNL.35.7.943; KASE CS, 1986, STROKE, V17, P590, DOI 10.1161/01.STR.17.4.590; KOMRAD MS, 1984, NEUROLOGY, V34, P1403, DOI 10.1212/WNL.34.11.1403; LIEBERMAN A, 1978, STROKE, V9, P18, DOI 10.1161/01.STR.9.1.18; LOSCALZO J, 1988, NEW ENGL J MED, V319, P925; MUELLER HS, 1987, J AM COLL CARDIOL, V10, P479, DOI 10.1016/S0735-1097(87)80188-2; NIEWIAROWSKI S, 1973, J CLIN INVEST, V52, P1647, DOI 10.1172/JCI107345; PASSAMANI E, 1987, J AM COLL CARDIOL, V10, pB51, DOI 10.1016/S0735-1097(87)80429-1; RAMIREZLASSEPAS M, 1984, NEUROLOGY, V34, P114, DOI 10.1212/WNL.34.1.114; RAO AK, 1988, J AM COLL CARDIOL, V11, P1; SCHAFER AI, 1985, J CLIN INVEST, V75, P456, DOI 10.1172/JCI111720; TOPOL EJ, 1988, J AM COLL CARDIOL, V11, P1150, DOI 10.1016/0735-1097(88)90275-6; TOPOL EJ, 1985, ANN INTERN MED, V103, P837, DOI 10.7326/0003-4819-103-6-837; VERSTRAETE M, 1986, BLOOD, V67, P1529; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; WEINREICH DJ, 1984, ANN INTERN MED, V100, P789, DOI 10.7326/0003-4819-100-6-789	20	91	94	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1990	112	1					17	21		10.7326/0003-4819-112-1-17	http://dx.doi.org/10.7326/0003-4819-112-1-17			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG723	2104561				2022-12-28	WOS:A1990CG72300004
J	CALLENDER, CO; HALL, LE; YEAGER, CL; BARBER, JB; DUNSTON, GM; PINNWIGGINS, VW				CALLENDER, CO; HALL, LE; YEAGER, CL; BARBER, JB; DUNSTON, GM; PINNWIGGINS, VW			ORGAN DONATION AND BLACKS - A CRITICAL FRONTIER	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSPLANTATION				CALLENDER, CO (corresponding author), HOWARD UNIV,WASHINGTON,DC 20060, USA.							BLENDON RJ, 1989, JAMA-J AM MED ASSOC, V261, P278, DOI 10.1001/jama.261.2.278; BRAITHWAITE RL, 1989, JAMA-J AM MED ASSOC, V261, P282, DOI 10.1001/jama.261.2.282; Callender C O, 1982, J Natl Med Assoc, V74, P807; CALLENDER CO, 1987, TRANSPLANT P, V19, P1551; CALLENDER CO, 1989, TRANSPLANT P, V21, P3407; CALLENDER CO, 1987, TRANSPLANT P, V19, P36; CALLENDER CO, 1987, RENALIFE         FEB, P11; CALLENDER CO, 1988, BLACK HEALTH, V1, P22; CALLENDER CO, 1983, 295350 PUBL, P183; DECHESSER AD, 1986, HEART LUNG, V15, P547; DUNSTON GM, 1987, TRANSPLANT P, V19, P870; HENDRICKS GFJ, 1983, TRANSPLANT P, V15, P1136; JOHNSON AH, 1986, 3RD P AS OC HIST WOR, P548; KUSSEROW RP, 1990, OEI018900550, P1; OLSON CM, 1989, JAMA-J AM MED ASSOC, V261, P194; 1988, CADAVERIC DONOR DEMO; 1987, GO87073 DOW CHEM CO, P22; 1990, 5GOP25033 DOW CHEM C, P1	18	79	79	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 8	1991	325	6					442	444		10.1056/NEJM199108083250631	http://dx.doi.org/10.1056/NEJM199108083250631			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ804	2062346				2022-12-28	WOS:A1991FZ80400034
J	GARFIELD, RM; NEUGUT, AI				GARFIELD, RM; NEUGUT, AI			EPIDEMIOLOGIC ANALYSIS OF WARFARE - A HISTORICAL REVIEW	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							COMBAT CASUALTY CARE; VIETNAM VETERANS; WAR; MORTALITY; SURGERY; DEATH	Although warfare is thought to be responsible for high and increasing levels of morbidity and mortality in the modern era, little comparative epidemiologic research is available on the subject. Most research on past wars has been carried out for purposes of military planning. The present report provides an overview of the direct health impacts of various wars on military and civilian populations during the last 200 years. Risk factors for injury and death are analyzed. Changes in weaponry, military strategy, and medical services are found to modify the health effects of warfare.	COLUMBIA UNIV COLL PHYS & SURG, NEW YORK, NY 10032 USA; COLUMBIA UNIV, SCH PUBL HLTH, DIV EPIDEMIOL, NEW YORK, NY 10027 USA	Columbia University; Columbia University	GARFIELD, RM (corresponding author), COLUMBIA UNIV, SCH NURSING, NEW YORK, NY 10027 USA.							ADDINGTON LH, 1984, PATTERNS WAR 18TH CE; ARNOLD K, 1978, MIL MED, V143, P161; BEEBE GW, 1952, BATTLE CASUALTIES IN, P36; BEEBE GW, 1956, FOLLOW UP STUDY WAR; BELLAMY RF, 1985, MIL MED, V150, P405, DOI 10.1093/milmed/150.8.405; BELLAMY RF, 1984, MIL MED, V149, P55; BERG SW, 1977, MIL MED, V142, P757; BERG SW, 1977, MIL MED, V142, P598; BERG W, 1977, MIL MED, V142, P514; Bobon-Schrod H, 1976, Acta Psychiatr Belg, V76, P56; BOYLE CA, 1989, EPIDEMIOL REV, V11, P1; BROGAN P, 1989, WORLD CONFLICTS WHY; Brogan Patrick, 1990, FIGHTING NEVER STOPP; BULLMAN TA, 1990, AM J EPIDEMIOL, V132, P670, DOI 10.1093/oxfordjournals.aje.a115708; BULLOUGH B, 1976, AM J NURS, V76, P118; BURNET FM, 1942, INFLUENZA; CAREY ME, 1987, MIL MED, V152, P6; CASH P, 1976, JAMA-J AM MED ASSOC, V236, P52; COALE AJ, 1974, SCI AM, V231, P40, DOI 10.1038/scientificamerican0974-40; COATES JB, 1958, PREVENTIVE MED WW 2; DAHL BB, 1977, MIL MED, V142, P146; DUDLEY HAF, 1968, BRIT J SURG, V55, P332, DOI 10.1002/bjs.1800550503; Dyer G., 1985, WAR; GARFIELD RM, 1987, AM J PUBLIC HEALTH, V77, P615, DOI 10.2105/AJPH.77.5.615; GARFIELD RM, IN PRESS HLTH CARE N; GORDON CV, 1983, MIL MED, V148, P103; GORDON JA, 1977, S AFR MED J, V52, P856; HADDAD FS, 1978, CAN J SURG, V21, P233; Hartigan Richard Shelly, 1982, FORGOTTEN VICTIM HIS; HAUBEN DJ, 1983, ANN PLAS SURG, V10, P65, DOI 10.1097/00000637-198301000-00009; HEARST N, 1986, NEW ENGL J MED, V314, P620, DOI 10.1056/NEJM198603063141005; HEGGERS JP, 1978, MIL MED, V143, P390; Henderson J V, 1983, J Med Syst, V7, P413, DOI 10.1007/BF00995741; Hill JH, 1942, SILENT ENEMIES STORY; HOEBER FP, 1981, MILITARY APPLICATION; Horiuchi S, 1983, Popul Bull UN, P80; HOWARD J M, 1956, Mil Med, V118, P343; JOHNSON DE, 1981, J TRAUMA, V21, P486; KEEGAN J, 1976, FACE BATTLE, P231; MCNEIL W, 1982, PURSUIT POWER, P307; McNeill W.H., 1976, PLAGUES PEOPLES, V1st ed.; MELSOM MA, 1975, ANN R COLL SURG ENGL, V56, P291; MILLER E, 1940, NEUROSES WAR, P1; MURPHY JM, 1975, ACTA PSYCHIAT SCAND, P16; Nightingale F, 1858, NOTES MATTERS AFFECT; PFEFFERMANN R, 1976, J TRAUMA, V16, P694, DOI 10.1097/00005373-197609000-00003; POPKIN MK, 1978, MIL MED, V143, P479; Prinzing F., 1916, EPIDEMICS RESULTING; Pyle G.F., 1986, DIFFUSION INFLUENZA; Reister F. A., 1973, BATTLE CASUALTIES ME; RICHARDSON LM, 1960, STATISTICS DEADLY QU, pR9; Robinson J. P., 1985, CHEM BIOL WARFARE DE; SIMON RR, 1988, ANN INTERN MED, V108, P477, DOI 10.7326/0003-4819-108-3-477; SINGER JD, 1972, WAGES WAR 1816 1965, P60; SIVARD RL, WORLD MILITARY SOCIA, P8; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; URLANIS B, 1971, WAR POPULATION, P38; URSANO RJ, 1990, MIL MED, V155, P176, DOI 10.1093/milmed/155.4.176; VASTYAN EA, 1971, ANN INTERN MED, V74, P611, DOI 10.7326/0003-4819-74-4-611; WESTING AH, 1988, CULTURAL NORMS WAR E; WESTING AH, 1984, ENV WARFARE TECHNICA; WOLFE LH, 1955, SURGERY WORLD WAR, V2, P2; ZARCONE VP, 1977, COMPR PSYCHIAT, V18, P41, DOI 10.1016/S0010-440X(77)80006-0; 1980, WARFARE FRAGILE WORL, P59; 1950, NAVMED P1318 US NAV, P3; 1977, WEAPONS MASS DESTRUC; 1991, OPERATION JUST CAUSE; 1988, CHILDREN FRONTLINE	68	80	81	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	1991	266	5					688	692		10.1001/jama.266.5.688	http://dx.doi.org/10.1001/jama.266.5.688			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ140	2072480				2022-12-28	WOS:A1991FZ14000028
J	SHIELDS, PG; HARRIS, CC				SHIELDS, PG; HARRIS, CC			MOLECULAR EPIDEMIOLOGY AND THE GENETICS OF ENVIRONMENTAL CANCER	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WHITE BLOOD-CELLS; L-MYC GENE; FRAGMENT-LENGTH-POLYMORPHISM; HYDROCARBON-DNA ADDUCTS; SISTER CHROMATID EXCHANGE; N-NITROSAMINO ACIDS; COKE-OVEN WORKERS; LOW-RISK AREAS; LUNG-CANCER; HEMOGLOBIN ADDUCTS	Environmental, occupational, and recreational exposures to carcinogens contribute to cancer risk in humans. Cancer formation is a multistage process involving tumor initiation, promotion, conversion, and progression. Carcinogens can affect any of these stages through genetic and epigenetic mechanisms. The association of a suspected carcinogenic exposure and cancer risk can be studied in populations with classic epidemiologic techniques. However, these techniques are not applicable to the assessment of risk in individuals. Molecular epidemiology, in contrast, is a field that integrates molecular biology, in vitro and in vivo laboratory models, biochemistry, and epidemiology to infer individual cancer risk. Carcinogen-macromolecular adduct levels, and somatic cell mutations can be measured to determine the biologically effective dose of a carcinogen. Molecular epidemiology also explores host cancer susceptibilities, such as carcinogen metabolic activation, DNA repair, endogenous mutation rates, and inheritance of mutated tumor suppressor genes. Substantial interindividual variation for each of these biologic end points has been shown and, therefore, highlights the need for assessing cancer risk on an individual basis. Given the pace of the last decade, it is feasible that the next 10 years will allow molecular epidemiologists to develop a cancer-risk profile for an individual that includes assessment of a number of factors. This will help focus preventive strategies and strengthen quantitative risk assessments.	NCI,HUMAN CARCINOGENESIS LAB,BLDG 37,ROOM 2C01,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Shields, Peter G/I-1644-2012					AMES BN, 1989, ENVIRON MOL MUTAGEN, V14, P66, DOI 10.1002/em.2850140614; AYESH R, 1984, NATURE, V312, P169, DOI 10.1038/312169a0; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARTSCH H, 1990, INT J CANCER, V46, P185, DOI 10.1002/ijc.2910460207; BELAND FA, 1989, PATHOBIOLOGY NEOPLAS, P57; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; BOUCK N, 1990, CANCER CELL-MON REV, V2, P179; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; BROWN K, 1990, P NATL ACAD SCI USA, V87, P538, DOI 10.1073/pnas.87.2.538; BRYANT MS, 1988, P NATL ACAD SCI USA, V85, P9788, DOI 10.1073/pnas.85.24.9788; CAPORASO N, 1989, CANCER RES, V49, P3675; CAPORASO NE, 1990, J NATL CANCER I, V82, P1264, DOI 10.1093/jnci/82.15.1264; CARMELLA SG, 1990, CANCER RES, V50, P5438; CARTWRIGHT RA, 1984, CARCINOGENESIS, V5, P1191, DOI 10.1093/carcin/5.9.1191; CAVENEE WK, 1986, NEW ENGL J MED, V314, P1201, DOI 10.1056/NEJM198605083141901; CHACKO M, 1988, CARCINOGENESIS, V9, P2309, DOI 10.1093/carcin/9.12.2309; EVERSON RB, 1986, SCIENCE, V231, P54, DOI 10.1126/science.3941892; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FIELDING JE, 1988, NEW ENGL J MED, V319, P1452, DOI 10.1056/NEJM198812013192205; FLOYD RA, 1990, CARCINOGENESIS, V11, P1447, DOI 10.1093/carcin/11.9.1447; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GERDE P, 1988, BRIT J IND MED, V45, P682; GERSON SL, 1988, CANCER RES, V48, P5368; GONZALEZ FJ, 1991, MUTAT RES, V247, P113, DOI 10.1016/0027-5107(91)90039-Q; GRAFSTROM RC, 1984, CANCER RES, V44, P2855; GROOPMAN JD, 1988, CRC CR REV TOXICOL, V19, P113, DOI 10.3109/10408448809014902; HALEVY O, 1990, SCIENCE, V250, P113, DOI 10.1126/science.2218501; HANSEN MF, 1985, P NATL ACAD SCI USA, V82, P6216, DOI 10.1073/pnas.82.18.6216; HARRIS CC, 1989, CARCINOGENESIS, V10, P1563, DOI 10.1093/carcin/10.9.1563; HARRIS CC, IN PRESS CANCER RES; HAUGEN A, 1986, CANCER RES, V46, P4178; HAUGEN A, 1990, CARCINOGENESIS MUTAG, P249; HECHT SS, 1988, CARCINOGENESIS, V9, P875, DOI 10.1093/carcin/9.6.875; HEIM M, 1990, LANCET, V336, P529, DOI 10.1016/0140-6736(90)92086-W; HEIN DW, 1988, BIOCHIM BIOPHYS ACTA, V948, P37, DOI 10.1016/0304-419X(88)90004-2; HEMMINKI K, 1990, CARCINOGENESIS, V11, P1229, DOI 10.1093/carcin/11.7.1229; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HORSFALL MJ, 1990, ENVIRON MOL MUTAGEN, V15, P107, DOI 10.1002/em.2850150208; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; HUH NH, 1989, CANCER RES, V49, P93; ISHIZAKI K, 1990, J NATL CANCER I, V82, P238, DOI 10.1093/jnci/82.3.238; JACKSON JH, 1987, J CLIN INVEST, V80, P1090, DOI 10.1172/JCI113165; KAKEHI Y, 1989, INT J CANCER, V43, P391, DOI 10.1002/ijc.2910430307; KAMIYAMA S, 1987, IARC SCI PUBL, V84, P497; KAMP DW, 1989, J LAB CLIN MED, V114, P604; KATO M, 1990, INT J CANCER, V45, P47, DOI 10.1002/ijc.2910450110; KAWAJIRI K, 1990, FEBS LETT, V263, P131, DOI 10.1016/0014-5793(90)80721-T; KAWASHIMA K, 1988, P NATL ACAD SCI USA, V85, P2353, DOI 10.1073/pnas.85.7.2353; KOURI RE, 1982, CANCER RES, V42, P5030; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; LEANDERSON P, 1990, CHEM-BIOL INTERACT, V75, P71, DOI 10.1016/0009-2797(90)90023-G; Li F P, 1990, Curr Probl Cancer, V14, P73; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; LIOTTA LA, 1986, CANCER RES, V46, P1; LIOU SH, 1989, CANCER RES, V49, P4929; LOEB LA, 1989, CANCER RES, V49, P5489; LU SH, 1986, CANCER RES, V46, P1485; LU SH, 1986, J CELL PHYSL S, V4, P51; MACLURE M, 1990, CANCER RES, V50, P181; MACLURE M, 1989, AM J PUBLIC HEALTH, V79, P1381, DOI 10.2105/AJPH.79.10.1381; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MCLEMORE TL, 1990, J NATL CANCER I, V82, P1333, DOI 10.1093/jnci/82.16.1333; MOMMSEN S, 1985, CARCINOGENESIS, V6, P199, DOI 10.1093/carcin/6.2.199; MOSSMAN BT, 1983, ENVIRON HEALTH PERSP, V51, P331, DOI 10.2307/3429773; MOSSMAN BT, 1989, ENVIRON HEALTH PERSP, V81, P91, DOI 10.2307/3430811; MYRNES B, 1983, CARCINOGENESIS, V4, P1565, DOI 10.1093/carcin/4.12.1565; NEWCOMB EW, 1989, ENVIRON HEALTH PERSP, V81, P33, DOI 10.2307/3430801; PEGG AE, 1983, REV BIOCHEM TOXICOL, V5, P83; PERERA F, 1989, CANCER RES, V49, P4446; PERERA FP, 1988, CANCER RES, V48, P2288; PETRUZZELLI S, 1988, CANCER RES, V48, P4695; PHILLIPS DH, 1988, NATURE, V336, P790, DOI 10.1038/336790a0; PHILLIPS DH, 1988, MUTAT RES, V204, P531, DOI 10.1016/0165-1218(88)90047-X; PHILLIPS DH, 1990, INT J CANCER, V46, P569, DOI 10.1002/ijc.2910460403; PRESTONMARTIN S, 1990, CANCER RES, V50, P7415; ROTHMAN N, 1990, CARCINOGENESIS, V11, P1241, DOI 10.1093/carcin/11.7.1241; ROWLEY JD, 1990, CANCER RES, V50, P3816; SCUDIERO DA, 1984, CANCER RES, V44, P2467; SEIDEGARD J, 1990, CARCINOGENESIS, V11, P33, DOI 10.1093/carcin/11.1.33; SHIELDS G, IN PRESS BIOMONITOR; SHIELDS PG, 1990, CANCER RES, V50, P6580; SHIELDS PG, 1990, MED CLIN N AM, V74, P263, DOI 10.1016/S0025-7125(16)30561-2; SHIELDS PG, 1991, IMMUNOASSAYS TRACE C, P186; STRANGE RC, 1991, CARCINOGENESIS, V12, P25, DOI 10.1093/carcin/12.1.25; SUGIMURA H, 1990, CANCER RES, V50, P1857; TAMAI S, 1990, INT J CANCER, V46, P411, DOI 10.1002/ijc.2910460314; UMBENHAUER D, 1985, INT J CANCER, V36, P661, DOI 10.1002/ijc.2910360607; VANSCHOOTEN FJ, 1990, J NATL CANCER I, V82, P927, DOI 10.1093/jnci/82.11.927; VINEIS P, 1991, INT J CANCER, V47, P26, DOI 10.1002/ijc.2910470106; VINEIS P, 1990, CANCER RES, V50, P3002; WEICHSELBAUM RR, 1989, INT J RADIAT ONCOL, V16, P277, DOI 10.1016/0360-3016(89)90043-6; WEINSTEIN IB, 1987, J CELL BIOCHEM, V33, P213, DOI 10.1002/jcb.240330308; WILD CP, 1990, CANCER RES, V50, P245; WILSON VL, 1989, CARCINOGENESIS, V10, P2149, DOI 10.1093/carcin/10.11.2149; YUSPA SH, 1988, ADV CANCER RES, V50, P25, DOI 10.1016/S0065-230X(08)60434-0; ZATONSKI W, 1989, INT J CANCER, V44, P823, DOI 10.1002/ijc.2910440513	96	168	169	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	1991	266	5					681	687		10.1001/jama.266.5.681	http://dx.doi.org/10.1001/jama.266.5.681			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ140	2072479				2022-12-28	WOS:A1991FZ14000027
J	RONNBLOM, LE; ALM, GV; OBERG, KE				RONNBLOM, LE; ALM, GV; OBERG, KE			AUTOIMMUNITY AFTER ALPHA-INTERFERON THERAPY FOR MALIGNANT CARCINOID-TUMORS	ANNALS OF INTERNAL MEDICINE			English	Article							SYSTEMIC LUPUS-ERYTHEMATOSUS; LEUKOCYTE-DERIVED INTERFERON; LONG-TERM THERAPY; THYROID-DISEASE; ANTIBODIES; AUTOANTIBODIES; LYMPHOCYTES; ENHANCEMENT; ASSOCIATION; CIRCULATION	Objective: To determine the incidence of autoantibodies and autoimmune disease and their influence on therapeutic results during alpha-interferon treatment in patients with malignant midgut carcinoid tumors. Design: Consecutive sample of patients. Setting: University hospital. Patients: One hundred thirty-five patients (70 women, 65 men; median age, 59 years) with biopsy-proven tumors, liver metastases, and no autoimmune disease. Interventions: Leukocyte alpha-interferon (n = 88) or alpha-interferon 2b (n = 47) three times a week. Main Outcome Measures: Signs and symptoms of autoimmune disease or development of autoantibodies to thyroid antigens, nuclear antigens, or gastric parietal cells. Tumor responses were determined by reduced liver metastases or reduced urinary 5-hydroxyindole acetic acid excretion, or both. Results: Twenty-five patients (19%) developed the following autoimmune disorders after a median of 9 months of therapy: thyroid disease (n = 18), systemic lupus erythematosus (n = 1), pernicious anemia (n = 4), and vasculitis (n = 2). Antibodies to microsomal thyroid antigen or thyroglobulin were detected in 16 patients before therapy and in another 11 patients during therapy. Antinuclear antibodies were detected in 16 patients before and in another 19 patients during therapy. Clinical thyroid disease developed in more than 60% of patients who had or developed thyroid antibodies but in only 7% of initially autoantibody-negative patients. Autoimmunity did not correlate with objective tumor response. Conclusion: Patients with malignant carcinoid tumors may develop autoimmune disease during alpha-interferon therapy, especially when autoantibodies are present. They should therefore be monitored for autoimmunity, which does not appear, however, to influence tumor responses.	UNIV HOSP UPPSALA, LUDWIG INST CANC RES, S-75185 UPPSALA, SWEDEN; CENT HOSP BODEN, BODEN, SWEDEN	Ludwig Institute for Cancer Research; Uppsala University; Uppsala University Hospital			Oberg, Kjell/AAG-7118-2019					ABDI EA, 1986, SCAND J HAEMATOL, V36, P515; BANKHURST AD, 1987, J RHEUMATOL, V14, P63; BJORO T, 1984, ACTA ENDOCRINOL-COP, V105, P324; BURMAN P, 1986, J CLIN ENDOCR METAB, V63, P1086, DOI 10.1210/jcem-63-5-1086; BURMAN P, 1985, LANCET, V2, P100; CANTELL K, 1978, J GEN VIROL, V39, P541, DOI 10.1099/0022-1317-39-3-541; CIAMPOLILLO A, 1989, LANCET, V1, P1096; CONLON KC, 1990, CANCER, V65, P2237, DOI 10.1002/1097-0142(19900515)65:10<2237::AID-CNCR2820651013>3.0.CO;2-5; DEVRIES RRP, 1985, PROG ALLERGY, V36, P1; DONIACH D, 1982, CLIN ASPECTS IMMUNOL, V2, P903; FAIRLEY GH, 1972, BR J HAEMATOL S, V23, P231; FENTIMAN IS, 1988, EUR J CANCER CLIN ON, V24, P1299, DOI 10.1016/0277-5379(88)90219-2; FESSEL WJ, 1974, ARCH INTERN MED, V134, P1027, DOI 10.1001/archinte.134.6.1027; GIDLUND M, 1978, NATURE, V273, P759, DOI 10.1038/273759a0; GRANDER D, 1990, LANCET, V336, P337, DOI 10.1016/0140-6736(90)91879-F; HARFAST B, 1981, J IMMUNOL, V127, P2146; HAWKINS BR, 1979, J CLIN LAB IMMUNOL, V2, P217; HAWKINS BR, 1980, LANCET, V2, P1057; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; HOOKS JJ, 1982, ARTHRITIS RHEUM, V25, P396, DOI 10.1002/art.1780250406; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; KARLSSONPARRA A, 1990, CLIN EXP IMMUNOL, V81, P72; KIM T, 1987, CLIN EXP IMMUNOL, V70, P562; LAZARUS JH, 1984, ACTA ENDOCRINOL-COP, V106, P199, DOI 10.1530/acta.0.1060199; LINDAHL P, 1972, P NATL ACAD SCI USA, V69, P721, DOI 10.1073/pnas.69.3.721; NELSON DS, 1977, PATHOLOGY, V9, P155, DOI 10.3109/00313027709085253; OBERG K, 1987, ACTA ONCOL, V26, P429; OBERG K, 1983, NEW ENGL J MED, V309, P129, DOI 10.1056/NEJM198307213090301; OBERG K, 1986, CANCER TREAT REP, V70, P1297; OBERG K, 1989, J NATL CANCER I, V81, P531, DOI 10.1093/jnci/81.7.531; PAK CY, 1988, LANCET, V2, P1; PANGALIS GA, 1988, CANCER, V61, P869, DOI 10.1002/1097-0142(19880301)61:5<869::AID-CNCR2820610503>3.0.CO;2-I; REVEL M, 1986, TRENDS BIOCHEM SCI, V11, P166, DOI 10.1016/0968-0004(86)90134-9; RONNBLOM LE, 1990, J INTERN MED, V227, P207; SCHATTNER A, 1986, CLIN IMMUNOL IMMUNOP, V38, P327, DOI 10.1016/0090-1229(86)90242-4; SCHULTZ RM, 1977, SCIENCE, V197, P674, DOI 10.1126/science.877584; STRANDER H, 1986, ADV CANCER RES, V46; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TUNBRIDGE WMG, 1981, BRIT MED J, V282, P258, DOI 10.1136/bmj.282.6260.258; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; VENTO S, 1987, CLIN EXP IMMUNOL, V68, P225	41	419	423	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	1991	115	3					178	183		10.7326/0003-4819-115-3-178	http://dx.doi.org/10.7326/0003-4819-115-3-178			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY152	2058872				2022-12-28	WOS:A1991FY15200003
J	TONNESEN, P; NORREGAARD, J; SIMONSEN, K; SAWE, U				TONNESEN, P; NORREGAARD, J; SIMONSEN, K; SAWE, U			A DOUBLE-BLIND TRIAL OF A 16-HOUR TRANSDERMAL NICOTINE PATCH IN SMOKING CESSATION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GUM; COMBINATION	Background. The use of nicotine chewing gum combined with psychological support improves the success rate in quitting smoking. We studied the safety and efficacy of a transdermal nicotine patch in smoking cessation. Methods. We conducted a double-blind randomized study comparing the effects of a 16-hour nicotine patch (15 +/- 3.5 mg of nicotine in 16 hours) with those of a placebo patch. Of the 289 smokers (207 women and 82 men) enrolled in the study, 145 were treated with nicotine patches and 144 with placebo patches for 16 weeks. Results. Rates of sustained abstinence were significantly better with active treatment than with placebo: 53, 41, 24, and 17 percent of those in the nicotine-patch group were abstinent after 6, 12, 26, and 52 weeks, respectively, as compared with 17, 10, 5, and 4 percent of those in the placebo-patch group (P < 0.0001). Only two subjects with the nicotine patch and one with the placebo patch had to withdraw from the study because of side effects. Conclusions. The nicotine skin patch proved to be safe and effective, as demonstrated by a higher rate of abstinence than with placebo. However, the absolute rate of abstinence after one year was only 17 percent, which is lower than the rate in studies that have combined the use of nicotine chewing gum with behavioral therapy.	KABI PHARMACIA THERAPEUT,HELSINGBORG,SWEDEN; BISPEBJERG HOSP,DEPT PULM MED,DK-2400 COPENHAGEN,DENMARK	University of Copenhagen; Bispebjerg Hospital								ABELIN T, 1989, METHOD FIND EXP CLIN, V11, P205; ABELIN T, 1989, LANCET, V1, P7; BELASCO JA, 1971, BRIT J ADDICT, V66, P39; BUCHKREMER G, 1989, ADDICT BEHAV, V14, P229, DOI 10.1016/0306-4603(89)90054-3; CURVALL M, 1990, CLIN PHARMACOL THER, V47, P42, DOI 10.1038/clpt.1990.6; Fagerstrom K O, 1988, Prog Clin Biol Res, V261, P109; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; FALKMAN SE, 1975, ANALYST, V100, P99, DOI 10.1039/an9750000099; HUGHES JR, 1985, J CLIN PSYCHOPHARM, V5, P138; HUGHES JR, 1989, JAMA-J AM MED ASSOC, V261, P1300, DOI 10.1001/jama.261.9.1300; HUGHES JR, 1984, JAMA-J AM MED ASSOC, V252, P2855, DOI 10.1001/jama.252.20.2855; HUNT WA, 1971, J CLIN PSYCHOL, V27, P455, DOI 10.1002/1097-4679(197110)27:4<455::AID-JCLP2270270412>3.0.CO;2-R; JARVIS MJ, 1980, BRIT MED J, V281, P484, DOI 10.1136/bmj.281.6238.484; KRUMPE P, 1989, American Review of Respiratory Disease, V139, pA337; Maddux J F, 1986, NIDA Res Monogr, V72, P49; MCNABB ME, 1984, CAN MED ASSOC J, V131, P589; MULLIGAN SC, 1990, CLIN PHARMACOL THER, V47, P331, DOI 10.1038/clpt.1990.36; PRIGNOT J, 1989, EUR RESPIR J, V2, P550; ROSE JE, 1990, CLIN PHARMACOL THER, V47, P323, DOI 10.1038/clpt.1990.35; RUSSELL MAH, 1974, J ROY STAT SOC A STA, V137, P313, DOI 10.2307/2344953; TONNESEN P, 1988, NEW ENGL J MED, V318, P15, DOI 10.1056/NEJM198801073180104; 1987, DIAGNOSTIC STATISTIC	22	257	266	0	5	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 1	1991	325	5					311	315		10.1056/NEJM199108013250503	http://dx.doi.org/10.1056/NEJM199108013250503			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FY715	2057036				2022-12-28	WOS:A1991FY71500003
J	WILSON, C; WARDELL, MR; WEISGRABER, KH; MAHLEY, RW; AGARD, DA				WILSON, C; WARDELL, MR; WEISGRABER, KH; MAHLEY, RW; AGARD, DA			3-DIMENSIONAL STRUCTURE OF THE LDL RECEPTOR-BINDING DOMAIN OF HUMAN APOLIPOPROTEIN-E	SCIENCE			English	Article							CYSTEINE-ARGININE INTERCHANGE; HUMAN-PLASMA-LIPOPROTEINS; E APOPROTEIN; AQUEOUS-SOLUTION; LEUCINE ZIPPER; TAU-PROTEIN; SITE; EVOLUTION; FIBROBLASTS; REFINEMENT	Human apolipoprotein E, a blood plasma protein, mediates the transport and uptake of cholesterol and lipid by way of its high affinity interaction with different cellular receptors, including the low-density lipoprotein (LDL) receptor. The three-dimensional structure of the LDL receptor-binding domain of apoE has been determined at 2.5 angstrom resolution by x-ray crystallography. The protein forms an unusually elongated (65 angstroms) four-helix bundle, with the helices apparently stabilized by a tightly packed hydrophobic core that includes leucine zipper-type interactions and by numerous salt bridges on the mostly charged surface. Basic amino acids important for LDL receptor binding are clustered into a surface patch on one long helix. This structure provides the basis for understanding the behavior of naturally occurring mutants that can lead to atherosclerosis.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,GRAD GRP BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PATHOL,CARDIOVASC RES INST,GLADSTONE FDN LABS CARDIOVASC DIS,SAN FRANCISCO,CA 94140; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041633] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-41633] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGGERBECK LP, 1988, J MOL BIOL, V202, P179, DOI 10.1016/0022-2836(88)90531-1; AGGERBECK LP, 1988, J BIOL CHEM, V263, P6249; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BOGUSKI MS, 1986, J LIPID RES, V27, P1011; BOGUSKI MS, 1986, J BIOL CHEM, V261, P6398; BREITER DR, 1991, BIOCHEMISTRY-US, V30, P603, DOI 10.1021/bi00217a002; BRUNGER AT, 1987, SCIENCE, V235, P4558; CROWTHER RA, 1971, MOL REPLACEMENT METH; DAS HK, 1985, J BIOL CHEM, V260, P6240; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; GIANTURCO SH, 1983, J BIOL CHEM, V258, P4526; GILSON MK, 1987, NATURE, V330, P84, DOI 10.1038/330084a0; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; HOPE H, 1990, ANNU REV BIOPHYS BIO, V19, P197; INNERARITY TL, 1983, J BIOL CHEM, V258, P2341; INNERARITY TL, 1984, J BIOL CHEM, V259, P7261; INNERARITY TL, 1979, J BIOL CHEM, V254, P4186; KANOST MR, 1988, J BIOL CHEM, V263, P10568; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; KUNDROT CE, 1988, PROTEINS, V3, P71; LALAZAR A, 1988, J BIOL CHEM, V263, P3542; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; LUO CC, 1986, J MOL BIOL, V187, P325, DOI 10.1016/0022-2836(86)90436-5; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MANN WA, 1989, BIOCHIM BIOPHYS ACTA, V1005, P239, DOI 10.1016/0005-2760(89)90043-X; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; PITAS RE, 1980, J BIOL CHEM, V255, P5454; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; POWNALL HJ, 1982, BIOPHYS J, V37, P175, DOI 10.1016/S0006-3495(82)84658-4; PRESNELL SR, 1989, P NATL ACAD SCI USA, V86, P6592, DOI 10.1073/pnas.86.17.6592; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; SPARROW JT, 1985, BIOCHEMISTRY-US, V24, P6984, DOI 10.1021/bi00345a035; SUSSMAN JL, 1985, METHOD ENZYMOL, V115, P271; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; TERWILLIGER TC, 1983, ACTA CRYSTALLOGR A, V39, P813, DOI 10.1107/S0108767383001592; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; WEISGRABER KH, UNPUB; WETTERAU J, UNPUB; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; YANG CY, 1986, NATURE, V323, P738, DOI 10.1038/323738a0	45	630	644	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1991	252	5014					1817	1822		10.1126/science.2063194	http://dx.doi.org/10.1126/science.2063194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU061	2063194				2022-12-28	WOS:A1991FU06100031
J	CRAWFORD, JD; CADERA, W; VILIS, T				CRAWFORD, JD; CADERA, W; VILIS, T			GENERATION OF TORSIONAL AND VERTICAL EYE POSITION SIGNALS BY THE INTERSTITIAL NUCLEUS OF CAJAL	SCIENCE			English	Article							VESTIBULO-OCULAR REFLEX; NEURAL INTEGRATOR; OCULOMOTOR SYSTEM; MOVEMENTS; MONKEY; VELOCITY; BEHAVIOR; LESIONS	The neural integrator, which converts eye velocity signals into position signals, is central to oculomotor theory. Similar integrators are probably necessary in any neural system that changes and maintains muscular tension. The integrator for horizontal eye position is in the pons, but the locations of the vertical and torsional integrators have not been clearly defined. Recording three-dimensional eye movements in alert monkeys during microstimulation and pharmacological inactivation of midbrain sites showed that the interstitial nucleus of Cajal generates both the torsional and vertical eye position signals. Up and down signals are linked with clockwise signals in the right brain and counterclockwise signals in the left brain. This three-dimensional coordinate system achieves orthogonality and bilateral symmetry without redundancy and optimizes energy efficiency for horizontal visual scanning.	UNIV WESTERN ONTARIO,DEPT OPHTHALMOL,LONDON N6A 5C1,ONTARIO,CANADA	Western University (University of Western Ontario)	CRAWFORD, JD (corresponding author), UNIV WESTERN ONTARIO,DEPT PHYSIOL,LONDON N6A 5C1,ONTARIO,CANADA.			Crawford, Doug/0000-0003-2288-1286				ANDERSON JH, 1979, NEUROSCI LETT, V14, P259, DOI 10.1016/0304-3940(79)96158-5; BUTTNERENNEVER JA, 1988, NEUROANATOMY OCULOMO, P137; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; CHERON G, 1987, J PHYSIOL-LONDON, V394, P267, DOI 10.1113/jphysiol.1987.sp016870; CRAWFORD JD, 1991, J NEUROPHYSIOL, V65, P407, DOI 10.1152/jn.1991.65.3.407; EZURE K, 1984, NEUROSCIENCE, V12, P85, DOI 10.1016/0306-4522(84)90140-4; FUCHS AF, 1985, ANNU REV NEUROSCI, V8, P307, DOI 10.1146/annurev.ne.08.030185.001515; FUKUSHIMA K, 1990, EXP BRAIN RES, V79, P43; FUKUSHIMA K, 1987, PROG NEUROBIOL, V29, P107, DOI 10.1016/0301-0082(87)90016-5; KING WM, 1981, J NEUROPHYSIOL, V46, P549, DOI 10.1152/jn.1981.46.3.549; KING WM, 1982, PHYSL VERTICAL GAZE, P267; ROBINSON DA, 1970, J NEUROPHYSIOL, V33, P393, DOI 10.1152/jn.1970.33.3.393; ROBINSON DA, 1982, BIOL CYBERN, V46, P53, DOI 10.1007/BF00335351; ROBINSON DA, 1971, CONTROL EYE MOVEMENT, P519; TWEED D, 1987, J NEUROPHYSIOL, V58, P832, DOI 10.1152/jn.1987.58.4.832; TWEED D, 1990, VISION RES, V30, P111, DOI 10.1016/0042-6989(90)90131-4; TWEED D, 1990, VISION RES, V30, P97, DOI 10.1016/0042-6989(90)90130-D; VILIS T, 1989, EXP BRAIN RES, V77, P1	18	180	181	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1991	252	5012					1551	1553		10.1126/science.2047862	http://dx.doi.org/10.1126/science.2047862			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR040	2047862				2022-12-28	WOS:A1991FR04000048
J	MORRELL, DC				MORRELL, DC			ROLE OF RESEARCH IN DEVELOPMENT OF ORGANIZATION AND STRUCTURE OF GENERAL-PRACTICE	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REFERRAL RATES; TIME; PRACTITIONER; CONTRACT; DISEASE				MORRELL, DC (corresponding author), UNITED MED DENT SCH GUYS & ST THOMASS HOSP, DEPT GEN PRACTICE, LONDON SE11 6SP, ENGLAND.							BARBER JH, 1979, BRIT MED J, V1, P843, DOI 10.1136/bmj.1.6167.843; BUTLER JR, 1987, BMJ-BRIT MED J, V295, P1383, DOI 10.1136/bmj.295.6610.1383; BYRNE P S, 1965, J Coll Gen Pract, V10, P101; CARTWRIGHT A, 1981, GENERAL PRACTICE REV, P157; COCHRANE AL, 1971, BRIT MED BULL, V27, P3, DOI 10.1093/oxfordjournals.bmb.a070810; DAVIES S, 1958, J R COLL GEN PRACT, V21, P315; FOREMAN J, 1962, J R COLL GEN PRACT, V5, P369; Fraser R C, 1981, J R Coll Gen Pract, V31, P410; FRIEDMAN GD, 1986, J CHRON DIS, V39, P453, DOI 10.1016/0021-9681(86)90112-8; FRY J, 1957, BRIT MED J, V2, P1453, DOI 10.1136/bmj.2.5059.1453; HART JT, 1990, BRIT J GEN PRACT, V40, P441; HAYNES RB, 1978, NEW ENGL J MED, V299, P741, DOI 10.1056/NEJM197810052991403; HOLLAND W, 1990, SCREENING HLTH CARE, P18; HULL FM, 1984, J ROY COLL GEN PRACT, V34, P71; KENNIE A, 1962, J R COLL GEN PRACT, V6, P353; KENNIE A, 1965, J R COLL GEN PRACT, V10, P101; LEES D S, 1963, J Coll Gen Pract, V6, P408; LOGAN WPD, 1958, STUDIES MED POPULATI, V14; MANT D, 1990, BMJ-BRIT MED J, V300, P1053, DOI 10.1136/bmj.300.6731.1053; MARTEAU TM, 1990, BRIT MED J, V301, P26, DOI 10.1136/bmj.301.6742.26; MOORE AT, 1989, BRIT MED J, V298, P500, DOI 10.1136/bmj.298.6672.500; MORRELL D, 1989, BRIT MED J, V298, P1005, DOI 10.1136/bmj.298.6679.1005; MORRELL DC, 1980, MED J AUSTRALIA, V1, P355, DOI 10.5694/j.1326-5377.1980.tb134920.x; PILL R, 1988, J ROY COLL GEN PRACT, V38, P53; RIDSDALE L, 1989, J ROY COLL GEN PRACT, V39, P488; ROLAND MO, 1986, BRIT MED J, V292, P874, DOI 10.1136/bmj.292.6524.874; ROLAND MO, 1990, BRIT MED J, V301, P98, DOI 10.1136/bmj.301.6743.98; SACKETT DL, 1975, LANCET, V2, P357, DOI 10.1016/S0140-6736(75)92790-7; SALISBURY CJ, 1989, BRIT MED J, V299, P608, DOI 10.1136/bmj.299.6699.608; SANCTUARY J C, 1965, J Coll Gen Pract, V9, P55; SCOTT R, 1962, J Coll Gen Pract, V5, P72; SCOTT R, 1960, BRIT MED J, V2, P293, DOI 10.1136/bmj.2.5194.293; STOATE HG, 1989, J ROY COLL GEN PRACT, V39, P193; SWIFT G, 1964, BRIT MED J, V1, P1697, DOI 10.1136/bmj.1.5399.1697; The South-East London Screening Study Group, 1977, INT J EPIDEMIOL, V6, P357; WILKIN D, 1984, BRIT MED J, V289, P1501, DOI 10.1136/bmj.289.6457.1501; 1963, FIELD WORK FAMILY DO; 1965, BMJ S, V3169, P153; 1965, BMJ S, V3150, P227; 1964, BMJ S, V3107, P113	40	19	19	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	1991	302	6788					1313	1316		10.1136/bmj.302.6788.1313	http://dx.doi.org/10.1136/bmj.302.6788.1313			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ444	2059688	Green Published, Bronze			2022-12-28	WOS:A1991FQ44400021
J	SENNHAUSER, FH; LIECHTIGALLATI, S; MOSER, H				SENNHAUSER, FH; LIECHTIGALLATI, S; MOSER, H			SCREENING FOR CARRIERS OF CYSTIC-FIBROSIS AMONG PARTNERS OF PEOPLE HETEROZYGOUS FOR THE DISEASE	BRITISH MEDICAL JOURNAL			English	Article									UNIV BERN,INSELSPITAL,KINDERKLIN,CH-3010 BERN,SWITZERLAND	University of Bern; University Hospital of Bern	SENNHAUSER, FH (corresponding author), OSTSCHWEIZER SAUGLINGS & KINDERSPITAL,CH-9006 ST GALLEN,SWITZERLAND.							COLTEN HR, 1990, NEW ENGL J MED, V322, P328, DOI 10.1056/NEJM199002013220510; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; TENKATE LP, 1989, NATURE, V342, P131, DOI 10.1038/342131a0	4	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 10	1990	301	6760					1081	1081		10.1136/bmj.301.6760.1081	http://dx.doi.org/10.1136/bmj.301.6760.1081			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG811	2103736	Green Published, Bronze			2022-12-28	WOS:A1990EG81100023
J	RUBIN, LJ; MENDOZA, J; HOOD, M; MCGOON, M; BARST, R; WILLIAMS, WB; DIEHL, JH; CROW, J; LONG, W				RUBIN, LJ; MENDOZA, J; HOOD, M; MCGOON, M; BARST, R; WILLIAMS, WB; DIEHL, JH; CROW, J; LONG, W			TREATMENT OF PRIMARY PULMONARY-HYPERTENSION WITH CONTINUOUS INTRAVENOUS PROSTACYCLIN (EPOPROSTENOL) - RESULTS OF A RANDOMIZED TRIAL	ANNALS OF INTERNAL MEDICINE			English	Article									MAYO CLIN & MAYO FDN, ROCHESTER, MN 55905 USA; COLUMBIA UNIV COLL PHYS & SURG, NEW YORK, NY 10032 USA; MAINE MED CTR, PORTLAND, ME 04102 USA; BURROUGHS WELLCOME CO, RES TRIANGLE PK, NC 27709 USA	Mayo Clinic; Columbia University; Maine Medical Center; Burroughs Wellcome Fund	RUBIN, LJ (corresponding author), UNIV MARYLAND, SCH MED, 10 PINE ST, ROOM 800, BALTIMORE, MD 21201 USA.							AROMATORIO GJ, 1985, CHEST, V87, P265, DOI 10.1378/chest.87.2.265; BARST RJ, 1986, CHEST, V89, P497, DOI 10.1378/chest.89.4.497; BERKENBOOM G, 1982, BRIT HEART J, V47, P511; BIHARI D, 1987, NEW ENGL J MED, V317, P397, DOI 10.1056/NEJM198708133170701; CHAN NS, 1987, BRIT HEART J, V57, P207; DALONZO GE, 1986, AM REV RESPIR DIS, V133, P380; FARBER HW, 1983, CHEST, V83, P708, DOI 10.1378/chest.83.4.708; FUSTER V, 1984, CIRCULATION, V70, P580, DOI 10.1161/01.CIR.70.4.580; GROVES BM, 1985, J AM COLL CARDIOL, V5, P442; GROVES BM, 1985, AM HEART J, V110, P1200, DOI 10.1016/0002-8703(85)90013-4; HUGHES JD, 1986, MEDICINE, V65, P56, DOI 10.1097/00005792-198601000-00004; JONES DK, 1987, BRIT HEART J, V57, P270; PACKER M, 1989, CHEST, V95, P1173, DOI 10.1378/chest.95.6.1173; REEVES JT, 1986, AM REV RESPIR DIS, V134, P342; REITZ BA, 1982, NEW ENGL J MED, V306, P557, DOI 10.1056/NEJM198203113061001; RICH S, 1988, PROG CARDIOVASC DIS, V31, P205, DOI 10.1016/0033-0620(88)90016-3; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; RICH S, 1987, CIRCULATION, V76, P135, DOI 10.1161/01.CIR.76.1.135; RUBIN LJ, 1983, ANN INTERN MED, V99, P433, DOI 10.7326/0003-4819-99-4-433; RUBIN LJ, 1982, CIRCULATION, V66, P334, DOI 10.1161/01.CIR.66.2.334; RUBINO JM, 1979, BRIT HEART J, V42, P362; WOOD BA, 1982, CHEST, V82, P793, DOI 10.1378/chest.82.6.793; YOSHIMURA K, 1989, J APPL PHYSIOL, V66, P929, DOI 10.1152/jappl.1989.66.2.929	23	562	585	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	1990	112	7					485	491		10.7326/0003-4819-112-7-485	http://dx.doi.org/10.7326/0003-4819-112-7-485			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW001	2107780				2022-12-28	WOS:A1990CW00100002
J	CANTEKIN, EI; MCGUIRE, TW; POTTER, RL				CANTEKIN, EI; MCGUIRE, TW; POTTER, RL			BIOMEDICAL INFORMATION, PEER-REVIEW, AND CONFLICT-OF-INTEREST AS THEY INFLUENCE PUBLIC-HEALTH	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	1ST INTERNATIONAL CONGRESS ON PEER REVIEW IN BIOMEDICAL PUBLICATION	MAY 10-12, 1989	CHICAGO, IL	AMER MED ASSOC					CARNEGIE MELLON UNIV,CARNEGIE MELLON UNIV GRAD SCH IND ADM,PITTSBURGH,PA 15213; STRASSBURGER MCKENNA GUTNICK & POTTER,PITTSBURGH,PA; UNIV PITTSBURGH,SCH MED,PITTSBURGH,PA 15261	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh								MANDEL EM, 1987, NEW ENGL J MED, V316, P432, DOI 10.1056/NEJM198702193160803; 1989, B ATOMIC SCI     APR, P32; 1988, NEW YORK NEWSDA 1206, P3; 1989, CHORNICLE HIGHER ED, V35, pA4; 1988, ECONOMIST       1008, P86; 1989, WASHINGTON POST 0613, P9; 1988, SCIENTIST       1031, P3; 1989, ECONOMIST       0603, P83; 1989, CHRONICLE HIGHE 0628, V35, pA4; 1989, NATURE, V340, P668; 1989, LANCET, V2, P38; 1989, NATURE, V340, P688; 1989, NY TIMES        0612, P1	13	21	23	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	1990	263	10					1427	1430		10.1001/jama.263.10.1427	http://dx.doi.org/10.1001/jama.263.10.1427			4	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CQ724	2078202				2022-12-28	WOS:A1990CQ72400022
J	ROBEY, E; AXEL, R				ROBEY, E; AXEL, R			CD4 - COLLABORATOR IN IMMUNE RECOGNITION AND HIV-INFECTION	CELL			English	Review									COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032	Columbia University; Howard Hughes Medical Institute	ROBEY, E (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT BIOCHEM & PATHOL,NEW YORK,NY 10032, USA.			Axel, Richard/0000-0002-3141-4076				ARTHOS J, 1989, CELL, V57, P469, DOI 10.1016/0092-8674(89)90922-7; CAMERINI D, 1990, CELL, V60, P747, DOI 10.1016/0092-8674(90)90089-W; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; EICHMANN K, 1987, EUR J IMMUNOL, V17, P643, DOI 10.1002/eji.1830170510; GABERT J, 1987, CELL, V50, P545, DOI 10.1016/0092-8674(87)90027-4; GERMAIN RN, 1986, NATURE, V322, P687, DOI 10.1038/322687a0; JUNE CH, 1990, IN PRESS J IMMUNOL, V144; KUPFER A, 1987, P NATL ACAD SCI USA, V84, P5888, DOI 10.1073/pnas.84.16.5888; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; PETERSON A, 1988, CELL, V54, P65, DOI 10.1016/0092-8674(88)90180-8; RAMSDELL F, 1989, J IMMUNOL, V143, P1467; ROBEY EA, 1990, IN PRESS SEMIN IMMUN, V2; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; SATTENTAU QJ, 1988, CELL, V52, P631, DOI 10.1016/0092-8674(88)90397-2; SCHWARTZ RH, 1989, CELL, V57, P1073, DOI 10.1016/0092-8674(89)90044-5; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2	19	83	85	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAR 9	1990	60	5					697	700		10.1016/0092-8674(90)90082-P	http://dx.doi.org/10.1016/0092-8674(90)90082-P			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CV174	2107022	hybrid			2022-12-28	WOS:A1990CV17400002
J	MARSDEN, PD				MARSDEN, PD			LETTER FROM BRASILIA - FERTILE FLUKES AND MEDIATING MOLLUSKS	BRITISH MEDICAL JOURNAL			English	Letter											MARSDEN, PD (corresponding author), UNIV BRASILIA,CP 153121,BR-70010 BRASILIA,BRAZIL.								0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 3	1990	300	6720					311	312		10.1136/bmj.300.6720.311	http://dx.doi.org/10.1136/bmj.300.6720.311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM195	2106964	Bronze, Green Published			2022-12-28	WOS:A1990CM19500025
J	JOHNSON, P; PEARCE, JM				JOHNSON, P; PEARCE, JM			RECURRENT SPONTANEOUS-ABORTION AND POLYCYSTIC OVARIAN DISEASE - COMPARISON OF 2 REGIMENS TO INDUCE OVULATION	BRITISH MEDICAL JOURNAL			English	Article									ST GEORGE HOSP,DEPT OBSTET & GYNAECOL,LONDON SW17,ENGLAND	St Georges University London								ADAMS J, 1986, BRIT MED J, V293, P355, DOI 10.1136/bmj.293.6543.355; Armitage P., 1975, SEQUENTIAL MED TRIAL; HOMBURG R, 1988, BRIT MED J, V297, P1024, DOI 10.1136/bmj.297.6655.1024; JUDD SJ, 1987, FERTIL STERIL, V47, P574; KERIN JF, 1985, J CLIN ENDOCR METAB, V61, P265, DOI 10.1210/jcem-61-2-265; MAGGREGOR AH, 1968, FERTIL STERIL, V19, P616; MIKKELSON TJ, 1986, FERTIL STERIL, V46, P392; STANGER JD, 1985, BRIT J OBSTET GYNAEC, V92, P385, DOI 10.1111/j.1471-0528.1985.tb01113.x; TSAFRIRI A, 1986, CLIN ENDOCRINOL META, V15, P157, DOI 10.1016/S0300-595X(86)80047-0; YEN SSC, 1980, CLIN ENDOCRINOL, V12, P177, DOI 10.1111/j.1365-2265.1980.tb02132.x	10	45	46	1	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					154	156		10.1136/bmj.300.6718.154	http://dx.doi.org/10.1136/bmj.300.6718.154			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105793	Green Published, Bronze			2022-12-28	WOS:A1990CK07700019
J	SHARPLES, PM; STOREY, A; AYNSLEYGREEN, A; EYRE, JA				SHARPLES, PM; STOREY, A; AYNSLEYGREEN, A; EYRE, JA			AVOIDABLE FACTORS CONTRIBUTING TO DEATH OF CHILDREN WITH HEAD-INJURY	BRITISH MEDICAL JOURNAL			English	Article									NO REG HLTH AUTHOR,REG INFORMAT SYST SECT,NEWCASTLE TYNE NE6 4PY,ENGLAND		SHARPLES, PM (corresponding author), UNIV NEWCASTLE UPON TYNE,DEPT CHILD HLTH,NEWCASTLE TYNE NE2 4AH,ENGLAND.			Storey, Alan/0000-0003-2001-9772	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON ID, 1988, BRIT MED J, V296, P1305, DOI 10.1136/bmj.296.6632.1305; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BASKETT P, 1987, BRIT MED J, V294, P508, DOI 10.1136/bmj.294.6570.508-c; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; BRUCE DA, 1979, CHILD BRAIN, V5, P174; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; FIELD JH, 1976, EPIDEMIOLOGY HEAD IN; GENTLEMAN D, 1981, LANCET, V2, P853; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; GRAHAM DI, 1971, LANCET, V1, P265; HAGGERTY R, 1968, AMBULATORY PEDIATRIC, P813; JEFFREYS RV, 1981, LANCET, V2, P459; JENNETT B, 1976, LANCET, V1, P1031; JENNETT B, 1978, INJURY, V10, P31; JENNETT B, 1981, MANAGEMENT HEAD INJU, P211; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; KRENN J, 1975, ADV NEUROSURG, V3, P134; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MAYER T, 1984, J TRAUMA, V24, P31, DOI 10.1097/00005373-198401000-00004; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1977, MED COLL VA QUART, V13, P97; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MORRAY JP, 1984, CRIT CARE MED, V12, P1018, DOI 10.1097/00003246-198412000-00002; PRICE DJE, 1972, INJURY-BR J ACCIDENT, V3, P218, DOI 10.1016/0020-1383(72)90104-0; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; REILLY PL, 1975, LANCET, V2, P375; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; SIMPSON D, 1982, LANCET, V2, P450; TEASDALE G, IN PRESS BR J SURG; TEASDALE G, 1981, BRAIN FAILURE RESUSC, P185; TURNER E, 1984, INTENS CARE MED, V10, P127, DOI 10.1007/BF00265801; YATES DW, 1977, BRIT MED J, V2, P1249, DOI 10.1136/bmj.2.6097.1249; 1984, BRIT MED J, V288, P983	38	112	112	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					87	91		10.1136/bmj.300.6717.87	http://dx.doi.org/10.1136/bmj.300.6717.87			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105782	Green Published, Bronze			2022-12-28	WOS:A1990CJ08000019
J	COHN, JN; JOHNSON, G; ZIESCHE, S; COBB, F; FRANCIS, G; TRISTANI, F; SMITH, R; DUNKMAN, WB; LOEB, H; WONG, ML; BHAT, G; GOLDMAN, S; FLETCHER, RD; DOHERTY, J; HUGHES, CV; CARSON, P; CINTRON, G; SHABETAI, R; HAAKENSON, C				COHN, JN; JOHNSON, G; ZIESCHE, S; COBB, F; FRANCIS, G; TRISTANI, F; SMITH, R; DUNKMAN, WB; LOEB, H; WONG, ML; BHAT, G; GOLDMAN, S; FLETCHER, RD; DOHERTY, J; HUGHES, CV; CARSON, P; CINTRON, G; SHABETAI, R; HAAKENSON, C			A COMPARISON OF ENALAPRIL WITH HYDRALAZINE ISOSORBIDE DINITRATE IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VASODILATOR THERAPY; EXERCISE CAPACITY; CARDIAC-FAILURE; CLINICAL-TRIALS; DRUG-THERAPY; TOLERANCE	Background and Methods. To define better the efficacy of vasodilator therapy in the treatment of chronic congestive heart failure, we compared the effects of hydralazine and isosorbide dinitrate with those of enalapril in 804 men receiving digoxin and diuretic therapy for heart failure. The patients were randomly assigned in a double-blind manner to receive 20 mg of enalapril daily or 300 mg of hydralazine plus 160 mg of isosorbide dinitrate daily. The latter regimen was identical to that used with a similar patient population in the effective-treatment arm of our previous Vasodilator-Heart Failure Trial. Results. Mortality after two years was significantly lower in the enalapril arm (1 8 percent) than in the hydralazine-isosorbide dinitrate arm (25 percent) (P = 0.016; reduction in mortality, 28.0 percent), and overall mortality tended to be lower (P = 0.08). The lower mortality in the enalapril arm was attributable to a reduction in the incidence of sudden death, and this beneficial effect was more prominent in patients with less severe symptoms (New York Heart Association class I or II). In contrast, body oxygen consumption at peak exercise was increased only by hydralazine-isosorbide dinitrate treatment (P < 0.05), and left ventricular ejection fraction, which increased with both regimens during the 2 years after randomization, increased more (P < 0.05) during the first 13 weeks in the hydralazine-isosorbide dinitrate group. Conclusions. The similar two-year mortality in the hydralazine-isosorbide dinitrate arms in our previous Vasodilator-Heart Failure Trial (26 percent) and in the present trial (25 percent), as compared with that in the placebo arm in the previous trial (34 percent), and the further survival benefit with enalapril in the present trial (18 percent) strengthen the conclusion that vasodilator therapy should be included in the standard treatment for heart failure. The different effects of the two regimens (enalapril and hydralazine-isosorbide dinitrate) on mortality and physiologic end points suggest that the profile of effects might be enhanced if the regimens were used in combination.			COHN, JN (corresponding author), UNIV MINNESOTA, SCH MED, BOX 488 UMHC, 420 DELAWARE ST SE, MINNEAPOLIS, MN 55455 USA.							[Anonymous], 1990, Am J Cardiol, V66, P315; CHATTERJEE K, 1977, PROG CARDIOVASC DIS, V19, P301, DOI 10.1016/0033-0620(77)90006-8; CODY RJ, 1985, AM J CARDIOL, V55, pA36, DOI 10.1016/0002-9149(85)90794-5; COHN J N, 1973, Circulation, V48, P5; COHN JN, 1988, CIRCULATION, V78, P1099, DOI 10.1161/01.CIR.78.5.1099; COHN JN, 1977, NEW ENGL J MED, V297, P27; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; COHN JN, 1987, CIRCULATION, V76, P443; COHN JN, 1977, NEW ENGL J MED, V297, P254; COHN JN, 1983, J AM COLL CARDIOL, V2, P755; COX DR, 1972, J R STAT SOC B, V34, P187; CREAGER MA, 1985, J AM COLL CARDIOL, V6, P163, DOI 10.1016/S0735-1097(85)80269-2; FRANCIOSA JA, 1980, AM J MED, V69, P559, DOI 10.1016/0002-9343(80)90468-4; FRANCIS GS, 1988, AM HEART J, V115, P699, DOI 10.1016/0002-8703(88)90829-0; LEIER CV, 1983, CIRCULATION, V67, P817, DOI 10.1161/01.CIR.67.4.817; LEVINE TB, 1984, CIRCULATION, V69, P548, DOI 10.1161/01.CIR.69.3.548; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PACKER M, 1986, AM J CARDIOL, V57, P1323, DOI 10.1016/0002-9149(86)90212-2; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PIERPONT GL, 1978, CHEST, V73, P8, DOI 10.1378/chest.73.1.8; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429	21	2256	2325	3	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	1991	325	5					303	310		10.1056/NEJM199108013250502	http://dx.doi.org/10.1056/NEJM199108013250502			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY715	2057035				2022-12-28	WOS:A1991FY71500002
J	WELCH, HG				WELCH, HG			SHOULD THE HEALTH-CARE FOREST BE SELECTIVELY THINNED BY PHYSICIANS OR CLEAR CUT BY PAYERS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RESOURCE-ALLOCATION; UNITED-STATES; RATIONING DECISIONS; MEDICAL-PRACTICE; PROMOTE QUALITY; INEVITABILITY; COST; TECHNOLOGY; EXPERIENCE; ECONOMICS	As the need to set limits in health care becomes more generally accepted, physicians and policymakers need to consider who can best decide how to allocate medical resources among patients. This commentary focuses on the two obvious candidates: payers and physicians. Although payer-based allocation has the advantage of allowing physicians to act strictly on behalf of their patients, it lacks precision and flexibility. Physician-based allocation places allocation decisions in the hands of individuals better positioned and better equipped to make choices that maximize health outputs. To preserve clinical freedom and minimize micromanagement of individual patients, physicians should expand their advocacy role beyond individual patients and recognize their responsibility to populations. In doing so, physicians would acknowledge that societal and patient interests differ and that health care is just one of many important social goods. For physicians willing to make these choices, five general guidelines are offered. Finally, mechanisms to encourage physician-based allocation are considered.	DARTMOUTH COLL, HITCHCOCK MED CTR, DARTMOUTH MED SCH, HANOVER, NH 03756 USA	Dartmouth College	WELCH, HG (corresponding author), VET AFFAIRS MED CTR, MED SERV, N HARTLAND RD, WHITE RIVER JCT, VT 05001 USA.		Embrett, Mark G./H-4466-2014	Embrett, Mark G./0000-0002-3969-0219				ALPER PR, 1987, NEW ENGL J MED, V316, P337, DOI 10.1056/NEJM198702053160611; BARRY MJ, 1988, JAMA-J AM MED ASSOC, V259, P3010, DOI 10.1001/jama.259.20.3010; BERRIEN R, 1987, NEW ENGL J MED, V316, P334, DOI 10.1056/NEJM198702053160610; CHURCHILL LR, 1988, J AM GERIATR SOC, V36, P644, DOI 10.1111/j.1532-5415.1988.tb06160.x; EISENBERG JM, 1989, JAMA-J AM MED ASSOC, V261, P2840; ENTHOVEN A, 1989, NEW ENGL J MED, V320, P94, DOI 10.1056/NEJM198901123200205; ENTHOVEN A, 1989, NEW ENGL J MED, V320, P29, DOI 10.1056/NEJM198901053200106; EVANS RW, 1983, JAMA-J AM MED ASSOC, V249, P2208, DOI 10.1001/jama.249.16.2208; EVANS RW, 1983, JAMA-J AM MED ASSOC, V249, P2047; FUCHS VR, 1984, NEW ENGL J MED, V311, P1572, DOI 10.1056/NEJM198412133112411; GRUMET GW, 1989, NEW ENGL J MED, V321, P607, DOI 10.1056/NEJM198908313210909; HEMENWAY D, 1990, NEW ENGL J MED, V322, P1059, DOI 10.1056/NEJM199004123221507; HIATT HH, 1975, NEW ENGL J MED, V293, P235, DOI 10.1056/NEJM197507312930506; HIMMELSTEIN DU, 1986, NEW ENGL J MED, V314, P441, DOI 10.1056/NEJM198602133140710; HIMMELSTEIN DU, 1989, NEW ENGL J MED, V320, P102, DOI 10.1056/NEJM198901123200206; KINZER D, 1988, NEW ENGL J MED, V318, P112, DOI 10.1056/NEJM198801143180210; LAPUMA J, 1988, ARCH INTERN MED, V148, P1809, DOI 10.1001/archinte.148.8.1809; LEAF A, 1989, NEW ENGL J MED, V321, P898, DOI 10.1056/NEJM198909283211311; LEE PR, 1989, LANCET, V1, P263; LINZER M, 1984, NEW ENGL J MED, V310, P469, DOI 10.1056/NEJM198402163100722; LUNDBERG GD, 1990, JAMA-J AM MED ASSOC, V263, P86, DOI 10.1001/jama.263.1.86; MORREIM EH, 1989, ARCH INTERN MED, V149, P1012, DOI 10.1001/archinte.149.5.1012; REUBEN DB, 1984, NEW ENGL J MED, V310, P591, DOI 10.1056/NEJM198403013100911; ROPER WL, 1988, NEW ENGL J MED, V319, P1197, DOI 10.1056/NEJM198811033191805; SAGER M, 1990, ARCH INTERN MED, V150, P1091, DOI 10.1001/archinte.150.5.1091; SCHWARTZ WB, 1987, JAMA-J AM MED ASSOC, V257, P220, DOI 10.1001/jama.257.2.220; SLOAN FA, 1989, JAMA-J AM MED ASSOC, V262, P3291, DOI 10.1001/jama.262.23.3291; THUROW LC, 1984, NEW ENGL J MED, V311, P1569, DOI 10.1056/NEJM198412133112410; WELCH HG, 1989, NEW ENGL J MED, V321, P1261, DOI 10.1056/NEJM198911023211809; WELCH HG, 1988, NEW ENGL J MED, V319, P171, DOI 10.1056/NEJM198807213190310; Welch W P, 1990, Health Care Financ Rev, V12, P103	31	25	25	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	1991	115	3					223	226		10.7326/0003-4819-115-3-223	http://dx.doi.org/10.7326/0003-4819-115-3-223			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY152	2058877				2022-12-28	WOS:A1991FY15200011
J	MANSON, JE; STAMPFER, MJ; COLDITZ, GA; WILLETT, WC; ROSNER, B; SPEIZER, FE; HENNEKENS, CH				MANSON, JE; STAMPFER, MJ; COLDITZ, GA; WILLETT, WC; ROSNER, B; SPEIZER, FE; HENNEKENS, CH			A PROSPECTIVE-STUDY OF ASPIRIN USE AND PRIMARY PREVENTION OF CARDIOVASCULAR-DISEASE IN WOMEN	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; LOW-DOSE ASPIRIN; PROSTACYCLIN PRODUCTION; ACETYLSALICYLIC-ACID; PHYSICAL-ACTIVITY; HEALTHY-SUBJECTS; BLEEDING-TIME; INHIBITION; SEX; METABOLITES	Objective.-The aim of the study was to examine prospectively the association between regular aspirin use and the risk of a first myocardial infarction and other cardiovascular events in women. Design. - Prospective cohort study including 6 years of follow-up. Setting. -Registered nurses residing in 11 US states. Participants. - US registered nurses (n = 87 678) aged 34 to 65 years and free of diagnosed coronary heart disease, stroke, and cancer at baseline. Follow-up was 96.7% of total potential person-years of follow-up. Main Outcome Measures.-Incidence of myocardial infarction, stroke, cardiovascular death, and all important vascular events. Results. - During 475 265 person-years of follow-up, we documented 240 nonfatal myocardial infarctions, 146 nonfatal strokes, and 130 deaths due to cardiovascular disease (total, 516 important vascular events). Among women who reported taking one through six aspirin per week, the age-adjusted relative risk (RR) of a first myocardial infarction was 0.68 (95% confidence interval [Cl], 0.52 to 0.89; P = .005), as compared with those women who took no aspirin. After simultaneous adjustment for risk factors for coronary disease, the RR was 0.75 (95% Cl, 0.58 to 0.99; P = .04). For women aged 50 years and older, the age-adjusted RR was 0.61 (95% Cl, 0.45 to 0.84; P = .002) and the multivariate RR was 0.68 (95% Cl, 0.50 to 0.93; P = .02). We observed no alteration in the risk of stroke (multivariate RR = 0.99; P = .94). The multivariate RR of cardiovascular death was 0.89 (P = .56) and of important vascular events was 0.85 (P = .12). When examined separately, the results were nearly identical for the subgroups who took one through three and four though six aspirin per week. Among women who took seven or more aspirin per week, there were no apparent reductions in risk. Conclusions.-The use of one through six aspirin per week appears to be associated with a reduced risk of a first myocardial infarction among women. A randomized trial in women is necessary, however, to provide conclusive data on the role of aspirin in the primary prevention of cardiovascular disease in women.	BRIGHAM & WOMENS HOSP, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PREVENT MED, BOSTON, MA 02115 USA; HARVARD UNIV, SCH PUBL HLTH, DEPT EPIDEMIOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH PUBL HLTH, DEPT NUTR, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	MANSON, JE (corresponding author), HARVARD UNIV, SCH MED, DEPT MED, CHANNING LAB, 180 LONGWOOD AVE, BOSTON, MA 02115 USA.		Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NCI NIH HHS [CA 40356] Funding Source: Medline; NHLBI NIH HHS [HL 34594, HL 07575] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040356, R37CA040356] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1988, BRIT MED J, V296, P320; [Anonymous], 1989, GUIDE CLIN PREVENTIV; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Boston, 1974, BMJ, V1, P440; ESCOLAR G, 1986, THROMB RES, V44, P837, DOI 10.1016/0049-3848(86)90029-0; HAMMOND EC, 1975, BMJ-BRIT MED J, V2, P269, DOI 10.1136/bmj.2.5965.269; HEAVEY DJ, 1985, NATURE, V318, P186, DOI 10.1038/318186a0; HENNEKENS CH, 1989, CIRCULATION, V80, P749, DOI 10.1161/01.CIR.80.4.749; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HO PC, 1985, BRIT J CLIN PHARMACO, V19, P675, DOI 10.1111/j.1365-2125.1985.tb02695.x; HUSTED SE, 1983, EUR J CLIN PHARMACOL, V24, P679, DOI 10.1007/BF00542222; KELTON JG, 1978, BLOOD, V52, P1073; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; MASOTTI G, 1979, LANCET, V2, P1213; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; MONCADA S, 1979, NEW ENGL J MED, V300, P1142, DOI 10.1056/NEJM197905173002006; OBRIEN JR, 1968, LANCET, V1, P779; OGRADY J, 1978, LANCET, V2, P780; PAGANINIHILL A, 1989, BRIT MED J, V299, P1247, DOI 10.1136/bmj.299.6710.1247; PATRIGNANI P, 1982, J CLIN INVEST, V69, P1366, DOI 10.1172/JCI110576; PATRONO C, 1980, THROMB RES, V17, P317, DOI 10.1016/0049-3848(80)90066-3; PATRONO C, 1985, CIRCULATION, V72, P1177, DOI 10.1161/01.CIR.72.6.1177; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; PHILPOT VB, 1985, PROSTA LEUKOTR MED, V19, P123, DOI 10.1016/0262-1746(85)90077-0; POWELL KE, 1987, ANNU REV PUBL HEALTH, V8, P253, DOI 10.1146/annurev.publhealth.8.1.253; Rose GA, 1982, WHO MONOGRAPH SERIES, V56; SPRANGER M, 1989, STROKE, V20, P34, DOI 10.1161/01.STR.20.1.34; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; STAMPFER MJ, 1985, NEW ENGL J MED, V313, P1044, DOI 10.1056/NEJM198510243131703; Walker AE, 1981, STROKE S1, V12, P13; 1988, PHS881114 US DEP HLT, V2, P170	32	240	246	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1991	266	4					521	527		10.1001/jama.266.4.521	http://dx.doi.org/10.1001/jama.266.4.521			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX021	2061978				2022-12-28	WOS:A1991FX02100025
J	DELFAVERO, A				DELFAVERO, A			PREVENTION OF BACTERIAL-INFECTION IN NEUTROPENIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES - A RANDOMIZED, MULTICENTER TRIAL COMPARING NORFLOXACIN WITH CIPROFLOXACIN	ANNALS OF INTERNAL MEDICINE			English	Article						NEUTROPENIA; BACTERIAL INFECTIONS; CIPROFLOXACIN; NORFLOXACIN; HEMATOLOGIC DISEASES	ACUTE-LEUKEMIA; GRANULOCYTOPENIC PATIENTS; FLUORINATED QUINOLONES; VANCOMYCIN POLYMYXIN; CO-TRIMOXAZOLE; PROPHYLAXIS; COTRIMOXAZOLE; OFLOXACIN	Objective: To compare the efficacy of norfloxacin and ciprofloxacin in preventing bacterial infection in neutropenic patients. Design: A randomized, controlled, multicenter trial. Setting. Twenty-one hematologic units in tertiary care or university hospitals. Patients: Eight hundred and one consecutive, afebrile, adult patients who had hematologic malignancies or who had bone marrow transplantation and chemotherapy-induced neutropenia (neutrophil count, < 1000/mm3) expected to last more than 10 days. Intervention: Patients were randomly assigned to receive orally every 12 hours norfloxacin, 400 mg, or ciprofloxacin, 500 mg. Measurements: Efficacy analysis was done for 619 patients: 319 treated with norfloxacin and 300 treated with ciprofloxacin. Main Results: More patients receiving ciprofloxacin did not develop fever during neutropenia and did not receive antibiotics (34%) compared with those receiving norfloxacin (25%) (P = 0.01). Patients receiving ciprofloxacin had a lower rate of microbiologically documented infection (17% compared with 24%; P = 0.058), particularly of infection from gram-negative bacilli (4% compared with 9%; P = 0.03). The interval to the first febrile episode was also longer in patients receiving ciprofloxacin (8.3 compared with 7.2 days; P = 0.055). The rates of clinically documented infection, fever of unknown origin, and mortality as well as compliance and tolerability were similar in the two groups. Patients who had neutropenia for less than 15 days, who had severe neutropenia for less than 7 days, and who received antifungal prophylaxis benefited most from ciprofloxacin therapy. Conclusion: Ciprofloxacin should be used to prevent the development of infection in neutropenic patients with hematologic malignancies.			DELFAVERO, A (corresponding author), UNIV PERUGIA, MONTELUCE POLICLIN, IST CLIN MED 1, I-06100 PERUGIA, ITALY.							BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BOW EJ, 1988, AM J MED, V84, P847, DOI 10.1016/0002-9343(88)90062-9; CASALI A, 1988, CHEMIOTERAPIA, V7, P327; COURVALIN P, 1990, ANTIMICROB AGENTS CH, V34, P681, DOI 10.1128/AAC.34.5.681; CRUCIANI M, 1989, INFECTION, V17, P65, DOI 10.1007/BF01646878; DEKKER AW, 1987, ANN INTERN MED, V106, P7, DOI 10.7326/0003-4819-106-1-7; Gaya H, 1975, Eur J Cancer, V11suppl, P1; HARTLAPP JH, 1987, DRUGS, V34, P131, DOI 10.2165/00003495-198700341-00028; HENRY SA, 1984, AM J MED, V76, P645, DOI 10.1016/0002-9343(84)90289-4; KARP JE, 1987, ANN INTERN MED, V106, P1, DOI 10.7326/0003-4819-106-1-1; LIANG RHS, 1990, ANTIMICROB AGENTS CH, V34, P215, DOI 10.1128/AAC.34.2.215; MARTINO P, 1984, AM J MED SCI, V287, P7, DOI 10.1097/00000441-198405000-00002; MENICHETTI F, 1989, BONE MARROW TRANSPL, V4, P489; SCHIMPFF SC, 1980, ANN INTERN MED, V93, P358, DOI 10.7326/0003-4819-93-2-358; VENDITTI M, 1989, ANTIMICROB AGENTS CH, V33, P209, DOI 10.1128/AAC.33.2.209; WINSTON DJ, 1990, AM J MED, V88, P36, DOI 10.1016/0002-9343(90)90125-W; WINSTON DJ, 1986, AM J MED, V80, P884, DOI 10.1016/0002-9343(86)90633-9; YOUNG LS, 1987, ANN INTERN MED, V106, P144, DOI 10.7326/0003-4819-106-1-144; YOUNG LS, 1988, EUR J CLIN MICROBIOL, V7, P93, DOI 10.1007/BF01962191; YOUNG LS, 1983, J INFECT DIS, V147, P611; 1990, 23 P INT SOC HEM C A	21	84	85	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1991	115	1					7	12		10.7326/0003-4819-115-1-7	http://dx.doi.org/10.7326/0003-4819-115-1-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT937	2048868				2022-12-28	WOS:A1991FT93700002
J	SCHRAG, JD; LI, Y; WU, S; CYGLER, M				SCHRAG, JD; LI, Y; WU, S; CYGLER, M			SER-HIS-GLU TRIAD FORMS THE CATALYTIC SITE OF THE LIPASE FROM GEOTRICHUM-CANDIDUM	NATURE			English	Article							AMINO-ACID-SEQUENCE; 2 MOLECULAR-FORMS; PANCREATIC LIPASE; CDNA; MECHANISM; ACETYLCHOLINESTERASE; RESOLUTION; CUTINASE; CLONING	THE Ser-His-Asp triad is a well known structural feature of the serine proteases. It has also been directly observed in the catalytic sites of two lipases, whose high-resolution three-dimensional structures have been determined 1,2. Lipases show a wide variety of sizes, substrate and positional specificities, and catalytic rates 3. They achieve maximal catalytic rates at oil-water interfaces. The fungus Geotrichum candidum produces several different forms of lipases, two of which have been purified to homogeneity 4,5. Two lipase genes have been identified, cloned and sequenced 6,7. Both code for proteins of 544 amino acids with a total relative molecular mass of about 60,000 (M(r) 60K). The two forms are 86% identical. Their isoelectric points differ slightly, being between 43 and 4.6. About 7% of the total M(r) is carbohydrate. Until now, only a low resolution structure of GCL has been reported 8, but no high resolution structure has followed. We now report the three-dimensional structure of a lipase from G. candidum (GCL) at 2.2 angstrom resolution. Unlike the other lipases and serine proteases, the catalytic triad of GCL is Ser-His-Glu, with glutamic acid replacing the usual aspartate. Although the sequence similarity with the other two lipases is limited to the region near the active-site serine, there is some similarity in their three-dimensional structures. The GCL is also an alpha/beta-protein with a central mixed beta-sheet whose topology is similar to that of the N-terminal domain of human pancreatic lipase. As in the other lipases 1,2, the catalytic site is buried under surface loops. Sequence comparisons with proteins from the cholinesterase family suggest that they also contain the Ser-His-Glu triad.	NATL RES COUNCIL CANADA, BIOTECHNOL RES INST, MONTREAL H4P 2R2, QUEBEC, CANADA	National Research Council Canada								BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BLOW D, 1990, NATURE, V343, P694, DOI 10.1038/343694a0; Borgstrom B, 1984, LIPASES; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; BRUNGER AT, 1989, ACTA CRYSTALLOGR A, V45, P50, DOI 10.1107/S0108767388009195; CHAPUS C, 1976, BIOCHEMISTRY-US, V15, P4980, DOI 10.1021/bi00668a006; CHAPUS C, 1976, BIOCHEMISTRY-US, V15, P4988, DOI 10.1021/bi00668a007; ETTINGER WF, 1987, BIOCHEMISTRY-US, V26, P7883, DOI 10.1021/bi00398a052; GARAVITO RM, 1976, BIOCHEMISTRY-US, V6, P5065; GARNER CW, 1980, J BIOL CHEM, V255, P5064; HADVARY P, 1991, J BIOL CHEM, V266, P2021; HATA Y, 1979, J BIOCHEM-TOKYO, V86, P1821, DOI 10.1093/oxfordjournals.jbchem.a132704; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAWAGUCHI Y, 1989, NATURE, V341, P164, DOI 10.1038/341164a0; KOLLER W, 1982, BIOCHEMISTRY-US, V21, P3083; LIAO DI, 1990, J BIOL CHEM, V265, P6528; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549; MACPHEEQUIGLEY K, 1985, J BIOL CHEM, V260, P2185; SCHRAG JD, IN PRESS J MOL BIOL; SHIMADA Y, 1989, J BIOCHEM-TOKYO, V106, P383, DOI 10.1093/oxfordjournals.jbchem.a122862; SHIMADA Y, 1990, J BIOCHEM-TOKYO, V107, P703, DOI 10.1093/oxfordjournals.jbchem.a123112; SIKORAV JL, 1987, EMBO J, V6, P1865, DOI 10.1002/j.1460-2075.1987.tb02445.x; SUGIHARA A, 1990, J BIOCHEM-TOKYO, V107, P426, DOI 10.1093/oxfordjournals.jbchem.a123061; VEERARAGAVAN K, 1990, BIOCHIM BIOPHYS ACTA, V1044, P26, DOI 10.1016/0005-2760(90)90214-I; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; YAMATO K, 1983, BIOCHEM GENET, V21, P135, DOI 10.1007/BF02395397	29	480	492	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 27	1991	351	6329					761	764		10.1038/351761a0	http://dx.doi.org/10.1038/351761a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU201	2062369				2022-12-28	WOS:A1991FU20100070
J	REERINK, E				REERINK, E			ARCADIA REVISITED - QUALITY ASSURANCE IN HOSPITALS IN THE NETHERLANDS	BRITISH MEDICAL JOURNAL			English	Article											REERINK, E (corresponding author), NATL ORG QUAL ASSURANCE HOSP,CBO,POB 3502LB,UTRECHT,NETHERLANDS.							REERINK E, 1990, QUAL ASSUR HLTH CARE, V2, P146; RITTERSMA J, 1980, J MAXILLOFAC SURG, V8, P206, DOI 10.1016/S0301-0503(80)80102-0; VANDEVOORDE F, 1981, QUALITY REV B, V6, P10; 1987, AUSTR CLIN REV, V7, P1	4	11	11	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1991	302	6790					1443	1445		10.1136/bmj.302.6790.1443	http://dx.doi.org/10.1136/bmj.302.6790.1443			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR403	2070113	Green Published, Bronze			2022-12-28	WOS:A1991FR40300025
J	FINKELSTEIN, AV; REVA, BA				FINKELSTEIN, AV; REVA, BA			A SEARCH FOR THE MOST STABLE FOLDS OF PROTEIN CHAINS	NATURE			English	Article							SECONDARY STRUCTURE; GLOBULAR-PROTEINS; SPIN-GLASSES; PATTERNS	IT is generally believed that it is not sensible to search for a thermodynamically stable structure of a protein 1,2 because neither a molecule nor a computer can look through all the 3 100 possible (for 100 residues) chain conformations. Here we show that the use of a molecular field theory for the long-range interactions, the use of one-dimensional statistical mechanics for the short-range ones and the discovery that there are 3,4 and there must be 5,6 only a small discrete set of folding patterns, make it possible to examine all the variety of 'potentially stable' structures. The general approach and its application is demonstrated here by calculation of stable folds for some beta-domains. The most stable of these folds correspond to the observed structures.	ACAD SCI USSR,RES COMP CTR,PUSHCHINO 142292,USSR	Russian Academy of Sciences	FINKELSTEIN, AV (corresponding author), ACAD SCI USSR,INST PROT RES,PUSHCHINO 142292,USSR.		Reva, Boris/AAB-8932-2022; Reva, Boris A./B-6436-2014; Finkelstein, Alexey V/M-1440-2015	Reva, Boris A./0000-0002-8805-389X; Finkelstein, Alexey V/0000-0002-2138-4803				BINDER K, 1986, REV MOD PHYS, V58, P801, DOI 10.1103/RevModPhys.58.801; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Creighton T. E., 1984, PROTEINS; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; FINKELSTEIN AV, 1990, BIOFIZIKA+, V35, P402; FINKELSTEIN AV, 1977, BIOPOLYMERS, V16, P525, DOI 10.1002/bip.1977.360160304; FINKELSTEIN AV, 1978, BIOORG KHIM+, V4, P340; FINKELSTEIN AV, 1987, PROG BIOPHYS MOL BIO, V50, P171, DOI 10.1016/0079-6107(87)90013-7; FINKELSTEIN AV, 1983, PROGRAM ALB; FRIEDRICHS MS, 1989, SCIENCE, V246, P371, DOI 10.1126/science.246.4928.371; KUBO R, 1965, STATISTICAL MECHANIC; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; LEVITT M, 1976, NATURE, V261, P552, DOI 10.1038/261552a0; LIFSHITZ IM, 1978, REV MOD PHYS, V50, P683, DOI 10.1103/RevModPhys.50.683; MCKAY DB, 1982, J BIOL CHEM, V257, P9518; MURZIN AG, 1988, J MOL BIOL, V204, P749, DOI 10.1016/0022-2836(88)90366-X; PTITSYN OB, 1987, J PROTEIN CHEM, V6, P273; PTITSYN OB, 1983, BIOPOLYMERS, V22, P15, DOI 10.1002/bip.360220105; REVA BA, 1987, 2ND P INT M MOL BAS; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; ROSSMANN MG, 1983, J MOL BIOL, V165, P711, DOI 10.1016/S0022-2836(83)80276-9; SASAI M, 1990, PHYS REV LETT, V65, P2740, DOI 10.1103/PhysRevLett.65.2740; SHAKHNOVICH EI, 1989, J PHYS A-MATH GEN, V22, P1647, DOI 10.1088/0305-4470/22/10/019; SHAKHNOVICH EI, 1989, BIOPOLYMERS, V28, P1667, DOI 10.1002/bip.360281003; SHAKHNOVICH EI, 1989, STUD BIOPHYS, V132, P47; VEDENOV A. A., 1967, MOL BIOL, V1, P313; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; WISTOW G, 1983, J MOL BIOL, V170, P175, DOI 10.1016/S0022-2836(83)80232-0; ZIMM BH, 1959, J CHEM PHYS, V31, P526, DOI 10.1063/1.1730390	29	125	131	0	10	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 6	1991	351	6326					497	499		10.1038/351497a0	http://dx.doi.org/10.1038/351497a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP758	2046752				2022-12-28	WOS:A1991FP75800061
J	KELLY, DR; MURRAY, TS				KELLY, DR; MURRAY, TS			20 YEARS OF VOCATIONAL-TRAINING IN THE WEST OF SCOTLAND	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE	Objective - To assess the career paths of doctors who completed vocational training in the west of Scotland between 1968 and 1987 and their views on the hospital component of their training. Design - Retrospective analysis of the experience and opinions of vocationally trained doctors obtained from a postal questionnaire. Setting - West of Scotland Subjects - 1255 Doctors identified from Glasgow University records who had been vocationally trained in the west of Scotland between 1968 and 1987. Main outcome measures - Personal details; employment; jobs held currently; additional professional commitments; importance of hospital posts held in various specialities to respondents currently in general practice; and retrospective choice of hospital posts, based on subsequent experience. Results - 619 Responses were received, 543 initially and 76 after a letter of reminder, from a possible total 974 (excluding 153 questionnaires returned by the post office and 128 returned because of misunderstanding between the name and address); the overall response rate was therefore 64%. 607/619 (98%) Respondents were employed at the time of the study, of whom 517/607 (85%) were in general practice. A third (202/609) had been unemployed at some point, significantly more of them women (122/243, 50% v 80/376, 21%; = 54.8, p < 0.001). 510/563 (91%) Respondents held one postgraduate qualification or more, and 284/612 (46%) had additional professional commitments. The hospital posts most commonly held were in obstetrics and gynaecology, psychiatry, paediatrics, and medicine. Medicine, obstetrics, paediatrics, and dermatology were considered to be the most relevant hospital specialities by those who had experience of them and were not in general practice. Although ophthalmology and ear, nose, and throat were not rated highly by these doctors, other respondents wished that they had held posts in these specialties (32 and 40 respectively). During the hospital training 354/475 (75%) respondents thought that they were looked on as a junior hospital doctor and not as a trainee for general practice. Conclusions - Most of those who had entered vocational training were in employment, and most were in general practice. According to them, the most beneficial hospital posts for vocational training are medicine, obstetrics, paediatrics, and dermatology. Trainees should be encouraged to attend clinics in gynaecology, ear, nose, and throat, and ophthalmology.	UNIV GLASGOW,DEPT POSTGRAD MED,GLASGOW G12 8QQ,SCOTLAND; UNIV GLASGOW,W SCOTLAND COMM POSTGRAD MED EDUC,GLASGOW G12 8QQ,SCOTLAND	University of Glasgow; University of Glasgow								CRAWLEY HS, 1990, BRIT MED J, V300, P911, DOI 10.1136/bmj.300.6729.911; DONALD JB, 1975, BRIT MED J, V1, P672, DOI 10.1136/bmj.1.5959.672; FREER CB, 1978, UPDATE, V16, P1461; GRAY DJP, 1982, TRANING GENERAL PRAC, P1; MARTYS CR, 1979, UPDATE, V18, P1079; PARKHOUSE J, 1989, UPDATE, V38, P924; REEVE H, 1989, BRIT MED J, V298, P1432, DOI 10.1136/bmj.298.6685.1432; RONALDS C, 1981, 4TH NAT TRAIN C REP; SHORT NL, 1987, MED TEACH, V9, P193, DOI 10.3109/01421598709089934; STYLES WM, 1989, VOCATIONAL TRAINING, V399, P158; THORNHAM JR, 1980, J R COLL GEN PRACT, V221, P725; WHITFIELD MJ, 1966, BMJ-BRIT MED J, V1, P663, DOI 10.1136/bmj.1.5488.663; 1989, TERMS SERVICE DOCTOR; 1985, 1985 REG GEN SCOTL A, P118	14	19	19	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 5	1991	302	6767					28	30		10.1136/bmj.302.6767.28	http://dx.doi.org/10.1136/bmj.302.6767.28			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER372	2053933	Green Published, Bronze			2022-12-28	WOS:A1991ER37200023
J	KUGIYAMA, K; KERNS, SA; MORRISETT, JD; ROBERTS, R; HENRY, PD				KUGIYAMA, K; KERNS, SA; MORRISETT, JD; ROBERTS, R; HENRY, PD			IMPAIRMENT OF ENDOTHELIUM-DEPENDENT ARTERIAL RELAXATION BY LYSOLECITHIN IN MODIFIED LOW-DENSITY LIPOPROTEINS	NATURE			English	Article									BAYLOR UNIV,DEPT MED,HOUSTON,TX 77030; BAYLOR UNIV,DEPT BIOCHEM,HOUSTON,TX 77030; BAYLOR UNIV,DEPT MOLEC PHYSIOL & BIOPHYS,HOUSTON,TX 77030	Baylor University; Baylor University; Baylor University								ANDREWS HE, 1987, NATURE, V327, P237, DOI 10.1038/327237a0; BOSSALLER C, 1987, J CLIN INVEST, V79, P170, DOI 10.1172/JCI112779; COOPER RA, 1975, J CLIN INVEST, V55, P115, DOI 10.1172/JCI107901; FERRELL JE, 1985, BIOCHEMISTRY-US, V24, P2849, DOI 10.1021/bi00333a006; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; HABIB JB, 1986, CIRC RES, V58, P305, DOI 10.1161/01.RES.58.2.305; HENRIKSEN T, 1983, ARTERIOSCLEROSIS, V3, P149, DOI 10.1161/01.ATV.3.2.149; HENRY PD, 1985, CIRCULATION, V72, P456, DOI 10.1161/01.CIR.72.3.456; MOHANDAS N, 1982, J BIOL CHEM, V257, P6537; PARTHASARATHY S, 1985, P NATL ACAD SCI USA, V82, P3000, DOI 10.1073/pnas.82.9.3000; POWNALL HJ, 1983, J AM CHEM SOC, V105, P2440, DOI 10.1021/ja00346a055; SAITO T, 1988, P NATL ACAD SCI USA, V85, P8246, DOI 10.1073/pnas.85.21.8246; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; TSAI SC, 1985, P NATL ACAD SCI USA, V82, P8310, DOI 10.1073/pnas.82.24.8310; VIDAVER GA, 1985, J THEOR BIOL, V115, P27, DOI 10.1016/S0022-5193(85)80005-9; WELTZIEN HU, 1977, BIOCHIM BIOPHYS ACTA, V466, P411, DOI 10.1016/0005-2736(77)90334-0; YAMAMOTO H, 1988, J CLIN INVEST, V81, P1752, DOI 10.1172/JCI113516; Yia-Herttuala S, 1989, J CLIN INVEST, V84, P1086; YOKOYAMA M, 1979, CIRC RES, V45, P479, DOI 10.1161/01.RES.45.4.479	20	825	855	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 8	1990	344	6262					160	162		10.1038/344160a0	http://dx.doi.org/10.1038/344160a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT095	2106627				2022-12-28	WOS:A1990CT09500072
J	HAWKEY, CJ				HAWKEY, CJ			NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND PEPTIC-ULCERS	BMJ-BRITISH MEDICAL JOURNAL			English	Review											HAWKEY, CJ (corresponding author), UNIV NOTTINGHAM HOSP, DEPT THERAPEUT, NOTTINGHAM NG7 2UH, ENGLAND.							ARAKI S, 1985, J EPIDEMIOL COMMUN H, V39, P82, DOI 10.1136/jech.39.1.82; ARMSTRONG CP, 1987, GUT, V28, P527, DOI 10.1136/gut.28.5.527; BEARD K, 1987, ARCH INTERN MED, V147, P1621, DOI 10.1001/archinte.147.9.1621; BENOWITZ NL, 1986, ANNU REV MED, V37, P21; CARSON JL, 1987, ARCH INTERN MED, V147, P85, DOI 10.1001/archinte.147.1.85; CARUSO I, 1980, BRIT MED J, V280, P75, DOI 10.1136/bmj.280.6207.75; CHAMBERLAIN J, 1982, PREVENTION CANCER, P259; CLINCH D, 1983, J ROY COLL PHYS LOND, V17, P228; COGGON D, 1982, GUT, V23, P340, DOI 10.1136/gut.23.4.340; COGGON D, 1981, LANCET, V1, P1302; COLLIER DS, 1985, GUT, V26, P359, DOI 10.1136/gut.26.4.359; COLLINS AJ, 1987, BRIT J RHEUMATOL, V26, P295; COOKE P, 1981, GUT, V22, pA430; DANESHMEND TK, 1988, GUT, V29, pA1442; Douthwaite AH, 1938, LANCET, V2, P1222; DUGGAN JM, 1986, GUT, V27, P929, DOI 10.1136/gut.27.8.929; EHSANULLAH RSB, 1988, BRIT MED J, V297, P1017, DOI 10.1136/bmj.297.6655.1017; FARAH D, 1988, ANN RHEUM DIS, V47, P478, DOI 10.1136/ard.47.6.478; FAULKNER G, 1988, BRIT MED J, V297, P1311, DOI 10.1136/bmj.297.6659.1311; Gillies M, 1968, Med J Aust, V2, P1132; GRAHAM DY, 1988, LANCET, V2, P1277; GRAHAM DY, 1988, GASTROENTEROLOGY, V95, P327, DOI 10.1016/0016-5085(88)90487-8; GRIFFIN MR, 1988, ANN INTERN MED, V109, P359, DOI 10.7326/0003-4819-109-5-359; IHAMAKI T, 1979, SCAND J GASTROENTERO, V14, P801, DOI 10.3109/00365527909181408; INMAN WHW, 1985, PEM NEWS, V3, P3; JICK SS, 1987, LANCET, V2, P380; JOLOBE OMP, 1984, DIGESTION, V29, P164, DOI 10.1159/000199027; JORDE R, 1987, SCAND J GASTROENTERO, V22, P129, DOI 10.3109/00365528708991869; KAWAI K, 1978, CLIN GASTROENTEROL, V7, P605; KREUNING I, 1979, THESIS U LEIDEN LEID; LANGMAN MJS, 1979, EPIDEMIOL CHRON, P15; LARKAI EN, 1987, AM J GASTROENTEROL, V82, P1153; LASSILA R, 1988, BRIT MED J, V297, P955, DOI 10.1136/bmj.297.6654.955; LEVY M, 1988, ARCH INTERN MED, V148, P281, DOI 10.1001/archinte.148.2.281; LEVY M, 1974, NEW ENGL J MED, V290, P1158, DOI 10.1056/NEJM197405232902102; MANTEL N, 1959, J NATL CANCER I, V22, P719; MCINTOSH JH, 1988, AM J EPIDEMIOL, V128, P761, DOI 10.1093/oxfordjournals.aje.a115029; MCINTOSH JH, 1985, GUT, V26, P789, DOI 10.1136/gut.26.8.789; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; NARDI RV, 1988, GASTROENTEROLOGY, V94, pA321; PIPER DW, 1981, GASTROENTEROLOGY, V80, P427; QUADER K, 1988, GUT, V29, pA1443; ROSSI AC, 1987, BRIT MED J, V294, P147, DOI 10.1136/bmj.294.6565.147; ROTH SH, 1987, ARCH INTERN MED, V147, P2093, DOI 10.1001/archinte.147.12.2093; ROTH SH, 1987, ARCH INTERN MED, V147, P1798, DOI 10.1001/archinte.147.10.1798; SEGI M., 1959, SCHWEIZ ZEITSCHR ALLG PATHOL U BAKTERIOL, V22, P777; SHORROCK CJ, 1987, GUT, V28, pA1411; SILVOSO GR, 1979, ANN INTERN MED, V91, P517, DOI 10.7326/0003-4819-91-4-517; SKANDER MP, 1988, BRIT MED J, V297, P833, DOI 10.1136/bmj.297.6652.833; SMEDLEY FH, 1988, GUT, V29, pA1443; SOMERVILLE K, 1986, LANCET, V1, P462; SUN DCH, 1974, AM J DIG DIS, V19, P405, DOI 10.1007/BF01255603; THOMPSON MR, 1980, BRIT MED J, V280, P448, DOI 10.1136/bmj.280.6212.448; WALT R, 1986, LANCET, V1, P489; WHITTLE BJR, 1986, P NATL ACAD SCI USA, V83, P5683, DOI 10.1073/pnas.83.15.5683; [No title captured]	56	328	333	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	1990	300	6720					278	284		10.1136/bmj.300.6720.278	http://dx.doi.org/10.1136/bmj.300.6720.278			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM195	2106956	Green Published, Bronze			2022-12-28	WOS:A1990CM19500004
J	TAYLOR, MW; RITCHIE, LD; TAYLOR, RJ; RYAN, MP; PATERSON, NIA; DUNCAN, R; BROTHERSTON, KG				TAYLOR, MW; RITCHIE, LD; TAYLOR, RJ; RYAN, MP; PATERSON, NIA; DUNCAN, R; BROTHERSTON, KG			GENERAL-PRACTICE COMPUTING IN SCOTLAND	BRITISH MEDICAL JOURNAL			English	Article									ARGYLL & CLYDE HLTH BOARD,W COAST COMP SERV CONSORTIUM,PAISLEY PA3 2HJ,SCOTLAND; HLTH SERV INFORMAT SYST,EDINBURGH EH12 7BD,SCOTLAND		TAYLOR, MW (corresponding author), UNIV ABERDEEN,FORESTERHILL HLTH CTR,DEPT GEN PRACTICE,ABERDEEN AB9 2AY,SCOTLAND.							FITTER MJ, 1986, PRESCRIPTION CHANGE; FRASER RC, 1985, BRIT MED J, V291, P1544, DOI 10.1136/bmj.291.6508.1544; FRASER RC, 1985, BRIT MED J, V291, P1473, DOI 10.1136/bmj.291.6507.1473; KNOX C, 1988, BRIT J HEALTHCARE CO, V5, P13; PRINGLE M, 1987, BRIT MED J, V295, P738, DOI 10.1136/bmj.295.6601.738; RITCHIE LD, 1984, COMPUTERS PRIMARY CA, P65; Ryan M P, 1989, Health Bull (Edinb), V47, P110; SPENCER JA, 1989, J ROY COLL GEN PRACT, V39, P270; 1987, SURVEY COMPUTERISED; 1989, S1 SCOTT HOM HLTH DE	10	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					170	172		10.1136/bmj.300.6718.170	http://dx.doi.org/10.1136/bmj.300.6718.170			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105801	Green Published, Bronze			2022-12-28	WOS:A1990CK07700028
J	TRAINOR, CD; EVANS, T; FELSENFELD, G; BOGUSKI, MS				TRAINOR, CD; EVANS, T; FELSENFELD, G; BOGUSKI, MS			STRUCTURE AND EVOLUTION OF A HUMAN ERYTHROID TRANSCRIPTION FACTOR	NATURE			English	Article									NIH,NATL LIB MED,NATL CTR BIOTECHNOL INFORMAT,BETHESDA,MD 20894	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	TRAINOR, CD (corresponding author), NIDDK,MOLEC BIOL LAB,BETHESDA,MD 20892, USA.							ALTSCHUL SF, 1989, J MOL BIOL, V207, P647, DOI 10.1016/0022-2836(89)90234-9; ARST HN, 1989, TRENDS GENET, V5, P291, DOI 10.1016/0168-9525(89)90105-4; BARNHART KM, 1989, MOL CELL BIOL, V9, P2606, DOI 10.1128/MCB.9.6.2606; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BRENDEL V, 1989, P NATL ACAD SCI USA, V86, P5698, DOI 10.1073/pnas.86.15.5698; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Dayhoff M.O., 1978, ATLAS PROTEIN SEQ ST; DEBOER E, 1988, EMBO J, V7, P4203, DOI 10.1002/j.1460-2075.1988.tb03317.x; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; GALSON DL, 1988, MOL CELL BIOL, V8, P381, DOI 10.1128/MCB.8.1.381; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LI WH, 1985, MOL BIOL EVOL, V2, P150; LIPMAN DJ, 1989, P NATL ACAD SCI USA, V86, P4412, DOI 10.1073/pnas.86.12.4412; MARTIN DIK, 1989, NATURE, V338, P435, DOI 10.1038/338435a0; MCLACHLAN AD, 1983, J MOL BIOL, V169, P15, DOI 10.1016/S0022-2836(83)80173-9; MIGNOTTE V, 1989, NUCLEIC ACIDS RES, V17, P37, DOI 10.1093/nar/17.1.37; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; PERKINS ND, 1989, NUCLEIC ACIDS RES, V17, P1299, DOI 10.1093/nar/17.4.1299; PLUMB M, 1989, NUCLEIC ACIDS RES, V17, P73, DOI 10.1093/nar/17.1.73; SUPERTIFURGA G, 1988, EMBO J, V7, P3099, DOI 10.1002/j.1460-2075.1988.tb03176.x; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; WALL L, 1988, GENE DEV, V2, P1089, DOI 10.1101/gad.2.9.1089	24	134	137	1	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 4	1990	343	6253					92	96		10.1038/343092a0	http://dx.doi.org/10.1038/343092a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG614	2104960	Green Published			2022-12-28	WOS:A1990CG61400064
J	ROCK, GA; SHUMAK, KH; BUSKARD, NA; BLANCHETTE, VS; KELTON, JG; NAIR, RC; SPASOFF, RA				ROCK, GA; SHUMAK, KH; BUSKARD, NA; BLANCHETTE, VS; KELTON, JG; NAIR, RC; SPASOFF, RA			COMPARISON OF PLASMA-EXCHANGE WITH PLASMA INFUSION IN THE TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background. Thrombotic thrombocytopenic purpura is an uncommon disease with a high mortality rate even with current treatment. The cause of the syndrome and its optimal treatment are unknown. Although both plasma exchange and plasma infusion have been useful treatments, it is not clear which is superior. In this report we describe a prospective randomized trial comparing plasma exchange with plasma infusion for the treatment of thrombotic thrombocytopenic purpura. Methods. One hundred two patients with thrombotic thrombocytopenic purpura were randomly assigned to receive either plasma exchange or plasma infusion with fresh-frozen plasma on seven of the first nine days after entry into the trial. The total volume of plasma received by patients undergoing plasma exchange was three times that received by patients undergoing plasma infusion. All the patients also received aspirin and dipyridamole. The outcomes in the two groups were compared at the end of the first treatment cycle (day 9) and after six months. Results. At the end of the first treatment cycle patients receiving plasma exchange had a higher rate of response as defined by an increase in the platelet count (24 of 51 patients) than those who received plasma infusion (13 of 51, P = 0.025). Of the 51 patients treated with plasma exchange, 2 died, whereas 8 of the 51 patients who received plasma infusion died (P = 0.035). After six months the outcome in the plasma-exchange group was still superior, with a response observed in 40 of 51 patients, whereas 25 of 51 patients in the plasma-infusion group responded (P = 0.002). Eleven patients in the plasma-exchange group died, as did 19 patients in the plasma-infusion group (P = 0.036). The overall mortality was 29 percent. Conclusions. Plasma exchange is more effective than plasma infusion in the treatment of thrombotic thrombocytopenic purpura.	UNIV OTTAWA,DEPT MED,OTTAWA K1N 6N5,ONTARIO,CANADA; UNIV OTTAWA,DEPT PATHOL,OTTAWA K1N 6N5,ONTARIO,CANADA; UNIV TORONTO,DEPT MED,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV BRITISH COLUMBIA,DEPT MED,VANCOUVER V6T 1W5,BC,CANADA; UNIV TORONTO,DEPT PEDIAT,TORONTO M5S 1A1,ONTARIO,CANADA; MCMASTER UNIV,DEPT PATHOL,HAMILTON L8S 4L8,ONTARIO,CANADA; UNIV OTTAWA,DEPT EPIDEMIOL,OTTAWA K1N 6N5,ONTARIO,CANADA	University of Ottawa; University of Ottawa; University of Toronto; University of British Columbia; University of Toronto; McMaster University; University of Ottawa			Nair, Rama C/G-5674-2011	Nair, Rama C/0000-0002-9101-0516				AMOROSI EL, 1966, MEDICINE, V45, P139, DOI 10.1097/00005792-196603000-00003; BRESLOW N, 1970, BIOMETRIKA, V57, P579, DOI 10.2307/2334776; BUKOWSKI RM, 1977, BLOOD, V50, P413; BYRNES JJ, 1979, SEMIN THROMB HEMOST, V5, P199; BYRNES JJ, 1977, NEW ENGL J MED, V297, P1386, DOI 10.1056/NEJM197712222972507; RIDOLFI RL, 1981, MEDICINE, V60, P413, DOI 10.1097/00005792-198111000-00003; SHEPARD KV, 1987, SEMIN HEMATOL, V24, P178; SUISSA S, 1985, J ROY STAT SOC A STA, V148, P317, DOI 10.2307/2981892	8	1379	1424	0	21	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 8	1991	325	6					393	397		10.1056/NEJM199108083250604	http://dx.doi.org/10.1056/NEJM199108083250604			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ804	2062330				2022-12-28	WOS:A1991FZ80400004
J	STANNARD, JN				STANNARD, JN			WHEN HEALTH-PHYSICS WAS THE NEW KID ON THE BLOCK	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									UNIV ROCHESTER, SCH MED & DENT, ROCHESTER, NY 14642 USA; UNIV CALIF SAN DIEGO, COMMUNITY MED & RADIOL, SAN DIEGO, CA 92103 USA	University of Rochester; University of California System; University of California San Diego									0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	1991	266	5					711	714		10.1001/jama.266.5.711	http://dx.doi.org/10.1001/jama.266.5.711			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ140	2072485				2022-12-28	WOS:A1991FZ14000034
J	EPHRUSSI, A; DICKINSON, LK; LEHMANN, R				EPHRUSSI, A; DICKINSON, LK; LEHMANN, R			OSKAR ORGANIZES THE GERM PLASM AND DIRECTS LOCALIZATION OF THE POSTERIOR DETERMINANT NANOS	CELL			English	Article							DROSOPHILA POLAR GRANULES; MATERNAL-EFFECT MUTATIONS; ANTEROPOSTERIOR POLARITY; GENE; EMBRYOS; SEGMENTATION; COMPONENT; SEQUENCE; PROTEIN; VASA	oskar is one of seven Drosophila maternal-effect genes that are necessary for germline and abdomen formation. We have cloned oskar and show that oskar RNA is localized to the posterior pole of the oocyte when germ plasm forms. This polar distribution of oskar RNA is established during oogenesis in three phases: accumulation in the oocyte, transport toward the posterior, and finally maintenance at the posterior pole of the oocyte. The colocalization of oskar and nanos in wild-type and bicaudal embryos suggests that oskar directs localization of the posterior determinant nanos. We propose that the pole plasm is assembled stepwise and that continued interaction among its components is required for germ cell determination.	MIT,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02142	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	EPHRUSSI, A (corresponding author), MIT,WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142, USA.		Ephrussi, Anne/AAG-4075-2020; Ephrussi, Anne/ABD-4393-2021	Ephrussi, Anne/0000-0002-5061-4620	NICHD NIH HHS [R01 HD27549-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027549] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BEAMS HW, 1974, INT REV CYTOL, V139, P413; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; EDDY EM, 1975, INT REV CYTOL, V43, P229; Ephrussi B, 1936, AM NAT, V70, P218, DOI 10.1086/280658; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; HAENLIN M, 1985, CELL, V40, P827, DOI 10.1016/0092-8674(85)90342-3; HAY B, 1988, DEVELOPMENT, V103, P625; HAY B, 1990, DEVELOPMENT, V109, P425; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; HUETNER AF, 1923, J MORPHOL, V39, P249; ILLMENSEE K, 1976, DEV BIOL, V49, P40, DOI 10.1016/0012-1606(76)90257-8; INGHAM PW, 1985, NATURE, V318, P439, DOI 10.1038/318439a0; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; LEHMANN R, 1991, DEVELOPMENT, V112, P679; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; LEHMANN R, 1987, NATURE, V329, P167, DOI 10.1038/329167a0; MACDONALD PM, 1988, NATURE, V336, P595, DOI 10.1038/336595a0; Mahowald A.P., 1980, Genetics and Biology of Drosophila, V2d, P141; MAHOWALD AP, 1962, J EXP ZOOL, V151, P201, DOI 10.1002/jez.1401510302; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; MOHLER J, 1986, GENETICS, V112, P808; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; NUSSLEINVOLHARD C, 1979, S SOC DEV BIOL, V37, P185; RAFF JW, 1990, DEVELOPMENT, V110, P1249; SAMBROOK G, 1989, MOL CLONING LABORATO; SCHUPBACH T, 1989, GENETICS, V121, P101; SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; STROME S, 1982, P NATL ACAD SCI-BIOL, V79, P1558, DOI 10.1073/pnas.79.5.1558; Suzuki D.T., 1989, INTRO GENETIC ANAL; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; WANG C, 1991, IN PRESS CELL; WHARTON RP, 1989, CELL, V59, P881, DOI 10.1016/0092-8674(89)90611-9; WHITFIELD WGF, 1989, NATURE, V338, P337, DOI 10.1038/338337a0	41	663	671	1	27	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 12	1991	66	1					37	50		10.1016/0092-8674(91)90137-N	http://dx.doi.org/10.1016/0092-8674(91)90137-N			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FW913	2070417				2022-12-28	WOS:A1991FW91300007
J	HATAKEYAMA, M; KONO, T; KOBAYASHI, N; KAWAHARA, A; LEVIN, SD; PERLMUTTER, RM; TANIGUCHI, T				HATAKEYAMA, M; KONO, T; KOBAYASHI, N; KAWAHARA, A; LEVIN, SD; PERLMUTTER, RM; TANIGUCHI, T			INTERACTION OF THE IL-2 RECEPTOR WITH THE SRC-FAMILY KINASE-P56LCK - IDENTIFICATION OF NOVEL INTERMOLECULAR ASSOCIATION	SCIENCE			English	Article							PROTEIN-TYROSINE KINASE; HUMAN INTERLEUKIN-2 RECEPTOR; HUMAN B-CELLS; BETA-CHAIN; CYTOPLASMIC DOMAINS; PROMOTER INSERTION; MOLECULAR-CLONING; LYMPHOCYTES-T; TAC ANTIGEN; EXPRESSION	In the interleukin-2 (IL-2) system, intracellular signal transduction is triggered by the beta-chain of the IL-2 receptor (IL-2R-beta); however, the responsible signaling mechanism remains unidentified. Evidence for the formation of a stable complex of IL-2R-beta and the lymphocyte-specific protein tyrosine kinase p56lck is presented. Specific association sites were identified in the tyrosine kinase catalytic domain of p56lck and in the cytoplasmic domain of IL-2R-beta. As a result of interaction, IL-2R-beta became phosphorylated in vitro by p56lck. Treatment of T lymphocytes with IL-2 promotes p56lck kinase activity. These data suggest the participation of p56lck as a critical signaling molecule downstream of IL-2R via a novel interaction.	UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	HATAKEYAMA, M (corresponding author), OSAKA UNIV,INST MOLEC & CELLULAR BIOL,SUITA,OSAKA 565,JAPAN.							ASAO H, 1990, J EXP MED, V171, P637, DOI 10.1084/jem.171.3.637; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BENEDICT SH, 1987, J IMMUNOL, V139, P1694; BLACKMAN MA, 1986, CELL, V47, P609, DOI 10.1016/0092-8674(86)90625-2; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; COOKE MP, 1991, CELL, V65, P281, DOI 10.1016/0092-8674(91)90162-R; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DYMECKI SM, 1990, SCIENCE, V247, P332, DOI 10.1126/science.2404338; EARDLEY DD, 1991, SCIENCE, V251, P78, DOI 10.1126/science.1824727; FERRIS DK, 1989, J IMMUNOL, V143, P870; HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7; HATAKEYAMA M, 1987, J EXP MED, V166, P362, DOI 10.1084/jem.166.2.362; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; HATAKEYAMA M, UNPUB; HATAKEYAMA M, 1990, PEPTIDE GROWTH FACTO, V1, P523; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HORAK ID, 1991, P NATL ACAD SCI USA, V88, P1996, DOI 10.1073/pnas.88.5.1996; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; KONO T, 1990, P NATL ACAD SCI USA, V87, P1806, DOI 10.1073/pnas.87.5.1806; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LI JP, 1990, NATURE, V343, P762, DOI 10.1038/343762a0; LINK M, 1983, BLOOD, V62, P722; LOUIE RR, 1988, J VIROL, V62, P4673, DOI 10.1128/JVI.62.12.4673-4679.1988; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; MAYER BJ, 1991, P NATL ACAD SCI USA, V88, P627, DOI 10.1073/pnas.88.2.627; MERIDA I, 1990, J BIOL CHEM, V265, P5690; MILLS GB, 1990, J BIOL CHEM, V265, P3561; MINAMOTO S, 1990, J IMMUNOL, V145, P2177; MORI H, 1991, INT IMMUNOL, V3, P149, DOI 10.1093/intimm/3.2.149; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; PERLMUTTER R M, 1988, Biochimica et Biophysica Acta, V948, P245; ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126; RUDD CE, 1990, IMMUNOL TODAY, V11, P400, DOI 10.1016/0167-5699(90)90159-7; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SALTZMAN EM, 1988, J BIOL CHEM, V263, P6956; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SAW AS, 1989, CELL, V59, P627; SHAW AS, 1990, MOL CELL BIOL, V10, P1853, DOI 10.1128/MCB.10.5.1853; SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; TAGA T, COMMUNICATION; TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223; TSUDO M, 1989, P NATL ACAD SCI USA, V86, P1982, DOI 10.1073/pnas.86.6.1982; TSUDO M, 1984, J EXP MED, V160, P612, DOI 10.1084/jem.160.2.612; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; UCHIYAMA T, 1981, J IMMUNOL, V126, P1393; VEILLETTE A, 1988, MOL CELL BIOL, V8, P4353, DOI 10.1128/MCB.8.10.4353; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VORONOVA AF, 1986, NATURE, V319, P682, DOI 10.1038/319682a0; WALDMANN TA, 1989, ANNU REV BIOCHEM, V58, P875, DOI 10.1146/annurev.bi.58.070189.004303; WALDMANN TA, 1984, J EXP MED, V160, P1450, DOI 10.1084/jem.160.5.1450; WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; YODOI J, 1985, J IMMUNOL, V134, P1623; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	57	636	646	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 14	1991	252	5012					1523	1528		10.1126/science.2047859	http://dx.doi.org/10.1126/science.2047859			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR040	2047859				2022-12-28	WOS:A1991FR04000039
J	ZIELINSKI, RM; LAWRENCE, WD				ZIELINSKI, RM; LAWRENCE, WD			INTERFERON-ALPHA FOR THE HYPEREOSINOPHILIC SYNDROME	ANNALS OF INTERNAL MEDICINE			English	Note									VET AFFAIRS MED CTR, BUFFALO, NY USA; SUNY BUFFALO, BUFFALO, NY 14260 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo								BROXMEYER HE, 1983, J IMMUNOL, V131, P1300; FAUCI AS, 1982, ANN INTERN MED, V97, P78, DOI 10.7326/0003-4819-97-1-78; MOORE PM, 1985, ANN INTERN MED, V102, P109, DOI 10.7326/0003-4819-102-1-109; OLSEN EGJ, 1985, PROG CARDIOVASC DIS, V27, P241, DOI 10.1016/0033-0620(85)90008-8; OWEN WF, 1989, J EXP MED, V170, P343, DOI 10.1084/jem.170.1.343; PARRILLO JE, 1978, ANN INTERN MED, V89, P167, DOI 10.7326/0003-4819-89-2-167; RAGHAVACHAR A, 1987, J IMMUNOL, V139, P3753; SAITO H, 1987, INT ARCH ALLER A IMM, V82, P133, DOI 10.1159/000234178; TALPAZ M, 1986, NEW ENGL J MED, V314, P1065, DOI 10.1056/NEJM198604243141701; WASSOM DL, 1981, J CLIN INVEST, V67, P651, DOI 10.1172/JCI110080	10	76	76	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1990	113	9					716	718		10.7326/0003-4819-113-9-716	http://dx.doi.org/10.7326/0003-4819-113-9-716			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE661	2088325				2022-12-28	WOS:A1990EE66100013
J	COAKLEY, JH; EDWARDS, RHT; MCCLELLAND, P; BONE, JM; HELLIWELL, TR				COAKLEY, JH; EDWARDS, RHT; MCCLELLAND, P; BONE, JM; HELLIWELL, TR			OCCULT ISCHEMIC NECROSIS OF SKELETAL-MUSCLE ASSOCIATED WITH RENAL-FAILURE	BMJ-BRITISH MEDICAL JOURNAL			English	Article									UNIV LIVERPOOL, DEPT PATHOL, LIVERPOOL L69 3BX, ENGLAND; UNIV LIVERPOOL, MUSCLE RES CTR, LIVERPOOL L69 3BX, ENGLAND; ROYAL LIVERPOOL HOSP, REG NEPHROL UNIT, LIVERPOOL L7 8XP, MERSEYSIDE, ENGLAND	University of Liverpool; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital								BAILEY RR, 1973, CLIN SCI MOL MED, V45, P1; BRAUNWALD E, 1982, NEW ENGL J MED, V307, P1618; Bywaters EGL, 1941, BRIT MED J, V1941, P427, DOI 10.1136/bmj.1.4185.427; GROSSMAN RA, 1974, NEW ENGL J MED, V291, P807, DOI 10.1056/NEJM197410172911601; RON D, 1984, ARCH INTERN MED, V144, P277, DOI 10.1001/archinte.144.2.277	5	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	1990	301	6748					370	370		10.1136/bmj.301.6748.370	http://dx.doi.org/10.1136/bmj.301.6748.370			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV522	2078214	Bronze, Green Published			2022-12-28	WOS:A1990DV52200019
J	JIN, YS; ANDERSON, KV				JIN, YS; ANDERSON, KV			DOMINANT AND RECESSIVE ALLELES OF THE DROSOPHILA-EASTER GENE ARE POINT MUTATIONS AT CONSERVED SITES IN THE SERINE PROTEASE CATALYTIC DOMAIN	CELL			English	Article											JIN, YS (corresponding author), UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA.			Jin, Yishi/0000-0002-9371-9860	NIGMS NIH HHS [GM 35437] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035437] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; ANDERSON KV, 1984, NATURE, V311, P223, DOI 10.1038/311223a0; ANDERSON KV, 1986, GAMETOGENESIS EARLY, P177; BODE W, 1975, J MOL BIOL, V98, P693, DOI 10.1016/S0022-2836(75)80005-2; BODE W, 1983, J MOL BIOL, V164, P237, DOI 10.1016/0022-2836(83)90077-3; BROWN JR, 1966, BIOCHEM J, V101, P214, DOI 10.1042/bj1010214; CHASAN R, 1989, CELL, V56, P391, DOI 10.1016/0092-8674(89)90242-0; CRAIK CS, 1985, SCIENCE, V228, P291, DOI 10.1126/science.3838593; DELOTTO R, 1986, NATURE, V323, P688, DOI 10.1038/323688a0; ERDELYI M, 1989, GENETICS, V122, P111; FURIE B, 1982, J BIOL CHEM, V257, P3875; GRAF L, 1987, BIOCHEMISTRY-US, V26, P2616, DOI 10.1021/bi00383a031; HARTLEY BS, 1970, PHILOS T ROY SOC B, V257, P77, DOI 10.1098/rstb.1970.0010; HUTCHISON CA, 1978, J BIOL CHEM, V253, P6551; KRIEG DR, 1963, GENETICS, V48, P561; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; KUDO I, 1981, P NATL ACAD SCI-BIOL, V78, P4753, DOI 10.1073/pnas.78.8.4753; MACGILLIVRAY RTA, 1984, BIOCHEMISTRY-US, V23, P1626, DOI 10.1021/bi00303a007; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; MIKES O, 1966, BIOCHEM BIOPH RES CO, V24, P346, DOI 10.1016/0006-291X(66)90162-8; RAZIN A, 1978, P NATL ACAD SCI USA, V75, P4268, DOI 10.1073/pnas.75.9.4268; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; Saiki R. K., 1988, Genome analysis: a practical approach., P141; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARTZ NM, 1963, GENETICS, V48, P1357; STEWARD R, 1989, CELL, V59, P1179, DOI 10.1016/0092-8674(89)90773-3; STEWARD R, 1988, CELL, V55, P487, DOI 10.1016/0092-8674(88)90035-9; STROUD RM, 1974, J MOL BIOL, V83, P185, DOI 10.1016/0022-2836(74)90387-8; TATE KM, 1987, BIOCHEMISTRY-US, V26, P338, DOI 10.1021/bi00376a002	30	44	46	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	1990	60	5					873	881		10.1016/0092-8674(90)90100-S	http://dx.doi.org/10.1016/0092-8674(90)90100-S			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CV174	2107028				2022-12-28	WOS:A1990CV17400018
J	HOWIE, PW; DAVEY, PG				HOWIE, PW; DAVEY, PG			PROPHYLACTIC ANTIBIOTICS AND CESAREAN-SECTION	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											HOWIE, PW (corresponding author), UNIV DUNDEE, NINEWELLS HOSP & MED SCH, DUNDEE DD1 9SY, SCOTLAND.							BURKE JF, 1973, ANNU REV MED, V24, P289, DOI 10.1146/annurev.me.24.020173.001445; CUNNINGHAM FG, 1978, OBSTET GYNECOL, V52, P656; CURRIE E, 1989, EC ASPECTS HOSPITAL; DUFF P, 1987, AM J OBSTET GYNECOL, V157, P794, DOI 10.1016/S0002-9378(87)80057-1; ENKIN M, 1989, EFFECTIVE CARE PREGN, P1246; GALASK RP, 1987, AM J OBSTET GYNECOL, V157, P491, DOI 10.1016/S0002-9378(87)80201-6; GIBBS RS, 1981, OBSTET GYNECOL, V57, P277; GORDON HR, 1979, OBSTET GYNECOL, V53, P151; GREEN SL, 1978, OBSTET GYNECOL, V51, P569, DOI 10.1097/00006250-197805000-00013; IAMS JD, 1984, AM J OBSTET GYNECOL, V149, P363, DOI 10.1016/0002-9378(84)90143-1; MCILWAINE GM, 1985, HLTH B, V7, P301; MOIRBUSSY BR, 1984, J HOSP INFECT, V5, P359, DOI 10.1016/0195-6701(84)90003-3; MUGFORD M, 1989, BMJ-BRIT MED J, V299, P1003, DOI 10.1136/bmj.299.6706.1003; PELLE H, 1986, INFECT CONT HOSP EP, V7, P456, DOI 10.1017/S019594170006495X; SPRUILL FG, 1974, JAMA-J AM MED ASSOC, V229, P440, DOI 10.1001/jama.229.4.440; SWARTZ WH, 1981, J REPROD MED, V26, P595; 1973, BRIT MED J, V2, P675	17	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	1990	300	6716					2	3		10.1136/bmj.300.6716.2	http://dx.doi.org/10.1136/bmj.300.6716.2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG773	2105116	Bronze, Green Published			2022-12-28	WOS:A1990CG77300002
J	SANDLER, DP; BURR, FR; WEINBERG, CR				SANDLER, DP; BURR, FR; WEINBERG, CR			NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND THE RISK FOR CHRONIC RENAL-DISEASE	ANNALS OF INTERNAL MEDICINE			English	Article							PLASMA-RENIN ACTIVITY; PROSTAGLANDIN SYNTHESIS; ANTIINFLAMMATORY DRUGS; ANALGESIC NEPHROPATHY; FAILURE; INDOMETHACIN; IBUPROFEN; ASPIRIN; INFORMATION; MECHANISM	Objective: To evaluate the risk for chronic renal disease associated with regular use of nonaspirin nonsteroidal anti-inflammatory drugs (NSAIDs). Design: Multicenter case-control study. Patients: Patients were 554 North Carolina residents (age range, 30 to 79 years) hospitalized between 1980 and 1982 with a discharge diagnosis indicating newly diagnosed chronic renal dysfunction and a serum creatinine level consistently at or above 130-mu-mol/L (1.5 mg/dL). Controls were 516 persons chosen randomly by telephone screening (if younger than 65 years of age) and from listings of Medicare recipients (if 65 years of age or older), frequency-matched to patients by age, race, sex, and proximity to study hospitals. Measurements: Data on use of prescription NSAIDs and other analgesics before 1980, other risk factors, and potential confounders were obtained by telephone interviews. Patients were classified by frequency and duration of use; daily users were those who took an NSAID for at least 360 consecutive days. Main Results: A twofold risk for chronic renal disease was associated with previous daily use of NSAIDs (adjusted odds ratio, 2.1; 95% Cl, 1.1 to 4.1). Increased risk was predominantly limited to men older than 65 years, for whom the odds ratio for daily use was 10.0 (Cl, 1.2 to 82.7) after adjusting for use of other analgesics. In other age-sex groups, the risk associated with NSAID use tended to be increased among those with heart disease or other factors that might indicate compromised renal circulation. These findings did not result from confounding by known renal disease risk factors and were not readily explained by potential biases. Conclusions: Regular use of NSAIDs may increase the risk for chronic kidney disease in some high-risk groups. With the recent over-the-counter availability and increasing popularity of NSAIDs, the possibility of an increased risk for chronic renal disease associated with their use may warrant further scrutiny.			SANDLER, DP (corresponding author), NIEHS, EPIDEMIOL BRANCH, MD A305, POB 12233, RES TRIANGLE PK, NC 27709 USA.			Weinberg, Clarice/0000-0002-7713-8556; Sandler, Dale/0000-0002-6776-0018				ADAMS DH, 1986, LANCET, V1, P57; BADR KF, 1988, NEW ENGL J MED, V319, P623; BENDER WL, 1984, AM J MED, V76, P1006, DOI 10.1016/0002-9343(84)90849-0; BLACKSHEAR JL, 1983, ARCH INTERN MED, V143, P1130, DOI 10.1001/archinte.143.6.1130; BOKELMAN DL, 1971, TOXICOL APPL PHARM, V19, P111, DOI 10.1016/0041-008X(71)90195-5; BOYER TD, 1979, GASTROENTEROLOGY, V77, P215; BRANDSTETTER RD, 1978, BRIT MED J, V2, P1194, DOI 10.1136/bmj.2.6146.1194-a; CIABATTONI G, 1984, NEW ENGL J MED, V310, P279, DOI 10.1056/NEJM198402023100502; CLIVE DM, 1984, NEW ENGL J MED, V310, P563, DOI 10.1056/NEJM198403013100905; DECRESPIGNY PJC, 1988, KIDNEY INT, V33, P135; DONKER AJM, 1976, NEPHRON, V17, P288, DOI 10.1159/000180733; DUNN MJ, 1980, KIDNEY INT, V18, P609, DOI 10.1038/ki.1980.179; FERREIRA SH, 1971, NATURE-NEW BIOL, V231, P237, DOI 10.1038/newbio231237a0; FINDLING JW, 1980, JAMA-J AM MED ASSOC, V244, P1127, DOI 10.1001/jama.244.10.1127; FOX DA, 1984, JAMA-J AM MED ASSOC, V251, P1299, DOI 10.1001/jama.251.10.1299; GARELLA S, 1984, MEDICINE, V63, P165, DOI 10.1097/00005792-198405000-00003; GRIFFIN MR, 1988, ANN INTERN MED, V109, P359, DOI 10.7326/0003-4819-109-5-359; HENRICH WL, 1983, AM J KIDNEY DIS, V2, P478, DOI 10.1016/S0272-6386(83)80083-3; HERRMANN N, 1985, AM J EPIDEMIOL, V121, P937, DOI 10.1093/oxfordjournals.aje.a114064; KIMBERLY RP, 1978, AM J MED, V64, P804, DOI 10.1016/0002-9343(78)90520-X; KIMBERLY RP, 1979, ARTHRITIS RHEUM, V22, P281, DOI 10.1002/art.1780220311; Kincaid-Smith P, 1986, Med Toxicol, V1 Suppl 1, P14; KLEINKNECHT D, 1986, CLIN NEPHROL, V25, P275; MORLANS M, 1990, BRIT J CLIN PHARMACO, V30, P717, DOI 10.1111/j.1365-2125.1990.tb03841.x; MURRAY MD, 1990, ANN INTERN MED, V112, P559, DOI 10.7326/0003-4819-112-8-559; NANRA RS, 1978, KIDNEY INT, V13, P79, DOI 10.1038/ki.1978.11; NANRA RS, 1973, PROBLEMS PHENACETIN, P67; ORME MLE, 1986, BRIT MED J, V292, P1621, DOI 10.1136/bmj.292.6536.1621; PAGANINIHILL A, 1982, AM J EPIDEMIOL, V116, P114; ROBERTSON CE, 1980, LANCET, V2, P232; ROTH SH, 1988, ANN INTERN MED, V109, P353, DOI 10.7326/0003-4819-109-5-353; SANDLER DP, 1989, NEW ENGL J MED, V320, P1238, DOI 10.1056/NEJM198905113201903; SCHNEIDER PD, 1986, ANN INTERN MED, V105, P303, DOI 10.7326/0003-4819-105-2-303_3; SEDOR JR, 1986, AM J MED, V81, P58, DOI 10.1016/0002-9343(86)90908-3; SHELLEY JH, 1978, KIDNEY INT, V13, P15, DOI 10.1038/ki.1978.3; SIMON LS, 1980, NEW ENGL J MED, V302, P1179; SIMON LS, 1980, NEW ENGL J MED, V302, P1237; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; WALSHE JJ, 1979, ANN INTERN MED, V91, P47, DOI 10.7326/0003-4819-91-1-47; WHELTON A, 1990, ANN INTERN MED, V112, P568, DOI 10.7326/0003-4819-112-8-568; WISEMAN EH, 1975, AGENTS ACTIONS, V5, P322, DOI 10.1007/BF02205239; 1984, JAMA-J AM MED ASSOC, V251, P3123	43	163	168	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	1991	115	3					165	172		10.7326/0003-4819-115-3-165	http://dx.doi.org/10.7326/0003-4819-115-3-165			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY152	2058870				2022-12-28	WOS:A1991FY15200001
J	ASAKAI, R; CHUNG, DW; DAVIE, EW; SELIGSOHN, U				ASAKAI, R; CHUNG, DW; DAVIE, EW; SELIGSOHN, U			FACTOR-XI DEFICIENCY IN ASHKENAZI JEWS IN ISRAEL	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOLECULAR-WEIGHT KININOGEN; THROMBOPLASTIN ANTECEDENT DEFICIENCY; TRANEXAMIC ACID; ORAL-SURGERY; HUMAN-PLASMA; GENE; PROTEINS; CHAIN; COMPLEX; SITE	Background and Methods. Severe factor XI deficiency, which is relatively common among Ashkenazi Jews, is associated with injury-related bleeding of considerable severity. Three point mutations - a splice-junction abnormality (Type 1), Glu117 --> Stop (Type 11), and Phe 283 --> Leu (Type III) - have been described in six patients with factor XI deficiency. Clinical correlations with these mutations have not been carried out. We determined the relative frequency of the mutations and their association with plasma levels of factor XI clotting activity and bleeding, analyzing the mutations with the polymerase chain reaction and restriction-enzyme digestion. Results. The Type 11 and Type III mutations had similar frequencies among 43 Ashkenazi Jewish probands with severe factor XI deficiency; these two mutations accounted for 49 percent and 47 percent, respectively, of a total of 86 analyzed alleles. Among 40 of the probands and 12 of their relatives with severe factor XI deficiency, patients homozygous for Type III mutation had a significantly higher level of factor XI clotting activity (mean [+/- SD] percentage of normal values, 9.7 +/- 3.8 percent; n = 13) than those homozygous for Type 11 mutation (1.2 +/- 0.5 percent, n = 16) or compound heterozygotes with Type 11/111 mutation (3.3 +/- 1.6 percent, n = 23), as well as significantly fewer episodes of injury-related bleeding. Each of these three groups had a similarly increased proportion of episodes, of bleeding complications after surgery at sites with enhanced local fibrinolysis, such as the urinary tract, or during tooth extraction. Conclusions. Type II and Type III mutations are the predominant causes of factor XI deficiency among Ashkenazi Jews. Genotypic analysis, assay for factor XI, and consideration of the type and location of surgery can be helpful in planning operations in patients with this disorder.	UNIV WASHINGTON, DEPT BIOCHEM, SJ-70, SEATTLE, WA 98195 USA; ICHILOV HOSP, INST HEMATOL, IL-64239 TEL AVIV, ISRAEL	University of Washington; University of Washington Seattle; Tel Aviv University			Sessum, Rachel/F-7312-2015	Sessum, Rachel/0000-0002-2444-7056; Asakai, Rei/0000-0002-1018-7556	NHLBI NIH HHS [HL-16919] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016919] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASAKAI R, 1987, BIOCHEMISTRY-US, V26, P7221, DOI 10.1021/bi00397a004; ASAKAI R, 1989, P NATL ACAD SCI USA, V86, P7667, DOI 10.1073/pnas.86.20.7667; BAGLIA FA, 1990, J BIOL CHEM, V265, P4149; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BIRN H, 1971, Scandinavian Journal of Dental Research, V79, P381; BOLTONMAGGS PHB, 1988, BRIT J HAEMATOL, V69, P521, DOI 10.1111/j.1365-2141.1988.tb02409.x; BOUMA BN, 1977, J BIOL CHEM, V252, P6432; GOODMAN RM, 1979, GENETIC DISORDERS JE, P1; HARKER LA, 1974, HEMOSTASIS MANUAL, P28; KATO A, 1989, CYTOGENET CELL GENET, V52, P77, DOI 10.1159/000132844; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANDLE RJ, 1976, P NATL ACAD SCI USA, V73, P4179, DOI 10.1073/pnas.73.11.4179; MANNHALTER C, 1987, BLOOD, V70, P31; PAGE JD, 1989, BLOOD S, V74, pA291; RAGNI MV, 1985, BLOOD, V65, P719; RAPAPORT SI, 1961, BLOOD, V18, P149, DOI 10.1182/blood.V18.2.149.149; Rasmussen A B, 1966, Acta Otolaryngol, V61, P221, DOI 10.3109/00016486609127059; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAITO H, 1985, J LAB CLIN MED, V106, P718; SELIGSOHN U, 1978, BLOOD, V51, P1223; Siegel S., 1956, NONPARAMETRIC STAT, P96; SINDETPEDERSEN S, 1989, NEW ENGL J MED, V320, P840, DOI 10.1056/NEJM198903303201305; SINDETPEDERSEN S, 1986, J ORAL MAXIL SURG, V44, P703, DOI 10.1016/0278-2391(86)90039-X; SINDETPEDERSEN S, 1987, J DENT RES, V66, P1199, DOI 10.1177/00220345870660062101; STUMP DC, 1986, J BIOL CHEM, V261, P1267; THOMPSON RE, 1977, J CLIN INVEST, V60, P1376, DOI 10.1172/JCI108898; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALSH PN, 1971, BRIT J HAEMATOL, V20, P463, DOI 10.1111/j.1365-2141.1971.tb07061.x	28	298	304	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 18	1991	325	3					153	158		10.1056/NEJM199107183250303	http://dx.doi.org/10.1056/NEJM199107183250303			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW752	2052060				2022-12-28	WOS:A1991FW75200003
J	WILENSKY, GR				WILENSKY, GR			MEDICARE EXPERIMENTS WITH BUNDLED FEES FOR CORONARY-ARTERY BYPASS-SURGERY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											WILENSKY, GR (corresponding author), HLTH CARE FINANCING ADM,OFF RES & DEMONSTRAT,ROOM 301-H,HUMPHREY BLDG,200 INDEPENDENCE AVE SW,WASHINGTON,DC 20201, USA.								0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1991	266	2					191	191						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU896	2056612				2022-12-28	WOS:A1991FU89600006
J	GOODMAN, B				GOODMAN, B			HOLY PHYLOGENY - DID BATS EVOLVE TWICE	SCIENCE			English	Editorial Material																		PETTIGREW, SYSTEMATIC ZOOLO JUN; 1986, SCIENCE, V23, P1304	2	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 5	1991	253	5015					36	36		10.1126/science.2063205	http://dx.doi.org/10.1126/science.2063205			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV177	2063205				2022-12-28	WOS:A1991FV17700027
J	STEWART, LMD; HIRST, M; FERBER, ML; MERRYWEATHER, AT; CAYLEY, PJ; POSSEE, RD				STEWART, LMD; HIRST, M; FERBER, ML; MERRYWEATHER, AT; CAYLEY, PJ; POSSEE, RD			CONSTRUCTION OF AN IMPROVED BACULOVIRUS INSECTICIDE CONTAINING AN INSECT-SPECIFIC TOXIN GENE	NATURE			English	Article							ANDROCTONUS-AUSTRALIS HECTOR; NUCLEAR POLYHEDROSIS-VIRUS; EXPRESSION VECTORS; BACILLUS-THURINGIENSIS; CELLS; VENOM	BACULOVIRUSES provide alternatives to chemicals for controlling insect pests 1-4 and can be applied by spraying. Baculoviruses have a limited host range, but work relatively slowly. They are dissolved in the midgut of insect larvae to release infectious virions which enter gut epithelial cells and begin to replicate. Replication in other organs causes extensive tissue damage and eventually death. This process can take 4-5 days, but in the field may last for more than a week, allowing the larvae to feed for longer and thereby damaging the host plant. Baculovirus expression vectors expreSSing foreign genes 5,6, such as those for insect-specific toxins, hormones or enzymes, might alleviate this problem 7-11. We have now constructed a recombinant baculovirus derived from Autographa californica nuclear polyhedrosis virus containing an insect-specific neurotoxin from the venom of the North African (Algerian) scorpion, Androctonus australis Hector 12. The neurotoxin acts by causing specific modifications to the Na+ conductance of neurons, producing a presynaptic excitatory effect leading to paralysis and death 15,16; it has no effect in mice 17,18. Expression of the neurotoxin by the virus causes a reduction in the time required to kill the host insect.	WELLCOME ENVIRONM HLTH,BERKHAMSTED HP4 2DY,HERTS,ENGLAND	GlaxoSmithKline	STEWART, LMD (corresponding author), NERC,INST VIROL & ENVIRONM MICROBIOL,MANSFIELD RD,OXFORD OX1 3SR,ENGLAND.		GUO, Zhaoyu/AAS-5699-2020; Lopez-Ferber, Miguel/F-5465-2012; Possee, Robert/E-7034-2012	Lopez-Ferber, Miguel/0000-0002-3850-1703; Possee, Robert/0000-0002-9575-6040				BOUGIS PE, 1989, J BIOL CHEM, V264, P19259; CARBONELL LF, 1988, GENE, V73, P409, DOI 10.1016/0378-1119(88)90505-7; COOK RF, 1977, INFECT IMMUN, V25, P396; Cunningham J.C., 1982, P335; DARBON H, 1982, INT J PEPT PROT RES, V20, P320; DEDIANOUS S, 1987, TOXICON, V25, P411, DOI 10.1016/0041-0101(87)90074-2; Entwistle P.F., 1985, P347; Evans H.F., 1987, P257; Finney D.J., 1971, PROBIT ANAL; HAMMOCK BD, 1990, NATURE, V344, P458, DOI 10.1038/344458a0; HARAP KA, 1977, VIROLOGY, V79, P14; HUBER J, 1986, BIOL BACULOVIRUSES, V2, P182; HUGHES PR, 1986, J INVERTEBR PATHOL, V48, P187, DOI 10.1016/0022-2011(86)90122-9; HUGHES PR, 1981, J INVERTEBR PATHOL, V37, P154, DOI 10.1016/0022-2011(81)90069-0; KITTS PA, 1990, NUCLEIC ACIDS RES, V18, P5667, DOI 10.1093/nar/18.19.5667; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LIVINGSTONE C, 1989, NUCLEIC ACIDS RES, V17, P2366, DOI 10.1093/nar/17.6.2366; MAEDA S, 1989, BIOCHEM BIOPH RES CO, V165, P1177, DOI 10.1016/0006-291X(89)92726-5; MARTENS JWM, 1990, APPL ENVIRON MICROB, V56, P2748; MATSUURA Y, 1987, J GEN VIROL, V68, P1233, DOI 10.1099/0022-1317-68-5-1233; MERRYWEATHER AT, 1990, J GEN VIROL, V71, P1535, DOI 10.1099/0022-1317-71-7-1535; PENNOCK GD, 1984, MOL CELL BIOL, V4, P399, DOI 10.1128/MCB.4.3.399; POSSEE RD, 1986, VIRUS RES, V5, P43, DOI 10.1016/0168-1702(86)90064-X; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; TEITELBAUM Z, 1979, INSECT BIOCHEM, V9, P343, DOI 10.1016/0020-1790(79)90080-5; WALTHER C, 1976, J INSECT PHYSIOL, V22, P1187, DOI 10.1016/0022-1910(76)90092-5; WEYER U, 1990, J GEN VIROL, V71, P1525, DOI 10.1099/0022-1317-71-7-1525; WHITFORD M, 1989, J VIROL, V63, P1393, DOI 10.1128/JVI.63.3.1393-1399.1989; ZLOTKIN E, 1971, BIOCHIMIE, V53, P1073, DOI 10.1016/S0300-9084(71)80195-5; ZLOTKIN E, 1983, INSECT BIOCHEM, V13, P219, DOI 10.1016/0020-1790(83)90043-4	30	303	346	0	21	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1991	352	6330					85	88		10.1038/352085a0	http://dx.doi.org/10.1038/352085a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV178	2062383				2022-12-28	WOS:A1991FV17800078
J	HEALY, B				HEALY, B			REPLACEMENT THERAPY EFFECTIVE FOR PATIENTS WITH GAUCHERS-DISEASE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											HEALY, B (corresponding author), NIH,BETHESDA,MD 20892, USA.							1991, NEW ENGL J MED, V324, P1464	1	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	1991	266	1					19	19						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT934	2046123				2022-12-28	WOS:A1991FT93400003
J	SCHRAMM, CJ				SCHRAMM, CJ			HEALTH-CARE FINANCING FOR ALL AMERICANS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Access to health care financing can be achieved by using a combination of public and private initiatives aimed at every American who wants access to health care but is currently denied access. Small-employer market reforms that would guarantee the availability and affordability of coverage to small employers and their employees should be enacted. A private, not-for-profit reinsurance mechanism should be established to absorb losses for high-risk individuals and high-risk employer groups insured by carriers. Stake risk pools should be established to provide coverage to high-risk individuals who cannot obtain coverage through an employer. Tax assistance should be provided to small employers who make health care coverage available to their employees. The Medicaid program should be extended to cover all poor and near-poor Americans and to provide primary and preventive care for the near poor.			SCHRAMM, CJ (corresponding author), HLTH INSURANCE ASSOC AMER,1025 CONNECTICUT AVE NW,WASHINGTON,DC 20036, USA.			Schramm, Carl/0000-0002-3243-1150				JENSEN GA, 1989, INQUIRY, V26, P419; LONG S, 1988, 116TH ANN M AM PUBL; MONHEIT AC, 1988, 116TH ANN M AM PUBL; MOYER ME, 1989, HEALTH AFFAIR, V8, P102, DOI 10.1377/hlthaff.8.2.102; 1988, SOCIAL SECURITY B S; 1990, CURRENT POPULATION S; 1990, SOURCE BOOK HLTH INS; 1991, RISING HLTH CARE COS, P68	8	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1991	265	24					3296	3299		10.1001/jama.265.24.3296	http://dx.doi.org/10.1001/jama.265.24.3296			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR835	2046112				2022-12-28	WOS:A1991FR83500038
J	KERN, SE; KINZLER, KW; BRUSKIN, A; JAROSZ, D; FRIEDMAN, P; PRIVES, C; VOGELSTEIN, B				KERN, SE; KINZLER, KW; BRUSKIN, A; JAROSZ, D; FRIEDMAN, P; PRIVES, C; VOGELSTEIN, B			IDENTIFICATION OF P53 AS A SEQUENCE-SPECIFIC DNA-BINDING PROTEIN	SCIENCE			English	Article							WILD-TYPE P53; GENE-MUTATIONS; LAC REPRESSOR; LUNG-CANCER; CELL-LINE; DELETIONS; ONCOGENE; TRANSFORMATION; ABNORMALITIES; REPLICATION	The tumor-suppressor gene p53 is altered by missense mutation in numerous human malignancies. However, the biochemical properties of p53 and the effect of mutation on these properties are unclear. A human DNA sequence was identified that binds specifically to wild-type human p53 protein in vitro. As few as 33 base pairs were sufficient to confer specific binding. Certain guanines within this 33-base pair region were critical, as methylation of these guanines or their substitution with thymine-abrogated binding. Human p53 proteins containing either of two missense mutations commonly found in human tumors were unable to bind significantly to this sequence. These data suggest that a function of p53 may be mediated by its ability to bind to specific DNA sequences in the human genome, and that this activity is altered by mutations that occur in human tumors.	JOHNS HOPK UNIV,SCH MED,CTR ONCOL,BALTIMORE,MD 21231; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21231; APPL BIOTECHNOL,CAMBRIDGE,MA 02142; COLUMBIA UNIV,DEPT BIOL SCI,NEW YORK,NY 10027	Johns Hopkins University; Johns Hopkins University; Columbia University					NCI NIH HHS [CA06973, CA43460, CA33620] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006973, P01CA033620, R01CA043460, R37CA043460] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; ANACHKOVA B, 1989, MOL CELL BIOL, V9, P532, DOI 10.1128/MCB.9.2.532; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BAKER SJ, 1990, CANCER RES, V50, P7717; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BARTEK J, 1990, ONCOGENE, V5, P893; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FRIEDMAN PN, 1990, P NATL ACAD SCI USA, V87, P9275, DOI 10.1073/pnas.87.23.9275; HUBERMAN JA, COMMUNICATION; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; JELINEK WR, 1980, P NATL ACAD SCI-BIOL, V77, P1398, DOI 10.1073/pnas.77.3.1398; KERN SE, 1991, ONCOGENE, V6, P131; LANE DP, 1983, CELL BIOL INT REP, V7, P513, DOI 10.1016/0309-1651(83)90154-6; LIN S, 1972, J MOL BIOL, V72, P671, DOI 10.1016/0022-2836(72)90184-2; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; LYONS J, 1990, INFECT IMMUN, V58, P4089, DOI 10.1128/IAI.58.12.4089-4098.1990; MANIATIS T, 1982, MOL CLONING LABORATO, P477; MCKAY RDG, 1981, J MOL BIOL, V145, P471, DOI 10.1016/0022-2836(81)90540-4; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; MERCER WE, 1990, P NATL ACAD SCI USA, V87, P6166, DOI 10.1073/pnas.87.16.6166; MISRA R, 1989, NUCLEIC ACIDS RES, V17, P8327, DOI 10.1093/nar/17.20.8327; MULLIGAN LM, 1990, P NATL ACAD SCI USA, V87, P5863, DOI 10.1073/pnas.87.15.5863; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; ROMANO JW, 1989, ONCOGENE, V4, P1483; STEINMEYER K, 1988, ONCOGENE, V3, P501; STRATTON MR, 1990, ONCOGENE, V5, P1297; SYLVESTER JE, 1989, GENE, V84, P193, DOI 10.1016/0378-1119(89)90155-8; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; TAKAHASHI T, 1990, J CLIN INVEST, V86, P363, DOI 10.1172/JCI114710; VOGELSTEIN B, 1990, NATURE, V348, P681, DOI 10.1038/348681a0; ZIMARINO V, 1990, SCIENCE, V249, P546, DOI 10.1126/science.2200124	35	1078	1111	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 21	1991	252	5013					1708	1711		10.1126/science.2047879	http://dx.doi.org/10.1126/science.2047879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT114	2047879				2022-12-28	WOS:A1991FT11400047
J	SITIA, R; NEUBERGER, M; ALBERINI, C; BET, P; FRA, A; VALETTI, C; WILLIAMS, G; MILSTEIN, C				SITIA, R; NEUBERGER, M; ALBERINI, C; BET, P; FRA, A; VALETTI, C; WILLIAMS, G; MILSTEIN, C			DEVELOPMENTAL REGULATION OF IGM SECRETION - THE ROLE OF THE CARBOXY-TERMINAL CYSTEINE	CELL			English	Article									MRC,MOLEC BIOL LAB,CAMBRIDGE,ENGLAND; UNIV BRESCIA,DEPT CHEM,BRESCIA,ITALY	MRC Laboratory Molecular Biology; University of Brescia	SITIA, R (corresponding author), INST NAZL RIC CANC,I-16132 GENOA,ITALY.		Sitia, Roberto/AAB-5005-2019; Fra, Annamaria/I-5532-2012	Sitia, Roberto/0000-0001-7086-4152; Fra, Annamaria/0000-0002-4327-3004				ALBERINI C, 1987, EUR J IMMUNOL, V17, P555, DOI 10.1002/eji.1830170419; BAKER MD, 1986, J IMMUNOL, V137, P1724; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BOYD AW, 1981, J IMMUNOL, V126, P2461; CATTANEO A, 1987, EMBO J, V6, P2753, DOI 10.1002/j.1460-2075.1987.tb02569.x; COOK GP, 1988, MOL GENETICS IMMUNOG, V17, P153; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; DAVIS AC, 1989, MOL IMMUNOL, V26, P147, DOI 10.1016/0161-5890(89)90096-5; DULIS BH, 1983, J BIOL CHEM, V258, P2181; DUPASQUIER L, 1989, FUNDAMENTAL IMMUNOLO, P139; ESSER V, 1988, J BIOL CHEM, V263, P13276; FAHEY RC, 1977, J MOL EVOL, V10, P155, DOI 10.1007/BF01751808; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; Galfre G, 1981, Methods Enzymol, V73, P3; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; HOMBACH J, 1988, J EXP MED, V167, P652, DOI 10.1084/jem.167.2.652; KIM KJ, 1979, J IMMUNOL, V122, P549; KOSHLAND ME, 1985, ANNU REV IMMUNOL, V3, P425; KREIS TE, 1986, CELL, V46, P929, DOI 10.1016/0092-8674(86)90075-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MILSTEIN C, 1965, NATURE, V205, P1171, DOI 10.1038/2051171a0; MILSTEIN CP, 1975, BIOCHEM J, V151, P615, DOI 10.1042/bj1510615; MUNRO S, 1986, CELL, V46, P2914; NEUBERGER MS, 1986, PHILOS T R SOC A, V317, P425, DOI 10.1098/rsta.1986.0052; NEUBERGER MS, 1983, EMBO J, V2, P1373, DOI 10.1002/j.1460-2075.1983.tb01594.x; NEUBERGER MS, 1988, NUCLEIC ACIDS RES, V16, P6713, DOI 10.1093/nar/16.14.6713; NISHIKAWA SI, 1986, IMMUNOGENETICS, V23, P137, DOI 10.1007/BF00377976; OI VT, 1983, P NATL ACAD SCI-BIOL, V80, P825, DOI 10.1073/pnas.80.3.825; ROGERS J, 1980, CELL, V20, P303, DOI 10.1016/0092-8674(80)90616-9; ROTH J, 1982, J CELL BIOL, V92, P223; ROTH RA, 1981, J BIOL CHEM, V256, P4633; ROTH RA, 1981, BIOCHEMISTRY-US, V20, P6594, DOI 10.1021/bi00526a012; ROTH RA, 1987, BIOCHEMISTRY-US, V26, P4179, DOI 10.1021/bi00388a001; SCHREIER PH, 1986, NUCLEIC ACIDS RES, V14, P2381, DOI 10.1093/nar/14.5.2381; SIDMAN C, 1981, CELL, V23, P379, DOI 10.1016/0092-8674(81)90133-1; SITIA R, 1985, J IMMUNOL, V135, P2859; SITIA R, 1984, MOL IMMUNOL, V21, P709, DOI 10.1016/0161-5890(84)90023-3; SITIA R, 1988, MOL IMMUNOL, V25, P189, DOI 10.1016/0161-5890(88)90067-3; SITIA R, 1987, EMBO J, V6, P3969, DOI 10.1002/j.1460-2075.1987.tb02739.x; TARTAKOFF A, 1979, J CELL BIOL, V83, P284, DOI 10.1083/jcb.83.2.284; WILLIAMSON AR, 1973, DEFENSE RECOGNITION, V10, P229; YAMAMOTO T, 1986, SCIENCE, V232, P1230, DOI 10.1126/science.3010466; ZIEGLER A, 1977, EUR J IMMUNOL, V7, P690, DOI 10.1002/eji.1830071007	45	227	238	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAR 9	1990	60	5					781	790		10.1016/0092-8674(90)90092-S	http://dx.doi.org/10.1016/0092-8674(90)90092-S			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CV174	2107027				2022-12-28	WOS:A1990CV17400010
J	PETCH, MC				PETCH, MC			DANGERS OF THROMBOLYSIS - THE BENEFITS OF THROMBOLYTIC TREATMENT FOR ACUTE MYOCARDIAL-INFARCTION OUTWEIGH THE RISKS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											PETCH, MC (corresponding author), PAPWORTH HOSP, REG CARDIAC UNIT, CAMBRIDGE CB3 8RE, ENGLAND.							[Anonymous], 1989, LANCET, V2, P655; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; BURRELL CJ, 1990, BMJ-BRIT MED J, V300, P237, DOI 10.1136/bmj.300.6719.237; CHAMBERLAIN DA, 1988, LANCET, V1, P545; JALIHAL S, 1990, LANCET, V335, P184, DOI 10.1016/0140-6736(90)90276-B; JULIAN DG, 1989, BMJ-BRIT MED J, V299, P555; PAYNE ST, 1989, LANCET, V2, P1398; STAFFORD PJ, 1989, BMJ-BRIT MED J, V299, P1310, DOI 10.1136/bmj.299.6711.1310; WHITE HD, 1987, NEW ENGL J MED, V317, P850, DOI 10.1056/NEJM198710013171402; WILCOX RG, 1988, LANCET, V2, P525	11	27	27	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	1990	300	6723					483	484		10.1136/bmj.300.6723.483	http://dx.doi.org/10.1136/bmj.300.6723.483			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107922	Bronze, Green Published			2022-12-28	WOS:A1990CQ87800002
J	ARMSTRONG, AP				ARMSTRONG, AP			HOW TO DO IT - PAY YOUR WAY THROUGH MEDICAL-SCHOOL	BRITISH MEDICAL JOURNAL			English	Article											ARMSTRONG, AP (corresponding author), UNIV BIRMINGHAM,UNDERGRAD OFF,VINCENT DR,BIRMINGHAM B15 2TJ,W MIDLANDS,ENGLAND.							ALEXANDER DA, 1988, BRIT MED J, V297, P1561, DOI 10.1136/bmj.297.6663.1561; FITTZHERBERT L, 1987, GUIDE GRANTS INDIVID; FITZHERBERT L, 1988, ED GRANTS DIRECTORY; LANGTON SG, 1988, BRIT J ORAL MAX SURG, V26, P89, DOI 10.1016/0266-4356(88)90001-0; SMITH R, 1989, BRIT MED J, V298, P1204; VILLEMUR A, 1989, DIRECTORY GRANT MAKI; 1988, CHARITIES DIGEST	7	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 17	1990	300	6722					453	454		10.1136/bmj.300.6722.453	http://dx.doi.org/10.1136/bmj.300.6722.453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP166	2107903	Green Published, Bronze			2022-12-28	WOS:A1990CP16600028
J	WILKINSON, C; JONES, JM; MCBRIDE, J				WILKINSON, C; JONES, JM; MCBRIDE, J			ANXIETY CAUSED BY ABNORMAL RESULT OF CERVICAL SMEAR TEST - A CONTROLLED TRIAL	BRITISH MEDICAL JOURNAL			English	Article									UNIV COLL CARDIFF,DEPT GEN PRACTICE,CARDIFF CF3 7PN,WALES; ST DAVIDS HOSP,S GLAMORGAN HLTH AUTHOR,CERV CYTOL CLIN,CARDIFF CF1 9TZ,WALES; UNIV HOSP WALES,DEPT CLIN PSYCHOL,CARDIFF CF4 4XW,S GLAM,WALES	Cardiff University; Cardiff University									0	121	121	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 17	1990	300	6722					440	440		10.1136/bmj.300.6722.440	http://dx.doi.org/10.1136/bmj.300.6722.440			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CP166	2107898	Green Published, Bronze			2022-12-28	WOS:A1990CP16600023
J	CRISP, AH; MATTHEWS, BM; OAKEY, M; CRUTCHFIELD, M				CRISP, AH; MATTHEWS, BM; OAKEY, M; CRUTCHFIELD, M			SLEEPWALKING, NIGHT TERRORS, AND CONSCIOUSNESS	BRITISH MEDICAL JOURNAL			English	Article											CRISP, AH (corresponding author), ST GEORGE HOSP,SCH MED,ACAD DEPT PSYCHIAT,SLEEP DISORDERS CLIN & LAB,LONDON SW17 0RE,ENGLAND.							ANTHONY EJ, 1959, BRIT J MED PSYCHOL, V32, P19; BROUGHTON RJ, 1968, SCIENCE, V159, P1070, DOI 10.1126/science.159.3819.1070; Caine TM, 1967, MANUAL HOSTILITY DIR; CRISP AH, 1978, BRIT J MED PSYCHOL, V51, P293, DOI 10.1111/j.2044-8341.1978.tb02474.x; CRISP AH, 1978, BRIT J MED PSYCHOL, V51, P269, DOI 10.1111/j.2044-8341.1978.tb02472.x; Crown S, 1979, MANUAL CROWN CRISP E; DEMARACEINE M, 1897, SLEEP ITS PHYSL PATH; Dorland W. A. N., 1965, DORLANDS ILLUSTRATED; Eysenck H.J., 1975, MANUAL EYSENCK PERSO; FISHER C, 1973, J NERV MENT DIS, V157, P75, DOI 10.1097/00005053-197308000-00001; KALES A, 1966, ARCH GEN PSYCHIAT, V14, P586; OSWALD I, 1985, BRIT J PSYCHIAT, V147, P688, DOI 10.1192/bjp.147.6.688; PODOLSKY E, 1959, DIS NERV SYST, V20, P534; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Roffwarg H. P., 1979, SLEEP, V2, P1; SOURS JA, 1963, ARCH GEN PSYCHIAT, V9, P400; 1961, BRIT MED J, V1, P1616	17	36	36	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					360	362		10.1136/bmj.300.6721.360	http://dx.doi.org/10.1136/bmj.300.6721.360			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN799	2106985	Green Published, Bronze			2022-12-28	WOS:A1990CN79900018
J	WILSON, A				WILSON, A			CERVICAL CYTOLOGY IN THE VALE-OF-TRENT FACULTY OF THE ROYAL-COLLEGE-OF-GENERAL-PRACTITIONERS, 1985-8	BRITISH MEDICAL JOURNAL			English	Article											WILSON, A (corresponding author), UNIV NOTTINGHAM,QUEENS MED CTR,DEPT GEN PRACTICE,NOTTINGHAM NG7 2UH,ENGLAND.							ANDERSON CM, 1988, BRIT MED J, V297, P113, DOI 10.1136/bmj.297.6641.113; BUCKLEY EG, 1989, J ROY COLL GEN PRACT, V39, P309; FLEMING DM, 1985, BRIT MED J, V291, P869, DOI 10.1136/bmj.291.6499.869; GROL R, 1988, J ROY COLL GEN PRACT, V38, P10; HAVELOCK C, 1988, J ROY COLL GEN PRACT, V38, P207; HORDER J, 1986, J ROY COLL GEN PRACT, V36, P517; PIERCE M, 1989, BMJ-BRIT MED J, V299, P160, DOI 10.1136/bmj.299.6692.160; ROSS SK, 1989, BRIT MED J, V299, P101, DOI 10.1136/bmj.299.6691.101; SMITH A, 1989, BRIT MED J, V298, P1662, DOI 10.1136/bmj.298.6689.1662; WILSON AD, 1987, FAM PRACT, V4, P56, DOI 10.1093/fampra/4.1.56; 1989, GENERAL PRACTICE NAT; 1987, REPORT INTERCOLLEGIA; 1986, MORTALITY STATISTICS; 1987, FRONT LINE HLTH SERV	14	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					376	378		10.1136/bmj.300.6721.376	http://dx.doi.org/10.1136/bmj.300.6721.376			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106993	Green Published, Bronze			2022-12-28	WOS:A1990CN79900026
J	ELFORD, J; PHILLIPS, A; THOMSON, AG; SHAPER, AG				ELFORD, J; PHILLIPS, A; THOMSON, AG; SHAPER, AG			MIGRATION AND GEOGRAPHIC VARIATIONS IN BLOOD-PRESSURE IN BRITAIN	BRITISH MEDICAL JOURNAL			English	Article											ELFORD, J (corresponding author), ROYAL FREE HOSP,SCH MED,DEPT CLIN EPIDEMIOL & GEN PRACTICE,LONDON NW3 2PF,ENGLAND.							BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; BENTHAM G, 1988, SOC SCI MED, V26, P49, DOI 10.1016/0277-9536(88)90044-5; BRUCE NG, 1988, J HYPERTENS, V6, P375; BRUCE NG, IN PRESS J CLIN EPID; BULPITT CJ, 1985, EPIDEMIOLOGY HYPERTE; CASSEL J, 1975, EPIDEMIOLOGY CONTROL; ELFORD J, 1989, LANCET, V1, P343; FAGARD R, 1985, EPIDEMIOLOGY HYPERTE; HAENSZEL W, 1970, J CHRON DIS, V23, P289, DOI 10.1016/0021-9681(70)90013-5; KNIGHT I, 1984, HEIGHTS WEIGHTS ADUL; MARMOT MG, 1984, BRIT MED BULL, V40, P380, DOI 10.1093/oxfordjournals.bmb.a072008; PICKERING G, 1967, EPIDEMIOLOGY HYPERTE; POCOCK SJ, 1980, BRIT MED J, V280, P1243, DOI 10.1136/bmj.280.6226.1243; POCOCK SJ, 1987, LANCET, V2, P197; RONA RJ, 1981, BRIT MED BULL, V37, P265, DOI 10.1093/oxfordjournals.bmb.a071713; SHAPER AG, 1988, J HUM HYPERTENS, V2, P71; SHAPER AG, 1981, BRIT MED J, V283, P179, DOI 10.1136/bmj.283.6285.179; SHAPER AG, 1988, J HYPERTENS, V6, P367; WHINCUP PH, 1988, LANCET, V2, P890; 1986, 1985 REG GEN ANN REP; 1987, DH512 SER; 1985, SAS USERS GUIDE STAT	22	60	61	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 3	1990	300	6720					291	295		10.1136/bmj.300.6720.291	http://dx.doi.org/10.1136/bmj.300.6720.291			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM195	2106957	Green Published, Bronze			2022-12-28	WOS:A1990CM19500016
J	KINNEAR, WJM; TATTERSFIELD, AE				KINNEAR, WJM; TATTERSFIELD, AE			EMPHYSEMATOUS BULLAE	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											KINNEAR, WJM (corresponding author), CITY HOSP NOTTINGHAM, RESP MED UNIT, NOTTINGHAM NG5 1PD, ENGLAND.							Davies G M, 1966, Br J Dis Chest, V60, P120, DOI 10.1016/S0007-0971(66)80029-3; FITZGERALD MX, 1974, J THORAC CARDIOV SUR, V68, P566; GELB AF, 1973, AM REV RESPIR DIS, V107, P571, DOI 10.1164/arrd.1973.107.4.571; GUNSTENSEN J, 1973, J THORAC CARDIOV SUR, V65, P920; HEAD JR, 1949, J THORAC SURG, V18, P761; HUGHES JA, 1984, THORAX, V39, P140, DOI 10.1136/thx.39.2.140; ITING EY, 1963, AM REV RESPIR DIS, V87, P538, DOI 10.1164/arrd.1963.87.4.538; MORGAN MDL, 1984, BRIT J DIS CHEST, V78, P10, DOI 10.1016/0007-0971(84)90093-7; MORGAN MDL, 1989, THORAX, V44, P533, DOI 10.1136/thx.44.7.533; MORGAN MDL, 1986, THORAX, V41, P855, DOI 10.1136/thx.41.11.855; PEARSON MG, 1983, THORAX, V38, P134, DOI 10.1136/thx.38.2.134; POTGIETER PD, 1981, THORAX, V36, P885, DOI 10.1136/thx.36.12.885; PRIDE NB, 1973, AM REV RESPIR DIS, V107, P83; REID L, 1967, PATHOLOGY EMPHYSEMA; SHAMJI FM, 1988, SURG CLIN N AM, V68, P581; WOOMING M, 1963, BRIT J DIS CHEST, V57, P79, DOI 10.1016/S0007-0971(63)80018-2; 1983, LANCET, V1, P1369	17	15	15	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	1990	300	6719					208	209		10.1136/bmj.300.6719.208	http://dx.doi.org/10.1136/bmj.300.6719.208			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL024	2106925	Green Published, Bronze			2022-12-28	WOS:A1990CL02400002
J	MARSDEN, CD; QUINN, NP				MARSDEN, CD; QUINN, NP			THE DYSTONIAS - NEUROLOGICAL DISORDERS AFFECTING 20000 PEOPLE IN BRITAIN	BRITISH MEDICAL JOURNAL			English	Review											MARSDEN, CD (corresponding author), NATL HOSP,INST NEUROL,LONDON WC1N 3BG,ENGLAND.							BERARDELLI A, 1985, BRAIN, V108, P593, DOI 10.1093/brain/108.3.593; Bressman S B, 1988, Adv Neurol, V50, P45; COHEN LG, 1989, J NEUROL NEUROSUR PS, V52, P355, DOI 10.1136/jnnp.52.3.355; FAHN S, 1987, MOVEMENT DISORD, V2, P332; FLETCHER NA, IN PRESS BRAIN; GRANDAS F, 1988, J NEUROL NEUROSUR PS, V51, P767, DOI 10.1136/jnnp.51.6.767; Herz E, 1944, ARCH NEURO PSYCHIATR, V51, P305, DOI 10.1001/archneurpsyc.1944.02290280003001; HORNYKIEWICZ O, 1986, NEW ENGL J MED, V315, P347, DOI 10.1056/NEJM198608073150602; LANCE JW, 1977, ANN NEUROL, V2, P285, DOI 10.1002/ana.410020405; LUDLOW CL, 1988, NEUROLOGY, V38, P1220, DOI 10.1212/WNL.38.8.1220; Marsden C D, 1988, Adv Neurol, V50, P35; MARSDEN CD, 1985, BRAIN, V108, P463, DOI 10.1093/brain/108.2.463; NAKASHIMA K, 1989, NEUROLOGY, V39, P1354, DOI 10.1212/WNL.39.10.1354; NAKASHIMA K, 1989, BRAIN, V112, P681, DOI 10.1093/brain/112.3.681; NOBREGA FT, 1967, PROGR NEUROGENETICS, P474; NUTT JG, 1988, MOVEMENT DISORD, V3, P188, DOI 10.1002/mds.870030302; Nygaard T G, 1988, Adv Neurol, V50, P377; Oppenheim H., 1911, NEUROL CENTRALBL, V30, P1090; OZELIUS L, 1989, NEURON, V2, P1427, DOI 10.1016/0896-6273(89)90188-8; PERCY AK, 1971, ARCH NEUROL-CHICAGO, V25, P105, DOI 10.1001/archneur.1971.00490020023002; Quinn N P, 1988, Adv Neurol, V50, P391; STELL R, 1988, J NEUROL NEUROSUR PS, V51, P920, DOI 10.1136/jnnp.51.7.920; ZILBER N, 1984, J MED GENET, V21, P13, DOI 10.1136/jmg.21.1.13; ZWEIG RM, 1988, NEUROLOGY, V38, P702, DOI 10.1212/WNL.38.5.702	24	110	111	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					139	144		10.1136/bmj.300.6718.139	http://dx.doi.org/10.1136/bmj.300.6718.139			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105790	Bronze, Green Published			2022-12-28	WOS:A1990CK07700005
J	LOCALIO, AR; LAWTHERS, AG; BRENNAN, TA; LAIRD, NM; HEBERT, LE; PETERSON, LM; NEWHOUSE, JP; WEILER, PC; HIATT, HH				LOCALIO, AR; LAWTHERS, AG; BRENNAN, TA; LAIRD, NM; HEBERT, LE; PETERSON, LM; NEWHOUSE, JP; WEILER, PC; HIATT, HH			RELATION BETWEEN MALPRACTICE CLAIMS AND ADVERSE EVENTS DUE TO NEGLIGENCE - RESULTS OF THE HARVARD MEDICAL-PRACTICE STUDY-III	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY; CARE	Background and Methods. By matching the medical records of a random sample of 31,429 patients hospitalized in New York State in 1984 with statewide data on medical-malpractice claims, we identified patients who had filed claims against physicians and hospitals. These results were then compared with our findings, based on a review of the same medical records, regarding the incidence of injuries to patients caused by medical management (adverse events). Results. We identified 47 malpractice claims among 30,195 patients' records located on our initial visits to the hospitals, and 4 claims among 580 additional records located during follow-up visits. The overall rate of claims per discharge (weighted) was 0.13 percent (95 percent confidence interval, 0.076 to 0.18 percent). Of the 280 patients who had adverse events caused by medical negligence as defined by the study protocol, 8 filed malpractice claims (weighted rate, 1.53 percent; 95 percent confidence interval, 0 to 3.2 percent). By contrast, our estimate of the statewide ratio of adverse events caused by negligence (27,179) to malpractice claims (3570) is 7.6 to 1. This relative frequency overstates the chances that a negligent adverse event will produce a claim, however, because most of the events for which claims were made in the sample did not meet our definition of adverse events due to negligence. Conclusions. Medical-malpractice litigation infrequently compensates patients injured by medical negligence and rarely identifies, and holds providers accountable for, substandard care.	HARVARD UNIV,SCH PUBL HLTH,DEPT HLTH POLICY & MANAGEMENT,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT SOCIAL MED,DIV MED ETH,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT HLTH CARE POLICY,BOSTON,MA 02115; HARVARD UNIV,JOHN F KENNEDY SCH GOVT,CAMBRIDGE,MA 02138; HARVARD UNIV,SCH LAW,CAMBRIDGE,MA 02138	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University	LOCALIO, AR (corresponding author), PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,CTR BIOSTAT & EPIDEMIOL,POB 850,HERSHEY,PA 17033, USA.		Newhouse, Joseph/AGJ-5632-2022					ABEL, 1987, OHIO ST LJ, V48, P443; BELL PA, 1984, SYRACUSE LAW REV, V35, P939; BENNETT WI, 1988, NY TIMES MAGAZI 0724, P31; BOVBJERG RR, 1986, LAW CONTEMP PROBL, V49, P321, DOI 10.2307/1191431; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; BROOK, 1975, DUKE LAW J, P1197; DANZON PM, 1985, MED MALPRACTICE THEO; DOHERTY EG, 1977, JAMA-J AM MED ASSOC, V238, P1656, DOI 10.1001/jama.238.15.1656; GAUMER GL, 1984, MILBANK FUND Q, V62, P380, DOI 10.2307/3349858; GUSTAFSON DH, 1973, ORGAN BEHAV HUM PERF, V9, P280, DOI 10.1016/0030-5073(73)90052-4; KUSSEROW RP, 1987, JAMA-J AM MED ASSOC, V257, P820; LEWIS R, 1985, AM MED NEWS, V1, P25; MEYERS AR, 1987, AM J PUBLIC HEALTH, V77, P1544, DOI 10.2105/AJPH.77.12.1544; Miller F H, 1986, Am J Law Med, V11, P433; NEWCOMBE HB, 1959, SCIENCE, V130, P954, DOI 10.1126/science.130.3381.954; RUBENSTEIN LV, 1990, JAMA-J AM MED ASSOC, V264, P1974, DOI 10.1001/jama.264.15.1974; SHAH BV, 1981, SESUDAAN STANDARD ER; SLOAN FA, 1989, JAMA-J AM MED ASSOC, V262, P3291, DOI 10.1001/jama.262.23.3291; 1988, SUDOC Y3T2222M4612; 1977, GAOHRD8755 GEN ACC O; 1988, 14 INS DEP CIRC LETT; 1980, 5 DEP COMM STAT POL, P12; 1977, REPORT MED INSURANCE; 1990, PATIENTS DOCTORS LAW	24	536	541	0	17	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	1991	325	4					245	251		10.1056/NEJM199107253250405	http://dx.doi.org/10.1056/NEJM199107253250405			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FX627	2057025				2022-12-28	WOS:A1991FX62700005
J	ILE, ML				ILE, ML			SHOULD PHYSICIANS TREAT PATIENTS WHO SEEK 2ND OPINIONS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											ILE, ML (corresponding author), AMER MED ASSOC,DIV HLTH LAW LITIGAT & POLICY,515 N STATE ST,CHICAGO,IL 60610, USA.							1989, CURRENT OPINIONS COU	1	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1991	266	2					273	274		10.1001/jama.266.2.273	http://dx.doi.org/10.1001/jama.266.2.273			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU896	2056631				2022-12-28	WOS:A1991FU89600042
J	ADAMS, MD; KELLEY, JM; GOCAYNE, JD; DUBNICK, M; POLYMEROPOULOS, MH; XIAO, H; MERRIL, CR; WU, A; OLDE, B; MORENO, RF; KERLAVAGE, AR; MCCOMBIE, WR; VENTER, JC				ADAMS, MD; KELLEY, JM; GOCAYNE, JD; DUBNICK, M; POLYMEROPOULOS, MH; XIAO, H; MERRIL, CR; WU, A; OLDE, B; MORENO, RF; KERLAVAGE, AR; MCCOMBIE, WR; VENTER, JC			COMPLEMENTARY-DNA SEQUENCING - EXPRESSED SEQUENCE TAGS AND HUMAN GENOME PROJECT	SCIENCE			English	Article								Automated partial DNA sequencing was conducted on more than 600 randomly selected human brain complementary DNA (cDNA) clones to generate expressed sequence tags (ESTs). ESTs have applications in the discovery of new human genes, mapping of the human genome, and identification of coding regions in genomic sequences. Of the sequences generated, 337 represent new genes, including 48 with significant similarity to genes from other organisms, such as a yeast RNA polymerase II subunit; Drosophila kinesin, Notch, and Enhancer of split; and a murine tyrosine kinase receptor. Forty-six ESTs were mapped to chromosomes after amplification by the polymerase chain reaction. This fast approach to cDNA characterization will facilitate the tagging of most human genes in a few years at a fraction of the cost of complete genomic sequencing, provide new genetic markers, and serve as a resource in diverse biological research fields.	NINCDS, RECEPTOR BIOCHEM & MOLEC BIOL SECT, BETHESDA, MD 20892 USA; ST ELIZABETH HOSP, NIMH, CTR NEUROSCI, BIOCHEM GENET LAB, WASHINGTON, DC 20032 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)			Martinez, Octavio/B-7375-2009	McCombie, W. Richard/0000-0003-1899-0682				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BALTIMORE D, 1988, REPORT AD HOC PROGRA; BANERJEE U, 1990, NEURON, V4, P177, DOI 10.1016/0896-6273(90)90093-U; BRENNER S, 1990, CIBA F SYMP, V149, P6; CAMPOSORTEGA JA, 1988, TRENDS NEUROSCI, V11, P400, DOI 10.1016/0166-2236(88)90077-X; CATHCART R, 1990, NATURE, V347, P310, DOI 10.1038/347310a0; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUGUID JR, 1990, NUCLEIC ACIDS RES, V18, P2789, DOI 10.1093/nar/18.9.2789; FARGNOLI J, 1990, ANAL BIOCHEM, V187, P364, DOI 10.1016/0003-2697(90)90471-K; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; FUCHS R, 1991, COMPUT APPL BIOSCI, V7, P105; HARTLEY DA, 1988, CELL, V55, P785, DOI 10.1016/0092-8674(88)90134-1; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; KATO K, 1990, EUR J NEUROSCI, V2, P704, DOI 10.1111/j.1460-9568.1990.tb00460.x; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; KOCH MSH, 1990, NUCLEIC ACIDS RES, V18, P5705; McKusick VA., ONLINE MENDELIAN INH; NISHI S, 1988, BIOCHEM BIOPH RES CO, V157, P937, DOI 10.1016/S0006-291X(88)80964-1; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; PALAZZOLO MJ, 1989, NEURON, V3, P527, DOI 10.1016/0896-6273(89)90211-0; PATANJALI SR, 1991, P NATL ACAD SCI USA, V88, P1943, DOI 10.1073/pnas.88.5.1943; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PUTNEY SD, 1983, NATURE, V302, P718, DOI 10.1038/302718a0; SCHMID DW, 1987, J NEUROCHEM, V48, P307, DOI 10.1111/j.1471-4159.1987.tb13163.x; Schwarz R, 1979, ATLAS PROTEIN SEQUEN, P353, DOI DOI 10.2307/2408678; SCHWEINFEST CW, 1990, GENET ANAL-BIOMOL E, V7, P64, DOI 10.1016/0735-0651(90)90042-E; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SIVE HL, 1988, NUCLEIC ACIDS RES, V16, P10937, DOI 10.1093/nar/16.22.10937; SUTCLIFFE JG, 1988, ANNU REV NEUROSCI, V11, P157, DOI 10.1146/annurev.ne.11.030188.001105; TRAVIS GH, 1988, P NATL ACAD SCI USA, V85, P1696, DOI 10.1073/pnas.85.5.1696; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; WAGSTAFF J, IN PRESS AM J HUM GE; 1991, HUM GENOME NEWS, V2, P1; 1988, REPORT COMMITTEE MAP	34	1738	2119	6	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	1991	252	5013					1651	1656		10.1126/science.2047873	http://dx.doi.org/10.1126/science.2047873			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT114	2047873				2022-12-28	WOS:A1991FT11400035
J	CREEL, SR; MONFORT, SL; WILDT, DE; WASER, PM				CREEL, SR; MONFORT, SL; WILDT, DE; WASER, PM			SPONTANEOUS LACTATION IS AN ADAPTIVE RESULT OF PSEUDOPREGNANCY	NATURE			English	Article							DWARF MONGOOSE; ESTROUS-CYCLE; PROGESTERONE; PREGNANCY; REPRODUCTION; ESTRADIOL; INFANTS; DOG	LACTATION is almost exclusively associated with pregnancy and giving birth. Although lactation can be induced without a preceding pregnancy in some species, this requires exogenous hormones, artificially intense or extended suckling or both 1, 2. Spontaneous lactation, lactation by females that have neither been pregnant nor experimentally manipulated, is extremely unusual among eutherians 3-8. Among nondomesticated animals, spontaneous lactation has been observed repeatedly only in the dwarf mongoose Helogale parvula 9. We report here spontaneous lactation by free-living dwarf mongooses using data on urinary oestrogen conjugate concentrations (n = 560, 65 females) and body weight (n = 3,096, 25 females) from a population in Serengeti National Park, Tanzania. We use demographic data from this population to demonstrate that spontaneous lactation, and thus the endocrine phenomena that induce it, increase the evolutionary fitness of lactating females.	SMITHSONIAN INST,NATL ZOOL PK,CTR CONSERVAT & RES,ENDOCRINE RES LAB,FRONT ROYAL,VA 22630	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	CREEL, SR (corresponding author), PURDUE UNIV,DEPT BIOL SCI,W LAFAYETTE,IN 47907, USA.							Brown J.L., 1981, P244; BROWN RE, 1977, PEDIATRICS, V60, P116; CONCANNON PW, 1977, BIOL REPROD, V16, P517; COWIE AT, 1984, HORMONAL CONTROL REP, P195; CREEL S, IN PRESS BEHAV ECOL; CREEL SR, IN PRESS ANIM BEHAV; CREEL SR, IN PRESS BEHAVL ECOL; DALY M, 1979, J THEOR BIOL, V78, P325, DOI 10.1016/0022-5193(79)90334-5; HADLEY JC, 1975, J REPROD FERTIL, V44, P453, DOI 10.1530/jrf.0.0440453; HOLMAN SD, 1980, HORM BEHAV, V14, P348, DOI 10.1016/0018-506X(80)90024-0; JAKUBOWSKI M, 1980, J REPROD FERTIL, V58, P55, DOI 10.1530/jrf.0.0580055; NALBANDOV AV, 1976, REPRODUCTIVE PHYSL B; PEREIRA ME, 1989, AM J PRIMATOL, V18, P101, DOI 10.1002/ajp.1350180204; RAPAPORT L, 1987, J MAMMAL, V68, P438, DOI 10.2307/1381494; RASA OAE, 1987, ADV STUD BEHAV, V17, P121, DOI 10.1016/S0065-3454(08)60178-3; RASA OAE, 1977, Z TIERPSYCHOL, V43, P337; ROOD JP, 1978, Z TIERPSYCHOL, V48, P277; ROOD JP, 1990, ANIM BEHAV, V39, P566, DOI 10.1016/S0003-3472(05)80423-3; ROOD JP, 1980, ANIM BEHAV, V28, P143, DOI 10.1016/S0003-3472(80)80019-4; ROOD JP, 1983, ADV STUDY MAMMALIAN, P454; SEAL US, 1979, BIOL REPROD, V21, P1057, DOI 10.1095/biolreprod21.5.1057; SMITH MS, 1974, ENDOCRINOLOGY, V94, P404, DOI 10.1210/endo-94-2-404; VERHAGE HG, 1976, BIOL REPROD, V14, P579, DOI 10.1095/biolreprod14.5.579; West Eberhard M.J., 1975, Quarterly Review of Biology, V50, P1	24	71	72	0	23	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 20	1991	351	6328					660	662		10.1038/351660a0	http://dx.doi.org/10.1038/351660a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT112	2052092				2022-12-28	WOS:A1991FT11200069
J	SWINNEN, LJ; COSTANZONORDIN, MR; FISHER, SG; OSULLIVAN, EJ; JOHNSON, MR; HEROUX, AL; DIZIKES, GJ; PIFARRE, R; FISHER, RI				SWINNEN, LJ; COSTANZONORDIN, MR; FISHER, SG; OSULLIVAN, EJ; JOHNSON, MR; HEROUX, AL; DIZIKES, GJ; PIFARRE, R; FISHER, RI			INCREASED INCIDENCE OF LYMPHOPROLIFERATIVE DISORDER AFTER IMMUNOSUPPRESSION WITH THE MONOCLONAL-ANTIBODY OKT3 IN CARDIAC-TRANSPLANT RECIPIENTS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									LOYOLA UNIV,DEPT MED,CARDIOL SECT,MAYWOOD,IL 60153; LOYOLA UNIV,DEPT PATHOL,MAYWOOD,IL 60153; LOYOLA UNIV,DEPT THORAC & CARDIOVASC SURG,MAYWOOD,IL 60153; VET AFFAIRS HOSP,COOPERAT STUDIES PROGRAM,HINES,IL	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	SWINNEN, LJ (corresponding author), LOYOLA UNIV,MED CTR,HEMATOL ONCOL SECT,BLDG 54,2160 S 1ST AVE,MAYWOOD,IL 60153, USA.							[Anonymous], 1982, CANCER, V49, P2112; ARMITAGE J M, 1990, Journal of Heart Transplantation, V9, P60; ARNOLD A, 1983, NEW ENGL J MED, V309, P1593, DOI 10.1056/NEJM198312293092601; BARR ML, IN PRESS CIRCULATION; BEVERIDGE T, 1984, LANCET, V1, P788, DOI 10.1016/S0140-6736(84)91293-5; BILLINGHAM ME, 1979, HUM PATHOL, V10, P367, DOI 10.1016/S0046-8177(79)80043-X; CLEARY ML, 1984, NEW ENGL J MED, V310, P477, DOI 10.1056/NEJM198402233100801; CLEARY ML, 1984, P NATL ACAD SCI-BIOL, V81, P593, DOI 10.1073/pnas.81.2.593; DOMENICO DR, 1989, AM J CLIN PATHOL, V91, P709, DOI 10.1093/ajcp/91.6.709; FRIZZERA G, 1981, CANCER RES, V41, P4262; HANTO DW, 1989, TRANSPLANTATION, V47, P458, DOI 10.1097/00007890-198903000-00012; HANTO DW, 1982, NEW ENGL J MED, V306, P913, DOI 10.1056/NEJM198204153061506; HANTO DW, 1985, TRANSPLANTATION, V39, P461, DOI 10.1097/00007890-198505000-00001; HO M, 1985, J INFECT DIS, V152, P876, DOI 10.1093/infdis/152.5.876; HO M, 1988, TRANSPLANTATION, V45, P719, DOI 10.1097/00007890-198804000-00011; JONCAS JH, 1990, J CLIN ONCOL, V8, P378, DOI 10.1200/JCO.1990.8.3.378; NALESNIK MA, 1988, AM J PATHOL, V133, P173; NALESNIK MA, 1988, CURR PROB SURG, V25, P371; OCONNELL JB, 1989, TRANSPLANT P, V21, P31; PENN I, 1983, TRANSPLANT P, V15, P2790; PURTILO DT, 1980, LANCET, V1, P300; RANDHAWA PS, 1989, AM J CLIN PATHOL, V92, P177, DOI 10.1093/ajcp/92.2.177; STARZL TE, 1984, LANCET, V1, P583; WEINTRAUB J, 1982, TRANSPLANTATION, V33, P347, DOI 10.1097/00007890-198204000-00002; WITHERSPOON RP, 1989, NEW ENGL J MED, V321, P784, DOI 10.1056/NEJM198909213211203; YOUNG L, 1989, NEW ENGL J MED, V321, P1080, DOI 10.1056/NEJM198910193211604; ZIEGLER JL, 1984, NEW ENGL J MED, V311, P565, DOI 10.1056/NEJM198408303110904; 1990, J HEART TRANSPLANT, V9, P61	29	794	801	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 20	1990	323	25					1723	1728		10.1056/NEJM199012203232502	http://dx.doi.org/10.1056/NEJM199012203232502			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN375	2100991				2022-12-28	WOS:A1990EN37500002
J	STEERE, AC; DWYER, E; WINCHESTER, R				STEERE, AC; DWYER, E; WINCHESTER, R			ASSOCIATION OF CHRONIC LYME ARTHRITIS WITH HLA-DR4 AND HLA-DR2 ALLELES	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									HOSP JOINT DIS & MED CTR, NEW YORK, NY 10003 USA; NYU MED CTR, DEPT MED, DIV RHEUMATOL, NEW YORK, NY 10016 USA	NYU Langone Medical Center; Hospital for Joint Disease NYULMC; New York University	STEERE, AC (corresponding author), TUFTS UNIV, NEW ENGLAND MED CTR,SCH MED,DIV RHEUMATOL IMMUNOL, NEMC 406, 750 WASHINGTON ST, BOSTON, MA 02111 USA.			Steere, Allen/0000-0002-5268-9853	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM020358] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019411, R37AI019411] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00125] Funding Source: Medline; NIADDK NIH HHS [AM-20358] Funding Source: Medline; NIAID NIH HHS [AI-19411] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACKERMANN R, 1988, ANN NY ACAD SCI, V539, P16, DOI 10.1111/j.1749-6632.1988.tb31834.x; BERARDI VP, 1988, J INFECT DIS, V158, P754, DOI 10.1093/infdis/158.4.754; CRAFT JE, 1984, J INFECT DIS, V149, P789, DOI 10.1093/infdis/149.5.789; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; GREGERSEN PK, 1986, P NATL ACAD SCI USA, V83, P2642, DOI 10.1073/pnas.83.8.2642; JOHNSTON YE, 1985, AM J PATHOL, V118, P26; KRISTOFERISTSCH W, 1986, LANCET, V2, P278; LAWSON JP, 1985, RADIOLOGY, V154, P37, DOI 10.1148/radiology.154.1.3964949; LIU N Y, 1989, Arthritis and Rheumatism, V32, pS46; MAJSKY A, 1987, TISSUE ANTIGENS, V30, P188, DOI 10.1111/j.1399-0039.1987.tb01619.x; MATSUYAMA T, 1988, J IMMUNOL, V140, P537; MERRYMAN PF, 1989, ARTHRITIS RHEUM, V32, P251, DOI 10.1002/anr.1780320304; NUNEZROLDAN A, 1982, J EXP MED, V156, P1872, DOI 10.1084/jem.156.6.1872; PFLUGER KH, 1988, ANN NY ACAD SCI, V539, P414, DOI 10.1111/j.1749-6632.1988.tb31889.x; STEERE AC, 1985, NEW ENGL J MED, V312, P869, DOI 10.1056/NEJM198504043121401; STEERE AC, 1979, ANN INTERN MED, V90, P896, DOI 10.7326/0003-4819-90-6-896; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; STEERE AC, 1988, ARTHRITIS RHEUM, V31, P487, DOI 10.1002/art.1780310405; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; Tiwari JL, 1985, HLA DIS ASS, P152; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; VANDOORN PA, 1987, JUN C LYM BORR UPD E; WEYAND CM, 1989, ARTHRITIS RHEUM, V32, P1057, DOI 10.1002/anr.1780320902; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; WINCHESTER RJ, 1988, SPRINGER SEMIN IMMUN, V10, P119, DOI 10.1007/BF01857219	25	303	307	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	1990	323	4					219	223		10.1056/NEJM199007263230402	http://dx.doi.org/10.1056/NEJM199007263230402			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP597	2078208				2022-12-28	WOS:A1990DP59700002
J	SPRUNG, CL				SPRUNG, CL			CHANGING ATTITUDES AND PRACTICES IN FORGOING LIFE-SUSTAINING TREATMENTS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									HEBREW UNIV JERUSALEM, JERUSALEM, ISRAEL; VET ADM MED CTR, DEPT MED, CRIT CARE MED SECT, MIAMI, FL 33125 USA; UNIV MIAMI, SCH MED, MIAMI, FL 33152 USA	Hebrew University of Jerusalem; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Miami	SPRUNG, CL (corresponding author), HADASSAH UNIV HOSP, DEPT ANESTHESIOL, POB 12000, IL-91120 JERUSALEM, ISRAEL.							ALEXANDER L, 1949, NEW ENGL J MED, V241, P39, DOI 10.1056/NEJM194907142410201; [Anonymous], 1957, ANESTHESIOLOGY, V18, P904; [Anonymous], 1968, JAMA, V205, P337; BEECHER HK, 1966, NEW ENGL J MED, V274, P1354, DOI 10.1056/NEJM196606162742405; Brandt A M, 1986, Law Med Health Care, V14, P231, DOI 10.1111/j.1748-720X.1986.tb00990.x; CALLAHAN D, 1987, HASTINGS CENT REP, V17, P21, DOI 10.2307/3562666; DEWACHTER MAM, 1989, JAMA-J AM MED ASSOC, V262, P3316, DOI 10.1001/jama.262.23.3316; ENGSTROM CG, 1954, BRIT MED J, V2, P666, DOI 10.1136/bmj.2.4889.666; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; Lifton R. J., 1986, NAZI DOCTORS MED KIL; MICETICH KC, 1983, ARCH INTERN MED, V143, P975, DOI 10.1001/archinte.143.5.975; RACHELS J, 1975, NEW ENGL J MED, V292, P78, DOI 10.1056/NEJM197501092920206; SCHAFFNER KF, 1988, CRIT CARE MED, V16, P1069, DOI 10.1097/00003246-198810000-00022; SKEEL JD, 1988, J CRIT CARE, V3, P195, DOI 10.1016/0883-9441(88)90091-3; Starr P, 1982, SOCIAL TRANSFORMATIO, P420; WANZER SH, 1989, NEW ENGL J MED, V320, P844, DOI 10.1056/NEJM198903303201306; ZOLL P, 1956, NEW ENGL J MED, P254; 1986, CAL RPTR, V225, P297; 1983, REPORT ETHICAL MED L; 1989, JAMA-J AM MED ASSOC, V259, P272; 1981, REPORT MED LEGAL ETH; 1989, CRIT CARE MED, V17, pS89; 1986, CURRENT OPINIONS COU; 1983, CAL RPTR, V195, P484; 1988, 1988 ROPER POLL ATTI	25	76	78	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	1990	263	16					2211	2215		10.1001/jama.263.16.2211	http://dx.doi.org/10.1001/jama.263.16.2211			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ676	2104033				2022-12-28	WOS:A1990CZ67600037
J	FAIRBURN, CG				FAIRBURN, CG			BULIMIA-NERVOSA - ANTIDEPRESSANT OR COGNITIVE THERAPY IS EFFECTIVE	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											FAIRBURN, CG (corresponding author), UNIV OXFORD, WARNEFORD HOSP, DEPT PSYCHIAT, OXFORD OX3 7JX, ENGLAND.		Fairburn, Christopher/AAG-6234-2019; Fairburn, Christopher/AAM-9792-2020	Fairburn, Christopher/0000-0002-9673-9795				ABRAHAM SF, 1982, PSYCHOL MED, V12, P625, DOI 10.1017/S0033291700055732; AGRAS W S, 1987, Annals of Behavioral Medicine, V9, P18; BURKE RC, 1986, J OTOLARYNGOL, V15, P49; COOPER Z, 1989, BRIT J PSYCHIAT, V154, P807, DOI 10.1192/bjp.154.6.807; COOPER Z, 1987, INT J EAT DISORDER, V6, P1, DOI 10.1002/1098-108X(198701)6:1<1::AID-EAT2260060102>3.0.CO;2-9; DREWNOWSKI A, 1988, AM J PSYCHIAT, V145, P753; FAIRBURN C, 1981, PSYCHOL MED, V11, P707, DOI 10.1017/S0033291700041209; FAIRBURN CG, 1986, BEHAV RES THER, V24, P629, DOI 10.1016/0005-7967(86)90058-6; FAIRBURN CG, 1986, INT J EAT DISORDER, V5, P403, DOI 10.1002/1098-108X(198603)5:3<403::AID-EAT2260050302>3.0.CO;2-Z; FAIRBURN CG, 1988, J PSYCHOSOM RES, V32, P635, DOI 10.1016/0022-3999(88)90012-8; FAIRBURN CG, IN PRESS AM J PSYCHI; FREEMAN CPL, 1988, J PSYCHOSOM RES, V32, P647, DOI 10.1016/0022-3999(88)90013-X; GARNER DM, 1982, COGNITIVE THER RES, V6, P123, DOI 10.1007/BF01183887; GARNER DM, 1985, HDB PSYCHOTHERAPY AN, P107; GWIRTSMAN HE, 1989, J CLIN PSYCHIAT, V50, P196; HUGHES PL, 1986, ARCH GEN PSYCHIAT, V43, P182; JOHNSONSABINE E, 1988, PSYCHOL MED, V18, P615, DOI 10.1017/S0033291700008291; KING MB, 1989, PSYCHOL MED, P1, DOI 10.1017/S0264180100000515; KING MB, 1986, BRIT MED J, V293, P1411; LACEY JH, 1986, BRIT J ADDICT, V81, P641; LEVIN PA, 1980, ANN INTERN MED, V93, P827, DOI 10.7326/0003-4819-93-6-827; LEVY AB, 1989, AM J PSYCHIAT, V146, P162; MITCHELL J, 1989, INT J EAT DISORDER, V8, P167, DOI 10.1002/1098-108X(198903)8:2<167::AID-EAT2260080205>3.0.CO;2-X; MITCHELL JE, 1983, PSYCHOL MED, V13, P273, DOI 10.1017/S0033291700050881; MITCHELL JE, 1985, AM J PSYCHIAT, V142, P482; MITCHELL JE, IN PRESS ARCH GEN PS; POPE HG, 1985, J CLIN PSYCHOPHARM, V5, P320, DOI 10.1097/00004714-198505060-00003; POPE HG, 1987, J CLIN PSYCHIAT, V48, P181; POPE HG, 1984, NEW HOPE BINGE EATER; ROSSITER EM, 1988, INT J EAT DISORDER, V7, P779, DOI 10.1002/1098-108X(198811)7:6<779::AID-EAT2260070607>3.0.CO;2-4; RUSSELL G, 1979, PSYCHOL MED, V9, P429, DOI 10.1017/S0033291700031974; RUSSELL GFM, 1988, DIAGNOSTIC ISSUES AN, P3; SCHOTTE DE, 1987, JAMA-J AM MED ASSOC, V258, P1213, DOI 10.1001/jama.258.9.1213; SIMMONS MS, 1986, AM J PSYCHIAT, V143, P783; STRIEGELMOORE RH, 1989, INT J EAT DISORDER, V8, P499, DOI 10.1002/1098-108X(198909)8:5&lt;499::AID-EAT2260080502&gt;3.0.CO;2-A; STROBER M, 1987, INT J EAT DISORDER, V6, P171, DOI 10.1002/1098-108X(198703)6:2<171::AID-EAT2260060202>3.0.CO;2-I; TURNBULL J, 1989, INT J EAT DISORDER, V8, P399, DOI 10.1002/1098-108X(198907)8:4&lt;399::AID-EAT2260080403&gt;3.0.CO;2-E; WALSH BT, 1988, ARCH GEN PSYCHIAT, V45, P471; WILSON G T, 1987, Annals of Behavioral Medicine, V9, P12, DOI 10.1207/s15324796abm0904_3; WILSON GT, 1986, BEHAV RES THER, V24, P277, DOI 10.1016/0005-7967(86)90187-7; 1987, DIAGNOSTIC STATISTIC	41	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	1990	300	6723					485	487		10.1136/bmj.300.6723.485	http://dx.doi.org/10.1136/bmj.300.6723.485			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107923	Bronze, Green Published			2022-12-28	WOS:A1990CQ87800004
J	BAKER, R				BAKER, R			PROBLEM-SOLVING WITH AUDIT IN GENERAL-PRACTICE	BRITISH MEDICAL JOURNAL			English	Article									UNIV BRISTOL,DEPT EPIDEMIOL & COMMUNITY MED,GEN PRACTICE UNIT,BRISTOL BS8 2PR,ENGLAND	University of Bristol								Crombie D, 1988, 41 ROYAL COLL GEN PR; MORRELL DC, 1988, EPIDEMIOLOGY GENERAL; 1989, CMND555	3	8	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					378	380		10.1136/bmj.300.6721.378	http://dx.doi.org/10.1136/bmj.300.6721.378			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106994	Bronze, Green Published			2022-12-28	WOS:A1990CN79900027
J	CLAYTONSMITH, J; FARNDON, PA; MCKEOWN, C; DONNAI, D				CLAYTONSMITH, J; FARNDON, PA; MCKEOWN, C; DONNAI, D			EXAMINATION OF FETUSES AFTER INDUCED-ABORTION FOR FETAL-ABNORMALITY	BRITISH MEDICAL JOURNAL			English	Article									ST MARYS HOSP,REG GENET CTR,MANCHESTER M13 0JH,LANCS,ENGLAND	University of Manchester								Bieber F R, 1979, Birth Defects Orig Artic Ser, V15, P51; CAREY JC, 1978, BIRTH DEFECTS B, V156, P253; DONNAI D, 1987, BAILLIERE CLIN OB GY, V1, P737, DOI 10.1016/S0950-3552(87)80014-7; JONES KL, 1988, SMITHS RECOGNIZABLE, P210; KELLING JW, 1987, FETAL NEONATAL PATHO, P3; MANCHESTER DK, 1988, PRENATAL DIAG, V8, P109, DOI 10.1002/pd.1970080205; MECKE S, 1971, ANN GENET-PARIS, V14, P97; SALONEN R, 1981, CLIN GENET, V19, P321; WINTER RM, 1988, MALFORMED FETUS STIL, P40	9	45	45	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 3	1990	300	6720					295	297		10.1136/bmj.300.6720.295	http://dx.doi.org/10.1136/bmj.300.6720.295			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM195	2106958	Green Published, Bronze			2022-12-28	WOS:A1990CM19500017
J	REYNOLDS, EH				REYNOLDS, EH			VIGABATRIN	BRITISH MEDICAL JOURNAL			English	Editorial Material											REYNOLDS, EH (corresponding author), MAUDSLEY & KINGS COLL HOSP,LONDON SE5 9RS,ENGLAND.							BENMENACHEM E, IN PRESS EPILEPSY RE; BROWNE TR, 1989, BR J CLIN PHARM S1, V27, P95; BUTLER WH, 1987, TOXICOL PATHOL, V15, P143, DOI 10.1177/019262338701500203; COSI V, 1989, BR J CLIN PHARM S1, V27, P61; GRAHAM DG, 1989, BR J CLIN PHARM S, V27, P43; GRAM L, 1985, ANN NEUROL, V17, P262, DOI 10.1002/ana.410170307; GRAM L, 1983, ACTA NEUROL SCAND, V68, P34, DOI 10.1111/j.1600-0404.1983.tb04812.x; IADAROLA MJ, 1981, MOL CELL BIOCHEM, V39, P305, DOI 10.1007/BF00232582; JUNG MJ, 1977, J NEUROCHEM, V29, P797, DOI 10.1111/j.1471-4159.1977.tb10721.x; LIEGEOISCHAUVEL C, 1989, BR J CLIN PHARM S1, V27, P69; LIVINGSTON JH, 1989, BR J CLIN PHARM S1, V27, P109; LOISEAU P, 1986, EPILEPSIA, V27, P115, DOI 10.1111/j.1528-1157.1986.tb03512.x; MELDRUM B, 1984, EPILEPSIA, V25, P140; MELDRUM BS, 1978, LANCET, V2, P304; PEDERSEN SA, 1985, ACTA NEUROL SCAND, V72, P295; PERRY TL, 1979, J NEUROCHEM, V32, P1641, DOI 10.1111/j.1471-4159.1979.tb02274.x; REMY C, 1989, BR J CLIN PHARM S1, V27, P125; REMY C, 1986, B LEGA IT EPIL, V54, P241; REYNOLDS EH, 1988, BRIT J CLIN PRACT, V42, P33; REYNOLDS EH, 1981, EPILEPSIA, V22, P1, DOI 10.1111/j.1528-1157.1981.tb04327.x; Richens A., 1989, ANTIEPILEPTIC DRUGS, V3rd ed, P937; RIMMER EM, 1984, LANCET, V1, P189; RIMMER EM, 1989, BR J CLIN PHARM S1, V27, P27; SCHECHTER PJ, 1984, NEUROLOGY, V34, P182, DOI 10.1212/WNL.34.2.182; SCHECHTER PJ, 1986, CURRENT PROBLEMS EPI, V4, P265; TARTARA A, 1986, EPILEPSIA, V27, P717, DOI 10.1111/j.1528-1157.1986.tb03600.x; TASSINARI CA, 1987, ARCH NEUROL-CHICAGO, V44, P907, DOI 10.1001/archneur.1987.00520210009010	27	20	20	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 3	1990	300	6720					277	278		10.1136/bmj.300.6720.277	http://dx.doi.org/10.1136/bmj.300.6720.277			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM195	2106955	Bronze, Green Published			2022-12-28	WOS:A1990CM19500003
J	STRADLING, JR; CROSBY, JH				STRADLING, JR; CROSBY, JH			RELATION BETWEEN SYSTEMIC HYPERTENSION AND SLEEP HYPOXEMIA OR SNORING - ANALYSIS IN 748 MEN DRAWN FROM GENERAL-PRACTICE	BRITISH MEDICAL JOURNAL			English	Article											STRADLING, JR (corresponding author), CHURCHILL HOSP,OSLER CHEST UNIT,OXFORD OX3 7LJ,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BLOOM JW, 1988, CHEST, V93, P678, DOI 10.1378/chest.93.4.678; CODY RP, 1987, APPLIED STATISTICS S; CROSBY J, 1989, THORAX, V44, P353; FARNEY RJ, 1986, CHEST, V89, P533, DOI 10.1378/chest.89.4.533; FLETCHER EC, 1985, ANN INTERN MED, V103, P190, DOI 10.7326/0003-4819-103-2-190; GEORGE CF, 1988, AM REV RESPIR DIS, V137, P1238, DOI 10.1164/ajrccm/137.5.1238; GOULD GA, 1987, THORAX, V42, P722; HIRSHKOWITZ M, 1989, SLEEP, V12, P223, DOI 10.1093/sleep/12.3.223; HOFFSTEIN V, 1988, LANCET, V2, P992; KALES A, 1984, LANCET, V2, P1005; KATZ I, 1989, AM REV RESPIR DIS, V139, P622; KOSKENVUO M, 1987, BRIT MED J, V294, P16, DOI 10.1136/bmj.294.6563.16; KOSKENVUO M, 1985, LANCET, V1, P893; KRIPKE DF, 1988, SLEEP RES, V17, P208; LAVIE P, 1984, AM HEART J, V108, P373, DOI 10.1016/0002-8703(84)90628-8; LUGARESI E, 1980, SLEEP, V3, P221, DOI 10.1093/sleep/3.3-4.221; LUGARESI E, 1975, ELECTROEN CLIN NEURO, V39, P59, DOI 10.1016/0013-4694(75)90127-3; MANCIA G, 1983, HYPERTENSION, V5, P5; MIALL WE, 1967, BRIT MED J, V2, P660, DOI 10.1136/bmj.2.5553.660; MOTTA J, 1978, ANN INTERN MED, V89, P454, DOI 10.7326/0003-4819-89-4-454; NORTON PG, 1985, BRIT MED J, V291, P630, DOI 10.1136/bmj.291.6496.630; PARTINEN M, 1985, LANCET, V2, P1325; Pedhazur E. J., 1982, MULTIPLE REGRESSION; SLEIGHT P, 1987, OXFORD TXB MED, P360; STANTON JL, 1982, HYPERTENSION, V4, P135; STRADLING JR, 1989, J AMB MON, V2, P203; WALLER PC, 1989, LANCET, V1, P143; WARLEY ARH, 1987, THORAX, V42, P892, DOI 10.1136/thx.42.11.892; WARLEY ARH, 1988, Q J MED, V68, P637; WEINSIER RL, 1985, HYPERTENSION, V7, P578, DOI 10.1161/01.HYP.7.4.578; WELIN L, 1987, NEW ENGL J MED, V317, P521, DOI 10.1056/NEJM198708273170901; WILLIAMS AJ, 1985, AM J CARDIOL, V55, P1019, DOI 10.1016/0002-9149(85)90738-6; 1984, LANCET, V1, P889	33	117	134	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					75	78		10.1136/bmj.300.6717.75	http://dx.doi.org/10.1136/bmj.300.6717.75			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105777	Green Published, Bronze			2022-12-28	WOS:A1990CJ08000013
J	SNORGAARD, O; BINDER, C				SNORGAARD, O; BINDER, C			MONITORING OF BLOOD-GLUCOSE CONCENTRATION IN SUBJECTS WITH HYPOGLYCEMIC SYMPTOMS DURING EVERYDAY LIFE	BRITISH MEDICAL JOURNAL			English	Article											SNORGAARD, O (corresponding author), STENO MEM HOSP,DK-2820 GENTOFTE,DENMARK.							BERNSTEIN RK, 1987, DIABETES CARE, V10, P792, DOI 10.2337/diacare.10.6.792; BETTERIDGE DJ, 1987, BRIT MED J, V295, P286, DOI 10.1136/bmj.295.6593.286; BUSS RW, 1982, HORM METAB RES, V14, P281, DOI 10.1055/s-2007-1018995; CHARLES MA, 1981, DIABETES, V30, P465, DOI 10.2337/diabetes.30.6.465; CRAPO PA, 1982, DIABETES CARE, V5, P512, DOI 10.2337/diacare.5.5.512; GASTINEAU CF, 1983, MAYO CLIN PROC, V58, P545; HOGAN MJ, 1983, MAYO CLIN PROC, V58, P491; JUNG Y, 1971, DIABETES, V20, P428, DOI 10.2337/diab.20.6.428; LEFEBVRE PJ, 1988, DIABETOLOGIA, V31, P68; LEVRAN A, 1981, DIABETES, V30, P996, DOI 10.2337/diabetes.30.12.996; MARKS V, 1986, SERONO S, V38, P1; YAGER J, 1974, NEW ENGL J MED, V291, P907, DOI 10.1056/NEJM197410242911713; 1982, DIABETES CARE, V5, P72	13	19	19	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	1990	300	6716					16	18		10.1136/bmj.300.6716.16	http://dx.doi.org/10.1136/bmj.300.6716.16			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG773	2105114	Bronze, Green Published			2022-12-28	WOS:A1990CG77300016
J	HAAHTELA, T; JARVINEN, M; KAVA, T; KIVIRANTA, K; KOSKINEN, S; LEHTONEN, K; NIKANDER, K; PERSSON, T; REINIKAINEN, K; SELROOS, O; SOVIJARVI, A; STENIUSAARNIALA, B; SVAHN, T; TAMMIVAARA, R; LAITINEN, LA				HAAHTELA, T; JARVINEN, M; KAVA, T; KIVIRANTA, K; KOSKINEN, S; LEHTONEN, K; NIKANDER, K; PERSSON, T; REINIKAINEN, K; SELROOS, O; SOVIJARVI, A; STENIUSAARNIALA, B; SVAHN, T; TAMMIVAARA, R; LAITINEN, LA			COMPARISON OF A BETA-2-AGONIST, TERBUTALINE, WITH AN INHALED CORTICOSTEROID, BUDESONIDE, IN NEWLY DETECTED ASTHMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM TREATMENT; BRONCHIAL RESPONSIVENESS; HYPERRESPONSIVENESS; FLOW	Background. The presence of airway inflammation even in mild asthma points to the potential value of antiinflammatory therapy. We compared the effect of an inhaled corticosteroid, budesonide, with that of an inhaled beta-2-agonist, terbutaline, in the long-term treatment of newly detected asthma. Methods. We studied 103 patients (29 male and 74 female patients 15 to 64 years old) in whom asthma had appeared within the previous year. The patients were randomly assigned in blinded fashion to two treatment groups: one to receive 600-mu-g of inhaled budesonide twice a day, and the other to receive 375-mu-g of inhaled terbutaline twice a day. The study period was two years. Results. After six weeks of treatment, the patients treated with budesonide tolerated inhaled histamine better than the patients treated with terbutaline (a difference of one doubling dose step, P < 0.001), and the difference was sustained. Patients' diaries kept during the first three months of the study and during the last month of the first and second years showed budesonide to be more effective than terbutaline in improving peak expiratory flow in the morning (average increase from the pretreatment value, 32.8 liters per minute for budesonide vs. 4.8 liters per minute for terbutaline; P < 0.001) and in the evening (P < 0.01). Budesonide was also more effective in reducing the symptoms of asthma (P < 0.01) and the use of supplemental beta-2-agonist medication (P < 0.01). Ten patients were withdrawn from the terbutaline group because treatment was insufficiently effective, whereas only one dropped out of the budesonide group. The adverse reactions to both treatments were few and mild. Conclusions. Antiinflammatory therapy with inhaled budesonide is an effective first-line treatment for patients with newly detected, mild asthma, and it is superior to the use of terbutaline in such patients.	KANTA HAME CENT HOSP,HAMEENLINNA,FINLAND; POHJOIS KARJALA CENT HOSP,JOENSUU,FINLAND; KILJAVA HOSP,KILJAVA,FINLAND; ETELA SAIMAA CENT HOSP,TIURUNIEMI,FINLAND; ASTRA DRACO AB,LUND,SWEDEN; MELTOLA HOSP,MELTOLA,FINLAND; UNIV LUND HOSP,S-22185 LUND,SWEDEN	Lund University; Skane University Hospital	HAAHTELA, T (corresponding author), UNIV HELSINKI,CENT HOSP,DEPT ALLERG DIS,MEILAHDENTIE 2,SF-00250 HELSINKI,FINLAND.		Sovijärvi, Anssi Raimo Antero/AAE-9512-2021					BROWN PJ, 1984, THORAX, V39, P131, DOI 10.1136/thx.39.2.131; DUTOIT JI, 1987, AM REV RESPIR DIS, V136, P1174, DOI 10.1164/ajrccm/136.5.1174; GLYNN A. A., 1960, THORAX, V15, P142, DOI 10.1136/thx.15.2.142; GREGG I, 1973, BMJ-BRIT MED J, V3, P282, DOI 10.1136/bmj.3.5874.282; JENKINS CR, 1988, THORAX, V43, P378, DOI 10.1136/thx.43.5.378; JUNIPER EF, 1990, AM REV RESPIR DIS, V142, P832, DOI 10.1164/ajrccm/142.4.832; KERREBIJN KF, 1987, J ALLERGY CLIN IMMUN, V79, P653, DOI 10.1016/S0091-6749(87)80163-X; KRAAN J, 1985, J ALLERGY CLIN IMMUN, V76, P628, DOI 10.1016/0091-6749(85)90786-9; LAITINEN LA, 1985, AM REV RESPIR DIS, V131, P599, DOI 10.1164/arrd.1985.131.4.599; PEAT JK, 1987, EUR J RESPIR DIS, V70, P171; RYAN G, 1985, J ALLERGY CLIN IMMUN, V75, P25, DOI 10.1016/0091-6749(85)90007-7; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; VANSCHAYCK CP, 1990, J ALLERGY CLIN IMMUN, V86, P793, DOI 10.1016/S0091-6749(05)80185-X; VATHENEN AS, 1988, LANCET, V1, P554; VILJANEN AA, 1984, SCAND J CLIN LAB INV, V159, P5	15	651	658	0	9	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 8	1991	325	6					388	392		10.1056/NEJM199108083250603	http://dx.doi.org/10.1056/NEJM199108083250603			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ804	2062329				2022-12-28	WOS:A1991FZ80400003
J	BENATAR, SR				BENATAR, SR			ACADEMIC BOYCOTT - THROUGH THE LOOKING-GLASS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SOUTH-AFRICA; MEDICINE; BUSINESS; STATE		GROOTE SCHUUR HOSP,CAPE TOWN 7925,SOUTH AFRICA	University of Cape Town	BENATAR, SR (corresponding author), UNIV CAPE TOWN,DEPT MED,CAPE TOWN 7925,SOUTH AFRICA.							Benatar S R, 1990, Law Med Health Care, V18, P140; BENATAR SR, 1990, NATURE, V343, P505, DOI 10.1038/343505a0; BENATAR SR, 1990, LANCET, V335, P1576, DOI 10.1016/0140-6736(90)91390-V; BENATAR SR, 1991, S AFR MED J, V79, P660; BENATAR SR, IN PRESS N ENGL J ME; BERWICK DM, 1989, NEW ENGL J MED, V320, P53, DOI 10.1056/NEJM198901053200110; Brock J. F., 1977, HIST SCI ENDEAVOUR S, P192; CHALK R, 1988, SCI TECHNOLOGY SOC E; CLARK AL, 1989, FELLOWSHIP AFF R AUS, V8, P3; CRAWSHAW R, 1989, JAMA-J AM MED ASSOC, V262, P1499; DOMMISSE J, 1987, SOC SCI MED, V24, P749, DOI 10.1016/0277-9536(87)90112-2; Fink P J, 1989, Am J Psychiatry, V146, P1097; GELLERT GA, 1990, JAMA-J AM MED ASSOC, V264, P610; JENKINS T, 1988, 4TH P U CAP TOWN FM, P50; KALK WJ, 1991, LANCET, V337, P660, DOI 10.1016/0140-6736(91)92465-E; LUNDBERG GD, 1990, JAMA-J AM MED ASSOC, V263, P86, DOI 10.1001/jama.263.1.86; MAYER J, 1990, CHRONICLE HIGHE 0411, pB1; PELLEGRINO ED, 1990, B NEW YORK ACAD MED, V66, P221; RAYNER M, 1987, TURNING BLIND EYE ME; RELMAN AS, 1987, NEW ENGL J MED, V316, P1150, DOI 10.1056/NEJM198704303161810; SAKHAROV AD, 1968, PROGR COEXISTENCE IN; Shaw W. H., 1986, J APPL PHILOS, V3, P59; SILOVE D, 1990, SOC SCI MED, V30, P417, DOI 10.1016/0277-9536(90)90344-R; SIMPSON GL, 1989, EINSTEIN Q J BIOL ME, V7, P36; WOLSTENHOLME G, 1989, J ROY COLL PHYS LOND, V23, P142; 1987, HASTINGS CTR REP S, V17, P1; 1990, S AFR MED J, V77, P225; 1987, T COLL MED S AFR, V31, pR4; 1989, SCHIZOPHR B S, V15, P1	29	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1991	266	4					501	&						0	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FX021	2061970				2022-12-28	WOS:A1991FX02100009
J	LENHARDT, ML; SKELLETT, R; WANG, P; CLARKE, AM				LENHARDT, ML; SKELLETT, R; WANG, P; CLARKE, AM			HUMAN ULTRASONIC SPEECH-PERCEPTION	SCIENCE			English	Article							GUINEA-PIG	Bone-conducted ultrasonic hearing has been found capable of supporting frequency discrimination and speech detection in normal, older hearing-impaired, and profoundly deaf human subjects. When speech signals were modulated into the ultrasonic range, listening to words resulted in the clear perception of the speech stimuli and not a sense of high-frequency vibration. These data suggest that ultrasonic bone conduction hearing has potential as an alternative communication channel in the rehabilitation of hearing disorders.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, BIOMED ENGN PROJECT, RICHMOND, VA 23298 USA; HEARING INNOVAT INC, TUCSON, AZ 85718 USA	Virginia Commonwealth University	LENHARDT, ML (corresponding author), VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT OTOLARYNGOL, RICHMOND, VA 23298 USA.							ABRAMOVICH SJ, 1978, J LARYNGOL OTOL, V92, P861, DOI 10.1017/S0022215100086230; BELLUCCI FJ, 1962, ANN OTO RHINOL LARYN, V71, P719, DOI 10.1177/000348946207100312; CAZALS Y, 1983, ACTA OTO-LARYNGOL, V95, P211, DOI 10.3109/00016488309130937; CAZALS Y, 1980, SCIENCE, V210, P83, DOI 10.1126/science.6968092; Cazals Y., 1987, VESTIBULAR SYSTEM NE, P601, DOI 10.1007/978-4-431-85908-6; CORSO JF, 1963, J ACOUST SOC AM, V35, P1738, DOI 10.1121/1.1918804; CORSO JF, 1965, AM J PSYCHOL, V78, P557, DOI 10.2307/1420916; DEATHERAGE BH, 1954, J ACOUST SOC AM, V26, P582, DOI 10.1121/1.1907379; DIEROFF HG, 1975, ARCH OTO-RHINO-LARYN, V209, P277, DOI 10.1007/BF00456548; HAEFF AV, 1963, SCIENCE, V139, P590, DOI 10.1126/science.139.3555.590; Hardy M, 1934, ANAT REC, V59, P403, DOI 10.1002/ar.1090590403; HUNTERDUVAR I, 1976, J OTOLARYNGOL, V5, P497; KEVETTER GA, 1989, BRAIN BEHAV EVOLUT, V34, P193, DOI 10.1159/000116505; OHYAMA K, 1985, HEARING RES, V17, P143, DOI 10.1016/0378-5955(85)90017-6; OHYAMA K, 1987, ACTA OTO-LARYNGOL, P73; PUMPHREY RJ, 1950, NATURE, V166, P571, DOI 10.1038/166571b0; ROSS R, 1971, WORD INTELLIGIBILITY; Stremler F. G., 1982, INTRO COMMUNICATION; Wever E.G., 1954, PHYSL ACOUSTICS	19	94	100	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 5	1991	253	5015					82	85		10.1126/science.2063208	http://dx.doi.org/10.1126/science.2063208			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV177	2063208				2022-12-28	WOS:A1991FV17700040
J	DRESNER, MS; KINCAID, MC				DRESNER, MS; KINCAID, MC			LYMPHOMA OF THE EYELID	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TUMORS		ST LOUIS UNIV,SCH MED,DEPT OPHTHALMOL,ST LOUIS,MO 63104; ST LOUIS UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63104	Saint Louis University; Saint Louis University								ELLIS JH, 1985, OPHTHALMOLOGY, V92, P1311; JAKOBIEC FA, 1986, OPHTHALMOLOGY, V93, P1547; KIRSCH LS, 1990, OPHTHALMOLOGY, V97, P1352; MAMALIS N, 1988, OPHTHALMIC SURG LAS, V19, P662; MCNALLY L, 1987, AM J OPHTHALMOL, V103, P555, DOI 10.1016/S0002-9394(14)74280-1	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	1991	266	1					29	29						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT934	2046126				2022-12-28	WOS:A1991FT93400009
J	LIANG, MH; DALTROY, LH; LARSON, MG; PARTRIDGE, AJ; ABELES, M; TAYLOR, C; FOSSEL, AH				LIANG, MH; DALTROY, LH; LARSON, MG; PARTRIDGE, AJ; ABELES, M; TAYLOR, C; FOSSEL, AH			EVALUATION OF SOCIAL-SECURITY DISABILITY IN CLAIMANTS WITH RHEUMATIC DISEASE	ANNALS OF INTERNAL MEDICINE			English	Article						ARTHRITIS; RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; SOCIAL SECURITY, DISABILITY; DISABILITY EVALUATION	ARTHRITIS; PATIENT	We compared the Social Security Administration's (SSA) judgment of disability with uninvolved rheumatologists' evaluations of ability to work. With the cooperation of the SSA, 52 new disability claimants who alleged rheumatoid arthritis, osteoarthritis, or systemic lupus erythematosus were identified at the beginning of their claim. At the same time that their claim was being formally reviewed, they had a standardized examination by an independent rheumatologist who was not involved with their care, and they had a standardized test of observed performance. Rheumatologists' judgments of ability to work were compared with the SSA judgments. Rheumatologist and SSA judgments were in agreement for 35 of the 52 claimants (67%). All 11 claimants who met or equaled the SSA medical evaluation criteria were judged work-disabled by the rheumatologist. Of 27 judged able to work by the SSA, the rheumatologist judged 11 to be unable. Agreement between the SSA judgment of residual functional capacity and observed performance was no more than would be expected by chance. Most SSA judgments agree with a clinician's evaluation but a standardized physical evaluation by a rheumatologist and performance-based tests appear to add important information.	UNIV CONNECTICUT, CTR HLTH, FARMINGTON, CT 06032 USA	University of Connecticut	LIANG, MH (corresponding author), BRIGHAM & WOMENS HOSP, CTR MULTIPURPOSE ARTHRITIS, PPB-B2, 75 FRANCIS ST, BOSTON, MA 02115 USA.			Larson, Martin/0000-0002-9631-1254	NCRR NIH HHS [RR-05669] Funding Source: Medline; NIADDK NIH HHS [AM-20580] Funding Source: Medline; NIAMS NIH HHS [AR-20621] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020621] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CAREY TS, 1988, J CLIN EPIDEMIOL, V41, P691, DOI 10.1016/0895-4356(88)90121-7; CAREY TS, 1986, ANN INTERN MED, V104, P706, DOI 10.7326/0003-4819-104-5-706; CAREY TS, 1987, MED CARE, V25, P267, DOI 10.1097/00005650-198704000-00001; Fleiss J. L., 1981, STAT METHODS RATES P, V2, P22; HADLER NM, 1984, SEMIN ARTHRITIS RHEU, V14, P45, DOI 10.1016/0049-0172(84)90008-8; HOLLINGSHEAD AB, 1958, SOCIAL CLASS MENTAL, P387; KELLOR M, 1977, SISTER KENNY I PUBLI, V721; LIANG MH, 1988, SUPPLEMENTARY ANAL D; LUDWIG AM, 1981, AM J PSYCHOTHER, V35, P5, DOI 10.1176/appi.psychotherapy.1981.35.1.5; MCCOY JL, 1989, SOC SECUR BULL, V52, P16; MEENAN RF, 1983, B RHEUM DIS, V33, P1; NAGI SZ, 1969, IND MED SURG, V38, P27; Osterweis M., 1987, PAIN DISABILITY CLIN; PARTRIDGE AJ, 1984, CLIN RHEUMATOLOGY PR, V2, P275; Stone D., 1984, DISABLED STATE; TURK DC, 1988, PAIN, V34, P217, DOI 10.1016/0304-3959(88)90117-0; YELIN E, 1980, ANN INTERN MED, V93, P551, DOI 10.7326/0003-4819-93-4-551; 1977, SELECTED CHARACTERIS; 1987, SSA64031 US DEP HLTH; 1982, DICT RHEUMATIC DISEA, V1, P73; 1986, SSA64014 US DEP HLTH	21	10	10	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1991	115	1					26	31		10.7326/0003-4819-115-1-26	http://dx.doi.org/10.7326/0003-4819-115-1-26			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT937	2048859				2022-12-28	WOS:A1991FT93700006
J	BURTIS, KC; THUMMEL, CS; JONES, CW; KARIM, FD; HOGNESS, DS				BURTIS, KC; THUMMEL, CS; JONES, CW; KARIM, FD; HOGNESS, DS			THE DROSOPHILA 74EF EARLY PUFF CONTAINS E74, A COMPLEX ECDYSONE-INDUCIBLE GENE THAT ENCODES 2 ETS-RELATED PROTEINS	CELL			English	Article									STANFORD UNIV,MED CTR,SCH MED,DEPT BIOCHEM,STANFORD,CA 94305; UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132	Stanford University; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah				Burtis, Kenneth/0000-0002-9644-3265				ARAI KI, 1980, P NATL ACAD SCI-BIOL, V77, P3322, DOI 10.1073/pnas.77.6.3322; Ashburner M, 1974, Cold Spring Harb Symp Quant Biol, V38, P655; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; BENSON M, 1988, EMBO J, V7, P3907, DOI 10.1002/j.1460-2075.1988.tb03277.x; BERK AJ, 1978, P NATL ACAD SCI USA, V75, P1274, DOI 10.1073/pnas.75.3.1274; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BONNER JJ, 1976, CHROMOSOMA, V58, P87, DOI 10.1007/BF00293443; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; BURTIS KC, 1985, THESIS STANFORD U ST; CARLSON JR, 1985, DEV BIOL, V108, P341, DOI 10.1016/0012-1606(85)90038-7; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CHAO AT, 1986, EMBO J, V5, P143, DOI 10.1002/j.1460-2075.1986.tb04188.x; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; CHERBAS L, 1984, BIOSYNTHESIS METABOL; Davis R., 1980, ADV BACTERIAL GENETI; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; FUJIWARA S, 1988, ONCOGENE, V2, P99; FUJIWARA S, 1988, MOL CELL BIOL, V8, P4700, DOI 10.1128/MCB.8.11.4700; GOLDBERG M, 1981, THESIS STANFORD U ST; HAYNES SR, 1987, P NATL ACAD SCI USA, V84, P1819, DOI 10.1073/pnas.84.7.1819; HULTMARK D, 1986, CELL, V44, P429, DOI 10.1016/0092-8674(86)90464-2; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LANGERSAFER PR, 1982, P NATL ACAD SCI-BIOL, V79, P4381, DOI 10.1073/pnas.79.14.4381; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3; Maniatis T., 1982, MOL CLONING; MAROY P, 1978, P NATL ACAD SCI USA, V75, P6035, DOI 10.1073/pnas.75.12.6035; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MORITZ T, 1984, EMBO J, V3, P289, DOI 10.1002/j.1460-2075.1984.tb01798.x; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; PAPAS TS, 1987, MOL MECHANISMS REGUL, V5, P123; PIRROTTA V, 1987, EMBO J, V6, P791, DOI 10.1002/j.1460-2075.1987.tb04821.x; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; PRIBYL LJ, 1988, DEV BIOL, V127, P45, DOI 10.1016/0012-1606(88)90187-X; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; REDDY ESP, 1988, ONCOGENE RES, V3, P239; REDDY ESP, 1987, P NATL ACAD SCI USA, V84, P6131, DOI 10.1073/pnas.84.17.6131; REGULSKI M, 1987, EMBO J, V6, P767, DOI 10.1002/j.1460-2075.1987.tb04819.x; RICHARDS G, 1981, MOL CELL ENDOCRINOL, V21, P181, DOI 10.1016/0303-7207(81)90013-7; RIDDIHOUGH G, 1987, EMBO J, V6, P3729, DOI 10.1002/j.1460-2075.1987.tb02707.x; SAGE BA, 1982, J BIOL CHEM, V257, P6373; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHALTMANN K, 1982, P NATL ACAD SCI-BIOL, V79, P6, DOI 10.1073/pnas.79.1.6; SCOTT MP, 1987, CELL, V51, P689, DOI 10.1016/0092-8674(87)90092-4; SEGRAVES WA, 1990, IN PRESS GENES DEV; SEGRAVES WA, 1988, THESIS STANFORD U ST; SMITH GE, 1980, ANAL BIOCHEM, V109, P123, DOI 10.1016/0003-2697(80)90019-6; STADEN R, 1982, NUCLEIC ACIDS RES, V10, P141, DOI 10.1093/nar/10.1.141; TAUTZ D, 1986, NATURE, V322, P652, DOI 10.1038/322652a0; THUMMEL CS, 1989, GENE DEV, V3, P782, DOI 10.1101/gad.3.6.782; THUMMEL CS, 1990, CELL, V61, P101, DOI 10.1016/0092-8674(90)90218-4; WATSON DK, 1985, P NATL ACAD SCI USA, V82, P7294, DOI 10.1073/pnas.82.21.7294; WATSON DK, 1986, P NATL ACAD SCI USA, V83, P1792, DOI 10.1073/pnas.83.6.1792; WEAVER RF, 1979, NUCLEIC ACIDS RES, V7, P1175, DOI 10.1093/nar/7.5.1175; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; WOLFNER M, 1980, THESIS STANFORD U ST; WU R, 1976, BIOCHEMISTRY-US, V15, P734, DOI 10.1021/bi00649a003; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YUND MA, 1978, P NATL ACAD SCI USA, V75, P6039, DOI 10.1073/pnas.75.12.6039	68	385	393	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	APR 6	1990	61	1					85	99		10.1016/0092-8674(90)90217-3	http://dx.doi.org/10.1016/0092-8674(90)90217-3			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CY382	2107982				2022-12-28	WOS:A1990CY38200012
J	LOWE, GDO				LOWE, GDO			NEW DRUGS - DRUGS IN CEREBRAL AND PERIPHERAL ARTERIAL-DISEASE	BMJ-BRITISH MEDICAL JOURNAL			English	Article											LOWE, GDO (corresponding author), UNIV GLASGOW, ROYAL INFIRM, DEPT MED, GLASGOW G31 2ER, SCOTLAND.							[Anonymous], 1988, BRIT MED J, V296, P320; ARCAN JC, 1988, ANGIOLOGY, V39, P802, DOI 10.1177/000331978803900904; BARER DH, 1988, BRIT MED J, V296, P737, DOI 10.1136/bmj.296.6624.737; CORBIN DOC, 1986, EUR HEART J, V7, P165, DOI 10.1093/oxfordjournals.eurheartj.a062040; DELZOPPO GJ, 1988, STROKE, V19, P307, DOI 10.1161/01.STR.19.3.307; GRAOR RA, 1985, J VASC SURG, V2, P406, DOI 10.1067/mva.1985.avs0020406; HENNEKENS CH, 1988, NEW ENGL J MED, V318, P923; HEROS RC, 1989, STROKE, V20, P423, DOI 10.1161/01.STR.20.3.423; MACMAHON SW, 1986, PROG CARDIOVASC DIS, V29, P99, DOI 10.1016/0033-0620(86)90038-1; MCCARTHY ST, 1986, AGE AGEING, V15, P84, DOI 10.1093/ageing/15.2.84; NEGUS D, 1987, J CARDIOVASC SURG, V28, P196; PAGANINIHILL A, 1988, BMJ-BRIT MED J, V297, P519, DOI 10.1136/bmj.297.6647.519; PEART WS, 1988, BRIT MED J, V296, P1565; PICKARD JD, 1989, BRIT MED J, V298, P636, DOI 10.1136/bmj.298.6674.636; ROSE FC, 1986, STROKE EPIDEMIOLOGIC; ROSS J, 1987, INTERCHANGE, V18, P1, DOI 10.1007/BF01807216; SANDERCOCK P, 1988, BMJ-BRIT MED J, V297, P995, DOI 10.1136/bmj.297.6655.995; SANDERCOCK P, 1987, BRIT MED J, V295, P1224, DOI 10.1136/bmj.295.6608.1224; STEINER TJ, 1988, CLIN REHABIL, V2, P151; TRUBESTEIN G, 1984, ANGIOLOGY, V35, P701, DOI 10.1177/000331978403501103; VERSTRAETE M, 1989, BRIT MED J, V298, P424	21	18	18	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	1990	300	6723					524	528		10.1136/bmj.300.6723.524	http://dx.doi.org/10.1136/bmj.300.6723.524			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107935	Green Published, Bronze			2022-12-28	WOS:A1990CQ87800027
J	BARBARA, JAJ; CONTRERAS, M				BARBARA, JAJ; CONTRERAS, M			ABC OF TRANSFUSION - INFECTIOUS COMPLICATIONS OF BLOOD-TRANSFUSION - VIRUSES	BRITISH MEDICAL JOURNAL			English	Article											BARBARA, JAJ (corresponding author), N LONDON BLOOD TRANSFUS CTR,MICROBIOL,LONDON,ENGLAND.								0	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 17	1990	300	6722					450	453		10.1136/bmj.300.6722.450	http://dx.doi.org/10.1136/bmj.300.6722.450			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP166	2107902	Bronze, Green Published			2022-12-28	WOS:A1990CP16600027
J	ANDERSON, G; STEINBERG, EP; WHITTLE, J; POWE, NR; ANTEBI, S; HERBERT, R				ANDERSON, G; STEINBERG, EP; WHITTLE, J; POWE, NR; ANTEBI, S; HERBERT, R			DEVELOPMENT OF CLINICAL AND ECONOMIC PROGNOSES FROM MEDICARE CLAIMS DATA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									JOHNS HOPKINS UNIV,CTR HOSP FINANCE & MANAGEMENT,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,DEPT HLTH POLICY & MANAGEMENT,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,DEPT MED,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,JOHNS HOPKINS PROGRAM MED TECHNOL & PRACTICE ASSESSMENT,BALTIMORE,MD 21218	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University				Whittle, Jeff/0000-0002-9544-838X				ANDERSON G, 1984, MED CARE, V22, P143, DOI 10.1097/00005650-198402000-00005; ANDERSON GF, 1984, NEW ENGL J MED, V311, P1349, DOI 10.1056/NEJM198411223112105; ANDERSON GF, 1986, MILBANK MEM FUND Q, V64, P549; ANDERSON GFD, 1989, PAYMENT AMOUNT CAPIT; BEAL R, 1982, 7 NAT IND SYST REP; DALEY J, 1988, JAMA-J AM MED ASSOC, V260, P3617, DOI 10.1001/jama.260.24.3617; DENSEN PM, 1959, MILBANK FUND Q, V37, P217, DOI 10.2307/3348768; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; Lubitz J, 1984, Health Care Financ Rev, V5, P117; LUBITZ J, 1987, INQUIRY-J HEALTH CAR, V24, P362; NEWHOUSE JP, 1987, OBJECTIVE MEASURES H; SCHROEDER SA, 1979, NEW ENGL J MED, V300, P1306, DOI 10.1056/NEJM197906073002304; THOMAS JW, 1984, HLTH STATUS MEASURE; WENNBERG JE, 1988, JAMA-J AM MED ASSOC, V259, P3027, DOI 10.1001/jama.259.20.3027; WENNBERG JE, 1987, JAMA-J AM MED ASSOC, V257, P933, DOI 10.1001/jama.257.7.933; ZOOK CJ, 1980, NEW ENGL J MED, V302, P996, DOI 10.1056/NEJM198005013021804	16	54	54	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	1990	263	7					967	972		10.1001/jama.263.7.967	http://dx.doi.org/10.1001/jama.263.7.967			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CM790	2105404				2022-12-28	WOS:A1990CM79000025
J	ROGERS, J; WATT, I; DIEPPE, P				ROGERS, J; WATT, I; DIEPPE, P			COMPARISON OF VISUAL AND RADIOGRAPHIC DETECTION OF BONY CHANGES AT THE KNEE-JOINT	BRITISH MEDICAL JOURNAL			English	Article											ROGERS, J (corresponding author), BRISTOL ROYAL INFIRM & GEN HOSP,RHEUMATOL UNIT,BRISTOL BS2 8HW,AVON,ENGLAND.							CLARKE GA, 1979, H FORD HOSP MED J, V27, P48; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; MCALINDON T, 1989, ANN RHEUM DIS, V48, P531, DOI 10.1136/ard.48.7.531; ROGERS J, 1987, J ARCHAEOL SCI, V14, P179, DOI 10.1016/0305-4403(87)90005-7; ROGERS J, 1981, BRIT MED J, V283, P1668, DOI 10.1136/bmj.283.6307.1668	5	45	46	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					367	368		10.1136/bmj.300.6721.367	http://dx.doi.org/10.1136/bmj.300.6721.367			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106987	Green Published, Bronze			2022-12-28	WOS:A1990CN79900020
J	ALP, MS; CROCKARD, HA				ALP, MS; CROCKARD, HA			LATE COMPLICATION OF UNDETECTED ODONTOID FRACTURE IN CHILDREN	BMJ-BRITISH MEDICAL JOURNAL			English	Article									NATL HOSP NERVOUS DIS, LONDON W9 1TL, ENGLAND	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust								CLARK CR, 1985, J BONE JOINT SURG AM, V67A, P1340, DOI 10.2106/00004623-198567090-00006; Crockard H A, 1988, Clin Neurosurg, V34, P389; CROCKARD HA, 1985, ANN ROY COLL SURG, V67, P321; KOOP SE, 1984, J BONE JOINT SURG AM, V66A, P403, DOI 10.2106/00004623-198466030-00013; RICHARDS PG, 1984, J NEUROL NEUROSUR PS, V47, P781, DOI 10.1136/jnnp.47.8.781; SCHATZKER J, 1971, Journal of Bone and Joint Surgery British Volume, V53, P392; SCHIESS RJ, 1982, J NEUROSURG, V57, P496, DOI 10.3171/jns.1982.57.4.0496; SCHNEIDER RC, 1985, NEUROSURGERY, V2, P1701	8	10	11	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	1990	300	6720					319	320		10.1136/bmj.300.6720.319	http://dx.doi.org/10.1136/bmj.300.6720.319			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM195	2106966	Green Published, Bronze			2022-12-28	WOS:A1990CM19500028
J	HAMBLIN, TJ				HAMBLIN, TJ			INTERLEUKIN-2	BRITISH MEDICAL JOURNAL			English	Editorial Material											HAMBLIN, TJ (corresponding author), ROYAL VICTORIA HOSP,IMMUNOHAEMATOL,BOURNEMOUTH NH1 4JG,ENGLAND.							ATKINS MB, 1988, NEW ENGL J MED, V318, P1557, DOI 10.1056/NEJM198806163182401; BLOOM M, 1987, SCIENCE, V235, P154, DOI 10.1126/science.3492042; CHRISTIANSEN NP, 1988, AM J MED, V84, P1072, DOI 10.1016/0002-9343(88)90314-2; COTRAN RS, 1986, J EXP MED, V164, P661, DOI 10.1084/jem.164.2.661; COTRAN RS, 1987, J IMMUNOL, V139, P1883; DENICOFF KD, 1987, ANN INTERN MED, V107, P293, DOI 10.7326/0003-4819-107-2-293; DUNN MJ, 1984, ANNU REV MED, V35, P411, DOI 10.1146/annurev.med.35.1.411; KOTASEK D, 1988, CANCER RES, V48, P5528; MITCHELL MS, 1988, J CLIN ONCOL, V6, P409, DOI 10.1200/JCO.1988.6.3.409; MOERTEL CG, 1986, JAMA-J AM MED ASSOC, V256, P3141, DOI 10.1001/jama.256.22.3141; NORA R, 1989, J NATL CANCER I, V81, P59, DOI 10.1093/jnci/81.1.59; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; SCHWARTZENTRUBER D, 1988, CANCER, V62, P2350, DOI 10.1002/1097-0142(19881201)62:11<2350::AID-CNCR2820621116>3.0.CO;2-S; SOSMAN JA, 1988, J NATL CANCER I, V80, P1451, DOI 10.1093/jnci/80.18.1451; WEST WH, 1987, NEW ENGL J MED, V316, P898, DOI 10.1056/NEJM198704093161502; 1989, LANCET, V1, P308	16	29	29	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 3	1990	300	6720					275	276		10.1136/bmj.300.6720.275	http://dx.doi.org/10.1136/bmj.300.6720.275			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM195	2106954	Green Published, Bronze			2022-12-28	WOS:A1990CM19500001
J	VALLELY, SR; MILLS, JOM				VALLELY, SR; MILLS, JOM			SHOULD RADIOLOGISTS TALK TO PATIENTS	BRITISH MEDICAL JOURNAL			English	Article									ROYAL VICTORIA HOSP,DEPT RADIOL,BELFAST BT12 6BA,NORTH IRELAND									CASSILETH BR, 1980, ANN INTERN MED, V92, P832, DOI 10.7326/0003-4819-92-6-832; LICHTER I, 1984, PALLIATIVE CARE MANA, P444; NOVACK DH, 1979, JAMA-J AM MED ASSOC, V241, P897, DOI 10.1001/jama.241.9.897; West TS, 1981, HOSPICE LIVING IDEA, P53	4	23	23	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 3	1990	300	6720					305	306		10.1136/bmj.300.6720.305	http://dx.doi.org/10.1136/bmj.300.6720.305			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM195	2106962	Green Published, Bronze			2022-12-28	WOS:A1990CM19500021
J	EAGLES, JM; BEATTIE, JAG; RESTALL, DB; RAWLINSON, F; HAGEN, S; ASHCROFT, GW				EAGLES, JM; BEATTIE, JAG; RESTALL, DB; RAWLINSON, F; HAGEN, S; ASHCROFT, GW			RELATION BETWEEN COGNITIVE IMPAIRMENT AND EARLY DEATH IN THE ELDERLY	BRITISH MEDICAL JOURNAL			English	Article									INVERURIE HLTH CTR,ABERDEEN AB5 9SU,SCOTLAND; UNIV ABERDEEN,ABERDEEN AB9 1FX,SCOTLAND	University of Aberdeen	EAGLES, JM (corresponding author), ROYAL CORNHILL HOSP,ROSS CLIN,ABERDEEN AB9 2ZF,SCOTLAND.							ANTHONY JC, 1982, PSYCHOL MED, V12, P397, DOI 10.1017/S0033291700046730; BARCLAY LL, 1985, NEUROLOGY, V35, P834, DOI 10.1212/WNL.35.6.834; BLESSED G, 1982, BRIT J PSYCHIAT, V141, P59, DOI 10.1192/bjp.141.1.59; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; CHANDRA V, 1986, NEUROLOGY, V36, P204, DOI 10.1212/WNL.36.2.204; CHANDRA V, 1986, NEUROLOGY, V36, P209, DOI 10.1212/WNL.36.2.209; CHRISTIE AB, 1984, BRIT J PSYCHIAT, V144, P9, DOI 10.1192/bjp.144.1.9; CLARKE M, 1986, AGE AGEING, V15, P278, DOI 10.1093/ageing/15.5.278; COOPER B, 1984, PSYCHOL MED, V14, P81, DOI 10.1017/S0033291700003093; DIESFELDT HFA, 1986, ACTA PSYCHIAT SCAND, V73, P366, DOI 10.1111/j.1600-0447.1986.tb02697.x; EAGLES JM, 1987, BRIT J PSYCHIAT, V150, P299, DOI 10.1192/bjp.150.3.299; EAGLES JM, 1987, BRIT J PSYCHIAT, V150, P293, DOI 10.1192/bjp.150.3.293; GILMORE AJJ, 1975, GERONTOL CLIN, V17, P72, DOI 10.1159/000245560; GO RCP, 1978, ANN NEUROL, V3, P559, DOI 10.1002/ana.410030620; GOLDFARB AI, 1969, ARCH GEN PSYCHIAT, V21, P172; GURLAND BJ, 1982, GERONTOLOGIST, V22, P180, DOI 10.1093/geront/22.2.180; GUZE SB, 1964, AM J PSYCHIAT, V120, P878, DOI 10.1176/ajp.120.9.878; HENDERSON AS, 1984, PSYCHOL MED, V14, P5, DOI 10.1017/S0033291700003020; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; INEICHEN B, 1987, BRIT J PSYCHIAT, V150, P193, DOI 10.1192/bjp.150.2.193; KAHN RL, 1960, AM J PSYCHIAT, V117, P326, DOI 10.1176/ajp.117.4.326; KAY DWK, 1964, BRIT J PSYCHIAT, V110, P146, DOI 10.1192/bjp.110.465.146; LIBOW LS, 1974, GERIATRICS, V29, P75; MARTIN DC, 1987, ARCH NEUROL-CHICAGO, V44, P1122, DOI 10.1001/archneur.1987.00520230012006; MCLAREN SM, 1986, BR J CLIN PSYCHOL, V25, P233; MOLSA PK, 1986, ACTA NEUROL SCAND, V74, P103; MORGAN K, 1987, BRIT J PSYCHIAT, V150, P801, DOI 10.1192/bjp.150.6.801; OCONNOR DW, 1988, BMJ-BRIT MED J, V297, P1107, DOI 10.1136/bmj.297.6656.1107; PFEFFER RI, 1984, AM J EPIDEMIOL, V120, P922, DOI 10.1093/oxfordjournals.aje.a113963; POST F, 1951, BRIT MED J, V1, P436, DOI 10.1136/bmj.1.4704.436; ROTH M, 1955, J MENT SCI, V101, P281, DOI 10.1192/bjp.101.423.281; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P276; SANGSTAD LF, 1979, ACTA PSYCHIAT SCAND, V59, P431; SHAH KV, 1969, BRIT J PSYCHIAT, V115, P1283, DOI 10.1192/bjp.115.528.1283; SHEPHERD M, 1984, PSYCHOL MED, V14, P1, DOI 10.1017/S0033291700003019; THOMPSON P, 1987, BRIT J PSYCHIAT, V151, P206, DOI 10.1192/bjp.151.2.206; WHITEHEAD A, 1982, PSYCHOL MED, V12, P149, DOI 10.1017/S0033291700043403; WILSON L A, 1973, Age and Ageing, V2, P92, DOI 10.1093/ageing/2.2.92	39	72	73	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1990	300	6719					239	240		10.1136/bmj.300.6719.239	http://dx.doi.org/10.1136/bmj.300.6719.239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL024	2106935	Bronze, Green Published			2022-12-28	WOS:A1990CL02400028
J	MORRIS, F; COPE, A; HAWES, S				MORRIS, F; COPE, A; HAWES, S			TRAINING IN ACCIDENT AND EMERGENCY - VIEWS OF SENIOR HOUSE OFFICERS	BRITISH MEDICAL JOURNAL			English	Article									ST BARTHOLOMEWS HOSP,ACCID & EMERGENCY,LONDON EC1A 7BE,ENGLAND; NEWHAM DIST GEN HOSP,ACCID & EMERGENCY,LONDON,ENGLAND; ST BARTHOLOMEWS HOSP,ACCID & EMERGENCY,LONDON EC1A 7BE,ENGLAND	University of London; Queen Mary University London; University of London; Queen Mary University London								HUGHES G, 1988, BRIT J ACCIDENT EMER, V3, P10; REEVE H, 1989, BRIT MED J, V298, P1432, DOI 10.1136/bmj.298.6685.1432; YATES DW, 1985, INJURY, V14, P456; 1987, 17TH REP; 1987, PROBLEMS SENIOR HOUS	5	10	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					165	166		10.1136/bmj.300.6718.165	http://dx.doi.org/10.1136/bmj.300.6718.165			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105798	Green Published, Bronze			2022-12-28	WOS:A1990CK07700025
J	MCCLELLAND, DBL				MCCLELLAND, DBL			ABC OF TRANSFUSION - HUMAN-ALBUMIN SOLUTIONS	BRITISH MEDICAL JOURNAL			English	Article											MCCLELLAND, DBL (corresponding author), SE SCOTLAND REG BLOOD TRANSFUS CTR,EDINBURGH,SCOTLAND.								0	36	36	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	1990	300	6716					35	37		10.1136/bmj.300.6716.35	http://dx.doi.org/10.1136/bmj.300.6716.35			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG773	2105125	Green Published, Bronze			2022-12-28	WOS:A1990CG77300028
J	HO, VC; CONKLIN, RJ				HO, VC; CONKLIN, RJ			EFFECT OF TOPICAL CYCLOSPORINE RINSE ON ORAL LICHEN-PLANUS	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter											HO, VC (corresponding author), UNIV BRITISH COLUMBIA,VANCOUVER V5Z 1L7,BC,CANADA.							BALATO N, 1989, ARCH DERMATOL, V125, P1430, DOI 10.1001/archderm.125.10.1430; EISEN D, 1990, NEW ENGL J MED, V323, P290, DOI 10.1056/NEJM199008023230502; FRANCES C, 1988, DERMATOLOGICA, V177, P194, DOI 10.1159/000248548	3	26	27	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 8	1991	325	6					435	435						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ804	2062343				2022-12-28	WOS:A1991FZ80400029
J	NEEL, JV				NEEL, JV			UPDATE ON THE GENETIC-EFFECTS OF IONIZING-RADIATION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MUTATION-RATES				NEEL, JV (corresponding author), UNIV MICHIGAN, SCH MED, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA.							DELEHANTY J, 1986, MUTAT RES, V167, P215, DOI 10.1016/0165-1110(86)90031-X; EDWARDS JH, 1990, BRIT MED J, V300, P678, DOI 10.1136/bmj.300.6725.678; GARDNER MJ, 1990, BRIT MED J, V300, P423, DOI 10.1136/bmj.300.6722.423; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; LITTLE M P, 1990, Journal of Radiological Protection, V10, P185, DOI 10.1088/0952-4746/10/3/002; MCKINNEY PA, 1991, BRIT MED J, V302, P681, DOI 10.1136/bmj.302.6778.681; MOHRENWEISER HW, 1989, MUTAT RES, V212, P241, DOI 10.1016/0027-5107(89)90075-4; NEEL JV, 1990, ANNU REV GENET, V24, P327; NEEL JV, 1990, AM J HUM GENET, V46, P1053; ROBERTS L, 1990, SCIENCE, V248, P24, DOI 10.1126/science.2321023; ROESCH WD, 1987, US JAPAN JOINT REASS, V1, P434; RUSSELL W. L., 1963, Repair from genetic radiation damage and differential radiosensitivity in germ cells., P205; RUSSELL WL, 1951, COLD SPRING HARB SYM, V16, P327, DOI 10.1101/SQB.1951.016.01.024; Russell WL, 1965, JAPAN J GENET      S, V40, P128; SATOH C, 1990, PROG CLIN BIOL RES, V340, P197; URQUHART JD, 1991, BRIT MED J, V302, P687, DOI 10.1136/bmj.302.6778.687; YOSHIMOTO Y, 1990, AM J HUM GENET, V46, P1041; 1977, SOURCES EFFECTS IONI, P725; 1990, HLTH EFFECTS EXPOSUR, V13, P421; 1980, EFFECTS POPULATIONS, V15, P524; 1988, SOURCES EFFECTS RISK, P647	21	14	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	1991	266	5					698	701		10.1001/jama.266.5.698	http://dx.doi.org/10.1001/jama.266.5.698			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ140	2072483				2022-12-28	WOS:A1991FZ14000031
J	BARR, PJ				BARR, PJ			MAMMALIAN SUBTILISINS - THE LONG-SOUGHT DIBASIC PROCESSING ENDOPROTEASES	CELL			English	Review							RNAS ENCODING CANDIDATES; FURIN GENE-PRODUCTS; CDNA SEQUENCE; PITUITARY; KEX2; PROTEINASES; EXPRESSION; PRECURSOR; CLEAVAGE; SITE				BARR, PJ (corresponding author), CHIRON CORP,4560 HORTON ST,EMERYVILLE,CA 94608, USA.							BAAR PJ, 1991, DNA CELL BIOL, V10, P319; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BENTLEY AK, 1986, CELL, V45, P343, DOI 10.1016/0092-8674(86)90319-3; BRESNAHAN PA, 1990, J CELL BIOL, V111, P2851, DOI 10.1083/jcb.111.6.2851; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; ROEBROEK AJM, 1986, MOL BIOL REP, V11, P117, DOI 10.1007/BF00364823; SCHALKEN JA, 1987, J CLIN INVEST, V80, P1545, DOI 10.1172/JCI113240; SEIDAH NG, 1991, MOL ENDOCRINOL, V5, P111, DOI 10.1210/mend-5-1-111; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; SMITH AI, 1988, ENDOCR REV, V9, P159, DOI 10.1210/edrv-9-1-159; THOMAS L, 1991, P NATL ACAD SCI USA, V88, P5297, DOI 10.1073/pnas.88.12.5297; TOMKINSON B, 1991, BIOCHEMISTRY-US, V30, P168, DOI 10.1021/bi00215a025; VANDEVEN WJM, 1990, MOL BIOL REP, V14, P265, DOI 10.1007/BF00429896; WISE RJ, 1990, P NATL ACAD SCI USA, V87, P9378, DOI 10.1073/pnas.87.23.9378; YOSHIMASA Y, 1990, J BIOL CHEM, V265, P17230	17	626	660	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 12	1991	66	1					1	3		10.1016/0092-8674(91)90129-M	http://dx.doi.org/10.1016/0092-8674(91)90129-M			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FW913	2070411				2022-12-28	WOS:A1991FW91300001
J	GRAY, GC; ESCAMILLA, J; HYAMS, KC; STRUEWING, JP; KAPLAN, EL; TUPPONCE, AK				GRAY, GC; ESCAMILLA, J; HYAMS, KC; STRUEWING, JP; KAPLAN, EL; TUPPONCE, AK			HYPERENDEMIC STREPTOCOCCUS-PYOGENES INFECTION DESPITE PROPHYLAXIS WITH PENICILLIN-G BENZATHINE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE RHEUMATIC-FEVER; GROUP-A STREPTOCOCCI; SHOCK-LIKE SYNDROME; UNITED-STATES; TOXIC SHOCK; CARRIER STATE; PHARYNGITIS; RESURGENCE; YOUNG	Background. In closely confined populations, in which epidemics of Streptococcus pyogenes infection are common, penicillin G benzathine has long been used prophylactically to reduce morbidity from this pathogen. We report on our investigations of the effectiveness of penicillin G benzathine prophylaxis at a military recruit camp. Methods. We prospectively studied the rates of pharyngeal colonization and infection by S. pyogenes among 736 male U.S. Marine Corps recruits from January through March 1989. Throat swabs for culture, clinical data, and questionnaire data were obtained during six examinations at intervals of two weeks. Serum samples obtained before training, after training, and from acutely ill recruits were analyzed with use of an antistreptolysin O microtitration technique. Results. Although 93 percent of the recruits received prophylaxis with two intramuscular injections of 1.2 million units of penicillin G benzathine each (administered 30 to 39 days apart), 33 percent of the recruits were colonized by S. pyogenes, and 42 percent had infection (as defined by a two-dilution increase in the antistreptolysin O titer). Thirty-seven percent of 265 recruits who reported a sore throat and were infected with S. pyogenes did not seek medical attention. The recruits who were allergic to penicillin (7 percent of the total), who received no prophylaxis, were more likely to be colonized; an increased risk of colonization and infection among the nonallergic recruits was associated with the presence of a higher percentage of allergic recruits in the platoon. After the study was completed, all recruits who were allergic to penicillin were prescribed 250 mg of oral erythromycin twice daily (a total daily dose of 500 mg) for 60 days. Subsequently, the average weekly rate of clinically evident S. pyogenes pharyngitis fell by more than 75 percent. Conclusions. If the prevention of S. pyogenes infection is to be effective in closely confined populations such as military recruits, prophylactic antibiotics must be administered to all members of the population. Exempting those who are allergic to penicillin may create a bacterial reservoir from which infection can be transmitted to nonallergic members of the population.	USN,ENVIRONM & PREVENT MED UNIT 5,DEPT EPIDEMIOL,SAN DIEGO,CA 92132; USN,ENVIRONM & PREVENT MED UNIT 5,DEPT MICROBIOL,SAN DIEGO,CA 92132; USN,MED RES UNIT,BETHESDA,MD 20814; UNIV MINNESOTA,DEPT PEDIAT,WHO,COLLABORATING CTR REFERENCE & RES STREPTOCOCCI,MINNEAPOLIS,MN 55455	United States Department of Defense; United States Navy; United States Department of Defense; United States Navy; United States Department of Defense; United States Navy; University of Minnesota System; University of Minnesota Twin Cities; World Health Organization			Gray, Gregory C./ABF-1298-2020; Struewing, Jeffery P/I-7502-2013; Struewing, Jeffery P/C-3221-2008	Struewing, Jeffery P/0000-0002-4848-3334; Gray, Gregory/0000-0002-4628-5908				AYOUB EM, 1989, J PEDIATR-US, V115, P89, DOI 10.1016/S0022-3476(89)80334-8; BARTTER T, 1988, ARCH INTERN MED, V148, P1421, DOI 10.1001/archinte.148.6.1421; BISNO AL, 1988, JAMA-J AM MED ASSOC, V259, P728, DOI 10.1001/jama.259.5.728; BISNO AL, 1986, RESPIRATORY INFECTIO, V5, P217; BROCK LL, 1953, J CLIN INVEST, V32, P630, DOI 10.1172/JCI102774; BROOKS TJ, 1956, JAMA-J AM MED ASSOC, V160, P162, DOI 10.1001/jama.1956.02960380010004; CHAMOVITZ R, 1954, NEW ENGL J MED, V251, P466, DOI 10.1056/NEJM195409162511203; CONE LA, 1987, NEW ENGL J MED, V317, P146, DOI 10.1056/NEJM198707163170305; DAJANI AS, 1989, PEDIATR INFECT DIS J, V8, P263; DAVIS J, 1957, NEW ENGL J MED, V256, P339, DOI 10.1056/NEJM195702212560803; FISCHETTI VA, 1989, SCIENCE, V244, P1487, DOI 10.1126/science.2660266; FRANK P F, 1958, U S Armed Forces Med J, V9, P543; FRANK PF, 1965, J AMER MED ASSOC, V193, P775, DOI 10.1001/jama.1965.03090100021005; Hosmer D., 1989, APPL LOGISTIC REGRES, P82; JAMES L, 1971, NEW ENGL J MED, V284, P750, DOI 10.1056/NEJM197104082841403; JARRETT ET, 1950, J INFECT DIS, V86, P164, DOI 10.1093/infdis/86.2.164; KAHN HA, 1989, STATISTICAL METHODS; KAPLAN EL, 1971, J INFECT DIS, V123, P490, DOI 10.1093/infdis/123.5.490; KAPLAN EL, 1989, J PEDIATR-US, V115, P146, DOI 10.1016/S0022-3476(89)80352-X; KAPLAN EL, 1989, J INFECT DIS, V159, P101, DOI 10.1093/infdis/159.1.101; KAPLAN EL, 1980, J PEDIATR-US, V97, P337, DOI 10.1016/S0022-3476(80)80178-8; KATZ D, 1978, BIOMETRICS, V34, P469, DOI 10.2307/2530610; KELLOGG JA, 1990, J CLIN MICROBIOL, V28, P165, DOI 10.1128/JCM.28.2.165-169.1990; KLEIN GC, 1968, APPL MICROBIOL, V16, P184, DOI 10.1128/AEM.16.1.184-.1968; KLEIN GC, 1970, AM J CLIN PATHOL, V53, P159; Last J., 1988, DICT EPIDEMIOLOGY; MARCON MJ, 1988, J CLIN MICROBIOL, V26, P1539, DOI 10.1128/JCM.26.8.1539-1542.1988; MARKOWITZ M, 1980, CLIN THER, V3, P49; MEYER RJ, 1962, PEDIATRICS, V29, P539; MORRIS AJ, 1957, JAMA-J AM MED ASSOC, V165, P664, DOI 10.1001/jama.1957.02980240022006; SCHREIER AJ, 1958, NEW ENGL J MED, V258, P1231; SCHWARTZ B, 1990, LANCET, V336, P1167, DOI 10.1016/0140-6736(90)92777-F; SIEGEL AC, 1961, NEW ENGL J MED, V265, P559, DOI 10.1056/NEJM196109212651201; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; STOLLERMAN GH, 1988, ARCH INTERN MED, V148, P1268, DOI 10.1001/archinte.148.6.1268; STOLLERMAN GH, 1988, ARCH INTERN MED, V148, P2600; THOMAS JC, 1989, J INFECT DIS, V160, P1086, DOI 10.1093/infdis/160.6.1086; THOMAS RJ, 1988, REV INFECT DIS, V10, P125; VEASY LG, 1987, NEW ENGL J MED, V316, P421, DOI 10.1056/NEJM198702193160801; WALLACE MR, 1989, JAMA-J AM MED ASSOC, V262, P2557, DOI 10.1001/jama.262.18.2557; WASHINGTON JA, 1974, LABORATORY PROCEDURE, P291; 1972, HIST ACCOMPLISHMENTS; [No title captured]; 1990, MMWR, V39, P3; 1988, WHO TECH REP SER, V764, P1; 1990, MMWR, V39, P11	46	46	46	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	1991	325	2					92	97		10.1056/NEJM199107113250204	http://dx.doi.org/10.1056/NEJM199107113250204			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV522	2052057				2022-12-28	WOS:A1991FV52200004
J	HAHN, DL; DODGE, RW; GOLUBJATNIKOV, R				HAHN, DL; DODGE, RW; GOLUBJATNIKOV, R			ASSOCIATION OF CHLAMYDIA-PNEUMONIAE (STRAIN TWAR) INFECTION WITH WHEEZING, ASTHMATIC BRONCHITIS, AND ADULT-ONSET ASTHMA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYCOPLASMA-PNEUMONIAE; VIRAL-INFECTIONS; TRACHOMATIS; TRACT; PATHOGENESIS; PSITTACOSIS; OUTBREAK; DISEASES; CULTURE; SCHOOL	Objective.- To study the clinical characteristics of respiratory tract illness caused by Chlamydia pneumoniae. Design.- Prospective clinical, bacteriologic, and serologic study. Secondarily, a matched comparison of patients with and without evidence of C pneumoniae infection (serologic titers greater-than-or-equal-to 1:64 and < 1:16, respectively). Setting.- Four primary care (family practice) clinics in Madison, Wis, and nearby towns. Patients. -The study included 365 white males and females (mean age, 34.2 years). Main Outcome Measures.- Association of acute C pneumoniae infection with signs and symptoms of respiratory illness and the relationship of C pneumoniae antibody titer with wheezing at the time of enrollment in the study, and with the diagnosis of asthmatic bronchitis. Results.- Nine (47%) of 19 patients with acute C pneumoniae infection had bronchospasm during respiratory illness, and there was a strong quantitative association of C pneumoniae titer with wheezing at the time of enrollment in the study (P = .01). In the matched study, C pneumoniae antibody was significantly associated with asthmatic bronchitis after, but not before, respiratory illness (odds ratio, 7.2; 95% confidence interval, 2.2 to 23.4). Four infected patients had newly diagnosed asthma after illness, and four. others had exacerbation of previously diagnosed asthma. There was no serologic evidence of coexisting Mycoplasma pneumoniae, Chlamydia trachomatis, or respiratory viral infection in 96% of patients with asthmatic bronchitis and asthma. Conclusions.- Some C pneumoniae antibody titers, although not diagnostic of chlamydial infection by present criteria, probably represent acute reinfection or ongoing chronic infection. Repeated or prolonged exposure to C pneumoniae may have a causal association with wheezing, asthmatic bronchitis, and asthma.	WISCONSIN STATE LAB HYG,MADISON,WI; UNIV WISCONSIN,DEPT PREVENT MED,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison	HAHN, DL (corresponding author), ARCAND PK CLIN,3434 E WASHINGTON AVE,MADISON,WI 53704, USA.							BEEM MO, 1990, CHLAMYDIAL INFECTION, P807; BELL TA, 1989, J INFECTION, V19, P47, DOI 10.1016/S0163-4453(89)94850-0; BRUNHAM RC, 1985, J INFECT DIS, V152, P1275, DOI 10.1093/infdis/152.6.1275; BUSSE WW, 1989, CLIN EXP ALLERGY, V19, P1, DOI 10.1111/j.1365-2222.1989.tb02336.x; CASEY HL, 1965, STANDARDIZED DIAGNOS, P1; CHIRGWIN K, 1989, CLIN RES, V37, pA865; DUNLOP EMC, 1985, SEX TRANSM DIS, V12, P68, DOI 10.1097/00007435-198504000-00003; FRYDEN A, 1989, SCAND J INFECT DIS, V21, P681, DOI 10.3109/00365548909021698; Grayston J. T., 1988, INFECT MED, V5, P215; GRAYSTON JT, 1989, CHEST, V95, P664, DOI 10.1378/chest.95.3.664; GRAYSTON JT, 1989, EUR J CLIN MICROBIOL, V8, P191, DOI 10.1007/BF01965260; GRAYSTON JT, 1985, REV INFECT DIS, V7, P717; GRAYSTON JT, 1989, INT J SYST BACTERIOL, V39, P88, DOI 10.1099/00207713-39-1-88; GRAYSTON JT, 1986, NEW ENGL J MED, V315, P161, DOI 10.1056/NEJM198607173150305; GRAYSTON JT, 1990, J INFECT DIS, V161, P618, DOI 10.1093/infdis/161.4.618; GRAYSTON JT, 1986, CHLAMYDIAL INFECTION, P337; GRAYSTON JT, 1982, CHLAMYDIAL INFECTION, P405; KENNY GE, 1965, J IMMUNOL, V95, P19; KLEEMOLA M, 1988, J INFECT DIS, V157, P230, DOI 10.1093/infdis/157.2.230; MANSEL JK, 1989, CHEST, V95, P639, DOI 10.1378/chest.95.3.639; MCCOMB DE, 1974, APPL MICROBIOL, V28, P727, DOI 10.1128/AEM.28.4.727-729.1974; MORRISON RP, 1989, J EXP MED, V169, P663, DOI 10.1084/jem.169.3.663; OATES JA, 1989, NEW ENGL J MED, V321, P1517; ORIE NGM, 1961, BRONCHITIS INT S, P44; OSSER S, 1989, European Journal of Clinical Microbiology and Infectious Diseases, V8, P532, DOI 10.1007/BF01967475; PATTON DL, 1987, J INFECT DIS, V155, P1292, DOI 10.1093/infdis/155.6.1292; PEDERSEN PA, 1987, CHEST, V91, pS107, DOI 10.1378/chest.91.6.107S; PETHER JVS, 1984, J HYG-CAMBRIDGE, V92, P337, DOI 10.1017/S002217240006455X; PETHER JVS, 1989, EPIDEMIOL INFECT, V103, P395, DOI 10.1017/S0950268800030752; SCHACHTER J, 1979, DIAGNOSTIC PROCEDURE, P1021; STEPHENS RS, 1982, J CLIN MICROBIOL, V16, P4, DOI 10.1128/JCM.16.1.4-7.1982; TAGER IB, 1987, CHEST, V91, pS114, DOI 10.1378/chest.91.6.114S; TATTERSFIELD AE, 1987, CHEST, V91, pS184, DOI 10.1378/chest.91.6.184S; THOM DH, 1990, AM J EPIDEMIOL, V132, P248, DOI 10.1093/oxfordjournals.aje.a115654; WEISS SG, 1986, J PEDIATR-US, V108, P659, DOI 10.1016/S0022-3476(86)81037-X; WILLIAMSON HA, 1987, J FAM PRACTICE, V24, P35; 1986, GLIM GENERALISED LIN	37	436	457	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1991	266	2					225	230		10.1001/jama.266.2.225	http://dx.doi.org/10.1001/jama.266.2.225			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU896	2056624				2022-12-28	WOS:A1991FU89600030
J	CHANT, J; HERSKOWITZ, I				CHANT, J; HERSKOWITZ, I			GENETIC-CONTROL OF BUD SITE SELECTION IN YEAST BY A SET OF GENE-PRODUCTS THAT CONSTITUTE A MORPHOGENETIC PATHWAY	CELL			English	Article							CEREVISIAE CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; MATING TYPES; CDC24 GENE; ACTIN; CDC42; LOCALIZATION; BINDING; MUTANTS	Yeast cells choose bud sites on their surface in two distinct spatial patterns: axial for a and alpha-cells and bipolar for a/alpha-cells. We have identified four genes, BUD1-BUD4, necessary for the axial pattern by isolating mutants of alpha-cells that do not exhibit this pattern. Mutations in BUD1 (which is the same as the previously identified gene RSR1) or BUD2 lead to a random budding pattern in all cell types; mutations in BUD3 or BUD4 lead to a bipolar pattern in all cell types. These observations indicate the existence of a basal budding pattern, requiring no BUD products, that is random; BUD1 and BUD2 act on this basal pattern to create the bipolar pattern; the further action of BUD3 and BUD4 leads to the axial pattern. These studies thus identify a set of gene products that directs cell morphogenesis to a genetically programmed site.	UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM & BIOPHYS, PROGRAM CELL BIOL, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco	CHANT, J (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM & BIOPHYS, PROGRAM GENET, SAN FRANCISCO, CA 94143 USA.							ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Byers B, 1981, MOL BIOL YEAST SACCH, P59; CHANT J, 1991, CELL, V65; DRANGINIS AM, 1990, NATURE, V347, P682, DOI 10.1038/347682a0; DRUBIN DG, 1988, J CELL BIOL, V107, P2551, DOI 10.1083/jcb.107.6.2551; FIELD C, 1980, J CELL BIOL, V86, P123, DOI 10.1083/jcb.86.1.123; FINEGOLD AA, 1991, IN PRESS P NATL ACAD; FREIFELDER D, 1960, J BACTERIOL, V80, P567, DOI 10.1128/JB.80.4.567-568.1960; GOUTTE C, 1988, CELL, V52, P875, DOI 10.1016/0092-8674(88)90429-1; Gunning B.E.S., 1982, DEV ORDER ITS ORIGIN, P379; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; HAYASHIBE M, 1973, J GEN APPL MICROBIOL, V19, P23, DOI 10.2323/jgam.19.23; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; HICKS JB, 1977, GENETICS, V85, P373; HICKS JB, 1976, GENETICS, V83, P245; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; HYMAN AA, 1989, J CELL BIOL, V109, P1185, DOI 10.1083/jcb.109.3.1185; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; JOHNSON DE, 1991, J CELL BIOL, V113, P339, DOI 10.1083/jcb.113.2.339; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; KLAPHOLZ S, 1982, GENETICS, V100, P387; Luria SE, 1943, GENETICS, V28, P491; MIYAMOTO S, 1987, GENE, V54, P125, DOI 10.1016/0378-1119(87)90354-4; MUNEMITSU S, 1990, MOL CELL BIOL, V10, P5977, DOI 10.1128/MCB.10.11.5977; NOVICK P, 1985, CELL, V40, P405, DOI 10.1016/0092-8674(85)90154-0; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; RINE J, 1987, GENETICS, V116, P9; ROBERTS RL, 1983, MOL CELL BIOL, V3, P922, DOI 10.1128/MCB.3.5.922; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sherman F., 1982, METHODS YEAST GENETI; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; SLOAT BF, 1978, SCIENCE, V200, P1171, DOI 10.1126/science.349694; SLOAT BF, 1981, J CELL BIOL, V89, P395, DOI 10.1083/jcb.89.3.395; SNYDER M, 1989, J CELL BIOL, V108, P1419, DOI 10.1083/jcb.108.4.1419; SNYDER M, 1991, IN PRESS J CELL BIOL; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; STRATHERN J, 1981, J MOL BIOL, V147, P357, DOI 10.1016/0022-2836(81)90488-5; TKACZ JS, 1972, J GEN MICROBIOL, V72, P243, DOI 10.1099/00221287-72-2-243; TKACZ JS, 1973, J BACTERIOL, V113, P1073, DOI 10.1128/JB.113.2.1073-1075.1973	43	340	343	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 28	1991	65	7					1203	1212		10.1016/0092-8674(91)90015-Q	http://dx.doi.org/10.1016/0092-8674(91)90015-Q			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FU899	2065354				2022-12-28	WOS:A1991FU89900012
J	HARVEY, PH; PURVIS, A				HARVEY, PH; PURVIS, A			COMPARATIVE METHODS FOR EXPLAINING ADAPTATIONS	NATURE			English	Review							LIFE-HISTORY TRAITS; EVOLUTIONARY TREES; EJACULATE QUALITY; TESTES SIZE; APOSEMATIC COLORATION; CHARACTER EVOLUTION; SPERM COMPETITION; SEXUAL DIMORPHISM; ANOLIS LIZARDS; BODY-WEIGHT	The ways that taxonomic differences in morphology, behaviour or life history are related to each other and to differences in lifestyle have been used regularly to test ideas about the selective forces involved in their evolution. Such comparative tests have been transformed recently by using increased statistical rigour. The realization that the statistical model against which comparisons are made is a model of how evolution proceeds, forms the basis of a new generation of comparative tests that are grounded properly on phylogenetic reconstruction.			HARVEY, PH (corresponding author), UNIV OXFORD, DEPT ZOOL, S PARKS RD, OXFORD OX1 3PS, ENGLAND.		Purvis, Andy/A-7529-2008	Purvis, Andy/0000-0002-8609-6204				BELL G, 1989, AM NAT, V133, P553, DOI 10.1086/284935; BLACKBURN TM, THESIS OXFORD U; BURT A, 1987, NATURE, V326, P803, DOI 10.1038/326803a0; BURT A, 1989, P33; CARPENTER JM, 1989, CLADISTICS, V5, P131, DOI 10.1111/j.1096-0031.1989.tb00560.x; CAVALLISFORZA LL, 1964, 11 P INT C GEN HAG, V3, P923; CHEVERUD JM, 1985, EVOLUTION, V39, P1335, DOI 10.1111/j.1558-5646.1985.tb05699.x; Clutton-Brock Timothy Hugh, 1984, BEHAV ECOLOGY EVOLUT, P7; CLUTTONBROCK TH, 1980, NATURE, V285, P565, DOI 10.1038/285565a0; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; Cope E. D., 1885, AM NAT, V19, P140; CRISCI JV, 1980, SYST BOT, V5, P112, DOI 10.2307/2418621; Darwin C., 1877, ORIGIN SPECIES; Darwin C., 1871, P475; DONOGHUE MJ, 1989, EVOLUTION, V43, P1137, DOI [10.2307/2409353, 10.1111/j.1558-5646.1989.tb02565.x]; DUNHAM AE, 1985, AM NAT, V126, P231, DOI 10.1086/284411; FELSENSTEIN J, 1973, SYST ZOOL, V22, P240, DOI 10.2307/2412304; FELSENSTEIN J, 1988, ANNU REV ECOL SYST, V19, P445, DOI 10.1146/annurev.es.19.110188.002305; FELSENSTEIN J, 1982, Q REV BIOL, V57, P379, DOI 10.1086/412935; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FRIDAY A, 1989, FOLIA PRIMATOL, V53, P221, DOI 10.1159/000156418; Futuyma DJ, 1986, EVOL BIOL; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Grant P. R., 1986, ECOLOGY EVOLUTION DA; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Harvey P.H., 1984, P589; Harvey P.H., 1982, P343; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HARVEY PH, 1981, OIKOS, V37, P391, DOI 10.2307/3544135; HARVEY PH, 1990, SCIENCE, V249, P140, DOI 10.1126/science.2196673; HARVEY PH, 1991, TRENDS ECOL EVOL, V6, P38, DOI 10.1016/0169-5347(91)90118-H; HARVEY PH, 1982, AM NAT, V119, P710, DOI 10.1086/283944; HARVEY PH, 1989, NATURE, V337, P508, DOI 10.1038/337508a0; HARVEY PH, 1978, NATURE, V276, P817, DOI 10.1038/276817a0; HARVEY PH, 1989, MORE EXACT ECOLOGY, P209; HOGLUND J, 1989, AM NAT, V134, P72, DOI 10.1086/284966; Huey R.B., 1987, P76; Huey R.B., 1986, P82; HUEY RB, 1987, EVOLUTION, V41, P1098, DOI 10.1111/j.1558-5646.1987.tb05879.x; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; KREBS JR, 1989, P NATL ACAD SCI USA, V86, P1388, DOI 10.1073/pnas.86.4.1388; Lack D., 1968, pvii; LAUDER GV, 1981, PALEOBIOLOGY, V7, P430, DOI 10.1017/S0094837300025495; Lindgren AR, 2010, CLADISTICS, V56, P1; LOSOS JB, 1990, ECOL MONOGR, V60, P369, DOI 10.2307/1943062; LOSOS JB, 1990, ANIM BEHAV, V39, P879, DOI 10.1016/S0003-3472(05)80952-2; MADDISON W, 1989, CLADISTICS, V5, P365, DOI 10.1111/j.1096-0031.1989.tb00569.x; MADDISON WP, 1984, SYST ZOOL, V33, P83, DOI 10.2307/2413134; MADDISON WP, 1989, FOLIA PRIMATOL, V53, P190, DOI 10.1159/000156416; MADDISON WP, 1990, EVOLUTION; Margulis L., 1981, P1; Martin R.D., 1985, P147; MARTINS EP, 1991, EVOLUTION; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; MOLLER AP, 1988, BIOL J LINN SOC, V33, P273, DOI 10.1111/j.1095-8312.1988.tb00812.x; MOLLER AP, 1989, FUNCT ECOL, V3, P91, DOI 10.2307/2389679; MOLLER AP, 1988, J HUM EVOL, V17, P479, DOI 10.1016/0047-2484(88)90037-1; MOLLER AP, IN PRESS AM NAT; NEE S, 1990, PARASITOLOGY, V100, pS5, DOI 10.1017/S0031182000072978; PACKER C, 1983, SCIENCE, V221, P1191, DOI 10.1126/science.221.4616.1191; PAGEL MD, 1989, FOLIA PRIMATOL, V53, P203, DOI 10.1159/000156417; PAGEL MD, 1988, Q REV BIOL, V63, P413, DOI 10.1086/416027; READ AF, IN PRESS AM NAT; RIDLEY M, 1986, ANIM BEHAV, V34, P1848, DOI 10.1016/S0003-3472(86)80271-8; RIDLEY M, 1988, BIOL REV, V63, P509, DOI 10.1111/j.1469-185X.1988.tb00669.x; Ridley M., 1983, EXPLANATION ORGANIC; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; ROHLF FJ, 1990, EVOLUTION, V44, P1671, DOI 10.1111/j.1558-5646.1990.tb03855.x; SESSIONS SK, 1987, EVOLUTION, V41, P1239, DOI 10.1111/j.1558-5646.1987.tb02463.x; Short R.V., 1981, P319; Short R.V., 1979, Advances in the Study of Behavior, V9, P131, DOI 10.1016/S0065-3454(08)60035-2; SHORT RV, 1977, P CANBERRA S REPRODU, P3; SILLENTULLBERG B, 1988, EVOLUTION, V42, P293, DOI 10.1111/j.1558-5646.1988.tb04133.x; SMITH TC, 1985, EVOLUTION GENOME SIZ; STEARNS SC, 1983, OIKOS, V41, P173, DOI 10.2307/3544261; TORO MA, 1982, HEREDITY, V49, P199, DOI 10.1038/hdy.1982.86; TREVELYAN R, 1990, FUNCT ECOL, V4, P135, DOI 10.2307/2389332; [No title captured]	79	289	292	0	51	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 20	1991	351	6328					619	624		10.1038/351619a0	http://dx.doi.org/10.1038/351619a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT112	2052088				2022-12-28	WOS:A1991FT11200054
J	ZEIDERMAN, MR; WYMAN, A; EUINTON, HA; SIMMS, JM; ROGERS, K				ZEIDERMAN, MR; WYMAN, A; EUINTON, HA; SIMMS, JM; ROGERS, K			DIAGNOSTIC DIFFICULTIES IN PATIENTS WITH A PANCREATIC MASS	BRITISH MEDICAL JOURNAL			English	Article							BILIARY ENDOPROSTHESIS; BILE-DUCT; OBSTRUCTION; ULTRASOUND; BIOPSY; TRIAL		UNIV SHEFFIELD,DEPT SURG,SHEFFIELD S10 2TN,S YORKSHIRE,ENGLAND; UNIV SHEFFIELD,NO GEN HOSP,DEPT RADIOL,SHEFFIELD S10 2TN,S YORKSHIRE,ENGLAND; CHESTERFIELD & N DERBYSHIRE ROYAL HOSP,DEPT SURG,CHESTERFIELD,ENGLAND	University of Sheffield; Northern General Hospital; University of Sheffield								ANDERSON JB, 1985, ANN ROY COLL SURG, V67, P139; ARMSTRONG CP, 1984, BRIT J SURG, V71, P234, DOI 10.1002/bjs.1800710326; BORNMAN PC, 1986, LANCET, V1, P69; CHRISTOFFERSEN P, 1970, ACTA PATHOL MIC SC, V212, P28; HOUDENAK N, 1982, BMJ, V285, P1183; JAEGER HJ, 1990, BMJ-BRIT MED J, V301, P1188, DOI 10.1136/bmj.301.6762.1188; LIGHTWOOD R, 1976, AM J SURG, V132, P451; MATZEN P, 1983, GASTROENTEROLOGY, V84, P1492; McLeod G G, 1986, J R Coll Surg Edinb, V31, P210; MITCHELL CJ, 1989, BRIT J SURG, V76, P706, DOI 10.1002/bjs.1800760718; SHEPHERD HA, 1988, BRIT J SURG, V75, P1166, DOI 10.1002/bjs.1800751207; VANSTIEGMANN G, 1981, S AFR MED J, V60, P97; VENNES JA, 1983, GASTROENTEROLOGY, V84, P1615	13	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 8	1991	302	6789					1395	1396		10.1136/bmj.302.6789.1395	http://dx.doi.org/10.1136/bmj.302.6789.1395			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR057	2059723	Bronze, Green Published			2022-12-28	WOS:A1991FR05700030
J	LEVINE, AJ; MOMAND, J; FINLAY, CA				LEVINE, AJ; MOMAND, J; FINLAY, CA			THE P53 TUMOR SUPPRESSOR GENE	NATURE			English	Review							TRANSFORMED-CELLS; LUNG-CANCER; T-ANTIGEN; SV40-TRANSFORMED CELLS; BREAST-CANCER; MUTANT P53; WILD-TYPE; MUTATIONS; SV40; ONCOGENE	The cell cycle is composed of a series of steps which can be negatively or positively regulated by various factors. Chief among the negative regulators is the p53 protein. Alteration or inactivation of p53 by mutation, or by its interactions with oncogene products of DNA tumour viruses, can lead to cancer. These mutations seem to be the most common genetic change in human cancers.			LEVINE, AJ (corresponding author), PRINCETON UNIV,LEWIS THOMAS LAB,DEPT MOLEC BIOL,PRINCETON,NJ 08544, USA.		Momand, Jamil/F-8154-2012; Dittmer, Dirk/AAH-3535-2021	Dittmer, Dirk/0000-0003-4968-5656				BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BAKER SJ, 1990, CANCER RES, V50, P7717; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BARTEK J, 1990, ONCOGENE, V5, P893; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; CHIBA I, 1990, ONCOGENE, V5, P1603; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; GANNON JV, 1991, NATURE, V349, P802; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; GINSBERG D, IN PRESS MOL CELL BI; HALVEY O, 1990, SCIENCE, V250, P113; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; JAMES CD, 1989, P NATL ACAD SCI USA, V86, P2858, DOI 10.1073/pnas.86.8.2858; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KELMAN Z, 1989, BLOOD, V74, P2318; KERN SE, 1991, ONCOGENE, V6, P131; LABOW MA, 1990, MOL CELL BIOL, V10, P3343, DOI 10.1128/MCB.10.7.3343; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; LINZER DIH, 1979, VIROLOGY, V98, P308, DOI 10.1016/0042-6822(79)90554-3; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; MACKAY J, 1988, LANCET, V2, P1384; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; MERCER WF, 1990, J CELL BIOCHEM, V14, P285; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; MULLIGAN LM, 1990, P NATL ACAD SCI USA, V87, P5863, DOI 10.1073/pnas.87.15.5863; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; OREN M, 1981, MOL CELL BIOL, V1, P101, DOI 10.1128/MCB.1.2.101; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PROSSER J, 1990, ONCOGENE, V5, P1573; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; REICH NC, 1983, MOL CELL BIOL, V3, P2143, DOI 10.1128/MCB.3.12.2143; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; ROMANO JW, 1989, ONCOGENE, V4, P1483; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, IN PRESS P NATN ACAD; SOUSSI T, 1990, ONCOGENE, V5, P945; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; VOGELSTEIN B, 1990, NATURE, V348, P681, DOI 10.1038/348681a0; WANG EH, 1989, CELL, V57, P379, DOI 10.1016/0092-8674(89)90913-6; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WILCOCK D, 1991, NATURE, V349, P429, DOI 10.1038/349429a0; WOLF D, 1984, CELL, V38, P119, DOI 10.1016/0092-8674(84)90532-4; YEWDELL JW, 1986, J VIROL, V59, P444, DOI 10.1128/JVI.59.2.444-452.1986	61	3950	4069	4	433	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 6	1991	351	6326					453	456		10.1038/351453a0	http://dx.doi.org/10.1038/351453a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP758	2046748				2022-12-28	WOS:A1991FP75800045
J	FREEMAN, J; GOLDMANN, DA; SMITH, NE; SIDEBOTTOM, DG; EPSTEIN, MF; PLATT, R				FREEMAN, J; GOLDMANN, DA; SMITH, NE; SIDEBOTTOM, DG; EPSTEIN, MF; PLATT, R			ASSOCIATION OF INTRAVENOUS LIPID EMULSION AND COAGULASE-NEGATIVE STAPHYLOCOCCAL BACTEREMIA IN NEONATAL INTENSIVE-CARE UNITS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									BRIGHAM & WOMENS HOSP, DEPT MED, CHANNING LAB, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DEPT NEWBORN MED, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, INFECT CONTROL UNIT, BOSTON, MA 02115 USA; BROCKTON W ROXBURY VET AFFAIRS MED CTR, BOSTON, MA USA; CHILDRENS HOSP MED CTR, DIV INFECT DIS, BOSTON, MA 02115 USA; CHILDRENS HOSP MED CTR, INFECT CONTROL PROGRAM, BOSTON, MA 02115 USA; CHILDRENS HOSP MED CTR, DIV NEWBORN MED, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA; HARVARD UNIV, SCH PUBL HLTH, DEPT EPIDEMIOL, CAMBRIDGE, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health					FDA HHS [FD-U-000315] Funding Source: Medline	FDA HHS		ADAMS JM, 1980, PEDIATRICS, V65, P94; AZIMI PH, 1988, PEDIATR INFECT DIS J, V7, P100, DOI 10.1097/00006454-198802000-00007; BALAGTAS RC, 1971, PEDIATRICS, V48, P359; BARD H, 1973, ARCH DIS CHILD, V48, P630, DOI 10.1136/adc.48.8.630; BATTISTI O, 1981, ARCH DIS CHILD, V56, P775, DOI 10.1136/adc.56.10.775; BAUMGART S, 1983, AM J DIS CHILD, V137, P461, DOI 10.1001/archpedi.1983.02140310043012; BELL LM, 1988, INFECT CONT HOSP EP, V9, P151, DOI 10.1086/645819; CAINEN G, 1984, CLIN PEDIATR, V23, P542; Cochran W.G, 1957, STAT METHODS, V6th ed; COCHRAN WD, 1968, PEDIATRICS, V42, P769; COOPER GL, 1988, J CLIN MICROBIOL, V26, P8, DOI 10.1128/JCM.26.1.8-12.1988; CROCKER KS, 1984, JPEN-PARENTER ENTER, V8, P391, DOI 10.1177/0148607184008004391; CROSSLEY K, 1972, J AMER MED ASSOC, V220, P985, DOI 10.1001/jama.220.7.985; DONOWITZ LG, 1987, AM J INFECT CONTROL, V15, P141, DOI 10.1016/0196-6553(87)90137-4; FEINSTEIN AR, 1988, SCIENCE, V242, P1257, DOI 10.1126/science.3057627; FISCHER GW, 1980, LANCET, V2, P819; FLEER A, 1983, PEDIATR INFECT DIS J, V2, P426, DOI 10.1097/00006454-198311000-00003; FREEMAN J, 1990, AM J DIS CHILD, V144, P324, DOI 10.1001/archpedi.1990.02150270074029; FREEMAN J, 1987, JAMA-J AM MED ASSOC, V258, P2548, DOI 10.1001/jama.258.18.2548; FREEMAN J, 1988, REV INFECT DIS, V10, P1118; GOLDMANN DA, 1988, J HOSP INFECT, V11, P340, DOI 10.1016/0195-6701(88)90209-5; GOLDMANN DA, 1981, J INFECT DIS, V144, P449, DOI 10.1093/infdis/144.5.449; HEMMING VG, 1976, NEW ENGL J MED, V294, P1310, DOI 10.1056/NEJM197606102942403; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; KRAUSS AN, 1972, NEW YORK STATE J MED, V72, P1136; Lennette E.H, 1985, MANUAL CLIN MICROBIO, V4th ed.; LONG JG, 1985, PEDIATRICS, V76, P896; MAKI DG, 1982, CURRENT CLIN TOPICS, V3, P309; MANROE BL, 1979, J PEDIATR-US, V95, P89, DOI 10.1016/S0022-3476(79)80096-7; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MELLY MA, 1975, ARCH SURG-CHICAGO, V110, P1479; MUNSON DP, 1982, J PEDIATR-US, V101, P602, DOI 10.1016/S0022-3476(82)80718-X; NEAL WA, 1972, PEDIATRICS, V50, P6; NELSON JD, 1988, HOSPITAL ACQUIRED IN, P273; PENNINGTON CR, 1988, LANCET, V1, P947; PETER G, 1972, J PEDIATR-US, V80, P78, DOI 10.1016/S0022-3476(72)80457-8; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; PLATT R, 1988, American Journal of Preventive Medicine, V4, P39; POWELL DA, 1984, J PEDIATR-US, V105, P987, DOI 10.1016/S0022-3476(84)80096-7; QUIE PG, 1987, J INFECT DIS, V156, P543, DOI 10.1093/infdis/156.4.543; RODWELL RL, 1988, J PEDIATR-US, V112, P761, DOI 10.1016/S0022-3476(88)80699-1; Rothman K, 1986, MODERN EPIDEMIOLOGY; Rothman KJ, 1979, EPIDEMIOLOGIC ANAL P; SARRUT S, 1969, ARCH FR PEDIATR, V26, P651; SCHMIDT BK, 1987, PEDIATR INFECT DIS J, V6, P1026, DOI 10.1097/00006454-198706110-00004; SCOTT JM, 1965, ARCH DIS CHILD, V40, P426, DOI 10.1136/adc.40.212.426; SIDEBOTTOM DG, 1988, J CLIN MICROBIOL, V26, P713, DOI 10.1128/JCM.26.4.713-718.1988; TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713; VALVANO MA, 1988, PEDIATR INFECT DIS J, V7, P116, DOI 10.1097/00006454-198802000-00010; VIDYASAGAR D, 1970, CLIN PEDIATR, V9, P332, DOI 10.1177/000992287000900609; WEESEMAYER DE, 1987, PEDIATR INFECT DIS J, V6, P190, DOI 10.1097/00006454-198702000-00009; [No title captured]	52	229	237	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 2	1990	323	5					301	308		10.1056/NEJM199008023230504	http://dx.doi.org/10.1056/NEJM199008023230504			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ996	2082952				2022-12-28	WOS:A1990DQ99600004
J	JURNAK, F; HEFFRON, S; BERGMANN, E				JURNAK, F; HEFFRON, S; BERGMANN, E			CONFORMATIONAL-CHANGES INVOLVED IN THE ACTIVATION OF RAS P21 - IMPLICATIONS FOR RELATED PROTEINS	CELL			English	Review											JURNAK, F (corresponding author), UNIV CALIF RIVERSIDE,DEPT BIOCHEM,RIVERSIDE,CA 92521, USA.							ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOSCH L, 1989, GUANINE NUCLEOTIDE B; CHEN JM, 1989, J BIOMOL STRUCT DYN, V6, P859, DOI 10.1080/07391102.1989.10506518; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; DEVOS AM, 1988, SCIENCE, V239, P888, DOI 10.1126/science.2448879; JONES TA, 1985, METHOD ENZYMOL, V115, P157; MCCORMICK F, 1989, NATURE, V340, P678, DOI 10.1038/340678a0; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; SCHULZ GE, 1987, COLD SPRING HARB SYM, V52, P429, DOI 10.1101/SQB.1987.052.01.050; SIGAL IS, 1988, COLD SPRING HARB SYM, V53, P863, DOI 10.1101/SQB.1988.053.01.099; TONG L, 1989, SCIENCE, V245, P244, DOI 10.1126/science.2665078; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624	13	60	60	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	FEB 23	1990	60	4					525	528		10.1016/0092-8674(90)90652-U	http://dx.doi.org/10.1016/0092-8674(90)90652-U			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ723	2105846				2022-12-28	WOS:A1990CQ72300002
J	GARRUD, P				GARRUD, P			COUNSELING NEEDS AND EXPERIENCE OF JUNIOR HOSPITAL DOCTORS	BRITISH MEDICAL JOURNAL			English	Article											GARRUD, P (corresponding author), QUEENS MED CTR,BEHAV SCI SECT,NOTTINGHAM NG7 2UH,ENGLAND.							Allen, 1988, DOCTORS THEIR CAREER; Allinson T., 1989, PSYCHOLOGIST, V2, P384; ALTMAIER EM, 1988, OBSTET GYNECOL, V72, P126; FIRTHCOZENS J, 1989, BRIT J HOSP MED, V41, P161; FIRTHCOZENS J, 1987, BRIT MED J, V295, P533, DOI 10.1136/bmj.295.6597.533; GANGSTER DC, 1982, J APPL PSYCHOL, V67, P533; HUNTER S, 1989, CAREERS COUNSELLING; MCINNES D, 1988, HLTH TRENDS, V20, P101; QUATTLEBAUM TG, 1988, AM J DIS CHILD, V142, P758, DOI 10.1001/archpedi.1988.02150070072028; 1987, CAREERS WOMEN MED PL; 1987, HOSPITAL MED STAFFIN; 1986, HOSPITAL MED STAFFIN	12	20	20	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 17	1990	300	6722					445	447		10.1136/bmj.300.6722.445	http://dx.doi.org/10.1136/bmj.300.6722.445			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP166	2107900	Green Published, Bronze			2022-12-28	WOS:A1990CP16600025
J	KNIGHT, RA; HODSON, ME				KNIGHT, RA; HODSON, ME			IDENTIFICATION OF THE CYSTIC-FIBROSIS GENE	BRITISH MEDICAL JOURNAL			English	Editorial Material											KNIGHT, RA (corresponding author), NATL HEART & LUNG INST,DEPT CYST FIBROSIS,LONDON SW3 6LY,ENGLAND.							CRAUFURD D, 1989, LANCET, V2, P603; DODGE JA, 1988, LANCET, V2, P672; DZIERZAK EA, 1988, NATURE, V331, P35, DOI 10.1038/331035a0; EIBERG H, 1985, CLIN GENET, V28, P265; GOODFELLOW PN, 1989, NATURE, V341, P102, DOI 10.1038/341102a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM BS, 1989, AM J HUM GENET, V44, P827; KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; TENKATE LP, 1989, NATURE, V342, P131, DOI 10.1038/342131a0; TENKATE LP, 1989, LANCET, V2, P973	12	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					345	346		10.1136/bmj.300.6721.345	http://dx.doi.org/10.1136/bmj.300.6721.345			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106981	Bronze, Green Published			2022-12-28	WOS:A1990CN79900003
J	NIXON, SJ				NIXON, SJ			DEFINING ESSENTIAL HOSPITAL DATA	BRITISH MEDICAL JOURNAL			English	Article											NIXON, SJ (corresponding author), WESTERN GEN HOSP,GEN SURG UNIT,D BLOCK,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.								0	6	6	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					380	381		10.1136/bmj.300.6721.380	http://dx.doi.org/10.1136/bmj.300.6721.380			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106995	Bronze, Green Published			2022-12-28	WOS:A1990CN79900028
J	ROWEJONES, DC; PEEL, ALG; KINGSTON, RD; SHAW, JFL; TEASDALE, C; COLE, DS				ROWEJONES, DC; PEEL, ALG; KINGSTON, RD; SHAW, JFL; TEASDALE, C; COLE, DS			SINGLE DOSE CEFOTAXIME PLUS METRONIDAZOLE VERSUS 3 DOSE CEFUROXIME PLUS METRONIDAZOLE AS PROPHYLAXIS AGAINST WOUND-INFECTION IN COLORECTAL SURGERY - MULTICENTER PROSPECTIVE RANDOMIZED STUDY	BRITISH MEDICAL JOURNAL			English	Article									N TEES GEN HOSP,STOCKTON ON TEES,CLEVELAND,ENGLAND; TRAFFORD GEN HOSP,MANCHESTER,ENGLAND; DERRIFORD & FREEDOM FIELDS HOSP,PLYMOUTH,DEVON,ENGLAND; ROUSSEL LABS LTD,UXBRIDGE,MIDDX,ENGLAND	University Hospital of North Tees	ROWEJONES, DC (corresponding author), POOLE GEN HOSP,POOLE BH15 2JB,DORSET,ENGLAND.							BURDON D W, 1987, South African Medical Journal, V71, P15; CANN KJ, 1988, J HOSP INFECT, V12, P207, DOI 10.1016/0195-6701(88)90008-4; COLIZZA S, 1987, J SURG ONCOL, V35, P266, DOI 10.1002/jso.2930350412; Cunliffe W J, 1985, J R Coll Surg Edinb, V30, P123; DANZIGER L, 1987, DRUG INTEL CLIN PHAR, V21, P406, DOI 10.1177/106002808702100502; DIAMOND T, 1988, J HOSP INFECT, V12, P215, DOI 10.1016/0195-6701(88)90009-6; DIPIRO JT, 1989, J ANTIMICROB CHEMOTH, V23, P71, DOI 10.1093/jac/23.suppl_D.71; EYKYN SJ, 1979, LANCET, V2, P761; FRY DE, 1988, AM J SURG, V155, P11, DOI 10.1016/S0002-9610(88)80206-X; FUCHS PC, 1989, J ANTIMICROB CHEMOTH, V23, P165, DOI 10.1093/jac/23.1.165; HADDOCK G, 1988, J HOSP INFECT, V11, P286, DOI 10.1016/0195-6701(88)90107-7; HASTINGS RP, 1986, SUGI SUPPLEMENTAL LI, P269; JAGELMAN DG, 1988, AM J SURG, V155, P71, DOI 10.1016/S0002-9610(88)80217-4; JONES RN, 1987, DIAGN MICR INFEC DIS, V7, P219, DOI 10.1016/0732-8893(87)90009-5; KEIGHLEY MRB, 1979, LANCET, V1, P894; Kingston R D, 1989, J R Coll Surg Edinb, V34, P208; KINGSTON RD, 1986, J HOSP INFECT, V7, P100, DOI 10.1016/0195-6701(86)90036-8; MITTERMAYER H, 1984, AM SURGEON, V50, P418; ROWEJONES DC, 1988, J HOSP INFECT, V12, P131, DOI 10.1016/0195-6701(88)90136-3; SHEPHERD A, 1985, 14TH P ICC KYOT  TOK, P2425; STUBBS RS, 1987, J HOSP INFECT, V9, P285, DOI 10.1016/0195-6701(87)90126-5; SUTTON GLJ, 1985, 14TH P ICC KYOT TOK, P2474; WHITEHEAD J, 1983, BIOMETRICS, V39, P227, DOI 10.2307/2530822	23	58	60	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	1990	300	6716					18	22		10.1136/bmj.300.6716.18	http://dx.doi.org/10.1136/bmj.300.6716.18			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG773	2105115	Bronze, Green Published			2022-12-28	WOS:A1990CG77300017
J	MOSLEY, JW; AACH, RD; HOLLINGER, FB; STEVENS, CE; BARBOSA, LH; NEMO, GJ; HOLLAND, PV; BANCROFT, WH; ZIMMERMAN, HJ; KUO, G; CHOO, QL; HOUGHTON, M				MOSLEY, JW; AACH, RD; HOLLINGER, FB; STEVENS, CE; BARBOSA, LH; NEMO, GJ; HOLLAND, PV; BANCROFT, WH; ZIMMERMAN, HJ; KUO, G; CHOO, QL; HOUGHTON, M			NON-A, NON-B HEPATITIS AND ANTIBODY TO HEPATITIS-C VIRUS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note									CHIRON CORP,EMERYVILLE,CA; NHLBI,TRANSFUS TRANSMITTED VIRUS STUDY GRP,BETHESDA,MD 20205; NHLBI,DIV BLOOD DIS & RESOURCES,BETHESDA,MD 20205; NHLBI,TRANSFUS TRANSMITTED VIRUS STUDY GRP,REPOSITORY USE COMM,EMERYVILLE,CA	Novartis; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)			Hollinger, F Blaine/AAY-3323-2021		NHLBI NIH HHS [N01-HB-42972] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AACH RD, 1981, NEW ENGL J MED, V304, P989, DOI 10.1056/NEJM198104233041701; BRADLEY DW, 1983, J INFECT DIS, V148, P254, DOI 10.1093/infdis/148.2.254; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; FEINSTONE SM, 1975, NEW ENGL J MED, V292, P767, DOI 10.1056/NEJM197504102921502; HOLLINGER FB, 1980, J INFECT DIS, V142, P400, DOI 10.1093/infdis/142.3.400; HOLLINGER FB, 1982, VIRAL HEPATITIS, P361; KARVOUNTZIS GG, 1975, AM J MED, V58, P815, DOI 10.1016/0002-9343(75)90637-3; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; MOSLEY JW, 1977, NEW ENGL J MED, V296, P75, DOI 10.1056/NEJM197701132960204; PRINCE AM, 1974, LANCET, V2, P241; STEVENS CE, 1984, ANN INTERN MED, V101, P733, DOI 10.7326/0003-4819-101-6-733	11	74	74	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	1990	263	1					77	78		10.1001/jama.263.1.77	http://dx.doi.org/10.1001/jama.263.1.77			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF777	2104549				2022-12-28	WOS:A1990CF77700028
J	KRISHNA, GG; KAPOOR, SC				KRISHNA, GG; KAPOOR, SC			POTASSIUM-DEPLETION EXACERBATES ESSENTIAL-HYPERTENSION	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-PRESSURE; DIETARY POTASSIUM; VASCULAR-RESISTANCE; RACIAL-DIFFERENCES; SODIUM; RATS; CHLORIDE; MEN; SUPPLEMENTATION; HYPOKALEMIA	Objective: To determine the effect of potassium depletion on blood pressure in patients with essential hypertension. Design: Double-blind, randomized, crossover study, with each patient serving as his or her own control. Setting: Clinical research center at a university hospital. Patients: Twelve patients with hypertension. Interventions: Patients were placed on 10-day isocaloric diets providing a daily potassium intake of either 16 mmol or 96 mmol. The intake of sodium (120 mmol/d) and other minerals was kept constant. On day 11 each patient received a 2-litre isotonic saline infusion over 4 hours. Measurements: Blood pressure; urinary excretion rates for sodium, potassium, calcium, and phosphorous; glomerular filtration rate; renal plasma flow; and plasma levels of vasoactive hormones. Main Results: With low potassium intake, systolic blood pressure increased (P = 0.01) by 7 mm Hg (95% Cl, 3 mm Hg to 11 mm Hg) and diastolic pressure increased (P = 0.04) by 6 mm Hg (Cl, 1 mm Hg to 11 mm Hg), whereas plasma potassium concentration decreased (P < 0.001) by 0.8 mmol/L (Cl, 0.4 to 1.0 mmol/L). In response to a 2-litre isotonic saline infusion, the mean arterial pressure increased similarly on both diets but reached higher levels on low potassium intake (115 +/- 2 mm Hg compared with 109 +/- 2 mm Hg, P = 0.03). Potassium depletion was associated with a decrease in sodium excretion (83 +/- 6 mmol/d compared with 110 +/- 5 mmol/d, P < 0.001). Plasma renin activity and plasma aldosterone concentrations also decreased in patients during low potassium intake, but concentrations of arginine vasopressin and atrial natriuretic peptide, glomerular filtration rate, and renal plasma flow were unchanged. Further, low potassium intake increased urinary excretion of calcium and phosphorus and of plasma immunoreactive parathyroid hormone levels. Conclusion: Dietary potassium restriction increases blood pressure in patients with essential hypertension. Both sodium retention and calcium depletion may contribute to the increase in blood pressure during potassium depletion.	TEMPLE UNIV, PHILADELPHIA, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	KRISHNA, GG (corresponding author), UNIV PENN, RENAL ELECTROLYTE SECT, 700 CLIN RES BLDG, 422 CURIE BLVD, PHILADELPHIA, PA 19104 USA.				NCRR NIH HHS [RR003934, RR00040] Funding Source: Medline; NHLBI NIH HHS [R23HL37372] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R23HL037372] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENEDETTI RG, 1985, KIDNEY INT, V28, P621, DOI 10.1038/ki.1985.174; BOEGEHOLD MA, 1989, HYPERTENSION, V14, P579, DOI 10.1161/01.HYP.14.6.579; BRACE RA, 1974, P SOC EXP BIOL MED, V145, P1389; COLTON T, 1974, STAT MED, P99; DUSTAN HP, 1983, ANN INTERN MED, V98, P660, DOI 10.7326/0003-4819-98-5-660; ELLIOTT P, 1988, BRIT MED J, V297, P319; FERRANNINI E, 1987, NEW ENGL J MED, V317, P350, DOI 10.1056/NEJM198708063170605; FUJITA T, 1983, KIDNEY INT, V24, P731, DOI 10.1038/ki.1983.220; FUJITA T, 1984, AM J PHYSIOL, V246, pF670, DOI 10.1152/ajprenal.1984.246.5.F670; GRIM CE, 1980, J CHRON DIS, V33, P87, DOI 10.1016/0021-9681(80)90032-6; GRIMM RH, 1990, NEW ENGL J MED, V322, P569, DOI 10.1056/NEJM199003013220901; HAMLYN JM, 1986, AM J PHYSIOL, V251, pF563, DOI 10.1152/ajprenal.1986.251.4.F563; HUTH EJ, 1959, J CLIN INVEST, V38, P1149, DOI 10.1172/JCI103891; KAPLAN NM, 1985, NEW ENGL J MED, V312, P746, DOI 10.1056/NEJM198503213121203; KHAW KT, 1987, NEW ENGL J MED, V316, P235, DOI 10.1056/NEJM198701293160502; KHAW KT, 1984, AM J CLIN NUTR, V39, P963, DOI 10.1093/ajcn/39.6.963; KRISHNA GG, 1990, J AM SOC NEPHROL, V1, P43; KRISHNA GG, 1991, AM J KIDNEY DIS, V17, P18, DOI 10.1016/S0272-6386(12)80244-7; KRISHNA GG, 1988, KIDNEY INT, V33, P578, DOI 10.1038/ki.1988.36; KRISHNA GG, 1989, NEW ENGL J MED, V320, P1177, DOI 10.1056/NEJM198905043201804; KRISHNA GG, 1987, J LAB CLIN MED, V109, P724; LANGFORD HG, 1983, ANN INTERN MED, V98, P770, DOI 10.7326/0003-4819-98-5-770; LAWTON WJ, 1990, CIRCULATION, V81, P173, DOI 10.1161/01.CIR.81.1.173; LEMANN J, 1989, KIDNEY INT, V35, P688, DOI 10.1038/ki.1989.40; LINAS SL, 1991, KIDNEY INT, V39, P771, DOI 10.1038/ki.1991.95; LINAS SL, 1986, HYPERTENSION, V8, P990, DOI 10.1161/01.HYP.8.11.990; MCCARRON DA, 1989, KIDNEY INT, V35, P717, DOI 10.1038/ki.1989.44; PRATT JH, 1989, NEW ENGL J MED, V321, P1152, DOI 10.1056/NEJM198910263211703; REED D, 1985, HYPERTENSION, V7, P405, DOI 10.1161/01.HYP.7.3_Pt_1.405; SCHEFLER WC, 1984, STATISTICS HLTH PROF, P179; SEBASTIAN A, 1990, KIDNEY INT, V37, P1341, DOI 10.1038/ki.1990.120; SMITH SJ, 1985, BMJ-BRIT MED J, V290, P110, DOI 10.1136/bmj.290.6462.110; SUZUKI H, 1981, HYPERTENSION, V3, P566, DOI 10.1161/01.HYP.3.5.566; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; WITTEMAN JCM, 1989, CIRCULATION, V80, P1320, DOI 10.1161/01.CIR.80.5.1320; WORKMAN ML, 1985, AM J PHYSIOL, V249, pH907, DOI 10.1152/ajpheart.1985.249.5.H907	36	116	120	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	1991	115	2					77	83		10.7326/0003-4819-115-2-77	http://dx.doi.org/10.7326/0003-4819-115-2-77			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW091	2058867				2022-12-28	WOS:A1991FW09100001
J	CHRISTINCK, ER; LUSCHER, MA; BARBER, BH; WILLIAMS, DB				CHRISTINCK, ER; LUSCHER, MA; BARBER, BH; WILLIAMS, DB			PEPTIDE BINDING TO CLASS-I MHC ON LIVING CELLS AND QUANTITATION OF COMPLEXES REQUIRED FOR CTL LYSIS	NATURE			English	Article							MONOCLONAL-ANTIBODIES; HLA MOLECULES; RECOGNITION; ANTIGENS; BETA-2-MICROGLOBULIN; INVITRO; H-2	ANTIGENIC peptides are presented to CD8+ T lymphocytes by class I major histocompatibility complex (MHC) molecules 1,2. Peptides specifically bind to purified class I molecules in vitro 3-7, and to class I molecules on cells at nonphysiological temperatures 8. We report here the kinetic and equilibrium parameters for the binding of radiolabelled influenza nucleoprotein peptides (NP-Y365-380 and shorter homologues) to the murine H-2D(b) molecule on intact, viable cells at 37-degrees-C. In contrast to earlier reports, we show that peptide binding is rapid and reversible, with dissociation constants ranging from nanomolar to micromolar, suggestive of typical ligand-receptor interactions. Only 10% of cell-surface D(b) molecules can bind these peptides. To address the relationship between peptide binding and T-cell recognition of the antigen-MHC complex, we determined the minimum number of complexes required to sensitize a target cell for lysis by class I-restricted cytotoxic T-lymphocytes. Our data indicate that EL4 thymoma cells (H-2b) can be sensitized for lysis by cytotoxic T-lymphocytes when as few as 200 class I-peptide complexes (less than 0.08% of surface D(b) molecules) are present per cell.	UNIV TORONTO,DEPT IMMUNOL,TORONTO M5S 1A8,ONTARIO,CANADA	University of Toronto	CHRISTINCK, ER (corresponding author), UNIV TORONTO,DEPT BIOCHEM,TORONTO M5S 1A8,ONTARIO,CANADA.							BODMER HC, 1989, IMMUNOLOGY, V66, P163; BUUS S, 1986, CELL, V47, P1071, DOI 10.1016/0092-8674(86)90822-6; CARRENO BM, 1990, P NATL ACAD SCI USA, V87, P3420, DOI 10.1073/pnas.87.9.3420; CEPPELLINI R, 1989, NATURE, V339, P392, DOI 10.1038/339392a0; CHEN BP, 1990, J EXP MED, V172, P931, DOI 10.1084/jem.172.3.931; CHEN BP, 1989, NATURE, V337, P743, DOI 10.1038/337743a0; CHOPPIN J, 1990, J EXP MED, V172, P889, DOI 10.1084/jem.172.3.889; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; FRELINGER JA, 1990, J EXP MED, V172, P827, DOI 10.1084/jem.172.3.827; GORER PA, 1950, BRIT J CANCER, V4, P372, DOI 10.1038/bjc.1950.36; HAMMERLING GJ, 1982, P NATL ACAD SCI-BIOL, V79, P4737, DOI 10.1073/pnas.79.15.4737; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; HYMAN R, 1976, IMMUNOGENETICS, V3, P75, DOI 10.1007/BF01576940; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; KOZLOWSKI S, 1991, NATURE, V349, P74, DOI 10.1038/349074a0; LAGARDE AE, 1984, SOMAT CELL MOLEC GEN, V10, P503, DOI 10.1007/BF01534855; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x; OZATO K, 1980, J IMMUNOL, V124, P533; OZATO K, 1982, TRANSPLANTATION, V34; ROCK KL, 1990, P NATL ACAD SCI USA, V87, P7517, DOI 10.1073/pnas.87.19.7517; ROCK KL, 1991, P NATL ACAD SCI USA, V88, P301, DOI 10.1073/pnas.88.1.301; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SMITH MH, 1986, MOL IMMUNOL, V23, P1077, DOI 10.1016/0161-5890(86)90006-4; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; VANBLEEK GM, 1990, NATURE, V348, P213; VITIELLO A, 1990, SCIENCE, V250, P1423, DOI 10.1126/science.2124002	29	340	350	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1991	352	6330					67	70		10.1038/352067a0	http://dx.doi.org/10.1038/352067a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV178	2062379				2022-12-28	WOS:A1991FV17800072
J	CHAKRABARTTY, A; SCHELLMAN, JA; BALDWIN, RL				CHAKRABARTTY, A; SCHELLMAN, JA; BALDWIN, RL			LARGE DIFFERENCES IN THE HELIX PROPENSITIES OF ALANINE AND GLYCINE	NATURE			English	Article							OCCURRING AMINO-ACIDS; COIL STABILITY-CONSTANTS; FORMING TENDENCIES; ALPHA-HELICES; PEPTIDES; WATER; PARAMETERS	THE standard view of alpha-helix formation in water, based on helix propensities determined by the host-guest method 1,2, is that differences in helix propensity among the amino acids are small, except for proline 3, and that the average value of the helix propagation parameter s is near 1. A contradictory view of alpha-helix formation in water is emerging from substitution experiments with short, unique-sequence peptides that contain only naturally occurring amino acids 4-9. Short peptides that contain only alanine and lysine, or alanine and glutamate, form surprisingly stable monomeric helices in water 9 and substitution of a single alanine residue by another amino acid in these or related peptides produces a wide range of changes in helix content, depending on which amino acid is substituted for alanine 4-6,8. We show here that the ratio of the helix propensities of alanine to glycine is large, about 100, in substitution experiments with a 17-residue reference peptide containing alanine and lysine. The helix propensity is identified with s, the helix propagation parameter of the statistical mechanics model for alpha-helix formation, and the results are interpreted by the Lifson-Roig theory 10. Single alanine --> glycine substitutions have been made at a series of positions in individual peptides. The helix-destabilizing effect of an Ala --> Gly substitution depends strongly on its position in the helix, as predicted by the Lifson-Roig theory if the ratio of s values for Ala:Gly is large.	UNIV OREGON,INST MOLEC BIOL,EUGENE,OR 97403	University of Oregon	CHAKRABARTTY, A (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT BIOCHEM,STANFORD,CA 94305, USA.			Chakrabartty, Avi/0000-0001-7002-8381				ALTMANN KH, 1990, BIOPOLYMERS, V30, P107, DOI 10.1002/bip.360300112; BRANT DA, 1967, J MOL BIOL, V23, P47, DOI 10.1016/S0022-2836(67)80066-4; CANTOR CR, 1980, BIOPHYSICAL CHEM, V3; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; CREIGHTON TE, 1983, PROTEINS STRUCTURES, P162; GO M, 1971, J CHEM PHYS, V54, P4489, DOI 10.1063/1.1674701; HOUGHTEN RA, 1986, BIOTECHNIQUES, V4, P522; LIFSON S, 1961, J CHEM PHYS, V34, P1963, DOI 10.1063/1.1731802; LOTAN N, 1966, BIOPOLYMERS, V4, P365, DOI 10.1002/bip.1966.360040309; LYU PC, 1990, SCIENCE, V250, P669, DOI 10.1126/science.2237416; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; MERUTKA G, 1990, BIOCHEMISTRY-US, V29, P7511, DOI 10.1021/bi00484a021; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; PADMANABHAN S, 1990, NATURE, V344, P268, DOI 10.1038/344268a0; POLAND D, 1970, THEORY HELIX COIL TR; SCHERAGA HA, 1985, P NATL ACAD SCI USA, V82, P5585, DOI 10.1073/pnas.82.17.5585; SHOEMAKER KR, 1987, NATURE, V326, P563, DOI 10.1038/326563a0; STREHLOW KG, 1989, BIOCHEMISTRY-US, V28, P2130, DOI 10.1021/bi00431a025; SUEKI M, 1984, MACROMOLECULES, V17, P148, DOI 10.1021/ma00132a006; ZIMM BH, 1959, J CHEM PHYS, V31, P526, DOI 10.1063/1.1730390	20	317	324	1	26	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 13	1991	351	6327					586	588		10.1038/351586a0	http://dx.doi.org/10.1038/351586a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR034	2046766				2022-12-28	WOS:A1991FR03400065
J	MCCORMICK, A				MCCORMICK, A			UNRECOGNIZED HIV RELATED DEATHS	BRITISH MEDICAL JOURNAL			English	Article								Objectives - To establish whether follow up of deaths from selected HIV related causes could increase the number of cases of HIV infection reported to the Public Health Laboratory Service Communicable Disease Surveillance Centre (CDSC), and to estimate the proportion of deaths among HIV positive men that occurred in men who were not known to be HIV positive at the time of death by the person who signed the death certificate. Design - Follow up of draft death entries received by the Office of Population Censuses and Surveys on which one of 11 medical or external causes likely to be related to HIV was stated; letters were sent to the people who signed the certificates. The respondents were invited to report men known to have been HIV positive who were not already on the CDSC register. Setting - England and Wales. Subjects - Men aged 15-54 who died in February 1989 to July 1989 with one of the 11 selected HIV related diseases as cause of death on their death certificates. Main outcome measures - Number of men reported to the CDSC as a result of this follow up; estimate of excess deaths due to an HIV related cause; estimate of the proportion of excess deaths that occurred in those who were not known to be HIV positive at the time of death. Results - Replies were received for 473 deaths (86%). Forty were for men known to have been HIV positive, 31 of whom had been reported to CDSC by the time they died; six were subsequently reported. The respondent did not know that the deceased was HIV positive for 20 (35%) of the 57 excess deaths in men for whom one of the medical causes was stated and 41 (93%) of the 44 excess deaths in men for whom one of the external causes was stated. Conclusion - Follow up of death registrations is not an efficient way of increasing the number of cases of HIV infection reported to CDSC. Between 35% and 60% of HIV positive people for whom certain causes are stated may be dying without HIV positivity having been diagnosed. There may be implications for those caring for people with these conditions and those who carry out postmortem examinations.			MCCORMICK, A (corresponding author), OFF POPULAT CENSUSES & SURVEYS,LONDON WC2B 6JP,ENGLAND.							MARZUK PM, 1988, JAMA-J AM MED ASSOC, V259, P1333, DOI 10.1001/jama.259.9.1333; MCCORMICK A, 1991, BRIT MED J, V302, P1375, DOI 10.1136/bmj.302.6789.1375	2	27	27	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 8	1991	302	6789					1365	1367		10.1136/bmj.302.6789.1365	http://dx.doi.org/10.1136/bmj.302.6789.1365			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR057	2059714	Green Published, Bronze			2022-12-28	WOS:A1991FR05700017
J	MACDONALD, NJ; KUHL, D; MAGUIRE, D; NAF, D; GALLANT, P; GOSWAMY, A; HUG, H; BUELER, H; CHATURVEDI, M; DELAFUENTE, J; RUFFNER, H; MEYER, F; WEISSMANN, C				MACDONALD, NJ; KUHL, D; MAGUIRE, D; NAF, D; GALLANT, P; GOSWAMY, A; HUG, H; BUELER, H; CHATURVEDI, M; DELAFUENTE, J; RUFFNER, H; MEYER, F; WEISSMANN, C			DIFFERENT PATHWAYS MEDIATE VIRUS INDUCIBILITY OF THE HUMAN IFN-ALPHA-1 AND IFN-BETA GENES	CELL			English	Article											MACDONALD, NJ (corresponding author), UNIV ZURICH,INST MOLEK BIOL 1,CH-8093 ZURICH,SWITZERLAND.		Kuhl, Dietmar/A-4689-2009	Kuhl, Dietmar/0000-0002-4772-6701				AUFFRAY C, 1980, EUR J BIOCHEM, V107, P121; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BALLARD DW, 1986, P NATL ACAD SCI USA, V83, P9626, DOI 10.1073/pnas.83.24.9626; BIENZ M, 1986, CELL, V45, P753, DOI 10.1016/0092-8674(86)90789-0; CAMPBELL MEM, 1984, J MOL BIOL, V180, P1, DOI 10.1016/0022-2836(84)90427-3; CHATURVEDI M, 1988, Experientia (Basel), V44, pA55; CLARK L, 1989, NUCLEIC ACIDS RES, V17, P499, DOI 10.1093/nar/17.2.499; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DINTER H, 1987, EUR J BIOCHEM, V166, P103, DOI 10.1111/j.1432-1033.1987.tb13488.x; FALKNER FG, 1984, NATURE, V310, P71, DOI 10.1038/310071a0; FAN CM, 1989, EMBO J, V8, P101, DOI 10.1002/j.1460-2075.1989.tb03353.x; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; FUJITA T, 1989, NUCLEIC ACIDS RES, V17, P3335, DOI 10.1093/nar/17.9.3335; FUJITA T, 1987, CELL, V49, P357, DOI 10.1016/0092-8674(87)90288-1; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; FUJITA T, 1985, CELL, V41, P489, DOI 10.1016/S0092-8674(85)80022-2; FUJITA T, 1986, CELL, V46, P401, DOI 10.1016/0092-8674(86)90660-4; FUJITA T, 1989, NATURE, V337, P270, DOI 10.1038/337270a0; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; GOODBOURN S, 1986, CELL, V45, P601, DOI 10.1016/0092-8674(86)90292-8; GOODBOURN S, 1988, P NATL ACAD SCI USA, V85, P1447, DOI 10.1073/pnas.85.5.1447; GOODBOURN S, 1985, CELL, V41, P509, DOI 10.1016/S0092-8674(85)80024-6; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HISCOTT J, 1989, J VIROL, V63, P2557, DOI 10.1128/JVI.63.6.2557-2566.1989; HOLLER M, 1988, GENE DEV, V2, P1127, DOI 10.1101/gad.2.9.1127; HUG H, 1988, MOL CELL BIOL, V8, P3065, DOI 10.1128/MCB.8.8.3065; HUG H, 1988, Experientia (Basel), V44, pA23; HUG H, 1988, THESIS A LUDWIGS U F; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KELLER AD, 1988, P NATL ACAD SCI USA, V85, P3309, DOI 10.1073/pnas.85.10.3309; KUHL D, 1987, CELL, V50, P1057, DOI 10.1016/0092-8674(87)90172-3; LAMARCO KL, 1989, GENE DEV, V3, P1372, DOI 10.1101/gad.3.9.1372; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; MANIATIS T, 1988, HARVEY LECT, V82, P71; Maniatis T., 1982, MOL CLONING; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MORRISON MR, 1974, J BIOL CHEM, V249, P5290; ONDEK B, 1988, NATURE, V333, P40, DOI 10.1038/333040a0; PARSLOW TG, 1984, P NATL ACAD SCI-BIOL, V81, P2650, DOI 10.1073/pnas.81.9.2650; POELLINGER L, 1989, MOL CELL BIOL, V9, P747, DOI 10.1128/MCB.9.2.747; POST LE, 1981, CELL, V24, P555, DOI 10.1016/0092-8674(81)90346-9; RAGG H, 1983, NATURE, V303, P439, DOI 10.1038/303439a0; RAJ NBK, 1989, J BIOL CHEM, V264, P11149; REID LE, 1989, P NATL ACAD SCI USA, V86, P840, DOI 10.1073/pnas.86.3.840; RYALS J, 1985, CELL, V41, P497, DOI 10.1016/S0092-8674(85)80023-4; Schreiber E., 1989, TISSUE SPECIFIC GENE, P33; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SEVERNE Y, 1988, EMBO J, V7, P2503, DOI 10.1002/j.1460-2075.1988.tb03097.x; SHAW GD, 1983, NUCLEIC ACIDS RES, V11, P555, DOI 10.1093/nar/11.3.555; SIEBENLIST U, 1980, P NATL ACAD SCI-BIOL, V77, P122, DOI 10.1073/pnas.77.1.122; SUTCLIFFE JG, 1979, COLD SPRING HARB SYM, V43, P77, DOI 10.1101/SQB.1979.043.01.013; TANIGUCHI T, 1988, ANNU REV IMMUNOL, V6, P439, DOI 10.1146/annurev.iy.06.040188.002255; TREISMAN R, 1985, NATURE, V315, P72, DOI 10.1038/315072a0; TRIEZENBERG SJ, 1988, GENE DEV, V2, P730, DOI 10.1101/gad.2.6.730; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; WATHELET MG, 1987, EUR J BIOCHEM, V169, P313, DOI 10.1111/j.1432-1033.1987.tb13614.x; WATHELET MG, 1988, EUR J BIOCHEM, V174, P323, DOI 10.1111/j.1432-1033.1988.tb14101.x; WEAVER RF, 1979, NUCLEIC ACIDS RES, V7, P1175, DOI 10.1093/nar/7.5.1175; WEISSMANN C, 1986, PROG NUCLEIC ACID RE, V33, P251, DOI 10.1016/S0079-6603(08)60026-4	61	156	157	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAR 9	1990	60	5					767	779		10.1016/0092-8674(90)90091-R	http://dx.doi.org/10.1016/0092-8674(90)90091-R			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CV174	2107026				2022-12-28	WOS:A1990CV17400009
J	KALDOR, JM; DAY, NE; PETTERSSON, F; CLARKE, EA; PEDERSEN, D; MEHNERT, W; BELL, J; HOST, H; PRIOR, P; KARJALAINEN, S; NEAL, F; KOCH, M; BAND, P; CHOI, W; KIRN, VP; ARSLAN, A; ZAREN, B; BELCH, AR; STORM, H; KITTELMANN, B; FRASER, P; STOVALL, M				KALDOR, JM; DAY, NE; PETTERSSON, F; CLARKE, EA; PEDERSEN, D; MEHNERT, W; BELL, J; HOST, H; PRIOR, P; KARJALAINEN, S; NEAL, F; KOCH, M; BAND, P; CHOI, W; KIRN, VP; ARSLAN, A; ZAREN, B; BELCH, AR; STORM, H; KITTELMANN, B; FRASER, P; STOVALL, M			LEUKEMIA FOLLOWING CHEMOTHERAPY FOR OVARIAN-CANCER	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									MRC, BIOSTAT UNIT, CAMBRIDGE, ENGLAND; KAROLINSKA HOSP, DEPT GYNECOL ONCOL, S-10401 STOCKHOLM 60, SWEDEN; ONTARIO CANC TREATMENT & RES FDN, TORONTO, ONTARIO, CANADA; AARHUS KOMMUNE HOSP, RADIUMSTN, DK-8000 AARHUS, DENMARK; NATL CANC REGISTRY GERMAN DEMOCRAT REPUBL, BERLIN, GERMANY; THAMES CANC REGISTRY, SURREY, ENGLAND; NORWEGIAN CANC REGISTRY, OSLO, NORWAY; UNIV BIRMINGHAM, CANC EPIDEMIOL RES UNIT, BIRMINGHAM B15 2TT, W MIDLANDS, ENGLAND; FINNISH CANC REGISTRY, HELSINKI, FINLAND; WESTON PK HOSP, SHEFFIELD, ENGLAND; ALBERTA CANC REGISTRY, EDMONTON, ALBERTA, CANADA; CANC CONTROL AGCY, VANCOUVER V5Z 3J3, BC, CANADA; MANITOBA CANC TREATMENT & RES FDN, WINNIPEG, MANITOBA, CANADA; CANC REGISTRY SLOVENIA, LJUBLJANA, YUGOSLAVIA; UNIV ALBERTA, EDMONTON T6G 2E1, ALBERTA, CANADA; DANISH CANC REGISTRY, COPENHAGEN, DENMARK; UNIV LONDON LONDON SCH HYG & TROP MED, DIV MED STAT & EPIDEMIOL, LONDON WC1E 7HT, ENGLAND; UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, CTR CANC, DEPT RADIAT PHYS, HOUSTON, TX 77030 USA	MRC Biostatistics Unit; Karolinska Institutet; Karolinska University Hospital; Aarhus University; University of Birmingham; Finnish Cancer Registry; Weston Park Hospital; University of Alberta; University of London; London School of Hygiene & Tropical Medicine; University of Texas System; UTMD Anderson Cancer Center	KALDOR, JM (corresponding author), INT AGCY RES CANC, 150 COURS ALBERT THOMAS, F-69372 Lyon 08, FRANCE.		Kaldor, John M/D-4545-2011					BENNETT JM, 1981, BRIT J HAEMATOL, V47, P553, DOI 10.1111/j.1365-2141.1981.tb02684.x; BOICE JD, 1987, J NATL CANCER I, V79, P1295; Breslow N. E., 1980, IARC SCI PUBLICATION, V32; Cox DR, 1974, THEORETICAL STATISTI; CRISTY M, 1981, PHYS MED BIOL, V26, P389, DOI 10.1088/0031-9155/26/3/003; CUZICK J, 1987, BRIT J CANCER, V55, P523, DOI 10.1038/bjc.1987.107; DEGRAMONT A, 1986, ONCOLOGY, V43, P165, DOI 10.1159/000226357; EINHORN N, 1982, CANCER, V49, P2234, DOI 10.1002/1097-0142(19820601)49:11<2234::AID-CNCR2820491106>3.0.CO;2-Q; EINHORN N, 1978, CANCER, V41, P444, DOI 10.1002/1097-0142(197802)41:2<444::AID-CNCR2820410210>3.0.CO;2-8; GREENE MH, 1986, ANN INTERN MED, V105, P360, DOI 10.7326/0003-4819-105-3-360; HAAS JF, 1987, BRIT J CANCER, V55, P213, DOI 10.1038/bjc.1987.40; KALDOR JM, 1987, INT J CANCER, V39, P571, DOI 10.1002/ijc.2910390506; KALDOR JM, 1988, EUR J CANCER CLIN ON, V24, P703, DOI 10.1016/0277-5379(88)90302-1; KALDOR JM, 1990, NEW ENGL J MED, V322, P7, DOI 10.1056/NEJM199001043220102; PEDERSENBJERGAARD J, 1980, CANCER-AM CANCER SOC, V45, P19, DOI 10.1002/1097-0142(19800101)45:1<19::AID-CNCR2820450106>3.0.CO;2-L; REIMER RR, 1977, NEW ENGL J MED, V297, P177, DOI 10.1056/NEJM197707282970402; STORER BE, 1983, J R STAT SOC C-APPL, V32, P172; STOVALL M, 1968, AMER J ROENTGENOL RA, V102, P677, DOI 10.2214/ajr.102.3.677; STOVALL MA, IN PRESS MED PHYS; TROPE C, 1987, OBSTET GYNECOL, V70, P582; VANDERVELDEN JW, 1988, INT J CANCER, V42, P252, DOI 10.1002/ijc.2910420218; 1987, IARC MONOGRAPHS S7, V1	22	219	222	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 4	1990	322	1					1	6		10.1056/NEJM199001043220101	http://dx.doi.org/10.1056/NEJM199001043220101			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG234	2104664	Bronze			2022-12-28	WOS:A1990CG23400001
J	LANDRIGAN, PJ; BAKER, DB				LANDRIGAN, PJ; BAKER, DB			THE RECOGNITION AND CONTROL OF OCCUPATIONAL-DISEASE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEW-YORK-STATE; PESTICIDE WORKERS; PUBLIC-HEALTH; UNITED-STATES; MEDICINE; CANCER; SURVEILLANCE; MAGNITUDE; LEUKEMIA	Occupational diseases account each year in the United States for an estimated 50 000 to 70 000 deaths and 350 000 new cases of illness. Often, however, occupational diseases are not correctly diagnosed, because they mimic diseases due to other causes and because most physicians are not well trained in their recognition. Opportunities for prevention and treatment are therefore lost. The occupational history is the most effective means for proper diagnosis of occupational illness. It should routinely be obtained for every patient. A brief but systematic guide for obtaining an occupational history is presented in this report. Also, approaches are summarized for the recognition and diagnosis of such important occupational diseases as occupational cancer, asbestosis and other respiratory disorders, and occupational neuropsychologic disorders. The management and prevention of occupational diseases depend on reduction of hazardous exposures in the workplace and better education of workers, industrial managers, and physicians. This report outlines a program for the control of occupational disease based on (1) preventing exposures in the workplace, (2) premarket toxicity testing of new chemicals and technologies, and (3) astute clinical diagnosis.			LANDRIGAN, PJ (corresponding author), MT SINAI MED CTR, MT SINAI SCH MED, DEPT COMMUNITY MED, BOX 1057, 1 GUSTAVE L LEVY PL, NEW YORK, NY 10029 USA.							BAILAR JC, 1991, NEW ENGL J MED, V324, P261; BAKER E L, 1988, Journal of Public Health Policy, V9, P198, DOI 10.2307/3343005; CHANYEUNG M, 1990, CHEST, V98, pS148, DOI 10.1378/chest.98.5.148S; CREECH JL, 1974, J OCCUP ENVIRON MED, V16, P150; CULLEN MR, 1990, NEW ENGL J MED, V322, P594, DOI 10.1056/NEJM199003013220905; CULLEN MR, 1990, NEW ENGL J MED, V322, P675, DOI 10.1056/NEJM199003083221007; FIGUEROA WG, 1973, NEW ENGL J MED, V288, P1096, DOI 10.1056/NEJM197305242882104; FINGERHUT MA, 1991, NEW ENGL J MED, V324, P212, DOI 10.1056/NEJM199101243240402; FREUND E, 1989, JAMA-J AM MED ASSOC, V262, P3041, DOI 10.1001/jama.262.21.3041; GOLDMAN RH, 1981, JAMA-J AM MED ASSOC, V246, P2831, DOI 10.1001/jama.246.24.2831; HOWE GR, 1991, JAMA-J AM MED ASSOC, V265, P1438, DOI 10.1001/jama.265.11.1438; LANDRIGAN PJ, 1983, ACTA PSYCHIAT SCAND, V67, P6, DOI 10.1111/j.1600-0447.1983.tb00937.x; LANDRIGAN PJ, 1989, ANN NY ACAD SCI, V572, P27; LEVY BS, 1985, AM J PUBLIC HEALTH, V75, P79, DOI 10.2105/AJPH.75.1.79; LOOMIS DP, 1990, BRIT J IND MED, V47, P633; MABUCHI K, 1979, ARCH ENVIRON HEALTH, V34, P312, DOI 10.1080/00039896.1979.10667423; MARKOWITZ S, 1989, TOXICOL IND HEALTH, V5, P9, DOI 10.1177/074823378900500402; NICHOLSON W J, 1982, American Journal of Industrial Medicine, V3, P259, DOI 10.1002/ajim.4700030305; Parkes W.R., 1982, OCCUPATIONAL LUNG DI; PEPYS J, 1975, AM REV RESPIR DIS, V112, P829; POTT P, 1775, CHIRUGICAL OBSERVATI; Rehn L, 1895, ARCH KLIN CHIR, V50, P588; REMPEL D, 1990, OCCUP MED, V5, P435; RINSKY RA, 1987, NEW ENGL J MED, V316, P1044, DOI 10.1056/NEJM198704233161702; ROM W, 1983, ENV OCCUPATIONAL MED; ROSENSTOCK L, 1986, ANNU REV PUBL HEALTH, V7, P337; RUTSTEIN DD, 1976, NEW ENGL J MED, V294, P582, DOI 10.1056/NEJM197603112941104; RUTSTEIN DD, 1983, AM J PUBLIC HEALTH, V73, P1054, DOI 10.2105/AJPH.73.9.1054; Selikoff I J, 1979, Ann N Y Acad Sci, V330, P91, DOI 10.1111/j.1749-6632.1979.tb18711.x; SELIKOFF IJ, 1968, J AMER MED ASSOC, V204, P106, DOI 10.1001/jama.204.2.106; SELIKOFF IJ, 1964, JAMA-J AM MED ASSOC, V188, P22; Spencer P. S., 1980, EXPT CLIN NEUROTOXIC; WHITE LJ, 1990, ANN INTERN MED, V113, P974, DOI 10.7326/0003-4819-113-12-974; WHORTON D, 1979, J OCCUP ENVIRON MED, V21, P161; WING S, 1991, JAMA-J AM MED ASSOC, V265, P1397, DOI 10.1001/jama.265.11.1397; 1975, PNEUMOCONIOSES ALLIE; 1986, PROPOSED NATIONAL ST; 1987, MONOGRAPHS EVALUATIO, V42; 1984, TOXICITY TESTING STR; 1984, ROLE INTERNIST OCCUP; 1989, 1989 1990 AAMC CURRI; 1972, PRESIDENTS REPORT OC; 1978, DHEW78114 NAT OCC HA; 1984, 981144 COMM GOV OP H; 1988, ROLE PRIMARY CARE PH; IN PRESS PREVENTION	46	40	42	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	1991	266	5					676	680		10.1001/jama.266.5.676	http://dx.doi.org/10.1001/jama.266.5.676			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ140	2072478				2022-12-28	WOS:A1991FZ14000026
J	GUERRANT, RL; BOBAK, DA				GUERRANT, RL; BOBAK, DA			MEDICAL PROGRESS - BACTERIAL AND PROTOZOAL GASTROENTERITIS	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; STABLE ENTERO-TOXIN; DAY-CARE-CENTERS; ENTEROHEMORRHAGIC ESCHERICHIA-COLI; CAMPYLOBACTER-JEJUNI INFECTIONS; CLOSTRIDIUM-DIFFICILE INFECTION; ISOSPORA-BELLI INFECTION; TISSUE-CULTURE CELLS; AUREUS DELTA-TOXIN; CHRONIC DIARRHEA		UNIV VIRGINIA, SCH MED, DEPT MICROBIOL, CHARLOTTESVILLE, VA 22908 USA	University of Virginia	GUERRANT, RL (corresponding author), UNIV VIRGINIA, SCH MED, DEPT MED, DIV GEOG MED, CHARLOTTESVILLE, VA 22908 USA.							Alam S A, 1977, Bangladesh Med Res Counc Bull, V3, P32; [Anonymous], 1978, LANCET, V2, P300; ANTONY MA, 1988, DIGEST DIS SCI, V33, P1141, DOI 10.1007/BF01535791; ARAUJO V, 1990, CURR OPIN INFECT DIS, V3, P521; ARONSSON B, 1985, J INFECT DIS, V151, P476, DOI 10.1093/infdis/151.3.476; ASHKENAZI S, 1990, J INFECT DIS, V161, P961, DOI 10.1093/infdis/161.5.961; AVERY ME, 1990, NEW ENGL J MED, V323, P891, DOI 10.1056/NEJM199009273231307; AZIZ KMS, 1974, SCIENCE, V183, P1206, DOI 10.1126/science.183.4130.1206; BALDINI MM, 1983, J PEDIATR GASTR NUTR, V2, P534, DOI 10.1097/00005176-198302030-00023; BARTLETT AV, 1985, J PEDIATR-US, V107, P495, DOI 10.1016/S0022-3476(85)80004-4; BARTLETT AV, 1985, J PEDIATR-US, V107, P503, DOI 10.1016/S0022-3476(85)80005-6; BARTLETT JG, 1990, REV INFECT DIS, V12, pS243, DOI 10.1093/clinids/12.Supplement_2.S243; Bean N H, 1990, MMWR CDC Surveill Summ, V39, P15; BENDER BS, 1986, LANCET, V2, P11, DOI 10.1016/S0140-6736(86)92559-6; Bennett J. V., 1987, AM J PREV MED; BENNISH ML, 1990, NEW ENGL J MED, V322, P1357, DOI 10.1056/NEJM199005103221905; BERNARD E, 1989, J INFECT DIS, V159, P143, DOI 10.1093/infdis/159.1.143; BERRY AJ, 1983, AM J TROP MED HYG, V32, P1289, DOI 10.4269/ajtmh.1983.32.1289; BHAN MK, 1989, J INFECT DIS, V159, P1061, DOI 10.1093/infdis/159.6.1061; BHATNAGAR S, 1986, INDIAN J MED RES, V84, P53; BHUTTA TI, 1990, LANCET, V335, P363, DOI 10.1016/0140-6736(90)90659-S; BILGE SS, 1989, J BACTERIOL, V171, P4281, DOI 10.1128/JB.171.8.4281-4289.1989; BLACK RE, 1986, REV INFECT DIS, V8, pS131; BLAKE PA, 1979, NEW ENGL J MED, V300, P1, DOI 10.1056/NEJM197901043000101; BODEY GP, 1986, ANNU REV MED, V37, P271; BOHNHOFF M, 1964, J EXP MED, V120, P805, DOI 10.1084/jem.120.5.805; BRANDBORG LL, 1970, NEW ENGL J MED, V283, P1306, DOI 10.1056/NEJM197012102832403; BRANDTZAEG P, 1989, GASTROENTEROLOGY, V97, P1562, DOI 10.1016/0016-5085(89)90406-X; Bryan R, 1990, PROGR CLIN PARASITOL, V2, P1; CELUM CL, 1987, J INFECT DIS, V156, P998, DOI 10.1093/infdis/156.6.998; CHEN LC, 1971, LANCET, V1, P939; CHRETIEN JH, 1982, MED CLIN N AM, V66, P675, DOI 10.1016/S0025-7125(16)31415-8; Cohen M L, 1988, Infect Dis Clin North Am, V2, P557; COLEBUNDERS R, 1987, AM J GASTROENTEROL, V82, P859; COLLINS M, 1978, MICROBIOL REV, V42, P725, DOI 10.1128/MMBR.42.4.725-746.1978; CONNOLLY GM, 1990, GUT, V31, P886, DOI 10.1136/gut.31.8.886; CRAVIOTO A, 1979, CURR MICROBIOL, V3, P95, DOI 10.1007/BF02602439; CRUZ T, 1966, NEW ENGL J MED, V275, P1093, DOI 10.1056/NEJM196611172752003; CUDMORE MA, 1982, ARCH INTERN MED, V142, P333, DOI 10.1001/archinte.142.2.333; CURRENT WL, 1983, NEW ENGL J MED, V308, P1252, DOI 10.1056/NEJM198305263082102; DEARING WH, 1960, GASTROENTEROLOGY, V38, P441; DEHOVITZ JA, 1986, NEW ENGL J MED, V315, P87, DOI 10.1056/NEJM198607103150203; DELALLA F, 1989, J ANTIMICROB CHEMOTH, V23, P623, DOI 10.1093/jac/23.4.623; DESPORTES I, 1985, J PROTOZOOL, V32, P250; DINGLE JH, 1964, ILLNESS HOME; DOSIK GM, 1979, AM J MED, V67, P646, DOI 10.1016/0002-9343(79)90248-1; DRIKS MR, 1987, NEW ENGL J MED, V317, P1376, DOI 10.1056/NEJM198711263172204; DUPONT HL, 1973, JAMA-J AM MED ASSOC, V226, P1525, DOI 10.1001/jama.226.13.1525; DUPONT HL, 1987, AM J MED, V82, P324; EDEN CS, 1988, J INFECT DIS, V157, P421, DOI 10.1093/infdis/157.3.421; ERICSSON CD, 1990, JAMA-J AM MED ASSOC, V263, P257, DOI 10.1001/jama.263.2.257; EVANS DG, 1975, INFECT IMMUN, V12, P656, DOI 10.1128/IAI.12.3.656-667.1975; FAINSTEIN V, 1981, J INFECT DIS, V143, P865; FANG G, IN PRESS INFECT DIS; FANG GD, 1991, CLIN RES, V39, pA223; FARBER BF, 1984, J AM GERIATR SOC, V32, P499, DOI 10.1111/j.1532-5415.1984.tb02234.x; FASANO A, 1990, INFECT IMMUN, V58, P3717, DOI 10.1128/IAI.58.11.3717-3723.1990; FASANO A, IN PRESS P NATL ACAD; FAYER R, 1986, MICROBIOL REV, V50, P458, DOI 10.1128/MMBR.50.4.458-483.1986; FIELD M, 1978, P NATL ACAD SCI USA, V75, P2800, DOI 10.1073/pnas.75.6.2800; FISCHL MA, 1986, ARCH INTERN MED, V146, P113, DOI 10.1001/archinte.146.1.113; FORMAL SB, 1963, J BACTERIOL, V85, P119, DOI 10.1128/JB.85.1.119-125.1963; GANDY W, 1983, CANCER-AM CANCER SOC, V51, P1551, DOI 10.1002/1097-0142(19830415)51:8<1551::AID-CNCR2820510833>3.0.CO;2-L; GELB A, 1986, AM J GASTROENTEROL, V81, P619; GIANNELLA RA, 1973, ANN INTERN MED, V78, P271, DOI 10.7326/0003-4819-78-2-271; GIRON JA, 1991, J INFECT DIS, V163, P507, DOI 10.1093/infdis/163.3.507; GITELSON S, 1971, ISRAEL J MED SCI, V7, P663; GOODMAN LJ, 1990, ARCH INTERN MED, V150, P541, DOI 10.1001/archinte.150.3.541; GORBACH SL, 1987, LANCET, V2, P1519; GORDON S, 1988, ARCH INTERN MED, V148, P1569, DOI 10.1001/archinte.148.7.1569; GOURLEY WK, 1988, LAB INVEST, V58, pA35; GRUTZKAU A, 1990, GUT, V31, P1011, DOI 10.1136/gut.31.9.1011; GUARINO A, 1989, INFECT IMMUN, V57, P649, DOI 10.1128/IAI.57.2.649-652.1989; Guerrant R. L., 1990, Textbook of secretory diarrhoea., P273; GUERRANT RL, 1990, CLIN RES, V38, pA391; GUERRANT RL, 1985, AM J MED, V78, P91, DOI 10.1016/0002-9343(85)90370-5; GUERRANT RL, 1976, J PEDIATR-US, V89, P885, DOI 10.1016/S0022-3476(76)80591-4; GUERRANT RL, 1987, INFECT IMMUN, V55, P2526, DOI 10.1128/IAI.55.10.2526-2530.1987; GUERRANT RL, 1972, J INFECT DIS, V125, P377, DOI 10.1093/infdis/125.4.377; GUERRANT RL, 1980, J INFECT DIS, V142, P220, DOI 10.1093/infdis/142.2.220; GUERRANT RL, 1981, J INFECT DIS, V143, P83, DOI 10.1093/infdis/143.1.83; GUERRANT RL, 1990, REV INFECT DIS, V12, pS41; GUERRANT RL, 1986, PEDIATR INFECT DIS J, V5, P353, DOI 10.1097/00006454-198605000-00015; GUERRANT RL, 1988, CURR OPIN INFECT DIS, V1, P868, DOI 10.1097/00001432-198811000-00006; GUERRANT RL, 1986, INFECTIOUS DIARRHEA, P287; GUERRANT RL, IN PRESS HELICOBACTE; GUERRANT RL, 1990, PRINCIPLES PRACTICE, P851; GUPTA TP, 1990, GASTROENTEROLOGY, V98, P780, DOI 10.1016/0016-5085(90)90303-I; GUTH BEC, 1986, INFECT IMMUN, V54, P587, DOI 10.1128/IAI.54.2.587-589.1986; HARIG JM, 1989, NEW ENGL J MED, V320, P23, DOI 10.1056/NEJM198901053200105; HART AS, 1990, LANCET, V335, P169, DOI 10.1016/0140-6736(90)90042-4; HAYES EB, 1989, NEW ENGL J MED, V320, P1372, DOI 10.1056/NEJM198905253202103; HERMANS PE, 1966, AM J MED, V40, P78, DOI 10.1016/0002-9343(66)90189-6; HEYWORTH B, 1975, ARCH DIS CHILD, V50, P27, DOI 10.1136/adc.50.1.27; HIGGINS JA, 1956, GASTROENTEROLOGY, V31, P708; HO MS, 1988, JAMA-J AM MED ASSOC, V260, P3281, DOI 10.1001/jama.260.22.3281; HOPKINS DG, 1983, AM J HEMATOL, V14, P289, DOI 10.1002/ajh.2830140311; HOVIUS SER, 1982, NETH J SURG, V34, P81; HUGHES JM, 1978, NATURE, V271, P755, DOI 10.1038/271755a0; HUGHES JM, 1978, CLIN RES, V26, pA28; HUGHES JM, 1990, PRINCIPLES PRACTICE, P893; Hughes JM, 1987, PREVENTION CONTROL N, P405; ISBERG RR, 1991, SCIENCE, V252, P934, DOI 10.1126/science.1674624; JACKSON MP, 1990, MICROB PATHOGENESIS, V8, P235, DOI 10.1016/0882-4010(90)90050-Z; JACOBS JL, 1985, ANN INTERN MED, V102, P186, DOI 10.7326/0003-4819-102-2-186; JOHANSON JF, 1990, ANN INTERN MED, V112, P942, DOI 10.7326/0003-4819-112-12-942; JOHNSON S, 1989, 29TH INT C ANT AG CH, P103; KANE JG, 1976, LANCET, V1, P335; KAPRAL FA, 1985, CIBA F SYMP, V112, P215; KARCH H, 1987, INFECT IMMUN, V55, P455, DOI 10.1128/IAI.55.2.455-461.1987; KASIMIR S, 1990, INFECT IMMUN, V58, P1653, DOI 10.1128/IAI.58.6.1653-1659.1990; KELLY TWJ, 1983, CRIT CARE MED, V11, P7, DOI 10.1097/00003246-198301000-00003; KELSALL BL, 1990, 39TH ANN M AM SOC TR, P197; KENNEDY DJ, 1984, INFECT IMMUN, V46, P639, DOI 10.1128/IAI.46.3.639-643.1984; KEUSCH GT, 1972, J CLIN INVEST, V51, P1212, DOI 10.1172/JCI106915; KIMBERG DV, 1971, J CLIN INVEST, V50, P1218, DOI 10.1172/JCI106599; KLONTZ KC, 1988, ANN INTERN MED, V109, P318, DOI 10.7326/0003-4819-109-4-318; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; KOPLAN JP, 1980, LANCET, V2, P413; KOTLER DP, 1990, ANN INTERN MED, V113, P444; LASSER KH, 1979, HUM PATHOL, V10, P234, DOI 10.1016/S0046-8177(79)80012-X; LAUGHON BE, 1988, GASTROENTEROLOGY, V94, P984, DOI 10.1016/0016-5085(88)90557-4; LAWRENCE GW, 1990, LANCET, V336, P1165, DOI 10.1016/0140-6736(90)92776-E; LEIGHTON PM, 1990, ARCH INTERN MED, V150, P1747, DOI 10.1001/archinte.150.8.1747; LEUNK RD, 1988, J MED MICROBIOL, V26, P93, DOI 10.1099/00222615-26-2-93; LEVINE MM, 1979, ANN HUM BIOL, V6, P369, DOI 10.1080/03014467900003751; LEVINE MM, 1990, LANCET, V336, P891; LEVINE MM, 1983, MICROBIOL REV, V47, P510, DOI 10.1128/MMBR.47.4.510-550.1983; LEVINE MM, 1978, LANCET, V1, P1119; LEVINE W C, 1991, Journal of Food Protection, V54, P71, DOI 10.4315/0362-028X-54.1.71; LIMA AAM, 1988, INFECT IMMUN, V56, P582, DOI 10.1128/IAI.56.3.582-588.1988; LIMA AAM, IN PRESS EDGE DEV HL; LIMA NL, 1990, J INFECT DIS, V161, P948, DOI 10.1093/infdis/161.5.948; LONG EG, 1990, J CLIN MICROBIOL, V28, P1101, DOI 10.1128/JCM.28.6.1101-1104.1990; LYERLY D M, 1988, Clinical Microbiology Reviews, V1, P1; MACFARLANE DE, 1987, ACTA PAEDIATR SCAND, V76, P474, DOI 10.1111/j.1651-2227.1987.tb10502.x; MAHALANABIS D, 1986, DEV VACCINES DRUGS D, P240; MARCIAL MA, 1986, GASTROENTEROLOGY, V90, P583, DOI 10.1016/0016-5085(86)91112-1; MARTIN DL, 1990, NEW ENGL J MED, V323, P1161, DOI 10.1056/NEJM199010253231703; MAURELLI AT, 1988, P NATL ACAD SCI USA, V85, P2820, DOI 10.1073/pnas.85.8.2820; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; MCGHEE JR, 1989, J CLIN IMMUNOL, V9, P175, DOI 10.1007/BF00916814; MENTZING LO, 1968, ACTA PATHOL MIC SC, V74, P405; MILLIGAN DW, 1979, J CLIN PATHOL, V32, P1237, DOI 10.1136/jcp.32.12.1237; MOBASSALEH M, 1988, J INFECT DIS, V157, P1023, DOI 10.1093/infdis/157.5.1023; MODIGLIANI R, 1985, GUT, V26, P179, DOI 10.1136/gut.26.2.179; MOLLA AM, 1989, LANCET, V2, P429; MURRAY BE, 1986, REV INFECT DIS, V8, pS172; MUSCH MW, 1982, SCIENCE, V217, P1255, DOI 10.1126/science.6810465; MYERS LL, 1990, J CLIN MICROBIOL, V28, P1658, DOI 10.1128/JCM.28.7.1658-1660.1990; NATARO JP, 1987, PEDIATR INFECT DIS J, V6, P829, DOI 10.1097/00006454-198709000-00008; NAVIN TR, 1984, REV INFECT DIS, V6, P313; NEILL MA, 1991, ANN INTERN MED, V114, P195, DOI 10.7326/0003-4819-114-3-195; NICOLLE LE, 1984, J AM GERIATR SOC, V32, P513, DOI 10.1111/j.1532-5415.1984.tb02236.x; OLDFIELD EC, 1991, REV INFECT DIS, V13, pS199; ONGERTH JE, 1989, AM J PUBLIC HEALTH, V79, P1633, DOI 10.2105/AJPH.79.12.1633; ORENSTEIN JM, 1990, HUM PATHOL, V21, P475; ORENSTEIN JM, 1990, LANCET, V336, P1127, DOI 10.1016/0140-6736(90)92600-M; OSTERHOLM MT, 1986, JAMA-J AM MED ASSOC, V256, P484, DOI 10.1001/jama.256.4.484; OSTERHOLM MT, IN PRESS J INFECT DI; PAGLIUCA A, 1988, BRIT MED J, V297, P1456, DOI 10.1136/bmj.297.6661.1456; PAPE JW, 1989, NEW ENGL J MED, V320, P1044, DOI 10.1056/NEJM198904203201604; PARSONNET J, 1989, ANN INTERN MED, V110, P985, DOI 10.7326/0003-4819-110-12-985; PAVIA AT, 1990, J INFECT DIS, V161, P255, DOI 10.1093/infdis/161.2.255; PELLETIER LL, 1988, J INFECT DIS, V157, P573, DOI 10.1093/infdis/157.3.573; PELLETIER LL, 1985, AM J MED, V78, P139, DOI 10.1016/0002-9343(85)90474-7; PENN D, 1990, J PEDIATR GASTR NUTR, V10, P1; PEREI.J, 1961, AM J DIG DIS, V6, P899, DOI 10.1007/BF02231086; PERLMAN DM, 1988, ANN INTERN MED, V108, P540, DOI 10.7326/0003-4819-108-4-540; PERRONNE C, 1990, 30TH INT C ANT AG CH, P293; PETRI WA, 1989, J BIOL CHEM, V264, P3007; PICHLER HET, 1987, AM J MED, V82, P329; PICKERING LK, 1981, J PEDIATR-US, V99, P51, DOI 10.1016/S0022-3476(81)80956-0; PIERCE NF, 1987, INFECT IMMUN, V55, P477, DOI 10.1128/IAI.55.2.477-481.1987; PLAUT AG, 1983, ANNU REV MICROBIOL, V37, P603, DOI 10.1146/annurev.mi.37.100183.003131; PROKOCIMER P, 1990, 30TH INT C ANT AG CH, P192; QUE JU, 1986, INFECT IMMUN, V53, P116, DOI 10.1128/IAI.53.1.116-123.1986; QUINN TC, 1981, AM J MED, V71, P395, DOI 10.1016/0002-9343(81)90167-4; RAVDIN JI, 1981, J CLIN INVEST, V68, P1305, DOI 10.1172/JCI110377; Ries A.A., 1990, 30 INT C ANT AG CHEM, P238; RIJPSTRA AC, 1988, J INFECT DIS, V157, P827, DOI 10.1093/infdis/157.4.827; ROBERTS SH, 1977, LANCET, V2, P1193; ROTHBAUM R, 1982, GASTROENTEROLOGY, V83, P441; RUIZPALACIOS GM, 1983, LANCET, V2, P250; RUTTER JM, 1975, NATURE, V257, P135, DOI 10.1038/257135a0; RYAN CA, 1987, JAMA-J AM MED ASSOC, V258, P3269, DOI 10.1001/jama.258.22.3269; RYBOLT AH, 1989, LANCET, V1, P1353; SALLON S, 1988, AM J DIS CHILD, V142, P312, DOI 10.1001/archpedi.1988.02150030086027; SANDEFUR PD, 1977, INFECT IMMUN, V15, P988, DOI 10.1128/IAI.15.3.988-992.1977; Sansonetti P. J., 1985, MICROBIOLOGY 1985, P74; SARABIAARCE S, 1990, PEDIATR INFECT DIS J, V9, P627; SATTERWHITE TK, 1978, LANCET, V2, P181; SAVARINO SJ, 1991, J CLIN INVEST, V87, P1450, DOI 10.1172/JCI115151; SCHEIFELE DW, 1990, J PEDIATR S, V117, pS45; SCHLAGER TA, 1990, INFECT IMMUN, V58, P1337, DOI 10.1128/IAI.58.5.1337-1343.1990; SCHORLING JB, 1990, AM J EPIDEMIOL, V132, P144, DOI 10.1093/oxfordjournals.aje.a115626; SCHWARTZ JN, 1980, J PEDIATR-US, V97, P661, DOI 10.1016/S0022-3476(80)80037-0; SILVA J, 1984, REV INFECT DIS, V6, pS214; SMITH HW, 1971, J MED MICROBIOL, V4, P467, DOI 10.1099/00222615-4-4-467; SMITH PD, 1988, ANN INTERN MED, V108, P328, DOI 10.7326/0003-4819-108-3-328; SNYDER JD, 1982, B WORLD HEALTH ORGAN, V60, P605; SOAVE R, 1986, REV INFECT DIS, V8, P1012; SOAVE R, 1986, CLIN RES, V34, pA533; SOAVE R, 1987, REV INFECT DIS, V9, P663; SOAVE R, 1988, J INFECT DIS, V157, P225, DOI 10.1093/infdis/157.2.225; SPERBER SJ, 1987, REV INFECT DIS, V9, P925; STAMM WE, 1981, AM J MED, V70, P393, DOI 10.1016/0002-9343(81)90778-6; STLOUIS ME, 1988, JAMA-J AM MED ASSOC, V259, P2103, DOI 10.1001/jama.259.14.2103; STROBER W, 1976, NEW ENGL J MED, V294, P351, DOI 10.1056/NEJM197602122940701; TAUXE RV, 1985, AM J PUBLIC HEALTH, V75, P659, DOI 10.2105/AJPH.75.6.659; TAYLOR DN, 1986, REV INFECT DIS, V8, pS136; TRELOAR AJ, 1987, LANCET, V2, P1279; TRIER JS, 1974, GASTROENTEROLOGY, V66, P923; TVEDE M, 1989, LANCET, V1, P1156; VANGOOL T, 1990, LANCET, V336, P697, DOI 10.1016/0140-6736(90)92198-Q; VIAL PA, 1988, J INFECT DIS, V158, P70, DOI 10.1093/infdis/158.1.70; WARREN KS, 1990, REV INFECT DIS, V12, P142; WASSEF JS, 1989, INFECT IMMUN, V57, P858, DOI 10.1128/IAI.57.3.858-863.1989; WEIKEL CS, 1986, J INFECT DIS, V153, P893, DOI 10.1093/infdis/153.5.893; WEIKEL CS, 1986, J INFECT DIS, V154, P1053; WEIKEL CS, 1984, CURRENT EMERGENCY TH, P732; WELLIVER RC, 1984, AM J DIS CHILD, V138, P131, DOI 10.1001/archpedi.1984.02140400017004; WELSH JK, 1979, J PEDIATR-US, V94, P1, DOI 10.1016/S0022-3476(79)80340-6; WOLFSON JS, 1985, NEW ENGL J MED, V312, P1278, DOI 10.1056/NEJM198505163122002; YOLKEN RH, 1982, NEW ENGL J MED, V306, P1009, DOI 10.1056/NEJM198204293061701; 1986, REV INFECT DIS S2, V8, pS109; 1990, MED LETT DRUGS THER, V32, P23; 1990, ASM NEWS, V56, P358; 1988, WEEKLY EPIDEMIOLOGIC, V63, P49; 1990, MMWR, V39, P909	230	106	110	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	1991	325	5					327	340		10.1056/NEJM199108013250506	http://dx.doi.org/10.1056/NEJM199108013250506			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY715	2057037				2022-12-28	WOS:A1991FY71500006
J	MISHU, B; GRIFFIN, PM; TAUXE, RV; CAMERON, DN; HUTCHESON, RH; SCHAFFNER, W				MISHU, B; GRIFFIN, PM; TAUXE, RV; CAMERON, DN; HUTCHESON, RH; SCHAFFNER, W			SALMONELLA-ENTERITIDIS GASTROENTERITIS TRANSMITTED BY INTACT CHICKEN EGGS	ANNALS OF INTERNAL MEDICINE			English	Article							GRADE-A EGGS; INFECTIONS	Objective: To determine the source and to describe the clinical importance of a large outbreak of Salmonella enteritidis gastroenteritis in Tennessee, which is outside the geographic focus of the S. enteritidis pandemic. Design: A case-control study and tracing of the source eggs. Setting: A Tennessee community and a large layer farm in Indiana. Patients: Case patients ate at the implicated restaurant and subsequently developed S. enteritidis gastroenteritis; controls ate with the case patients, but did not develop gastroenteritis. Measurements: Eighty-one case patients were identified; 73 (90%) had eaten egg-containing sauces at a local restaurant on a given evening. The eggs were traced to their farm of origin in Indiana. The farm was inspected 5 weeks after the outbreak. Main Results: Of 24 patients with culture-proved cases, 11 were hospitalized. Hollandaise and bernaise sauces prepared with intact, extra-large, grade-A eggs were strongly associated with illness (P < 0.001). Salmonella enteritidis was isolated from specimens collected from chickens and the farm. Antimicrobial susceptibility patterns, phage typing, and plasmid profiles of isolates from the farm and from patients were indistinguishable. Conclusions: Salmonella enteritidis infection is a large and growing public health problem that is spreading beyond the northeastern United States. This study shows a direct link between infected poultry flocks and an outbreak of human illness.	VANDERBILT UNIV, NASHVILLE, TN 37240 USA; TENNESSEE DEPT HLTH & ENVIRONM, NASHVILLE, TN USA	Vanderbilt University; Tennessee Department Health	MISHU, B (corresponding author), CTR DIS CONTROL, ENTER DIS BRANCH, MSC09, ATLANTA, GA 30333 USA.							BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BROWNELL JR, 1969, AVIAN DIS, V13, P804, DOI 10.2307/1588588; HOPPER SA, 1988, VET REC, V123, P351, DOI 10.1136/vr.123.13.351; HUMPHREY TJ, 1989, EPIDEMIOL INFECT, V103, P415, DOI 10.1017/S0950268800030818; HUMPHREY TJ, 1989, EPIDEMIOL INFECT, V103, P35, DOI 10.1017/S0950268800030338; LISTER SA, 1988, VET REC, V123, P350, DOI 10.1136/vr.123.13.350; PAVIA AT, 1990, J INFECT DIS, V161, P255, DOI 10.1093/infdis/161.2.255; POTTER M, 1987, POULTRY EGG RELATED, P44; RODRIGUE D, 1989, 29TH INT C ANT AG CH; RODRIGUE DC, 1990, EPIDEMIOL INFECT, V105, P21, DOI 10.1017/S0950268800047609; ROMBAUER IS, 1975, JOY COOKING, P357; STLOUIS ME, 1988, JAMA-J AM MED ASSOC, V259, P2103, DOI 10.1001/jama.259.14.2103; TAYLOR DN, 1982, J INFECT DIS, V146, P322, DOI 10.1093/infdis/146.3.322; TELZAK EE, 1990, NEW ENGL J MED, V323, P394, DOI 10.1056/NEJM199008093230607; THOMAS RD, 1989, JAMA-J AM MED ASSOC, V261, P2064, DOI 10.1001/jama.261.14.2064; WAITES WM, 1990, LANCET, V336, P722, DOI 10.1016/0140-6736(90)92213-2; WARD LR, 1987, EPIDEMIOL INFECT, V99, P291, DOI 10.1017/S0950268800067765; WILLIAMS LP, 1970, AM J PUBLIC HEALTH N, V60, P926, DOI 10.2105/AJPH.60.5.926; 1988, USDA FDA FOOD SERVIC, P1; 1989, J AM VET MED ASSOC, V194, P626; 1988, LANCET, V2, P720; 1990, RETAIL FOOD PROTECTI, P1; 1990, MMWR, V38, P877; 1990, FED REG         0216, V55, P5576; 1990, FED REG         0401; 1990, MMWR, V39, P909	27	65	67	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	1991	115	3					190	194		10.7326/0003-4819-115-3-190	http://dx.doi.org/10.7326/0003-4819-115-3-190			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY152	2058873				2022-12-28	WOS:A1991FY15200005
J	BIGELOW, V; TREES, CB				BIGELOW, V; TREES, CB			A MODEL FOR PRIMARY CARE DELIVERY TO A WIDELY DISPERSED MEDICALLY INDIGENT POPULATION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Access to Care is a unique program uniting private and public resources to provide primary care to the uninsured poor. The model was designed to serve a medically indigent population that is dispersed over a large geographic area, where clinics are not a practical option. Care for illness is provided in the off ices of private physicians throughout the area and supported by laboratory, radiology, and pharmacy services. The program is designed for the estimated 88 000 persons in suburban Cook County, Illinois, with family incomes of less than twice the federal poverty level, who are uninsured and ineligible for Medicaid and Medicare. Supported by grants from foundations and local governments, the program, which has been in operation for 2 years in two demonstration areas, is administered by a private not-for-profit confederation of four health and social service organizations.			BIGELOW, V (corresponding author), SUBURBAN PRIMARY HLTH CARE COUNCIL,2235 ENTERPRISE DR,SUITE 3501,WESTCHESTER,IL 60154, USA.							MCLEMORE T, 1987, PHS871250 US DEP HLT; 1986, COST COMPASSION RECO	2	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1991	266	4					563	564						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX021	2061985				2022-12-28	WOS:A1991FX02100033
J	HAYNES, BE; MENDOZA, A; MCNEIL, M; SCHROEDER, J; SMILEY, DR				HAYNES, BE; MENDOZA, A; MCNEIL, M; SCHROEDER, J; SMILEY, DR			A STATEWIDE EARLY DEFIBRILLATION INITIATIVE INCLUDING LAYPERSONS AND OUTCOME REPORTING	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AUTOMATIC EXTERNAL DEFIBRILLATOR; EMERGENCY MEDICAL TECHNICIANS; HOSPITAL CARDIAC ARRESTS; RECOMMENDATIONS; EXPERIENCE	Rapid delivery of defibrillatory shocks increases survival in patients with cardiac arrest. The automated external defibrillator interprets cardiac rhythms and delivers electrical shocks, permitting appropriate defibrillation by persons with minimal training. California initiated a program for early defibrillation by basic emergency medical technicians, using manual or automated external defibrillators, and by public safety personnel (fire fighters, peace officers, and public lifeguards), using automated external defibrillators. The program includes a system for reporting outcomes statewide. In the first 46 months under this program, 1487 patients received defibrillatory shocks; 1009 (68%) of these patients had witnessed ventricular fibrillation. Of the latter group, 191 were discharged from the hospital, representing 19% of those with witnessed ventricular fibrillation and 13% of all patients who had had shocks applied. California also implemented a framework of training and medical direction for defibrillation by laypersons using automated external defibrillators. Early defibrillation by basic emergency medical technicians and public safety personnel, encouraged by appropriate regulatory changes, results in gratifying survival rates.	CALIF EMERGENCY MED SERV AUTHOR,SACRAMENTO,CA		HAYNES, BE (corresponding author), KAISER PERMANENTE SAN DIEGO MED CTR,EMERGENCY SERV,4647 ZION AVE,SAN DIEGO,CA 92120, USA.							ADGEY AAJ, 1969, LANCET, V1, P1169; BACHMAN JW, 1986, JAMA-J AM MED ASSOC, V256, P477, DOI 10.1001/jama.256.4.477; CUMMINS RO, 1989, ANN EMERG MED, V18, P1269, DOI 10.1016/S0196-0644(89)80257-4; CUMMINS RO, 1990, JAMA-J AM MED ASSOC, V264, P1019, DOI 10.1001/jama.264.8.1019; EISENBERG MS, 1980, NEW ENGL J MED, V302, P1379, DOI 10.1056/NEJM198006193022502; EISENBERG MS, 1979, JAMA-J AM MED ASSOC, V241, P1905, DOI 10.1001/jama.241.18.1905; EISENBERG MS, 1990, ANN EMERG MED, V19, P1249, DOI 10.1016/S0196-0644(05)82283-8; EISENBERG MS, 1984, SUDDEN CARDIAC DEATH; GENTILE D, 1988, J TENN MED ASS   MAR, P144; GRAY AJ, 1987, BRIT MED J, V294, P1133, DOI 10.1136/bmj.294.6580.1133; STULTS KR, 1984, NEW ENGL J MED, V310, P219, DOI 10.1056/NEJM198401263100403; STULTS KR, 1988, J EMERG MED SERV AUG, P39; WEAVER WD, 1986, AM J CARDIOL, V57, P1017, DOI 10.1016/0002-9149(86)90667-3; WEAVER WD, 1988, NEW ENGL J MED, V319, P661, DOI 10.1056/NEJM198809153191101; 1991, INSTRUCTORS MANUAL A, P33	15	26	27	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1991	266	4					545	547		10.1001/jama.266.4.545	http://dx.doi.org/10.1001/jama.266.4.545			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX021	2061982				2022-12-28	WOS:A1991FX02100029
J	SIU, AL				SIU, AL			SCREENING FOR DEMENTIA AND INVESTIGATING ITS CAUSES	ANNALS OF INTERNAL MEDICINE			English	Review							MINI-MENTAL STATE; MULTI-INFARCT DEMENTIA; SERUM COBALAMIN LEVELS; ALZHEIMERS-DISEASE; DIFFERENTIAL-DIAGNOSIS; VASCULAR DEMENTIA; COGNITIVE IMPAIRMENT; STATUS QUESTIONNAIRE; SENILE DEMENTIA; REVERSIBLE DEMENTIA	Objective: To examine, from the perspective of primary care physicians, the value of mental status findings and ancillary tests in diagnosing dementia or its causes. Data Sources: Studies identified using MEDLINE and bibliographies of pertinent articles. Study Selection: Selection based on availability of information on specific findings or tests, the criterion standard used to confirm diagnoses, the disease spectrum, and the richness of the reported data. Data Extraction: Data collected on sensitivity and specificity. In many cases, the originally reported data are re-analyzed to illustrate the usefulness of alternative cut-off values or to answer specific clinical questions. Likelihood ratios estimated to summarize test results. Data Synthesis: Probability of dementia is greatly reduced (likelihood ratio, 0.06 to 0.2) when either normal serial 7s, 7-digit span, 3-item recall, or clock drawing test results are obtained; abnormal results only moderately increase the odds of disease. Low (less-than-or-equal-to 20), intermediate (21 to 25), or high (greater-than-or-equal-to 26) scores on the Mini-Mental State Examination (MMSE) increase (likelihood ratio greater-than-or-equal-to 8.2), have little effect (likelihood ratio, 1.3 to 2.4), or decrease (likelihood ratio, 0.06 to 0.1) the odds of disease. The usefulness of tests to investigate the cause of dementia varies depending on the pretest probability of the specific condition. Conclusions: Several useful methods exist to screen for cognitive impairment, and clinicians need to be familiar with the strengths and limitations of their preferred screening methods. In investigating the cause of dementia, routinely obtaining a VDRL test, cerebral imaging studies, serum cobalamin level, or folate level is unwarranted.	RAND CORP, SANTA MONICA, CA 90406 USA	RAND Corporation	SIU, AL (corresponding author), UNIV CALIF LOS ANGELES, DEPT MED, LOS ANGELES, CA 90024 USA.							AHARONPERETZ J, 1988, ARCH NEUROL-CHICAGO, V45, P719, DOI 10.1001/archneur.1988.00520310025011; ANTHONY JC, 1982, PSYCHOL MED, V12, P397, DOI 10.1017/S0033291700046730; BAKER HL, 1980, RADIOLOGY, V136, P91, DOI 10.1148/radiology.136.1.7384529; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; BRINK TL, 1978, J AM GERIATR SOC, V26, P380, DOI 10.1111/j.1532-5415.1978.tb03690.x; BUCHT G, 1984, J AM GERIATR SOC, V32, P491, DOI 10.1111/j.1532-5415.1984.tb02233.x; CALTAGIRONE C, 1979, ACTA PSYCHIAT SCAND, V60, P50, DOI 10.1111/j.1600-0447.1979.tb00264.x; CARMEL R, 1988, ARCH INTERN MED, V148, P1712, DOI 10.1001/archinte.148.8.1712; CLARFIELD AM, 1988, ANN INTERN MED, V109, P476, DOI 10.7326/0003-4819-109-6-476; COLLINS JG, 1986, VITAL HLTH STATIS 10, V155; CUMMINGS J, 1983, DEMENTIA CLIN APPROA; CUMMINGS JL, 1986, J AM GERIATR SOC, V34, P12, DOI 10.1111/j.1532-5415.1986.tb06334.x; DEPAULO JR, 1978, ANN NEUROL, V4, P225, DOI 10.1002/ana.410040306; DICK JPR, 1984, J NEUROL NEUROSUR PS, V47, P496, DOI 10.1136/jnnp.47.5.496; DIETCH JT, 1983, WESTERN J MED, V138, P835; EASTWOOD MR, 1983, J AM GERIATR SOC, V31, P342, DOI 10.1111/j.1532-5415.1983.tb05744.x; Engedal K, 1988, Compr Gerontol A, V2, P87; ERKINJUNTTI T, 1987, J NEUROL NEUROSUR PS, V50, P37, DOI 10.1136/jnnp.50.1.37; ERKINJUNTTI T, 1987, ACTA NEUROL SCAND, V75, P262, DOI 10.1111/j.1600-0404.1987.tb07931.x; ERKINJUNTTI T, 1987, ACTA NEUROL SCAND, V76, P433, DOI 10.1111/j.1600-0404.1987.tb03599.x; ERKINJUNTTI T, 1986, ARCH INTERN MED, V146, P1923, DOI 10.1001/archinte.146.10.1923; ESLINGER PJ, 1985, JAMA-J AM MED ASSOC, V253, P670, DOI 10.1001/jama.253.5.670; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; FILLENBAUM G, 1990, J CLIN EPIDEMIOL, V43, P651, DOI 10.1016/0895-4356(90)90035-N; FILLENBAUM GG, 1980, J AM GERIATR SOC, V28, P381, DOI 10.1111/j.1532-5415.1980.tb01103.x; FILLENBAUM GG, 1988, PSYCHOL MED, V18, P1021, DOI 10.1017/S0033291700009946; FOLSTEIN M, 1985, J AM GERIATR SOC, V33, P228, DOI 10.1111/j.1532-5415.1985.tb07109.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FREEMON FR, 1982, J AM GERIATR SOC, V30, P449, DOI 10.1111/j.1532-5415.1982.tb03382.x; Fuld PA., 1978, ALZHEIMERS DIS SENIL, V7, P185; GALLASSI R, 1986, ACTA PSYCHIAT SCAND, V74, P62, DOI 10.1111/j.1600-0447.1986.tb06228.x; GOLDEN RR, 1983, INT J AGING HUM DEV, V16, P241, DOI 10.2190/BY6J-960Y-EHN7-6LBC; GUSTAFSON L, 1982, ACTA PSYCHIAT SCAND, V65, P194, DOI 10.1111/j.1600-0447.1982.tb00840.x; HACHINSKI VC, 1987, ARCH NEUROL-CHICAGO, V44, P21, DOI 10.1001/archneur.1987.00520130013009; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; HAGLUND RMJ, 1976, J GERONTOL, V31, P654, DOI 10.1093/geronj/31.6.654; HART G, 1986, ANN INTERN MED, V104, P368, DOI 10.7326/0003-4819-104-3-368; HAUGHTON VM, 1986, RADIOLOGY, V160, P751, DOI 10.1148/radiology.160.3.3737914; HECTOR M, 1988, J AM GERIATR SOC, V36, P1105, DOI 10.1111/j.1532-5415.1988.tb04397.x; HERSHEY LA, 1987, INT J PSYCHIAT MED, V17, P183; HING EE, 1989, VITAL HLTH STATIS 13, V97; HINTON J, 1971, BRIT J PSYCHIAT, V119, P9, DOI 10.1192/bjp.119.548.9; HOMER AC, 1988, BMJ-BRIT MED J, V297, P894, DOI 10.1136/bmj.297.6653.894; HOPKINS B, 1953, J MENT SCI, V99, P451, DOI 10.1192/bjp.99.416.451; HUBER SJ, 1986, ARCH NEUROL-CHICAGO, V43, P392, DOI 10.1001/archneur.1986.00520040072023; ISAACS B, 1973, BRIT J PSYCHIAT, V123, P467, DOI 10.1192/bjp.123.4.467; JACOBS JW, 1977, ANN INTERN MED, V86, P40, DOI 10.7326/0003-4819-86-1-40; JENKYN LR, 1977, J NEUROL NEUROSUR PS, V40, P956, DOI 10.1136/jnnp.40.10.956; KAHN RL, 1960, AM J PSYCHIAT, V117, P326, DOI 10.1176/ajp.117.4.326; KARNAZE DS, 1987, ARCH INTERN MED, V147, P429, DOI 10.1001/archinte.147.3.429; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; KAUFMAN DM, 1979, GEN HOSP PSYCHIAT, V1, P247, DOI 10.1016/0163-8343(79)90026-4; KAY DWK, 1985, PSYCHOL MED, V15, P771, DOI 10.1017/S0033291700005006; KENDRICK DC, 1979, BRIT J SOC CLIN PSYC, V18, P329, DOI 10.1111/j.2044-8260.1979.tb00343.x; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; KLEIN LE, 1985, J AM GERIATR SOC, V33, P483, DOI 10.1111/j.1532-5415.1985.tb05460.x; KOKMEN E, 1987, MAYO CLIN PROC, V62, P281, DOI 10.1016/S0025-6196(12)61905-3; KRAMER M, 1985, J AM GERIATR SOC, V33, P236, DOI 10.1111/j.1532-5415.1985.tb07110.x; LADURNER G, 1982, J NEUROL NEUROSUR PS, V45, P97, DOI 10.1136/jnnp.45.2.97; LARSON EB, 1986, ARCH INTERN MED, V146, P1917, DOI 10.1001/archinte.146.10.1917; LARSON EB, 1986, WESTERN J MED, V145, P488; LINDENBAUM J, 1988, NEW ENGL J MED, V318, P1720, DOI 10.1056/NEJM198806303182604; MAHLER ME, 1987, WESTERN J MED, V146, P705; MARTIN DC, 1987, ARCH INTERN MED, V147, P77, DOI 10.1001/archinte.147.1.77; MCCARTNEY JR, 1985, J AM GERIATR SOC, V33, P467, DOI 10.1111/j.1532-5415.1985.tb05457.x; MCLEAN S, 1987, AUST NZ J PSYCHIAT, V21, P142, DOI 10.3109/00048678709160910; MOLSA PK, 1985, J NEUROL NEUROSUR PS, V48, P1085, DOI 10.1136/jnnp.48.11.1085; MULROW CD, 1987, J GERONTOL, V42, P277, DOI 10.1093/geronj/42.3.277; NELSON A, 1986, J NERV MENT DIS, V174, P73, DOI 10.1097/00005053-198602000-00002; OCONNOR DW, 1989, J PSYCHIAT RES, V23, P87, DOI 10.1016/0022-3956(89)90021-6; OMER H, 1983, J AM GERIATR SOC, V31, P266, DOI 10.1111/j.1532-5415.1983.tb04868.x; ONEILL D, 1989, IRISH MED J, V82, P24; PFEFFER RI, 1984, AM J EPIDEMIOL, V120, P922, DOI 10.1093/oxfordjournals.aje.a113963; PFEFFER RI, 1981, AM J EPIDEMIOL, V114, P515, DOI 10.1093/oxfordjournals.aje.a113217; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; RABINS PV, 1984, BRIT J PSYCHIAT, V144, P488, DOI 10.1192/bjp.144.5.488; RAMSDELL JW, 1990, J GEN INTERN MED, V5, P55, DOI 10.1007/BF02602310; REYNOLDS CF, 1988, AM J PSYCHIAT, V145, P1099; RITCHIE KA, 1989, INT J EPIDEMIOL, V18, P717, DOI 10.1093/ije/18.3.717; ROGERS RL, 1988, J AM GERIATR SOC, V36, P13, DOI 10.1111/j.1532-5415.1988.tb03428.x; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; ROTH M, 1953, J MENT SCI, V99, P439, DOI 10.1192/bjp.99.416.439; Sackett D., 1985, CLIN EPIDEMIOLOGY BA, P59; SHAPIRO MB, 1956, J MENT SCI, V102, P233, DOI 10.1192/bjp.102.427.233; SLUSS TK, 1982, NEUROPSYCHOBIOLOGY, V8, P109, DOI 10.1159/000117884; SMALL GW, 1985, J CLIN PSYCHIAT, V46, P514; SMYER MA, 1979, J AM GERIATR SOC, V27, P263, DOI 10.1111/j.1532-5415.1979.tb06128.x; STORANDT M, 1984, ARCH NEUROL-CHICAGO, V41, P497, DOI 10.1001/archneur.1984.04050170043013; TAYLOR MA, 1980, J NERV MENT DIS, V168, P167, DOI 10.1097/00005053-198003000-00007; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; THOMPSON WG, 1989, ACTA HAEMATOL-BASEL, V82, P169, DOI 10.1159/000205371; THOMPSON WG, 1987, AM J MED, V82, P291, DOI 10.1016/0002-9343(87)90070-2; TIERNEY MC, 1987, ARCH NEUROL-CHICAGO, V44, P720, DOI 10.1001/archneur.1987.00520190032013; TINETTI ME, 1986, AM J MED, V80, P844, DOI 10.1016/0002-9343(86)90626-1; WADE JPH, 1987, ARCH NEUROL-CHICAGO, V44, P24, DOI 10.1001/archneur.1987.00520130016010; WEBSTER JS, 1984, J CLIN PSYCHOL, V40, P237, DOI 10.1002/1097-4679(198401)40:1<237::AID-JCLP2270400146>3.0.CO;2-T; Weingartner H, 1982, Psychopharmacol Bull, V18, P27; WELLS CE, 1979, AM J PSYCHIAT, V136, P895; WENTWORTH BB, 1978, SEX TRANSM DIS, V5, P103, DOI 10.1097/00007435-197807000-00005; WOLFKLEIN GP, 1989, J AM GERIATR SOC, V37, P730, DOI 10.1111/j.1532-5415.1989.tb02234.x; ZARIT SH, 1978, J AM GERIATR SOC, V26, P58, DOI 10.1111/j.1532-5415.1978.tb02542.x; ZUBENKO GS, 1990, AM J PSYCHIAT, V147, P435; 1987, DIAGNOSTIC STATISTIC; 1980, JAMA-J AM MED ASSOC, V244, P259	105	151	152	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	1991	115	2					122	132		10.7326/0003-4819-115-2-122	http://dx.doi.org/10.7326/0003-4819-115-2-122			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW091	2058860				2022-12-28	WOS:A1991FW09100009
J	METZ, T; GRAF, T				METZ, T; GRAF, T			FUSION OF THE NUCLEAR ONCOPROTEINS V-MYB AND V-ETS IS REQUIRED FOR THE LEUKEMOGENICITY OF E26 VIRUS	CELL			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; HEMATOPOIETIC TARGET-CELLS; LONG TERMINAL REPEAT; RECEPTOR-ALPHA-GENE; DNA-BINDING DOMAIN; TRANSCRIPTIONAL ACTIVATION; T(15-17) TRANSLOCATION; TRANS-ACTIVATION; PROTO-ONCOGENE; MYELOID CELLS	The highly leukemogenic avian retrovirus E26 expresses the two transcriptional activator-type oncogenes v-myb and v-ets as a nuclear fusion protein. Previous studies have shown that both oncogenes cooperate in the transformation of erythroid cells in vitro and that the phenotypes of transformed cells differ, depending on whether the oncogenes are coexpressed as separate proteins or as a fusion protein. Here we show that virus constructs encoding either v-Myb or v-Ets as their only oncoprotein are nonleukemogenic and that constructs coexpressing nonfused v-Myb and v-Ets proteins appear to be weakly leukemogenic. Surprisingly, leukemic animals injected with the latter contain highly leukemogenic variant viruses that exhibit internal deletions in their genome, resulting in the synthesis of novel Myb-Ets fusion proteins. These results show that v-Myb and v-Ets must be fused to cause leukemia and establish a new mechanism of oncogene activation and cooperation.			METZ, T (corresponding author), EUROPEAN MOLEC BIOL LAB, DIFFERENTIAT PROGRAMME, W-6900 HEIDELBERG, GERMANY.		Graf, Thomas/B-4252-2015	Graf, Thomas/0000-0003-2774-4117				BARTLETT JA, 1986, BIOTECHNIQUES, V4, P208; BEUG H, 1982, J CELL PHYSIOL, P195; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; BEUG H, 1982, EMBO J, V1, P1069, DOI 10.1002/j.1460-2075.1982.tb01298.x; BISTER K, 1982, P NATL ACAD SCI-BIOL, V79, P3677, DOI 10.1073/pnas.79.12.3677; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; BOSSELUT R, 1990, EMBO J, V9, P3137, DOI 10.1002/j.1460-2075.1990.tb07511.x; BOULUKOS KE, 1989, MOL CELL BIOL, V9, P5718, DOI 10.1128/MCB.9.12.5718; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; FRAMPTON J, 1989, NATURE, V342, P134, DOI 10.1038/342134a0; GHYSDAEL J, 1986, P NATL ACAD SCI USA, V83, P1714, DOI 10.1073/pnas.83.6.1714; GRAF T, 1981, EXP CELL RES, V131, P331, DOI 10.1016/0014-4827(81)90236-6; GRAF T, 1979, VIROLOGY, V99, P431, DOI 10.1016/0042-6822(79)90024-2; GUNTHER CV, 1990, GENE DEV, V4, P667, DOI 10.1101/gad.4.4.667; HO IC, 1990, SCIENCE, V250, P814, DOI 10.1126/science.2237431; IBANEZ CE, 1990, MOL CELL BIOL, V10, P2285, DOI 10.1128/MCB.10.5.2285; Ivanov X, 1962, B I PATHOL COMP ANIM, V9, P5; KAMPS MP, 1991, GENE DEV, V5, P358, DOI 10.1101/gad.5.3.358; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KLEMPNAUER KH, 1989, GENE DEV, V3, P1582, DOI 10.1101/gad.3.10.1582; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KORNFELD S, 1983, EXP CELL RES, V143, P383, DOI 10.1016/0014-4827(83)90065-4; LEMONS RS, 1990, GENE CHROMOSOME CANC, V2, P79, DOI 10.1002/gcc.2870020202; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; LEPRINCE D, 1988, J VIROL, V62, P3233, DOI 10.1128/JVI.62.9.3233-3241.1988; LEUTZ A, 1984, EMBO J, V3, P3191, DOI 10.1002/j.1460-2075.1984.tb02278.x; Maniatis T., 1982, MOL CLONING; METZ T, 1991, GENE DEV, V5, P369, DOI 10.1101/gad.5.3.369; METZ T, 1991, EMBO J, V10, P837, DOI 10.1002/j.1460-2075.1991.tb08016.x; MOSCOVICI C, 1981, VIROLOGY, V113, P765, DOI 10.1016/0042-6822(81)90205-1; MOSCOVICI MG, 1983, VIROLOGY, V129, P65, DOI 10.1016/0042-6822(83)90396-3; NESS SA, 1987, CELL, V51, P41, DOI 10.1016/0092-8674(87)90008-0; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; NISHINA Y, 1989, NUCLEIC ACIDS RES, V17, P107, DOI 10.1093/nar/17.1.107; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; NUNN MF, 1983, NATURE, V306, P391, DOI 10.1038/306391a0; NUNN MF, 1989, J VIROL, V63, P398, DOI 10.1128/JVI.63.1.398-402.1989; ORKIN SH, 1975, P NATL ACAD SCI USA, V72, P98, DOI 10.1073/pnas.72.1.98; RADKE K, 1982, CELL, V31, P643, DOI 10.1016/0092-8674(82)90320-8; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; WEISS R, 1985, RNA TUMOR VIRUSES MO, V2, P657; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895	44	98	98	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 12	1991	66	1					95	105		10.1016/0092-8674(91)90142-L	http://dx.doi.org/10.1016/0092-8674(91)90142-L			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FW913	2070421				2022-12-28	WOS:A1991FW91300012
J	CALIGIURI, MG; BAUERLE, R				CALIGIURI, MG; BAUERLE, R			SUBUNIT COMMUNICATION IN THE ANTHRANILATE SYNTHASE COMPLEX FROM SALMONELLA-TYPHIMURIUM	SCIENCE			English	Article								The anthranilate synthase - phosphoribosyl transferase complex of the tryptophan biosynthetic pathway in Salmonella typhimurium is an allosteric, heterotetrameric (TrpE2-TrpD2) enzyme whose multiple activities are negatively feedback-regulated by L-tryptophan. A hybrid complex containing one catalytically active, feedback-insensitive and one catalytically inactive, feedback-sensitive mutant TrpE subunit was assembled in vitro and used to investigate communication between regulatory and catalytic sites located on different subunits. The properties of the hybrid complex demonstrate that the binding of a single inhibitor molecule to one TrpE subunit is sufficient for the propagation of a conformational change that affects the active site of the companion subunit.	UNIV VIRGINIA, DEPT BIOL, CHARLOTTESVILLE, VA 22901 USA; UNIV VIRGINIA, INST MOLEC BIOL, CHARLOTTESVILLE, VA 22901 USA	University of Virginia; University of Virginia					NIGMS NIH HHS [GM07082, GM35889] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035889] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAUERLE R, 1987, METHOD ENZYMOL, V142, P366; CALIGIURI M, UNPUB; CALIGIURI MG, 1991, J BIOL CHEM, V266, P8328; CRICK FHC, 1964, J MOL BIOL, V8, P161, DOI 10.1016/S0022-2836(64)80156-X; FOOTE J, 1985, J MOL BIOL, V186, P175, DOI 10.1016/0022-2836(85)90267-0; FOREMAN JE, 1985, J BIOL CHEM, V260, P19; GRIESHABER M, 1978, Z NATURFORSCH C, V33, P235; GRIESHABER M, 1972, NATURE-NEW BIOL, V236, P232, DOI 10.1038/newbio236232a0; HENDERSON EJ, 1970, J BIOL CHEM, V245, P1416; HENDERSON EJ, 1971, J BIOL CHEM, V246, P6891; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KUO LC, 1982, P NATL ACAD SCI-BIOL, V79, P2250, DOI 10.1073/pnas.79.7.2250; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NAGANO H, 1970, J BIOL CHEM, V245, P3097; Segel I.H., 1975, ENZYME KINETICS; SENNEWALD J, UNPUB; SMITH D, 1969, BIOCHEMISTRY-US, V8, P1451, DOI 10.1021/bi00832a021; VALDEZ BC, 1989, J BIOL CHEM, V264, P131; ZABIN I, 1975, ANNU REV BIOCHEM, V44, P295, DOI 10.1146/annurev.bi.44.070175.001455; ZALKIN H, 1968, BIOCHEMISTRY-US, V7, P3566, DOI 10.1021/bi00850a034; ZALKIN H, 1980, MULTIFUNCTIONAL PROT, P123	21	33	35	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	1991	252	5014					1845	1848		10.1126/science.2063197	http://dx.doi.org/10.1126/science.2063197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU061	2063197				2022-12-28	WOS:A1991FU06100039
J	LEW, JF; GLASS, RI; GANGAROSA, RE; COHEN, IP; BERN, C; MOE, CL				LEW, JF; GLASS, RI; GANGAROSA, RE; COHEN, IP; BERN, C; MOE, CL			DIARRHEAL DEATHS IN THE UNITED-STATES, 1979 THROUGH 1987 - A SPECIAL PROBLEM FOR THE ELDERLY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GASTROENTERITIS; COMMUNITY	Objective. - Diarrhea is an important cause of death among young children in both developing and developed countries, but little is known about diarrheal deaths among adults. In this study, we examined trends in diarrheal deaths among all age groups in the United States. Design/Setting/Participants. - We reviewed national mortality data compiled by the National Center for Health Statistics, Hyattsville, Md, which consist of information from all death certificates filed in the United States for the period 1979 through 1987. A death for which diarrhea was listed as an immediate or underlying cause was considered a "diarrheal death" and included in the analysis. Results. - We found that 28 538 persons died of diarrhea cited as either an immediate or the underlying cause of death during the 9-year period. A majority of diarrheal deaths occurred among the elderly (older than 74 years of age, 51%), followed by adults 55 to 74 years of age (27%), and young children (younger than 5 years of age, 11 %). For the elderly, adjusted risk factors for dying of diarrhea included being white, female, and residing in a long-term care facility. Only the elderly and young children had clear, distinct winter peaks of diarrheal deaths, suggesting that the diarrhea may, in part, be infectious in origin. Conclusion. - For the elderly, more directed studies of those at risk, such as nursing home residents, are needed to determine if oral rehydration therapy, vaccines, or other preventive measures might benefit this population.	EMORY UNIV,SCH PUBL HLTH,ATLANTA,GA 30322; LYCEE ST LOUIS,PARIS,FRANCE	Emory University	LEW, JF (corresponding author), CTR DIS CONTROL,DIV VIRAL & RICKETTSIAL DIS,RESP & ENTER VIRUS BRANCH,ATLANTA,GA 30333, USA.		Moe, Christine L/G-6118-2012					AVERY ME, 1990, NEW ENGL J MED, V323, P891, DOI 10.1056/NEJM199009273231307; BRESLOW L, 1990, ANNU REV PUBL HEALTH, V11, P1; FITZGERALD JF, 1989, PEDIATR INFECT DIS J, V8, P564, DOI 10.1097/00006454-198908000-00044; GELLERT GA, 1990, INFECT CONT HOSP EP, V11, P459; GORDON SM, 1990, AM J EPIDEMIOL, V131, P702, DOI 10.1093/oxfordjournals.aje.a115554; HING E, 1989, VITA HLTH STAT, V102, P24; HING E, 1987, PHS871270 US DEP HLT; HO MS, 1988, J INFECT DIS, V158, P1112, DOI 10.1093/infdis/158.5.1112; HO MS, 1988, JAMA-J AM MED ASSOC, V260, P3281, DOI 10.1001/jama.260.22.3281; ISRAEL RA, 1986, AM J EPIDEMIOL, V124, P161, DOI 10.1093/oxfordjournals.aje.a114375; LEBARON CW, 1990, JAMA-J AM MED ASSOC, V264, P983, DOI 10.1001/jama.264.8.983; MAASDAM CF, 1981, GERIATRICS, V36, P127; MATSON DO, 1990, J INFECT DIS, V162, P598, DOI 10.1093/infdis/162.3.598; Smith P W, 1989, Infect Dis Clin North Am, V3, P763; WING S, 1985, J GERONTOL, V40, P78, DOI 10.1093/geronj/40.1.78; 1990, PHS901232 US DEP HLT; [No title captured]; 1982, US BUREAU CENSUS P25, V917; 1987, MMWR, V36, P1; 1988, US BUREAU CENSUS P25, V1022; 1990, STATE WORLDS CHILDRE	21	119	121	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1991	265	24					3280	3284		10.1001/jama.265.24.3280	http://dx.doi.org/10.1001/jama.265.24.3280			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR835	2046110				2022-12-28	WOS:A1991FR83500035
J	GRAY, DP				GRAY, DP			RESEARCH IN GENERAL-PRACTICE - LAW OF INVERSE OPPORTUNITY	BRITISH MEDICAL JOURNAL			English	Article							CARE				GRAY, DP (corresponding author), UNIV EXETER,POSTGRAD MED SCH,EXETER EX2 5DW,ENGLAND.			PEREIRA GRAY, DENIS/0000-0001-7917-3841				EDWARDS B, 1987, DISTINCTION MERITORI; Gray D J, 1978, J R Coll Gen Pract, V28, P6; Grol R., 1988, HEAL HARM PREVENTION; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Huygen FJA., 1990, FAMILY MED MED LIFE; IRVINE D, 1983, J ROY COLL GEN PRACT, V33, P521; LOUDEN I, 1986, MED CARE GENERAL PRA; MAIR A, 1986, J MACKENZIE 1853 192; Pickles W, 1984, EPIDEMIOLOGY COUNTRY; PORTERFIELD JS, 1989, BMJ, V299, P155; SMITH R, 1991, BRIT MED J, V302, P977, DOI 10.1136/bmj.302.6783.977; VANSCHAYCK CP, 1990, THESIS U NIJMEGEN; WILLIAMS WO, 1990, BRIT J GEN PRACT, V40, P491; WRIGHT AF, 1990, BRIT J GEN PRACT, V40, P459; 1991, INTEGRATING PRIMARY; 1989, HLTH TRENDS, V21, P137; 1986, CMND9771, P34; 1990, HLTH SOCIAL SERVICES; 1974, ORAL CONTRACEPTIVES; 1989, HOSPITAL MED STAFF E; 1989, MED QUALIFIED STAFF; 1990, 49 ROYAL COLL GEN PR, P19; 1987, FRONT LINE HLTH SERV; 1990, HLTH TRENDS, V22, P96	24	25	26	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 8	1991	302	6789					1380	1382		10.1136/bmj.302.6789.1380	http://dx.doi.org/10.1136/bmj.302.6789.1380			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR057	2059720	Bronze, Green Published			2022-12-28	WOS:A1991FR05700024
J	TEICHER, BA; HERMAN, TS; HOLDEN, SA; WANG, YY; PFEFFER, MR; CRAWFORD, JW; FREI, E				TEICHER, BA; HERMAN, TS; HOLDEN, SA; WANG, YY; PFEFFER, MR; CRAWFORD, JW; FREI, E			TUMOR RESISTANCE TO ALKYLATING-AGENTS CONFERRED BY MECHANISMS OPERATIVE ONLY INVIVO	SCIENCE			English	Article									JOINT CTR RADIAT THERAPY,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital	TEICHER, BA (corresponding author), HARVARD UNIV,SCH MED,DANA FARBER CANC INST,44 BINNEY ST,BOSTON,MA 02115, USA.				NATIONAL CANCER INSTITUTE [P01CA038497] Funding Source: NIH RePORTER; NCI NIH HHS [P01-CA38497] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BATES SE, 1987, SEMIN ONCOL, V14, P102; BROWN RK, 1980, CANCER TREAT REP, V64, P643; COHEN VH, 1986, ANAL BIOCHEM, V14, P434; COLDMAN AJ, 1985, CANCER TREAT REP, V69, P1041; DEWYS WD, 1973, JNCI-J NATL CANCER I, V50, P783, DOI 10.1093/jnci/50.3.783; DINCALCI M, 1983, CANCER RES, V43, P5674; DRUMMER OH, 1984, CLIN CHIM ACTA, V136, P65, DOI 10.1016/0009-8981(84)90248-1; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FISHER B, 1989, CANCER RES, V49, P1996; FREI E, 1988, CANCER RES, V48, P6417; FREI E, 1988, MECHANISMS DRUG RESI, P69; FRONDOZA CG, 1982, CANCER TREAT REP, V66, P1535; FURNER RL, 1977, CANCER TREAT REP, V61, P1637; GOLDIE JH, 1983, CANCER TREAT REP, V67, P923; GOLDIE JH, 1984, CANCER RES, V44, P3643; HERMAN TS, 1988, CANCER RES, V48, P2335; HERMAN TS, 1988, CANCER RES, V48, P5101; JOCELYN PC, 1970, ANAL BIOCHEM, V37, P417, DOI 10.1016/0003-2697(70)90067-9; KEYES SR, 1985, ADV ENZYME REGUL, V23, P291; MCMILLAN TJ, 1985, BRIT J CANCER, V52, P823, DOI 10.1038/bjc.1985.265; MULCAHY RT, 1982, BRIT J CANCER, V45, P835, DOI 10.1038/bjc.1982.135; Odell W D, 1989, Adv Intern Med, V34, P325; Rheinwald J G, 1980, Methods Cell Biol, V21A, P229, DOI 10.1016/S0091-679X(08)60769-4; ROCKWELL S, 1977, LAB ANIM SCI, V27, P831; ROCKWELL S, 1978, BRIT J CANCER, V37, P212; ROCKWELL S, 1973, RADIAT RES, V53, P281, DOI 10.2307/3573534; ROCKWELL SC, 1972, J NATL CANCER I, V49, P735; SARTORELLI A C, 1988, Cancer Research, V48, P775; Schabel F M Jr, 1978, Antibiot Chemother (1971), V23, P200; SCHABEL FM, 1983, CANCER TREAT REP, V67, P905; SCHABEL FM, 1983, PHARMACOL THERAPEUT, V20, P282; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; SEEBER S, 1984, CANCER TREAT REV, V11, P55, DOI 10.1016/0305-7372(84)90043-4; SEEBER S, 1982, CANCER RES, V42, P4719; STEPHENS TC, 1984, BRIT J CANCER, V50, P77, DOI 10.1038/bjc.1984.141; TEICHER BA, 1987, CANCER RES, V47, P513; TEICHER BA, 1981, CANCER RES, V41, P73; TEICHER BA, 1987, CANCER RES, V47, P388; TEICHER BA, 1986, CANCER RES, V46, P4379; TEICHER BA, 1988, DRUG RESISTANCE MAMM, V2, P1; VARNES ME, 1979, CANCER RES, V39, P2960; WONG TW, 1977, RADIAT RES, V71, P132, DOI 10.2307/3574718	42	286	307	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 23	1990	247	4949					1457	1461		10.1126/science.2108497	http://dx.doi.org/10.1126/science.2108497			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV282	2108497				2022-12-28	WOS:A1990CV28200035
J	SKIDMORE, CA; ROBERTSON, JR; ROBERTSON, AA; ELTON, RA				SKIDMORE, CA; ROBERTSON, JR; ROBERTSON, AA; ELTON, RA			AFTER THE EPIDEMIC - FOLLOW-UP-STUDY OF HIV SEROPREVALENCE AND CHANGING PATTERNS OF DRUG-USE	BRITISH MEDICAL JOURNAL			English	Article									MUIRHOUSE MED GRP,EDINBURGH EH4 4PL,SCOTLAND; UNIV EDINBURGH,MED STAT UNIT,EDINBURGH EH8 9AG,MIDLOTHIAN,SCOTLAND	University of Edinburgh								[Anonymous], 1988, AIDS DRUG MISUSE 1; BEWLEY TH, 1968, BRIT MED J, V1, P727, DOI 10.1136/bmj.1.5594.727; BLUMBERG HH, 1976, BRIT J ADDICT, V71, P65; CHAPPLE PAL, 1972, BRIT MED J, V2, P680, DOI 10.1136/bmj.2.5815.680; GHODSE AH, 1985, BRIT MED J, V290, P425, DOI 10.1136/bmj.290.6466.425; MARLATT GA, 1984, BRIT J ADDICT, V79, P261; ROBERTS JJK, 1989, J ROY COLL GEN PRACT, V39, P373; ROBERTSON JR, 1986, BRIT MED J, V292, P527, DOI 10.1136/bmj.292.6519.527; ROBERTSON JR, 1989, INT J ADDICT, V24, P229, DOI 10.3109/10826088909047286; ROBERTSON JR, 1989, AIDS FAMILY 2ND REPO; ROBERTSON JR, 1987, HEROIN AIDS SOC; Stimson G., 1982, HEROIN ADDICTION TRE; STIMSON GV, 1978, BRIT MED J, V1, P1190, DOI 10.1136/bmj.1.6121.1190; VAILLANT GE, 1973, ARCH GEN PSYCHIAT, V29, P237; WILLE R, 1981, BRIT J ADDICT, V76, P259; WINICK C, 1962, B NARCOTICS, V14, P1; 1989, AIDS DRUG MISUSE 2	17	48	48	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1990	300	6719					219	223		10.1136/bmj.300.6719.219	http://dx.doi.org/10.1136/bmj.300.6719.219			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL024	2106928	Bronze, Green Published			2022-12-28	WOS:A1990CL02400018
J	GARDINER, PVG; GRIFFITHS, ID				GARDINER, PVG; GRIFFITHS, ID			SUDDEN-DEATH AFTER TREATMENT WITH PULSED METHYLPREDNISOLONE	BRITISH MEDICAL JOURNAL			English	Letter											GARDINER, PVG (corresponding author), QUEEN ELIZABETH HOSP,DRUG & THERAPEUT UNIT,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND.		Gardiner, Philip/O-6706-2019	Gardiner, Philip/0000-0002-7972-1040				BARRY M, 1985, ARCH INTERN MED, V145, P1483, DOI 10.1001/archinte.145.8.1483; BOCANEGRA TS, 1981, ANN INTERN MED, V95, P122, DOI 10.7326/0003-4819-95-1-122_1; MOSES RE, 1981, ANN INTERN MED, V95, P781, DOI 10.7326/0003-4819-95-6-781_3; SCHMIDT GB, 1972, J AMER MED ASSOC, V221, P1402, DOI 10.1001/jama.221.12.1402; TVEDE N, 1986, SCAND J RHEUMATOL, V15, P302, DOI 10.3109/03009748609092597	5	27	27	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					125	125		10.1136/bmj.300.6717.125	http://dx.doi.org/10.1136/bmj.300.6717.125			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105769	Bronze, Green Published			2022-12-28	WOS:A1990CJ08000060
J	RAW, M; MCNEILL, A				RAW, M; MCNEILL, A			BRITAIN BANS ORAL SNUFF	BRITISH MEDICAL JOURNAL			English	Editorial Material									INST PSYCHIAT,ADDICT RES UNIT,LONDON SE5 8AF,ENGLAND	University of London; King's College London	RAW, M (corresponding author), KINGS COLL,SCH MED & DENT,DEPT COMMUNITY MED,LONDON SE5 9PJ,ENGLAND.			McNeill, Ann/0000-0002-6223-4000				ARY DV, 1987, PREV MED, V16, P385, DOI 10.1016/0091-7435(87)90039-9; BENOWITZ NL, 1988, CLIN PHARMACOL THER, V44, P23, DOI 10.1038/clpt.1988.107; CONNOLLY GN, 1986, NEW ENGL J MED, V314, P1020, DOI 10.1056/NEJM198604173141605; HATSUKAMI DK, 1987, CLIN PHARMACOL THER, V41, P103, DOI 10.1038/clpt.1987.17; MARTY PJ, 1986, AM J PUBLIC HEALTH, V76, P190, DOI 10.2105/AJPH.76.2.190; RUSSELL MAH, 1985, LANCET, V2, P1370; 1988, WHO TECHNICAL REP SE, V773; 1986, HLTH CONSEQUENCES US; 1985, EVALUATION CARCINOGE; 1986, BRIT MED J, V292, P504; 1988, HLTH CONSEQUENCES SM	11	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					65	66		10.1136/bmj.300.6717.65-a	http://dx.doi.org/10.1136/bmj.300.6717.65-a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105774	Green Published, Bronze			2022-12-28	WOS:A1990CJ08000005
J	FREEDMAN, M; STUSS, DT; GORDON, M				FREEDMAN, M; STUSS, DT; GORDON, M			ASSESSMENT OF COMPETENCY: THE ROLE OF NEUROBEHAVIORAL DEFICITS	ANNALS OF INTERNAL MEDICINE			English	Review							RETROGRADE-AMNESIA; INFORMED CONSENT; MEMORY; PATIENT; ISSUES	We present a practical set of guidelines for assessing competency in patients with cognitive deficits due to neurologic disorders such as stroke, head injury, Alzheimer disease, and multi-infarct dementia. Our focus is the evaluation of cognitive processes underlying the ability to make competent decisions, with an emphasis on the identification of areas of preserved function that may be used to bypass intellectual deficits. The assessment of the cognitive processes underlying competency involves a series of steps designed to evaluate attention, language, memory, and frontal lobe function. The examiner must first show that the patient has an adequate level of attention for participation in the further testing of specific cognitive functions; second, that the patient is able to comprehend relevant instructions, retain information long enough to evaluate it in relation to relevant recent and remote experiences, and express his or her wishes; and finally, that the patient has sufficiently intact judgment and awareness. The examiner must determine whether the patient's preserved cognitive abilities are sufficient for him or her to make an adequate judgment in relation to the specific question being asked. If cognitive function is found to be significantly impaired, the examiner should do a detailed assessment for the presence of compensatory abilities that can be used to bypass the deficits. For example, the examiner should assess whether patients who cannot speak are still able to express their wishes by pointing, using gesture, or even by drawing pictures. Unless such an assessment has been done, patients should not be considered incompetent.	UNIV TORONTO, TORONTO M5S 1A1, ONTARIO, CANADA; MT SINAI HOSP, BAYCREST CTR GERIATR CARE, TORONTO M5G 1X5, ONTARIO, CANADA	University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest; Sinai Health System Toronto								Albert M.L., 1981, CLIN ASPECTS DYSPHAS; ALEXANDER MP, 1984, NEUROLOGY, V34, P752, DOI 10.1212/WNL.34.6.752; ALEXANDER MP, 1988, ARCH NEUROL-CHICAGO, V45, P23, DOI 10.1001/archneur.1988.00520250029013; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; BENARON MH, 1989, ONTARIO MED REV  APR, P8; Benson D. F., 1975, AM HDB PSYCHIATRY, VIV, P208; BENSON DF, 1976, CLIN NEUROLOGY; BENSON DF, 1985, PRINCIPLES BEHAVIORA; BUTTERS N, 1985, CLIN NEUROPSYCHOLOGY; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FEDIO P, 1974, BRAIN LANG, V1, P29, DOI 10.1016/0093-934X(74)90024-8; GOLDBERG E, 1981, SCIENCE, V213, P1392, DOI 10.1126/science.7268442; Lezak MD, 2012, NEUROPSYCHOLOGICAL A, V5; LIEFF S, 1984, CAN MED ASSOC J, V130, P1293; Lipowski ZJ, 1980, DELIRIUM ACUTE BRAIN; LIPOWSKI ZJ, 1984, CLIN NEUROLOGY AGING, P277; MYERS B, 1986, PSYCHOSOMATICS, V27, P782, DOI 10.1016/S0033-3182(86)72605-4; Plum F, 1980, DIAGNOSIS STUPOR COM, Vthird; SCHACTER DL, 1982, NEUROPSYCHOLOGIA, V20, P523, DOI 10.1016/0028-3932(82)90026-4; STANLEY B, 1984, JAMA-J AM MED ASSOC, V252, P1302, DOI 10.1001/jama.252.10.1302; Stuss D.T., 1986, FRONTAL LOBES; STUSS DT, 1981, BIOL PSYCHIAT, V16, P1085; STUSS DT, IN PRESS FRONTAL LOB; STUSS DT, IN PRESS AWARENESS D; TAUB HA, 1980, GERONTOLOGIST, V20, P686, DOI 10.1093/geront/20.6.686; ULRICH G, 1978, BRAIN LANG, V5, P286, DOI 10.1016/0093-934X(78)90027-5; VIGNOLO LA, 1969, CONTRIBUTIONS CLIN N	27	56	58	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	1991	115	3					203	208		10.7326/0003-4819-115-3-203	http://dx.doi.org/10.7326/0003-4819-115-3-203			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY152	2058875				2022-12-28	WOS:A1991FY15200008
J	SZER, IS; TAYLOR, E; STEERE, AC				SZER, IS; TAYLOR, E; STEERE, AC			THE LONG-TERM COURSE OF LYME ARTHRITIS IN CHILDREN	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BILATERAL KERATITIS; ANTIBODY-RESPONSE; DISEASE; MANIFESTATIONS; NEUROBORRELIOSIS; PENICILLIN; CHILDHOOD; THERAPY	Background and Methods. The natural history of Lyme disease is not completely known. We studied the long-term course of Lyme arthritis in 46 children in whom the onset of the disease occurred between 1976 and 1979 and who received no antibiotic therapy for at least the first four years of the illness. Results. Of the 46 children-(age range, 2 to 15 years), 33 (72 percent) initially had erythema migrans, 7 (15 percent) had influenza-like symptoms, and 6 (13 percent) had migratory joint pain. These manifestations were followed by brief attacks of arthritis, particularly affecting the knee. The percentage of children with recurrent episodes of arthritis declined each year. By year 4, only 10 children still had a mean of two episodes of arthritis per year; the duration of arthritis was generally longer in older children (P < 0.05). During the sixth year of illness, two children (4 percent) had keratitis, and more than 10 years after the onset of disease, a subtle encephalopathy developed in two other children. Of the 39 children whom we were able to contact in 1988-1989, 12 (31 percent) still had occasional brief episodes of joint pain and 1 (3 percent) had marked fatigue. All 46 children had positive IgG antibody responses to Borrelia burgdorferi throughout the illness and on long-term follow-up. As compared with those who became asymptomatic, the children with recurrent symptoms more often had IgM responses to the spirochete and had significantly higher IgG titers-(P < 0.05). Conclusions. The course of initially untreated Lyme disease in children may include acute infection followed by attacks of arthritis and then by keratitis, subtle joint pain, or chronic encephalopathy.	TUFTS UNIV,NEW ENGLAND MED CTR,FLOATING HOSP INFANTS & CHILDREN,SCH MED,DEPT PEDIAT,BOSTON,MA 02111; TUFTS UNIV,NEW ENGLAND MED CTR,FLOATING HOSP INFANTS & CHILDREN,SCH MED,DEPT MED,BOSTON,MA 02111	Floating Hospital For Children; Tufts Medical Center; Tufts University; Floating Hospital For Children; Tufts Medical Center; Tufts University				Steere, Allen/0000-0002-5268-9853	NIAMS NIH HHS [AR-20358] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR020358] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANDERSON LJ, 1987, PEDIATR INFECT DIS J, V6, P711, DOI 10.1097/00006454-198708000-00003; BAUM J, 1988, AM J OPHTHALMOL, V105, P75, DOI 10.1016/0002-9394(88)90124-9; CRAFT JE, 1984, J INFECT DIS, V149, P789, DOI 10.1093/infdis/149.5.789; CULP RW, 1987, J BONE JOINT SURG AM, V69A, P96, DOI 10.2106/00004623-198769010-00016; EICHENFIELD AH, 1986, J PEDIATR-US, V109, P753, DOI 10.1016/S0022-3476(86)80688-6; HALPERIN JJ, 1989, NEUROLOGY, V39, P753, DOI 10.1212/WNL.39.6.753; KORNMEHL EW, 1989, OPHTHALMOLOGY, V96, P1194; LOGIGIAN EL, 1990, NEW ENGL J MED, V323, P1438, DOI 10.1056/NEJM199011223232102; STEER AC, 1983, ANN INTERN MED, V99, P767, DOI 10.7326/0003-4819-99-6-767; STEERE AC, 1990, NEW ENGL J MED, V323, P219, DOI 10.1056/NEJM199007263230402; STEERE AC, 1985, NEW ENGL J MED, V312, P869, DOI 10.1056/NEJM198504043121401; STEERE AC, 1980, ANN INTERN MED, V93, P1, DOI 10.7326/0003-4819-93-1-1; STEERE AC, 1990, J INFECT DIS, V161, P1203, DOI 10.1093/infdis/161.6.1203; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; STEERE AC, 1983, ANN INTERN MED, V99, P22, DOI 10.7326/0003-4819-99-1-22; STEERE AC, 1977, ARTHRITIS RHEUM, V20, P7, DOI 10.1002/art.1780200102; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; SWARTZ TA, 1971, AM J EPIDEMIOL, V94, P246, DOI 10.1093/oxfordjournals.aje.a121318; WILLIAMS CL, 1990, PEDIATR INFECT DIS J, V9, P10, DOI 10.1097/00006454-199001000-00003; YANEZ JE, 1966, ANN INTERN MED, V64, P772, DOI 10.7326/0003-4819-64-4-772	20	131	132	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	1991	325	3					159	163		10.1056/NEJM199107183250304	http://dx.doi.org/10.1056/NEJM199107183250304			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW752	2052061				2022-12-28	WOS:A1991FW75200004
J	PERRILLO, RP; BRUNT, EM				PERRILLO, RP; BRUNT, EM			HEPATIC HISTOLOGIC AND IMMUNOHISTOCHEMICAL CHANGES IN CHRONIC HEPATITIS-B AFTER PROLONGED CLEARANCE OF HEPATITIS-B E-ANTIGEN AND HEPATITIS-B SURFACE-ANTIGEN	ANNALS OF INTERNAL MEDICINE			English	Note							POLYMERASE CHAIN-REACTION; ANTIVIRAL THERAPY; CONTROLLED TRIAL; PREDNISONE WITHDRAWAL; ALPHA-INTERFERON; DNA; LIVER; SERUM		WASHINGTON UNIV, SCH MED, ST LOUIS, MO 63110 USA	Washington University (WUSTL)	PERRILLO, RP (corresponding author), VET AFFAIRS MED CTR, 111 JC, 915 N GRAND BLVD, ST LOUIS, MO 63106 USA.							BROOK MG, 1988, VIRAL HEPATITIS LIVE, P906; DIBISCEGLIE AM, 1987, GASTROENTEROLOGY, V93, P1236, DOI 10.1016/0016-5085(87)90250-2; HOOFNAGLE JH, 1988, GASTROENTEROLOGY, V95, P1318, DOI 10.1016/0016-5085(88)90367-8; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; KORENMAN J, 1991, ANN INTERN MED, V114, P629, DOI 10.7326/0003-4819-114-8-629; KUHNS M, 1990, HEPATOLOGY, V12, P904; KUHNS MC, 1989, J MED VIROL, V27, P274, DOI 10.1002/jmv.1890270404; MARCELLIN P, 1990, ANN INTERN MED, V112, P227, DOI 10.7326/0003-4819-112-3-227; PERRILLO RP, 1988, ANN INTERN MED, V109, P95, DOI 10.7326/0003-4819-109-2-95; PERRILLO RP, 1990, NEW ENGL J MED, V323, P295, DOI 10.1056/NEJM199008023230503	10	66	66	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	1991	115	2					113	115		10.7326/0003-4819-115-2-113	http://dx.doi.org/10.7326/0003-4819-115-2-113			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW091	2058858				2022-12-28	WOS:A1991FW09100007
J	BREO, DL				BREO, DL			TODD LOOKS TOWARD AMAS FUTURE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1991	265	24					3306	3307		10.1001/jama.265.24.3306	http://dx.doi.org/10.1001/jama.265.24.3306			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR835	2046115				2022-12-28	WOS:A1991FR83500041
J	CHERLIN, AJ; FURSTENBERG, FF; CHASELANSDALE, PL; KIERNAN, KE; ROBINS, PK; MORRISON, DR; TEITLER, JO				CHERLIN, AJ; FURSTENBERG, FF; CHASELANSDALE, PL; KIERNAN, KE; ROBINS, PK; MORRISON, DR; TEITLER, JO			LONGITUDINAL-STUDIES OF EFFECTS OF DIVORCE ON CHILDREN IN GREAT-BRITAIN AND THE UNITED-STATES	SCIENCE			English	Article							MARITAL DISRUPTION	National, longitudinal surveys from Great Britain and the United States were used to investigate the effects of divorce on children. In both studies, a subsample of children who were in two-parent families during the initial interview (at age 7 in the British data and at ages 7 to 11 in the U.S. data) were followed through the next interview (at age 11 and ages 11 to 16, respectively). At both time points in the British data, parents and teachers independently rated the children's behavior problems, and the children were given reading and mathematics achievement tests. At both time points in the U.S. data, parents rated the children's behavior problems. Children whose parents divorced or separated between the two time points were compared to children whose families remained intact. For boys, the apparent effect of separation or divorce on behavior problems and achievement at the later time point was sharply reduced by considering behavior problems, achievement levels, and family difficulties that were present at the earlier time point, before any of the families had broken up. For girls, the reduction in the apparent effect of divorce occurred to a lesser but still noticeable extent once preexisting conditions were considered.	UNIV CHICAGO,CHAPIN HALL CTR CHILDREN,CHICAGO,IL 60637; FAMILY POLICY STUDIES CTR,LONDON NW1 6XE,ENGLAND; UNIV PENN,DEPT SOCIOL,PHILADELPHIA,PA 19104; UNIV MIAMI,DEPT ECON,CORAL GABLES,FL 33124	University of Chicago; University of Pennsylvania; University of Miami	CHERLIN, AJ (corresponding author), JOHNS HOPKINS UNIV,DEPT SOCIOL,BALTIMORE,MD 21218, USA.		Furstenberg, Frank F/A-7837-2009		NICHD NIH HHS [HD25936] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025936, R37HD025936] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ACHENBACH TM, 1981, MONOGRAPHS SOC RES C, V33; BAYDAR N, 1988, J MARRIAGE FAM, V50, P967, DOI 10.2307/352108; BLOCK JH, 1986, CHILD DEV, V57, P827, DOI 10.1111/j.1467-8624.1986.tb00249.x; BUMPASS LL, 1984, DEMOGRAPHY, V21, P71, DOI 10.2307/2061028; CHASELANSDALE PL, 1990, LIFE-SPAN DEV BEHAV, V10, P105; Emery R. E., 1988, MARRIAGE DIVORCE CHI; EMERY RE, 1982, PSYCHOL BULL, V92, P310, DOI 10.1037/0033-2909.92.2.310; FOGELMAN K, 1978, BRIT J EDUC PSYCHOL, V48, P148, DOI 10.1111/j.2044-8279.1978.tb02380.x; FURSTENBERG FF, 1983, AM SOCIOL REV, V48, P656, DOI 10.2307/2094925; Garfinkel Irwin, 1986, SINGLE MOTHERS THEIR; Glendon M. A., 1987, ABORTION DIVORCE W L; HETHERINGTON E, 1984, REV CHILD DEV RES, V7; HETHERINGTON EM, 1985, J AM ACAD CHILD PSY, V24, P518, DOI 10.1016/S0002-7138(09)60052-2; Hetherington EM, 1982, NONTRADITIONAL FAMIL; HETHERINGTON EM, 1978, MOTHER CHILD FATHER; HETHERINGTON EM, 1987, REMARRIAGE STEPPAREN; KIERNAN KE, 1986, POPULATION STUDIES, V40, P1; Maddala G.S., 1986, LTD DEPENDENT QUALIT; MCLANAHAN S, 1988, AM J SOCIOL, V94, P130, DOI 10.1086/228954; Pringle M. K., 1966, 11000 7 YEAR OLDS; PRINGLE MLK, 1965, 6TH MENTAL MEASUREME; RUTTER M, 1970, ED HLTH BEHAVIOR; SHEPHERD PM, 1985, NATIONAL CHILD DEV S; Southgate V, 1962, SOUTHGATE GROUP READ; Stott D. H., 1969, SOCIAL ADJUSTMENT CH; WALLERSTEIN JS, 1980, SURVIVING BREAKUP CH, P316; WEITZMAN L, 1985, DIVORCE REVOLUTION	27	406	410	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 7	1991	252	5011					1386	1389		10.1126/science.2047851	http://dx.doi.org/10.1126/science.2047851			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FP868	2047851				2022-12-28	WOS:A1991FP86800024
J	MOLNAR, Z; BLAKEMORE, C				MOLNAR, Z; BLAKEMORE, C			LACK OF REGIONAL SPECIFICITY FOR CONNECTIONS FORMED BETWEEN THALAMUS AND CORTEX IN COCULTURE	NATURE			English	Article							CEREBRAL-CORTEX; CORTICAL AREAS; VISUAL-CORTEX; RAT; CULTURES; PROJECTIONS; PATHWAY; NEURONS	THE mammalian cerebral cortex consists of many structurally 1 and functionally 2 specialized areas, with characteristic input from particular nuclei of the thalamus. Some localized external influence, such as the arrival of fibres from the appropriate thalamic nucleus before or around the time of birth 3-6, could trigger the emergence of committed cortical fields from an undifferentiated 'protocortex' 7,8. The guidance of axons from each thalamic nucleus to its appropriate target area in the cortex could, then, be crucial in the regulation of cortical differentiation. Recently, Yamamoto et al. 9 and Bolz et al. 10 have demonstrated that cocultured explants of rat lateral geniculate nucleus and visual cortex can form layer-specific interconnections. We have now tested the possibility that each cortical area exerts a selective trophic influence on axons from its appropriate thalamic nucleus, and vice versa, by coculturing explants of different regions of the thalamus and cortex taken at various stages of development.			MOLNAR, Z (corresponding author), UNIV OXFORD,PHYSIOL LAB,PARKS RD,OXFORD OX1 3PT,ENGLAND.		Molnar, Zoltan/J-7281-2012	Molnar, Zoltan/0000-0002-6852-6004; Blakemore, Colin/0000-0003-2659-7899	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BLAKEMORE C, 1990, COLD SPRING HARB SYM, V55, P491; BOLZ J, 1990, NATURE, V346, P359, DOI 10.1038/346359a0; Brodmann K, 1909, VERGLEICHENDE LOKALI; GAHWILER BH, 1988, TRENDS NEUROSCI, V11, P484, DOI 10.1016/0166-2236(88)90007-0; HENDERSON Z, 1986, Neuroscience Research, V3, P628, DOI 10.1016/0168-0102(86)90059-3; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; JONES EG, 1986, CEREBRAL CORTEX, V5; LUND RD, 1977, J COMP NEUROL, V173, P289, DOI 10.1002/cne.901730206; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; MCCONNELL SK, 1989, TRENDS NEUROSCI, V12, P342, DOI 10.1016/0166-2236(89)90041-6; MILLER MW, 1988, CEREB CORTEX, V7, P133; MOLNAR Z, 1990, J PHYSIOL-LONDON, V430, pP104; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; PETERS A, 1985, CEREBRAL CORTEX, V3; PETERS A, 1985, CEREBRAL CORTEX, V4; RAKIC P, 1977, PHILOS T R SOC B, V278, P245, DOI 10.1098/rstb.1977.0040; ROMIJN HJ, 1988, J NEUROSCI METH, V23, P75, DOI 10.1016/0165-0270(88)90025-8; SHATZ CJ, 1988, CEREB CORTEX, V7, P35; VALVERDE F, 1989, J COMP NEUROL, V290, P118, DOI 10.1002/cne.902900108; YAMAMOTO N, 1989, SCIENCE, V245, P192, DOI 10.1126/science.2749258	20	193	195	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 6	1991	351	6326					475	477		10.1038/351475a0	http://dx.doi.org/10.1038/351475a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP758	2046749				2022-12-28	WOS:A1991FP75800053
J	BROUN, ER; GREIST, A; TRICOT, G; HOFFMAN, R				BROUN, ER; GREIST, A; TRICOT, G; HOFFMAN, R			EXCESSIVE ZINC INGESTION - A REVERSIBLE CAUSE OF SIDEROBLASTIC ANEMIA AND BONE-MARROW DEPRESSION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note									INDIANA UNIV,SCH MED,DEPT MED,HEMATOL ONCOL SECT,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis								BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; BREWER GJ, 1983, ANN INTERN MED, V99, P314, DOI 10.7326/0003-4819-99-3-314; DUNLAP WM, 1974, ANN INTERN MED, V80, P470, DOI 10.7326/0003-4819-80-4-470; GRIGGS RC, 1964, PROGR HEMATOLOGY, V4, P17; JACOBS RH, 1986, BLOOD, V67, P1765; MCWHIRTER N, 1972, GUINNESS BOOK RECORD, P22; PATTERSON WP, 1985, ANN INTERN MED, V103, P385, DOI 10.7326/0003-4819-103-3-385; PRASAD AS, 1978, JAMA-J AM MED ASSOC, V240, P2166, DOI 10.1001/jama.240.20.2166; PROVAD AS, 1978, JAMA-J AM MED ASSOC, V240, P2166; SKOSEY JL, 1985, ARTHRITIS ALLIED CON, P487; VANCAMPEN DR, 1966, J NUTR, V88, P125, DOI 10.1093/jn/88.1.125; VANREEN R, 1966, ZINC METABOLISM, P411; YELIN G, 1987, AM J FOREN MED PATH, V8, P78, DOI 10.1097/00000433-198703000-00019; ZIDAR BL, 1977, AM J HEMATOL, V3, P177, DOI 10.1002/ajh.2830030209; 1989, SPECIFICATIONS US CO	15	89	91	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	1990	264	11					1441	1443		10.1001/jama.264.11.1441	http://dx.doi.org/10.1001/jama.264.11.1441			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY428	2094240				2022-12-28	WOS:A1990DY42800029
J	CURRAN, WJ				CURRAN, WJ			COURT-ORDERED CESAREAN SECTIONS RECEIVE JUDICIAL DEFEAT	NEW ENGLAND JOURNAL OF MEDICINE			English	Note																		ANNAS GJ, 1987, AM J LAW MED, V13, P213; BALISY SS, 1987, SOUTHERN CALIF LAW R, V60, P1209; BROSS D, 1986, CHILD LEG RIGHTS J, V7, P11; CHASNOFF IJ, 1989, ANN NY ACAD SCI, V562, P208, DOI 10.1111/j.1749-6632.1989.tb21019.x; CURRAN WJ, 1981, NEW ENGL J MED, V305, P75, DOI 10.1056/NEJM198107093050205; CURRAN WJ, 1978, NEW ENGL J MED, V298, P499, DOI 10.1056/NEJM197803022980907; CURRAN WJ, 1973, NEW ENGL J MED, V289, P955, DOI 10.1056/NEJM197311012891807; CURRAN WJ, 1985, NEW ENGL J MED, V313, P940, DOI 10.1056/NEJM198510103131507; CURRAN WJ, 1982, LAW MED FORENSIC SCI, P777; CURRAN WJ, 1982, LAW MED FORENSIC SCI, P822; Field M A, 1989, Law Med Health Care, V17, P114; FINNEGAN L, 1976, ANN NY ACAD SCI, V281, P74, DOI 10.1111/j.1749-6632.1976.tb27921.x; KOLDER VEB, 1987, NEW ENGL J MED, V316, P1192, DOI 10.1056/NEJM198705073161905; RHODEN NK, 1986, CALIF LAW REV, V74, P1951, DOI 10.2307/3480420; ROBERTSON JA, 1983, VA LAW REV, V69, P405, DOI 10.2307/1072766; 1988, HARVARD LAW REV, V101, P994	16	16	16	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	1990	323	7					489	492		10.1056/NEJM199008163230719	http://dx.doi.org/10.1056/NEJM199008163230719			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU273	2082954				2022-12-28	WOS:A1990DU27300029
J	GALLIN, JI; MALECH, HL				GALLIN, JI; MALECH, HL			UPDATE ON CHRONIC GRANULOMATOUS DISEASES OF CHILDHOOD - IMMUNOTHERAPY AND POTENTIAL FOR GENE-THERAPY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											GALLIN, JI (corresponding author), NIAID,BACTERIAL DIS SECT,CLIN INVEST LAB,BLDG 10,ROOM 11C103,BETHESDA,MD 20892, USA.			Malech, Harry/0000-0001-5874-5775				EZEKOWITZ RAB, 1987, J CLIN INVEST, V80, P1009, DOI 10.1172/JCI113153; EZEKOWITZ RAB, 1988, NEW ENGL J MED, V319, P146, DOI 10.1056/NEJM198807213190305; GALLIN JI, 1983, ANN INTERN MED, V99, P657, DOI 10.7326/0003-4819-99-5-657; GALLIN JI, 1988, INFLAMMATION BASIC P, P493; HOLMES B, 1967, J CLIN INVEST, V46, P1422, DOI 10.1172/JCI105634; HSIEH CL, IN PRESS CYTOGENET C; JOHNSTON RB, 1983, ADV HOST DEFENSE MEC, V3, P77; Klebanoff SJ., 1988, INFLAMMATION BASIC P, P391; LETO T L, 1989, Journal of Cell Biology, V109, p49A; LOMAX KJ, 1988, CLIN RES, V36, pA413; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; NEWBURGER PE, 1988, P NATL ACAD SCI USA, V85, P5215, DOI 10.1073/pnas.85.14.5215; NUNOI H, 1988, SCIENCE, V242, P1298, DOI 10.1126/science.2848319; OHNO Y, 1986, BLOOD, V67, P1132; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; QUIE PG, 1967, J CLIN INVEST, V46, P668, DOI 10.1172/JCI105568; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SECHLER JMG, 1988, P NATL ACAD SCI USA, V85, P4874, DOI 10.1073/pnas.85.13.4874; SEGAL AW, 1987, NATURE, V326, P88, DOI 10.1038/326088a0; SEGAL AW, 1983, NEW ENGL J MED, V308, P245, DOI 10.1056/NEJM198302033080503; VOLPP BD, 1988, SCIENCE, V242, P1295, DOI 10.1126/science.2848318; WEENING RS, 1985, J PEDIATR-US, V107, P102, DOI 10.1016/S0022-3476(85)80626-0; WEISS SJ, 1989, NEW ENGL J MED, V320, P365	25	60	60	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	1990	263	11					1533	1537		10.1001/jama.263.11.1533	http://dx.doi.org/10.1001/jama.263.11.1533			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT013	2106591				2022-12-28	WOS:A1990CT01300030
J	TURNER, JM; BRODSKY, MH; IRVING, BA; LEVIN, SD; PERLMUTTER, RM; LITTMAN, DR				TURNER, JM; BRODSKY, MH; IRVING, BA; LEVIN, SD; PERLMUTTER, RM; LITTMAN, DR			INTERACTION OF THE UNIQUE N-TERMINAL REGION OF TYROSINE KINASE P56LCK WITH CYTOPLASMIC DOMAINS OF CD4 AND CD8 IS MEDIATED BY CYSTEINE MOTIFS	CELL			English	Article									UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, SAN FRANCISCO, CA 94143 USA; UNIV WASHINGTON, DEPT IMMUNOL, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA; UNIV WASHINGTON, HOWARD HUGHES MED INST, SEATTLE, WA 98195 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	TURNER, JM (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT MICROBIOL & IMMUNOL, SAN FRANCISCO, CA 94143 USA.							ACRES RB, 1986, J BIOL CHEM, V261, P6210; ACRES RB, 1987, J IMMUNOL, V139, P2268; BALK SP, 1989, P NATL ACAD SCI USA, V86, P252, DOI 10.1073/pnas.86.1.252; BALLHAUSEN WG, 1988, J EXP MED, V167, P1493, DOI 10.1084/jem.167.4.1493; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; BEDINGER P, 1988, NATURE, V334, P162, DOI 10.1038/334162a0; BIDDISON WE, 1984, J EXP MED, V159, P783, DOI 10.1084/jem.159.3.783; BLACKMAN MA, 1989, SCIENCE, V244, P214, DOI 10.1126/science.2784868; BRODSKY MH, 1990, IN PRESS J IMMUNOL; BUSS JE, 1984, MOL CELL BIOL, V4, P2697, DOI 10.1128/MCB.4.12.2697; CALABI F, 1986, NATURE, V323, P540, DOI 10.1038/323540a0; COOPER JA, 1990, PEPTIDES PROTEIN PHO; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; EMMRICH F, 1986, P NATL ACAD SCI USA, V83, P8298, DOI 10.1073/pnas.83.21.8298; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; FUREY WF, 1986, SCIENCE, V231, P704, DOI 10.1126/science.3945804; GABERT J, 1987, CELL, V50, P545, DOI 10.1016/0092-8674(87)90027-4; GARBER EA, 1987, P NATL ACAD SCI USA, V84, P80, DOI 10.1073/pnas.84.1.80; GODDARD C, 1989, J BIOL CHEM, V264, P15173; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREEN S, 1987, NATURE, V325, P75, DOI 10.1038/325075a0; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HURLEY TR, 1989, SCIENCE, V245, P407, DOI 10.1126/science.2787934; KAPLAN JM, 1988, MOL CELL BIOL, V8, P2435, DOI 10.1128/MCB.8.6.2435; KAPLAN JM, 1990, IN PRESS MOL CELL BI; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KOGA Y, 1986, EUR J IMMUNOL, V16, P1643, DOI 10.1002/eji.1830161229; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KUPFER A, 1987, P NATL ACAD SCI USA, V84, P5888, DOI 10.1073/pnas.84.16.5888; LEDBETTER JA, 1985, J IMMUNOL, V134, P4250; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; LITTMAN DR, 1987, ANNU REV IMMUNOL, V5, P561, DOI 10.1146/annurev.iy.05.040187.003021; LITTMAN DR, 1987, NATURE, V325, P453, DOI 10.1038/325453a0; LITTMAN DR, 1985, CELL, V40, P237, DOI 10.1016/0092-8674(85)90138-2; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MARCHILDON GA, 1984, P NATL ACAD SCI-BIOL, V81, P7679, DOI 10.1073/pnas.81.24.7679; MARRACK P, 1983, J EXP MED, V158, P1077, DOI 10.1084/jem.158.4.1077; MARTH JD, 1987, EMBO J, V6, P2727, DOI 10.1002/j.1460-2075.1987.tb02566.x; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MARTIN PJ, 1984, J IMMUNOL, V132, P759; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; PARNES JR, 1989, ADV IMMUNOL, V44, P265; PERLMUTTER RM, 1988, J CELL BIOCHEM, V38, P117, DOI 10.1002/jcb.240380206; PERLMUTTER RM, 1989, BIOCHIM BIOPHYS ACTA, V948, P245, DOI 10.1016/0304-419X(89)90001-2; RESH MD, 1989, CELL, V58, P281, DOI 10.1016/0092-8674(89)90842-8; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; SAIZAWA K, 1987, NATURE, V328, P260, DOI 10.1038/328260a0; SEVERNE Y, 1988, EMBO J, V7, P2503, DOI 10.1002/j.1460-2075.1988.tb03097.x; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SIMPSON SC, 1989, ONCOGENE, V4, P1141; SNOW PM, 1985, EUR J IMMUNOL, V15, P529, DOI 10.1002/eji.1830150520; TAGAWA M, 1986, P NATL ACAD SCI USA, V83, P3422, DOI 10.1073/pnas.83.10.3422; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TONKS NK, 1988, BIOCHEMISTRY-US, V27, P8696; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VORONOVA AF, 1986, NATURE, V319, P682, DOI 10.1038/319682a0; WEYAND CM, 1987, J IMMUNOL, V138, P1351; ZAMOYSKA R, 1985, CELL, V43, P153, DOI 10.1016/0092-8674(85)90020-0; ZUNIGAPFLUCKER JC, 1989, NATURE, V338, P76, DOI 10.1038/338076a0	62	625	651	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	1990	60	5					755	765		10.1016/0092-8674(90)90090-2	http://dx.doi.org/10.1016/0092-8674(90)90090-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CV174	2107025				2022-12-28	WOS:A1990CV17400008
J	HENTHORN, P; KILEDJIAN, M; KADESCH, T				HENTHORN, P; KILEDJIAN, M; KADESCH, T			2 DISTINCT TRANSCRIPTION FACTORS THAT BIND THE IMMUNOGLOBULIN ENHANCER MU-E5/KE2 MOTIF	SCIENCE			English	Article									UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104	University of Pennsylvania	HENTHORN, P (corresponding author), UNIV PENN,SCH MED,HOWARD HUGHES MED INST,PHILADELPHIA,PA 19104, USA.							ATCHISON ML, 1988, ANNU REV CELL BIOL, V4, P127, DOI 10.1146/annurev.cellbio.4.1.127; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BECKMANN H, 1989, MOL CELL BIOL, V9, P4535, DOI 10.1128/MCB.9.10.4535; BECKMANN H, IN PRESS GENES DEV, V4; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CHURCH GM, 1985, NATURE, V313, P608; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; GUARENTE L, 1983, CELL, V32, P1279, DOI 10.1016/0092-8674(83)90309-4; HENTHORN P, 1988, P NATL ACAD SCI USA, V85, P6342, DOI 10.1073/pnas.85.17.6342; HENTHORN P, UNPUB; KADESCH T, 1986, NUCLEIC ACIDS RES, V14, P8209, DOI 10.1093/nar/14.20.8209; KILEDJIAN M, 1988, MOL CELL BIOL, V8, P145, DOI 10.1128/MCB.8.1.145; LEE F, 1984, NUCLEIC ACIDS RES, V12, P4191, DOI 10.1093/nar/12.10.4191; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; Maniatis T., 1982, MOL CLONING; MELLENTIN JD, 1989, CELL, V58, P77, DOI 10.1016/0092-8674(89)90404-2; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NEUBERGER MS, 1983, EMBO J, V2, P1373, DOI 10.1002/j.1460-2075.1983.tb01594.x; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; PEREZMUTUL J, 1988, NUCLEIC ACIDS RES, V16, P6085, DOI 10.1093/nar/16.13.6085; PETERSON CL, 1988, MOL CELL BIOL, V8, P4972, DOI 10.1128/MCB.8.11.4972; RUEZINSKY D, UNPUB; RYMOND BC, 1983, GENE, V25, P249, DOI 10.1016/0378-1119(83)90229-9; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; STAUDT LM, 1986, NATURE, V323, P640, DOI 10.1038/323640a0; SUBRAMANI S, 1981, MOL CELL BIOL, V1, P854, DOI 10.1128/MCB.1.9.854; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; TSAO BP, 1988, NUCLEIC ACIDS RES, V16, P3239, DOI 10.1093/nar/16.8.3239; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; WASYLYK C, 1986, EMBO J, V5, P553, DOI 10.1002/j.1460-2075.1986.tb04246.x; WEINBERGER J, 1988, MOL CELL BIOL, V8, P988, DOI 10.1128/MCB.8.2.988; WEISS MJ, 1988, J BIOL CHEM, V263, P12002; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7	43	435	441	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 26	1990	247	4941					467	470		10.1126/science.2105528	http://dx.doi.org/10.1126/science.2105528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK705	2105528				2022-12-28	WOS:A1990CK70500043
J	BARON, JH				BARON, JH			START AND RUN A MEDICAL DINING CLUB	BMJ-BRITISH MEDICAL JOURNAL			English	Article											BARON, JH (corresponding author), HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, DEPT SURG, LONDON W12 0NN, ENGLAND.							ALLIBONE TE, 1976, ROYAL SOC ITS DINING; BEWLEY G, 1960, IRISH J MED SCI, V409, P1; CAMPBELL M, 1962, BRIT HEART J, V24, P673; Cowan J, 1939, BRIT HEART J, V1, P3; CRITCHLEY M, 1985, CITADEL SENSES OTHER, P109; FOOT AW, 1892, DUBLIN J MED SCI, V93, P425; GEIKIE RA, 1917, ROYAL SOC CLUB RECOR; GUTHRIE D, 1962, SHORT HIST ROYAL SOC; HARVEY W, 1962, HIST CHELSEA CLIN SO; MURDOCH T, 1988, COUNTRY LIFE, V182, P180; PAYNE JF, 1909, HIST COLLEGE CLUB RO; Price R, 1979, J Int Wine Food Soc, V6, P7; 1986, VISION HIST, P24	13	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	1990	300	6717					110	112		10.1136/bmj.300.6717.110	http://dx.doi.org/10.1136/bmj.300.6717.110			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105754	Bronze, Green Published			2022-12-28	WOS:A1990CJ08000025
J	REED, RR				REED, RR			HOW DOES THE NOSE KNOW	CELL			English	Review									JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205	Johns Hopkins University	REED, RR (corresponding author), JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205, USA.		Reed, Russell/HGU-0528-2022					BRUCH RC, 1987, J BIOL CHEM, V262, P2401; JONES DT, 1989, SCIENCE, V244, P730; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LABARCA P, 1988, P NATL ACAD SCI USA, V85, P944, DOI 10.1073/pnas.85.3.944; LIBERT F, 1989, SCIENCE, V244, P569, DOI 10.1126/science.2541503; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NOVOSELOV VI, 1988, FEBS LETT, V234, P471, DOI 10.1016/0014-5793(88)80140-6; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; PFEUFFER E, 1989, J BIOL CHEM, V264, P18803; WOODARD C, 1989, GENETICS, V123, P315	10	51	51	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 12	1990	60	1					1	2		10.1016/0092-8674(90)90706-K	http://dx.doi.org/10.1016/0092-8674(90)90706-K			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ358	2104777	hybrid			2022-12-28	WOS:A1990CJ35800001
J	MOTT, A; KINNERSLEY, P				MOTT, A; KINNERSLEY, P			OVERPRESCRIPTION OF CHOLERA VACCINE TO TRAVELERS BY GENERAL-PRACTITIONERS	BRITISH MEDICAL JOURNAL			English	Article									CHILDRENS HOSP,SYDNEY,AUSTRALIA; UNIV SYDNEY,DEPT COMMUNITY MED,SYDNEY,NSW 2006,AUSTRALIA	University of Sydney; University of Sydney								BELL DR, 1987, MANSONS TROPICAL DIS, P1185; CAMPBELL H, 1937, J R COLL GEN PRACT, V37, P70; MORGER H, 1983, BRIT MED J, V286, P184, DOI 10.1136/bmj.286.6360.184; PEPPIATT R, 1989, J ROY COLL GEN PRACT, V39, P42; REID D, 1986, BRIT MED J, V293, P1472, DOI 10.1136/bmj.293.6560.1472; STRUM WB, 1988, POSTGRAD MED, V84, P163; USHERWOOD V, 1989, J ROY COLL GEN PRACT, V39, P148; WOLFE MS, 1985, PRINCIPLES PRACTICE, P2307; 1987, VACCINATION CERTIFIC; 1988, IMMUNISATION INFECTI	10	18	18	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	1990	300	6716					25	26		10.1136/bmj.300.6716.25	http://dx.doi.org/10.1136/bmj.300.6716.25			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG773	2105120	Green Published, Bronze			2022-12-28	WOS:A1990CG77300022
J	STONE, RJ				STONE, RJ			NO EXPERIENCE NECESSARY	BRITISH MEDICAL JOURNAL			English	Article											STONE, RJ (corresponding author), UNIV COLL CARDIFF,CARDIFF CF4 4XN,S GLAM,WALES.								0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	1990	300	6716					27	28		10.1136/bmj.300.6716.27	http://dx.doi.org/10.1136/bmj.300.6716.27			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG773	2105121	Green Published, Bronze			2022-12-28	WOS:A1990CG77300023
J	KUNTZ, RE; TOSTESON, ANA; BERMAN, AD; GOLDMAN, L; GORDON, PC; LEONARD, BM; MCKAY, RG; DIVER, DJ; SAFIAN, RD				KUNTZ, RE; TOSTESON, ANA; BERMAN, AD; GOLDMAN, L; GORDON, PC; LEONARD, BM; MCKAY, RG; DIVER, DJ; SAFIAN, RD			PREDICTORS OF EVENT-FREE SURVIVAL AFTER BALLOON AORTIC VALVULOPLASTY	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANS-LUMINAL VALVULOPLASTY; LEFT-VENTRICULAR FUNCTION; VALVE-REPLACEMENT; FOLLOW-UP; ELDERLY PATIENTS; NONCARDIAC SURGERY; NATURAL-HISTORY; STENOSIS; RISK; OCTOGENARIANS	Background. Balloon aortic valvuloplasty was developed as an alternative to aortic-valve replacement in selected elderly patients with aortic stenosis. The use of this procedure is limited, however, by a high incidence of restenosis. Methods. Between December 1985 and April 1989, valvuloplasty was performed in 205 patients. We evaluated 40 demographic and hemodynamic variables as univariate predictors of event-free survival by Cox regression analysis and identified independent predictors of event-free survival by stepwise multivariate analysis. Results. Early hemodynamic results indicated a decrease in the peak transaortic-valve pressure gradient from 67 +/- 28 to 33 +/- 15 mm Hg after valvuloplasty and an increase in aortic-valve area from 0.6 +/- 0.2 to 0.9 +/- 0.3 cm2 (P < 0.001 for both comparisons). The rate of event-free survival (defined as survival without recurrent symptoms, repeated valvuloplasty, or aortic-valve replacement) was 18 percent over the mean (+/- SD) follow-up period of 24 +/- 12 months (range, 1 to 47). Significant predictors of event-free survival included the left ventricular ejection fraction and the left ventricular and aortic systolic pressure before valvuloplasty, and the percent reduction in the aortic-valve pressure gradient; the pulmonary-capillary wedge pressure was inversely associated with event-free survival. Although the predicted event-free survival rate for the entire patient group was 50 percent at one year (95 percent confidence interval, 43 to 57 percent) and 25 percent at two years (95 percent confidence interval, 19 to 31 percent), the probability of event-free survival at one year varied between 23 and 65 percent when patients were stratified according to three independent predictors: the aortic systolic pressure, the pulmonary-capillary wedge pressure, and the percent reduction in the peak aortic-valve gradient. Conclusions. The most important predictors of event-free survival after balloon aortic valvuloplasty were related to base-line left ventricular performance. The best long-term results after valvuloplasty were observed among patients who would also have been expected to have excellent long-term results after aortic-valve replacement.	CHARLES A DANA RES INST,BOSTON,MA; HARVARD UNIV,BETH ISRAEL HOSP,THORNDIKE LAB,DIV CARDIOVASC,BOSTON,MA 02215; BETH ISRAEL HOSP,DIV CLIN EPIDEMIOL,BOSTON,MA 02215; BRIGHAM & WOMENS HOSP,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT HLTH POLICY & MANAGEMENT,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL007987] Funding Source: NIH RePORTER; NHLBI NIH HHS [IF32 HL07987-01A1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACAR J, 1981, J THORAC CARDIOV SUR, V82, P114; BERLAND J, 1989, CIRCULATION, V79, P1189, DOI 10.1161/01.CIR.79.6.1189; BERMAN AD, 1988, J AM COLL CARDIOL, V11, P1213, DOI 10.1016/0735-1097(88)90284-7; BLOCK PC, 1988, AM J CARDIOL, V62, P760, DOI 10.1016/0002-9149(88)91218-0; BLOCK PC, 1987, AM J CARDIOL, V60, P659, DOI 10.1016/0002-9149(87)90377-8; COPELAND JG, 1977, J THORAC CARDIOV SUR, V74, P875; CORMIER B, 1988, EUR HEART J, V9, P113, DOI 10.1093/eurheartj/9.suppl_E.113; CRIBIER A, 1986, LANCET, V1, P63; DEAN LS, 1989, CATHETER CARDIO DIAG, V16, P130, DOI 10.1002/ccd.1810160213; DESNOYERS MR, 1988, AM J CARDIOL, V62, P1078, DOI 10.1016/0002-9149(88)90552-8; DORROS G, 1987, CATHETER CARDIO DIAG, V13, P151, DOI 10.1002/ccd.1810130302; EDMUNDS LH, 1988, NEW ENGL J MED, V319, P131, DOI 10.1056/NEJM198807213190302; FRANK S, 1973, BRIT HEART J, V35, P41; FREMES SE, 1989, CIRCULATION, V80, P77; ISNER JM, 1988, AM J CARDIOL, V61, P583, DOI 10.1016/0002-9149(88)90769-2; ISNER JM, 1987, AM J CARDIOL, V59, P313, DOI 10.1016/0002-9149(87)90805-8; ISNER JM, 1988, ANN INTERN MED, V108, P377, DOI 10.7326/0003-4819-108-3-377; JOHNSON RG, 1990, ANN THORAC SURG, V49, P740, DOI 10.1016/0003-4975(90)90013-V; KENNEDY JW, 1977, CIRCULATION, V56, P944, DOI 10.1161/01.CIR.56.6.944; LEMBO NJ, 1987, AM J CARDIOL, V60, P733, DOI 10.1016/0002-9149(87)90397-3; LETAC B, 1988, AM J CARDIOL, V62, P598, DOI 10.1016/0002-9149(88)90663-7; LEVINE MJ, 1988, AM J CARDIOL, V62, P1309, DOI 10.1016/0002-9149(88)90284-6; LEVINSON JR, 1989, CIRCULATION, V80, P49; LEWIN RF, 1989, CATHETER CARDIO DIAG, V16, P123, DOI 10.1002/ccd.1810160212; LEWIN RF, 1989, J AM COLL CARDIOL, V14, P1210, DOI 10.1016/0735-1097(89)90419-1; LOMBARD JT, 1987, ANN INTERN MED, V106, P292, DOI 10.7326/0003-4819-106-2-292; LYTLE BW, 1983, CIRCULATION, V68, P1149, DOI 10.1161/01.CIR.68.6.1149; MAGOVERN JA, 1987, J AM COLL CARDIOL, V9, P38, DOI 10.1016/S0735-1097(87)80079-7; MCKAY RG, 1987, CIRCULATION, V75, P192, DOI 10.1161/01.CIR.75.1.192; MCKAY RG, 1986, CIRCULATION, V74, P119, DOI 10.1161/01.CIR.74.1.119; MCKAY RG, 1988, CIRCULATION, V76, P1298; MIRSKY I, 1981, AM J CARDIOL, V48, P295, DOI 10.1016/0002-9149(81)90610-X; OKEEFE JH, 1987, MAYO CLIN PROC, V62, P986, DOI 10.1016/S0025-6196(12)65068-X; PANTELY G, 1978, J THORAC CARDIOV SUR, V75, P383; RIOUX C, 1988, EUR HEART J, V9, P121, DOI 10.1093/eurheartj/9.suppl_E.121; ROBICSEK F, 1988, ANN THORAC SURG, V45, P515, DOI 10.1016/S0003-4975(10)64524-9; Ross J Jr, 1968, Circulation, V38, P61; ROTH RB, 1989, J AM COLL CARDIOL, V13, P1039, DOI 10.1016/0735-1097(89)90258-1; SAFIAN RD, 1987, J AM COLL CARDIOL, V9, P655, DOI 10.1016/S0735-1097(87)80061-X; SAFIAN RD, 1988, NEW ENGL J MED, V319, P125, DOI 10.1056/NEJM198807213190301; SHERMAN W, 1989, ANN INTERN MED, V110, P421, DOI 10.7326/0003-4819-110-6-421; SMITH N, 1978, CIRCULATION, V58, P255, DOI 10.1161/01.CIR.58.2.255; TURINA J, 1987, EUR HEART J, V8, P471, DOI 10.1093/oxfordjournals.eurheartj.a062307	43	53	59	1	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 4	1991	325	1					17	23		10.1056/NEJM199107043250104	http://dx.doi.org/10.1056/NEJM199107043250104			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU342	2046709				2022-12-28	WOS:A1991FU34200004
J	ORCHINIK, M; MURRAY, TF; MOORE, FL				ORCHINIK, M; MURRAY, TF; MOORE, FL			A CORTICOSTEROID RECEPTOR IN NEURONAL MEMBRANES	SCIENCE			English	Article								Steroids may rapidly alter neuronal function and behavior through poorly characterized, direct actions on neuronal membranes. The membrane-bound receptors mediating these behavioral responses have not been identified. [H-3]Corticosterone labels a population of specific, high-affinity recognition sites (dissociation constant = 0.51 nanomolar) in synaptic membranes from an amphibian brain. These binding sites were localized by receptor autoradiography in the neuropil, outside the regions of perikarya. The affinities of corticoids for this [H-3]corticosterone binding site were linearly related to their potencies in rapidly suppressing male reproductive behavior. Thus, it appears that brain membranes contain a corticosteroid receptor that could participate in the regulation of behavior.	OREGON STATE UNIV, DEPT PHARM, CORVALLIS, OR 97331 USA	Oregon State University	ORCHINIK, M (corresponding author), OREGON STATE UNIV, DEPT ZOOL, CORVALLIS, OR 97331 USA.							BOYD SK, 1990, HORM BEHAV, V24, P128, DOI 10.1016/0018-506X(90)90032-S; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; COZZA EN, 1990, J STEROID BIOCHEM, V35, P511, DOI 10.1016/0022-4731(90)90261-P; DEKLOET ER, 1987, PSYCHONEUROENDOCRINO, V12, P83, DOI 10.1016/0306-4530(87)90040-0; FEYEREISEN R, 1985, COMP BIOCHEM PHYS B, V82, P559, DOI 10.1016/0305-0491(85)90023-9; FUNDER JW, 1987, ANNU REV PHYSIOL, V49, P397; GEE KW, 1987, EUR J PHARMACOL, V136, P419, DOI 10.1016/0014-2999(87)90317-7; GEE KW, 1988, MOL NEUROBIOL, V2, P291, DOI 10.1007/BF02935636; GUSTAFSSON JA, 1987, ENDOCR REV, V8, P185, DOI 10.1210/edrv-8-2-185; HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346; HUA SY, 1989, ENDOCRINOLOGY, V124, P687, DOI 10.1210/endo-124-2-687; KE FC, 1990, J NEUROCHEM, V54, P467, DOI 10.1111/j.1471-4159.1990.tb01895.x; KELLY MJ, 1977, EXP BRAIN RES, V30, P53; KUBLIGARFIAS C, 1990, HORM BEHAV, V24, P443, DOI 10.1016/0018-506X(90)90033-T; LANGE CB, 1988, GEN COMP ENDOCR, V71, P141; LESHCHENKO MV, 1987, FARMAKOL TOKSIKOL MO, V3, P60; LIMBIRD LE, 1986, CELL SURFACE RECEPTO, P60; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; MAJEWSKA MD, 1990, BRAIN RES, V526, P143, DOI 10.1016/0006-8993(90)90261-9; MCEWEN BS, 1986, PHYSIOL REV, V66, P1121, DOI 10.1152/physrev.1986.66.4.1121; MEDHI AD, 1984, GEN COMP ENDOCR, V53, P475; MOORE FL, 1990, J EXP ZOOL, P157; MOORE FL, 1984, HORM BEHAV, V18, P400, DOI 10.1016/0018-506X(84)90026-6; MORROW AL, 1990, MOL PHARMACOL, V37, P263; NABEKURA J, 1986, SCIENCE, V233, P226, DOI 10.1126/science.3726531; ORCHINIK M, 1989, Society for Neuroscience Abstracts, V15, P759; PUIA G, 1990, NEURON, V4, P759, DOI 10.1016/0896-6273(90)90202-Q; RIKER WF, 1982, ADRENAL ACTIONS BRAI, P69; SAPHIER D, 1988, BRAIN RES, V453, P183, DOI 10.1016/0006-8993(88)90157-6; SATRE M, 1974, BIOCHEMISTRY-US, V13, P2201, DOI 10.1021/bi00707a029; SCHUMACHER M, 1990, SCIENCE, V13, P359; SMITH SS, 1987, BRAIN RES, V422, P40, DOI 10.1016/0006-8993(87)90538-5; TALLARIDA RJ, 1979, DOSE RESPONSE RELATI, P107; TOWLE AC, 1983, J STEROID BIOCHEM, V18, P135, DOI 10.1016/0022-4731(83)90079-1; TURNER DM, 1989, J PHARMACOL EXP THER, V248, P960; WEILAND GA, 1981, LIFE SCI, V29, P313, DOI 10.1016/0024-3205(81)90324-6; Whittaker VP, 1969, HDB NEUROCHEMISTRY, VII, P327, DOI DOI 10.1007/978-1-4899-7321-4_14; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	38	460	468	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	1991	252	5014					1848	1851		10.1126/science.2063198	http://dx.doi.org/10.1126/science.2063198			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU061	2063198				2022-12-28	WOS:A1991FU06100040
J	VARGA, J; HAUSTEIN, UF; CREECH, RH; DWYER, JP; JIMENEZ, SA				VARGA, J; HAUSTEIN, UF; CREECH, RH; DWYER, JP; JIMENEZ, SA			EXAGGERATED RADIATION-INDUCED FIBROSIS IN PATIENTS WITH SYSTEMIC-SCLEROSIS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GROWTH-FACTOR-BETA; TOTAL LYMPHOID IRRADIATION; COLLAGEN-SYNTHESIS; D-PENICILLAMINE; SCLERODERMA; SKIN; FIBROBLASTS; EXPRESSION; LUNG; FIBRONECTIN	Four patients with stable systemic sclerosis and limited skin involvement received radiation for the treatment of solid malignant neoplasms. Following localized irradiation, each patient developed an exaggerated cutaneous and internal fibrotic reaction in the irradiated areas. The surface area of fibrosis extended beyond the radiation portals employed, and the fibrotic process was poorly responsive to antifibrotic therapy. Three of the patients died of complications caused by fibrous encasement of internal organs. The extent and severity of postradiation fibrosis in these patients was distinctly unusual. These observations suggest that patients with systemic sclerosis are particularly susceptible to developing excessive radiation-induced fibrosis.	KLIN HAUTKRANKENHEUTEN,LEIPZIG,GERMANY; BURLINGTON MEM HOSP,BURLINGTON,NJ; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT MED,PHILADELPHIA,PA 19107; FOX CHASE CANC INST,PHILADELPHIA,PA 19111	Jefferson University; Fox Chase Cancer Center				Jimenez, Sergio/0000-0001-5213-1203	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR019101, K08AR001817] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 19101, AR 01817] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CANNEY PA, 1990, BRIT J RADIOL, V63, P620, DOI 10.1259/0007-1285-63-752-620; CLAMAN HN, 1985, CELL IMMUNOL, V94, P73, DOI 10.1016/0008-8749(85)90086-3; CONNOR TB, 1989, J CLIN INVEST, V83, P1661, DOI 10.1172/JCI114065; COOPER SG, 1990, BRIT J RADIOL, V64, P804; DERING SB, 1960, MODERN RADIOLOGY HIS, P105; ELNABOUT R, 1989, MATRIX, V9, P411, DOI 10.1016/S0934-8832(89)80047-2; FLECK R, 1989, INT J RADIAT ONCOL, V17, P829, DOI 10.1016/0360-3016(89)90074-6; FLEISCHMAJER R, 1977, SEMIN ARTHRITIS RHEU, V13, P104; FREUNDLICH B, 1986, IMMUNOL TODAY, V7, P303, DOI 10.1016/0167-5699(86)90067-8; GIBSON PG, 1988, ANN INTERN MED, V109, P288, DOI 10.7326/0003-4819-109-4-288; GRUSCHWITZ M, 1990, J INVEST DERMATOL, V94, P197, DOI 10.1111/1523-1747.ep12874503; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; JIMENEZ SA, IN PRESS J RHEUMATOL; KAHALEH MB, 1986, CLIN EXP RHEUMATOL, V4, P367; KOTZIN BL, 1981, NEW ENGL J MED, V305, P969, DOI 10.1056/NEJM198110223051702; LEROY EC, 1988, J RHEUMATOL, V15, P202; LEROY EC, 1972, J EXP MED, V135, P1351, DOI 10.1084/jem.135.6.1351; MARTIN M, 1986, INT J RADIAT BIOL, V49, P821; MATTHEWS RH, 1989, INT J RADIAT ONCOL, V17, P1123, DOI 10.1016/0360-3016(89)90169-7; Medsger Jr TA, 1989, ARTHRITIS ALLIED CON, V11th, P1118; ODELL JR, 1989, J RHEUMATOL, V16, P1050; PELTONEN J, 1990, J INVEST DERMATOL, V94, P365, DOI 10.1111/1523-1747.ep12874491; RANSOM D T, 1987, Australasian Radiology, V31, P317, DOI 10.1111/j.1440-1673.1987.tb01840.x; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; SMITH EA, 1990, J INVEST DERMATOL, V95, P1255; STEEN VD, 1982, ANN INTERN MED, V97, P652, DOI 10.7326/0003-4819-97-5-652; STROBER S, 1985, ANN INTERN MED, V102, P450, DOI 10.7326/0003-4819-102-4-450; TRASK CWL, 1985, CANCER, V55, P57, DOI 10.1002/1097-0142(19850101)55:1<57::AID-CNCR2820550110>3.0.CO;2-L; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; WARD WF, 1983, RADIOLOGY, V146, P533, DOI 10.1148/radiology.146.2.6849102; WOLBACH SB, 1969, J MED RES, V21, P415	31	90	90	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 26	1991	265	24					3292	3295		10.1001/jama.265.24.3292	http://dx.doi.org/10.1001/jama.265.24.3292			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR835	2046111				2022-12-28	WOS:A1991FR83500037
J	MOSS, B				MOSS, B			VACCINIA VIRUS - A TOOL FOR RESEARCH AND VACCINE DEVELOPMENT	SCIENCE			English	Article								Vaccinia virus is no longer needed for smallpox immunization, but now serves as a useful vector for expressing genes within the cytoplasm of eukaryotic cells. As a research tool, recombinant vaccinia viruses are used to synthesize biologically active proteins and analyze structure-function relations, determine the targets of humoral- and cell-mediated immunity, and investigate the immune responses needed for protection against specific infectious diseases. When more data on safety and efficacy are available, recombinant vaccinia and related poxviruses may be candidates for live vaccines and for cancer immunotherapy.			MOSS, B (corresponding author), NIAID, VIRAL DIS LAB, BETHESDA, MD 20892 USA.			Moss, Bernard/0000-0002-2154-8564				ALEXANDER WA, 1991, VACCINES 91, P221; ANDREW ME, 1987, SCAND J IMMUNOL, V25, P21, DOI 10.1111/j.1365-3083.1987.tb01042.x; ANDREW ME, 1990, J VIROL, V64, P4776, DOI 10.1128/JVI.64.10.4776-4783.1990; ASHORN PA, 1990, J VIROL, V64, P2149, DOI 10.1128/JVI.64.5.2149-2156.1990; BARRETT N, 1989, AIDS RES HUM RETROV, V5, P159, DOI 10.1089/aid.1989.5.159; BAXBY D, 1977, J INFECT DIS, V136, P453, DOI 10.1093/infdis/136.3.453; BENNINK JR, 1984, NATURE, V311, P578, DOI 10.1038/311578a0; BENNINK JR, 1990, CURR TOP MICROBIOL, V163, P153; BENNINK JR, 1987, J VIROL, V61, P1098, DOI 10.1128/JVI.61.4.1098-1102.1987; BENNINK JR, 1986, J VIROL, V57, P786, DOI 10.1128/JVI.57.3.786-791.1986; BERNARDS R, 1987, P NATL ACAD SCI USA, V84, P6854, DOI 10.1073/pnas.84.19.6854; BLANCOU J, 1986, NATURE, V322, P373, DOI 10.1038/322373a0; BOYLE DB, 1988, GENE, V65, P123, DOI 10.1016/0378-1119(88)90424-6; BRAINERD HD, 1967, NEW ENGL J MED, V276, P620, DOI 10.1056/NEJM196703162761106; BULLER RML, 1988, J VIROL, V62, P866, DOI 10.1128/JVI.62.3.866-874.1988; BULLER RML, 1985, NATURE, V317, P813, DOI 10.1038/317813a0; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; BUONOCORE L, 1990, NATURE, V345, P625, DOI 10.1038/345625a0; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; CHILD SJ, 1990, VIROLOGY, V174, P625, DOI 10.1016/0042-6822(90)90119-C; COCHRAN MA, 1985, P NATL ACAD SCI USA, V82, P19, DOI 10.1073/pnas.82.1.19; CONDIT RC, 1983, VIROLOGY, V128, P224; COONEY EL, 1991, LANCET, V337, P567, DOI 10.1016/0140-6736(91)91636-9; COUPAR BEH, 1986, EUR J IMMUNOL, V16, P1479, DOI 10.1002/eji.1830161203; DALES S, 1990, ANNU REV MICROBIOL, V44, P173, DOI 10.1146/annurev.mi.44.100190.001133; DAVISON AJ, 1990, NUCLEIC ACIDS RES, V18, P4285, DOI 10.1093/nar/18.14.4285; DELANGE AM, 1990, CURR TOP MICROBIOL, V163, P71; DEUSCHLE U, 1989, P NATL ACAD SCI USA, V86, P5400, DOI 10.1073/pnas.86.14.5400; EARL PL, 1986, SCIENCE, V234, P728, DOI 10.1126/science.3490689; EARL PL, 1991, J VIROL, V65, P31, DOI 10.1128/JVI.65.1.31-41.1991; EARL PL, 1990, J VIROL, V64, P2448, DOI 10.1128/JVI.64.5.2448-2451.1990; EARL PL, IN PRESS PROTOCOLS M; ELROYSTEIN O, 1990, P NATL ACAD SCI USA, V87, P6743, DOI 10.1073/pnas.87.17.6743; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; ESPOSITO JJ, 1985, VIROLOGY, V143, P230, DOI 10.1016/0042-6822(85)90111-4; ESPOSITO JJ, 1988, VIROLOGY, V165, P313, DOI 10.1016/0042-6822(88)90692-7; ESTIN CD, 1988, P NATL ACAD SCI USA, V85, P1052, DOI 10.1073/pnas.85.4.1052; FALKNER FG, 1988, J VIROL, V62, P1849, DOI 10.1128/JVI.62.6.1849-1854.1988; FENNER F, 1958, VIROLOGY, V5, P530, DOI 10.1016/0042-6822(58)90043-6; FENNER F, 1988, ORTHOPOXVIRUSES; FISCHETTI VA, 1989, SCIENCE, V244, P1487, DOI 10.1126/science.2660266; FLEXNER C, 1988, NATURE, V335, P259, DOI 10.1038/335259a0; FLEXNER C, 1990, VACCINE, V8, P17, DOI 10.1016/0264-410X(90)90171-H; FLEXNER C, 1987, NATURE, V330, P259, DOI 10.1038/330259a0; FRANKE CA, 1985, MOL CELL BIOL, V5, P1918, DOI 10.1128/MCB.5.8.1918; FUERST TR, 1989, J MOL BIOL, V206, P333, DOI 10.1016/0022-2836(89)90483-X; FUERST TR, 1987, MOL CELL BIOL, V7, P2538, DOI 10.1128/MCB.7.7.2538; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; GOTCH F, 1987, J EXP MED, V165, P408, DOI 10.1084/jem.165.2.408; GOULD K, 1989, J EXP MED, V170, P1051, DOI 10.1084/jem.170.3.1051; HANY M, 1989, EUR J IMMUNOL, V19, P417, DOI 10.1002/eji.1830190302; ISAACS SN, 1990, VIROLOGY, V178, P626, DOI 10.1016/0042-6822(90)90367-Z; JARAQUEMADA D, 1990, J EXP MED, V172, P947, DOI 10.1084/jem.172.3.947; Jenner E., 1959, CLASSICS MED SURG, P213; Jezek Z, 1988, HUMAN MONKEYPOX; JONJIC S, 1988, J VIROL, V62, P1653; KANESAKI T, 1991, J VIROL, V65, P657, DOI 10.1128/JVI.65.2.657-663.1991; KARSCHIN A, IN PRESS P NATL ACAD; KARUPIAH G, 1990, J EXP MED, V172, P1495, DOI 10.1084/jem.172.5.1495; KARUPIAH G, 1990, J IMMUNOL, V144, P290; KEIL W, 1989, VIROLOGY, V170, P392, DOI 10.1016/0042-6822(89)90430-3; KEMPE CH, 1960, PEDIATRICS, V26, P176; KOENIG S, 1990, J IMMUNOL, V145, P127; KOENIG S, 1988, P NATL ACAD SCI USA, V85, P8638, DOI 10.1073/pnas.85.22.8638; KOHONENCORISH MRJ, 1990, EUR J IMMUNOL, V20, P157, DOI 10.1002/eji.1830200123; KOTWAL GJ, 1989, VIROLOGY, V171, P579, DOI 10.1016/0042-6822(89)90627-2; LANGFORD CJ, 1986, MOL CELL BIOL, V6, P3191, DOI 10.1128/MCB.6.9.3191; LATHE R, 1987, NATURE, V326, P878, DOI 10.1038/326878a0; LI Y, 1988, J VIROL, V62, P776, DOI 10.1128/JVI.62.3.776-782.1988; LIEBER A, 1989, NUCLEIC ACIDS RES, V17, P8485, DOI 10.1093/nar/17.21.8485; MACKETT M, 1982, P NATL ACAD SCI-BIOL, V79, P7415, DOI 10.1073/pnas.79.23.7415; MACKETT M, 1984, J VIROL, V49, P857, DOI 10.1128/JVI.49.3.857-864.1984; MALVOISIN E, 1990, J VIROL, V64, P5160, DOI 10.1128/JVI.64.10.5160-5162.1990; MASSUNG RF, 1990, J VIROL, V64, P2280, DOI 10.1128/JVI.64.5.2280-2289.1990; MCMICHAEL AJ, 1986, J GEN VIROL, V67, P719, DOI 10.1099/0022-1317-67-4-719; MEN R, 1991, J VIROL, V65, P1400, DOI 10.1128/JVI.65.3.1400-1407.1991; MIZUKAMI T, 1988, P NATL ACAD SCI USA, V85, P9273, DOI 10.1073/pnas.85.23.9273; MORRISON LA, 1986, J EXP MED, V163, P903, DOI 10.1084/jem.163.4.903; MOSS B, 1984, NATURE, V311, P67, DOI 10.1038/311067a0; MOSS B, 1991, J BIOL CHEM, V266, P1355; MOSS B, 1987, ANNU REV IMMUNOL, V5, P305, DOI 10.1146/annurev.iy.05.040187.001513; MOSS B, 1990, ANNU REV BIOCHEM, V59, P661, DOI 10.1146/annurev.biochem.59.1.661; MOSS B, 1990, VIROLOGY, V2, P2079; MOSS B, IN PRESS VACCINES NE; MURPHY BR, 1988, J VIROL, V62, P3907, DOI 10.1128/JVI.62.10.3907-3910.1988; NAKANO E, 1982, P NATL ACAD SCI-BIOL, V79, P1593, DOI 10.1073/pnas.79.5.1593; NIXON DF, 1988, NATURE, V336, P484, DOI 10.1038/336484a0; PANICALI D, 1983, P NATL ACAD SCI-BIOL, V80, P5364, DOI 10.1073/pnas.80.17.5364; PANICALI D, 1986, GENE, V47, P193, DOI 10.1016/0378-1119(86)90063-6; PANICALI D, 1982, P NATL ACAD SCI-BIOL, V79, P4927, DOI 10.1073/pnas.79.16.4927; PATEL DD, 1988, P NATL ACAD SCI USA, V85, P9431, DOI 10.1073/pnas.85.24.9431; PATTNAIK AK, 1991, P NATL ACAD SCI USA, V88, P1379, DOI 10.1073/pnas.88.4.1379; PERKUS ME, 1985, SCIENCE, V229, P981, DOI 10.1126/science.2992092; PERKUS ME, 1989, J VIROL, V63, P3829, DOI 10.1128/JVI.63.9.3829-3836.1989; PICCINI A, 1987, METHOD ENZYMOL, V153, P545; POLYDEFKIS M, 1990, J EXP MED, V171, P875, DOI 10.1084/jem.171.3.875; RAMSHAW IA, 1987, NATURE, V329, P545, DOI 10.1038/329545a0; REDFIELD RR, 1987, NEW ENGL J MED, V316, P673, DOI 10.1056/NEJM198703123161106; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RODRIGUEZ D, 1990, J VIROL, V64, P4851, DOI 10.1128/JVI.64.10.4851-4857.1990; RODRIGUEZ JF, 1989, J VIROL, V63, P997, DOI 10.1128/JVI.63.2.997-1001.1989; ROIZMAN B, 1985, SCIENCE, V229, P1208, DOI 10.1126/science.2994215; RUBY J, 1990, IMMUNOL CELL BIOL, V68, P113, DOI 10.1038/icb.1990.16; RUPPRECHT CE, 1986, P NATL ACAD SCI USA, V83, P7947, DOI 10.1073/pnas.83.20.7947; SAM CK, 1981, ANN INST PASTEUR VIR, V132, P135, DOI 10.1016/S0769-2617(81)80016-0; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; SHIDA H, 1988, J VIROL, V62, P4474, DOI 10.1128/JVI.62.12.4474-4480.1988; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; SMALL PA, 1985, VACCINIA VIRUSES VEC, P175; SMITH GL, 1983, NATURE, V302, P490, DOI 10.1038/302490a0; SMITH GL, 1983, GENE, V25, P21, DOI 10.1016/0378-1119(83)90163-4; SMITH GL, 1987, VIROLOGY, V160, P336, DOI 10.1016/0042-6822(87)90004-3; STAMATOS NM, 1987, J VIROL, V61, P516, DOI 10.1128/JVI.61.2.516-525.1987; SWEETSER MT, 1989, NATURE, V342, P180, DOI 10.1038/342180a0; TAYLOR J, 1988, VACCINE, V6, P497, DOI 10.1016/0264-410X(88)90100-4; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; TRAKTMAN P, 1990, CURR TOP MICROBIOL, V163, P93; TURNER PC, 1990, CURR TOP MICROBIOL, V163, P125; VANSLYKE JK, 1990, CURR TOP MICROBIOL, V163, P185; VIJAYA S, 1988, MOL CELL BIOL, V8, P1709, DOI 10.1128/MCB.8.4.1709; WACHSMAN M, 1989, J GEN VIROL, V70, P2513, DOI 10.1099/0022-1317-70-9-2513; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; WALKER BD, 1988, SCIENCE, V240, P64, DOI 10.1126/science.2451288; WEIR JP, 1982, P NATL ACAD SCI-BIOL, V79, P1210, DOI 10.1073/pnas.79.4.1210; WHITT MA, 1989, J VIROL, V63, P3569, DOI 10.1128/JVI.63.9.3569-3578.1989; WHITT MA, 1991, FOCUS, V13, P8; WHITTON JL, 1989, J EXP MED, V170, P1033, DOI 10.1084/jem.170.3.1033; WIKTOR TJ, 1984, P NATL ACAD SCI-BIOL, V81, P7194, DOI 10.1073/pnas.81.22.7194; YANG XC, 1991, FASEB J, V5, P2209, DOI 10.1096/fasebj.5.8.1708738; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; YILMA T, 1988, SCIENCE, V242, P1058, DOI 10.1126/science.3194758; YILMA T, 1987, HYBRIDOMA, V6, P329, DOI 10.1089/hyb.1987.6.329; Yilma T, 1987, VACCINES 87, P393; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417; ZHOU YW, 1990, MOL CELL BIOL, V10, P4529, DOI 10.1128/MCB.10.9.4529	136	373	451	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	1991	252	5013					1662	1667		10.1126/science.2047875	http://dx.doi.org/10.1126/science.2047875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT114	2047875				2022-12-28	WOS:A1991FT11400037
J	JONES, DA; BEYNON, D; LITTLEPAGE, BNC				JONES, DA; BEYNON, D; LITTLEPAGE, BNC			AUDIT OF AN OFFICIAL RECOMMENDATION ON SCREENING FOR CONGENITAL DISLOCATION OF THE HIP	BRITISH MEDICAL JOURNAL			English	Article									W GLAMORGAN HLTH AUTHOR,SWANSEA SA1 5AQ,WALES									[Anonymous], 1986, ARCH DIS CHILD, V61, P921; [Anonymous], 1969, SCREENING DETECTION; CATFORD JC, 1982, BMJ-BRIT MED J, V285, P1527, DOI 10.1136/bmj.285.6354.1527; MACFARLANE A, 1987, BRIT MED J, V294, P1047, DOI 10.1136/bmj.294.6579.1047; 1986, SCREENING DETECTION	5	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 15	1991	302	6790					1435	1436		10.1136/bmj.302.6790.1435	http://dx.doi.org/10.1136/bmj.302.6790.1435			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR403	2070110	Green Published, Bronze			2022-12-28	WOS:A1991FR40300022
J	HUBER, BT; WOODLAND, RT; WORTIS, HH				HUBER, BT; WOODLAND, RT; WORTIS, HH			THE IMANISHI-KARI AFFAIR - OPINIONS FROM AN INQUIRY PANEL	NATURE			English	Editorial Material									UNIV MASSACHUSETTS,SCH MED,WORCESTER,MA 01605	University of Massachusetts System; University of Massachusetts Worcester	HUBER, BT (corresponding author), TUFTS UNIV,SCH MED,BOSTON,MA 02111, USA.							OTOOLE M, 1991, NATURE, V351, P180, DOI 10.1038/351180a0	1	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 13	1991	351	6327					514	514						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FR034	2046759				2022-12-28	WOS:A1991FR03400019
J	SIGFUSSON, N; SIGVALDASON, H; STEINGRIMSDOTTIR, L; GUDMUNDSDOTTIR, II; STEFANSDOTTIR, I; THORSTEINSSON, T; SIGURDSSON, G				SIGFUSSON, N; SIGVALDASON, H; STEINGRIMSDOTTIR, L; GUDMUNDSDOTTIR, II; STEFANSDOTTIR, I; THORSTEINSSON, T; SIGURDSSON, G			DECLINE IN ISCHEMIC-HEART-DISEASE IN ICELAND AND CHANGE IN RISK FACTOR LEVELS	BRITISH MEDICAL JOURNAL			English	Article							MORTALITY; TRENDS	Objective - To monitor trends in mortality and morbidity due to ischaemic heart disease and compare these with observed levels of risk factors from population surveys. Design - Analysis of trends in death rates from ischaemic heart disease in Iceland compared with expected rates computed from population surveys. Risk factor levels together with beta-factors obtained from Cox's regression analysis were used to compute expected death rates. Trends in morbidity due to acute myocardial infarction were assessed and secular trends in dietary consumption compared with trends in cholesterol concentrations. Setting - Reykjavik, Iceland (total population 250 000; over half the population live in Reykjavik). Subjects - 12 814 randomly selected residents in the Reykjavik area aged 45-64 (6623 men, 6191 women; 72% and 80% of those invited). Main outcome measures - Age adjusted rates of myocardial infarction and deaths from ischaemic heart disease. Expected risk from risk factor levels (smoking, total serum cholesterol concentration, systolic blood pressure) at each unique survey visit. Results - Mortality from ischaemic heart disease has decreased by 17-18% since 1970. During 1981-6 the myocardial infarction attack rate in men under 75 decreased by 23%. A decrease occurred in the level of all three major risk factors after 1968. The fall in the serum cholesterol concentration coincided with a reduction in consumption of dairy fat and margarine . The calculated reduction in risk for the age group 45-64 was about 35%, which was closely similar to the observed decrease in mortality due to ischaemic heart disease in that age group. Conclusion - The reduction in mortality from ischaemic heart disease was substantially due to a decreased incidence of myocardial infarction and could be attributed largely to the reduction in risk factors.	REYKJAVIK CITY HOSP,DEPT MED,IS-108 REYKJAVIK,ICELAND; ICELAND HEART ASSOC,REYKJAVIK,ICELAND; ICELAND NUTR COUNCIL,REYKJAVIK,ICELAND	Landspitali National University Hospital; Icelandic Heart Association			Steingrimsdottir, Laufey/L-3150-2015					BEAGLEHOLE R, 1981, NEW ZEAL MED J, V93, P371; BLOCK WD, 1966, CLIN CHEM, V10, P681; Breslow N. E., 1980, IARC SCI PUBLICATION, V32; COX DR, 1972, J R STAT SOC B, V34, P187; DOBSON AJ, 1987, COMMUNITY HEALTH ST, V11, P2; DWYER T, 1980, INT J EPIDEMIOL, V9, P65, DOI 10.1093/ije/9.1.65; HILMARSDOTTIR E, 1989, MANNELDI NEYSLA, P155; KEYS A, 1957, LANCET, V1, P787; RAGNARSSON JO, 1981, ICELANDIC NUTRITIONA, P74; RIFKIND BM, 1988, ATHEROSCLER REV, V18, P59; ROSE GA, 1968, CARDIOVASCULAR SURVE, P160; SEGI M, 1960, CANCER MORTALITY SEL; SYTKOWSKI PA, 1990, NEW ENGL J MED, V322, P1635, DOI 10.1056/NEJM199006073222304; THORGEIRSSON G, 1990, European Heart Journal, V11, P326; TUNSTALLPEDOE H, 1989, INT J EPIDEMIOL, V18, P169; TUOMILEHTO J, 1989, INT J EPIDEMIOL, V18, pS38; UEMURA K, 1988, World Health Statistics Quarterly, V41, P155; WAXVEILER RJ, 1983, J OCCUP MED, V25, P115; 1971, HAGTIDINDI IDNADARVO, V56; 1980, ARBOK LANDBUNADARINS; 1987, ARBOK LANDBUNADARINS; 1983, WHOMNC821; 1982, JAMA-J AM MED ASSOC, V248, P1465; 1975, ARBOK LANDBUNADARINS; 1970, ARBOK LANDBUNADARINS; 1981, HAGTIDINDI IDNADARVO, V66; 1985, ARBOK LANDBUNADARINS	27	86	86	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 8	1991	302	6789					1371	1375		10.1136/bmj.302.6789.1371	http://dx.doi.org/10.1136/bmj.302.6789.1371			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR057	2059715	Green Published, Bronze			2022-12-28	WOS:A1991FR05700019
J	CO, MS; QUEEN, C				CO, MS; QUEEN, C			HUMANIZED ANTIBODIES FOR THERAPY	NATURE			English	Article							INTERLEUKIN-2 RECEPTOR; MOUSE				CO, MS (corresponding author), PROT DESIGN LABS INC,2375 GARCIA AVE,MT VIEW,CA 94043, USA.							BROWN PS, 1991, P NATL ACAD SCI USA, V88, P2663, DOI 10.1073/pnas.88.7.2663; CO MS, 1991, P NATL ACAD SCI USA, V88, P2869, DOI 10.1073/pnas.88.7.2869; DiMaggio J J, 1990, Cancer Chemother Biol Response Modif, V11, P177; HALE G, 1988, LANCET, V2, P1394; JAFFERS GJ, 1986, TRANSPLANTATION, V41, P572, DOI 10.1097/00007890-198605000-00004; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; JUNGHANS RP, 1990, CANCER RES, V50, P1495; MATHIESON PW, 1990, NEW ENGL J MED, V323, P250, DOI 10.1056/NEJM199007263230407; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; REICHMANN L, 1988, NATURE, V332, P323; TEMPEST PR, 1991, BIO-TECHNOL, V9, P266, DOI 10.1038/nbt0391-266; 1991, 6TH INT C MON ANT IM	13	78	124	0	7	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 6	1991	351	6326					501	502		10.1038/351501a0	http://dx.doi.org/10.1038/351501a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP758	2046753				2022-12-28	WOS:A1991FP75800062
J	EPNER, DE; KOEFFLER, HP				EPNER, DE; KOEFFLER, HP			MOLECULAR GENETIC ADVANCES IN CHRONIC MYELOGENOUS LEUKEMIA	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									UNIV CALIF LOS ANGELES, CEDARS SINAI MED CTR, LOS ANGELES, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles	EPNER, DE (corresponding author), LAB BIOMED & ENVIRONM SCI, LOS ANGELES, CA 90024 USA.				NCI NIH HHS [CA26038, CA32737] Funding Source: Medline; NIGMS NIH HHS [GM 08243] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA032737, R01CA026038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R13GM108243, T32GM008243] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CANAANI E, 1984, LANCET, V1, P593; CATOVSKY D, 1979, BRIT J HAEMATOL, V42, P493, DOI 10.1111/j.1365-2141.1979.tb01161.x; CHAN LC, 1987, NATURE, V325, P635, DOI 10.1038/325635a0; CLARK SS, 1987, SCIENCE, V235, P85, DOI 10.1126/science.3541203; CLARK SS, 1988, SCIENCE, V239, P775, DOI 10.1126/science.3422516; COLLINS SJ, 1984, SCIENCE, V225, P72, DOI 10.1126/science.6587568; COOK WD, 1987, MOL CELL BIOL, V7, P2631, DOI 10.1128/MCB.7.7.2631; COOK WD, 1985, CELL, V41, P677, DOI 10.1016/S0092-8674(85)80048-9; DOBROVIC A, 1988, BLOOD, V72, P2063; DREAZEN O, 1988, SEMIN HEMATOL, V25, P35; DREAZEN O, 1987, LANCET, V1, P1402; EK B, 1982, NATURE, V295, P419, DOI 10.1038/295419a0; ERIKSON J, 1986, P NATL ACAD SCI USA, V83, P1807, DOI 10.1073/pnas.83.6.1807; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; HARIHARAN IK, 1987, EMBO J, V6, P115, DOI 10.1002/j.1460-2075.1987.tb04727.x; HEISTERKAMP N, 1983, Journal of Molecular and Applied Genetics, V2, P57; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; HEISTERKAMP N, 1989, BLOOD, V73, P1307; HERMANS A, 1987, CELL, V51, P33, DOI 10.1016/0092-8674(87)90007-9; HOOBERMAN AL, 1989, P NATL ACAD SCI USA, V86, P4259, DOI 10.1073/pnas.86.11.4259; KASUGA M, 1982, NATURE, V298, P667, DOI 10.1038/298667a0; KAWASAKI ES, 1988, P NATL ACAD SCI USA, V85, P5698, DOI 10.1073/pnas.85.15.5698; KLOETZER W, 1985, VIROLOGY, V140, P230, DOI 10.1016/0042-6822(85)90361-7; KOEFFLER HP, 1981, NEW ENGL J MED, V304, P1269, DOI 10.1056/NEJM198105213042105; KOEFFLER HP, 1981, NEW ENGL J MED, V304, P1201, DOI 10.1056/NEJM198105143042004; KONOPKA JB, 1985, P NATL ACAD SCI USA, V82, P1810, DOI 10.1073/pnas.82.6.1810; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; KURZROCK R, 1986, ANN INTERN MED, V105, P673, DOI 10.7326/0003-4819-105-5-673; KURZROCK R, 1987, NATURE, V325, P631, DOI 10.1038/325631a0; MATHEYPREVOT B, 1986, MOL CELL BIOL, V6, P4133, DOI 10.1128/MCB.6.11.4133; MORRIS CM, 1986, NATURE, V320, P281, DOI 10.1038/320281a0; NISHIMURA J, 1982, P NATL ACAD SCI-BIOL, V79, P4303, DOI 10.1073/pnas.79.14.4303; NOWELL PC, 1960, SCIENCE, V132, P1497; OLIFF A, 1985, P NATL ACAD SCI USA, V82, P3306, DOI 10.1073/pnas.82.10.3306; PRYWES R, 1985, J VIROL, V54, P114, DOI 10.1128/JVI.54.1.114-122.1985; RETTENMIER CW, 1985, SCIENCE, V228, P320, DOI 10.1126/science.2580348; RODENHUIS S, 1985, NEW ENGL J MED, V313, P51; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; RUBIN JB, 1983, NATURE, V305, P438, DOI 10.1038/305438a0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; SHTIVELMAN E, 1987, BLOOD, V69, P971; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; USHIRO H, 1980, J BIOL CHEM, V255, P8363; WALKER LC, 1987, NATURE, V329, P851, DOI 10.1038/329851a0; WIEDEMANN LM, 1988, BLOOD, V71, P349; WITTE ON, 1980, P NATL ACAD SCI-BIOL, V77, P4993, DOI 10.1073/pnas.77.8.4993; WITTE ON, 1980, NATURE, V283, P826, DOI 10.1038/283826a0	50	43	43	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1990	113	1					3	6		10.7326/0003-4819-113-1-3	http://dx.doi.org/10.7326/0003-4819-113-1-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL180	2073245				2022-12-28	WOS:A1990DL18000002
J	HOLLINGSWORTH, NM; GOETSCH, L; BYERS, B				HOLLINGSWORTH, NM; GOETSCH, L; BYERS, B			THE HOP1 GENE ENCODES A MEIOSIS-SPECIFIC COMPONENT OF YEAST CHROMOSOMES	CELL			English	Article									UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195	University of Washington; University of Washington Seattle					NIGMS NIH HHS [GM07735, GM18541] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007735, R37GM018541, R01GM018541] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATCHESON CL, 1987, P NATL ACAD SCI USA, V84, P8035, DOI 10.1073/pnas.84.22.8035; BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; BLUMBERG H, 1987, NATURE, V328, P443, DOI 10.1038/328443a0; BYERS B, 1975, P NATL ACAD SCI USA, V72, P5056, DOI 10.1073/pnas.72.12.5056; CARPENTER ATC, 1979, CHROMOSOMA, V75, P259, DOI 10.1007/BF00293472; DAVIDOW LS, 1984, GENETICS, V106, P165; DIECKMANN CL, 1985, J BIOL CHEM, V260, P1513; DONAHUE TF, 1988, CELL, V54, P621, DOI 10.1016/S0092-8674(88)80006-0; ENGELS FM, 1968, CHROMOSOMA, V25, P104, DOI 10.1007/BF00338237; ESPOSITO RE, 1981, MOL BIOL YEAST SACCH, V1, P211; FARNET C, 1988, MECHANISMS CONSEQUEN; FRIDEN P, 1987, MOL CELL BIOL, V7, P2708, DOI 10.1128/MCB.7.8.2708; FRIDEN P, 1988, MOL CELL BIOL, V8, P2690, DOI 10.1128/MCB.8.7.2690; GOETSCH L, 1982, MOL GEN GENET, V187, P54, DOI 10.1007/BF00384383; Gowen JW, 1933, J EXP ZOOL, V65, P83, DOI 10.1002/jez.1400650106; GUSTAFSON TA, 1989, MOL CELL BIOL, V9, P3269, DOI 10.1128/MCB.9.8.3269; HARTWELL LH, 1967, J BACTERIOL, V93, P1662, DOI 10.1128/JB.93.5.1662-1670.1967; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HEYTING C, 1987, EUR J CELL BIOL, V43, P148; HEYTING C, 1988, CHROMOSOMA, V96, P325, DOI 10.1007/BF00286921; HOLLINGSWORTH NM, 1989, GENETICS, V121, P445; HOTTA Y, 1984, CHROMOSOMA, V90, P243, DOI 10.1007/BF00287031; JOHNSTON M, 1987, P NATL ACAD SCI USA, V84, P2401, DOI 10.1073/pnas.84.8.2401; JOHNSTON M, 1987, NATURE, V328, P353, DOI 10.1038/328353a0; KADANOGA JT, 1987, CELL, V51, P1079; KAMMERER B, 1984, J MOL BIOL, V180, P239, DOI 10.1016/S0022-2836(84)80002-9; KASSIR Y, 1976, GENETICS, V82, P187; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; KLAPHOLZ S, 1985, GENETICS, V110, P187; LAUGHON A, 1984, MOL CELL BIOL, V4, P260, DOI 10.1128/MCB.4.2.260; MALONE RE, 1981, MOL CELL BIOL, V1, P891, DOI 10.1128/MCB.1.10.891; Maniatis T., 1982, MOL CLONING; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; MOENS PB, 1987, J CELL BIOL, V105, P93, DOI 10.1083/jcb.105.1.93; MORTIMER RK, 1969, YEASTS, V1, P385; Parent S A, 1985, Yeast, V1, P83, DOI 10.1002/yea.320010202; PIKIELNY CW, 1983, CELL, V34, P395, DOI 10.1016/0092-8674(83)90373-2; POWERS PA, 1986, GENETICS, V112, P343; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; REDEMANN N, 1988, NATURE, V332, P90, DOI 10.1038/332090a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SHERMAN F, 1963, GENETICS, V48, P255; SMITH HE, 1989, MOL CELL BIOL, V9, P2142, DOI 10.1128/MCB.9.5.2142; SMITH M, 1985, ANNU REV GENET, V19, P423, DOI 10.1146/annurev.genet.19.1.423; SMITH PA, 1968, GENETICS, V60, P335; STERN H, 1987, P303; THOMPSON EA, 1989, MOL GEN GENET, V218, P293, DOI 10.1007/BF00331281; VONWETTSTEIN D, 1984, ANNU REV GENET, V18, P331, DOI 10.1146/annurev.ge.18.120184.001555; WAGSTAFF JE, 1985, MOL CELL BIOL, V5, P3532, DOI 10.1128/MCB.5.12.3532; WANG HT, 1987, MOL CELL BIOL, V7, P1425, DOI 10.1128/MCB.7.4.1425; WESTERGAARD M, 1972, ANNU REV GENET, V6, P71, DOI 10.1146/annurev.ge.06.120172.000443; WOOD JS, 1982, MOL CELL BIOL, V2, P1064, DOI 10.1128/MCB.2.9.1064	54	243	248	1	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	APR 6	1990	61	1					73	84		10.1016/0092-8674(90)90216-2	http://dx.doi.org/10.1016/0092-8674(90)90216-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CY382	2107981				2022-12-28	WOS:A1990CY38200011
J	DAUT, J; MAIERRUDOLPH, W; VONBECKERATH, N; MEHRKE, G; GUNTHER, K; GOEDELMEINEN, L				DAUT, J; MAIERRUDOLPH, W; VONBECKERATH, N; MEHRKE, G; GUNTHER, K; GOEDELMEINEN, L			HYPOXIC DILATION OF CORONARY-ARTERIES IS MEDIATED BY ATP-SENSITIVE POTASSIUM CHANNELS	SCIENCE			English	Article									TECH UNIV MUNICH,KLINIKUM RECHTS ISAR,MED KLIN 1,W-8000 MUNICH 80,GERMANY	Technical University of Munich	DAUT, J (corresponding author), TECH UNIV MUNICH,INST PHYSIOL,BIEDERSTEINER STR 29,W-8000 MUNICH 40,GERMANY.							ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; BERNE RM, 1963, PHYSIOL REV, V44, P1; BUSSE R, 1984, PFLUG ARCH EUR J PHY, V401, P77, DOI 10.1007/BF00581536; CHANG AE, 1980, AM J PHYSIOL, V238, pH716, DOI 10.1152/ajpheart.1980.238.5.H716; COOK NS, 1988, TRENDS PHARMACOL SCI, V9, P21, DOI 10.1016/0165-6147(88)90238-6; DAUT J, 1982, J MOL CELL CARDIOL, V14, P189, DOI 10.1016/0022-2828(82)90119-5; DAUT J, 1982, J PHYSIOL-LONDON, V330, P243, DOI 10.1113/jphysiol.1982.sp014339; DAUT J, UNPUB; DEWEILLE J, 1988, P NATL ACAD SCI USA, V85, P1312; DUNNE MJ, 1988, J MEMBRANE BIOL, V104, P165, DOI 10.1007/BF01870928; ESCANDE D, 1988, BIOCHEM BIOPH RES CO, V154, P620, DOI 10.1016/0006-291X(88)90184-2; GERLACH E, 1963, NATURWISSENSCHAFTEN, V50, P228, DOI 10.1007/BF00639287; HAMILTON TC, 1989, GEN PHARMACOL, V20, P1, DOI 10.1016/0306-3623(89)90052-9; KELM M, 1988, EUR J PHARMACOL, V155, P317, DOI 10.1016/0014-2999(88)90522-5; LAIRD JD, 1983, CARDIAC METABOLISM, P257; LONGMAN SD, 1988, J CARDIOVASC PHARM, V12, P535, DOI 10.1097/00005344-198811000-00006; MEHRKE G, 1990, Pfluegers Archiv European Journal of Physiology, V415, pR115; NEES S, 1985, BASIC RES CARDIOL, V80, P515, DOI 10.1007/BF01907915; NELSON MT, 1988, NATURE, V336, P382, DOI 10.1038/336382a0; OLSSON RA, 1987, PROG CARDIOVASC DIS, V29, P369, DOI 10.1016/0033-0620(87)90003-X; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; POHL U, 1989, AM J PHYSIOL, V256, pH1595, DOI 10.1152/ajpheart.1989.256.6.H1595; SANGUINETTI MC, 1988, P NATL ACAD SCI USA, V85, P8360, DOI 10.1073/pnas.85.21.8360; STANDEN NB, 1989, SCIENCE, V245, P177, DOI 10.1126/science.2501869; WEIR SW, 1986, BRIT J PHARMACOL, V88, P121, DOI 10.1111/j.1476-5381.1986.tb09478.x	25	623	627	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1341	1344		10.1126/science.2107575	http://dx.doi.org/10.1126/science.2107575			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	2107575				2022-12-28	WOS:A1990CU25300039
J	REYES, GR; PURDY, MA; KIM, JP; LUK, KC; YOUNG, LM; FRY, KE; BRADLEY, DW				REYES, GR; PURDY, MA; KIM, JP; LUK, KC; YOUNG, LM; FRY, KE; BRADLEY, DW			ISOLATION OF A CDNA FROM THE VIRUS RESPONSIBLE FOR ENTERICALLY TRANSMITTED NON-A, NON-B HEPATITIS	SCIENCE			English	Article									CTR DIS CONTROL,DIV VIRAL DIS,HEPATITIS BRANCH,ATLANTA,GA 30333	Centers for Disease Control & Prevention - USA	REYES, GR (corresponding author), GENELABS INC,DEPT MOLEC VIROL,REDWOOD CITY,CA 94063, USA.							AHLQUIST P, 1981, CELL, V23, P183, DOI 10.1016/0092-8674(81)90283-X; ALTER MJ, 1989, JAMA-J AM MED ASSOC, V262, P1201, DOI 10.1001/jama.262.9.1201; ARANKALLE VA, 1988, LANCET, V1, P550; BALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370; BRADLEY D, 1988, J GEN VIROL, V69, P731, DOI 10.1099/0022-1317-69-3-731; BRADLEY DM, UNPUB; BRADLEY DW, 1987, P NATL ACAD SCI USA, V84, P6277, DOI 10.1073/pnas.84.17.6277; BRADLEY DW, 1988, LANCET, V1, P819; BRADLEY DW, 1986, SEMIN LIVER DIS, V6, P56, DOI 10.1055/s-2008-1040794; CARROLL AR, 1984, NUCLEIC ACIDS RES, V12, P2461, DOI 10.1093/nar/12.5.2461; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; COHEN JI, 1987, J VIROL, V61, P50, DOI 10.1128/JVI.61.1.50-59.1987; CORNELISSEN BJC, 1983, NUCLEIC ACIDS RES, V11, P3019, DOI 10.1093/nar/11.10.3019; DECOCK KM, 1987, ANN INTERN MED, V106, P227, DOI 10.7326/0003-4819-106-2-227; DW Bradley, 1988, VIRAL HEPATITIS LIVE, P138; FEINSTONE SM, 1975, NEW ENGL J MED, V292, P767, DOI 10.1056/NEJM197504102921502; FRY KE, UNPUB; GOELET P, 1982, P NATL ACAD SCI-BIOL, V79, P5818, DOI 10.1073/pnas.79.19.5818; HOUGHTON M, 1989, Patent No. 883109225; KAMER G, 1984, NUCLEIC ACIDS RES, V12, P7269, DOI 10.1093/nar/12.18.7269; KIM J, UNPUB; KRAWCZYNSKI K, 1989, J INFECT DIS, V159, P1042, DOI 10.1093/infdis/159.6.1042; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LOMONOSOFF GB, 1983, EMBO J, V2, P221; LOVE DN, 1975, ARCH VIROL, V48, P213, DOI 10.1007/BF01317964; MOUNT DW, 1986, MANUAL COMPUTER PROG; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NOMOTO A, 1982, P NATL ACAD SCI-BIOL, V79, P5793, DOI 10.1073/pnas.79.19.5793; PALMENBERG AC, 1984, NUCLEIC ACIDS RES, V12, P2969, DOI 10.1093/nar/12.6.2969; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PRINCE AM, 1974, LANCET, V2, P241; PURCELL RH, 1988, VIRAL HEPATITIS LIVE, P131; REYES G, UNPUB; REYES GR, 1989, J CELL BIOCH WH S13E, V160, P293; REYES GR, IN PRESS VIRAL HEPAT; SAGER R, 1981, CELL, V23, P41, DOI 10.1016/0092-8674(81)90268-3; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHABEL F, 1979, PADIATR PADOL, V14, P249; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STRAUSS EG, 1984, VIROLOGY, V133, P92, DOI 10.1016/0042-6822(84)90428-8; SUMIYOSHI H, 1987, VIROLOGY, V161, P497, DOI 10.1016/0042-6822(87)90144-9; TABOR E, 1985, LANCET, V1, P743; TANDON BN, 1982, INDIAN J MED RES, V75, P739; 1987, MORBID MORTAL WKLY R, V36, P241; 1987, MORBID MORTAL WKLY R, V36, P597	49	629	683	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 16	1990	247	4948					1335	1339		10.1126/science.2107574	http://dx.doi.org/10.1126/science.2107574			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU253	2107574				2022-12-28	WOS:A1990CU25300037
J	CHATELLIER, G; LACOMBLEZ, L				CHATELLIER, G; LACOMBLEZ, L			TACRINE (TETRAHYDROAMINOACRIDINE - THA) AND LECITHIN IN SENILE DEMENTIA OF THE ALZHEIMER TYPE - A MULTICENTER TRIAL	BRITISH MEDICAL JOURNAL			English	Article									CHU PITIE SALPETRIERE,DEPT PHARMACOL,F-75634 PARIS 13,FRANCE; GRP FRANCAIS ETUD TETRAHYDROAMINOACRIDINE,PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	CHATELLIER, G (corresponding author), CHU PITIE SALPETRIERE,DEPT MED INFORMAT,SERV INFORMAT MED,91 BD HOP,F-75634 PARIS 13,FRANCE.							AMES DJ, 1988, LANCET, V1, P887; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GAUTHIER S, 1988, CURRENT RES ALZHEIME, P237; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; HILLS M, 1979, BRIT J CLIN PHARMACO, V8, P7, DOI 10.1111/j.1365-2125.1979.tb05903.x; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; KAYE WH, 1982, BIOL PSYCHIAT, V17, P275; LACOMBLEZ L, 1989, FUNDAM CLIN PHARM, V3, P172; LEVY R, 1987, LANCET, V1, P322; LITTLE A, 1985, J NEUROL NEUROSUR PS, V48, P736, DOI 10.1136/jnnp.48.8.736; MACNAIR DM, 1983, ASSESSMENT GERIATRIC, P137; MARX JL, 1987, SCIENCE, V238, P1041, DOI 10.1126/science.3317822; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MEER B, 1966, J GERONTOL, V21, P392, DOI 10.1093/geronj/21.3.392; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; PENN RD, 1988, NEUROLOGY, V38, P219, DOI 10.1212/WNL.38.2.219; PERRY EK, 1978, BRIT MED J, V2, P1457, DOI 10.1136/bmj.2.6150.1457; PIRROZZOLO FJ, 1987, NEW ENGL J MED, V316, P1603; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; SUMMERS WK, 1986, NEW ENGL J MED, V315, P1241, DOI 10.1056/NEJM198611133152001; WILCOCK GK, 1988, LANCET, V2, P1305; 1987, DIAGNOSTIC STATISTIC; 1985, SAS USERS GUIDE STAT	23	169	172	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	1990	300	6723					495	499		10.1136/bmj.300.6723.495	http://dx.doi.org/10.1136/bmj.300.6723.495			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107926	Green Published, Bronze			2022-12-28	WOS:A1990CQ87800017
J	BERAL, V				BERAL, V			LEUKEMIA AND NUCLEAR INSTALLATIONS	BRITISH MEDICAL JOURNAL			English	Editorial Material											BERAL, V (corresponding author), RADCLIFFE INFIRM,IMPERIAL CANC RES FUND,CANC EPIDEMIOL UNIT,OXFORD OX2 6HE,ENGLAND.							BERAL V, 1985, BRIT MED J, V291, P440, DOI 10.1136/bmj.291.6493.440; BERAL V, 1988, BRIT MED J, V297, P757, DOI 10.1136/bmj.297.6651.757; GODDARD AJH, 1986, DOERW8703 REP; ISHIMARU T, 1981, RERF1181 RAD EFF RES; KNUDSON AG, 1986, ANNU REV GENET, V20, P231; NOMURA T, 1982, NATURE, V296, P575, DOI 10.1038/296575a0; SMITH PG, 1986, BRIT MED J, V293, P845, DOI 10.1136/bmj.293.6551.845; 1988, 2ND COMM MED ASP RAD; 1989, 3RD COMM MED ASP RAD; 1984, INVESTIGATION POSSIB	10	25	25	1	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 17	1990	300	6722					411	412		10.1136/bmj.300.6722.411	http://dx.doi.org/10.1136/bmj.300.6722.411			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP166	2107888	Bronze, Green Published			2022-12-28	WOS:A1990CP16600001
J	ANDERSON, KE; GOEGER, DE; CARSON, RW; LEE, SMK; STEAD, RB				ANDERSON, KE; GOEGER, DE; CARSON, RW; LEE, SMK; STEAD, RB			ERYTHROPOIETIN FOR THE TREATMENT OF PORPHYRIA CUTANEA-TARDA IN A PATIENT ON LONG-TERM HEMODIALYSIS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV TEXAS, MED BRANCH, DEPT INTERNAL MED, GALVESTON, TX 77550 USA; ST ELIZABETH HOSP, BEAUMONT, TX USA; AMGEN INC, THOUSAND OAKS, CA USA	University of Texas System; University of Texas Medical Branch Galveston; Amgen	ANDERSON, KE (corresponding author), UNIV TEXAS, MED BRANCH, DEPT PREVENT MED & COMMUNITY HLTH, DIV HUMAN NUTR, ROUTE J09, GALVESTON, TX 77550 USA.			Anderson, Karl/0000-0002-6499-8573	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000073] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR-00073] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDERSON CD, 1987, PHOTODERMATOLOGY, V4, P14; ANDERSON KE, 1990, HEMATOLOGY, P722; de Verneuil H, 1978, Hum Genet, V44, P145; DISLER P, 1982, AM J MED, V72, P989, DOI 10.1016/0002-9343(82)90860-9; ELDER GH, 1985, LANCET, V2, P229; ELDER GH, 1977, SEMIN HEMATOL, V14, P227; ELDER GH, 1978, NEW ENGL J MED, V299, P274, DOI 10.1056/NEJM197808102990603; ELDER GH, 1988, DERMATOLOGY 5 CONTIN, P857; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; GOLDSMAN CI, 1983, CLEVELAND CLIN Q, V50, P151, DOI 10.3949/ccjm.50.2.151; HARLAN SL, 1983, MAYO CLIN PROC, V58, P467; KAPPAS A, 1983, METABOLIC BASIS INHE, P1301; LICHTENSTEIN JR, 1981, BRIT J DERMATOL, V104, P575, DOI 10.1111/j.1365-2133.1981.tb08174.x; LIM VS, 1989, ANN INTERN MED, V110, P108, DOI 10.7326/0003-4819-110-2-108; MCCOLL KEL, 1986, PHOTODERMATOLOGY, V3, P169; Parrilla JG, 1980, BRIT MED J, V280, P1358; POHFITZPATRICK MB, 1978, NEW ENGL J MED, V299, P292, DOI 10.1056/NEJM197808102990607; POHFITZPATRICK MB, 1976, J LAB CLIN MED, V87, P362; PRAGA M, 1987, NEW ENGL J MED, V316, P547; RICCIONI N, 1987, NEPHRON, V46, P125, DOI 10.1159/000184326; SANCHEZ JR, 1984, MED CLIN-BARCELONA, V83, P762; SASSA S, 1983, T ASSOC AM PHYSICIAN, V96, P65; SEUBERT S, 1985, J INVEST DERMATOL, V85, P107, DOI 10.1111/1523-1747.ep12276482; SWEENEY GD, 1986, CLIN BIOCHEM, V19, P3, DOI 10.1016/S0009-9120(86)80064-9; TOPI GC, 1981, BRIT J DERMATOL, V104, P579, DOI 10.1111/j.1365-2133.1981.tb08175.x; Toriyama F, 1987, Nihon Hifuka Gakkai Zasshi, V97, P1189; VANWYCK DB, 1989, KIDNEY INT, V35, P712, DOI 10.1038/ki.1989.43; WINEARLS CG, 1986, LANCET, V2, P1175, DOI 10.1016/S0140-6736(86)92192-6	28	75	77	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	1990	322	5					315	317		10.1056/NEJM199002013220507	http://dx.doi.org/10.1056/NEJM199002013220507			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL199	2104958				2022-12-28	WOS:A1990CL19900007
J	BOWER, M; NELSON, M; GAZZARD, BG				BOWER, M; NELSON, M; GAZZARD, BG			DUPUYTRENS CONTRACTURES IN PATIENTS INFECTED WITH HIV	BRITISH MEDICAL JOURNAL			English	Article									WESTMINSTER MED SCH & HOSP,GEN MED & HIV RELATED MED,LONDON SW1P 2AP,ENGLAND	Imperial College London				Bower, Mark/0000-0002-4077-6351				EVANS RA, 1986, BRIT J HOSP MED, V36, P198; LING RSM, 1963, J BONE JOINT SURG BR, V45, P709, DOI 10.1302/0301-620X.45B4.709; MURRELL GAC, 1987, BMJ-BRIT MED J, V295, P1373, DOI 10.1136/bmj.295.6610.1373; MURRELL GAC, 1987, SPECULAT SCI TECHNOL, V10, P107; SONNERBORG A, 1988, SCAND J INFECT DIS, V20, P287, DOI 10.3109/00365548809032453	5	31	33	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	1990	300	6718					164	165		10.1136/bmj.300.6718.164	http://dx.doi.org/10.1136/bmj.300.6718.164			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK077	2105797	Green Published, Bronze			2022-12-28	WOS:A1990CK07700024
J	DIFFORD, F				DIFFORD, F			DEFINING ESSENTIAL DATA FOR AUDIT IN GENERAL-PRACTICE	BRITISH MEDICAL JOURNAL			English	Article																			0	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					92	94		10.1136/bmj.300.6717.92	http://dx.doi.org/10.1136/bmj.300.6717.92			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105783	Bronze, Green Published			2022-12-28	WOS:A1990CJ08000020
J	KEELER, JR; HURST, CG; DUNN, MA				KEELER, JR; HURST, CG; DUNN, MA			PYRIDOSTIGMINE USED AS A NERVE AGENT PRETREATMENT UNDER WARTIME CONDITIONS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note								Objective.-To determine the adverse effects of pretreatment with pyridostigmine bromide for nerve agent exposure during wartime. Design. -A retrospective study Setting. - Southwest Asia. Participants. -Personnel who provided medical support to the XVIII Airborne Corps. These medical officers supplied information pertaining to symptoms and disposition of 41 650 soldiers who received pyridostigmine at the onset of hostilities of Operation Desert Storm. Intervention.-Pyridostigmine bromide, 30 mg orally, was self-administered every 8 hours while under the threat of nerve agent attack (for 1 to 7 days). Main Outcome Measure.-Physiologic changes attributable to pyridostigmine that resulted in need for medical attention, discontinuation of the drug, hospitalization, and/or evacuation f rom Southwest Asia. Results.- About half of the population noted physiologic changes that were not incapacitating, such as increased flatus, abdominal cramps, soft stools, and urinary urgency Approximately 1% of the soldiers believed they had effects that warranted medical attention, but fewer than 0.1% had effects sufficient to discontinue the drug. Nonincapacitating symptoms often occurred; however, military mission performance was not impaired. Conclusion.-While under the threat of nerve agent attack, pyridostigmine can be administered to virtually all soldiers.			KEELER, JR (corresponding author), USA,MED RES INST CHEM DEF,SGRD UV YY LTC KEELER,ABERDEEN PROVING GROUND,MD 21010, USA.							DUNN MA, 1989, JAMA-J AM MED ASSOC, V262, P649, DOI 10.1001/jama.262.5.649; GALL E, 1981, FUNDAM APPL TOXICOL, V1, P214; GAWRON VJ, 1988, ADA198828; KLUWE WM, 1987, 6TH P MED CHEM DEF B, P227; KOLKA MA, 1991, ADA232726; KORNHAUSER D, 1986, BIOAVAILABILITY ORAL; KORNHAUSER D, 1990, SAFETY TOLERANCE PHA; 1990, FED REG         1221, V55, P5281; 1990, FM8285 HEADQ DEP ARM	9	154	154	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 7	1991	266	5					693	695		10.1001/jama.266.5.693	http://dx.doi.org/10.1001/jama.266.5.693			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ140	2072481				2022-12-28	WOS:A1991FZ14000029
J	BRAUNWALD, E				BRAUNWALD, E			ACE INHIBITORS - A CORNERSTONE OF THE TREATMENT OF HEART-FAILURE	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VASODILATOR THERAPY				BRAUNWALD, E (corresponding author), BRIGHAM & WOMENS HOSP, BOSTON, MA 02115 USA.							BRAUNWALD E, 1977, NEW ENGL J MED, V297, P331, DOI 10.1056/NEJM197708112970609; BRAUNWALD E, 1984, NEW ENGL J MED, V310, P459, DOI 10.1056/NEJM198402163100711; CLAUSS RH, 1961, J THORAC CARDIOV SUR, V41, P447; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; COWLEY AJ, 1988, BRIT MED J, V297, P169, DOI 10.1136/bmj.297.6642.169; EICHNA LW, 1956, T ASSOC AM PHYSICIAN, V69, P207; HEADY JA, 1980, LANCET, V2, P379; HOLTZ J, 1987, J CARDIOVASC PHARM, V9, P348, DOI 10.1097/00005344-198703000-00011; JUGDUTT, 1989, CIRCULATION, V79, P1151; JUGDUTT BI, 1988, CIRCULATION, V78, P906, DOI 10.1161/01.CIR.78.4.906; LINDPAINTNER K, 1991, CIRC RES, V68, P905, DOI 10.1161/01.RES.68.4.905; MAJID PA, 1971, LANCET, V2, P719; PFEFFER JM, 1982, P NATL ACAD SCI-BIOL, V79, P3310, DOI 10.1073/pnas.79.10.3310; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501	17	154	160	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 1	1991	325	5					351	353		10.1056/NEJM199108013250508	http://dx.doi.org/10.1056/NEJM199108013250508			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY715	2057038				2022-12-28	WOS:A1991FY71500008
J	KESSLER, DA				KESSLER, DA			DRUG PROMOTION AND SCIENTIFIC EXCHANGE - THE ROLE OF THE CLINICAL INVESTIGATOR	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											KESSLER, DA (corresponding author), US FDA,ROCKVILLE,MD 20857, USA.								0	55	55	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	1991	325	3					201	203		10.1056/NEJM199107183250310	http://dx.doi.org/10.1056/NEJM199107183250310			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW752	2052064				2022-12-28	WOS:A1991FW75200010
J	LAPUMA, J; ORENTLICHER, D; MOSS, RJ				LAPUMA, J; ORENTLICHER, D; MOSS, RJ			ADVANCE DIRECTIVES ON ADMISSION - CLINICAL IMPLICATIONS AND ANALYSIS OF THE PATIENT SELF-DETERMINATION ACT OF 1990	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELDERLY OUTPATIENTS; CARDIOPULMONARY RESUSCITATION; LIFE; CARE; PREFERENCES; INFORMATION; PHYSICIANS; ATTITUDES; PROXIES; ETHICS		LUTHERAN GEN HOSP, GERIATR MED SECT, PK RIDGE, IL 60068 USA; AMER MED ASSOC, OFF GEN COUNSEL, CHICAGO, IL 60610 USA	American Medical Association	LAPUMA, J (corresponding author), LUTHERAN GEN HOSP, CTR CLIN ETH, 1775 DEMPSTER ST, PK RIDGE, IL 60068 USA.		La Puma, John/M-5558-2019	La Puma, John/0000-0002-0514-720X				ANNAS GJ, 1991, NEW ENGL J MED, V324, P1210, DOI 10.1056/NEJM199104253241711; BEDELL SE, 1986, JAMA-J AM MED ASSOC, V256, P233, DOI 10.1001/jama.256.2.233; BERMAN H, 1990, CHOOSING RIGHT HLTH, P3; CAPRON AM, 1990, HASTINGS CENT REP, V20, P35, DOI 10.2307/3562537; CASSEL CK, 1987, GERONTOLOGIST, V27, pA229; COTLER M, 1988, GERONTOLOGIST, V28, pA186; DANIS M, 1988, JAMA-J AM MED ASSOC, V260, P797, DOI 10.1001/jama.260.6.797; DANIS M, 1991, NEW ENGL J MED, V324, P882, DOI 10.1056/NEJM199103283241304; DAVIDSON KW, 1989, JAMA-J AM MED ASSOC, V262, P2415, DOI 10.1001/jama.262.17.2415; Emanuel E J, 1990, J Clin Ethics, V1, P9; EMANUEL LL, 1991, NEW ENGL J MED, V324, P889, DOI 10.1056/NEJM199103283241305; ENDE J, 1989, J GEN INTERN MED, V4, P23, DOI 10.1007/BF02596485; EPSTEIN AM, 1989, MED CARE, V27, pS91, DOI 10.1097/00005650-198903001-00008; EVERHART MA, 1990, CHEST, V97, P159, DOI 10.1378/chest.97.1.159; FINUCANE TE, 1988, J GEN INTERN MED, V3, P322, DOI 10.1007/BF02595788; GAMBLE ER, 1991, ARCH INTERN MED, V151, P277, DOI 10.1001/archinte.151.2.277; GLEESON K, 1990, ARCH INTERN MED, V150, P1057, DOI 10.1001/archinte.150.5.1057; HARE J, 1991, J GEN INTERN MED, V6, P41, DOI 10.1007/BF02599390; HENDEE WR, 1990, ARCH INTERN MED, V150, P1184; HENDERSON M, 1990, GERONTOLOGIST, V30, P480, DOI 10.1093/geront/30.4.480; HIGH DM, 1988, GERONTOLOGIST, V28, P46, DOI 10.1093/geront/28.Suppl.46; HSIAO WC, 1987, INQUIRY, V24, P2120; KAMER RS, 1990, AM J MED, V88, P108, DOI 10.1016/0002-9343(90)90457-O; KOHN M, 1988, J AM GERIATR SOC, V36, P840, DOI 10.1111/j.1532-5415.1988.tb04270.x; LAPUMA J, 1991, ANN INTERN MED, V114, P98, DOI 10.7326/0003-4819-114-1-98_2; LAPUMA J, 1988, JAMA-J AM MED ASSOC, V260, P808, DOI 10.1001/jama.260.6.808; Lapuma J, 1991, ANN INTERN MED, V114, P155, DOI 10.7326/0003-4819-114-2-155; LEE MA, IN PRESS J AM GERIAT; LO B, 1986, ARCH INTERN MED, V146, P1613, DOI 10.1001/archinte.146.8.1613; MURPHY DJ, 1990, J AM GERIATR SOC, V38, P1251, DOI 10.1111/j.1532-5415.1990.tb01507.x; ORENTLICHER D, 1990, JAMA-J AM MED ASSOC, V264, P2444, DOI 10.1001/jama.264.18.2444; ORENTLICHER D, 1990, JAMA-J AM MED ASSOC, V263, P2365, DOI 10.1001/jama.263.17.2365; OUSLANDER JG, 1989, ARCH INTERN MED, V149, P1367, DOI 10.1001/archinte.149.6.1367; PEARLMAN RA, 1988, J GERONTOL, V43, pM25, DOI 10.1093/geronj/43.2.M25; SACHS GA, 1990, J AM GERIATR SOC, V38, pA3; SHMERLING RH, 1988, J GEN INTERN MED, V3, P317, DOI 10.1007/BF02595786; SLAVENAS JP, 1990, J AM GERIATR SOC, V38, pA12; SPARK M, 1982, MEMENTO MORI; TARNOWSKI KJ, 1990, PEDIATRICS, V85, P58; UHLMANN RF, 1988, J GERONTOL, V43, pM115, DOI 10.1093/geronj/43.5.M115; WEBSTER JR, 1990, ARCH INTERN MED, V150, P1795, DOI 10.1001/archinte.150.9.1795; Zinberg Joel M, 1989, Vt Law Rev, V13, P445; 1989, PHYSICIAN PUBLIC ATT, P113; 1982, MAKING HLTH CARE DEC, V2; 1989, GUIDE AWARENESS EVAL; 1991, REFUSAL TREATMENT LE; 1987, LIFE SUSTAINING TREA, P187	47	149	150	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	1991	266	3					402	405		10.1001/jama.266.3.402	http://dx.doi.org/10.1001/jama.266.3.402			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV960	2056650				2022-12-28	WOS:A1991FV96000032
J	CASANOVA, JE; APODACA, G; MOSTOV, KE				CASANOVA, JE; APODACA, G; MOSTOV, KE			AN AUTONOMOUS SIGNAL FOR BASOLATERAL SORTING IN THE CYTOPLASMIC DOMAIN OF THE POLYMERIC IMMUNOGLOBULIN RECEPTOR	CELL			English	Article							CANINE KIDNEY-CELLS; POLARIZED EPITHELIAL-CELLS; INFLUENZA-VIRUS HEMAGGLUTININ; COATED PIT LOCALIZATION; MDCK CELLS; MEMBRANE GLYCOPROTEIN; INTRACELLULAR-TRANSPORT; ENDOPLASMIC-RETICULUM; G-PROTEIN; SURFACE	The polymeric immunoglobulin receptor is normally delivered from the Golgi to the basolateral surface of epithelial cells and then transports polymeric IgA and IgM to the apical surface. We now report that a 14 residue segment of the 103 amino acid cytoplasmic domain, proximal to the plasma membrane, directs the receptor to the basolateral surface. A mutant receptor lacking these 14 amino acids is sorted directly to the apical surface from the Golgi. Furthermore, this sequence is sufficient to redirect an apical membrane protein, placental alkaline phosphatase, to the basolateral plasma membrane. We conclude that this sequence contains an autonomous signal, which specifies sorting from the Golgi to the basolateral surface, a process previously postulated to occur by default.	UNIV CALIF SAN FRANCISCO, SCH MED, CARDIOVASC RES INST, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco	CASANOVA, JE (corresponding author), UNIV CALIF SAN FRANCISCO, SCH MED, DEPT ANAT, SAN FRANCISCO, CA 94143 USA.		Apodaca, Gerard/HCJ-0048-2022	mostov, keith/0000-0002-8123-6247	PHS HHS [A1 RO1 25144] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BALCAROVASTANDER J, 1984, EMBO J, V3, P2687, DOI 10.1002/j.1460-2075.1984.tb02194.x; BARTLES JR, 1988, TRENDS BIOCHEM SCI, V13, P181, DOI 10.1016/0968-0004(88)90147-8; BERGER J, 1988, J BIOL CHEM, V263, P10016; BREITFELD PP, 1990, J CELL BIOL, V111, P2365, DOI 10.1083/jcb.111.6.2365; BREITFELD PP, 1990, J BIOL CHEM, V265, P13750; BREITFELD PP, 1989, J CELL BIOL, V109, P475, DOI 10.1083/jcb.109.2.475; BREITFELD PP, 1989, METHOD CELL BIOL, V32, P329; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; CAPLAN M, 1989, FUNCTIONAL EPITHELIA, P71; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; CHOUDARY PV, 1986, COLD SPRING HARB SYM, V51, P1047, DOI 10.1101/SQB.1986.051.01.121; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; COMPTON T, 1989, P NATL ACAD SCI USA, V86, P4112, DOI 10.1073/pnas.86.11.4112; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; GERSTEN DM, 1978, J IMMUNOL METHODS, V24, P305, DOI 10.1016/0022-1759(78)90133-3; GONZALEZ A, 1987, P NATL ACAD SCI USA, V84, P3738, DOI 10.1073/pnas.84.11.3738; HOWARD AD, 1987, P NATL ACAD SCI USA, V84, P6055, DOI 10.1073/pnas.84.17.6055; HUNZIKER W, 1989, J CELL BIOL, V109, P3291, DOI 10.1083/jcb.109.6.3291; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; JONES LV, 1985, MOL CELL BIOL, V5, P2181, DOI 10.1128/MCB.5.9.2181; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; KTISTAKIS NT, 1990, J CELL BIOL, V111, P1393, DOI 10.1083/jcb.111.4.1393; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAZAROVITS J, 1988, CELL, V53, P743, DOI 10.1016/0092-8674(88)90092-X; LEBIVIC A, 1990, J CELL BIOL, V110, P1533, DOI 10.1083/jcb.110.5.1533; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; LISANTI MP, 1988, P NATL ACAD SCI USA, V85, P9557, DOI 10.1073/pnas.85.24.9557; MATLIN KS, 1984, J CELL BIOL, V99, P2131, DOI 10.1083/jcb.99.6.2131; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; MIETTINEN HM, 1989, CELL, V58, P317, DOI 10.1016/0092-8674(89)90846-5; MOSTOV KE, 1985, CELL, V43, P389, DOI 10.1016/0092-8674(85)90166-7; MOSTOV KE, 1987, J CELL BIOL, V105, P2031, DOI 10.1083/jcb.105.5.2031; MOSTOV KE, 1986, CELL, V47, P359, DOI 10.1016/0092-8674(86)90592-1; MOSTOV KE, 1986, CELL, V46, P613, DOI 10.1016/0092-8674(86)90887-1; MOSTOV KE, 1984, NATURE, V308, P37, DOI 10.1038/308037a0; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; MUSIL LS, 1987, J CELL BIOL, V104, P1725, DOI 10.1083/jcb.104.6.1725; PUDDINGTON L, 1987, P NATL ACAD SCI USA, V84, P2756; RINDLER MJ, 1984, J CELL BIOL, V98, P1304, DOI 10.1083/jcb.98.4.1304; ROMAN LM, 1986, J CELL BIOL, V103, P2607, DOI 10.1083/jcb.103.6.2607; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAERER E, 1990, J CELL BIOL, V110, P987, DOI 10.1083/jcb.110.4.987; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; SKIBBENS JE, 1989, J CELL BIOL, V108, P821, DOI 10.1083/jcb.108.3.821; SOLARI R, 1984, CELL, V36, P61, DOI 10.1016/0092-8674(84)90074-6; STEPHENS EB, 1986, CELL, V47, P1053, DOI 10.1016/0092-8674(86)90820-2; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; URBAN J, 1987, J CELL BIOL, V105, P2735, DOI 10.1083/jcb.105.6.2735; VENKATAKRISHNAN G, 1991, BIOCHEMISTRY-US, V30, P2748, DOI 10.1021/bi00225a002; VONBONSDORFF CH, 1985, EMBO J, V4, P2781, DOI 10.1002/j.1460-2075.1985.tb04004.x; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8	53	278	281	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 12	1991	66	1					65	75		10.1016/0092-8674(91)90139-P	http://dx.doi.org/10.1016/0092-8674(91)90139-P			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FW913	2070419				2022-12-28	WOS:A1991FW91300009
J	HOLT, VL; CHU, J; DALING, JR; STERGACHIS, AS; WEISS, NS				HOLT, VL; CHU, J; DALING, JR; STERGACHIS, AS; WEISS, NS			TUBAL-STERILIZATION AND SUBSEQUENT ECTOPIC PREGNANCY - A CASE-CONTROL STUDY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; POPULATION; FAILURES	Objective.- To assess the relative risk of ectopic pregnancy associated with postpartum or interval tubal sterilization. Design.- Case-control study using a comparison group of women of reproductive age at risk of pregnancy. Setting.- Group Health Cooperative of Puget Sound, a health maintenance organization based in Seattle, Wash. Participants.- Cases were 249 enrollees diagnosed as having an ectopic pregnancy between October 1, 1981, and September 30, 1986. Controls were 835 randomly selected enrollees matched to cases on age and county of residence. Measurements.- Information on interval sterilization history was obtained from interviews, examination of medical records, automated hospitalization files, and a previously validated algorithm. A logistic regression model was used to estimate relative risks (RRs) for sterilized women compared with women using other types of or no contraception at the reference date. Results.- Controlling for age, county, race, smoking, income, gravidity, and prior use of a Dalkon Shield intrauterine device, the risk of ectopic pregnancy in women who had undergone interval sterilization was 3.7 (95% confidence interval [Cl], 1.7 to 8.0) times that of women currently using oral contraception and 2.8 (95% Cl, 1.5 to 5.5) times that of women currently using barrier contraceptive methods. Use of interval sterilization was associated with a risk of ectopic pregnancy similar to that of women using intrauterine devices (RR, 0.8; 95% Cl, 0.4 to 1.7) and a risk lower than that of women who were not using contraception (RR, 0.2; 95% Cl, 0.1 to 0.3). The corresponding RRs associated with postpartum sterilization were lower: 1.2 (95% Cl, 0.3 to 3.9), 0.9 (95% Cl, 0.3 to 2.8), 0.3 (95% Cl, 0.1 to 0.8), and 0. 1 (95% Cl, 0.0 to 0.2), respectively. Conclusion.- Tubal sterilization provides some protection against extrauterine as well as intrauterine pregnancy. It is likely that postpartum sterilization can be a safe alternative to all types of temporary contraception in terms of risk of ectopic pregnancy, while some types of interval sterilization may lead to an increased risk, in comparison with use of oral contraceptives or barrier methods.	UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,DEPT EPIDEMIOL,SEATTLE,WA 98195; FRED HUTCHINSON CANC RES CTR,DIV PUBL HLTH SCI,SEATTLE,WA 98104; UNIV WASHINGTON,SCH MED,DEPT OBSTET & GYNECOL,SEATTLE,WA 98195; GRP HLTH COOPERAT PUGET SOUND,CTR HLTH STUDIES,SEATTLE,WA; UNIV WASHINGTON,SCH PHARM,DEPT PHARM PRACTICE,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle					NICHD NIH HHS [1RO1HD17657, 3RO1HD17657-S1] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017657] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 1985, Clin Reprod Fertil, V3, P131; BACHRACH CA, 1984, FAM PLANN PERSPECT, V16, P253, DOI 10.2307/2134914; Breslow N, 1980, STATISTICAL METHODS, V32; CHENG MCE, 1977, STUD FAMILY PLANN, V8, P109, DOI 10.2307/1966115; CHI IC, 1980, AM J OBSTET GYNECOL, V136, P768, DOI 10.1016/0002-9378(80)90454-8; CHI IC, 1981, ADV PLANNED PARENT, V16, P52; DESTEFANO F, 1982, OBSTET GYNECOL, V60, P326; DESTEFANO F, 1984, JAMA-J AM MED ASSOC, V251, P1432; GRAY RH, 1984, INTRAUTERINE CONTRAC, P354; HOLT VL, 1989, AM J PUBLIC HEALTH, V79, P1234, DOI 10.2105/AJPH.79.9.1234; KJER JJ, 1989, AM J OBSTET GYNECOL, V160, P1202, DOI 10.1016/0002-9378(89)90190-7; Loffer F D, 1975, Obstet Gynecol Surv, V30, P407, DOI 10.1097/00006254-197507000-00001; MARCHBANKS PA, 1988, JAMA-J AM MED ASSOC, V259, P1823, DOI 10.1001/jama.259.12.1823; MCCAUSLAND A, 1980, AM J OBSTET GYNECOL, V136, P97, DOI 10.1016/0002-9378(80)90573-6; MOSHER WD, 1990, ADV DATA VITAL HLTH, V182; PEARSON DC, 1987, PREV MED, V16, P783, DOI 10.1016/0091-7435(87)90018-1; STERGACHIS A, 1990, JAMA-J AM MED ASSOC, V264, P2893, DOI 10.1001/jama.264.22.2893; TATUM HJ, 1977, FERTIL STERIL, V28, P407; WEISS NS, 1988, JAMA-J AM MED ASSOC, V260, P1553, DOI 10.1001/jama.1988.03410110061019; WEISS NS, 1985, AM J PUBLIC HEALTH, V75, P67, DOI 10.2105/AJPH.75.1.67; 1988, MMWR, V37, P637	21	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1991	266	2					242	246		10.1001/jama.266.2.242	http://dx.doi.org/10.1001/jama.266.2.242			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU896	2056626				2022-12-28	WOS:A1991FU89600033
J	FRIEDMAN, Y; FRANKLIN, C; FREELS, S; WEIL, MH				FRIEDMAN, Y; FRANKLIN, C; FREELS, S; WEIL, MH			LONG-TERM SURVIVAL OF PATIENTS WITH AIDS, PNEUMOCYSTIS-CARINII PNEUMONIA, AND RESPIRATORY-FAILURE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACQUIRED IMMUNODEFICIENCY SYNDROME; LIFE-SUSTAINING TREATMENT; INTENSIVE-CARE UNIT; MECHANICAL VENTILATION; PROGNOSTIC FACTORS; CORTICOSTEROIDS; EXPERIENCE; ADMISSION	Objective. - To evaluate the long-term survival of patients admitted to the medical intensive care unit, Cook County Hospital, Chicago, Ill, with Pneumocystis carinii pneumonia and acute respiratory failure. Design. - Cohort study over a 4-year period. Setting. - Municipal teaching hospital. Patients. - Seventy-three consecutive patients who had 75 episodes of P carinii pneumonia and acute respiratory failure were followed up from the time of hospital admission until their deaths or the termination of the study. Outcome Measures. - Duration of survival from the time of initial hospital admission with diagnoses of P carinii pneumonia and acute respiratory failure. Results. - Consistent with recent reports of improved short-term outcome, the immediate hospital survival was 47% (35/75). The 1-year survival was 37% (95% confidence interval, 26% to 49%). Two patients have survived for 40 months. Almost three quarters of the patients who survived hospitalization lived for at least 1 year. Conclusions. - The long-term prognosis for patients with the acquired immunodeficiency syndrome, P carinii pneumonia, and acute respiratory failure is now substantially better than anticipated. Respiratory failure due to P carinii pneumonia does not necessarily signify the terminal phase of human immunodeficiency virus infection. Accordingly, patients with the acquired immunodeficiency syndrome, P carinii pneumonia, and acute respiratory failure can be appropriate candidates for life support in medical intensive care units.	UNIV HLTH SCI CHICAGO MED SCH,N CHICAGO,IL 60064; UNIV ILLINOIS,SCH PUBL HLTH,DEPT EPIDEMIOL BIOSTAT,CHICAGO,IL 60680	Chicago Medical School; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	FRIEDMAN, Y (corresponding author), COOK CTY HOSP,DEPT MED,DIV CRIT CARE MED,1835 W HARRISON ST,CHICAGO,IL 60612, USA.							ALLEGRA CJ, 1987, NEW ENGL J MED, V317, P978, DOI 10.1056/NEJM198710153171602; BRENNER M, 1987, AM REV RESPIR DIS, V136, P1199, DOI 10.1164/ajrccm/136.5.1199; CREAGHKIRK T, 1988, JAMA-J AM MED ASSOC, V260, P3009, DOI 10.1001/jama.260.20.3009; EFFEREN LS, 1989, AM J MED, V87, P401, DOI 10.1016/S0002-9343(89)80821-6; ELSADR W, 1988, AM REV RESPIR DIS, V137, P1264, DOI 10.1164/ajrccm/137.6.1264; ENGELHARDT HT, 1986, JAMA-J AM MED ASSOC, V255, P1159, DOI 10.1001/jama.255.9.1159; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; FRIEDMAN Y, 1990, CRIT CARE MED, V18, P346, DOI 10.1097/00003246-199003000-00027; FRIEDMAN Y, 1989, CHEST, V96, P862, DOI 10.1378/chest.96.4.862; HARDY WD, 1989, 1989 AIDS CLIN REV, P125; KAPLAN RM, 1989, MED CARE, V27, pS27, DOI 10.1097/00005650-198903001-00003; LUCE JM, 1988, AM REV RESPIR DIS, V137, P1261, DOI 10.1164/ajrccm/137.6.1261; MACFADDEN DK, 1987, LANCET, V1, P1477, DOI 10.1016/S0140-6736(87)92219-7; MONTANER JSG, 1989, CHEST, V95, P881, DOI 10.1378/chest.95.4.881; MURRAY JF, 1984, NEW ENGL J MED, V310, P1682, DOI 10.1056/NEJM198406213102529; ROGERS PL, 1989, CRIT CARE MED, V17, P113, DOI 10.1097/00003246-198902000-00001; ROSEN MJ, 1986, J INTENSIVE CARE MED, V1, P55; ROTHENBERG R, 1987, NEW ENGL J MED, V317, P1297, DOI 10.1056/NEJM198711193172101; SCHEIN RMH, 1986, CRIT CARE MED, V14, P1026, DOI 10.1097/00003246-198612000-00006; STEINBROOK R, 1986, NEW ENGL J MED, V314, P457, DOI 10.1056/NEJM198602133140730; STOVER DE, 1985, AM J MED, V78, P429, DOI 10.1016/0002-9343(85)90334-1; VEACH L, 1990, CHEST, V97, P1499, DOI 10.1378/chest.97.6.1499-b; WACHTER RM, 1990, CHEST, V97, P1499, DOI 10.1378/chest.97.6.1499-b; WACHTER RM, 1989, CHEST, V96, P714, DOI 10.1378/chest.96.4.714; WACHTER RM, 1988, ARCH INTERN MED, V148, P149, DOI 10.1001/archinte.148.1.149; WACHTER RM, 1989, CHEST, V95, P647, DOI 10.1378/chest.95.3.647; WACHTER RM, 1986, AM REV RESPIR DIS, V134, P891, DOI 10.1164/arrd.1986.134.5.891; WACHTER RM, 1989, 5TH INT C AIDS MONTR; 1985, MMWR, V34, P373	29	35	35	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	1991	266	1					89	92		10.1001/jama.266.1.89	http://dx.doi.org/10.1001/jama.266.1.89			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT934	2046133				2022-12-28	WOS:A1991FT93400033
J	HEALY, B				HEALY, B			ALLELIC LOSS CORRELATED WITH PRIMARY BREAST-CANCER	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											HEALY, B (corresponding author), NIH,BETHESDA,MD 20892, USA.							1991, P NATL ACAD SCI USA, V88, P3847	1	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	1991	266	1					19	19						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT934	2046123				2022-12-28	WOS:A1991FT93400004
J	FERGUSONSMITH, AC; CATTANACH, BM; BARTON, SC; BEECHEY, CV; SURANI, MA				FERGUSONSMITH, AC; CATTANACH, BM; BARTON, SC; BEECHEY, CV; SURANI, MA			EMBRYOLOGICAL AND MOLECULAR INVESTIGATIONS OF PARENTAL IMPRINTING ON MOUSE CHROMOSOME-7	NATURE			English	Article							GROWTH FACTOR-II; GENE-EXPRESSION; EMBRYOGENESIS; CHIMERAS; PATTERN; CELLS; MICE; RNA	MOUSE embryos with duplications of whole maternal (parthenogenetic and gynogenetic) or paternal (androgenetic) genomes show reciprocal phenotypes and do not develop to term 1, 2. Genetic complementation has identified the distal region of chromosome 7 (Chr 7) as one of the regions for which both a maternal and paternal chromosome copy are essential for normal development, presumably because of the presence of imprinted genes whose expression is dependent on their parental origin 3, 4. Embryos with the maternal duplication and paternal deficiency of distal Chr 7 are growth retarded and died around day 16 of gestation; the reciprocal paternal duplication embryos die at an unidentified earlier stage 4. We report here the incorporation of cells with the paternal duplication into chimaeras, resulting in a striking growth enhancement of the embryos. One gene located on mouse distal Chr 7 (ref. 5) is the insulin-like growth factor 2 (Igf2) gene, an embryonic mitogen 6. In embryos with the maternal duplication of distal Chr 7, the two maternal alleles of the Igf2 gene are repressed. The presence of two paternal alleles of this gene in many cells is probably responsible for the growth enhancement observed in chimaeras. We propose that there are other imprinted genes in this Chr 7 region. We also compare the imprinting of this subgenomic region with phenotypes resulting from the duplication of the whole parental genome in parthenogenones and androgenones.	MRC,RADIOBIOL UNIT,OXFORD OX1 0RD,ENGLAND		FERGUSONSMITH, AC (corresponding author), AFRC,INST ANIM PHYSIOL & GENET RES,DEPT MOLEC EMBRYOL,CAMBRIDGE CB2 4AT,ENGLAND.		Ferguson-Smith, Anne C/G-7534-2011	Surani, Azim/0000-0002-8640-4318; Ferguson-Smith, Anne/0000-0002-7608-5894				BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTON SC, 1985, J EMBRYOL EXP MORPH, V90, P267; BATINET C, 1980, EXP CELL RES, V130, P15; BECK F, 1987, DEVELOPMENT, V101, P175; CATTANACH BM, 1986, J EMBRYOL EXP MORPH, V97, P137; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; FERGUSONSMITH AC, 1990, CANCER SURV, V9, P487; FUNDELE R, 1989, DEVELOPMENT, V106, P28; FUNDELE RH, 1990, DEVELOPMENT, V108, P203; Gardner R. L., 1978, Methods in mammalian reproduction., P137; HALL JG, 1990, AM J HUM GENET, V46, P857; LEE JE, 1990, DEVELOPMENT, V110, P151; LYON MF, 1989, GENETIC VARIANTS STR, P592; Maniatis T., 1982, MOL CLONING; MANN JR, 1990, CELL, V62, P251, DOI 10.1016/0092-8674(90)90363-J; NICHOLLS R, 1990, AM J HUM GENET, V46, pA230; OHLSSON R, 1989, EMBO J, V8, P1993, DOI 10.1002/j.1460-2075.1989.tb03606.x; REIK W, 1989, TRENDS GENET, V5, P331, DOI 10.1016/0168-9525(89)90138-8; ROTWEIN P, 1990, DNA CELL BIOL, V9, P725, DOI 10.1089/dna.1990.9.725; SEARLE AG, 1971, GENET RES, V18, P215, DOI 10.1017/S0016672300012611; SEARLE AG, 1990, GENET RES, V56, P237, DOI 10.1017/S0016672300035333; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; SOLTER D, 1988, ANNU REV GENET, V22, P127; STYLIANOPOULOU F, 1988, DEVELOPMENT, V103, P497; SURANI MA, 1990, DEVELOPMENT, P89; SURANI MAH, 1986, EXPT APPROACHES MAMM, P401; WINKING H, 1984, GENETICS, V108, P1013	30	256	261	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 20	1991	351	6328					667	670		10.1038/351667a0	http://dx.doi.org/10.1038/351667a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT112	2052093				2022-12-28	WOS:A1991FT11200072
J	GINZBERG, E				GINZBERG, E			HIGH-TECH MEDICINE AND RISING HEALTH-CARE COSTS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											GINZBERG, E (corresponding author), COLUMBIA UNIV,CONSERVAT HUMAN RESOURCES,NEW YORK,NY 10027, USA.							BARONDESS JA, 1988, J AM GERIATR SOC, V36, P919, DOI 10.1111/j.1532-5415.1988.tb05786.x; EBERT RH, 1988, HEALTH AFFAIR, V7, P5, DOI 10.1377/hlthaff.7.2.5; Letsch S W, 1988, Health Care Financ Rev, V10, P109; Lubitz J, 1984, Health Care Financ Rev, V5, P117; 1989, SOURCE BOOK HLTH INS; 1989, PHYSICIAN CHARACTERI; 1989, REPORT NATIONAL LEAD	7	34	34	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	1990	263	13					1820	1822		10.1001/jama.263.13.1820	http://dx.doi.org/10.1001/jama.263.13.1820			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW229	2107340				2022-12-28	WOS:A1990CW22900031
J	GREENBERG, JM; BOEHM, T; SOFRONIEW, MV; KEYNES, RJ; BARTON, SC; NORRIS, ML; SURANI, MA; SPILLANTINI, MG; RABBITTS, TH				GREENBERG, JM; BOEHM, T; SOFRONIEW, MV; KEYNES, RJ; BARTON, SC; NORRIS, ML; SURANI, MA; SPILLANTINI, MG; RABBITTS, TH			SEGMENTAL AND DEVELOPMENTAL REGULATION OF A PRESUMPTIVE T-CELL ONCOGENE IN THE CENTRAL-NERVOUS-SYSTEM	NATURE			English	Article									LAB MOLEC BIOL,CAMBRIDGE CB2 2QH,ENGLAND; UNIV CAMBRIDGE,DEPT ANAT,CAMBRIDGE CB3 2DY,ENGLAND; AFRC,INST ANIM PHYSIOL & GENET RES,DEPT MOLEC EMBRYOL,CAMBRIDGE CB2 4AT,ENGLAND	MRC Laboratory Molecular Biology; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute			; Rabbitts, Terence/D-6262-2016	Surani, Azim/0000-0002-8640-4318; Rabbitts, Terence/0000-0002-4982-2609				ALLEN ND, 1988, NATURE, V333, P852, DOI 10.1038/333852a0; Baer v., 1828, ENTWICKLUNGSGESCHICH; BOEHM T, 1988, EMBO J, V7, P385, DOI 10.1002/j.1460-2075.1988.tb02825.x; BOEHM T, 1989, EUR J BIOCHEM, V185, P1, DOI 10.1111/j.1432-1033.1989.tb15074.x; BOEHM T, IN PRESS EMBO J; FAINSOD A, 1987, DEV BIOL, V124, P125, DOI 10.1016/0012-1606(87)90465-9; GAUNT SJ, 1987, DEVELOPMENT, V101, P51; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GOEDERT M, 1987, EMBO J, V6, P3627, DOI 10.1002/j.1460-2075.1987.tb02694.x; GROENEWEGEN HJ, 1977, J COMP NEUROL, V174, P417, DOI 10.1002/cne.901740304; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; KAPPEN C, 1989, ANN NY ACAD SCI, V6, P243; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KNUDSON AG, 1986, ANNU REV GENET, V20, P231; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MCCLURE CFW, 1890, J MORPHOL, V4, P35; MCGUIRE EA, 1989, MOL CELL BIOL, V9, P2124, DOI 10.1128/MCB.9.5.2124; MURPHY P, 1989, NATURE, V341, P156, DOI 10.1038/341156a0; Orr H, 1887, J MORPHOL, V1, P311, DOI DOI 10.1002/JMOR.1050010204; PETERS G, 1983, CELL, V33, P364; RABBITTS TH, 1988, TRENDS GENET, V4, P300, DOI 10.1016/0168-9525(88)90106-0; SPILLANTINI MG, 1989, P NATL ACAD SCI USA, V86, P8555, DOI 10.1073/pnas.86.21.8555; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1988, EMBO J, V7, P691, DOI 10.1002/j.1460-2075.1988.tb02864.x; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0	26	113	115	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 8	1990	344	6262					158	160		10.1038/344158a0	http://dx.doi.org/10.1038/344158a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT095	2106626				2022-12-28	WOS:A1990CT09500071
J	HERXHEIMER, A; COLLIER, J				HERXHEIMER, A; COLLIER, J			PROMOTION BY THE BRITISH PHARMACEUTICAL-INDUSTRY, 1983-8 - A CRITICAL ANALYSIS OF SELF REGULATION	BRITISH MEDICAL JOURNAL			English	Article									ST GEORGE HOSP,SCH MED,DEPT PHARMACOL & CLIN PHARMACOL,LONDON SW17 0RE,ENGLAND	St Georges University London	HERXHEIMER, A (corresponding author), CHARING CROSS & WESTMINSTER MED SCH,DEPT CLIN PHARMACOL & THERAPEUT,LONDON W6 8RF,ENGLAND.							COLLIER J, 1988, LANCET, V1, P1349; COLLIER J, 1987, LANCET, V1, P113; ERLICHMAN J, 1986, GUARDIAN        0910, P3; HARVEY K, 1988, MED J AUSTRALIA, V150, P664; KWOK YS, 1988, MED J AUSTRALIA, V150, P664; KWOK YS, 1989, NATIONAL MED DRUG PO, P22; MANGOLD T, 1983, LISTENER, V110, P1; RANDALL H, 1988, MED J AUSTRALIA, V149, P713; RANDALL H, 1989, MED J AUSTRALIA, V150, P463; STIMSON GV, 1975, BRIT MED J, V4, P508, DOI 10.1136/bmj.4.5995.508; 1982, CASE REPORT, V2; 1989, ABPI1988 89 ASS BRIT, P43; 1979, CASE REPORT, V1; 1989, ABPI DATA SHEET COMP, pR7; 1980, CASE REPORT, V1; 1989, SCRIP           0224, P14; 1967, CMND3410; 1985, DRUG THER B, V23, P98; 1981, CASE REPORT, V2	19	32	35	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 3	1990	300	6720					307	311		10.1136/bmj.300.6720.307	http://dx.doi.org/10.1136/bmj.300.6720.307			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM195	2106963	Green Published, Bronze			2022-12-28	WOS:A1990CM19500024
J	GORDON, RR				GORDON, RR			POSTNEONATAL MORTALITY AMONG ILLEGITIMATE CHILDREN REGISTERED BY ONE OR BOTH PARENTS	BRITISH MEDICAL JOURNAL			English	Article																		BALARAJAN R, 1989, BRIT MED J, V298, P716, DOI 10.1136/bmj.298.6675.716; FOX AJ, 1986, CLASS HLTH, P100; GORDON RR, 1989, SCOT MED J, V34, P401, DOI 10.1177/003693308903400107; GORDON RR, 1988, BRIT MED J, V297, P773; WHITEHEAD M, 1987, HLTH DIVIDE, P10	5	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1990	300	6719					236	237		10.1136/bmj.300.6719.236-a	http://dx.doi.org/10.1136/bmj.300.6719.236-a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CL024	2106933	Green Published, Bronze			2022-12-28	WOS:A1990CL02400025
J	LOWRY, S				LOWRY, S			HOUSING AND HEALTH - HEALTH AND HOMELESSNESS	BRITISH MEDICAL JOURNAL			English	Editorial Material																		CANTER D, 1989, FACES HOMELESSNESS L; CONWAY J, 1988, PRESCRIPTION POOR HL; ELKABIR DJ, 1982, BRIT MED J, V284, P480, DOI 10.1136/bmj.284.6314.480; ENGELS F, 1892, CONDITION WORKING CL; HILFIKER D, 1989, JAMA-J AM MED ASSOC, V262, P1375; MARSHALL M, 1989, BRIT MED J, V299, P706, DOI 10.1136/bmj.299.6701.706; RAMSDEN SS, 1988, J ROY COLL PHYS LOND, V22, P16; TYLER A, 1985, TIME OUT        1205, P12; WILLIAMS S, 1989, HLTH CARE SINGLE HOM; 1989, HOMELESS FAMILIES TH; 1987, SEAKING OURSELVES FA	11	16	16	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	1990	300	6716					32	34		10.1136/bmj.300.6716.32	http://dx.doi.org/10.1136/bmj.300.6716.32			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG773	2105124	Green Published, Bronze			2022-12-28	WOS:A1990CG77300027
J	GAZMURI, RJ; MECHER, C; WEIL, MH				GAZMURI, RJ; MECHER, C; WEIL, MH			THE HA-1A MONOCLONAL-ANTIBODY FOR GRAM-NEGATIVE SEPSIS	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter											GAZMURI, RJ (corresponding author), UNIV HLTH SCI CHICAGO MED SCH,N CHICAGO,IL 60064, USA.			Gazmuri, Raul J./0000-0002-3848-7227				BONE RC, 1989, CRIT CARE MED, V17, P389, DOI 10.1097/00003246-198905000-00002; RISTUCCIA PA, 1987, SCAND J INFECT DIS, V19, P215, DOI 10.3109/00365548709032401; VANDEVENTER SJH, 1988, LANCET, V1, P605; WEIL MH, 1964, ANN INTERN MED, V60, P384, DOI 10.7326/0003-4819-60-3-384; ZIEGLER EJ, 1991, NEW ENGL J MED, V324, P429, DOI 10.1056/NEJM199102143240701	5	9	9	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 25	1991	325	4					279	280						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX627	2057029				2022-12-28	WOS:A1991FX62700011
J	WHEELER, MC; ROE, MH; KAPLAN, EL; SCHLIEVERT, PM; TODD, JK				WHEELER, MC; ROE, MH; KAPLAN, EL; SCHLIEVERT, PM; TODD, JK			OUTBREAK OF GROUP-A STREPTOCOCCUS SEPTICEMIA IN CHILDREN - CLINICAL, EPIDEMIOLOGIC, AND MICROBIOLOGICAL CORRELATES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE RHEUMATIC-FEVER; SHOCK-LIKE SYNDROME; STAPHYLOCOCCUS-AUREUS; OPACITY FACTOR; UNITED-STATES; TOXIN; RESURGENCE; MORTALITY; INFECTION; VARICELLA	Objective.-To determine the epidemiologic, clinical, and microbiological features of group A streptococcus septicemia in children. Design. - A descriptive series of 34 cases over an 11 -year period from 1980 through 1990. Setting.-An academically affiliated tertiary-care pediatric hospital, the principal referral center for the state of Colorado and surrounding states. Participants.-Thirty-four patients with positive blood cultures for group A streptococcus (33 medical records were available). Main Outcome Measures.-Yearly incidence and clinical features of cases; microbiological features of isolated organisms. Results. -There was a significant increase (P = .01) in the incidence of group A streptococcus bacteremia over an 11-year period, with 14 (41 %) of these cases occurring in 1989 and 1990. Patients had a rapidly progressing illness, usually without preceding pharyngitis. The prominent M and T types were 1 (4) and 12 (4). Eleven (73%) of the 15 strains produced pyrogenic exotoxin B that significantly correlated with production of proteinase. Conclusion.-There appears to be an increase in group A streptococcus bacteremia in children that is associated with a strain phenotype that suggests a change in organism virulence.	CHILDRENS HOSP,DEPT PEDIAT,DENVER,CO 80218; CHILDRENS HOSP,DEPT PATHOL,DENVER,CO 80218; UNIV COLORADO,SCH MED,DEPT PEDIAT,DENVER,CO 80202; UNIV COLORADO,SCH MED,DEPT MICROBIOL IMMUNOL,DENVER,CO 80202; WHO,COLLABORATING CTR REFERENCE & RES STREPTOCOCCI,MINNEAPOLIS,MN; UNIV MINNESOTA,SCH MED,DEPT PEDIAT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH MED,DEPT MICROBIOL,MINNEAPOLIS,MN 55455	Children's Hospital Colorado; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; World Health Organization; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	WHEELER, MC (corresponding author), CHILDRENS HOSP,EPIDEMIOL SECT,1056 E 19TH AVE,DENVER,CO 80218, USA.			Schlievert, Patrick/0000-0001-8314-9369				ALTEMEIER WA, 1978, SURGERY, V84, P534; ANDIMAN WA, 1979, CLIN PEDIATR PHILA, V19, P495; ARMITAGE P, 1971, STATISTICAL METHODS; BARTTER T, 1988, ARCH INTERN MED, V148, P1421, DOI 10.1001/archinte.148.6.1421; BELETSKAYA LV, 1981, 8TH P INT S STREPT S, P141; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; CONE LA, 1987, NEW ENGL J MED, V317, P146, DOI 10.1056/NEJM198707163170305; CONGENI B, 1987, J PEDIATR-US, V111, P176, DOI 10.1016/S0022-3476(87)80063-X; DUDDING B, 1969, PEDIATRICS, V43, P359; FALCONE PA, 1988, CLIN PEDIATR, V27, P339, DOI 10.1177/000992288802700706; FISCHBACHER CM, 1987, SCAND J INFECT DIS, V19, P519, DOI 10.3109/00365548709032416; GAWORZEWSKA E, 1988, EPIDEMIOL INFECT, V100, P257, DOI 10.1017/S095026880006739X; GAWORZEWSKA ET, 1989, NEW ENGL J MED, V321, P1546; GERLACH D, 1983, ZBL BAKT-INT J MED M, V255, P221, DOI 10.1016/S0174-3031(83)80161-9; GOODER H, 1961, J GEN MICROBIOL, V25, P347, DOI 10.1099/00221287-25-3-347; HALLAS G, 1983, J MED MICROBIOL, V16, P13, DOI 10.1099/00222615-16-1-13; HANSMAN D, 1989, NEW ENGL J MED, V321, P1546; HOSIER DM, 1987, AM J DIS CHILD, V141, P730, DOI 10.1001/archpedi.1987.04460070032015; JOHNSON DR, 1988, J CLIN MICROBIOL, V26, P2025, DOI 10.1128/JCM.26.10.2025-2030.1988; JOHNSON LP, 1986, MOL GEN GENET, V203, P354, DOI 10.1007/BF00333979; KAVEY REW, 1989, PEDIATRICS, V84, P585; KOHLER W, 1987, ZBL BAKT-INT J MED M, V266, P104; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACKENBACH JP, 1988, INT J EPIDEMIOL, V17, P618, DOI 10.1093/ije/17.3.618; MASSELL BF, 1988, NEW ENGL J MED, V318, P280, DOI 10.1056/NEJM198802043180504; MOLINA A M, 1985, European Journal of Epidemiology, V1, P37; RAPHAEL SA, 1989, PEDIATR INFECT DIS J, V8, P187; SCHLIEVERT PM, 1983, J INFECT DIS, V147, P236, DOI 10.1093/infdis/147.2.236; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; STOLLERMAN GH, 1982, ADV INTERNAL MED, V27, P373; Swift HF, 1943, J EXP MED, V78, P127, DOI 10.1084/jem.78.2.127; TODD JK, 1984, INFECT IMMUN, V45, P339, DOI 10.1128/IAI.45.2.339-344.1984; TOP FH, 1968, J HYG-CAMB, V66, P49, DOI 10.1017/S0022172400040936; VEASY LG, 1987, NEW ENGL J MED, V316, P421, DOI 10.1056/NEJM198702193160801; WALD ER, 1987, PEDIATRICS, V80, P371; WINCHESTER PD, 1977, AM J DIS CHILD, V131, P753, DOI 10.1001/archpedi.1977.02120200035009; WONG VK, 1988, AM J DIS CHILD, V142, P831, DOI 10.1001/archpedi.1988.02150080037016; 1985, PEDIATRICS, V76, P322; 1990, MMWR, V39, P3; 1990, METHODS DILUTION ANT; 1989, STATISTICAL ABSTRACT, P22	41	122	123	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 24	1991	266	4					533	537		10.1001/jama.266.4.533	http://dx.doi.org/10.1001/jama.266.4.533			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX021	2061980				2022-12-28	WOS:A1991FX02100027
J	PACALA, SW; HASSELL, MP; MAY, RM				PACALA, SW; HASSELL, MP; MAY, RM			HOST PARASITOID ASSOCIATIONS IN PATCHY ENVIRONMENTS	NATURE			English	Article									UNIV LONDON IMPERIAL COLL SCI & TECHNOL, DEPT BIOL, ASCOT SL5 7PY, BERKS, ENGLAND; UNIV LONDON IMPERIAL COLL SCI & TECHNOL, CTR POPULAT BIOL, ASCOT SL5 7PY, BERKS, ENGLAND	Imperial College London; Imperial College London	PACALA, SW (corresponding author), UNIV CONNECTICUT, DEPT ECOL & EVOLUT BIOL, STORRS, CT 06268 USA.							BROWN MW, 1979, ENVIRON ENTOMOL, V8, P77, DOI 10.1093/ee/8.1.77; CASAS J, 1988, PHYSIOL ENTOMOL, V13, P373, DOI 10.1111/j.1365-3032.1988.tb01119.x; CASAS J, 1989, ECOL ENT, V14; CHESSON PL, 1986, AM NAT, V127, P696, DOI 10.1086/284514; EHLER LE, 1986, ENVIRON ENTOMOL, V15, P1268, DOI 10.1093/ee/15.6.1268; ELLIOTT JM, 1983, J ANIM ECOL, V52, P315, DOI 10.2307/4603; FREEMAN BE, 1983, J ANIM ECOL, V42, P779; GRIFFITH.KJ, 1969, CAN ENTOMOL, V101, P673, DOI 10.4039/Ent101673-7; GRIFFITH.KJ, 1969, CAN ENTOMOL, V101, P785, DOI 10.4039/Ent101785-8; HASSELL MP, 1985, ECOL ENTOMOL, V10, P393, DOI 10.1111/j.1365-2311.1985.tb00737.x; HASSELL MP, 1988, ANN ZOOL FENN, V25, P55; HASSELL MP, 1982, ECOL ENTOMOL, V7, P365, DOI 10.1111/j.1365-2311.1982.tb00678.x; HASSELL MP, 1973, J ANIM ECOL, V42, P693, DOI 10.2307/3133; HASSELL MP, 1974, J ANIM ECOL, V43, P567, DOI 10.2307/3384; HASSELL MP, 1984, IMA J APPL MED BIOL, V1, P33; HASSELL MP, IN PRESS AM NAT; Hassell MP., 1978, DYNAMICS ARTHROPOD P; HEADS PA, 1983, OIKOS, V40, P267, DOI 10.2307/3544591; HIROSE Y, 1976, Applied Entomology and Zoology, V11, P116; JONES TH, 1988, ECOL ENTOMOL, V13, P309, DOI 10.1111/j.1365-2311.1988.tb00361.x; LESSELLS CM, 1985, J ANIM ECOL, V54, P27, DOI 10.2307/4618; MAY RM, 1978, J ANIM ECOL, V47, P833, DOI 10.2307/3674; MCCLURE MS, 1977, ENVIRON ENTOMOL, V6, P551, DOI 10.1093/ee/6.4.551; MUNSTERSWENDSEN M, 1980, ECOL ENTOMOL, V5, P373, DOI 10.1111/j.1365-2311.1980.tb01161.x; MURDOCH WW, 1984, AM NAT, V123, P371, DOI 10.1086/284210; PACALA S, IN PRESS AM NAT; REEVE JD, 1988, AM NAT, V132, P810, DOI 10.1086/284891; SMITH ADM, 1986, ECOL ENTOMOL, V11, P425, DOI 10.1111/j.1365-2311.1986.tb00321.x; STILING PD, 1980, J ANIM ECOL, V49, P793, DOI 10.2307/4227; STILING PD, 1987, ECOLOGY, V68, P844, DOI 10.2307/1938356; STRASSMANN JE, 1981, ECOLOGY, V62, P1225, DOI 10.2307/1937287; TAYLOR AD, 1988, AM NAT, V132, P417, DOI 10.1086/284861; THORARINSSON K, IN PRESS ECOLOGY; TREXLER JC, 1985, OIKOS, V44, P415, DOI 10.2307/3565782; WAAGE JK, 1983, ECOL ENTOMOL, V8, P447, DOI 10.1111/j.1365-2311.1983.tb00523.x; WALDE SJ, 1988, ANNU REV ENTOMOL, V33, P441, DOI 10.1146/annurev.en.33.010188.002301; WESELOH RM, 1972, ANN ENTOMOL SOC AM, V65, P64, DOI 10.1093/aesa/65.1.64	37	176	177	1	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 8	1990	344	6262					150	153		10.1038/344150a0	http://dx.doi.org/10.1038/344150a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT095	2103109				2022-12-28	WOS:A1990CT09500068
J	NAKAMURA, Y; YOSHIMOTO, K; SAIMA, S				NAKAMURA, Y; YOSHIMOTO, K; SAIMA, S			GYNECOMASTIA INDUCED BY ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR	BRITISH MEDICAL JOURNAL			English	Letter											NAKAMURA, Y (corresponding author), NATL MED CTR HOSP,DEPT INTERNAL MED,TOKYO,JAPAN.							MARKUSSE HM, 1988, BRIT MED J, V296, P1262, DOI 10.1136/bmj.296.6631.1262-c	1	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	1990	300	6723					541	541		10.1136/bmj.300.6723.541	http://dx.doi.org/10.1136/bmj.300.6723.541			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107949	Green Published, Bronze			2022-12-28	WOS:A1990CQ87800060
J	LOWRY, S				LOWRY, S			FAMILIES AND FLATS	BRITISH MEDICAL JOURNAL			English	Article																		BIRTCHNELL J, 1988, BRIT J PSYCHIAT, V153, P56, DOI 10.1192/bjp.153.1.56; Coleman Alice, 1985, UTOPIA TRIAL VISION; FANNING DM, 1967, BRIT MED J, V4, P382, DOI 10.1136/bmj.4.5576.382; GOODMAN M, 1974, J R SOC HLTH, V94, P165; HANNAY DR, 1981, J CHRON DIS, V34, P431, DOI 10.1016/0021-9681(81)90001-1; Hill B.W., 1988, ROBERT HARLEY SPEAKE, p[42, 153]; HILLIER B, 1986, ARCHITECTS J    0709, P39; MARTIN F M, 1957, Br J Prev Soc Med, V11, P196; Newman O., 1972, DEFENSIBLE SPACE CRI; RICHMAN N, 1974, DEV MED CHILD NEUROL, V16, P53; 1987, ASBESTOS FACT PACK	11	14	14	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1990	300	6719					245	247		10.1136/bmj.300.6719.245	http://dx.doi.org/10.1136/bmj.300.6719.245			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL024	2106938	Green Published, Bronze			2022-12-28	WOS:A1990CL02400031
J	SEYMOUR, DG; GREEN, M; VAZ, FG				SEYMOUR, DG; GREEN, M; VAZ, FG			MAKING BETTER DECISIONS - CONSTRUCTION OF CLINICAL SCORING SYSTEMS BY THE SPIEGELHALTER-KNILLJONES APPROACH	BRITISH MEDICAL JOURNAL			English	Article									UNIV DUNDEE,DEPT MATH & COMP SCI,DUNDEE DD1 4HN,SCOTLAND; N TEES GEN HOSP,STOCKTON ON TEES,CLEVELAND,ENGLAND	University of Dundee; University Hospital of North Tees	SEYMOUR, DG (corresponding author), UNIV COLL CARDIFF,CARDIFF ROYAL INFIRM,DEPT GERIATR MED,W WING,CARDIFF CF2 1SZ,WALES.							ADAMS ID, 1986, BRIT MED J, V293, P800, DOI 10.1136/bmj.293.6550.800; CARD WI, 1981, INT J MAN MACH STUD, V14, P49, DOI 10.1016/S0020-7373(81)80032-6; DEDOMBAL FT, 1985, CLIN GASTROENTEROL, V14, P531; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; KNILLJONES RP, 1985, CLIN GASTROENTEROL, V14, P517; KNILLJONES RP, 1987, BRIT MED J, V295, P1392, DOI 10.1136/bmj.295.6610.1392; KNILLJONES RP, 1986, LECTURE NOTES MED IN, V28, P215; Sackett DL, 1985, CLIN EPIDEMIOLOGY BA; SEYMOUR DG, 1989, AGE AGEING, V18, P316, DOI 10.1093/ageing/18.5.316; SEYMOUR DG, 1988, THESIS U BIRMINGHAM; SEYMOUR DG, 1986, MED ASSESSMENT ELDER; SIMEL DL, 1985, LANCET, V1, P329; Spiegelhalter D.J., 1986, ARTIF INTELL, P17; SPIEGELHALTER DJ, 1985, CLIN GASTROENTEROL, V14, P489; SPIEGELHALTER DJ, 1984, J R STAT SOC A STAT, V147, P35, DOI 10.2307/2981737; SPIEGELHALTER DJ, 1986, STAT MED, V5, P421, DOI 10.1002/sim.4780050506; VAZ FG, 1989, AGE AGEING, V18, P309, DOI 10.1093/ageing/18.5.309; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306	18	42	43	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1990	300	6719					223	226		10.1136/bmj.300.6719.223	http://dx.doi.org/10.1136/bmj.300.6719.223			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL024	2106929	Bronze, Green Published			2022-12-28	WOS:A1990CL02400019
J	COLLINS, CD				COLLINS, CD			CONTRIBUTION OF REGIONAL SPECIALTY SUBCOMMITTEES TO ORGANIZING AUDIT	BRITISH MEDICAL JOURNAL			English	Article											COLLINS, CD (corresponding author), TAUNTON & SOMERSET HOSP,DEPT SURG,SOMERSET TA1 5DA,ENGLAND.							1989, CMD555; 1989, GUIDELINES CLIN AUDI	2	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					94	95		10.1136/bmj.300.6717.94	http://dx.doi.org/10.1136/bmj.300.6717.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105784	Green Published, Bronze			2022-12-28	WOS:A1990CJ08000021
J	WATSON, JM; GILL, ON				WATSON, JM; GILL, ON			HIV INFECTION AND TUBERCULOSIS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									COMMUN DIS SURVEILLANCE CTR, PUBL HLTH LAB SERV, CTR AIDS, LONDON NW9 5EQ, ENGLAND	Public Health England	WATSON, JM (corresponding author), COMMUN DIS SURVEILLANCE CTR, RESP DIS SECT, LONDON NW9 5EQ, ENGLAND.							ADLER MW, 1987, BMJ-BRIT MED J, V294, P1083, DOI 10.1136/bmj.294.6579.1083; BRAUN MM, 1989, JAMA-J AM MED ASSOC, V261, P393, DOI 10.1001/jama.261.3.393; CHAISSON RE, 1987, AM REV RESPIR DIS, V136, P570, DOI 10.1164/ajrccm/136.3.570; DARBYSHIRE JH, 1989, BRIT MED J, V299, P874, DOI 10.1136/bmj.299.6704.874; DOBLE N, 1985, BRIT MED J, V291, P849, DOI 10.1136/bmj.291.6499.849; GOLDMAN KP, 1987, BRIT MED J, V295, P511, DOI 10.1136/bmj.295.6597.511; HELBERT M, IN PRESS THORAX; LOUIE E, 1986, CHEST, V90, P542, DOI 10.1378/chest.90.4.542; MILLER D, 1987, BRIT MED J, V294, P1671, DOI 10.1136/bmj.294.6588.1671; PITCHENIK AE, 1984, ANN INTERN MED, V101, P641, DOI 10.7326/0003-4819-101-5-641; REICHMAN LB, 1979, ARCH INTERN MED, V139, P337, DOI 10.1001/archinte.139.3.337; RIEDER HL, 1989, JAMA-J AM MED ASSOC, V262, P385, DOI 10.1001/jama.262.3.385; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; SUNDERAM G, 1986, JAMA-J AM MED ASSOC, V256, P362, DOI 10.1001/jama.256.3.362; WATSON JM, 1988, THORAX, V43, pP855; 1986, MMWR, V35, P587; 1983, BRIT MED J, V287, P1118; 1987, MMWR S1S, V36, pS1; 1989, MMWR, V38, P256; 1987, MMWR, V36, P785; 1989, MMWR, V38, P236; 1989, WHOGPAINF894 INT UN; 1985, BRIT MED J, V291, P658; 1986, MMWR, V35, P74; 1987, MMWR, V36, P133; 1988, IMMUNISATION INFECTI; 1985, MMWR, V34, P227	27	43	43	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 13	1990	300	6717					63	65		10.1136/bmj.300.6717.63	http://dx.doi.org/10.1136/bmj.300.6717.63			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105772	Green Published, Bronze			2022-12-28	WOS:A1990CJ08000003
J	BONIFACE, JJ; REICHERT, LE				BONIFACE, JJ; REICHERT, LE			EVIDENCE FOR A NOVEL THIOREDOXIN-LIKE CATALYTIC PROPERTY OF GONADOTROPIC-HORMONES	SCIENCE			English	Article									UNION UNIV,DEPT BIOCHEM,ALBANY,NY 12208	Union College					NICHD NIH HHS [HD-13938] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD013938] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSEN TT, 1983, MOL CELL ENDOCRINOL, V33, P37, DOI 10.1016/0303-7207(83)90055-2; CHENG KW, 1975, BIOCHEM J, V149, P123, DOI 10.1042/bj1490123; CLARK S, 1983, J BIOL CHEM, V258, P1434; CREIGHTON TE, 1980, J MOL BIOL, V142, P43, DOI 10.1016/0022-2836(80)90205-3; CROOK EM, 1960, BIOCHEM J, V74, P234, DOI 10.1042/bj0740234; CZECH MP, 1976, J CELL PHYSIOL, V89, P661, DOI 10.1002/jcp.1040890424; DATTATREYAMURTY B, 1983, J BIOL CHEM, V258, P3140; DATTATREYAMURTY B, IN PRESS J BIOL CHEM; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; EKLUND H, 1984, EMBO J, V3, P1443, DOI 10.1002/j.1460-2075.1984.tb01994.x; GORDON WL, 1985, LUTEINIZING HORMONE, P174; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; KATIKINENI M, 1980, ENDOCRINOLOGY, V107, P1980, DOI 10.1210/endo-107-6-1980; KRYSTEK SR, 1985, ENDOCRINOLOGY, V117, P1110, DOI 10.1210/endo-117-3-1110; KUHL PW, 1985, EXPERIENTIA, V41, P1118; LIM CJ, 1986, J BACTERIOL, V168, P1258, DOI 10.1128/jb.168.3.1258-1264.1986; LOOSFELT H, 1989, SCIENCE, V245, P525, DOI 10.1126/science.2502844; MACFARLAND KC, 1989, SCIENCE, V245, P494; PETERSON DA, 1988, PROSTAGLANDINS, V36, P667, DOI 10.1016/0090-6980(88)90012-3; PETERSON DA, 1982, SCIENCE, V215, P71, DOI 10.1126/science.6274020; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; PIGIET VP, 1986, P NATL ACAD SCI USA, V83, P7643, DOI 10.1073/pnas.83.20.7643; RATHNAM P, 1982, BIOCHIM BIOPHYS ACTA, V708, P160, DOI 10.1016/0167-4838(82)90216-3; Reichert L E Jr, 1975, Methods Enzymol, V37, P360; REICHERT LE, 1969, J BIOL CHEM, V244, P5110; REICHERT LE, 1989, BIOL REPROD, V40, P13, DOI 10.1095/biolreprod40.1.13; ROBILLARD GT, 1982, EUR J BIOCHEM, V127, P597; ROBINSON G G W, 1971, Colorado Division of Game Fish and Parks Special Report, P1; SAVIOLAKIS GA, 1981, J BIOL CHEM, V256, P4924; SHIN J, 1985, J BIOL CHEM, V260, P2828; SIGAFOOS JF, 1986, ENDOCRINOLOGY, V119, P1432, DOI 10.1210/endo-119-4-1432; SMITH RA, 1986, J BIOL CHEM, V261, P9850; SOJAR HT, 1989, J BIOL CHEM, V264, P2552; SUTTAJIT M, 1971, J BIOL CHEM, V246, P3405; TAGAYA Y, 1989, EMBO J, V8, P757, DOI 10.1002/j.1460-2075.1989.tb03436.x; WEARE JA, 1979, J BIOL CHEM, V254, P6964; WOLLMAN EE, 1988, J BIOL CHEM, V263, P15506; YAMADA K, 1985, BIOCHEM J, V228, P383, DOI 10.1042/bj2280383; ZHANG SB, 1988, MOL ENDOCRINOL, V122, P148	39	102	102	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 5	1990	247	4938					61	64		10.1126/science.2104678	http://dx.doi.org/10.1126/science.2104678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG620	2104678				2022-12-28	WOS:A1990CG62000035
J	SHAUGHNESSY, PW; KRAMER, AM				SHAUGHNESSY, PW; KRAMER, AM			THE INCREASED NEEDS OF PATIENTS IN NURSING-HOMES AND PATIENTS RECEIVING HOME HEALTH-CARE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV COLORADO,SCH MED,DEPT INTERNAL MED,DENVER,CO 80202	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	SHAUGHNESSY, PW (corresponding author), UNIV COLORADO,HLTH SCI CTR,CTR HLTH SERV RES,SUITE 706,1355 S COLORADO BLVD,DENVER,CO 80222, USA.							AIKEN LH, 1984, NEW ENGL J MED, V311, P1196, DOI 10.1056/NEJM198411013111833; Beebe K, 1985, Health Care Financ Rev, V7, P117; BLUMENTHAL D, 1986, NEW ENGL J MED, V314, P722; CAIRL RE, 1984, FLORIDA PRENURSING H; FEDER J, 1987, NEW ENGL J MED, V317, P867, DOI 10.1056/NEJM198710013171405; FITZGERALD JF, 1988, NEW ENGL J MED, V319, P1392, DOI 10.1056/NEJM198811243192106; FRIES BE, 1985, MED CARE, V23, P110, DOI 10.1097/00005650-198502000-00002; FRIES BE, 1986, 114TH ANN M AM PUBL; GREENBERG J, 1983, ANAL RESPONSES MEDIC; IVERSON LH, 1986, DESCRIPTION ANAL STA; JENCKS SF, 1987, NEW ENGL J MED, V317, P679, DOI 10.1056/NEJM198709103171106; KANE RA, 1985, NEW ENGL J MED, V312, P1357, DOI 10.1056/NEJM198505233122105; Kemper P, 1987, Health Care Financ Rev, V8, P87; Knowlton J, 1982, Health Care Financ Rev, V3, P75; KOREN MJ, 1986, NEW ENGL J MED, V314, P917, DOI 10.1056/NEJM198604033141410; LEADER S, 1986, HOME HLTH BENEFITS M; Liu K, 1988, EFFECTS MEDICARES HO; LYLES YM, 1986, J AM GERIATR SOC, V34, P573, DOI 10.1111/j.1532-5415.1986.tb05762.x; MOON M, 1986, PRELIMINARY ANAL MED; Neu CR, 1988, POSTHOSPITAL CARE ME; OMENN GS, 1984, NEW ENGL J MED, V311, P1314, DOI 10.1056/NEJM198411153112011; PETTIGREW ML, 1988, HOME HEALTH CARE SER, V8, P75; ROWE JW, 1985, NEW ENGL J MED, V312, P827, DOI 10.1056/NEJM198503283121305; RUBENSTEIN LZ, 1984, NEW ENGL J MED, V311, P1664, DOI 10.1056/NEJM198412273112604; SHAUGHNESSY PW, 1985, INQUIRY-J HEALTH CAR, V22, P162; SHAUGHNESSY PW, 1987, FINDINGS CASE MIX QU; SMITS HL, 1984, NEW ENGL J MED, V311, P1612, DOI 10.1056/NEJM198412203112505; STERN RS, 1985, NEW ENGL J MED, V312, P621, DOI 10.1056/NEJM198503073121005; Sulvetta M B, 1986, Health Care Financ Rev, V7, P75; VLADECK BC, 1988, NEW ENGL J MED, V319, P1411, DOI 10.1056/NEJM198811243192109; 1985, HRD85110 GEN ACC OFF; 1986, PEMD8610 GEN ACC OFF; 1987, CURRENT POPULATI P25, V1000; 1984, CURRENT POPULATI P23, V138; 1984, NEW YORK STATE LONG	35	101	101	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 4	1990	322	1					21	27		10.1056/NEJM199001043220105	http://dx.doi.org/10.1056/NEJM199001043220105			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CG234	2104666	Bronze			2022-12-28	WOS:A1990CG23400005
J	IGLEHART, JK				IGLEHART, JK			THE FOOD-AND-DRUG-ADMINISTRATION AND ITS PROBLEMS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FEDERAL-REGULATION											KESSLER DA, 1987, NEW ENGL J MED, V317, P357, DOI 10.1056/NEJM198708063170606; KESSLER DA, 1990, JAMA-J AM MED ASSOC, V264, P2409, DOI 10.1001/jama.264.18.2409; SAMUEL FE, 1991, HEALTH AFFAIR, V10, P192, DOI 10.1377/hlthaff.10.1.192; 1991, ECRI EMERGENCY CARE; 1991, DEPARTMENT HLTH HUMA	5	4	4	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 18	1991	325	3					217	220		10.1056/NEJM199107183250322	http://dx.doi.org/10.1056/NEJM199107183250322			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW752	2052069				2022-12-28	WOS:A1991FW75200031
J	BUCKLEY, RH; SCHIFF, RI				BUCKLEY, RH; SCHIFF, RI			DRUG-THERAPY - THE USE OF INTRAVENOUS IMMUNE GLOBULIN IN IMMUNODEFICIENCY DISEASES	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NON-B-HEPATITIS; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PRIMARY HUMORAL IMMUNODEFICIENCY; CAPSULAR POLYSACCHARIDE ANTIGEN; ANTIBODY-DEFICIENCY SYNDROMES; IGG-SUBCLASS DEFICIENCY; INFLUENZAE TYPE-B; GAMMA-GLOBULIN; IMMUNOGLOBULIN PREPARATIONS; NON-A		DUKE UNIV, MED CTR, DEPT MICROBIOL & IMMUNOL, DURHAM, NC 27710 USA	Duke University	BUCKLEY, RH (corresponding author), DUKE UNIV, MED CTR, DEPT PEDIAT, BOX 2898, DURHAM, NC 27710 USA.		Buckley, Rebecca/AAB-1578-2019					AMBROSINO DM, 1988, J ALLERGY CLIN IMMUN, V81, P1175, DOI 10.1016/0091-6749(88)90887-1; AMMANN AJ, 1982, CLIN IMMUNOL IMMUNOP, V22, P60, DOI 10.1016/0090-1229(82)90022-8; [Anonymous], 1969, Lancet, V1, P163; APFELZWEIG R, 1987, J CLIN IMMUNOL, V7, P46, DOI 10.1007/BF00915424; BARANDUN S, 1986, VOX SANG, V51, P157, DOI 10.1111/j.1423-0410.1986.tb00235.x; BASS JL, 1983, NEW ENGL J MED, V309, P430; BERKMAN SA, 1990, ANN INTERN MED, V112, P278, DOI 10.7326/0003-4819-112-4-278; BESA EC, 1984, AM J MED, V76, P209, DOI 10.1016/0002-9343(84)90344-9; BJORKANDER J, 1988, AM J MED, V84, P107, DOI 10.1016/0002-9343(88)90016-2; Bjorkander J, 1986, Monogr Allergy, V20, P157; BRANIGAN EF, 1983, OBSTET GYNECOL, V61, pS47; BRUTON OC, 1952, PEDIATRICS, V9, P722; BUCKLEY RH, 1982, J CLIN IMMUNOL, V2, pS15, DOI 10.1007/BF00918362; BUCKLEY RH, 1972, AM J DIS CHILD, V124, P376, DOI 10.1001/archpedi.1972.02110150074014; BUNCH C, 1988, NEW ENGL J MED, V319, P902; BURKS AW, 1986, NEW ENGL J MED, V314, P560, DOI 10.1056/NEJM198602273140907; BUSSEL J, 1986, J CLIN IMMUNOL, V6, P50, DOI 10.1007/BF00915364; BUSSEL JB, 1986, PROG HEMOST THROMB, V8, P103; CALVELLI TA, 1986, PEDIATR INFECT DIS J, V5, pS207; CASTEELSVANDAELE M, 1990, NEW ENGL J MED, V323, P614; CHEHIMI J, 1987, BONE MARROW TRANSPL, V2, P395; CHRISTENSEN KK, 1986, PEDIATR INFECT DIS J, V5, pS189; CLARK JA, 1983, AM J CLIN PATHOL, V80, P210, DOI 10.1093/ajcp/80.2.210; COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034; Cohn EJ, 1940, J AM CHEM SOC, V62, P3396, DOI 10.1021/ja01869a032; Dwyer J M, 1987, Adv Intern Med, V32, P111; DWYER JM, 1988, PEDIATR INFECT DIS J, V7, pS30; Eibl M M, 1989, Immunodefic Rev, V1 Suppl, P1; EIBL MM, 1984, CLIN IMMUNOL IMMUNOP, V31, P151, DOI 10.1016/0090-1229(84)90200-9; ENGELHARD D, 1986, J PEDIATR-US, V108, P77, DOI 10.1016/S0022-3476(86)80772-7; FAHEY JL, 1963, AM J MED, V35, P698, DOI 10.1016/0002-9343(63)90140-2; GELFAND EW, 1988, MONOGR ALLERGY, V23, P177; GLOSER H, 1986, PEDIATR INFECT DIS J, V5, pS176; GUPTA A, 1986, AM J DIS CHILD, V140, P143, DOI 10.1001/archpedi.1986.02140160061033; HAMAMOTO Y, 1987, VOX SANG, V53, P65, DOI 10.1111/j.1423-0410.1987.tb04919.x; HANSON LA, 1986, VOX SANG, V51, P50, DOI 10.1111/j.1423-0410.1986.tb02008.x; HASHIMOTO F, 1986, CLIN EXP IMMUNOL, V65, P409; HEPPNER GH, 1976, ANNU REV PHARMACOL, V16, P367, DOI 10.1146/annurev.pa.16.040176.002055; HERRERA AM, 1989, J ALLERGY CLIN IMMUN, V84, P556, DOI 10.1016/0091-6749(89)90370-9; HOOFNAGLE JH, 1976, J LAB CLIN MED, V88, P102; JANEWAY CA, 1953, T ASSOC AM PHYSICIAN, V66, P200; JANEWAY CA, 1966, NEW ENGL J MED, V275, P826, DOI 10.1056/NEJM196610132751508; Janeway CA, 1970, IMMUNOGLOBULINS BIOL, P3; JAYNE DRW, 1991, LANCET, V337, P1137, DOI 10.1016/0140-6736(91)92797-6; JOHN TJ, 1979, LANCET, V1, P1074; KAWADA K, 1987, EXP HEMATOL, V15, P133; KISTLER P, 1962, VOX SANG, V7, P414, DOI 10.1111/j.1423-0410.1962.tb03274.x; KNUTSEN AP, 1981, J PEDIATR-US, V98, P420, DOI 10.1016/S0022-3476(81)80709-3; KOBAYASHI RH, 1990, PEDIATRICS, V85, P705; LANE HC, 1985, NEW ENGL J MED, V313, P79, DOI 10.1056/NEJM198507113130204; LEDERMAN HM, 1986, AM J MED, V81, P443, DOI 10.1016/0002-9343(86)90296-2; LEFRANC M-P, 1991, Immunodeficiency Reviews, V2, P265; LEVER AML, 1987, CLIN EXP IMMUNOL, V67, P441; LEVER AML, 1984, LANCET, V2, P1062; LUNDBLAD JL, 1987, J INFECTION, V15, P3, DOI 10.1016/S0163-4453(87)92414-5; MANKARIOUS S, 1988, J LAB CLIN MED, V112, P634; MCKINNEY RE, 1987, REV INFECT DIS, V9, P334; MOFENSON LM, 1991, NEW ENGL J MED, V325, P73, DOI 10.1056/NEJM199107113250201; MONTANARO A, 1984, AM J MED, V76, P67, DOI 10.1016/0002-9343(84)90322-X; OCHS HD, 1980, LANCET, V2, P1158; OCHS HD, 1985, LANCET, V1, P404; OCHS HD, 1984, AM J MED, V76, P78, DOI 10.1016/0002-9343(84)90324-3; PRINCE AM, 1986, LANCET, V1, P706; PRINCE AM, 1984, VOX SANG, V46, P36, DOI 10.1111/j.1423-0410.1984.tb00045.x; Roberton D M, 1987, Dev Biol Stand, V67, P273; ROBERTON DM, 1988, AUST PAEDIATR J, V24, P174; ROIFMAN CM, 1987, LANCET, V1, P1075; ROIFMAN CM, 1988, PEDIATR INFECT DIS J, V7, pS92; ROMER J, 1982, VOX SANG, V42, P74; ROMER J, 1982, VOX SANG, V42, P62; ROUSELL RH, 1988, VOX SANG, V54, P6, DOI 10.1111/j.1423-0410.1988.tb01605.x; Schiff R I, 1983, Birth Defects Orig Artic Ser, V19, P209; SCHIFF RI, 1986, REV INFECT DIS, V8, pS449; SCHIFF RI, 1986, J CLIN IMMUNOL, V6, P256, DOI 10.1007/BF00918706; SCHIFF RI, 1991, J ALLERGY CLIN IMMUN, V88, P61, DOI 10.1016/0091-6749(91)90301-4; SCHIFF RI, 1984, CLIN IMMUNOL IMMUNOP, V31, P13, DOI 10.1016/0090-1229(84)90185-5; SCHIFF RI, 1987, NATURE CELLULAR BIOC, P523; SCHMIDT AP, 1969, NEW ENGL J MED, V280, P188, DOI 10.1056/NEJM196901232800404; SCOTT MG, 1988, DIAGN CLIN IMMUNOL, V5, P241; SHACKELFORD PG, 1990, PEDIATR RES, V27, P16, DOI 10.1203/00006450-199001000-00004; SILK H, 1990, ANN ALLERGY, V64, P418; SILK HJ, 1990, ANN ALLERGY, V64, P21; SILVERMAN BA, 1985, AM J MED, V78, P728, DOI 10.1016/0002-9343(85)90275-X; SORENSEN RU, 1987, J ALLERGY CLIN IMMUN, V80, P810, DOI 10.1016/S0091-6749(87)80270-1; SORENSEN RU, 1984, AM J MED, V76, P83, DOI 10.1016/0002-9343(84)90325-5; STEELE RW, 1987, AM J MED SCI, V293, P69, DOI 10.1097/00000441-198702000-00001; Stiehm E R, 1988, Adv Pediatr, V35, P1; STIEHM ER, 1966, BLOOD-J HEMATOL, V28, P918, DOI 10.1182/blood.V28.6.918.918; STOHL W, 1986, J IMMUNOL, V136, P4407; SULLIVAN KM, 1990, NEW ENGL J MED, V323, P705, DOI 10.1056/NEJM199009133231103; TILLER TL, 1978, J PEDIATR-US, V92, P347, DOI 10.1016/S0022-3476(78)80417-X; UMETSU DT, 1985, NEW ENGL J MED, V313, P1247, DOI 10.1056/NEJM198511143132002; VYAS GN, 1968, LANCET, V2, P312; WALDMANN TA, 1969, PROG ALLERGY, V13, P1, DOI 10.1159/000287491; WEILAND O, 1986, LANCET, V1, P976; WELLS JV, 1977, CLIN IMMUNOL IMMUNOP, V8, P265, DOI 10.1016/0090-1229(77)90116-7; WELLS MA, 1986, TRANSFUSION, V26, P210, DOI 10.1046/j.1537-2995.1986.26286152919.x; WORDELL CJ, 1987, PHARMACOTHERAPY, V7, pS27; ZIEGLER EJ, 1991, NEW ENGL J MED, V324, P429, DOI 10.1056/NEJM199102143240701; 1982, B WORLD HEALTH ORGAN, V60, P43; 1989, IMMUNODEFIC REV, V1, P173	101	263	275	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 11	1991	325	2					110	117						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV522	2052044				2022-12-28	WOS:A1991FV52200007
J	GUYTON, AC				GUYTON, AC			BLOOD-PRESSURE CONTROL - SPECIAL ROLE OF THE KIDNEYS AND BODY-FLUIDS	SCIENCE			English	Article							SALT-INDUCED HYPERTENSION; LONG-TERM REGULATION; ARTERIAL-PRESSURE; SYSTEMS-ANALYSIS	The arterial pressure of the adult human rarely deviates from normal by more than 10 to 15 percent, during each day. To achieve such constancy, the body has a network of pressure control systems. Several are based on neural receptors that respond within seconds to help correct any abnormal pressure. The activities of these systems are followed within minutes by activation of hormonal controllers. Within hours or days, a kidney pressure control system is induced that increases body fluid volume when the pressure falls (or decreases the volume when the pressure rises). This kidney-fluid system is the dominant method of establishing long-term pressure control.			GUYTON, AC (corresponding author), UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT PHYSIOL & BIOPHYS,JACKSON,MS 39216, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL011678] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 11678-23] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRUNNER HR, 1985, J CARDIOVASC PHAR S1, V7, P2; COLEMAN TG, 1969, CIRC RES, V25, P152; CONN JW, 1972, ARCH INTERN MED, V130, P682, DOI 10.1001/archinte.130.5.682; CONN JW, 1966, J AMER MED ASSOC, V195, P21, DOI 10.1001/jama.1966.03100010077019; DECLUE JW, 1978, CIRC RES, V43, P503, DOI 10.1161/01.RES.43.4.503; DICKINSON CJ, 1959, LANCET, V2, P46; Dickinson CJ, 1991, NEUROGENIC HYPERTENS; DOBBS WA, 1971, AM J CARDIOL, V27, P507, DOI 10.1016/0002-9149(71)90413-9; DOUGLAS BH, 1964, AM J PHYSIOL, V207, P669, DOI 10.1152/ajplegacy.1964.207.3.669; GRANGER HJ, 1969, CIRC RES, V25, P379, DOI 10.1161/01.RES.25.4.379; GUYTON AC, 1952, FED PROC, V11, P61; GUYTON AC, 1972, AM J MED, V52, P584, DOI 10.1016/0002-9343(72)90050-2; GUYTON AC, 1948, AM J PHYSIOL, V154, P45, DOI 10.1152/ajplegacy.1948.154.1.45; GUYTON AC, 1974, CIRC RES, V35, P159, DOI 10.1161/01.RES.35.2.159; GUYTON AC, 1972, ANN BIOMED ENG, V1, P254, DOI 10.1007/BF02584211; Guyton AC, 1980, ARTERIAL PRESSURE HY; GUYTON AC, 1950, AM J PHYSIOL, V164, P351; GUYTON AC, 1967, PHYSICAL BASES CIRCU, P179; HALL JE, 1986, J HYPERTENS, V4, P387, DOI 10.1097/00004872-198608000-00001; Heymans C, 1934, CR SOC BIOL, V117, P252; Heymans C., 1958, REFLEXOGENIC AREAS C; KEZDI P, 1958, CIRCULATION, V17, P785, DOI 10.1161/01.CIR.17.4.785; KIMURA G, 1990, AM J HYPERTENS, V3, P854, DOI 10.1093/ajh/3.11.854; KIMURA G, 1987, HYPERTENSION, V10, P11, DOI 10.1161/01.HYP.10.1.11; KIMURA G, 1989, AM J HYPERTENS, V2, P532, DOI 10.1093/ajh/2.7.532; KIMURA G, 1986, J HYPERTENS, V4, pS192; LANGSTON JB, 1963, CIRC RES, V12, P508, DOI 10.1161/01.RES.12.5.508; MANNING RD, 1979, AM J PHYSIOL, V236, pR40, DOI 10.1152/ajpregu.1979.236.1.R40; MCCUBBIN JW, 1958, CIRCULATION, V17, P791, DOI 10.1161/01.CIR.17.4.791; MCCUBBIN JW, 1956, CIRC RES, V4, P205, DOI 10.1161/01.RES.4.2.205; PAGE IH, 1974, ANGIOTENSIN; SELKURT EE, 1949, AM J PHYSIOL, V159, P359; SHIPLEY RE, 1951, AM J PHYSIOL, V167, P676, DOI 10.1152/ajplegacy.1951.167.3.676; THOMPSON DD, 1952, AM J PHYSIOL, V168, P490, DOI 10.1152/ajplegacy.1952.168.2.490; NIH HL1167823 GRANT	35	697	740	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 28	1991	252	5014					1813	1816		10.1126/science.2063193	http://dx.doi.org/10.1126/science.2063193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU061	2063193				2022-12-28	WOS:A1991FU06100030
J	LOUDON, I				LOUDON, I			OBSTETRICS AND THE GENERAL-PRACTITIONER	BRITISH MEDICAL JOURNAL			English	Article											LOUDON, I (corresponding author), GREEN COLL,OXFORD OX2 6HG,ENGLAND.							ANDERSON EG, 1898, BMJ-BRIT MED J, V2, P927; BAIRD D, 1960, LANCET, V2, P609; BAIRD D, 1960, LANCET, V2, P557; Burton John, 1751, ESSAY COMPLETE NEW S; CAMPBELL R, 1987, WHERE BE BORN DEBATE; DEASE W, 1783, OBSERVATIONS MIDWIFE; EDIS AW, 1877, T OBSTETRICAL SOC LO, V19, P69; FARR W, 1870 79 REG GEN ANN; LEAVITT J, 1986, BROUGHT BED CHILDBIR, P213; LOUDON I, 1986, BMJ-BRIT MED J, V293, P606, DOI 10.1136/bmj.293.6547.606; LOUDON I, 1984, B HIST MED, V58, P347; Loudon I, 1988, Soc Hist Med, V1, P183, DOI 10.1093/shm/1.2.183; LOUDON I, 1987, BMJ-BRIT MED J, V295, P485, DOI 10.1136/bmj.295.6596.485; LOUDON I, 1986, MED HIST, V30, P1; MAUBRAY J, 1752, MIDWIFERY BROUGHT PE; PHAFF JML, 1986, PERINATAL HLTH SERVI, P117; TOOGOOD J, 1844, PROVINCIAL MED SURGI, V4, P103; Williams JW, 1912, J AMER MED ASSOC, V58, P1; WILLIAMS W, 1904, DEATH CHILDBED; Young J, 1936, AM J OBSTET GYNECOL, V31, P198, DOI 10.1016/S0002-9378(36)90430-1; 1928, TIMES           0305, P13; RECORD M FLINDERS SU; 1809, MED PHYSICAL J, V29, P382; 1892, PARLIAMENTARY PAPERS, V14; 1945, MEMORANDUM GOODENOUG; 1939, MEMORANDUM REPORT JO; 1934, TIMES           0623, P13; 1930, TIMES           1028, P15; 1932, MH6690 MIN HLTH; 1989, REPORT CONFIDENTAL E	30	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 3	1990	301	6754					703	707		10.1136/bmj.301.6754.703	http://dx.doi.org/10.1136/bmj.301.6754.703			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB580	2078220	Green Published, Bronze			2022-12-28	WOS:A1990EB58000011
J	KIM, SK; KAISER, D				KIM, SK; KAISER, D			C-FACTOR - A CELL CELL SIGNALING PROTEIN REQUIRED FOR FRUITING BODY MORPHOGENESIS OF M-XANTHUS	CELL			English	Article									STANFORD UNIV,MED CTR,SCH MED,DEPT DEV BIOL,STANFORD,CA 94305	Stanford University	KIM, SK (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT BIOCHEM,STANFORD,CA 94305, USA.			Kim, Seung/0000-0001-6135-7810	NIGMS NIH HHS [GM23441, GM07365] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023441, R37GM023441, T32GM007365] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DEVREOTES PN, 1983, ADV CYCLIC NUCLEOTID, P55; DOE CQ, 1985, DEV BIOL, V111, P206, DOI 10.1016/0012-1606(85)90446-4; FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; FOSTER TJ, 1981, CELL, V23, P201, DOI 10.1016/0092-8674(81)90285-3; GILL RE, 1986, J BACTERIOL, V168, P341, DOI 10.1128/jb.168.1.341-347.1986; HAGEN DC, 1978, DEV BIOL, V64, P284, DOI 10.1016/0012-1606(78)90079-9; HAGEN TJ, 1990, J BACTERIOL, V172, P15, DOI 10.1128/JB.172.1.15-23.1990; HODGKIN J, 1977, P NATL ACAD SCI USA, V74, P2938, DOI 10.1073/pnas.74.7.2938; JANSSEN GR, 1985, DEV BIOL, V112, P194, DOI 10.1016/0012-1606(85)90133-2; JEKEL PA, 1983, ANAL BIOCHEM, V134, P347, DOI 10.1016/0003-2697(83)90308-1; KAY RR, 1983, EUR J BIOCHEM, V136, P51, DOI 10.1111/j.1432-1033.1983.tb07703.x; KIM SK, 1990, IN PRESS P NATL ACAD; KROOS L, 1990, J BACTERIOL, V172, P484, DOI 10.1128/JB.172.1.484-487.1990; KROOS L, 1988, GENE DEV, V2, P1677, DOI 10.1101/gad.2.12a.1677; KROOS L, 1984, P NATL ACAD SCI-BIOL, V81, P5816, DOI 10.1073/pnas.81.18.5816; KROOS L, 1987, GENE DEV, V1, P840, DOI 10.1101/gad.1.8.840; KROOS L, 1986, DEV BIOL, V117, P252, DOI 10.1016/0012-1606(86)90368-4; KUNER JM, 1982, J BACTERIOL, V151, P458, DOI 10.1128/JB.151.1.458-461.1982; KUSPA A, 1986, DEV BIOL, V117, P267, DOI 10.1016/0012-1606(86)90369-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAROSSA R, 1983, J BACTERIOL, V153, P1394, DOI 10.1128/JB.153.3.1394-1404.1983; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; Murray J.D., 2003, BER DEUT BOT GES; PFEFFER SR, 1987, J CELL BIOL, V105, P229, DOI 10.1083/jcb.105.1.229; SCHALLER HC, 1981, P NATL ACAD SCI-BIOL, V78, P7000, DOI 10.1073/pnas.78.11.7000; SHIMKETS LJ, 1988, MOL GEN GENET, V211, P63, DOI 10.1007/BF00338394; SHIMKETS LJ, 1983, P NATL ACAD SCI-BIOL, V80, P1406, DOI 10.1073/pnas.80.5.1406; SHIMKETS LJ, 1982, J BACTERIOL, V152, P462; SHIMKETS LJ, 1981, DEV BIOL, V84, P51, DOI 10.1016/0012-1606(81)90369-9; SMITH JC, 1987, DEVELOPMENT, V99, P3; THALLER C, 1987, NATURE, V327, P625, DOI 10.1038/327625a0; WIREMAN JW, 1975, SCIENCE, V189, P516, DOI 10.1126/science.806967; [No title captured]	34	178	180	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	APR 6	1990	61	1					19	26		10.1016/0092-8674(90)90211-V	http://dx.doi.org/10.1016/0092-8674(90)90211-V			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CY382	2107980				2022-12-28	WOS:A1990CY38200006
J	PETTERSSON, S; COOK, GP; BRUGGEMANN, M; WILLIAMS, GT; NEUBERGER, MS				PETTERSSON, S; COOK, GP; BRUGGEMANN, M; WILLIAMS, GT; NEUBERGER, MS			A 2ND B-CELL-SPECIFIC ENHANCER 3' OF THE IMMUNOGLOBULIN HEAVY-CHAIN LOCUS	NATURE			English	Article									MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND	MRC Laboratory Molecular Biology			Pettersson, Sven/F-9511-2015	Cook, Graham/0000-0003-0223-3652				AGUILERA RJ, 1985, EMBO J, V4, P3689, DOI 10.1002/j.1460-2075.1985.tb04136.x; ALT FW, 1987, SCIENCE, V238, P1079, DOI 10.1126/science.3317825; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; BRUGGEMANN M, 1986, P NATL ACAD SCI USA, V83, P6075, DOI 10.1073/pnas.83.16.6075; BRUGGEMANN M, 1988, GENE, V74, P473, DOI 10.1016/0378-1119(88)90180-1; CROCE CM, 1987, CELL, V49, P155, DOI 10.1016/0092-8674(87)90552-6; DREYFUS M, 1987, EMBO J, V6, P1685, DOI 10.1002/j.1460-2075.1987.tb02418.x; ECKHARDT LA, 1985, MOL CELL BIOL, V5, P856, DOI 10.1128/MCB.5.4.856; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; GERSTER T, 1987, EMBO J, V6, P1323, DOI 10.1002/j.1460-2075.1987.tb02371.x; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; GROSSCHEDL R, 1988, CELL, V55, P646; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KLEIN S, 1984, EMBO J, V3, P2473, DOI 10.1002/j.1460-2075.1984.tb02158.x; KLEIN S, 1985, NUCLEIC ACIDS RES, V13, P8901, DOI 10.1093/nar/13.24.8901; MASON JO, 1985, CELL, V41, P479, DOI 10.1016/S0092-8674(85)80021-0; MEYER KB, 1989, EMBO J, V8, P1959, DOI 10.1002/j.1460-2075.1989.tb03601.x; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NEUBERGER MS, 1983, NATURE, V305, P240, DOI 10.1038/305240a0; NEUBERGER MS, 1983, EMBO J, V2, P1373, DOI 10.1002/j.1460-2075.1983.tb01594.x; PEAR WS, 1988, MOL CELL BIOL, V8, P441, DOI 10.1128/MCB.8.1.441; Pettersson S, 1989, Int Immunol, V1, P509, DOI 10.1093/intimm/1.5.509; SCHAFFNER W, 1988, NATURE, V336, P427, DOI 10.1038/336427a0; WABL MR, 1984, P NATL ACAD SCI-BIOL, V81, P2452, DOI 10.1073/pnas.81.8.2452; WIRTH T, 1987, NATURE, V329, P174, DOI 10.1038/329174a0	25	207	239	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 8	1990	344	6262					165	168		10.1038/344165a0	http://dx.doi.org/10.1038/344165a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT095	2106628				2022-12-28	WOS:A1990CT09500074
J	ASHLEYMILLER, M				ASHLEYMILLER, M			COMMUNITY CARE - RESEARCH STUDIES ARE ESSENTIAL	BRITISH MEDICAL JOURNAL			English	Editorial Material											ASHLEYMILLER, M (corresponding author), NUFFIELD PROV HOSP TRUST,LONDON NW1 7SP,ENGLAND.		Chan, Cecilia Lai Wan/D-4931-2009; Wong, Kam Pun/D-4950-2009					BANHAM BJ, 1989, COMMUNITY CARE PARTN; Blaxter M., 1976, MEANING DISABILITY; DANT T, 1989, COORDINATING CARE; LIVESLEY B, 1989, BRIT MED J, V299, P1, DOI 10.1136/bmj.299.6690.1; MACLEAN U, 1989, DEPENDENT TERRITORIE; STOWE K, 1989, CARING NATIONAL HLTH; 1989, CMND902; 1989, CMND849; 1983, POPULATION PROJECTIO; 1989, CMND555; 1988, 3RD LORDS SEL COMM S	11	3	3	1	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	1990	300	6723					487	488		10.1136/bmj.300.6723.487	http://dx.doi.org/10.1136/bmj.300.6723.487			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	2107924	Bronze, Green Published			2022-12-28	WOS:A1990CQ87800005
J	ODONNELL, LJD; VIRJEE, J; HEATON, KW				ODONNELL, LJD; VIRJEE, J; HEATON, KW			DETECTION OF PSEUDODIARRHEA BY SIMPLE CLINICAL-ASSESSMENT OF INTESTINAL TRANSIT RATE	BMJ-BRITISH MEDICAL JOURNAL			English	Article									BRISTOL ROYAL INFIRM & GEN HOSP, DEPT MED, BRISTOL BS2 8HW, AVON, ENGLAND; BRISTOL ROYAL INFIRM & GEN HOSP, DEPT RADIOL, BRISTOL BS2 8HW, AVON, ENGLAND	Bristol Royal Infirmary; Bristol Royal Infirmary								CUMMINGS JH, 1976, GUT, V17, P219, DOI 10.1136/gut.17.3.219; DAVIES GJ, 1986, GUT, V27, P164, DOI 10.1136/gut.27.2.164; MANNING AP, 1978, BRIT MED J, V2, P653, DOI 10.1136/bmj.2.6138.653; Metcalf AM, 1987, GASTROENTEROLOGY, V92, P40, DOI 10.1016/0016-5085(87)90837-7; RAO SSC, 1988, GUT, V29, P342, DOI 10.1136/gut.29.3.342	5	337	357	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	1990	300	6722					439	440		10.1136/bmj.300.6722.439	http://dx.doi.org/10.1136/bmj.300.6722.439			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP166	2107897	Green Published, Bronze			2022-12-28	WOS:A1990CP16600022
J	LOWRY, S				LOWRY, S			HOUSING AND HEALTH - GETTING THINGS DONE	BRITISH MEDICAL JOURNAL			English	Editorial Material																		BLACKMAN T, 1987, HOUSING HLTH W BELFA; GRAHAM D, 1986, DIVIS REPORT SET THE; Robertson D. S., 1989, Health Promotion, V4, P159, DOI 10.1093/heapro/4.2.159; 1978, HLTH ALL SERIES WHO, V1; 1987, EASTHALL HARD HEAT H	5	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					390	392		10.1136/bmj.300.6721.390	http://dx.doi.org/10.1136/bmj.300.6721.390			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106998	Bronze, Green Published			2022-12-28	WOS:A1990CN79900032
J	CACERES, A; KOSIK, KS				CACERES, A; KOSIK, KS			INHIBITION OF NEURITE POLARITY BY TAU ANTISENSE OLIGONUCLEOTIDES IN PRIMARY CEREBELLAR NEURONS	NATURE			English	Article									HARVARD UNIV,SCH MED,DEPT NEUROL NEUROSCI,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,DIV NEUROL,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital								CHOREY J, 1989, CURRENT PROTOCOLS MO, V1; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; FERREIRA A, 1987, DEV BRAIN RES, V34, P9, DOI 10.1016/0165-3806(87)90191-X; FERREIRA A, 1989, DEV BRAIN RES, V49, P215, DOI 10.1016/0165-3806(89)90023-0; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; JAHN R, 1984, P NATL ACAD SCI-BIOL, V81, P1684, DOI 10.1073/pnas.81.6.1684; KOSIK KS, 1988, J NEUROCHEM, V51, P587, DOI 10.1111/j.1471-4159.1988.tb01079.x; KOSIK KS, 1987, J NEUROSCI, V7, P3142; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514; LOKE SL, 1989, P NATL ACAD SCI USA, V86, P3474, DOI 10.1073/pnas.86.10.3474; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; OKABE S, 1988, J CELL BIOL, V107, P651, DOI 10.1083/jcb.107.2.651; TABOR S, 1989, CURRENT PROTOCOLS MO, V1	15	583	595	0	18	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 1	1990	343	6257					461	463		10.1038/343461a0	http://dx.doi.org/10.1038/343461a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL818	2105469				2022-12-28	WOS:A1990CL81800060
J	LOGUE, FC; BEASTALL, GH; FRASER, WD; OREILLY, DS				LOGUE, FC; BEASTALL, GH; FRASER, WD; OREILLY, DS			INTACT PARATHYROID-HORMONE ASSAYS	BRITISH MEDICAL JOURNAL			English	Editorial Material											LOGUE, FC (corresponding author), GLASGOW ROYAL INFIRM,INST BIOCHEM,ENDOCRINE SECT,GLASGOW G4 0SF,SCOTLAND.							BERSON SA, 1963, P NATL ACAD SCI USA, V49, P613, DOI 10.1073/pnas.49.5.613; BROWN EM, 1983, J CLIN ENDOCR METAB, V56, P572, DOI 10.1210/jcem-56-3-572; BROWN RC, 1987, J CLIN ENDOCR METAB, V65, P407, DOI 10.1210/jcem-65-3-407; LOGUE FC, 1989, J ENDOCRINOL, V121, pR1, DOI 10.1677/joe.0.121R001; LOGUE FC, 1989, P NATIONAL M LONDON, P78; LOGUE FC, 1989, J ENDOCRINOL S, V121, P157; LOGUE FC, 1988, J ENDOCRINOLOGY S, V117, P67; LUNDBERG PA, 1989, CLIN CHEM, V35, P340; NEWMAN DJ, 1988, ANN CLIN BIOCHEM, V25, P654, DOI 10.1177/000456328802500610; NUSSBAUM SR, 1987, CLIN CHEM, V33, P1364; RATCLIFFE WA, 1989, P NATIONAL M ASS CLI, P79; SILVERMAN R, 1973, J CLIN INVEST, V52, P1958, DOI 10.1172/JCI107380; VANDERMERWE W, 1988, SCOTTISH RENAL A OCT, P9	13	16	16	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1990	300	6719					210	211		10.1136/bmj.300.6719.210	http://dx.doi.org/10.1136/bmj.300.6719.210			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL024	2106926	Green Published, Bronze			2022-12-28	WOS:A1990CL02400004
J	SMITS, A; MANSFIELD, S; SINGH, S				SMITS, A; MANSFIELD, S; SINGH, S			FACILITATING CARE OF PATIENTS WITH HIV-INFECTION BY HOSPITAL AND PRIMARY CARE TEAMS	BRITISH MEDICAL JOURNAL			English	Article									LONDON LIGHTHOUSE,LONDON W11 1QT,ENGLAND; ST MARYS HOSP,LONDON W2 1NY,ENGLAND	Imperial College London								ADLER MW, 1987, BRIT MED J, V295, P27, DOI 10.1136/bmj.295.6589.27; Anand J K, 1989, Health Trends, V21, P46; ANDERSON P, 1988, BRIT MED J, V296, P535, DOI 10.1136/bmj.296.6621.535; BATES T, 1981, LANCET, V1, P1201, DOI 10.1016/S0140-6736(81)92361-8; BOULD M, 1989, AIDS MODELS CARE; BOYTON R, 1988, BRIT MED J, V296, P538, DOI 10.1136/bmj.296.6621.538; COX DR, 1988, SHORT TERM PREDICTIO; CUNNINGHAM D, 1987, BRIT MED J, V295, P921, DOI 10.1136/bmj.295.6603.921; HARDING J, 1987, J ROY COLL GEN PRACT, V37, P494; HODGKIN P, 1988, BRIT MED J, V296, P5; King M B, 1987, Health Trends, V19, P1; KING MB, 1988, BRIT MED J, V297, P182, DOI 10.1136/bmj.297.6642.182; MANSFIELD SJ, 1989, J ROY COLL GEN PRACT, V39, P104; MILNE GRG, 1988, BRIT MED J, V296, P533; NEVILLE RG, 1987, J ROY COLL GEN PRACT, V37, P496; ROBERTSON JR, 1988, LANCET, V1, P422; SEARLE ES, 1987, LANCET, V1, P26; SIBBALD B, 1988, J ROY COLL GEN PRACT, V38, P500; STOTTER A, 1989, BRIT MED J, V298, P536, DOI 10.1136/bmj.298.6672.536; 1987, DH120 OFF POP CENS S; 1989, LANCET, V2, P778	21	30	30	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1990	300	6719					241	243		10.1136/bmj.300.6719.241	http://dx.doi.org/10.1136/bmj.300.6719.241			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL024	2106936	Green Published, Bronze			2022-12-28	WOS:A1990CL02400029
J	HEWITT, PE; MACHIN, SJ				HEWITT, PE; MACHIN, SJ			ABC OF TRANSFUSION - MASSIVE BLOOD-TRANSFUSION	BRITISH MEDICAL JOURNAL			English	Article									MIDDLESEX HOSP,LONDON W1,ENGLAND	University of London; University College London	HEWITT, PE (corresponding author), N LONDON BLOOD TRANSFUS CTR,LONDON,ENGLAND.								0	25	28	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					107	109		10.1136/bmj.300.6717.107	http://dx.doi.org/10.1136/bmj.300.6717.107			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	2105753	Bronze, Green Published			2022-12-28	WOS:A1990CJ08000024
J	STEVENS, CE; TAYLOR, PE; PINDYCK, J; CHOO, QL; BRADLEY, DW; KUO, G; HOUGHTON, M				STEVENS, CE; TAYLOR, PE; PINDYCK, J; CHOO, QL; BRADLEY, DW; KUO, G; HOUGHTON, M			EPIDEMIOLOGY OF HEPATITIS-C VIRUS - A PRELIMINARY-STUDY IN VOLUNTEER BLOOD-DONORS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									INTERFAITH MED CTR,BROOKLYN,NY; CHIRON CORP,EMERYVILLE,CA; CTR DIS CONTROL,ATLANTA,GA 30333	Novartis; Centers for Disease Control & Prevention - USA	STEVENS, CE (corresponding author), NEW YORK BLOOD CTR,WOLF SZMUNESS LAB EPIDEMIOL,310 E 67TH ST,NEW YORK,NY 10021, USA.				NHLBI NIH HHS [N01-HB-3-7011] Funding Source: Medline; DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB037011] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AACH RD, 1981, NEW ENGL J MED, V304, P989, DOI 10.1056/NEJM198104233041701; Aach RD, 1978, VIRAL HEPATITIS, P383; ALTER HJ, 1981, JAMA-J AM MED ASSOC, V246, P630, DOI 10.1001/jama.246.6.630; ALTER HJ, 1972, ANN INTERN MED, V77, P691, DOI 10.7326/0003-4819-77-5-691; ALTER HJ, 1975, LANCET, V2, P838, DOI 10.1016/S0140-6736(75)90234-2; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; HOLLINGER FB, 1982, VIRAL HEPATITIS, P361; KNODELL RG, 1976, LANCET, V1, P557; KOZIOL DE, 1986, ANN INTERN MED, V104, P488, DOI 10.7326/0003-4819-104-4-488; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; PRINCE AM, 1974, LANCET, V2, P241; SEEFF LB, 1977, GASTROENTEROLOGY, V72, P111; STEVENS CE, 1984, ANN INTERN MED, V101, P733, DOI 10.7326/0003-4819-101-6-733; ZUCK TF, 1987, TRANSFUSION, V27, P203, DOI 10.1046/j.1537-2995.1987.27287150202.x	14	266	267	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 5	1990	263	1					49	53		10.1001/jama.263.1.49	http://dx.doi.org/10.1001/jama.263.1.49			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CF777	2104548				2022-12-28	WOS:A1990CF77700022
J	HIMMELSTEIN, DU; WOOLHANDLER, S				HIMMELSTEIN, DU; WOOLHANDLER, S			WHO CARES FOR THE CARE GIVERS - LACK OF HEALTH-INSURANCE AMONG HEALTH AND INSURANCE PERSONNEL	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note								Objective. - To analyze the health insurance status of physicians, other health personnel, and insurance industry personnel. Design. - The study was based on data collected by the US Bureau of the Census in the March 1991 Current Population Survey for six groups of workers in health care occupations and three classifications of insurance employees. This survey included 6182 civilian health personnel and 1498 insurance workers under the age of 65 years. Results. - Of civilian health personnel under the age of 65 years, 9% (90% confidence interval [Cl], 8.2% to 9.8%) are uninsured, equivalent to 834 000 persons, including 15 000 (90% Cl, 5000 to 25 000) physicians. Among insurance workers, 5.1% (90% Cl, 3.9% to 6.2%) are uninsured. While 6% (90% Cl, 4.2% to 7.9%) of those working in physicians' offices are uninsured, 52.2% (90% Cl, 48.2% to 56.3%) receive no employer contribution toward their coverage. More than a fifth of nursing home employees lack insurance coverage, as do nearly a quarter of the 1.868 million health care workers with annual incomes less than $10 000. Conclusion. - Nearly a million health care and insurance workers are themselves uninsured and at high risk for being unable to obtain needed care.	PUBL CITIZEN HLTH RES GRP,WASHINGTON,DC; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Harvard Medical School	HIMMELSTEIN, DU (corresponding author), CAMBRIDGE HOSP,CTR NATL HLTH PROGRAM STUDIES,DEPT MED,1493 CAMBRIDGE ST,CAMBRIDGE,MA 02139, USA.							GRUMBACH K, 1991, JAMA-J AM MED ASSOC, V265, P2549, DOI 10.1001/jama.265.19.2549; 1990, MONEY INCOME POVERTY; 1990, CURRENT POPULATION S; 1990, 17 1795130013190CR D	4	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 17	1991	266	3					399	401		10.1001/jama.266.3.399	http://dx.doi.org/10.1001/jama.266.3.399			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV960	2056649				2022-12-28	WOS:A1991FV96000031
J	FRAZIER, LM; BROWN, JT; DIVINE, GW; FLEMING, GR; PHILIPS, NM; SIEGAL, WC; KHAYRALLAH, MA				FRAZIER, LM; BROWN, JT; DIVINE, GW; FLEMING, GR; PHILIPS, NM; SIEGAL, WC; KHAYRALLAH, MA			CAN PHYSICIAN EDUCATION LOWER THE COST OF PRESCRIPTION DRUGS - A PROSPECTIVE, CONTROLLED TRIAL	ANNALS OF INTERNAL MEDICINE			English	Article							GENERIC PHARMACEUTICALS; MILD HYPERTENSION; LIPID PROFILE; THERAPY; PRICE	Objective: To determine whether an educational program featuring a drug cost manual can assist physicians in reducing their patients' out-of-pocket prescription drug expenses. Design: Prospective controlled trial. Setting: A general internal medicine-teaching clinic in a university hospital. Participants: Fifty-one medical interns. Intervention: Thirty-one interns received a manual of comparative drug prices annotated with prescribing advice, two feedback reports, and weekly cost-oriented prescribing reminders. A control group concurrently participated in a manual-based educational program on cholesterol management. Measurements: Copies of 3012 prescriptions written over 8 months were analyzed. Main Results: Intervention group physicians prescribed less expensive drugs within classes of drugs. The change in drug price score per prescription was -0.15 (95% Cl, - 0.27 to - 0.04; P = 0.01). A score of 3 was assigned to the most expensive, 2 was assigned to intermediate-priced, and 1 was assigned to the least expensive drug or drugs in the class. An increase of 0.74 months' (Cl, 0.49 to 0.98; P < 0.001) supply of medication was dispensed per prescription, reducing dispensing fees. The program was well accepted by the physicians. Conclusion: This relatively simple educational intervention can help physicians to reduce their patients' drug expenses and may serve as a model for incorporating cost information into the routine practice of medicine.	UNIV N CAROLINA, SCH EDUC, CHAPEL HILL, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	FRAZIER, LM (corresponding author), DUKE UNIV, MED CTR, BOX 2914, DURHAM, NC 27710 USA.							AMES RP, 1987, AM HEART J, V114, P998, DOI 10.1016/0002-8703(87)90599-0; [Anonymous], 1981, JAMA, V246, P2073; [Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; [Anonymous], 1980, LANCET, V1, P1261; [Anonymous], 1970, JAMA, V213, P1143; AVORN J, 1986, JAMA-J AM MED ASSOC, V255, P357, DOI 10.1001/jama.255.3.357; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; BLOOM BS, 1986, JAMA-J AM MED ASSOC, V256, P2523, DOI 10.1001/jama.256.18.2523; BRICELAND LL, 1988, ARCH INTERN MED, V148, P2019, DOI 10.1001/archinte.148.9.2019; BRITTON HL, 1981, AM J HOSP PHARM, V38, P1897, DOI 10.1093/ajhp/38.12.1897; CARDINALE VA, 1988, DRUG TOPICS RED BOOK; CLAPHAM CE, 1988, AM J HOSP PHARM, V45, P2329, DOI 10.1093/ajhp/45.11.2329; CRAIG WA, 1978, ANN INTERN MED, V89, P793, DOI 10.7326/0003-4819-89-5-793; DURBIN WA, 1981, JAMA-J AM MED ASSOC, V246, P1796, DOI 10.1001/jama.246.16.1796; FAICH GA, 1987, NEW ENGL J MED, V316, P1473, DOI 10.1056/NEJM198706043162309; FRAZIER LM, 1986, N C MED J, V47, P115; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; GEHLBACH SH, 1984, MED CARE, V22, P193, DOI 10.1097/00005650-198403000-00002; GROOP L, 1985, EUR J CLIN PHARMACOL, V28, P697, DOI 10.1007/BF00607919; HELGELAND A, 1980, AM J MED, V69, P725, DOI 10.1016/0002-9343(80)90438-6; HOLTZMAN E, 1987, J CARDIOVASC PHARM, V10, pS86, DOI 10.1097/00005344-198706102-00026; Hypertension Detection Follow-up Program Cooperative Group, 1979, JAMA-J AM MED ASSOC, V242, P2562, DOI DOI 10.1001/JAMA.1979.03300230018021; KAPLAN NM, 1987, AM J MED, V82, P9, DOI 10.1016/0002-9343(87)90137-9; KLEIN LE, 1981, J MED EDUC, V56, P504; Kreling D H, 1989, Health Care Financ Rev, V10, P67; LASAGNA L, 1986, JAMA-J AM MED ASSOC, V256, P2566, DOI 10.1001/jama.1986.03380180128035; MARTON KI, 1985, ARCH INTERN MED, V145, P816, DOI 10.1001/archinte.145.5.816; NIGHTINGALE SL, 1987, JAMA-J AM MED ASSOC, V258, P1200, DOI 10.1001/jama.258.9.1200; PROSSER PR, 1985, AM J MED SCI, V289, P179, DOI 10.1097/00000441-198505000-00001; ROBERTS WC, 1987, AM J CARDIOL, V60, pE33; SAMUEL P, 1986, AM J CARDIOL, V57, pC24, DOI 10.1016/0002-9149(86)91023-4; SCHAFFNER W, 1983, JAMA-J AM MED ASSOC, V250, P1728, DOI 10.1001/jama.250.13.1728; SKILLMAN TG, 1981, AM J MED, V70, P361, DOI 10.1016/0002-9343(81)90773-7; SMITH WM, 1977, CIRC RES, V40, P98; Snedecor G W, 1967, STAT METHODS, P327; Stoudemire A, 1984, Psychiatr Med, V2, P211; STROM BL, 1987, NEW ENGL J MED, V316, P1456, DOI 10.1056/NEJM198706043162306; WALDO DR, 1989, HLTH CARE FINANC REV, V9, P83; WALLIN JD, 1987, ARCH INTERN MED, V147, P654, DOI 10.1001/archinte.147.4.654; WOODWARD RS, 1987, AM J MED, V83, P817, DOI 10.1016/0002-9343(87)90636-X; 1987, APPROVED DRUG PRODUC, P1	41	61	61	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	1991	115	2					116	121		10.7326/0003-4819-115-2-116	http://dx.doi.org/10.7326/0003-4819-115-2-116			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW091	2058859				2022-12-28	WOS:A1991FW09100008
J	ALLEN, PN; NOLLER, HF				ALLEN, PN; NOLLER, HF			A SINGLE BASE SUBSTITUTION IN 16S RIBOSOMAL-RNA SUPPRESSES STREPTOMYCIN DEPENDENCE AND INCREASES THE FREQUENCY OF TRANSLATIONAL ERRORS	CELL			English	Article							ESCHERICHIA-COLI; MUTATIONS; PROTEIN; MUTANTS; RESISTANT; SUBUNITS; DOMAIN	A C to U substitution at position 1469 of 16S ribosomal RNA (rRNA) from Escherichia coli suppresses streptomycin dependence and causes increased translational error frequencies. Strains containing the rpsL252 or StrM287 streptomycin-dependent alleles are able to grow in the absence of streptomycin when transformed with plasmids containing the U1469 mutation in 16S rRNA. Ribosomes containing wild-type proteins and U1469 mutant 16S rRNA misincorporate leucine in vitro at elevated levels, comparable to that of some typical S4 ram ribosomes. These results provide additional support for the participation of 16S rRNA in maintaining translational accuracy.			ALLEN, PN (corresponding author), UNIV CALIF SANTA CRUZ, SINSHEIMER LABS, SANTA CRUZ, CA 95064 USA.				NIGMS NIH HHS [GM-17129] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM017129, R37GM017129] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN PN, 1989, J MOL BIOL, V208, P457, DOI 10.1016/0022-2836(89)90509-3; ANDERSSON DI, 1982, MOL GEN GENET, V187, P467, DOI 10.1007/BF00332630; ANDERSSON DI, 1983, MOL GEN GENET, V191, P378, DOI 10.1007/BF00425749; BIRGE EA, 1970, MOL GEN GENET, V109, P356, DOI 10.1007/BF00267704; BJARE U, 1971, J MOL BIOL, V57, P423, DOI 10.1016/0022-2836(71)90101-X; BOHMAN K, 1984, MOL GEN GENET, V198, P90, DOI 10.1007/BF00328706; DAHLBERG AE, 1989, CELL, V57, P525, DOI 10.1016/0092-8674(89)90122-0; DOUTHWAITE S, 1985, P NATL ACAD SCI USA, V82, P8330, DOI 10.1073/pnas.82.24.8330; GREEN M, 1971, NATURE-NEW BIOL, V234, P273, DOI 10.1038/newbio234273a0; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HASENBANK R, 1973, MOL GEN GENET, V127, P1, DOI 10.1007/BF00267778; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; JELENC PC, 1980, ANAL BIOCHEM, V105, P369, DOI 10.1016/0003-2697(80)90472-8; JEMIOLO DK, 1985, NUCLEIC ACIDS RES, V13, P8631, DOI 10.1093/nar/13.23.8631; KIRSEBOM LA, 1985, P NATL ACAD SCI USA, V82, P717, DOI 10.1073/pnas.82.3.717; KORN AP, 1985, EUR J CELL BIOL, V39, P56; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; KURLAND CG, 1990, RIBOSOME, P513; MOAZED D, 1986, J MOL BIOL, V191, P483, DOI 10.1016/0022-2836(86)90143-9; MOORE PB, 1986, STRUCTURE FUNCTION G, P87; MURGOLA EJ, 1988, P NATL ACAD SCI USA, V85, P4162, DOI 10.1073/pnas.85.12.4162; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; NOLLER HF, 1990, RIBOSOME STRUCTURE F, P513; NOMURA M, 1969, COLD SPRING HARB SYM, V34, P49, DOI 10.1101/SQB.1969.034.01.009; OLSSON MO, 1979, MOL GEN GENET, V169, P251, DOI 10.1007/BF00382271; POWERS T, 1990, P NATL ACAD SCI USA, V87, P1042, DOI 10.1073/pnas.87.3.1042; REMAUT E, 1983, GENE, V22, P103, DOI 10.1016/0378-1119(83)90069-0; ROSSET R, 1969, J MOL BIOL, V39, P95, DOI 10.1016/0022-2836(69)90336-2; RUUSALA T, 1984, EMBO J, V3, P2575, DOI 10.1002/j.1460-2075.1984.tb02176.x; SANCHEZANZALDO FJ, 1974, MOL GEN GENET, V130, P47, DOI 10.1007/BF00270518; SCHROEDER AL, 1983, CAN J GENET CYTOL, V25, P16, DOI 10.1139/g83-003; SHEN ZH, 1989, NUCLEIC ACIDS RES, V17, P4535, DOI 10.1093/nar/17.12.4535; SIGMUND CD, 1988, METHOD ENZYMOL, V164, P673; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; STERN S, 1988, J MOL BIOL, V204, P447, DOI 10.1016/0022-2836(88)90588-8; Traub P, 1971, METHOD ENZYMOL, V20, P391; TRIMAN K, 1989, J MOL BIOL, V209, P645, DOI 10.1016/0022-2836(89)92000-7; WEISSBRUMMER B, 1989, MOL GEN GENET, V217, P362, DOI 10.1007/BF02464905; WOOD WB, 1962, P NATL ACAD SCI USA, V48, P94, DOI 10.1073/pnas.48.1.94	39	50	50	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 12	1991	66	1					141	148		10.1016/0092-8674(91)90146-P	http://dx.doi.org/10.1016/0092-8674(91)90146-P			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FW913	2070415				2022-12-28	WOS:A1991FW91300016
J	KIMHA, J; SMITH, JL; MACDONALD, PM				KIMHA, J; SMITH, JL; MACDONALD, PM			OSKAR MESSENGER-RNA IS LOCALIZED TO THE POSTERIOR POLE OF THE DROSOPHILA OOCYTE	CELL			English	Article							MATERNAL-EFFECT MUTATIONS; ANTEROPOSTERIOR POLARITY; ANTERIOR LOCALIZATION; BICOID RNA; GENE; EMBRYO; SEGMENTATION; SEQUENCE; PATTERN; MELANOGASTER	Mutants of the maternal posterior-group genes of Drosophila lack posterior body pattern elements and germ cells, both of which form through the action of determinants localized to the posterior pole of the oocyte. We report that transcripts of one of these genes, oskar, become localized to the posterior pole of oocytes shortly after the oocyte begins to differentiate visibly. Analysis of various posterior-group mutants reveals that localization of oskar mRNA is an early step in the posterior localization pathway. In addition, we find that nonsense oskar mutations disrupt osk mRNA localization, while missense oskar mutations do not.			KIMHA, J (corresponding author), STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305, USA.				NIGMS NIH HHS [GM42612] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042612] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; CASANOVA J, 1989, GENE DEV, V3, P2025, DOI 10.1101/gad.3.12b.2025; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; FROHNHOFER HG, 1987, GENE DEV, V1, P880, DOI 10.1101/gad.1.8.880; GUTZEIT HO, 1982, J EMBRYOL EXP MORPH, V67, P101; HAY B, 1988, DEVELOPMENT, V103, P625; HAY B, 1990, DEVELOPMENT, V109, P425; King R. C., 1970, OVARIAN DEV DROSOPHI; KLINGLER M, 1988, NATURE, V335, P275, DOI 10.1038/335275a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LASKI FA, 1986, CELL, V44, P7, DOI 10.1016/0092-8674(86)90480-0; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; LEHMANN R, 1987, DEV BIOL, V119, P402, DOI 10.1016/0012-1606(87)90045-5; LEHMANN R, 1987, NATURE, V329, P167, DOI 10.1038/329167a0; MACDONALD PM, 1988, NATURE, V336, P595, DOI 10.1038/336595a0; MACDONALD PM, 1986, CELL, V47, P721, DOI 10.1016/0092-8674(86)90515-5; Mahowald A.P., 1980, Genetics and Biology of Drosophila, V2d, P141; MAHOWALD AP, 1968, J EXP ZOOL, V167, P237, DOI 10.1002/jez.1401670211; MAHOWALD AP, 1962, J EXP ZOOL, V151, P201, DOI 10.1002/jez.1401510302; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; MOHLER J, 1986, GENETICS, V112, P803; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; PIROTTA V, 1988, VECTORS SURVEY MOL C, P437; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANDER K, 1988, NATURE, V335, P68, DOI 10.1038/335068a0; SCHUPBACH T, 1986, ROUX ARCH DEV BIOL, V195, P302, DOI 10.1007/BF00376063; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; STEPHENSON EC, 1988, GENE DEV, V2, P1655, DOI 10.1101/gad.2.12a.1655; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; STRECKER TR, 1989, SCIENCE, V243, P1062, DOI 10.1126/science.2922596; SUTER B, 1989, GENE DEV, V3, P1957, DOI 10.1101/gad.3.12a.1957; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Tearle R., 1987, DROSOPHILA INFORMATI, V66, P209; WHARTON RP, 1989, CELL, V59, P881, DOI 10.1016/0092-8674(89)90611-9; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315	41	483	488	1	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 12	1991	66	1					23	34		10.1016/0092-8674(91)90136-M	http://dx.doi.org/10.1016/0092-8674(91)90136-M			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FW913	2070416				2022-12-28	WOS:A1991FW91300006
J	BRADLEY, JD; BRANDT, KD; KATZ, BP; KALASINSKI, LA; RYAN, SI				BRADLEY, JD; BRANDT, KD; KATZ, BP; KALASINSKI, LA; RYAN, SI			COMPARISON OF AN ANTIINFLAMMATORY DOSE OF IBUPROFEN, AN ANALGESIC DOSE OF IBUPROFEN, AND ACETAMINOPHEN IN THE TREATMENT OF PATIENTS WITH OSTEOARTHRITIS OF THE KNEE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FENOPROFEN CALCIUM; ARTHRITIS; DRUGS; PAIN; DISEASE; SODIUM	Background. The optimal short-term, symptomatic therapy for osteoarthritis of the knee has not been fully determined. Accordingly, we compared the efficacy of a nonsteroidal antiinflammatory drug, ibuprofen, given in either an antiinflammatory dose (high dose) or an analgesic dose (low dose), with that of acetaminophen, a pure analgesic. Methods. In a randomized, double-blind trial, 184 patients with chronic knee pain due to osteoarthritis were given either 2400 or 1200 mg of ibuprofen per day or 4000 mg of acetaminophen per day. They were evaluated after a washout period of three to seven days before the beginning of the study, and again after four weeks of treatment. The major measures of outcome included scores on the pain and disability scales of the Stanford Health Assessment Questionnaire (range of possible scores, 0 to 3), scores on the visual-analogue scales for pain at rest and pain while walking, the time needed to walk 50 ft (15 m), and the physician's global assessment of the patient's arthritis. Results. Seventy-eight percent of the patients completed four weeks of therapy. No significant differences were noted among the three treatment groups with respect to failure to complete the trial because of noncompliance or adverse events. All three groups had improvement in all major outcome variables, and the groups did not differ significantly in the magnitude of improvement in most variables. The mean improvement (change) in the scores on the pain scale of the Health Assessment Questionnaire was 0.33 with acetaminophen (95 percent confidence interval, 0.14 to 0.52), 0.30 with the low dose of ibuprofen (95 percent confidence interval, 0.09 to 0.51), and 0.35 with the high dose of ibuprofen (95 percent confidence interval, 0.13 to 0.57). Side effects were minor and similar in all three groups. Conclusions. In short-term, symptomatic treatment of osteoarthritis of the knee, the efficacy of acetaminophen was similar to that of ibuprofen, whether the latter was administered in an analgesic or an antiinflammatory dose.	INDIANA UNIV,SCH MED,DIV RHEUMATOL,541 CLIN DR,RM 492,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,REGENSTRIEF HLTH CTR,DEPT MED,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc			Bannuru, Raveendhara/G-2601-2011	Bannuru, Raveendhara/0000-0002-8069-5783	NIAMS NIH HHS [AR-39250] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR039250] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALTMAN RD, 1983, CLIN RHEUM DIS, V9, P681; AMADIO P, 1983, CURR THER RES CLIN E, V34, P59; AMADIO P, 1984, AM J MED, V77, P17, DOI 10.1016/S0002-9343(84)80099-6; ANDERSON JJ, 1989, ARTHRITIS RHEUM, V32, P844; BAUM C, 1985, ARTHRITIS RHEUM, V28, P686, DOI 10.1002/art.1780280613; BOLLET AJ, 1981, SEMIN ARTHRITIS RHEU, V11, P130, DOI 10.1016/0049-0172(81)90074-3; BRESNIHAN B, 1978, CURR MED RES OPIN, V5, P556, DOI 10.1185/03007997809109001; BULLOUGH P, 1981, SEMIN ARTHRITIS RHEU, V11, P146, DOI 10.1016/0049-0172(81)90083-4; CALIN A, 1984, AM J MED, V77, P9, DOI 10.1016/S0002-9343(84)80098-4; CIMMINO MA, 1982, J INT MED RES, V10, P46, DOI 10.1177/030006058201000110; CLIVE DM, 1984, NEW ENGL J MED, V310, P563, DOI 10.1056/NEJM198403013100905; COLES LS, 1983, AM J MED, V74, P820, DOI 10.1016/0002-9343(83)91073-2; CRAIN DC, 1961, JAMA-J AM MED ASSOC, V175, P1049, DOI 10.1001/jama.1961.03040120011003; de Blecourt J. J., 1975, CURR MED RES OPIN, V3, P477; DIEPPE P, 1990, British Journal of Rheumatology, V29, P129; DOYLE DV, 1984, CLIN RHEUM DIS, V10, P277; DOYLE DV, 1981, ANN RHEUM DIS, V40, P75, DOI 10.1136/ard.40.1.75; FRIES JF, 1982, J RHEUMATOL, V9, P789; GALL EP, 1982, J RHEUMATOL, V9, P402; GORDON GV, 1984, J RHEUMATOL, V11, P681; GRIFFIN MR, 1991, ANN INTERN MED, V114, P257, DOI 10.7326/0003-4819-114-4-257; HOWELL D S, 1976, Seminars in Arthritis and Rheumatism, V5, P365, DOI 10.1016/0049-0172(76)90015-9; HUSKISSON EC, 1971, PRACTITIONER, V207, P639; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; LANZA FL, 1984, AM J MED, V77, P19, DOI 10.1016/S0002-9343(84)80014-5; LAWRENCE JS, 1966, ANN RHEUM DIS, V25, P1; Lemperg RK, 1978, CLIN ORTHOP RELAT R, V136, P143; LEVINSON DJ, 1983, CURR THER RES CLIN E, V34, P280; MILLER MR, 1963, ANAT REC, V145, P13, DOI 10.1002/ar.1091450104; MOXLEY TE, 1975, J AM GERIATR SOC, V23, P343, DOI 10.1111/j.1532-5415.1975.tb00324.x; MYERS SL, 1990, J RHEUMATOL, V17, P1662; PARR G, 1989, BRIT J CLIN PHARMACO, V27, P235, DOI 10.1111/j.1365-2125.1989.tb05356.x; SANDLER DP, 1989, NEW ENGL J MED, V320, P1238, DOI 10.1056/NEJM198905113201903; SOLL AH, 1991, ANN INTERN MED, V114, P307, DOI 10.7326/0003-4819-114-4-307; STAMP J, 1989, BRIT J CLIN PRACT, V43, P24; TYSON VCH, 1980, J RHEUMATOL S, V6, P132; 1966, VITAL HLTH STATIS 11, V15; [No title captured]	38	463	472	0	23	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 11	1991	325	2					87	91		10.1056/NEJM199107113250203	http://dx.doi.org/10.1056/NEJM199107113250203			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV522	2052056	Bronze			2022-12-28	WOS:A1991FV52200003
J	GREENBERG, AE; NSA, W; RYDER, RW; MEDI, M; NZEZA, M; KITADI, N; BAANGI, M; MALANDA, N; DAVACHI, F; HASSIG, SE				GREENBERG, AE; NSA, W; RYDER, RW; MEDI, M; NZEZA, M; KITADI, N; BAANGI, M; MALANDA, N; DAVACHI, F; HASSIG, SE			PLASMODIUM-FALCIPARUM MALARIA AND PERINATALLY ACQUIRED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN KINSHASA, ZAIRE - A PROSPECTIVE, LONGITUDINAL COHORT STUDY OF 587 CHILDREN	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIV SEROPOSITIVITY; ASSOCIATION; DISEASES; INFANTS; QUININE; AIDS	Background. It is uncertain whether Plasmodium falciparum malaria is more frequent or more severe in children with perinatally acquired human immunodeficiency virus type 1 (HIV-1) infection and whether P. falciparum infection accelerates the progression of HIV-related disease. Methods. We conducted a prospective, longitudinal cohort study in Kinshasa, Zaire. Two hundred sixty children 5 to 9 months of age who had been born to HIV-1-seropositive mothers and 327 children of the same age who had been born to seronegative mothers were monitored intensively for malaria over a 13-month period. All episodes of fever were evaluated with blood smears for malaria, and children found to be infected with P. falciparum were treated with a standard regimen of oral quinine. Results. A total of 2899 fevers were evaluated, with 271 cases of malaria identified. No statistically significant differences were found in the incidence, severity, or response to therapy of malaria among four well-defined groups of children: those with the acquired immunodeficiency syndrome (AIDS), those who were HIV-1-seropositive throughout the study, those who were born to HIV-1-seropositive mothers but reverted to seronegative, and those who were seronegative throughout the study. During the 13-month period the incidence of malaria in the 36 children with HIV infection in whom AIDS developed was lower, although not significantly so, than in the 37 in whom AIDS did not develop. Conclusions. In this study malaria was not more frequent or more severe in children with progressive HIV-1 infection and malaria did not appear to accelerate the rate of progression of HIV-1 disease.	PROJET SIDA, KINSHASA, DEM REP CONGO; CTR DIS CONTROL, CTR INFECT DIS, DIV PARASIT DIS, MALARIA BRANCH, ATLANTA, GA 30333 USA; MAMA YEMO HOSP, DEPT PEDIAT, KINSHASA, DEM REP CONGO	Centers for Disease Control & Prevention - USA	GREENBERG, AE (corresponding author), CTR DIS CONTROL, CTR INFECT DIS, DIV HIV AIDS, MAILSTOP E-45, ATLANTA, GA 30333 USA.							BADI N, 1989, 5TH INT C AIDS MONTR; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; COLEBUNDERS R, 1990, J INFECTION, V21, P167, DOI 10.1016/0163-4453(90)91701-E; COLEBUNDERS RI, 1987, AIDS, V1, P151; FEORINO PM, 1984, SCIENCE, V225, P69, DOI 10.1126/science.6328663; GOODGAME RW, 1990, NEW ENGL J MED, V323, P383, DOI 10.1056/NEJM199008093230605; GREENBERG AE, 1988, JAMA-J AM MED ASSOC, V259, P545, DOI 10.1001/jama.259.4.545; GREENBERG AE, 1989, B WORLD HEALTH ORGAN, V67, P189; GREENBERG AE, 1989, AM J TROP MED HYG, V40, P360, DOI 10.4269/ajtmh.1989.40.360; HO M, 1989, PARASITE IMMUNOL, V11, P105, DOI 10.1111/j.1365-3024.1989.tb00652.x; MARGOLICK JB, 1987, J IMMUNOL, V138, P1719; MCGREGOR IA, 1971, T ROY SOC TROP MED H, V65, P136, DOI 10.1016/0035-9203(71)90211-2; MERTENS TE, 1990, AIDS, V4, P57, DOI 10.1097/00002030-199001000-00008; MORROW RH, 1989, AIDS, V3, pS79, DOI 10.1097/00002030-198901001-00012; NGIMBI NP, 1982, ANN SOC BELG MED TR, V62, P121; NGUYENDINH P, 1981, B WORLD HEALTH ORGAN, V59, P641; NGUYENDINH P, 1987, AM J TROP MED HYG, V37, P217, DOI 10.4269/ajtmh.1987.37.217; NGUYENDINH P, 1987, B WORLD HEALTH ORGAN, V65, P607; NGUYENDINH P, 1987, 36TH ANN M AM SOC TR; NGUYENDINH P, 1987, 3RD INT C AIDS WASH; NSA W, 1989, 5TH P INT C AIDS MON; NSA W, 1988, 4TH INT C AIDS STOCK; ROGERS MF, 1989, NEW ENGL J MED, V320, P1649, DOI 10.1056/NEJM198906223202503; RYDER RW, 1989, NEW ENGL J MED, V320, P1637, DOI 10.1056/NEJM198906223202501; SHAFFER N, 1990, AIDS, V4, P1231, DOI 10.1097/00002030-199012000-00008; SIMOOYA OO, 1988, BRIT MED J, V297, P30, DOI 10.1136/bmj.297.6640.30; SMITH PG, 1988, INT J EPIDEMIOL, V17, P705, DOI 10.1093/ije/17.4.705; SULZER A, 1986, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V24, P159; TROYEBLOMBERG M, 1988, PROG ALLERGY, V41, P253; World health organization malaria action program, 1986, T R SOC TROP MED H S, V80, P3; 1987, MMWR S1S, V36, pS1; 1986, T R SOC TROP MED HYG, V80, P571; 1986, WEEKLY EPIDEMIOLOGIC, V61, P69	33	93	95	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 11	1991	325	2					105	109		10.1056/NEJM199107113250206	http://dx.doi.org/10.1056/NEJM199107113250206			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV522	2052043	Bronze			2022-12-28	WOS:A1991FV52200006
J	ESKENAZI, B; FENSTER, L; SIDNEY, S				ESKENAZI, B; FENSTER, L; SIDNEY, S			A MULTIVARIATE-ANALYSIS OF RISK-FACTORS FOR PREECLAMPSIA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREGNANCY-INDUCED HYPERTENSION; 6TH PERIODIC REPORT; LOW-DOSE ASPIRIN; REMOTE PROGNOSIS; PRE-ECLAMPSIA; GESTATIONAL HYPERTENSION; WOMEN; DISEASES; MANAGEMENT; DIAGNOSIS	Objective.- To determine, in a multivariate analysis, risk factors for preeclampsia that could be observed early in pregnancy and to establish whether these risk factors are different for nulliparas and multiparas. Design.- A case-control study of preeclampsia. Setting.- Women who gave birth at Northern California Kaiser Permanente Medical Centers in 1984 and 1985. Participants.- Preeclamptic cases (n = 139) were determined from discharge diagnosis of severe preeclampsia and by confirmation of blood pressures and proteinuria from medical records. Controls (n = 132) were randomly selected women who had no discharge diagnosis of any hypertensive disorder of pregnancy and who had no evidence of hypertension or proteinuria from medical record review. Main Variables Examined.- Medical records were abstracted for information regarding maternal age, race, previous pregnancy history, family medical history, socioeconomic status, employment during pregnancy, body mass, and smoking and alcohol consumption. Results.- Multiple logistic regression analyses confirmed that case patients were more likely than control patients to be nulliparous (adjusted odds ratio [OR], 5.4; 95% confidence interval [Cl], 2.8 to 10.3) and that preeclampsia in a previous pregnancy greatly increased the risk in a subsequent one (adjusted OR, 10.8; 95% Cl, 1.2 to 29.1). However, regardless of parity, preeclamptic women were also more likely to be of high body mass (adjusted OR, 2.7; 95% Cl, 1.2 to 6.2), to work during pregnancy (adjusted OR, 2.1; 95% Cl, 1.1 to 4.4), and to have a family history of hypertension (adjusted OR, 1.7; 95% Cl, 0.92 to 3.2). Having a previous history of a spontaneous abortion was protective but only in multiparous women (adjusted OR for multiparas, 0.09; 95% Cl, 0.02 to 0.48). In contrast, being black was a significant risk for preeclampsia but only in nulliparous women (adjusted OR for nulliparas, 12.3; 95% Cl, 1.6 to 100.8). Conclusions.- There are a number of risk factors for preeclampsia that may be determined early in a woman's pregnancy Multiparas and nulliparas share certain risk factors but not others. A cohort investigation is needed to determine the ability of these risk factors to predict who develops preeclampsia.	UNIV CALIF BERKELEY,SCH PUBL HLTH,NO CALIF OCCUPAT HLTH CTR,BERKELEY,CA 94720; KAISER PERMANENTE MED CTR,DIV RES,OAKLAND,CA; UNIV CALIF BERKELEY,SCH PUBL HLTH,PROGRAM EPIDEMIOL,BERKELEY,CA 94720; CALIF DEPT HLTH SERV,REPROD ENDOCRINOL PROGRAM,BERKELEY,CA 94704	University of California System; University of California Berkeley; Kaiser Permanente; University of California System; University of California Berkeley; California Department of Health Care Services	ESKENAZI, B (corresponding author), UNIV CALIF BERKELEY,SCH PUBL HLTH,PROGRAM MATERNAL & CHILD HLTH,312 EARL WARREN HALL,BERKELEY,CA 94720, USA.							BAIRD D, 1949, LANCET, V1, P1070; BARRON SL, 1968, P ROY SOC MED, V61, P120; BEAUFILS M, 1985, LANCET, V1, P840, DOI 10.1016/S0140-6736(85)92207-X; BENIGNI A, 1989, NEW ENGL J MED, V321, P357, DOI 10.1056/NEJM198908103210604; CHESLEY LC, 1976, AM J OBSTET GYNECOL, V124, P446, DOI 10.1016/0002-9378(76)90168-X; CHESLEY LC, 1984, CLIN OBSTET GYNECOL, V27, P801, DOI 10.1097/00003081-198412000-00004; Chiang CL, 1980, INTRO STOCHASTIC PRO; DAVIES AM, 1970, ISRAEL J MED SCI, V6, P253; DENMAN T, 1821, INTRO PRACTICE MIDWI; DUFFUS GM, 1968, LANCET, V1, P994; ESKENAZI B, 1988, AM J IND MED, V14, P177, DOI 10.1002/ajim.4700140208; FITZGIBBON G, 1922, J OBSTET GYN BR COMM, V29, P402; FRIEDMAN GD, 1982, HYPERTENSION, V4, P143; GLEICHER N, 1986, AM J OBSTET GYNECOL, V154, P1044, DOI 10.1016/0002-9378(86)90747-7; Goldhaber M K, 1991, Epidemiology, V2, P33; HERTZPICCIOTTO I, 1990, EPIDEMIOL REV, V12, P108, DOI 10.1093/oxfordjournals.epirev.a036049; HIATT RA, 1982, KIDNEY INT, V22, P63, DOI 10.1038/ki.1982.133; Klatsky A L, 1978, Compr Ther, V4, P60; KLEBANOFF MA, 1990, NEW ENGL J MED, V323, P1040, DOI 10.1056/NEJM199010113231506; KRIEGER N, 1991, J EPIDEMIOL COMMUN H, V45, P35, DOI 10.1136/jech.45.1.35; LEHMANN K, 1983, EKLAMPSIEN DANMARK A; MACGILLIVRAY I, 1961, J OBSTET GYN BR COMM, V68, P557; MARCOUX S, 1989, AM J EPIDEMIOL, V130, P950, DOI 10.1093/oxfordjournals.aje.a115427; MARCOUX S, 1989, J EPIDEMIOL COMMUN H, V43, P147, DOI 10.1136/jech.43.2.147; NELSON TR, 1955, J OBSTET GYNAECOL, V62, P48; Niswander K.R., 1972, COLLABORATIVE PERINA; PALMGREN B, 1973, ACTA OBSTET GYN SCAN, V52, P183, DOI 10.3109/00016347309158310; Roberts JM, 1984, MATERNAL FETAL MED P, P703; SCHIFF E, 1989, NEW ENGL J MED, V321, P351, DOI 10.1056/NEJM198908103210603; SIBAI BM, 1988, AM J OBSTET GYNECOL, V159, P1; SIBAI BM, 1986, AM J OBSTET GYNECOL, V155, P1011, DOI 10.1016/0002-9378(86)90336-4; WALLENBURG HCS, 1986, LANCET, V1, P1; 1980, 1980 CENSUS POPULATI; 1987, WHO TECHNICAL REPORT, V758; 1985, SAS USERS GUIDE VERS	35	362	366	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1991	266	2					237	241						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU896	2056625				2022-12-28	WOS:A1991FU89600032
J	WILBER, JF				WILBER, JF			NEUROPEPTIDES, APPETITE REGULATION, AND HUMAN OBESITY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-WEIGHT; ENERGY-EXPENDITURE; INSULIN; TWINS		NICHHD, ENDOCRINOL & REPROD RES BRANCH, BETHESDA, MD 20892 USA; UNIV MARYLAND, SCH MED, DEPT MED, DIV ENDOCRINOL & METAB, BALTIMORE, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Maryland; University of Maryland Baltimore					NIDDK NIH HHS [DK37378] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037378] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERNSTEIN IL, 1975, P SOC EXP BIOL MED, V150, P546, DOI 10.3181/00379727-150-39075; Bierman E.L, 1981, TXB ENDOCRINOLOGY, P907; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; BRAY GA, 1975, MEDICINE, V54, P301, DOI 10.1097/00005792-197507000-00002; FOREYT JP, 1984, PROG BEHAV MODIFIC, V16, P231; FOSTER WR, 1985, ANN INTERN MED, V103, P981; KEESEY RE, 1988, POSTGRAD MED, V83, P114, DOI 10.1080/00325481.1988.11700259; PORTE D, 1981, DIABETOLOGIA, V20, P274, DOI 10.1007/BF00254493; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; ROBERTS SB, 1988, NEW ENGL J MED, V318, P461, DOI 10.1056/NEJM198802253180801; STUART RB, 1976, DHEW HIH76852 PUBL, V2, P367; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; SULLIVAN AC, 1978, INT J OBESITY, V2, P167; WILBER JF, 1983, T ASSOC AM PHYSICIAN, V96, P131; WILBER JF, 1989, ENDOCRINOLOGY, P2769	16	14	14	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 10	1991	266	2					257	259		10.1001/jama.266.2.257	http://dx.doi.org/10.1001/jama.266.2.257			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU896	2056628				2022-12-28	WOS:A1991FU89600036
J	YUSUF, S; WITTES, J; PROBSTFIELD, J; TYROLER, HA				YUSUF, S; WITTES, J; PROBSTFIELD, J; TYROLER, HA			ANALYSIS AND INTERPRETATION OF TREATMENT EFFECTS IN SUBGROUPS OF PATIENTS IN RANDOMIZED CLINICAL-TRIALS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEART-DISEASE; MORTALITY; PREVENTION; OVERVIEWS	A key principle for interpretation of subgroup results is that quantitative interactions (differences in degree) are much more likely than qualitative interactions (differences in kind). Quantitative interactions are likely to be truly present whether or not they are apparent, whereas apparent qualitative interactions should generally be disbelieved as they have usually not been replicated consistently. Therefore, the overall trial result is usually a better guide to the direction of effect in subgroups than the apparent effect observed within a subgroup. Failure to specify prior hypotheses, to account for multiple comparisons, or to correct P values increases the chance of finding spurious subgroup effects. Conversely, inadequate sample size, classification of patients into the wrong subgroup, and low power of tests of interaction make finding true subgroup effects difficult. We recommend examining the architecture of the entire set of subgroups within a trial, analyzing similar subgroups across independent trials, and interpreting the evidence in the context of known biologic mechanisms and patient prognosis.	NEW ENGLAND RES INST INC, WASHINGTON, DC USA; UNIV N CAROLINA, SCH PUBL HLTH, DEPT EPIDEMIOL, CHAPEL HILL, NC 27514 USA	HealthCore, Inc; University of North Carolina; University of North Carolina Chapel Hill	YUSUF, S (corresponding author), NHLBI, DIV EPIDEMIOL & CLIN APPLICAT, CLIN TRIALS BRANCH, BETHESDA, MD 20892 USA.			Yusuf, Salim/0000-0003-4776-5601				ANDERSEN MP, 1979, LANCET, V2, P865; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; [Anonymous], 1986, LANCET, V2, P57; [Anonymous], 1990, Am J Cardiol, V66, P315; BARBER JM, 1976, ACTA MED SCAND, P213; Bernard C., 1957, INTRO LIT CORRES TON; BULPITT CJ, 1988, LANCET, V2, P31; CANNER PL, 1980, NEW ENGL J MED, V303, P1038; COLLINS R, 1987, STAT MED, V6, P245, DOI 10.1002/sim.4780060308; CURB JD, 1983, JAMA-J AM MED ASSOC, V250, P2814; DAVIS CE, 1990, CONTROL CLIN TRIALS, V11, P37, DOI 10.1016/0197-2456(90)90030-6; FURBERG CD, 1984, CIRCULATION, V69, P761, DOI 10.1161/01.CIR.69.4.761; HJALMARSON A, 1981, LANCET, V2, P823; HJALMARSON A, 1985, EUR HEART J, V6, P199; KNOKE JD, 1985, CONTROL CLIN TRIALS, V6, P136, DOI 10.1016/0197-2456(85)90119-9; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lan KKG, 1982, COMMUN STATIST C, V1, P207, DOI DOI 10.1080/07474948208836014; LEIZOROVICZ A, 1988, EUR HEART J, V9, P8; MILLER RG, 1985, SIMULTANEOUS STATIST; Nelder J. A., 1971, J R STAT SOC B, V33, P244; SIMON R, 1982, BRIT J CLIN PHARMACO, V14, P473, DOI 10.1111/j.1365-2125.1982.tb02015.x; SIMON R, 1985, CANCER TREAT REP, V69, P1; TAYLOR SH, 1982, NEW ENGL J MED, V307, P1293, DOI 10.1056/NEJM198211183072101; WILCOX RG, 1988, LANCET, V2, P525; WILHELMSSON C, 1974, LANCET, V2, P1157; WITTES J, 1989, STAT MED, V8, P415, DOI 10.1002/sim.4780080405; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2088, DOI 10.1001/jama.260.14.2088; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; YUSUF S, 1990, STAT MED, V9, P73, DOI 10.1002/sim.4780090114; YUSUF S, 1990, CIRCULATION, V82, P117; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2259, DOI 10.1001/jama.260.15.2259; 1972, JAMA-J AM MED ASSOC, V219, P990; 1977, BMJ, V2, P419; 1985, LANCET, V1, P545; 1989, J CLIN EPIDEMIOL, V41, P1197	37	695	696	2	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 3	1991	266	1					93	98		10.1001/jama.266.1.93	http://dx.doi.org/10.1001/jama.266.1.93			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT934	2046134				2022-12-28	WOS:A1991FT93400034
J	THIER, SO				THIER, SO			HEALTH-CARE REFORM - WHO WILL LEAD	ANNALS OF INTERNAL MEDICINE			English	Article						HEALTH CARE REFORM; HEALTH SERVICES ACCESSIBILITY; COST CONTROL; COST ALLOCATION; HEALTH RESOURCES		The United States is almost alone among industrialized nations in failing to assure access to at least some health care for all of its citizens. Three major obstacles impede the provision of universal access. First is the deeply embedded sense among our citizens and in our health care system that some persons are more deserving than others of care. Second is a focus on costs and reimbursement mechanisms rather than on defining effective and appropriate care. Third and most serious is an absence of leadership in addressing the problems of access and of reform in the U. S. health care system. In choosing among the possible leaders, which include the federal government, the states, the business sector, unions, and physicians, a compelling argument can be made that physicians should lead, particularly in defining effective and appropriate care. Physicians may also lead in redesigning the health care system, but they are likely to be only one interested voice in the debates about financing health care.			THIER, SO (corresponding author), INST MED, 2101 CONSTITUT AVE NW, WASHINGTON, DC 20418 USA.							BRANDEIS LD, 1986, FAMILIAR MED QUOTATI; MARMOR TR, 1973, POLITICS MED; Rosenberg Charles E., 1987, CARE STRANGERS RISE; Stevens Rosemary, 1989, SICKNESS WEALTH AM H; Tuchman B., 1984, MARCH FOLLY TROY VIE	5	8	8	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1991	115	1					54	58		10.7326/0003-4819-115-1-54	http://dx.doi.org/10.7326/0003-4819-115-1-54			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT937	2048861				2022-12-28	WOS:A1991FT93700010
J	LEACOX, C; HALL, A				LEACOX, C; HALL, A			ATTENDANCE OF GENERAL-PRACTITIONERS AT CHILD PROTECTION CASE CONFERENCES	BRITISH MEDICAL JOURNAL			English	Article								Objective - To investigate general practitioners' attendance at and views on child protection conferences and their confidence in dealing with sexual abuse in children. Design - Anonymous postal questionnaire sent to all general practitioners in Tower Hamlets and review of consecutive case conferences held by social services for three months in 1989. Setting - Tower Hamlets health district. Subjects - 91 general practitioners, 56 of whom (62%) responded. Main outcome measures - Number of conferences attended, reasons for non-attendance, and reported confidence in dealing with sexual abuse. Results - General practitioners estimated that 202 child protection conferences had been held in 1989 on their patients and that they had attended 85 of these. Information from social services for three months suggested that general practitioners had attended only nine of the 114 conferences reviewed. Timing of the conference was the most important reason for non-attendance. All respondents wanted access to the minutes of these conferences irrespective of their own attendance. Most general practitioners were very or moderately confident of their ability to detect child sexual abuse and nonaccidental injury and to communicate with the family. Conclusion - More effort should be made to ensure that general practitioners are notified of case conferences and that the timing and location of conferences is compatible with their other commitments.	EMANUEL MILLER CTR CHILDREN & FAMILIES,LONDON E14 8HG,ENGLAND		LEACOX, C (corresponding author), CHRISP ST HLTH CTR,LONDON E14 6PG,ENGLAND.							BUTLERSLOSS E, 1988, CM412; Hall A, 1988, Health Trends, V20, P39; HALL A, 1989, HOSPITAL DOCTOR, V22, P28; Meadow R., 1989, ABC CHILD ABUSE; 1988, WORKING TOGETHER GUI; 1988, 1 DEP COMM MED PUBL; 1989, 2 DEP COMM MED PUBL	7	4	4	2	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 8	1991	302	6789					1378	1379		10.1136/bmj.302.6789.1378	http://dx.doi.org/10.1136/bmj.302.6789.1378			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR057	2059719	Green Published, Bronze			2022-12-28	WOS:A1991FR05700023
J	MALIN, AS; WATERS, MFR; SHEHADE, SA; ROBERTS, MM				MALIN, AS; WATERS, MFR; SHEHADE, SA; ROBERTS, MM			LESSON OF THE WEEK - LEPROSY IN REACTION - A MEDICAL EMERGENCY	BMJ-BRITISH MEDICAL JOURNAL			English	Article									UNIV MANCHESTER, HOSP SKIN, SCH MED, SALFORD M60 9EP, ENGLAND	University of Manchester	MALIN, AS (corresponding author), HOSP TROP DIS, LONDON NW1 0PE, ENGLAND.							BULLOCK WE, 1981, IMMUNOLOGY HUMAN I 1, P369; IYER CGS, 1971, B WORLD HEALTH ORGAN, V45, P719; MCDOUGALL AC, 1977, BRIT MED J, V1, P23, DOI 10.1136/bmj.1.6052.23-a; MYERS B, 1987, PRACTITIONER, V231, P637; Parikh D A, 1986, Indian J Lepr, V58, P560; Pearson J M, 1975, Lepr Rev, V46, P199; PEARSON JMH, 1981, LEPROSY REV, V52, P293; POWELL S, 1974, BMJ-BRIT MED J, V1, P612, DOI 10.1136/bmj.1.5908.612; RIDLEY D S, 1969, Leprosy Review, V40, P77; Waters M F, 1967, Int J Lepr Other Mycobact Dis, V35, P311; WATERS M F R, 1971, International Journal of Leprosy and Other Mycobacterial Diseases, V39, P417; WATERS MFR, 1987, OXFORD TXB MED, V5, P305	12	13	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	1991	302	6788					1324	1326		10.1136/bmj.302.6788.1324	http://dx.doi.org/10.1136/bmj.302.6788.1324			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ444	2059690	Green Published, Bronze			2022-12-28	WOS:A1991FQ44400025
J	WILKES, HC; MEADE, TW				WILKES, HC; MEADE, TW			HORMONE REPLACEMENT THERAPY IN GENERAL-PRACTICE - A SURVEY OF DOCTORS IN THE MRCS GENERAL-PRACTICE RESEARCH FRAMEWORK	BRITISH MEDICAL JOURNAL			English	Article								Objectives - To survey current prescribing practice for hormone replacement therapy among general practitioners and to elicit their views on the role of hormone replacement therapy in the prevention of osteoporosis and cardiovascular disease; to determine whether they would participate in randomized controlled trials to evaluate the long term beneficial and adverse effects of hormone replacement therapy. Design - Postal questionnaires to general practitioners throughout the United Kingdom. Participants - 1268 general practitioners in the Medical Research Council's general practice research framework. Results - 1081 (85%) doctors in 220 (95%) practices responded. The doctors were currently prescribing hormone replacement therapy to an estimated 9% of their female patients aged 40 to 64, and 55% of doctors were prescribing opposed hormone replacement therapy (oestrogen plus progestogen) to more patients than a year previously. Over half the doctors would consider prescribing hormone replacement therapy for prevention of osteoporosis (670, 62%) and cardiovascular disease (611, 57%) to asymptomatic women. Overall, 79% of the doctors (851) would definitely or probably consider entering women who have had a hysterectomy into a randomized controlled trial comparing unopposed (oestrogen only) hormone replacement therapy with opposed hormone replacement therapy; 49% (524) would enter patients with a uterus into such a trial. Among a subsample, 85% (180/210) would consider entering patients without menopausal symptoms into a trial comparing hormone replacement therapy with no treatment (unopposed in patients who have had a hysterectomy, opposed in those with a uterus). Conclusion - There is considerable uncertainty among general practitioners as to the balance of beneficial and harmful effects of hormone replacement therapy in the long term, particularly relating to its use for prevention of osteoporosis and cardiovascular disease. Most of these doctors would be prepared to participate in randomized controlled trials to determine the long term effects of this increasingly widely used treatment.			WILKES, HC (corresponding author), NORTHWICK PK HOSP & CLIN RES CTR,MRC,EPIDEMIOL & MED CARE UNIT,HARROW HA1 3UJ,MIDDX,ENGLAND.							DRAPER J, 1990, BRIT MED J, V300, P786, DOI 10.1136/bmj.300.6727.786; MONTGOMERY JC, 1990, HRT AND OSTEOPOROSIS, P197; PERSSON I, 1990, HRT AND OSTEOPOROSIS, P165; ROSS RK, 1984, LANCET, V2, P505; SMITH DC, 1975, NEW ENGL J MED, V293, P1164, DOI 10.1056/NEJM197512042932302; VANDENBROUCKE JP, 1991, LANCET, P833	6	90	90	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1991	302	6788					1317	1320		10.1136/bmj.302.6788.1317	http://dx.doi.org/10.1136/bmj.302.6788.1317			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ444	2059689	Bronze, Green Published			2022-12-28	WOS:A1991FQ44400022
J	GANGAR, KF; FRASER, D; WHITEHEAD, MI; CUST, MP				GANGAR, KF; FRASER, D; WHITEHEAD, MI; CUST, MP			PROLONGED ENDOMETRIAL STIMULATION ASSOCIATED WITH ESTRADIOL IMPLANTS	BRITISH MEDICAL JOURNAL			English	Article									CHELSEA HOSP WOMEN,MENOPAUSE CLIN,LONDON SW3,ENGLAND	Imperial College London	GANGAR, KF (corresponding author), UNIV LONDON KINGS COLL HOSP,SCH MED & DENT,ACAD DEPT OBSTET & GYNAECOL,MENOPAUSE CLIN,LONDON SE5 8RX,ENGLAND.							GANGAR K, 1989, BRIT MED J, V299, P601, DOI 10.1136/bmj.299.6699.601-a; MAGOS AL, 1986, BRIT J OBSTET GYNAEC, V93, P1290, DOI 10.1111/j.1471-0528.1986.tb07868.x; PADWICK ML, 1985, AM J OBSTET GYNECOL, V152, P1085, DOI 10.1016/0002-9378(85)90567-8; PAGANINIHILL A, 1989, BRIT J CANCER, V59, P445, DOI 10.1038/bjc.1989.91; PATERSON MEL, 1980, BRIT MED J, V280, P822, DOI 10.1136/bmj.280.6217.822; PERSSON I, 1989, BRIT MED J, V298, P147, DOI 10.1136/bmj.298.6667.147; SAVVAS M, 1988, BRIT MED J, V297, P331, DOI 10.1136/bmj.297.6644.331; THOM MH, 1981, BRIT J OBSTET GYNAEC, V88, P426, DOI 10.1111/j.1471-0528.1981.tb01008.x; WHITEHEAD MI, 1985, AM J OBSTET GYNECOL, V152, P1079, DOI 10.1016/0002-9378(85)90566-6; 1989, DATA SHEET COMPENDIU, P1143; 1989, BRIT NATIONAL FORMUL, P254	11	17	17	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 17	1990	300	6722					436	438		10.1136/bmj.300.6722.436	http://dx.doi.org/10.1136/bmj.300.6722.436			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP166	2107895	Bronze, Green Published			2022-12-28	WOS:A1990CP16600020
J	OREILLY, SM; RICHARDS, MA				OREILLY, SM; RICHARDS, MA			NODE NEGATIVE BREAST-CANCER	BMJ-BRITISH MEDICAL JOURNAL			English	Review											OREILLY, SM (corresponding author), GUYS & ST THOMAS HOSP, IMPERIAL CANC RES FUND, CLIN ONCOL UNIT, LONDON SE1 9RT, ENGLAND.							BAUM M, 1988, BRIT J CANCER, V57, P608; BONADONNA G, 1985, BREAST CANCER RES TR, V5, P95, DOI 10.1007/BF01805984; BONADONNA G, 1987, ADJUVANT THERAPY CAN, V5, P211; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; CLARK GM, 1989, NEW ENGL J MED, V320, P627, DOI 10.1056/NEJM198903093201003; FISHER B, 1989, NEW ENGL J MED, V320, P473, DOI 10.1056/NEJM198902233200801; FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; FISHER B, 1988, J CLIN ONCOL, V6, P1076, DOI 10.1200/JCO.1988.6.7.1076; FORNANDER T, 1989, LANCET, V1, P117; GILCHRIST KW, 1985, BREAST CANCER RES TR, V5, P15, DOI 10.1007/BF01807644; GOLDHIRSCH A, 1989, NEW ENGL J MED, V320, P491; GOLDHIRSCH A, 1989, J CLIN ONCOL, V7, P36, DOI 10.1200/JCO.1989.7.1.36; JAKESZ R, 1987, ADJUVANT THERAPY CAN, V5, P223; MANSOUR EG, 1989, NEW ENGL J MED, V320, P485, DOI 10.1056/NEJM198902233200803; MASON BH, 1983, CANCER RES, V43, P2985; MAYNARD PV, 1978, BRIT J CANCER, V38, P745, DOI 10.1038/bjc.1978.282; MEYER JS, 1988, BREAST CANCER RES TR, V12, P191, DOI 10.1007/BF01805940; MEYER JS, 1986, LAB INVEST, V54, P41; MORRISON JM, 1987, ADJUVANT THERAPY CAN, V5, P311; NEMOTO T, 1980, CANCER, V45, P2917, DOI 10.1002/1097-0142(19800615)45:12<2917::AID-CNCR2820451203>3.0.CO;2-M; NISSENMEYER R, 1985, RECENT RES CANCER, V98, P91; OREILLY SM, 1989, BRIT J CANCER, V59, P825; RILEY D, 1988, BRIT J CANCER, V57, P604; SEMIGLAZOV VF, 1986, CANCER, V57, P1957, DOI 10.1002/1097-0142(19860515)57:10<1957::AID-CNCR2820571012>3.0.CO;2-A; SENN HJ, 1987, ADJUVANT THERAPY CAN, V5, P243; SILVESTRINI R, 1986, BREAST CANCER RES TR, V7, P161, DOI 10.1007/BF01806246; SINGH L, 1988, BRIT J CANCER, V57, P612, DOI 10.1038/bjc.1988.139; STEWART HJ, 1987, LANCET, V2, P171; VALAGUSSA P, 1978, CANCER, V41, P1170, DOI 10.1002/1097-0142(197803)41:3<1170::AID-CNCR2820410355>3.0.CO;2-I; 1988, BREAST CANCER RES TR, V12, P3	31	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	1990	300	6721					346	348		10.1136/bmj.300.6721.346	http://dx.doi.org/10.1136/bmj.300.6721.346			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106982	Bronze, Green Published			2022-12-28	WOS:A1990CN79900004
J	POLLOCK, AM; WHITTY, PM				POLLOCK, AM; WHITTY, PM			CRISIS IN OUR HOSPITAL KITCHENS - ANCILLARY STAFFING LEVELS DURING AN OUTBREAK OF FOOD POISONING IN A LONG STAY HOSPITAL	BRITISH MEDICAL JOURNAL			English	Article									TOWER HAMLETS HLTH AUTHOR,PUBL HLTH MED,LONDON EC1,ENGLAND		POLLOCK, AM (corresponding author), NEWHAM HLTH AUTHOR,PUBL HLTH MED,LONDON E13 0DZ,ENGLAND.			pollock, allyson/0000-0002-7388-3110				COYLE A, 1986, DIRTY BUSINESS WOMEN; DYSON R, 1989, BRIT MED J, V298, P654, DOI 10.1136/bmj.298.6674.654; NEWBIGGIN R, 1988, PRIVATE HLTH CARE RE; RISE C, 1987, CUTTING DOWN CARE EX; ROBINSON R, 1989, BRIT MED J, V298, P819, DOI 10.1136/bmj.298.6676.819; SALVAGE J, 1989, BRIT MED J, V298, P5, DOI 10.1136/bmj.298.6665.5; SMITH T, 1988, BRIT MED J, V296, P414, DOI 10.1136/bmj.296.6619.414; 1986, REPORT COMMITTEE INQ; 1989, CMND555	9	7	7	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 10	1990	300	6721					383	385		10.1136/bmj.300.6721.383	http://dx.doi.org/10.1136/bmj.300.6721.383			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN799	2106996	Bronze, Green Published			2022-12-28	WOS:A1990CN79900029
J	LARNER, AJ				LARNER, AJ			LIFE THREATENING THROMBOCYTOPENIA IN SARCOIDOSIS	BRITISH MEDICAL JOURNAL			English	Article											LARNER, AJ (corresponding author), HAMMERSMITH HOSP,DEPT MED,LONDON W12 0HS,ENGLAND.							DICKERMAN JD, 1972, J PEDIATR-US, V81, P758, DOI 10.1016/S0022-3476(72)80098-2; DOAN CA, 1960, ANN INTERN MED, V53, P861, DOI 10.7326/0003-4819-53-5-861; HENKE M, 1986, KLIN WOCHENSCHR, V64, P1209, DOI 10.1007/BF01728464; LAWRENCE HJ, 1985, AM J MED, V79, P761, DOI 10.1016/0002-9343(85)90528-5; MAYCOCK RL, 1963, AM J MED, V35, P67; Semple P, 1975, Br Med J, V4, P440; THOMAS LLM, 1982, SCAND J HAEMATOL, V28, P357	7	12	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 3	1990	300	6720					317	319		10.1136/bmj.300.6720.317	http://dx.doi.org/10.1136/bmj.300.6720.317			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM195	2106965	Bronze, Green Published			2022-12-28	WOS:A1990CM19500027
J	SMITH, SJ				SMITH, SJ			AIDS, HOUSING, AND HEALTH	BRITISH MEDICAL JOURNAL			English	Article											SMITH, SJ (corresponding author), GLASGOW UNIV,CTR HOUSING RES,GLASGOW G12 8RT,SCOTLAND.							[Anonymous], 1989, CM849; BELCHER JR, 1988, SOC WORK, V33, P398; CLAPHAM D, IN PRESS POLICY POLI; DRAKE M, 1989, HOUSING STUDIES, V4, P119; Forrest R., 1988, SELLING WELFARE STAT; FRONER G, 1989, J PSYCHOACTIVE DRUGS, V20, P197; JEFFREY V, 1988, ROOF             MAR, P38; JEFFREY V, 1988, VOLUNTARY HOUSING, V21, P32; MAY F, 1988, ROOF             MAR, P17; PARSONS L, 1987, PUBLIC HEALTH, V101, P435, DOI 10.1016/S0033-3506(87)80005-7; SHANKS NJ, 1988, J EPIDEMIOL COMMUN H, V42, P183, DOI 10.1136/jech.42.2.183; Smith C., 1988, LOCATION STIGMA CONT; Smith S. J., 1989, 27 GLASG U CTR HOUS; Sontag S, 1988, AIDS ITS METAPHORS; SPICKER P, 1989, SOCIAL HOUSING SOCIA; TRASKA MR, 1986, HOSPITALS, V60, P69; WELLER MPI, 1989, NATURE, V339, P249, DOI 10.1038/339249a0; WILLIAMS S, 1989, HLTH CARE SINGLE HOM; 1988, HOUSING HIV INFECTIO; 1989, HOUSING AIDS ISSUE; 1987, AIDS ISSUES HOUSING	21	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1990	300	6719					243	244		10.1136/bmj.300.6719.243	http://dx.doi.org/10.1136/bmj.300.6719.243			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL024	2106937	Bronze, Green Published			2022-12-28	WOS:A1990CL02400030
J	SESHADRI, T; CAMPISI, J				SESHADRI, T; CAMPISI, J			REPRESSION OF C-FOS TRANSCRIPTION AND AN ALTERED GENETIC PROGRAM IN SENESCENT HUMAN-FIBROBLASTS	SCIENCE			English	Article									BOSTON UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02118	Boston University					NIA NIH HHS [AG07114] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTERMAN RBM, 1984, MOL CELL BIOL, V4, P123, DOI 10.1128/MCB.4.1.123; ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0; BANTLE JA, 1976, ANAL BIOCHEM, V72, P413, DOI 10.1016/0003-2697(76)90549-2; BASERGA R, 1985, BIOL CELL REPRODUCTI; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; BROOKS KM, 1987, J CELL PHYSIOL, V133, P523, DOI 10.1002/jcp.1041330313; BURMER GC, 1982, J CELL BIOL, V94, P187, DOI 10.1083/jcb.94.1.187; CHANG ZF, 1988, J BIOL CHEM, V263, P11431; CHEN KY, 1986, J CELL PHYSIOL, V128, P27, DOI 10.1002/jcp.1041280106; CROY RG, 1983, P NATL ACAD SCI-BIOL, V80, P4699, DOI 10.1073/pnas.80.15.4699; DEAN M, 1986, J BIOL CHEM, V261, P9161; FISCH TM, 1989, MOL CELL BIOL, V9, P1327, DOI 10.1128/MCB.9.3.1327; GIORDANO A, IN PRESS EXP GERONTO; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HEIKKILA R, 1987, NATURE, V328, P448; HOLT JT, 1986, P NATL ACAD SCI USA, V83, P4794, DOI 10.1073/pnas.83.13.4794; KACZMAREK L, 1987, J CELL PHYSIOL, V132, P545, DOI 10.1002/jcp.1041320318; KAO HT, 1983, MOL CELL BIOL, V3, P2058, DOI 10.1128/MCB.3.11.2058; LEVINE RA, IN PRESS CELL REG; LIN AH, 1988, MOL CELL BIOL, V8, P5052, DOI 10.1128/MCB.8.11.5052; LU KH, 1989, MOL CELL BIOL, V9, P3411, DOI 10.1128/MCB.9.8.3411; LUMPKIN CK, 1986, SCIENCE, V232, P393, DOI 10.1126/science.2421407; LUMPKIN CK, 1986, MOL CELL BIOL, V6, P2990, DOI 10.1128/MCB.6.8.2990; MARTIN GM, 1974, AM J PATHOL, V74, P137; MARTIN GM, 1970, LAB INVEST, V23, P86; MCCAFFREY P, 1987, J BIOL CHEM, V262, P1442; MOHUN T, 1987, EMBO J, V6, P667, DOI 10.1002/j.1460-2075.1987.tb04806.x; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NISHIKURA K, 1987, MOL CELL BIOL, V7, P639, DOI 10.1128/MCB.7.2.639; NORWOOD TH, 1974, P NATL ACAD SCI USA, V71, P2231, DOI 10.1073/pnas.71.6.2231; OBRIEN TG, 1987, P NATL ACAD SCI USA, V84, P8927, DOI 10.1073/pnas.84.24.8927; PARDEE AB, 1978, ANNU REV BIOCHEM, V47, P715, DOI 10.1146/annurev.bi.47.070178.003435; PAULSSON Y, 1986, EMBO J, V5, P2157, DOI 10.1002/j.1460-2075.1986.tb04479.x; PEREIRASMITH OM, 1983, SCIENCE, V221, P964, DOI 10.1126/science.6879195; PEREIRASMITH OM, 1988, P NATL ACAD SCI USA, V85, P6042, DOI 10.1073/pnas.85.16.6042; PHILLIPS PD, 1987, J CELL PHYSIOL, V133, P135, DOI 10.1002/jcp.1041330117; PONTEN J, 1976, BIOCHIM BIOPHYS ACTA, V458, P397, DOI 10.1016/0304-419X(76)90009-3; RAYCHAUDHURY A, UNPUB; RIABOWOL KT, 1988, MOL CELL BIOL, V8, P1670, DOI 10.1128/MCB.8.4.1670; RICKLES R, 1982, P NATL ACAD SCI-BIOL, V79, P749, DOI 10.1073/pnas.79.3.749; RITTLING SR, 1986, P NATL ACAD SCI USA, V83, P3316, DOI 10.1073/pnas.83.10.3316; ROSSOW PW, 1979, P NATL ACAD SCI USA, V76, P4446, DOI 10.1073/pnas.76.9.4446; SAGER R, 1984, CANCER CELL, V2, P487; SCHER CD, 1979, BIOCHIM BIOPHYS ACTA, V560, P217, DOI 10.1016/0304-419X(79)90020-9; SCHNEIDER EL, 1976, P NATL ACAD SCI USA, V73, P3584, DOI 10.1073/pnas.73.10.3584; SESHADRI T, UNPUB; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; STACEY DW, 1984, NATURE, V310, P508, DOI 10.1038/310508a0; STEIN GS, 1984, HIST GENES STRUCTURE; THOMAS JO, 1975, P NATL ACAD SCI USA, V72, P2626, DOI 10.1073/pnas.72.7.2626; WANG E, 1985, J CELL BIOL, V100, P545, DOI 10.1083/jcb.100.2.545; WU RS, 1982, CELL, V31, P367, DOI 10.1016/0092-8674(82)90130-1; ZAMBETTI G, 1987, EXP CELL RES, V172, P397, DOI 10.1016/0014-4827(87)90397-1; ZULLO JN, 1988, MOL CELL BIOL, V8, P5080, DOI 10.1128/MCB.8.12.5080; [No title captured]	57	454	461	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 12	1990	247	4939					205	209		10.1126/science.2104680	http://dx.doi.org/10.1126/science.2104680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH520	2104680				2022-12-28	WOS:A1990CH52000034
